data_2l5t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l5t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -79.61 129.17 34.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.839 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 57.1 mp0 -105.87 118.77 37.45 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -95.86 122.28 38.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.218 0.532 . . . . 0.0 110.733 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.63 145.22 49.09 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.66 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 tt -68.73 113.4 15.7 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.045 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 N--CA 1.491 1.381 0 C-N-CA 121.59 1.527 . . . . 0.0 112.008 -179.322 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.482 ' OE2' ' CG2' ' A' ' 65' ' ' VAL . 30.8 tp10 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.92 110.45 0.72 Allowed Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -126.27 131.91 51.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 110.355 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -102.37 119.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.17 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 7.6 p -93.08 -43.81 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.426 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 83.2 mtp180 -139.57 145.07 38.15 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.808 0.337 . . . . 0.0 111.243 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -111.68 139.84 46.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.91 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 18.2 p-10 -101.36 -6.51 23.98 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.37 159.95 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.027 0.441 . . . . 0.0 111.4 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.33 149.99 49.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.7 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -59.55 138.63 57.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.257 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.64 8.87 76.16 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.604 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -121.98 149.84 42.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 117.431 0.616 . . . . 0.0 111.156 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.2 mtm -86.59 154.19 21.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.265 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.9 152.61 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.937 0.399 . . . . 0.0 110.515 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -117.44 157.23 26.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.012 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -67.55 65.6 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.962 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -176.11 73.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.531 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -147.1 122.09 10.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.409 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -128.14 39.45 3.84 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.454 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.8 mt -110.51 33.67 4.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.107 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.11 128.15 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -116.85 123.91 48.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.533 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.92 130.16 72.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.375 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.3 ttm -109.7 126.4 53.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.287 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -95.1 -77.28 0.47 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.054 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.424 ' N ' ' OG1' ' A' ' 40' ' ' THR . 62.1 t0 -95.99 -74.24 0.57 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.269 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -151.37 50.71 0.83 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.334 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.03 149.34 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.897 0.379 . . . . 0.0 110.75 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.8 m -107.97 118.82 37.75 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.957 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.96 133.79 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -95.51 135.5 37.08 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.426 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.4 mt -135.75 133.57 20.15 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.36 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.3 147.69 33.18 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.175 1.917 . . . . 0.0 111.162 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -96.98 107.89 40.28 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 111.371 0.137 . . . . 0.0 111.371 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -86.59 41.78 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.373 2.049 . . . . 0.0 111.358 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.39 156.2 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.716 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -154.33 149.07 26.51 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.276 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.29 -132.93 2.94 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.84 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -130.3 135.76 48.43 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -91.87 120.18 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.147 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.5 t -84.53 -50.07 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -164.16 157.06 17.61 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.898 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.0 tt -116.07 121.96 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.446 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.55 -16.88 18.97 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.21 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.543 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 17.8 m-85 -107.31 144.4 34.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.291 0.567 . . . . 0.0 111.58 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -123.83 161.48 25.21 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.86 137.02 57.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.45 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.41 4.99 85.5 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.492 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.52 ' OE1' ' CD2' ' A' ' 60' ' ' TYR . 55.3 tt0 -89.32 137.39 32.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.414 0.607 . . . . 0.0 110.563 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.482 ' CG2' ' OE2' ' A' ' 15' ' ' GLU . 3.4 p -124.42 131.21 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.375 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 t -148.3 140.86 14.89 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.249 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.19 148.17 32.69 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.501 1.467 . . . . 0.0 112.661 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.08 132.83 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.456 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.99 49.44 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.014 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.7 p -160.33 162.84 33.59 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.399 0.6 . . . . 0.0 111.355 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -96.37 120.99 37.68 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.2 mm? -82.45 -4.32 57.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.553 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.8 142.45 2.45 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.58 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -104.84 122.39 45.67 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.35 127.51 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.095 0.474 . . . . 0.0 111.081 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -88.0 141.32 28.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.087 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.493 179.825 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -82.84 130.12 35.09 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 51.0 mp0 -93.79 138.7 31.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.95 101.79 11.82 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 6' ' ' LEU . 68.6 mttm -108.28 105.19 14.77 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 5' ' ' LYS . 5.6 mt -29.23 93.84 0.06 OUTLIER Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 123.845 0.716 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' LYS . 92.0 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 C-N-CA 121.644 1.563 . . . . 0.0 112.127 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.65 109.92 3.54 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -121.78 127.35 50.52 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 mm -100.92 117.94 46.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.05 0.452 . . . . 0.0 111.565 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.7 p -91.74 -41.85 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.583 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -143.37 141.88 31.07 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -111.93 145.4 39.62 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 35' ' ' LEU . 87.7 m-20 -128.54 20.85 6.1 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.43 0.559 . . . . 0.0 111.255 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.9 m -136.33 154.63 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 68.4 mttm -135.05 137.13 42.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.448 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -44.25 135.75 4.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.91 5.94 70.29 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 43.9 p-10 -104.19 150.88 23.98 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.806 0.303 . . . . 0.0 110.222 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.2 mtp -90.06 145.74 24.85 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.86 0.362 . . . . 0.0 110.645 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.9 t -126.42 132.85 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.478 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -105.7 158.2 16.88 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -62.88 136.4 57.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.639 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 58.66 36.46 25.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.141 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -141.81 89.76 2.22 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 51.4 t0 -172.91 158.16 3.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.901 0.382 . . . . 0.0 110.455 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.47 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 92.7 mt -135.22 86.35 2.24 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.322 0.582 . . . . 0.0 110.009 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.71 136.69 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.565 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.1 mp0 -123.06 128.14 49.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.056 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 p -128.15 130.0 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.0 ttp -109.3 133.49 52.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.547 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -99.65 -92.38 0.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.492 ' N ' ' OG1' ' A' ' 40' ' ' THR . 14.3 p-10 -83.69 -52.73 6.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.356 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -174.45 57.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.612 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -159.33 151.83 6.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.901 0.382 . . . . 0.0 110.417 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -103.87 117.53 34.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.284 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.88 132.59 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.064 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -92.53 135.71 33.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.954 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.94 90.8 13.8 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.55 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.08 147.73 92.04 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 122.638 2.225 . . . . 0.0 112.018 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.5 m -60.65 111.27 3.82 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 119.51 -0.281 . . . . 0.0 110.7 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.56 -16.81 30.39 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.413 1.409 . . . . 0.0 114.521 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.89 124.58 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.245 0.475 . . . . 0.0 111.084 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -89.74 151.49 21.8 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.415 0.15 . . . . 0.0 110.827 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.77 -145.47 7.97 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -114.46 133.74 55.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.85 0.325 . . . . 0.0 110.845 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -87.91 120.22 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 t -88.99 -52.63 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -156.27 160.74 40.04 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.186 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.445 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.0 tt -106.0 123.37 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.618 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.1 tp -101.11 -18.32 16.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.068 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -111.15 146.82 36.18 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.217 0.532 . . . . 0.0 111.053 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.516 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 99.8 mtt180 -122.5 167.3 13.52 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.111 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -62.37 140.54 58.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.838 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.52 5.02 82.6 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.382 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.516 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 83.5 mt-30 -85.61 135.17 33.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.488 0.644 . . . . 0.0 111.955 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 p -128.46 126.5 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.733 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.5 t -149.52 135.93 10.49 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.746 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.39 141.96 59.46 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.377 1.385 . . . . 0.0 111.905 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 p -52.98 128.32 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.849 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.03 48.24 0.06 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.187 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.4 p -164.17 162.24 22.65 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 117.407 0.604 . . . . 0.0 110.926 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 t -88.96 126.48 35.42 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.2 mt -97.36 -5.48 36.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.402 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 74' ' ' GLN . 3.4 tt -170.51 149.08 3.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.424 ' N ' HD22 ' A' ' 73' ' ' LEU . 66.7 mt-30 -103.17 125.52 49.9 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.8 mt -126.45 128.55 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.199 0.523 . . . . 0.0 111.723 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 18.6 p-10 -97.09 115.66 27.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.543 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.591 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -106.78 137.52 44.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.147 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.33 130.51 40.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.125 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -108.64 120.46 42.53 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.203 0.525 . . . . 0.0 110.331 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -127.18 153.34 46.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.955 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 tp -71.52 117.87 61.16 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.742 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 C-N-CA 121.664 1.576 . . . . 0.0 111.886 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.988 0.423 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.54 150.81 18.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -137.16 146.56 45.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.954 0.377 . . . . 0.0 110.262 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.89 115.93 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.37 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 10.7 p -86.04 -43.62 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.373 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.404 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 83.6 mtp180 -139.54 147.37 41.11 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.724 0.297 . . . . 0.0 111.264 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -111.95 141.84 45.1 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.46 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 16.5 p-10 -105.56 -3.51 22.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.542 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -134.59 160.35 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 120.891 0.377 . . . . 0.0 111.36 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.22 147.17 45.64 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.56 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.34 134.23 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.619 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.75 8.53 85.84 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.322 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -117.07 129.13 55.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.068 0.434 . . . . 0.0 111.431 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.1 ptp -59.54 150.25 27.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.843 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 30' ' ' GLU . 52.9 t -123.25 159.06 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.019 0.438 . . . . 0.0 110.138 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.2 mp0 -135.1 149.59 50.07 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.57 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 87.9 tttt -65.29 137.6 57.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.138 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 9.9 m-20 94.21 76.03 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.817 0.698 . . . . 0.0 110.704 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -146.16 95.66 2.66 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.594 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -104.1 52.35 0.76 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.653 0.263 . . . . 0.0 110.916 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -117.87 30.53 7.2 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.239 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.93 128.28 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -121.86 126.64 49.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.644 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.0 129.89 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.6 ttp -103.95 110.98 23.33 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.831 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 p -61.91 -48.13 81.85 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -146.31 -67.45 0.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.432 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -142.11 41.38 1.65 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.842 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.3 t -136.33 155.85 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -109.17 118.2 36.13 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.76 120.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.06 138.57 31.4 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -136.42 109.84 9.62 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.08 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.69 145.27 60.78 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.67 1.58 . . . . 0.0 111.369 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.5 m -105.04 99.62 20.35 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.08 44.44 1.28 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.295 1.997 . . . . 0.0 110.432 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.76 154.68 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -161.47 131.82 5.02 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.713 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.02 -136.49 3.85 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.855 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -124.44 132.13 53.5 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.88 0.34 . . . . 0.0 110.242 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mm -91.77 121.33 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.8 t -87.46 -51.81 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -155.29 161.42 41.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.681 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.428 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.6 tt -122.0 123.78 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.695 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.06 -16.48 17.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -107.15 143.9 34.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.15 0.5 . . . . 0.0 111.375 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -123.61 164.99 17.95 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.272 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -59.34 134.4 56.97 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.631 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.98 5.64 90.01 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.009 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -82.15 137.39 34.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.041 0.42 . . . . 0.0 110.823 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.84 133.03 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.605 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.7 t -148.63 141.28 15.16 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.691 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.16 146.11 61.5 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.317 1.345 . . . . 0.0 111.373 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.6 p -64.89 130.2 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.018 0.437 . . . . 0.0 110.713 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.55 53.15 0.08 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.2 m -160.41 170.3 21.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.054 0.427 . . . . 0.0 111.255 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.2 m -99.43 112.5 24.68 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.838 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.52 -43.4 76.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.161 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 74' ' ' GLN . 2.2 tt -151.38 145.74 25.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.072 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.463 ' H ' HD23 ' A' ' 73' ' ' LEU . 39.1 mt-30 -104.11 130.73 51.84 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.9 mt -131.71 127.34 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.142 0.496 . . . . 0.0 111.536 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.76 140.97 29.28 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.918 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.568 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 1' ' ' MET . 4.4 mpp? . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -97.65 127.87 43.93 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 37.6 mp0 -107.74 111.72 24.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.131 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -75.55 100.94 4.72 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -112.55 147.16 37.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.554 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.3 tt -66.35 113.35 12.21 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo . . . . . 0 N--CA 1.494 1.532 0 CA-C-N 120.499 1.214 . . . . 0.0 112.09 -179.861 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 121.004 0.431 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.14 132.38 8.05 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -133.84 142.03 47.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.96 0.41 . . . . 0.0 110.101 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -100.01 121.66 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.048 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 11.5 p -88.18 -45.69 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.167 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.42 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 63.0 ttm-85 -146.76 139.31 25.02 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -108.19 143.94 36.31 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.2 m-20 -127.55 15.89 7.05 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.892 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.15 155.91 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -130.07 147.56 51.83 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.941 0.401 . . . . 0.0 111.063 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.59 139.47 58.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.238 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.92 7.97 73.42 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.843 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -117.92 148.99 41.63 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.865 0.333 . . . . 0.0 110.68 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 63.8 mtt -76.77 147.29 37.36 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.105 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.99 132.74 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -98.89 154.92 17.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.432 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -96.05 84.26 3.79 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.86 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 34' ' ' ASP . 46.5 p-10 -173.5 131.22 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 110.853 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' ASP . 96.7 mm-40 53.78 -80.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.609 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 32' ' ' ASP . 93.8 m-20 57.01 150.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.457 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 89.5 mt -122.12 76.68 1.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.283 0.563 . . . . 0.0 111.629 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.07 131.59 70.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -123.16 121.72 36.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.274 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.3 m -115.19 130.88 68.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 43' ' ' VAL . 5.4 tpp -91.83 152.18 20.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.896 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -156.66 -89.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.589 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.448 ' N ' ' OG1' ' A' ' 40' ' ' THR . 91.7 m-20 -76.16 44.84 0.34 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.286 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 58.37 37.72 25.85 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.61 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.452 ' O ' ' SD ' ' A' ' 39' ' ' MET . 30.6 m -147.54 158.98 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.67 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -100.17 118.49 36.61 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 110.727 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -119.59 130.45 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.543 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -94.98 138.78 32.26 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.28 92.99 34.2 Favored Pre-proline 0 N--CA 1.472 0.639 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.184 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' O ' ' OG ' ' A' ' 49' ' ' SER . 88.3 Cg_endo -80.03 143.87 16.45 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.227 1.951 . . . . 0.0 113.133 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 48' ' ' PRO . 6.0 p 81.7 69.68 0.12 Allowed Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.408 ' CD ' ' OD2' ' A' ' 34' ' ' ASP . 64.2 Cg_endo -88.87 26.94 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.953 2.435 . . . . 0.0 112.177 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t 69.76 115.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.142 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -79.83 147.65 31.68 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 112.064 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.24 -133.92 2.57 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -122.48 134.33 54.58 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.7 mm -92.98 119.62 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -79.37 -52.39 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -168.44 157.96 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.705 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.4 tt -104.01 122.68 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.009 0.433 . . . . 0.0 111.334 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -100.93 -17.17 16.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -106.73 142.54 36.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.97 0.414 . . . . 0.0 110.884 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -117.47 169.83 9.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.313 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.29 134.19 56.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.246 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.49 6.17 86.43 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.866 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -79.09 131.85 36.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.2 0.524 . . . . 0.0 111.324 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -127.03 132.21 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.596 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.87 140.31 15.53 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.609 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.94 147.2 15.12 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.038 1.159 . . . . 0.0 112.187 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.1 p -60.13 130.4 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.51 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.08 55.99 0.21 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.4 m -151.38 175.69 12.0 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.055 0.455 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 m -101.14 109.7 21.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.252 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.05 -45.52 70.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.089 0.471 . . . . 0.0 110.946 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 tt -152.72 147.16 25.76 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -103.56 128.18 50.84 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.403 HG23 HD11 ' A' ' 75' ' ' ILE . 91.5 mt -128.07 129.52 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.164 0.507 . . . . 0.0 111.118 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -95.69 112.05 23.86 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.099 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.1 m . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.618 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 75' ' ' ILE . 21.6 t80 -79.75 127.58 32.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 110.217 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 54.8 mp0 -88.29 133.7 33.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.311 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -101.69 113.29 26.31 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 6' ' ' LEU . 54.0 mtmt -120.1 113.77 20.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 5' ' ' LYS . 12.6 mt -32.89 97.22 0.11 Allowed Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.521 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo . . . . . 0 N--CA 1.492 1.4 0 C-N-CA 121.721 1.614 . . . . 0.0 111.957 -179.918 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.69 109.76 3.91 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -121.49 132.61 54.82 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -101.91 120.58 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.94 0.4 . . . . 0.0 111.193 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 8.7 p -92.95 -42.43 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.62 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.402 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 43.2 ttm180 -148.79 134.51 18.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -104.2 140.44 37.83 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -120.24 16.77 12.33 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.094 0.406 . . . . 0.0 111.279 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.38 157.66 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.922 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -131.8 136.47 47.55 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.546 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.68 140.18 36.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 0.0 111.042 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.96 6.96 74.89 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.88 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -116.21 149.6 38.87 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.879 0.339 . . . . 0.0 110.723 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.5 mmm -83.47 147.32 27.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.643 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.2 t -118.9 132.54 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.353 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE1' ' OE1' ' A' ' 33' ' ' GLN . 95.5 mt-10 -96.23 155.59 16.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.721 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -67.83 134.13 50.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.859 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 57.86 34.56 24.5 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.241 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.414 ' OE1' ' OE1' ' A' ' 30' ' ' GLU . 82.7 mt-30 -143.13 87.49 1.97 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.868 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -174.62 168.95 3.7 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -136.31 97.69 3.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.244 0.545 . . . . 0.0 110.683 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.53 132.63 67.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.186 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -125.12 126.17 44.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.329 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.84 125.89 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.232 0.539 . . . . 0.0 109.567 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.0 ttp -105.86 137.91 42.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.069 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.535 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.6 t -102.81 -121.34 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.92 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.535 ' N ' ' OG1' ' A' ' 40' ' ' THR . 63.8 t0 -63.78 -46.77 83.73 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -177.13 60.55 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -150.33 149.13 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.741 0.305 . . . . 0.0 110.305 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -101.88 117.73 35.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.85 117.08 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.871 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -97.1 134.53 40.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.77 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.0 mt -138.9 129.58 14.96 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.556 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.45 143.59 22.0 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.134 1.889 . . . . 0.0 112.464 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 p -47.76 106.9 0.65 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.3 -23.51 32.84 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.077 1.185 . . . . 0.0 114.745 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.76 123.53 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.401 0.546 . . . . 0.0 111.732 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -83.04 161.22 21.76 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.38 -142.35 7.99 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.091 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -119.47 134.52 55.18 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.836 0.35 . . . . 0.0 111.187 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.443 HG21 HD13 ' A' ' 55' ' ' ILE . 5.3 mm -95.93 117.74 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.64 -53.46 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -151.58 156.8 41.22 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.478 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.7 tt -108.84 120.35 60.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.004 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.47 -17.93 18.49 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.302 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.522 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 7.6 m-85 -111.42 144.62 40.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.44 0.638 . . . . 0.0 111.391 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.508 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 99.9 mtt180 -120.82 162.19 20.22 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.078 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -58.33 142.28 48.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.609 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.76 6.03 70.59 Favored Glycine 0 N--CA 1.469 0.869 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.508 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 85.9 mt-30 -94.13 132.06 39.04 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.364 0.602 . . . . 0.0 112.161 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.95 125.8 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.007 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 t -147.97 137.17 11.91 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.646 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -50.48 137.4 40.23 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.016 1.144 . . . . 0.0 112.213 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.58 126.44 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.469 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.08 49.32 0.04 OUTLIER Glycine 0 CA--C 1.531 1.034 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.956 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.8 p -159.75 160.46 34.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 117.182 0.491 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.496 ' O ' ' CG2' ' A' ' 71' ' ' THR . 5.2 t -91.66 104.27 16.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.803 0.811 . . . . 0.0 109.982 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.2 mm? -67.31 -39.91 85.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.483 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 74' ' ' GLN . 3.5 tt -141.55 148.63 39.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.467 ' N ' ' CD2' ' A' ' 73' ' ' LEU . 57.5 tt0 -102.6 130.22 49.41 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 75' ' ' ILE . 96.3 mt -127.41 127.91 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.247 0.546 . . . . 0.0 111.398 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -102.1 114.9 29.42 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.167 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.114 -0.946 . . . . 0.0 110.599 179.825 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' OD1' ' A' ' 76' ' ' ASP . 97.8 mmm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -148.02 147.97 30.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.398 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -126.69 138.72 53.44 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.08 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.35 113.89 27.56 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.317 0.58 . . . . 0.0 110.573 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 6' ' ' LEU . 98.9 mttt -119.49 112.83 19.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.172 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.413 ' CD2' ' C ' ' A' ' 6' ' ' LEU . 3.7 tt -35.93 99.53 0.18 Allowed Pre-proline 0 N--CA 1.475 0.798 0 O-C-N 123.342 0.401 . . . . 0.0 110.446 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 N--CA 1.493 1.445 0 C-N-CA 121.702 1.601 . . . . 0.0 112.061 -179.024 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.751 0.31 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.05 111.0 3.25 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -121.28 129.99 53.43 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -102.35 118.8 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.405 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 9.8 p -96.77 -47.48 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.831 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 82.4 mtp180 -141.53 145.49 35.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.8 m95 -117.03 139.51 50.6 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.549 ' CG ' HH22 ' A' ' 52' ' ' ARG . 7.7 p-10 -108.09 5.15 25.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.492 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 3.8 m -133.84 157.2 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.626 0.251 . . . . 0.0 110.535 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.86 145.11 51.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.846 0.355 . . . . 0.0 110.496 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -61.54 138.5 58.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.196 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.07 8.01 65.2 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.913 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 28' ' ' MET . 68.1 t0 -117.32 135.95 53.48 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.926 0.363 . . . . 0.0 111.365 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.495 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 2.5 mpt? -90.48 131.69 36.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.047 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.17 146.0 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.743 0.306 . . . . 0.0 110.675 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.3 mm-40 -92.85 160.08 15.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.436 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -52.12 129.77 28.44 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.196 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 30' ' ' GLU . 2.5 p30 168.79 133.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.647 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -67.09 80.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.627 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 68.0 t0 -63.45 -43.2 98.07 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.363 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.523 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 1.4 mt 154.87 86.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.036 0.835 . . . . 0.0 110.824 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.47 126.05 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -121.13 123.09 41.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.467 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.93 130.42 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.418 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 25.1 ptm -128.12 152.05 48.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -94.71 -114.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.317 178.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.543 ' N ' ' OG1' ' A' ' 40' ' ' THR . 69.7 m-20 -65.03 -45.24 86.29 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -176.1 57.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.779 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 39' ' ' MET . 48.7 t -137.42 139.47 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -95.9 116.93 29.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.484 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.23 119.39 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -92.44 132.13 37.03 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 57.3 mt -141.26 138.04 17.31 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.466 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -52.3 141.64 49.28 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 CA-C-N 120.178 1.099 . . . . 0.0 111.083 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.494 ' CB ' ' HE ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -46.6 162.94 0.24 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.017 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 51' ' ' VAL . 95.4 Cg_endo -78.16 54.81 5.09 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 123.23 2.62 . . . . 0.0 112.991 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 50' ' ' PRO . 4.1 t 59.12 109.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.144 -0.623 . . . . 0.0 109.52 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.549 HH22 ' CG ' ' A' ' 22' ' ' ASP . 95.9 mtt180 -102.81 146.07 28.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 111.828 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.45 -85.84 0.06 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -125.11 114.04 18.52 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mm -91.54 120.02 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.0 t -79.44 -52.83 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -169.88 157.37 6.72 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.084 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.458 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 2.1 tt -110.33 119.26 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.439 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.21 -17.6 20.67 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.569 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.429 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 28.2 m-85 -110.2 141.76 42.69 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.909 0.385 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -132.13 165.81 23.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.069 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.02 141.94 21.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.802 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.69 5.0 60.26 Favored Glycine 0 N--CA 1.471 0.995 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.235 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -99.51 131.25 45.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.494 0.664 . . . . 0.0 111.861 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.98 123.51 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.354 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.27 138.69 13.04 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.301 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -52.68 143.79 45.47 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.356 1.37 . . . . 0.0 112.394 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.6 p -52.03 128.95 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.601 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.28 52.76 0.08 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.738 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -156.48 161.8 40.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.033 0.417 . . . . 0.0 111.164 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.3 p -92.91 111.29 22.86 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.807 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.3 mm? -89.08 -6.98 56.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.086 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.427 HD21 ' H ' ' A' ' 74' ' ' GLN . 0.6 OUTLIER -176.45 142.54 0.45 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.196 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.427 ' H ' HD21 ' A' ' 73' ' ' LEU . 58.0 tt0 -104.37 126.48 51.5 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 57.7 mt -128.35 128.26 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.18 0.514 . . . . 0.0 111.474 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.507 ' OD1' ' SD ' ' A' ' 1' ' ' MET . 85.6 m-20 -101.28 111.06 23.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.131 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.351 180.0 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -75.31 142.71 43.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.724 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -112.03 135.95 52.01 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.289 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -101.21 117.16 34.43 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.312 0.577 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 6' ' ' LEU . 99.4 mttt -119.54 107.37 13.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.146 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 5' ' ' LYS . 16.2 tp -31.06 93.2 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.931 0 O-C-N 123.665 0.603 . . . . 0.0 110.886 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 5' ' ' LYS . 30.8 Cg_exo . . . . . 0 N--CA 1.498 1.756 0 C-N-CA 122.214 1.943 . . . . 0.0 112.585 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.69 110.04 3.95 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -118.41 130.8 56.18 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.7 mm -100.12 120.15 49.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.107 0.48 . . . . 0.0 111.777 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 7.4 p -90.43 -45.61 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.467 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.449 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 99.6 mtt180 -147.7 149.33 32.23 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -114.79 140.62 48.77 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -121.74 12.23 10.59 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.004 0.365 . . . . 0.0 111.009 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.09 131.07 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.81 141.65 36.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.187 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -54.91 135.77 47.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.879 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.27 6.48 84.17 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.516 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 28' ' ' MET . 64.2 t0 -110.82 146.95 35.53 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.245 0.522 . . . . 0.0 110.872 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.539 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 77.2 mtm -87.65 149.38 24.31 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.738 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.23 137.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.799 0.333 . . . . 0.0 110.444 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -90.21 158.83 17.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.51 138.16 58.26 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.42 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 58.6 37.02 25.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.057 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.33 87.21 1.87 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.489 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -172.82 167.09 5.25 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.733 0.302 . . . . 0.0 110.452 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -136.05 88.56 2.4 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.229 0.538 . . . . 0.0 110.138 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.16 128.61 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.522 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -117.08 118.01 31.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.561 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -109.52 129.3 64.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.0 ttp -117.14 154.97 30.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.647 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.426 ' CG2' ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -140.16 -86.21 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.868 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.426 ' H ' ' CG2' ' A' ' 40' ' ' THR . 67.2 t0 -94.43 52.63 1.58 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.329 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 60.04 44.33 13.36 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 121.035 0.445 . . . . 0.0 110.835 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -130.1 138.32 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.748 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 m -94.89 118.13 31.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.215 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.83 117.54 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.148 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -93.1 128.84 39.16 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 110.467 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.7 mt -137.99 90.21 14.16 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.451 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.74 144.62 92.84 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.528 2.152 . . . . 0.0 112.413 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.8 m -51.06 108.63 1.09 Allowed Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.803 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.9 -15.35 23.72 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 121.638 1.559 . . . . 0.0 115.035 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.89 124.6 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.42 0.555 . . . . 0.0 111.779 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -89.16 149.01 23.35 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 120.689 0.28 . . . . 0.0 111.112 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.24 -138.42 4.89 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -122.31 144.14 49.19 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.958 0.409 . . . . 0.0 111.084 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mm -99.75 120.58 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.7 t -83.52 -50.96 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -158.86 154.69 26.46 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.592 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.2 tt -91.47 108.23 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.42 0.629 . . . . 0.0 109.513 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.4 tp -82.01 -27.65 32.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.803 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -117.15 145.33 43.89 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.366 0.603 . . . . 0.0 111.649 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.524 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 90.2 mtm-85 -120.48 168.41 11.36 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.952 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -62.73 146.85 51.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 111.968 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.32 5.08 85.63 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.182 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.524 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 86.0 mt-30 -89.22 132.1 35.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.444 0.64 . . . . 0.0 111.942 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.07 121.13 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.848 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.96 139.33 14.0 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.342 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.38 143.85 25.78 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.183 1.255 . . . . 0.0 112.246 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 p -61.68 129.2 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.162 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.35 52.54 0.07 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.452 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.4 t -167.05 153.65 8.42 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.991 0.396 . . . . 0.0 110.998 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.7 t -79.57 130.9 35.8 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.2 mt -105.52 0.07 26.31 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 74' ' ' GLN . 3.2 tp -173.13 143.35 1.12 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.423 ' H ' HD13 ' A' ' 73' ' ' LEU . 12.7 mm-40 -102.98 129.68 49.81 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.013 0.435 . . . . 0.0 110.47 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 83.1 mt -129.82 126.18 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.327 0.584 . . . . 0.0 111.611 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -89.78 138.75 31.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.653 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.329 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.526 ' H3 ' ' CB ' ' A' ' 77' ' ' THR . 22.5 ttm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.47 150.36 45.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.198 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -130.55 129.76 43.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.54 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.67 120.35 32.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -129.49 149.35 51.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.605 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 tt -95.16 106.46 25.89 Favored Pre-proline 0 N--CA 1.473 0.675 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.677 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 N--CA 1.492 1.427 0 C-N-CA 121.874 1.716 . . . . 0.0 111.892 179.482 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.7 0.286 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.57 110.52 0.5 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' OE1' ' CE ' ' A' ' 39' ' ' MET . 83.7 tt0 -122.87 135.88 54.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.842 0.353 . . . . 0.0 110.268 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 mm -102.56 121.24 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.931 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.5 p -92.63 -42.44 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.36 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -142.31 137.51 30.64 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -109.27 141.05 42.12 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 10.8 p-10 -114.87 3.04 14.49 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.42 155.83 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.701 0.286 . . . . 0.0 110.684 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 99.0 mttt -135.11 150.54 50.23 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.221 0.534 . . . . 0.0 111.239 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -50.03 131.21 22.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.114 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.79 5.3 68.72 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.65 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 31.7 p-10 -106.67 150.06 26.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 117.52 0.66 . . . . 0.0 110.734 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.7 mmm -85.55 153.28 22.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.913 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.6 t -125.18 160.57 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.957 0.408 . . . . 0.0 110.807 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.1 mp0 -118.45 152.26 36.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.355 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -80.64 140.4 35.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.31 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.11 141.96 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.051 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 65.9 114.11 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.496 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 45.0 t0 -163.49 -173.03 3.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.516 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 84.8 mt -138.15 69.94 1.39 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.082 0.467 . . . . 0.0 111.341 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.88 131.06 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 57.3 mp0 -128.54 123.27 33.04 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 110.937 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.78 131.85 64.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.425 ' CE ' ' OE1' ' A' ' 17' ' ' GLU . 63.2 ttp -99.5 121.59 41.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.659 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -96.49 -86.26 0.32 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.248 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' N ' ' OG1' ' A' ' 40' ' ' THR . 99.7 m-20 -101.26 49.98 0.87 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.206 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.1 tttm 73.08 28.25 1.92 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.932 0.396 . . . . 0.0 110.304 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.27 137.46 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.534 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 m -94.48 117.16 29.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.914 0.388 . . . . 0.0 110.13 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.5 m -124.16 131.22 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.557 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -90.07 139.23 30.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.593 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.8 mt -133.5 137.41 28.91 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.322 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 49' ' ' SER . 53.1 Cg_exo -51.99 140.59 49.02 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 121.79 1.66 . . . . 0.0 112.862 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.441 ' OG ' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -40.67 165.71 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.21 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.29 42.57 1.36 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.079 2.52 . . . . 0.0 113.172 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.7 t 62.22 118.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.661 0.267 . . . . 0.0 110.974 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -44.04 150.33 0.28 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.902 0.382 . . . . 0.0 111.756 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.04 -146.38 11.66 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -118.23 131.65 56.36 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.907 0.384 . . . . 0.0 110.383 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.419 HG22 HD13 ' A' ' 55' ' ' ILE . 8.1 mm -96.63 118.87 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.9 t -91.0 -52.5 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -150.49 156.9 42.33 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.109 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.435 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.7 tt -117.6 123.33 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.751 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.46 -16.85 16.69 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.172 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.516 ' CD2' ' OE1' ' A' ' 64' ' ' GLN . 15.6 m-85 -106.74 141.99 37.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.115 0.483 . . . . 0.0 111.161 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -122.2 168.92 11.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.204 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.22 134.65 57.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.833 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.91 4.9 90.4 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.704 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.516 ' OE1' ' CD2' ' A' ' 60' ' ' TYR . 49.7 tt0 -82.97 135.65 34.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.504 0.652 . . . . 0.0 110.919 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -126.93 131.92 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.08 140.65 15.13 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 119.328 -0.367 . . . . 0.0 111.083 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.3 148.88 48.6 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 121.42 1.413 . . . . 0.0 112.225 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -57.8 132.55 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.204 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.78 51.84 0.11 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.5 ' HG ' ' HH ' ' A' ' 60' ' ' TYR . 36.4 p -159.06 163.27 36.44 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.445 0.623 . . . . 0.0 111.617 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.7 m -93.34 109.32 20.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.154 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.75 -46.04 87.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.406 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 74' ' ' GLN . 2.9 tt -152.55 146.47 25.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.492 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.46 ' N ' ' CD2' ' A' ' 73' ' ' LEU . 55.2 tt0 -102.95 130.06 49.89 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.6 mt -125.23 127.69 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.159 0.504 . . . . 0.0 111.342 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -91.92 137.27 32.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.526 ' CB ' ' H3 ' ' A' ' 1' ' ' MET . 19.1 m . . . . . 0 C--O 1.222 -0.392 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.252 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -139.78 149.9 44.09 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.92 133.78 50.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.265 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.423 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -88.23 112.82 23.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 109.933 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -117.64 117.57 29.73 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.697 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tt -47.26 107.66 0.75 Allowed Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.77 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 N--CA 1.492 1.421 0 C-N-CA 121.543 1.496 . . . . 0.0 111.55 -179.711 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 57.0 mp0 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 120.815 0.34 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.99 117.81 5.94 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -123.27 131.98 53.86 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.58 120.67 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.031 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 7.7 p -92.18 -43.12 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.72 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' NH2' ' OE1' ' A' ' 37' ' ' GLU . 86.2 mtm180 -144.92 151.4 38.61 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -118.68 140.98 49.04 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -116.64 9.06 14.0 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.1 0.409 . . . . 0.0 111.847 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.61 156.74 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.676 0.274 . . . . 0.0 110.342 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 62.6 mttp -115.34 142.34 46.81 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.275 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -57.33 134.64 56.17 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.36 6.43 66.32 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 40.1 p-10 -102.36 151.72 21.93 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.026 0.441 . . . . 0.0 110.86 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.9 mtm -81.64 144.61 31.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.199 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.0 t -122.54 133.61 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.389 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -104.03 159.94 15.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.114 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.87 133.46 54.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.279 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.1 37.96 26.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.522 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -139.43 81.46 1.83 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.727 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 68.0 t0 -177.67 132.17 0.16 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.43 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 41.5 tp -111.02 96.77 6.35 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.148 0.499 . . . . 0.0 109.99 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.77 124.03 72.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.542 ' OE1' ' NH2' ' A' ' 20' ' ' ARG . 76.0 tt0 -106.06 120.24 41.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.045 0.45 . . . . 0.0 110.6 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.32 131.55 67.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.678 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 43' ' ' VAL . 6.0 tpp -114.72 145.43 42.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.363 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 2.6 t -115.4 -131.35 0.32 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.027 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.532 ' N ' ' OG1' ' A' ' 40' ' ' THR . 67.3 t0 -65.13 -43.77 90.82 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.458 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -173.13 53.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.786 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.506 ' O ' ' SD ' ' A' ' 39' ' ' MET . 5.1 t -145.01 133.69 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.253 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -101.2 119.47 38.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.62 157.76 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.547 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -125.57 135.65 52.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.239 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.3 mt -133.58 88.26 34.52 Favored Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.503 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.18 142.53 97.26 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 122.409 2.072 . . . . 0.0 112.302 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.2 m -41.55 102.45 0.27 Allowed Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.203 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.32 -23.12 38.86 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.081 1.188 . . . . 0.0 114.466 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.83 126.4 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 118.246 0.476 . . . . 0.0 111.32 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -84.75 146.01 27.61 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 120.514 0.197 . . . . 0.0 110.897 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.23 -145.94 7.2 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.698 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -115.94 135.51 53.91 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.641 0.258 . . . . 0.0 110.392 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 55' ' ' ILE . 7.5 mm -95.59 119.8 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.19 -53.27 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.531 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -164.1 157.73 18.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.727 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.471 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.7 tt -89.35 114.84 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.179 0.514 . . . . 0.0 110.691 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.94 -25.17 24.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.352 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.37 145.98 39.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.096 0.474 . . . . 0.0 111.192 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -123.23 165.65 16.55 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.017 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.4 142.39 48.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.417 0.627 . . . . 0.0 112.159 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.37 4.95 90.33 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.075 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -86.69 130.18 34.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 111.499 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.75 129.65 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.544 -0.753 . . . . 0.0 108.972 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.79 140.41 14.68 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 119.374 -0.346 . . . . 0.0 110.575 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.92 146.22 47.78 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.326 1.351 . . . . 0.0 112.584 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -56.12 130.47 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.09 49.78 0.15 Allowed Glycine 0 N--CA 1.47 0.903 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 p -160.52 164.52 32.02 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.135 0.467 . . . . 0.0 111.03 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.4 p -87.65 127.72 35.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.221 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 74.9 mt -93.58 -4.56 50.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.321 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 74' ' ' GLN . 2.0 tp 174.76 149.55 0.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.446 ' H ' HD12 ' A' ' 73' ' ' LEU . 58.2 tt0 -104.76 128.12 52.77 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.922 0.392 . . . . 0.0 111.394 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.3 mt -126.56 128.01 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.094 0.473 . . . . 0.0 110.976 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -96.9 110.97 23.37 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.068 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.506 -179.763 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.638 ' H1 ' ' H ' ' A' ' 77' ' ' THR . 28.3 ttt . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -126.77 148.87 49.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.739 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -124.62 135.42 53.08 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.281 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -100.76 119.74 39.07 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.33 147.24 48.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.917 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 tt -76.24 116.68 58.19 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.686 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo . . . . . 0 N--CA 1.496 1.621 0 C-N-CA 121.949 1.766 . . . . 0.0 112.812 -179.268 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.657 0.265 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.09 168.31 13.74 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -156.68 142.78 18.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.482 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 mm -102.87 121.33 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.462 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -92.35 -45.4 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.434 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -139.77 146.83 39.98 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.26 0.552 . . . . 0.0 112.077 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -114.57 142.99 45.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.263 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -118.17 8.34 12.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.451 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.21 156.06 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.792 0.33 . . . . 0.0 110.73 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.86 146.55 39.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.275 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.31 138.75 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.907 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.21 7.91 69.34 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.601 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 28' ' ' MET . 60.7 t0 -120.8 148.09 44.47 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.93 0.395 . . . . 0.0 111.038 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.537 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 96.9 mtp -83.94 150.13 25.87 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.561 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.4 t -119.73 133.59 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.807 0.337 . . . . 0.0 110.321 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.3 mp0 -101.96 155.41 18.18 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.443 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -71.34 140.8 50.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.024 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 t0 80.61 64.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.766 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -140.36 87.58 2.15 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -98.01 89.28 4.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.724 0.297 . . . . 0.0 111.354 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.9 mt -140.92 27.16 2.01 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 m -116.61 135.81 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -122.7 126.24 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.598 0.237 . . . . 0.0 110.602 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.33 155.74 34.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 110.464 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 43' ' ' VAL . 28.0 tpp -106.71 125.42 50.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.624 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.69 -49.77 3.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.974 0.416 . . . . 0.0 110.079 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.423 ' OD1' ' CG2' ' A' ' 43' ' ' VAL . 47.8 p-10 -139.23 49.72 1.83 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.438 ' C ' ' SD ' ' A' ' 39' ' ' MET . 48.5 tttm 72.76 23.8 2.84 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.589 ' N ' ' SD ' ' A' ' 39' ' ' MET . 47.6 t -123.69 134.57 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.754 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.3 m -95.68 118.74 32.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.661 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.12 155.11 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.251 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -109.67 135.1 51.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.711 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.32 157.88 75.73 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 49' ' ' SER . 37.2 Cg_exo -55.2 147.24 55.87 Favored 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 121.914 1.743 . . . . 0.0 112.452 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -48.4 179.9 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.352 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 49' ' ' SER . 88.0 Cg_endo -89.31 44.91 0.77 Allowed 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 123.094 2.529 . . . . 0.0 113.056 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.1 t 62.79 117.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 120.682 0.277 . . . . 0.0 111.745 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -39.26 147.12 0.07 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.695 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.53 -147.14 12.85 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.27 139.1 51.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.963 0.382 . . . . 0.0 110.309 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mm -103.31 119.02 51.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -93.6 -51.62 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -147.17 157.5 43.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.441 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.4 tt -116.94 124.24 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.376 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.22 -16.42 15.21 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 8.1 m-85 -109.89 145.51 36.71 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.269 0.557 . . . . 0.0 111.751 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -124.87 161.8 25.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.254 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -56.11 138.52 49.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.558 0.694 . . . . 0.0 112.33 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.85 5.67 89.91 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.202 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -81.2 133.83 35.52 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.332 -0.51 . . . . 0.0 110.832 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.9 t -118.02 128.62 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.157 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 t -149.84 139.38 13.17 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.513 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.04 143.28 83.92 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.205 1.27 . . . . 0.0 111.746 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.21 130.95 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.73 50.13 0.05 OUTLIER Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.975 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -166.65 164.07 16.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.388 0.594 . . . . 0.0 111.451 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.459 ' O ' ' CG2' ' A' ' 71' ' ' THR . 7.8 t -94.71 114.43 26.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.188 0.518 . . . . 0.0 109.628 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.533 ' CD1' ' CD2' ' A' ' 60' ' ' TYR . 2.9 mm? -64.72 -40.32 95.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.334 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD2' ' N ' ' A' ' 74' ' ' GLN . 2.9 tt -142.62 147.7 36.24 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.462 ' N ' ' CD2' ' A' ' 73' ' ' LEU . 55.5 tt0 -102.74 130.7 49.78 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.0 mt -128.3 127.78 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.982 0.42 . . . . 0.0 111.296 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -96.0 116.37 28.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.47 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.638 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 17.7 m . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.108 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -80.32 141.05 35.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.66 138.51 51.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.737 0.303 . . . . 0.0 110.756 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -101.36 106.02 17.13 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -114.84 120.81 41.27 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.066 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.416 ' C ' ' CD2' ' A' ' 6' ' ' LEU . 4.4 tt -47.11 107.64 0.75 Allowed Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo . . . . . 0 N--CA 1.496 1.633 0 C-N-CA 121.533 1.488 . . . . 0.0 112.332 -179.916 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.69 144.59 17.31 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -157.06 126.7 6.16 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.54 120.09 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.802 0.334 . . . . 0.0 111.65 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 9.1 p -87.27 -47.45 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.851 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 99.8 mtt180 -142.77 147.77 36.09 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -113.24 136.17 53.03 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 22.3 p-10 -99.69 -7.12 26.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.8 m -145.37 161.12 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.48 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 99.0 mttt -139.36 155.44 47.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.151 0.501 . . . . 0.0 111.215 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -46.78 142.31 3.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.389 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.9 8.53 67.08 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.137 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 47.2 p-10 -129.65 149.47 51.39 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.015 0.908 . . . . 0.0 111.659 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.5 mtt -84.94 151.39 24.27 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.54 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.18 147.1 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.093 0.473 . . . . 0.0 110.309 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 97.6 mt-10 -140.56 152.77 45.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.068 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 30' ' ' GLU . 33.7 tptt 94.59 124.11 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.955 0.784 . . . . 0.0 110.707 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 49' ' ' SER . 9.0 p-10 -72.75 -3.32 24.57 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.469 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -132.49 87.27 2.4 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.621 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 53.1 p-10 -97.82 -112.32 0.15 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.621 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 54.5 tp -166.84 80.51 0.23 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.275 0.559 . . . . 0.0 110.714 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.64 132.35 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -109.27 123.77 49.82 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 110.582 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.76 128.23 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.621 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttm -109.2 155.94 20.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.03 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.5 t -132.21 -118.33 0.21 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.629 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.536 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.2 p-10 -66.73 -46.33 75.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.941 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.46 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 30.8 ttmt -174.64 56.2 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.485 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -162.21 151.76 3.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.826 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 m -117.09 122.49 44.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.065 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.59 157.31 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.055 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.26 134.44 51.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.0 mt -118.53 137.63 24.99 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.92 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 49' ' ' SER . 50.2 Cg_exo -51.11 142.07 36.26 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.442 1.428 . . . . 0.0 112.467 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -36.58 157.44 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.37 44.93 1.72 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.496 2.131 . . . . 0.0 112.578 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.8 t 63.62 117.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -50.25 146.7 4.85 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.933 0.396 . . . . 0.0 111.704 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.73 -136.59 4.33 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -127.04 143.84 51.18 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.033 0.416 . . . . 0.0 110.239 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -104.0 117.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.3 t -91.18 -50.72 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -149.97 157.17 42.89 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.427 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 tt -132.02 126.84 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.766 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.13 -16.11 20.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.914 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.516 ' CZ ' ' CD2' ' A' ' 72' ' ' LEU . 25.2 m-85 -102.01 134.65 44.9 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.36 0.6 . . . . 0.0 111.782 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.81 178.99 4.28 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.987 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.69 128.16 35.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.781 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.46 5.88 81.56 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.527 177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -83.72 139.49 32.71 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.198 0.999 . . . . 0.0 111.743 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 p -125.73 132.63 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.378 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -147.99 137.59 12.24 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.032 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.51 150.6 41.99 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 121.472 1.448 . . . . 0.0 112.439 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.37 130.6 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.307 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.7 48.15 0.11 Allowed Glycine 0 N--CA 1.471 1.018 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.247 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.3 p -163.12 162.89 25.88 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 117.376 0.588 . . . . 0.0 111.171 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -90.28 130.79 36.35 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.516 ' CD2' ' CZ ' ' A' ' 60' ' ' TYR . 78.3 mt -89.27 -12.36 40.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.469 HD21 ' N ' ' A' ' 74' ' ' GLN . 2.3 tt -169.59 146.78 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.976 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.469 ' N ' HD21 ' A' ' 73' ' ' LEU . 2.7 tm0? -102.81 122.31 44.26 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.421 HG21 HD12 ' A' ' 75' ' ' ILE . 90.0 mt -124.97 128.73 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.398 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -98.54 111.26 23.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.229 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.56 -179.951 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -80.68 137.22 36.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -114.02 126.64 55.35 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -96.97 113.65 25.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.211 0.529 . . . . 0.0 110.161 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -117.71 139.42 51.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.023 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -71.51 113.15 17.25 Favored Pre-proline 0 N--CA 1.47 0.549 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.546 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 N--CA 1.492 1.401 0 C-N-CA 122.057 1.838 . . . . 0.0 111.929 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.22 110.22 0.79 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -123.23 137.04 54.97 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.03 121.42 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 112.056 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 9.8 p -87.19 -46.56 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.609 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.467 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 72.2 ttt180 -149.16 137.28 20.71 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -100.84 145.6 28.36 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 11.5 p-10 -121.3 8.89 10.3 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.31 155.68 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.075 0.464 . . . . 0.0 111.018 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -134.74 147.57 50.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 56' ' ' VAL . 24.0 tp10 -60.11 135.25 57.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.167 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.77 8.06 70.39 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.224 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -118.4 156.33 29.16 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.125 0.463 . . . . 0.0 111.322 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.2 mmt -96.4 150.96 20.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -138.32 154.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.809 0.337 . . . . 0.0 110.405 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 30' ' ' GLU . 1.3 pm0 -109.98 155.19 22.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.974 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -83.8 92.75 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.765 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -178.61 75.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.99 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 38.74 91.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.957 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.45 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 27.4 t70 -84.67 11.97 8.02 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.339 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.9 mt 66.0 66.33 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.918 0.761 . . . . 0.0 110.859 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.06 128.93 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.413 ' OE2' ' NZ ' ' A' ' 46' ' ' LYS . 95.9 mt-10 -120.56 125.54 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.14 0.495 . . . . 0.0 111.091 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.5 m -121.04 133.57 67.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.265 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.9 ttp -103.88 109.54 21.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.413 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -51.96 62.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.201 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -138.49 -65.48 0.5 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.545 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -149.47 43.83 0.93 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.701 0.286 . . . . 0.0 110.37 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.0 p -150.87 149.71 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.951 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 m -102.19 118.86 37.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.516 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.64 133.54 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.482 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' NZ ' ' OE2' ' A' ' 37' ' ' GLU . 68.2 mttm -94.24 137.45 33.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.745 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.2 mt -132.03 139.15 34.11 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.059 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 49' ' ' SER . 50.4 Cg_exo -52.97 142.74 52.24 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.356 1.371 . . . . 0.0 112.379 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.93 164.85 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.551 -179.218 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.28 44.55 1.63 Allowed 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.149 2.566 . . . . 0.0 112.663 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t 64.38 116.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.732 0.301 . . . . 0.0 110.901 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -49.78 146.93 4.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 111.665 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 167.3 -134.57 3.31 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.0 139.55 53.34 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.87 0.335 . . . . 0.0 110.192 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -99.01 120.25 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.464 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 21.4 t -87.05 -54.76 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -154.13 158.76 40.89 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.302 0.572 . . . . 0.0 112.038 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.4 tt -116.87 119.54 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.198 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 74.3 mt -100.17 -18.22 17.02 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.3 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -115.17 142.75 46.23 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -123.7 165.92 16.42 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.142 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.42 150.25 11.99 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.014 0.435 . . . . 0.0 111.983 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.55 6.47 77.17 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.303 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -101.72 129.97 48.01 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 112.071 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.95 128.94 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 t -147.08 140.43 14.94 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.783 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.48 140.82 63.7 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.239 1.293 . . . . 0.0 112.05 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.2 p -59.43 131.75 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.555 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.28 50.48 0.12 Allowed Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.014 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.1 p -156.36 164.55 38.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.269 0.535 . . . . 0.0 111.304 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.4 m -88.26 121.06 30.22 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.88 -27.69 13.48 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 74' ' ' GLN . 1.7 tt -156.12 141.71 17.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.431 ' N ' ' CD2' ' A' ' 73' ' ' LEU . 52.2 tt0 -104.25 132.81 50.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.86 0.362 . . . . 0.0 110.205 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.7 mt -130.99 127.47 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.191 0.519 . . . . 0.0 111.34 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -87.46 142.95 27.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.717 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 83.9 m . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.299 179.535 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -116.26 141.49 48.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -114.6 126.41 54.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.88 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -99.62 118.69 36.71 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.21 0.528 . . . . 0.0 110.503 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -124.65 140.91 52.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.882 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.81 114.75 12.21 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo . . . . . 0 N--CA 1.493 1.484 0 C-N-CA 121.622 1.548 . . . . 0.0 112.662 -178.914 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 120.768 0.318 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.82 135.71 8.83 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.38 137.88 54.72 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 mm -102.66 121.18 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.688 0.28 . . . . 0.0 111.616 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 t -101.53 -34.65 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.751 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -153.49 133.21 13.06 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.88 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -105.37 130.48 53.47 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 16.8 p-10 -98.98 3.66 47.05 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.719 0.295 . . . . 0.0 111.086 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.46 157.64 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.792 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -132.33 145.7 51.45 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.32 0.581 . . . . 0.0 111.402 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -58.39 140.48 53.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.919 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.71 6.89 65.26 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -121.48 126.6 49.65 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.082 0.441 . . . . 0.0 111.225 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -71.34 141.17 50.44 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.2 t -142.1 161.5 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 1.6 pm0 -127.66 152.1 48.11 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.055 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 30' ' ' GLU . 52.4 pttt -26.8 145.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.583 0.552 . . . . 0.0 111.752 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.5 ' O ' ' O ' ' A' ' 33' ' ' GLN . 94.6 m-20 61.69 58.31 2.03 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.227 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.66 ' NE2' ' H ' ' A' ' 49' ' ' SER . 1.4 pm0 -43.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.488 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.485 ' H ' ' CG ' ' A' ' 33' ' ' GLN . 66.4 t0 -153.4 61.17 0.76 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.036 0.446 . . . . 0.0 110.672 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 34' ' ' ASP . 19.3 mt 55.73 124.62 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.999 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.73 131.78 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -92.87 120.53 33.31 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.331 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -129.22 134.93 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.967 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.0 ttp -116.43 153.15 32.6 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.723 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -135.31 -82.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' N ' ' OG1' ' A' ' 40' ' ' THR . 99.0 m-20 -91.6 44.43 1.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.0 tttt 68.46 38.06 2.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.79 0.328 . . . . 0.0 110.443 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.3 t -132.31 136.95 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -94.22 113.78 25.77 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.03 0.443 . . . . 0.0 110.012 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.39 133.75 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.822 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -93.53 125.26 38.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.31 0.576 . . . . 0.0 110.58 179.368 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 47' ' ' ILE . 80.4 mt -135.46 85.68 31.27 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.471 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.09 145.02 99.07 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 122.483 2.122 . . . . 0.0 111.722 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.66 ' H ' ' NE2' ' A' ' 33' ' ' GLN . 1.2 m -74.69 131.9 78.87 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.754 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.89 -15.45 40.33 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.816 1.677 . . . . 0.0 113.749 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -136.97 155.51 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.769 0.319 . . . . 0.0 111.424 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.18 160.02 9.4 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.42 -82.63 0.05 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -124.63 124.13 41.55 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -97.76 115.66 38.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.68 -54.07 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -165.36 152.64 10.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.514 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.445 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 2.8 tt -105.62 121.12 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.542 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -95.24 -17.48 21.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.077 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.407 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 12.3 m-85 -109.8 142.78 40.57 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.216 0.531 . . . . 0.0 111.261 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.435 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 60.7 ttm-85 -126.69 162.54 25.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.757 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -55.0 147.2 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.212 0.53 . . . . 0.0 111.875 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.44 6.48 87.56 Favored Glycine 0 N--CA 1.47 0.919 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.945 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.435 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 86.8 mt-30 -98.76 133.32 43.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.368 0.604 . . . . 0.0 111.715 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.81 129.14 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.29 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.9 t -147.64 141.04 15.29 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.722 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.04 142.47 34.39 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.466 1.444 . . . . 0.0 112.332 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -60.8 133.82 26.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.822 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.53 51.81 0.16 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 m -153.02 159.43 42.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 117.457 0.629 . . . . 0.0 111.561 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.2 m -88.04 98.08 11.33 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.867 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 3.1 mm? -65.21 -41.63 94.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.641 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.512 HD22 ' H ' ' A' ' 74' ' ' GLN . 1.8 tt -146.39 148.6 32.5 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.512 ' H ' HD22 ' A' ' 73' ' ' LEU . 54.3 mt-30 -103.26 127.18 50.66 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 mt -126.08 127.86 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.1 0.476 . . . . 0.0 111.575 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -101.83 114.16 28.0 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.961 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.4 -179.935 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 ttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -85.54 147.15 26.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.897 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -121.33 135.72 55.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.325 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -99.55 118.51 36.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -121.54 146.44 46.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.293 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.19 115.99 17.14 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo . . . . . 0 N--CA 1.495 1.616 0 C-N-CA 121.391 1.394 . . . . 0.0 113.291 -179.211 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.653 0.263 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.11 122.61 6.97 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -131.63 135.19 46.75 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 mm -102.7 120.0 51.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.185 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 m -92.37 -43.58 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.719 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -142.93 145.52 33.11 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -118.22 140.28 50.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.1 m-20 -119.8 13.47 12.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.781 0.324 . . . . 0.0 110.82 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.35 158.92 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 26.4 pttm -138.94 144.36 39.0 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 110.574 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 26' ' ' GLY . 13.1 tm-20 -47.78 138.88 8.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.725 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' N ' ' CD ' ' A' ' 25' ' ' GLU . . . 87.56 6.82 76.61 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.451 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 42.4 p-10 -106.93 150.01 26.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.206 0.503 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.6 mtp -90.31 142.69 27.48 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.091 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.9 t -120.01 133.38 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.672 0.272 . . . . 0.0 110.705 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -101.47 156.49 17.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.238 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.39 135.9 55.83 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.704 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 57.9 34.4 24.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.303 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -144.43 88.27 1.92 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.76 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -172.67 170.87 4.63 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.938 0.399 . . . . 0.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.442 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 81.0 mt -140.14 88.42 2.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.61 133.38 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.444 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -123.1 124.91 44.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.189 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.04 154.64 26.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.215 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.6 ttp -106.84 152.4 23.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.216 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.65 -42.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.479 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -136.0 49.0 2.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.92 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 56.81 43.46 25.0 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.066 0.46 . . . . 0.0 109.961 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.43 152.1 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.25 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.6 m -95.9 118.29 32.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.612 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.74 131.38 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.193 0.52 . . . . 0.0 110.769 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -92.03 139.24 30.84 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.086 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.3 mt -134.73 135.2 22.95 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.078 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 49' ' ' SER . 43.0 Cg_exo -51.6 146.17 27.42 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 121.689 1.593 . . . . 0.0 112.308 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.26 166.31 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.466 -179.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.71 49.85 3.32 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 123.044 2.496 . . . . 0.0 113.082 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t 68.29 119.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.838 0.351 . . . . 0.0 111.492 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -47.41 135.9 10.25 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.753 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.15 -141.52 6.51 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -123.59 144.98 49.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.021 0.411 . . . . 0.0 110.559 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.2 mm -100.96 120.76 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.2 t -92.43 -51.13 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -154.6 159.15 40.67 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.761 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.1 tt -106.95 132.76 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.221 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.44 -24.6 10.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.459 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -108.4 141.41 40.29 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.035 0.445 . . . . 0.0 111.418 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.494 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 90.4 mtm180 -120.2 162.62 19.05 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.39 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -56.17 134.83 53.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.174 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.75 4.98 84.62 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.929 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.494 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 79.8 mt-30 -83.27 135.53 34.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.688 0.744 . . . . 0.0 111.875 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.3 t -120.11 126.84 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 t -148.67 132.5 8.53 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -56.47 149.65 55.86 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.459 1.439 . . . . 0.0 112.106 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.89 128.56 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.783 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.52 49.72 0.05 OUTLIER Glycine 0 CA--C 1.531 1.078 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.131 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m -163.92 166.97 21.18 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.388 0.594 . . . . 0.0 111.165 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.454 ' O ' ' CG2' ' A' ' 71' ' ' THR . 6.3 t -95.4 115.92 28.09 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.99 -42.98 89.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.291 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.457 HD21 ' N ' ' A' ' 74' ' ' GLN . 4.0 tt -144.01 151.28 39.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.457 ' N ' HD21 ' A' ' 73' ' ' LEU . 36.8 mt-30 -102.62 121.12 41.77 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.9 127.19 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.965 0.412 . . . . 0.0 111.827 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.56 136.95 32.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.482 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.397 -179.872 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtm . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -111.77 143.65 42.34 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.328 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -139.49 114.31 9.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.017 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -88.87 122.44 32.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.135 0.493 . . . . 0.0 110.633 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -121.76 157.85 30.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.178 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 tp -44.43 126.24 4.76 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.495 1.611 0 C-N-CA 121.186 1.257 . . . . 0.0 112.539 -178.449 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 C--O 1.232 0.15 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.79 137.09 10.29 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -151.97 133.47 14.63 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.921 0.391 . . . . 0.0 109.986 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -102.77 124.34 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.561 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.58 -44.24 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.527 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -151.61 137.87 18.42 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -107.75 136.9 46.72 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.1 m-20 -108.16 0.46 21.56 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.665 0.269 . . . . 0.0 110.766 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.5 m -133.54 158.49 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -137.5 154.33 49.89 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -54.73 143.21 25.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.059 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.51 7.13 76.29 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.762 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 28' ' ' MET . 62.0 t0 -123.19 150.57 43.2 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.602 0.701 . . . . 0.0 111.089 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.553 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 76.5 mtm -78.07 149.09 33.99 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -121.8 133.93 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.69 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.86 157.41 17.22 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.348 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.05 94.48 6.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' ASP . 8.0 p30 173.12 113.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.936 0.398 . . . . 0.0 111.381 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 53.67 -82.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.829 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' ASP . 9.7 t0 74.88 13.14 3.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.864 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.3 mt 21.08 84.48 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.761 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.93 130.33 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.6 mp0 -116.37 124.38 49.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.475 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.56 135.14 58.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.637 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.7 ttp -124.83 151.46 45.21 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.675 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -104.27 -51.83 3.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.742 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' OG1' ' A' ' 40' ' ' THR . 94.7 m-20 -138.01 -62.5 0.59 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.327 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -146.31 39.19 1.08 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.855 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.6 t -129.87 133.33 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.798 0.332 . . . . 0.0 110.134 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.5 m -114.96 115.79 27.45 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.09 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.0 m -129.46 131.13 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.852 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -95.2 133.35 39.15 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.095 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mt -128.85 134.48 26.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.993 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.35 144.23 50.27 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.678 1.586 . . . . 0.0 111.219 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.1 m -99.0 104.01 23.14 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.22 48.43 2.49 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.186 1.924 . . . . 0.0 110.663 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.61 158.91 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -160.36 144.98 14.45 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.128 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.01 -137.05 4.98 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.07 141.72 51.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.902 0.351 . . . . 0.0 110.087 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -97.09 119.97 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.33 -49.61 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -158.26 158.43 34.43 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.734 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 4.4 tt -123.96 122.8 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.255 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.3 mt -99.15 -18.02 17.88 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.668 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.54 ' HH ' ' HG ' ' A' ' 70' ' ' SER . 21.3 m-85 -105.43 136.5 44.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.156 0.503 . . . . 0.0 110.827 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -121.06 -176.45 3.27 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.031 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -64.57 126.78 28.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.59 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.47 5.57 86.79 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.22 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -70.48 133.97 47.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.802 0.801 . . . . 0.0 110.835 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.71 126.9 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.3 t -149.17 139.49 13.44 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.189 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.91 150.34 64.25 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.034 1.156 . . . . 0.0 111.707 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.0 p -64.05 127.66 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.347 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.74 52.38 0.07 OUTLIER Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.027 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.54 ' HG ' ' HH ' ' A' ' 60' ' ' TYR . 29.7 p -162.84 163.45 26.51 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 117.289 0.545 . . . . 0.0 111.38 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.441 ' H ' ' HG1' ' A' ' 71' ' ' THR . 1.8 p -89.76 113.09 24.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.156 0.503 . . . . 0.0 110.182 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.19 -39.14 86.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.559 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.57 144.91 24.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.606 -177.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -103.38 125.91 50.25 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.4 mt -132.63 128.77 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.222 0.535 . . . . 0.0 111.333 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -100.65 136.08 41.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.838 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.431 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.595 ' SD ' ' NE2' ' A' ' 74' ' ' GLN . 14.3 ptp . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -101.71 134.69 44.48 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 40.5 mp0 -111.51 116.87 31.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.747 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -76.93 100.56 5.62 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -105.83 155.75 19.0 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.108 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.9 mt -93.33 108.25 31.98 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 N--CA 1.497 1.686 0 C-N-CA 121.847 1.698 . . . . 0.0 112.169 -179.674 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.765 0.317 . . . . 0.0 111.126 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.63 123.63 7.74 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -126.14 140.05 52.88 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 117.334 0.567 . . . . 0.0 110.158 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.54 121.8 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.29 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.96 -42.74 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.762 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -155.89 133.84 11.28 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -102.01 134.41 45.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 24.0 p-10 -106.21 -0.52 24.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.662 0.268 . . . . 0.0 111.149 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.63 160.37 37.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -139.6 155.78 47.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -50.87 135.72 23.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.079 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.17 4.61 66.49 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.858 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 36.7 p-10 -114.46 154.06 28.84 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.628 0.714 . . . . 0.0 110.908 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.9 mtm -114.12 148.73 36.71 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.01 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -139.43 150.4 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.92 0.391 . . . . 0.0 110.706 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -90.06 159.35 16.88 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.54 136.62 58.08 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.986 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 60.0 36.43 21.5 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.821 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -145.4 86.32 1.75 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 17.3 t0 -176.27 161.06 2.24 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.531 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 76.6 mt -134.55 88.63 2.46 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.107 0.479 . . . . 0.0 109.882 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.38 130.09 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -111.92 124.63 52.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.582 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.5 m -121.91 131.21 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.1 ttm -101.93 123.31 45.62 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.692 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -88.1 -90.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.418 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 42' ' ' LYS . 23.0 p-10 -96.03 -68.98 0.77 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.726 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.53 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 25.0 pttm -149.2 43.17 0.95 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.73 0.3 . . . . 0.0 110.977 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.19 151.21 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.909 0.385 . . . . 0.0 110.598 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 m -99.63 117.78 34.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.069 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.9 m -118.0 134.02 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.239 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.43 134.18 41.03 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.928 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.0 mt -137.23 85.41 21.98 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.732 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -55.74 141.43 84.51 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.705 2.27 . . . . 0.0 112.333 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.9 t -36.23 100.27 0.19 Allowed Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.589 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.92 -21.92 36.82 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.073 1.182 . . . . 0.0 113.843 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.19 120.96 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 122.104 -0.372 . . . . 0.0 111.212 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.48 152.94 33.95 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 121.167 -0.213 . . . . 0.0 110.547 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.2 -134.29 3.04 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.31 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -136.93 134.03 36.32 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.741 0.305 . . . . 0.0 110.234 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 55' ' ' ILE . 7.0 mm -90.77 118.44 36.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.95 -51.47 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -146.17 156.74 43.63 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.885 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 5.6 tt -121.79 122.77 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.362 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.15 -18.88 16.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.639 0.257 . . . . 0.0 110.933 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -105.98 141.08 37.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.17 0.509 . . . . 0.0 111.406 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.05 162.89 25.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.313 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.03 140.78 42.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.545 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.55 6.09 81.03 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.388 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -99.43 134.81 41.77 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.347 0.594 . . . . 0.0 111.854 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -126.38 129.2 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.566 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 t -147.79 138.03 12.65 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.38 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.15 140.95 70.73 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.43 1.42 . . . . 0.0 112.426 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 m -53.23 144.65 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.703 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.48 50.28 0.42 Allowed Glycine 0 N--CA 1.471 1.014 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.5 p -156.64 162.59 39.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 117.012 0.406 . . . . 0.0 111.024 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 m -82.33 100.61 10.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.005 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.19 -42.43 93.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.8 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 74' ' ' GLN . 3.3 tt -158.27 148.32 19.98 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.595 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 56.8 tt0 -103.05 128.24 49.99 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 86.8 mt -126.05 127.21 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.072 0.463 . . . . 0.0 111.262 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -98.56 111.98 24.17 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.212 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.182 179.771 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.39 141.01 40.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 33.8 mp0 -111.14 120.39 42.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.435 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -88.65 105.1 17.45 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 6' ' ' LEU . 67.9 tttt -111.85 173.08 6.53 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.137 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.403 ' H ' ' HG2' ' A' ' 5' ' ' LYS . 2.5 tt -106.42 82.97 1.06 Allowed Pre-proline 0 N--CA 1.471 0.594 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.493 1.495 0 C-N-CA 121.473 1.449 . . . . 0.0 111.854 -179.948 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 120.829 0.347 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.59 110.74 3.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -125.14 134.01 52.6 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 mm -102.6 119.05 50.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.659 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 8.8 p -90.1 -43.58 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.405 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.405 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 99.7 mtt180 -140.9 144.58 35.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.878 0.37 . . . . 0.0 111.405 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -109.36 136.89 48.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 18.7 p-10 -93.76 -11.66 30.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.731 0.301 . . . . 0.0 110.522 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.78 159.89 7.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.263 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 73.8 mmtt -129.52 144.73 51.39 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -46.51 138.3 5.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.914 0.388 . . . . 0.0 111.339 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.18 7.55 58.31 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.445 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 24' ' ' LYS . 50.0 p-10 -129.07 151.26 49.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.603 0.702 . . . . 0.0 111.212 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.3 mtt -103.08 150.32 23.72 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.496 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.462 ' CG2' ' OE1' ' A' ' 33' ' ' GLN . 3.5 p -138.34 154.26 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.343 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -102.82 160.84 14.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.801 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 86.4 tttt -65.65 137.17 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.055 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 8.9 m-20 92.63 81.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.676 0.61 . . . . 0.0 111.575 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.462 ' OE1' ' CG2' ' A' ' 29' ' ' VAL . 57.2 tt0 -153.56 98.73 2.26 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.887 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -96.49 77.12 2.93 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -141.25 25.84 2.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.926 0.393 . . . . 0.0 110.295 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.23 131.61 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.9 131.04 53.51 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.232 0.539 . . . . 0.0 111.557 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.2 124.28 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.176 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.3 ttp -110.78 157.39 19.84 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.911 0.386 . . . . 0.0 110.83 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.3 t -136.31 -118.08 0.16 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.034 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.521 ' N ' ' OG1' ' A' ' 40' ' ' THR . 87.5 m-20 -64.02 -49.41 72.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.793 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -175.46 56.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.503 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.52 150.22 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.977 0.417 . . . . 0.0 110.894 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -109.77 120.09 41.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.853 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.37 118.47 58.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.951 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -88.28 133.94 33.93 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mt -145.69 117.63 5.1 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.318 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.34 142.94 19.25 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.947 1.765 . . . . 0.0 111.586 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 m -46.57 106.64 0.6 Allowed Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.86 -25.72 45.16 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.338 1.359 . . . . 0.0 114.539 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.5 123.35 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 118.066 0.394 . . . . 0.0 111.607 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -85.53 149.89 25.06 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.65 -134.56 2.59 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.179 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -126.29 131.22 51.92 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.003 0.402 . . . . 0.0 110.828 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 mm -93.9 119.08 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.8 t -93.08 -49.39 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.463 ' O ' ' CD2' ' A' ' 73' ' ' LEU . 60.6 pttt -148.86 150.28 32.73 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.5 tt -127.64 128.86 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.187 0.518 . . . . 0.0 110.968 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.5 mt -98.31 -17.36 18.94 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.141 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -94.5 142.72 27.11 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.311 0.577 . . . . 0.0 111.404 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -125.82 159.83 31.42 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.491 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.86 128.99 39.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.526 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.06 3.54 88.98 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.638 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -77.28 132.33 38.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.179 0.514 . . . . 0.0 111.079 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.94 128.54 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.764 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.34 135.84 10.79 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 119.499 -0.286 . . . . 0.0 110.579 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.63 146.7 42.56 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.388 1.392 . . . . 0.0 112.305 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 p -58.68 126.97 17.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.682 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.32 51.65 0.08 OUTLIER Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.3 m -153.83 159.73 41.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.131 0.465 . . . . 0.0 110.749 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.8 m -84.63 112.4 20.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.033 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.95 -43.84 82.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.991 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.7 OUTLIER -159.69 149.81 18.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.175 -177.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.465 ' H ' HD23 ' A' ' 73' ' ' LEU . 12.7 mm-40 -103.5 118.45 36.78 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.3 mt -118.18 128.68 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.486 0.66 . . . . 0.0 111.572 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -95.19 115.48 27.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.335 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.777 -179.715 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -84.13 131.56 34.77 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 51.9 mp0 -102.73 113.28 26.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.184 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -79.85 101.14 8.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.726 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.514 ' NZ ' ' OG1' ' A' ' 71' ' ' THR . 68.5 mttm -112.4 145.8 39.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.2 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -63.04 111.9 5.81 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo . . . . . 0 N--CA 1.498 1.77 0 C-N-CA 121.061 1.174 . . . . 0.0 112.013 179.462 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.79 139.46 14.5 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -152.48 116.05 4.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.1 118.27 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.897 0.379 . . . . 0.0 111.668 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.0 p -92.65 -40.02 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.398 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -144.73 137.37 26.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -110.63 146.55 35.96 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 56.7 t0 -130.69 26.84 5.0 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.948 0.34 . . . . 0.0 111.304 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.89 155.01 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.848 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -141.98 147.47 37.01 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.02 0.438 . . . . 0.0 111.158 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.18 140.48 38.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.938 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.3 88.08 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.233 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -108.38 125.75 52.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.116 0.458 . . . . 0.0 111.356 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.9 mtm -85.61 129.42 34.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.108 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.77 135.46 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.313 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -90.99 156.3 18.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.961 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 88.5 tttt -61.24 130.32 45.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 16.2 t0 94.87 69.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.057 0.848 . . . . 0.0 110.802 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 34' ' ' ASP . 52.2 tt0 -176.93 -118.58 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 33' ' ' GLN . 67.1 t0 29.49 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.8 tp -84.51 94.72 8.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.19 134.01 62.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.883 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.42 113.18 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.315 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.7 132.56 59.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.2 ttp -118.87 124.39 47.02 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.54 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.451 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -90.25 -86.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.54 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 18.4 p-10 -86.07 -59.18 2.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.625 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.461 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 7.5 tmtt? -172.83 57.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 p -153.39 151.3 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.353 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -94.3 116.11 28.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.155 0.503 . . . . 0.0 109.987 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.66 117.33 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.876 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' CD ' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -98.35 132.96 43.39 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.046 0.45 . . . . 0.0 111.316 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mt -138.63 85.29 17.43 Favored Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.588 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -87.35 53.82 2.66 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.516 2.144 . . . . 0.0 113.511 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 51' ' ' VAL . 59.6 p -170.51 47.52 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.038 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 49' ' ' SER . 71.5 Cg_endo -73.26 25.12 0.31 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.36 2.04 . . . . 0.0 111.457 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 49' ' ' SER . 4.5 t 66.79 67.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.229 0.537 . . . . 0.0 109.799 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -76.79 150.2 36.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.44 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.94 -92.99 0.09 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -122.36 133.78 54.64 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mm -104.69 120.31 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.3 t -87.55 -51.19 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -155.65 159.98 40.03 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.278 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.487 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.7 tt -98.04 116.04 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.873 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -99.16 -16.81 18.45 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.679 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -119.79 143.83 47.64 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.524 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 83.4 mtp180 -120.88 166.98 13.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.656 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.36 143.99 57.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.005 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 5.98 89.49 Favored Glycine 0 N--CA 1.466 0.693 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.168 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.524 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 24.5 mt-30 -82.34 126.88 32.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.268 0.556 . . . . 0.0 111.275 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.0 124.16 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.11 155.14 37.35 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.299 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.04 151.85 62.15 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.721 2.281 . . . . 0.0 111.685 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -59.83 129.52 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.259 0.552 . . . . 0.0 110.999 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.82 55.01 0.12 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.825 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.6 m -154.68 166.2 34.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.978 0.418 . . . . 0.0 111.272 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.514 ' OG1' ' NZ ' ' A' ' 5' ' ' LYS . 19.3 m -94.59 114.17 26.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.285 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.07 -46.9 61.04 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.513 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.472 HD13 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -160.99 158.01 27.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.715 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.472 ' H ' HD13 ' A' ' 73' ' ' LEU . 58.7 tt0 -103.35 128.03 50.55 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.07 -0.394 . . . . 0.0 111.079 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.2 mt -127.12 128.71 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.215 0.531 . . . . 0.0 112.302 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -100.24 115.74 30.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.38 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.275 179.549 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.484 ' H3 ' ' CB ' ' A' ' 77' ' ' THR . 63.4 ttp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' ILE . 2.1 t80 -122.73 149.85 43.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.737 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -132.23 134.59 45.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.322 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -96.36 113.32 24.89 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -115.65 153.91 30.45 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.914 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tt -102.81 92.67 3.68 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.85 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.494 1.55 0 C-N-CA 121.531 1.487 . . . . 0.0 111.98 -179.835 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.46 145.82 18.22 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -145.32 138.11 26.14 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.509 0.654 . . . . 0.0 110.995 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -100.63 122.11 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.509 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 p -90.22 -44.76 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.234 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -143.89 148.44 35.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -118.84 143.57 46.88 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 34' ' ' ASP . 1.1 m-20 -128.42 18.38 6.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.222 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.49 159.31 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.44 142.24 51.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.827 0.346 . . . . 0.0 110.414 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.2 137.27 58.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.083 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.67 7.23 71.9 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 28' ' ' MET . 58.0 t0 -114.55 142.34 46.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.045 0.45 . . . . 0.0 111.084 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.543 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 94.9 mtp -79.94 152.33 29.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.432 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.89 160.82 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.363 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -123.53 152.0 42.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.896 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -57.9 90.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.2 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 63.7 t0 -178.95 134.01 0.13 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.078 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 4.2 pp0? -45.06 124.91 4.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.663 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' ASP . 89.7 m-20 -95.07 9.44 39.51 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 32.8 tp 63.1 73.85 0.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.235 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 m -117.32 134.57 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -119.12 137.81 53.34 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.603 0.716 . . . . 0.0 110.999 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 p -131.89 128.94 60.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.309 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.1 ttp -101.41 109.34 21.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.812 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -48.9 78.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.209 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 23.8 p-10 -152.4 -45.92 0.1 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.33 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -165.22 52.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.956 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -160.89 155.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 110.367 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -95.22 117.85 30.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.161 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.22 118.26 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.135 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -98.54 133.59 42.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.797 0.332 . . . . 0.0 110.365 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.1 mt -135.95 137.37 25.01 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 49' ' ' SER . 38.3 Cg_exo -54.59 147.48 48.52 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.325 1.35 . . . . 0.0 111.408 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -40.48 166.61 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 120.746 0.308 . . . . 0.0 111.133 -179.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.99 47.92 2.69 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.752 2.301 . . . . 0.0 113.42 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t 64.39 119.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.943 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -49.76 150.51 2.09 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.912 0.387 . . . . 0.0 111.76 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.65 -143.55 8.95 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -113.16 132.7 55.37 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 122.569 -0.371 . . . . 0.0 110.64 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mm -95.33 115.6 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.4 t -70.57 -50.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -173.84 155.03 2.52 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.667 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.502 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.7 tt -89.31 110.83 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.407 0.622 . . . . 0.0 110.633 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.6 -27.51 34.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.237 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.622 ' HH ' ' HG ' ' A' ' 70' ' ' SER . 5.0 m-85 -110.37 145.86 36.81 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.27 0.557 . . . . 0.0 112.002 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -115.24 169.21 9.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.353 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.63 133.29 53.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.591 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.11 6.26 88.99 Favored Glycine 0 N--CA 1.466 0.672 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.994 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -80.62 133.26 35.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.849 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 p -124.76 127.96 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.927 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 t -148.54 137.33 11.86 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.316 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.2 137.27 46.17 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.155 1.237 . . . . 0.0 111.66 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.5 m -52.37 144.1 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.774 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.29 50.74 0.28 Allowed Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.622 ' HG ' ' HH ' ' A' ' 60' ' ' TYR . 37.0 p -161.4 164.05 30.18 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 p -91.29 108.28 19.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.122 0.487 . . . . 0.0 110.544 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 3.7 mm? -63.85 -38.81 92.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.522 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 74' ' ' GLN . 4.0 tp -155.04 143.96 20.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.413 ' H ' HD12 ' A' ' 73' ' ' LEU . 53.3 tt0 -104.5 131.92 51.34 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.87 0.366 . . . . 0.0 111.173 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' ' 2' ' ' TYR . 92.8 mt -128.12 127.78 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -93.65 134.8 35.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.032 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.484 ' CB ' ' H3 ' ' A' ' 1' ' ' MET . 20.2 m . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.363 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.549 ' N ' ' H ' ' A' ' 77' ' ' THR . 5.0 ptt? . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -79.6 147.12 32.2 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.95 125.47 50.49 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -95.05 112.33 24.04 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -119.11 148.88 42.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.927 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.33 159.08 86.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.5 1.895 0 C-N-CA 121.573 1.516 . . . . 0.0 113.467 -179.316 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.459 ' OE2' ' CG2' ' A' ' 65' ' ' VAL . 43.6 tt0 . . . . . 0 C--O 1.232 0.159 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.17 114.08 3.1 Favored Glycine 0 N--CA 1.468 0.795 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -130.28 127.46 39.57 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -102.02 121.32 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.738 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.07 -42.3 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.293 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -142.31 140.72 32.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.747 0.308 . . . . 0.0 110.613 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.567 ' C ' ' H ' ' A' ' 23' ' ' VAL . 14.5 m95 -101.81 -18.28 15.83 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.289 0.566 . . . . 0.0 109.71 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 35' ' ' LEU . 19.5 m-20 43.51 3.32 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.671 -1.15 . . . . 0.0 113.89 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 21' ' ' TRP . 3.7 m -140.18 156.54 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -126.26 136.6 52.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -45.99 142.09 2.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.039 0.447 . . . . 0.0 111.091 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.17 69.47 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.048 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 51.4 p-10 -107.74 149.67 27.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.0 0.4 . . . . 0.0 110.732 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.6 mtt -83.85 144.15 29.44 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.553 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.1 t -121.07 132.8 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -109.92 154.29 23.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.036 0.446 . . . . 0.0 111.202 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -69.13 138.97 54.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.633 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t0 70.01 23.53 5.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.303 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -149.62 86.35 1.46 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.411 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -173.64 141.87 0.89 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.131 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 76.5 mt -137.16 92.2 2.69 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.17 131.8 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.511 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 58.6 mp0 -106.78 124.89 50.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.179 0.514 . . . . 0.0 111.224 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.15 132.06 70.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.768 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.6 ttp -116.46 117.53 30.16 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.207 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -64.83 -49.72 69.5 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.048 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -151.72 -64.7 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.686 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -138.23 36.87 2.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.122 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.34 133.76 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.635 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.6 m -102.36 118.22 36.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.77 162.21 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.784 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -134.77 134.95 41.47 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.926 0.393 . . . . 0.0 110.792 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.8 mt -123.78 85.62 53.49 Favored Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.448 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 49' ' ' SER . 92.0 Cg_endo -80.35 147.19 17.95 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.674 2.25 . . . . 0.0 112.482 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 48' ' ' PRO . 1.2 t 89.72 61.19 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.02 28.83 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.732 2.288 . . . . 0.0 111.343 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t 72.25 111.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.151 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -59.73 146.52 41.15 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.785 0.326 . . . . 0.0 111.775 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.04 -141.3 6.24 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -125.17 136.8 53.95 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 55' ' ' ILE . 7.1 mm -91.85 118.58 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -79.0 -50.74 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -171.07 158.76 5.72 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.92 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.6 tt -108.96 123.61 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.869 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.0 mt -97.78 -17.92 19.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.919 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.494 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 6.3 m-85 -108.9 144.24 37.06 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.886 0.374 . . . . 0.0 110.696 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -117.0 160.84 20.33 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.281 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 -57.24 140.58 49.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.698 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.32 4.97 90.35 Favored Glycine 0 N--CA 1.468 0.78 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.965 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -84.71 134.91 34.33 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.516 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' CG2' ' OE2' ' A' ' 15' ' ' GLU . 4.4 p -125.92 129.01 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.774 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.1 t -148.94 139.83 13.79 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.02 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.64 145.55 81.05 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.12 1.213 . . . . 0.0 111.378 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -55.33 125.94 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.088 0.471 . . . . 0.0 111.379 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.42 49.06 0.04 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.231 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.9 p -160.68 162.38 32.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.972 0.386 . . . . 0.0 111.091 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -94.55 107.8 19.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.199 0.523 . . . . 0.0 109.993 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.8 mm? -67.18 -39.28 86.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.813 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.502 HD22 ' H ' ' A' ' 74' ' ' GLN . 1.7 tt -153.19 145.72 24.15 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.332 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.502 ' H ' HD22 ' A' ' 73' ' ' LEU . 66.3 mt-30 -104.15 130.31 51.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.402 HG22 HD13 ' A' ' 75' ' ' ILE . 83.3 mt -127.73 126.62 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.279 0.561 . . . . 0.0 111.738 -177.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -86.65 143.11 27.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.727 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.549 ' H ' ' N ' ' A' ' 1' ' ' MET . 8.9 t . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.127 -0.939 . . . . 0.0 110.017 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -88.53 129.56 35.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 52.9 mp0 -112.28 125.43 54.15 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -92.12 123.46 35.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.237 0.541 . . . . 0.0 110.745 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -122.14 145.79 47.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.286 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.78 115.63 20.28 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.807 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.494 1.53 0 C-N-CA 121.881 1.721 . . . . 0.0 112.3 -179.124 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.79 109.87 0.44 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -123.4 142.64 50.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.017 0.436 . . . . 0.0 110.164 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 mt -102.0 121.85 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.545 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 9.8 p -101.29 -48.16 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 61.3 ttt85 -146.9 136.64 23.1 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -109.76 137.62 47.29 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.61 177.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 8.0 p-10 -101.86 -5.04 25.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.018 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.25 160.18 32.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.371 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 43.8 mmtm -129.22 153.29 47.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.842 0.353 . . . . 0.0 110.683 -179.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -53.09 142.44 20.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.37 6.69 66.05 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.859 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 53.0 p30 -123.41 151.98 42.05 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.901 0.85 . . . . 0.0 111.466 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -86.09 154.56 21.3 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.862 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.1 p -138.11 147.08 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.806 0.336 . . . . 0.0 110.203 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -107.33 155.47 19.95 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.492 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -62.3 138.07 58.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.273 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 t0 66.79 20.13 10.65 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.19 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -137.0 81.54 1.88 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 35.3 t70 -173.6 104.46 0.12 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.437 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.552 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 51.0 tp -84.06 99.38 10.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.688 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.63 130.01 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -115.74 123.76 49.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.842 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.82 137.03 59.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.955 0.407 . . . . 0.0 110.397 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.4 ptm -115.22 142.01 47.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.141 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -103.19 -64.35 1.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.817 0.341 . . . . 0.0 110.468 -179.595 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.529 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.4 t70 -128.39 56.08 1.65 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.4 tttp 73.71 47.46 0.17 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.9 t -133.69 159.57 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.946 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.1 m -121.75 113.83 20.24 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.915 0.388 . . . . 0.0 110.404 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -132.84 130.63 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.972 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.4 ' HZ3' ' CD1' ' A' ' 35' ' ' LEU . 52.5 tttp -92.2 136.29 33.3 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.98 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -136.25 96.36 12.63 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.098 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.77 146.6 76.89 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.343 2.029 . . . . 0.0 111.505 178.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.5 m -85.36 112.87 47.2 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.442 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.48 24.94 0.72 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.191 1.928 . . . . 0.0 111.052 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.55 155.96 37.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.68 -177.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -145.91 146.95 31.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.297 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.59 -132.38 2.56 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -129.37 148.41 51.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.694 0.283 . . . . 0.0 110.309 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mm -99.56 120.37 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.7 t -78.55 -50.93 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -172.84 154.25 2.87 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.312 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.482 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.7 tt -101.72 114.92 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.194 0.521 . . . . 0.0 110.331 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.27 -41.61 89.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.771 -179.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.461 ' CG ' ' NE2' ' A' ' 64' ' ' GLN . 5.5 m-85 -139.72 150.21 44.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.279 -178.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -109.93 -166.53 1.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.678 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -53.62 150.96 6.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.734 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.47 6.3 57.54 Favored Glycine 0 N--CA 1.474 1.231 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.461 ' NE2' ' CG ' ' A' ' 60' ' ' TYR . 49.7 tt0 -98.81 135.23 40.57 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 p -142.91 116.83 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -148.53 142.62 16.46 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.03 146.21 70.65 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.456 1.438 . . . . 0.0 112.162 177.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.9 p -48.79 131.27 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.587 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.29 51.2 0.06 OUTLIER Glycine 0 CA--C 1.527 0.785 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.809 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.8 t -165.18 157.56 15.68 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.779 179.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.7 p -89.92 131.01 36.05 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.117 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.45 -15.63 24.09 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.543 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.559 HD22 ' H ' ' A' ' 74' ' ' GLN . 0.8 OUTLIER -171.32 145.73 2.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.014 -0.674 . . . . 0.0 110.746 -179.218 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.559 ' H ' HD22 ' A' ' 73' ' ' LEU . 56.7 mt-30 -104.7 127.59 52.52 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.1 mt -129.25 126.95 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.311 0.577 . . . . 0.0 111.784 -177.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -88.0 135.98 33.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.825 178.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.6 m . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.541 -179.986 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttp . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -76.83 143.29 39.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.62 136.65 54.3 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.795 0.331 . . . . 0.0 110.181 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.14 118.46 36.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.721 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -118.52 134.85 54.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.42 -179.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.95 126.1 91.92 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.491 1.335 0 C-N-CA 121.198 1.265 . . . . 0.0 112.192 -179.484 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.532 0.206 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.46 151.08 17.49 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -153.39 128.29 9.56 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.265 0.533 . . . . 0.0 110.984 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 mm -102.22 119.75 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.36 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.5 m -93.55 -40.06 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.729 178.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.8 149.06 43.06 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.013 0.435 . . . . 0.0 111.836 -178.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -116.1 145.36 43.09 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.769 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 51.7 t0 -109.33 -6.6 15.44 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.461 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.25 159.54 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.87 0.367 . . . . 0.0 111.574 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -136.38 155.74 49.61 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.582 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -66.07 141.91 57.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.514 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.3 7.72 86.26 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.556 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -118.18 143.46 46.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.31 0.555 . . . . 0.0 111.621 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.7 mtm -87.87 147.13 25.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.563 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.09 151.4 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.032 0.444 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 32' ' ' ASP . 93.9 mt-10 -112.05 154.9 24.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.442 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.05 80.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.562 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' GLU . 68.0 t0 -179.44 94.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.17 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -142.27 151.89 42.49 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.155 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 63.8 t0 -165.74 24.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.976 0.417 . . . . 0.0 110.206 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.7 mt -121.99 27.84 7.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.689 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.42 129.24 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.07 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.453 ' OE2' ' N ' ' A' ' 45' ' ' VAL . 3.8 tm-20 -127.13 128.33 46.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.611 -179.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.36 141.52 43.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.046 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.9 ttp -126.16 136.59 53.04 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 -72.55 0.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.833 0.349 . . . . 0.0 110.421 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -97.56 41.12 1.13 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.525 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 tttp 71.22 37.76 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.402 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.5 t -127.17 134.68 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.5 m -96.64 116.66 29.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.142 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.453 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 34.3 m -133.27 132.64 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.052 0.453 . . . . 0.0 111.642 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -94.04 139.22 31.23 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.948 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mt -138.89 121.6 10.6 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 119.605 -0.235 . . . . 0.0 110.645 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.28 143.17 19.59 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.33 2.02 . . . . 0.0 112.081 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.1 p -69.7 114.13 22.38 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.394 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.71 8.43 4.63 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.947 1.765 . . . . 0.0 113.553 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -140.3 157.32 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.157 0.503 . . . . 0.0 111.841 -177.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -143.32 149.79 38.28 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.734 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.87 -134.94 2.91 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -118.37 131.34 56.31 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 117.224 0.512 . . . . 0.0 109.986 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 55' ' ' ILE . 5.1 mm -94.57 118.71 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.2 t -97.03 -48.91 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -143.36 157.17 44.69 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -177.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.0 tt -125.32 122.01 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.573 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.8 mt -98.86 -17.42 18.43 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.62 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -104.13 138.65 40.33 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.165 0.507 . . . . 0.0 111.288 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -122.05 166.29 14.73 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.077 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.87 130.48 44.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.979 0.418 . . . . 0.0 111.214 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.22 5.58 89.62 Favored Glycine 0 N--CA 1.467 0.755 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.882 179.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -79.22 140.49 37.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.979 0.419 . . . . 0.0 110.898 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.92 130.62 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.752 -179.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.5 t -148.96 138.15 12.39 Favored Pre-proline 0 N--CA 1.474 0.769 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.332 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -54.13 139.6 71.51 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.394 1.396 . . . . 0.0 112.069 177.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.9 t -65.14 131.84 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.45 51.05 0.13 Allowed Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.7 p -159.82 162.79 34.81 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 122.508 -0.407 . . . . 0.0 111.31 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.458 ' O ' ' CG2' ' A' ' 71' ' ' THR . 4.9 t -84.53 114.25 21.82 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.482 0.658 . . . . 0.0 109.953 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.83 -42.16 90.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.487 -178.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 74' ' ' GLN . 2.5 tt -143.77 146.85 33.42 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -177.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.444 ' N ' HD22 ' A' ' 73' ' ' LEU . 57.5 tt0 -101.74 123.51 45.84 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.26 129.53 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.495 -177.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -100.33 111.16 23.41 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.62 179.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.222 -0.358 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.021 -179.721 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OE2' ' A' ' 3' ' ' GLU . 68.4 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -77.43 133.9 38.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.917 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.545 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 54.4 mp0 -109.83 128.64 55.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.206 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -92.64 117.32 29.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -119.7 147.16 44.91 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.014 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mt -67.9 113.7 16.19 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.497 1.694 0 C-N-CA 120.985 1.124 . . . . 0.0 112.14 179.149 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 CA--C 1.523 -0.078 0 CA-C-O 120.633 0.254 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.77 153.19 21.27 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -138.28 142.87 39.81 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.82 121.39 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.876 0.369 . . . . 0.0 111.992 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -94.27 -40.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.492 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -139.6 146.79 40.24 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -119.45 140.79 49.87 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.618 179.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 9.1 p-10 -114.87 5.52 15.16 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -135.24 156.72 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.513 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -142.52 149.09 38.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.406 0.622 . . . . 0.0 111.516 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -56.62 140.11 47.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.489 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.93 9.14 78.07 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 116.328 -0.396 . . . . 0.0 112.695 178.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 28' ' ' MET . 67.3 t0 -121.86 135.85 54.91 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.184 0.492 . . . . 0.0 111.705 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.531 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 62.9 ttp -94.2 127.54 40.11 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.456 179.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 p -129.82 136.88 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.203 0.525 . . . . 0.0 111.956 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 56.5 mp0 -83.86 157.19 22.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.584 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 37.0 ttpt -81.45 130.54 35.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.72 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 52.7 t0 130.5 122.02 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.433 1.083 . . . . 0.0 110.19 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.447 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 60.8 tp60 58.29 103.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.458 178.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 33' ' ' GLN . 97.3 m-20 -143.08 141.18 31.2 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.1 tp -101.73 79.44 1.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.198 0.523 . . . . 0.0 111.441 -178.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.61 126.06 74.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -118.34 118.58 32.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.741 -179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 m -125.57 132.79 70.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.927 0.394 . . . . 0.0 110.26 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.9 ttp -96.35 123.69 40.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.258 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.1 p -89.53 -64.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.729 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 40' ' ' THR . 68.3 t0 -137.57 60.14 1.65 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.246 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 35.5 tttp 74.69 21.89 2.09 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.51 139.59 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 m -94.69 115.74 27.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.794 0.33 . . . . 0.0 110.269 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 m -125.69 131.04 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.898 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -99.67 135.02 41.71 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -131.76 85.27 52.03 Favored Pre-proline 0 N--CA 1.471 0.6 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.844 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.483 ' O ' ' OG ' ' A' ' 49' ' ' SER . 91.2 Cg_endo -80.44 151.22 19.89 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.571 2.181 . . . . 0.0 113.201 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 48' ' ' PRO . 6.0 p 80.74 67.6 0.14 Allowed Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.08 37.85 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.857 2.372 . . . . 0.0 112.755 178.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 t 63.25 114.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.725 0.298 . . . . 0.0 111.24 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -77.37 152.77 34.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.475 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.72 -140.36 6.04 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -112.17 129.76 56.14 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.37 0.585 . . . . 0.0 110.465 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -93.9 119.89 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.1 t -93.31 -52.74 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -151.87 158.65 43.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.902 -177.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.7 tt -112.25 121.76 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.027 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.6 mt -99.3 -17.15 18.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.19 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -109.25 143.35 38.83 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.062 0.458 . . . . 0.0 111.004 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -120.58 164.42 16.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.084 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.38 127.09 30.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.171 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.2 5.4 89.02 Favored Glycine 0 N--CA 1.468 0.785 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 178.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -76.7 136.53 39.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.648 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.74 132.92 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.698 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.78 140.68 14.56 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.777 -178.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.03 147.17 76.56 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.265 1.31 . . . . 0.0 110.596 176.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.02 126.67 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.246 0.546 . . . . 0.0 110.997 -179.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 146.0 48.56 0.03 OUTLIER Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.388 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 p -164.97 166.41 19.41 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.268 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.456 ' O ' ' CG2' ' A' ' 71' ' ' THR . 6.6 t -88.98 117.43 27.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.776 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.46 -43.36 97.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.277 0.561 . . . . 0.0 110.428 -179.29 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.419 HD21 ' N ' ' A' ' 74' ' ' GLN . 3.8 tt -145.99 146.32 30.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.419 ' N ' HD21 ' A' ' 73' ' ' LEU . 37.4 tp60 -101.91 124.89 48.31 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.2 mt -127.2 127.3 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.223 -178.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -87.52 142.54 27.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.46 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.216 -179.886 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 75' ' ' ILE . 24.1 t80 -74.72 131.88 41.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 43.1 mp0 -95.95 125.9 40.82 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.697 -179.149 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -94.71 109.24 21.2 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.19 150.22 26.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.078 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.45 116.37 39.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.495 1.606 0 C-N-CA 121.774 1.649 . . . . 0.0 112.985 -178.402 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 . . . . . 0 C--O 1.232 0.156 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.85 111.43 4.23 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -118.38 125.01 49.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.069 0.461 . . . . 0.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 mm -102.41 120.35 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.232 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -107.92 -25.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -141.72 129.96 22.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.03 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -112.44 139.59 47.88 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 17.8 p-10 -111.49 2.09 17.27 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.3 m -135.5 161.23 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.81 0.338 . . . . 0.0 110.696 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.46 153.02 50.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.046 -178.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -52.74 140.76 22.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.376 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.71 8.33 76.89 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.374 177.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 41.7 p-10 -113.98 150.01 34.48 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.822 0.811 . . . . 0.0 110.691 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.6 mtm -97.63 149.63 22.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.284 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -145.16 140.12 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.906 0.384 . . . . 0.0 111.118 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 32' ' ' ASP . 95.7 mt-10 -87.03 163.93 16.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.869 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.36 74.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.235 0.541 . . . . 0.0 110.435 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 30' ' ' GLU . 11.5 p-10 170.07 78.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.518 ' HB2' ' H ' ' A' ' 49' ' ' SER . 18.1 tp60 -46.98 167.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.35 -179.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 99.0 m-20 -87.77 -34.48 18.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.529 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 0.9 OUTLIER 159.62 106.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.784 0.678 . . . . 0.0 110.734 179.511 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.62 131.73 69.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -117.98 123.3 45.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.989 0.424 . . . . 0.0 111.459 -178.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.74 128.49 71.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.503 ' SD ' ' N ' ' A' ' 41' ' ' ASP . 10.6 tmm? -133.48 127.82 34.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.564 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -46.23 64.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.503 ' N ' ' SD ' ' A' ' 39' ' ' MET . 24.5 p-10 -152.47 -54.73 0.12 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.551 -179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.423 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 59.8 pttt -145.74 42.07 1.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.148 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.83 137.91 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.168 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -103.33 119.24 38.51 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.89 119.02 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.756 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.53 112.9 24.79 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 mt -129.99 109.78 16.89 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.63 147.66 17.61 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.37 2.047 . . . . 0.0 111.744 179.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.518 ' H ' ' HB2' ' A' ' 33' ' ' GLN . 6.9 t -58.39 120.39 43.94 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.17 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.96 -3.05 13.35 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 122.088 1.859 . . . . 0.0 114.218 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.23 125.45 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.027 0.376 . . . . 0.0 110.927 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -97.04 153.54 17.86 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.634 0.254 . . . . 0.0 111.037 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.89 -129.71 1.75 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.612 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -126.76 133.59 50.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.708 0.289 . . . . 0.0 110.408 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 mm -86.74 123.59 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 t -82.94 -52.17 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.679 -178.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -164.25 158.88 19.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.801 -178.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.481 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.2 tt -91.14 114.54 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.281 0.562 . . . . 0.0 110.481 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -90.94 -24.36 20.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -113.2 140.21 48.13 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.284 0.564 . . . . 0.0 111.154 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.511 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 86.8 mtm-85 -114.42 166.52 11.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.636 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -62.16 129.34 40.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.861 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.26 69.38 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.808 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.511 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 78.5 mt-30 -80.99 134.68 35.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.616 0.708 . . . . 0.0 111.174 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.95 124.07 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.465 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 t -147.29 138.61 13.27 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 -179.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -55.07 148.81 46.61 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.138 1.225 . . . . 0.0 111.809 179.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.8 p -59.27 129.68 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.169 0.509 . . . . 0.0 111.112 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.09 49.16 0.09 OUTLIER Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.068 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.9 p -159.84 163.78 34.15 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 117.299 0.549 . . . . 0.0 110.846 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.465 ' O ' ' CG2' ' A' ' 71' ' ' THR . 8.5 t -86.75 114.21 23.24 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.261 0.553 . . . . 0.0 110.391 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -65.55 -41.4 93.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.442 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.438 HD11 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -152.37 153.99 34.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.369 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.438 ' H ' HD11 ' A' ' 73' ' ' LEU . 50.7 tt0 -103.11 129.4 49.95 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.171 0.51 . . . . 0.0 110.992 -178.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 75' ' ' ILE . 89.7 mt -128.7 129.15 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.665 -178.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -96.24 114.44 26.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.699 178.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.665 179.904 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -95.71 142.74 27.64 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -118.55 135.6 54.32 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.951 0.405 . . . . 0.0 110.638 -179.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -88.7 116.31 26.87 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.096 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -116.87 132.01 56.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.888 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.94 115.69 42.86 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.729 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo . . . . . 0 N--CA 1.492 1.427 0 C-N-CA 121.314 1.343 . . . . 0.0 111.977 179.608 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.77 123.18 3.42 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -134.89 139.85 45.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.975 0.417 . . . . 0.0 110.174 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.43 119.02 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.554 -179.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.3 p -92.27 -41.98 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -144.83 138.47 27.07 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -110.86 140.19 45.52 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 34' ' ' ASP . 4.4 p30 -108.02 -4.05 18.18 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.01 162.69 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.959 0.409 . . . . 0.0 111.383 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.2 151.91 35.9 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.842 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -61.06 138.37 58.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.883 0.373 . . . . 0.0 111.219 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.78 64.21 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.682 179.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 41.9 p-10 -117.73 152.22 35.69 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.399 0.6 . . . . 0.0 111.021 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -81.35 151.22 28.09 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.041 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -140.28 140.32 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.195 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -95.76 152.41 18.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.723 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 52' ' ' ARG . 64.2 tttm -82.04 89.39 6.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.343 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 33' ' ' GLN . 62.6 t0 -176.3 78.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.188 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 32' ' ' ASP . 4.7 tp-100 37.08 93.02 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.047 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 31.8 t0 -90.17 15.33 10.49 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.0 mt 62.19 66.84 0.77 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.398 -179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.57 130.25 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -110.15 123.38 49.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.332 0.587 . . . . 0.0 110.647 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 m -124.23 137.62 56.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.886 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 39' ' ' MET . 3.4 ppp? -121.92 147.44 46.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.148 0.499 . . . . 0.0 110.837 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -109.41 -59.41 1.91 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.415 -179.542 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.517 ' N ' ' OG1' ' A' ' 40' ' ' THR . 55.7 t0 -135.95 68.55 1.44 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.96 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 62.67 38.83 11.78 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.71 138.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.074 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.0 m -114.86 116.11 28.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.213 0.53 . . . . 0.0 110.758 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.71 157.81 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.431 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -100.72 136.16 41.03 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.925 179.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.5 tt -127.26 135.11 26.93 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.446 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 49' ' ' SER . 33.9 Cg_exo -54.69 144.32 65.47 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 121.516 1.477 . . . . 0.0 112.226 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -41.32 164.46 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.649 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -81.45 47.12 2.44 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.772 2.315 . . . . 0.0 113.45 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 t 67.04 117.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.922 0.391 . . . . 0.0 111.417 179.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 73.7 ttt-85 -48.25 135.68 13.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.425 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.16 -145.45 8.11 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -118.51 133.91 55.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.033 0.417 . . . . 0.0 110.182 -179.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -95.05 121.38 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 t -81.63 -51.18 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -164.55 155.61 15.15 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.437 -178.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.7 tt -90.51 118.27 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.584 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -93.86 -18.24 22.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.716 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -119.08 140.58 49.84 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.089 0.471 . . . . 0.0 110.909 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -115.97 167.32 11.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.234 0.54 . . . . 0.0 111.523 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -62.57 132.65 53.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.902 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.01 3.38 90.59 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -80.63 134.49 35.9 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.308 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.76 131.47 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.761 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 t -146.62 139.09 13.97 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.526 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.68 149.04 25.97 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.387 1.391 . . . . 0.0 111.626 178.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 p -59.35 133.61 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.723 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.46 48.03 0.12 Allowed Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.1 p -162.63 165.08 26.26 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 117.43 0.615 . . . . 0.0 111.367 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.449 ' O ' ' CG2' ' A' ' 71' ' ' THR . 14.7 t -96.95 118.16 32.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.985 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.671 ' CD2' ' H ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -66.26 -36.13 82.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.919 -179.188 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 74' ' ' GLN . 2.1 tp -151.18 149.97 30.07 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.458 ' H ' HD13 ' A' ' 73' ' ' LEU . 3.7 tm0? -103.78 131.97 50.47 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 -179.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.5 mt -130.17 129.24 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.138 0.494 . . . . 0.0 111.958 -178.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -97.11 117.2 30.77 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.985 178.287 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.679 -179.527 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mmm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -74.39 130.38 39.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.131 -179.131 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 42.9 mp0 -102.51 125.19 49.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.174 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -86.4 116.26 24.44 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.28 147.27 49.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.791 -179.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.8 tt -75.68 111.51 14.83 Favored Pre-proline 0 N--CA 1.471 0.604 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo . . . . . 0 N--CA 1.496 1.665 0 CA-C-N 120.492 1.212 . . . . 0.0 112.388 179.986 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.55 133.38 8.88 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -140.03 133.07 29.48 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.973 0.416 . . . . 0.0 109.892 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.7 mm -102.81 119.62 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.879 -178.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 p -98.8 -37.37 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.03 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -141.01 133.43 28.36 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -110.55 144.85 38.79 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.08 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -128.65 19.91 6.13 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.094 0.407 . . . . 0.0 111.275 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.53 155.41 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -128.16 145.13 51.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.038 0.447 . . . . 0.0 110.512 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.79 137.86 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.054 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.56 7.75 71.53 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.133 179.452 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -116.73 147.82 41.67 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.121 0.461 . . . . 0.0 111.103 -179.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.4 mmm -84.37 147.71 27.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.4 133.98 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.252 179.019 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -91.61 158.31 16.49 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.193 -179.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.78 137.67 57.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.51 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.408 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 94.3 m-20 60.57 37.07 19.68 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.543 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 32' ' ' ASP . 99.4 mm-40 -143.44 86.78 1.91 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -174.36 162.73 3.63 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -134.06 89.74 2.61 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.233 0.539 . . . . 0.0 109.825 178.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.54 130.94 70.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.175 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.9 119.89 37.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.891 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.1 m -117.33 133.17 64.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.068 0.461 . . . . 0.0 109.975 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.0 ttp -113.55 132.57 55.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -116.77 -88.71 0.59 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.658 -179.663 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.445 ' N ' ' OG1' ' A' ' 40' ' ' THR . 23.2 p-10 -90.06 50.72 1.91 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.214 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 62.22 43.79 8.22 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.3 t -131.7 158.25 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.735 178.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.6 m -111.28 116.17 30.56 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.095 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.34 135.33 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.958 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -101.23 134.7 43.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.949 0.404 . . . . 0.0 110.808 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.8 mt -136.54 87.72 20.97 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.696 179.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.55 145.66 94.05 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 122.85 2.366 . . . . 0.0 112.543 179.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.9 m -51.65 108.41 1.06 Allowed Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.329 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.23 -14.72 28.6 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.461 1.441 . . . . 0.0 114.638 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.5 126.0 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 118.511 0.596 . . . . 0.0 111.228 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -92.01 150.44 20.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.574 0.226 . . . . 0.0 110.714 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.26 -134.33 2.89 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -119.29 147.26 44.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.944 0.372 . . . . 0.0 110.38 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mm -103.91 119.29 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.9 t -77.76 -52.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.874 -179.018 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -169.24 154.85 6.1 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.158 -178.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.1 tt -81.77 115.75 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.292 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.4 mt -93.99 -19.23 21.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.653 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -117.58 143.07 46.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.239 0.543 . . . . 0.0 111.192 -179.681 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -112.13 163.37 14.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.752 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.65 139.78 58.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.504 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.08 5.33 89.66 Favored Glycine 0 N--CA 1.468 0.79 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.86 179.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -79.01 133.63 36.82 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.227 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.45 127.75 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.18 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -149.35 136.19 10.75 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.45 148.97 69.01 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 121.615 1.543 . . . . 0.0 112.17 177.046 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -48.48 147.73 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.734 179.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.11 47.98 0.63 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.503 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.5 p -162.02 163.16 28.99 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.634 179.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.446 ' O ' ' CG2' ' A' ' 71' ' ' THR . 15.0 t -103.1 118.96 37.98 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.097 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.635 ' CD2' ' H ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -66.86 -35.75 80.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.891 -179.678 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.424 HD13 ' H ' ' A' ' 74' ' ' GLN . 1.8 tp -149.98 149.47 30.43 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.424 ' H ' HD13 ' A' ' 73' ' ' LEU . 57.9 tt0 -104.03 131.81 50.91 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.709 0.29 . . . . 0.0 110.793 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 87.5 mt -127.37 128.74 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.388 0.613 . . . . 0.0 112.036 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -94.54 140.93 29.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.915 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.472 179.389 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -116.38 147.16 41.91 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.13 134.12 47.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -93.94 118.04 30.93 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.542 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -125.98 145.52 50.25 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tp -82.29 113.75 46.21 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 N--CA 1.494 1.554 0 C-N-CA 121.841 1.694 . . . . 0.0 112.963 -179.566 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 121.045 0.45 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.67 110.51 0.93 Allowed Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' OE1' ' CE ' ' A' ' 39' ' ' MET . 79.1 tt0 -115.81 129.59 56.5 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.632 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 mm -102.17 119.62 50.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.329 -178.152 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.8 m -109.37 -38.83 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -138.22 148.94 45.31 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -132.98 141.42 48.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.641 -1.163 . . . . 0.0 107.919 177.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -128.46 16.45 6.53 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.41 160.8 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.98 143.47 51.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.826 0.346 . . . . 0.0 110.812 -179.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -61.26 140.55 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.162 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.21 7.19 77.29 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.889 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -118.41 149.54 41.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.975 0.417 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.0 mtm -81.95 151.15 27.33 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.908 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -135.47 145.64 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.965 179.334 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -110.49 132.13 54.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.587 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 64.4 tttm -52.83 137.48 31.8 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.561 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 3.7 m-20 83.61 -11.7 0.88 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.408 0.442 . . . . 0.0 111.795 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -115.43 76.78 1.03 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.572 0.225 . . . . 0.0 110.42 179.229 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 57.2 t0 -176.66 137.73 0.27 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.245 179.559 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.477 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 81.2 mt -119.45 108.25 14.31 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.558 0.694 . . . . 0.0 110.598 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.21 133.1 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.631 179.576 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.462 ' OE2' ' CG2' ' A' ' 44' ' ' THR . 44.2 tt0 -116.57 120.0 37.33 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 110.397 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.21 140.85 46.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.539 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.444 ' CE ' ' OE1' ' A' ' 17' ' ' GLU . 66.0 ttp -124.71 144.46 50.21 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.832 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -129.18 -85.96 0.55 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.952 179.355 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.453 ' N ' ' OG1' ' A' ' 40' ' ' THR . 67.3 t0 -82.86 47.01 1.15 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.801 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 61.8 38.88 14.52 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.335 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.26 135.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.462 ' CG2' ' OE2' ' A' ' 37' ' ' GLU . 6.9 m -95.61 119.38 34.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.121 -179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.52 153.88 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 110.734 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -119.26 133.49 55.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.773 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.4 mt -125.63 137.97 30.99 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.088 -179.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' SER . 31.2 Cg_exo -52.49 153.97 12.72 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 121.54 1.493 . . . . 0.0 111.557 178.159 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.33 164.39 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.952 0.406 . . . . 0.0 111.304 -179.514 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.1 49.07 3.1 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.946 2.431 . . . . 0.0 113.669 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 t 69.93 117.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 120.889 0.376 . . . . 0.0 111.693 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -46.81 135.84 8.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.2 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.5 -143.41 7.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.26 144.76 48.44 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.084 0.442 . . . . 0.0 110.545 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 55' ' ' ILE . 7.2 mm -102.02 121.57 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.1 t -80.25 -52.14 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.54 -179.024 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -167.54 156.99 10.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.932 -179.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.463 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.6 tt -85.87 116.37 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.085 0.469 . . . . 0.0 110.398 -179.688 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.71 -29.68 22.24 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.8 -179.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' ' CB ' ' A' ' 70' ' ' SER . 15.4 m-85 -119.15 145.8 45.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.072 0.463 . . . . 0.0 111.387 -179.649 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -126.62 172.54 10.18 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.962 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.5 145.92 55.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.407 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.99 6.13 82.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.761 178.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -100.41 124.4 45.87 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.46 0.648 . . . . 0.0 112.059 -179.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 p -125.01 126.74 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.515 178.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 t -148.67 140.54 14.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.555 -177.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.09 148.45 48.61 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.164 1.242 . . . . 0.0 111.325 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.29 130.33 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 111.127 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.72 52.86 0.07 OUTLIER Glycine 0 CA--C 1.528 0.863 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.921 179.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.459 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 8.5 m -156.54 164.57 38.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.195 0.498 . . . . 0.0 111.077 179.608 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 p -96.07 111.85 23.75 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.56 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 72' ' ' LEU . 5.8 mp -64.01 -41.03 97.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.357 179.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.42 HD13 ' H ' ' A' ' 74' ' ' GLN . 2.3 tp -162.45 146.26 11.73 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.138 -178.614 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' H ' HD13 ' A' ' 73' ' ' LEU . 3.2 tm0? -103.09 130.54 50.26 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.921 0.391 . . . . 0.0 110.741 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.2 mt -128.2 128.92 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.301 0.572 . . . . 0.0 111.923 -178.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -95.82 139.98 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.686 178.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.439 179.932 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -80.16 148.08 31.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.824 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.79 118.92 29.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -83.37 104.28 13.4 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -102.34 148.22 25.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.477 -179.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.38 117.32 59.48 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.288 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo . . . . . 0 N--CA 1.498 1.75 0 C-N-CA 121.939 1.76 . . . . 0.0 111.597 179.641 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 43.9 mp0 . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.01 162.62 26.3 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -155.11 135.97 13.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.199 0.5 . . . . 0.0 110.55 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.3 mm -102.64 121.44 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.484 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.6 p -91.72 -44.53 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.407 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -140.86 138.53 34.02 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.054 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.0 m95 -112.45 141.57 46.03 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 34' ' ' ASP . 15.4 p-10 -125.59 18.43 8.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.13 0.423 . . . . 0.0 111.555 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.79 156.24 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.86 139.9 51.94 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.49 140.93 53.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.045 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.78 5.71 68.31 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.821 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 28' ' ' MET . 43.9 t0 -110.11 -174.39 2.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 117.02 0.41 . . . . 0.0 110.676 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.536 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 94.9 mtp -120.22 151.95 38.42 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.0 t -128.63 161.26 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.088 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -130.85 156.01 45.75 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.684 -179.402 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.73 140.37 58.44 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.382 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 59.62 32.44 21.55 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.437 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -147.43 87.67 1.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.312 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 65.8 t0 -171.83 130.33 0.66 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.258 -178.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.5 mt -108.93 84.01 1.85 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.423 0.63 . . . . 0.0 110.34 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.48 132.83 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.494 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -111.1 116.54 31.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.635 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 m -113.25 131.99 63.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 110.568 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.8 ttp -111.18 112.68 24.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 p -63.0 -47.87 81.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.175 0.512 . . . . 0.0 110.001 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -149.56 -68.1 0.21 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.67 -179.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -138.64 35.23 2.22 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.264 179.503 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.36 137.58 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 m -103.47 118.0 35.73 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.12 156.85 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.24 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -99.71 138.34 36.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.177 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 47' ' ' ILE . 19.8 tt -133.48 113.95 13.27 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.484 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.29 142.98 17.16 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.003 1.802 . . . . 0.0 112.289 -179.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.0 p -58.38 109.46 1.85 Allowed Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.15 -23.13 39.86 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.057 1.172 . . . . 0.0 114.705 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.99 127.46 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.253 0.479 . . . . 0.0 111.34 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -92.86 148.82 21.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.672 0.272 . . . . 0.0 110.849 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.11 -131.48 1.7 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.9 146.87 49.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.015 0.408 . . . . 0.0 110.448 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.9 mm -103.58 119.89 52.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.139 -179.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 t -79.28 -52.42 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.908 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -163.68 158.39 20.36 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.167 -179.203 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.5 tt -88.73 118.28 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.054 0.454 . . . . 0.0 111.253 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.4 mt -96.92 -17.87 19.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.167 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.24 146.61 39.05 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.018 0.437 . . . . 0.0 110.586 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -124.08 160.88 26.76 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.816 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.79 138.03 58.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.03 5.35 90.2 Favored Glycine 0 N--CA 1.467 0.735 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.543 178.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -75.69 129.18 36.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.209 0.528 . . . . 0.0 111.174 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.9 t -119.7 127.64 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.31 154.92 36.67 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.499 -178.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.25 145.7 55.03 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.84 2.36 . . . . 0.0 112.238 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -55.4 130.42 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.193 0.521 . . . . 0.0 110.421 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.13 55.49 0.25 Allowed Glycine 0 N--CA 1.467 0.736 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -149.71 173.18 13.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.18 0.514 . . . . 0.0 111.07 -179.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -102.05 114.29 28.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.935 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.68 -47.46 69.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.914 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.489 HD13 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -159.01 159.4 34.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.806 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.489 ' H ' HD13 ' A' ' 73' ' ' LEU . 51.3 tt0 -104.5 127.91 52.31 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.834 0.349 . . . . 0.0 111.412 -178.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.6 mt -128.86 128.73 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.189 0.519 . . . . 0.0 111.757 -179.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -100.05 119.05 37.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.359 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.819 -179.832 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OE2' ' A' ' 3' ' ' GLU . 99.3 mtp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -80.99 131.45 35.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 56.0 mp0 -113.52 123.78 50.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -95.85 122.16 38.34 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -128.72 129.46 45.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.973 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 tp -45.62 105.9 0.51 Allowed Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.498 1.764 0 C-N-CA 121.351 1.367 . . . . 0.0 111.989 -179.796 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.622 0.248 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.85 154.18 17.07 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -141.05 140.72 34.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.968 0.413 . . . . 0.0 110.096 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.64 124.25 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.992 -178.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.45 -44.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.91 142.71 40.62 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -121.2 135.83 55.08 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -106.99 -3.8 19.71 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.686 0.279 . . . . 0.0 111.186 179.053 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.08 159.17 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -144.99 161.12 40.18 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.065 0.46 . . . . 0.0 111.53 -178.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -56.78 139.78 49.84 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.371 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.76 8.05 62.41 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.28 -0.486 . . . . 0.0 112.943 178.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -128.02 155.01 44.99 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.543 0.672 . . . . 0.0 111.837 -179.307 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.0 mtp -88.75 154.62 20.13 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.016 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -134.64 150.84 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.007 0.432 . . . . 0.0 110.624 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.63 159.66 17.97 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.147 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -71.43 87.79 0.88 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.034 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 34' ' ' ASP . 38.0 t0 -174.46 159.71 3.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.663 178.63 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -44.78 95.5 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.553 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' ASP . 79.4 m-20 -72.33 -3.65 25.16 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.588 0.709 . . . . 0.0 109.131 179.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.412 ' O ' ' CG ' ' A' ' 22' ' ' ASP . 35.6 tp 60.79 80.48 0.21 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.337 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.11 131.81 70.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.268 178.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -111.26 121.75 46.08 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.52 138.23 54.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.741 -178.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.0 ttp -103.82 108.98 20.53 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.27 -46.14 74.55 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.246 -0.581 . . . . 0.0 110.903 -179.221 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 42' ' ' LYS . 18.9 p-10 -139.69 -63.83 0.5 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.156 -179.588 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.541 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 64.9 mttp -150.96 45.2 0.83 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.921 0.391 . . . . 0.0 110.624 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -158.71 146.01 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.311 178.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -98.84 120.94 40.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.274 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.47 156.53 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.64 135.47 52.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.902 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.9 mt -127.11 112.63 21.69 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.891 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.46 150.95 39.87 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.33 1.353 . . . . 0.0 110.954 178.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.7 m -104.29 97.72 12.48 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -88.12 41.97 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.675 2.25 . . . . 0.0 111.576 178.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.3 m -129.76 156.55 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.812 0.339 . . . . 0.0 111.508 -177.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.485 ' CD ' ' N ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -151.12 148.06 27.82 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.469 179.874 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.55 -137.52 5.5 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -131.14 147.53 52.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 mm -97.88 118.07 43.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.15 -47.5 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -152.55 157.01 40.45 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -177.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.9 tt -131.68 126.06 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.256 178.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.3 mt -104.46 -15.48 15.36 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.98 -178.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.536 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 8.5 m-85 -108.71 144.03 37.04 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.281 0.563 . . . . 0.0 111.581 -178.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.487 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 84.9 mtt85 -131.39 166.25 21.69 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.149 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.58 138.66 51.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.581 -179.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.35 5.33 67.43 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.117 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 61' ' ' ARG . 34.9 mt-30 -96.11 131.26 42.73 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.234 0.54 . . . . 0.0 111.505 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.72 127.91 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 t -147.02 140.44 14.97 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.23 146.31 61.13 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.154 1.236 . . . . 0.0 111.275 177.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.66 129.49 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.204 0.526 . . . . 0.0 110.811 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.69 51.18 0.06 OUTLIER Glycine 0 CA--C 1.53 1.03 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.595 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 p -160.55 162.23 32.87 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 122.424 -0.456 . . . . 0.0 111.25 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 p -92.75 116.8 29.35 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.314 179.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.4 mm? -83.72 -18.23 38.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.589 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.55 144.16 4.27 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.05 -178.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -106.81 119.49 39.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 176.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.3 mt -126.79 127.54 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.267 0.556 . . . . 0.0 112.156 -177.031 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -85.15 145.68 27.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.738 179.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.537 179.785 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -110.98 142.48 43.05 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.32 130.83 55.58 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -96.0 118.67 33.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.06 0.457 . . . . 0.0 110.116 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -122.34 138.79 54.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.891 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 tp -64.1 115.25 17.86 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.495 1.608 0 C-N-CA 121.967 1.778 . . . . 0.0 112.41 -178.989 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.19 119.2 6.21 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -134.25 138.2 44.88 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.34 0.57 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.4 mm -103.45 121.8 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.749 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.59 -40.75 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -138.69 147.93 43.37 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -128.2 141.58 51.42 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 54.9 t0 -125.46 22.65 7.66 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.79 0.329 . . . . 0.0 111.076 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.0 156.08 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.2 135.33 55.16 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -58.69 138.2 57.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.46 6.8 76.99 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -114.79 156.48 24.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.716 0.293 . . . . 0.0 110.402 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.6 mtt -80.34 148.15 30.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.719 -179.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.4 t -121.36 135.42 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.458 -178.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -109.56 137.6 47.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.763 179.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.521 ' CB ' ' HE ' ' A' ' 52' ' ' ARG . 37.1 ttmt -68.08 137.64 55.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 6.6 t0 84.73 -11.78 0.78 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.585 179.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -118.87 82.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.654 0.264 . . . . 0.0 110.478 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 67.5 t0 -169.81 139.22 1.91 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.831 0.348 . . . . 0.0 110.423 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 69.4 mt -113.31 89.2 3.02 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.285 0.564 . . . . 0.0 109.919 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.64 130.92 71.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.43 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -121.29 126.36 49.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.821 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.93 149.88 32.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.9 ttp -118.41 134.86 54.72 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.384 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -110.99 -58.91 2.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.49 -179.58 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.482 ' N ' ' OG1' ' A' ' 40' ' ' THR . 51.9 p-10 -131.49 61.63 1.64 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.081 -179.41 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt 61.02 33.96 19.46 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 121.208 0.527 . . . . 0.0 110.119 -178.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.8 t -127.51 136.36 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.32 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 m -106.67 120.33 41.69 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.831 0.348 . . . . 0.0 110.139 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.89 156.59 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 121.244 0.545 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.55 135.74 53.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.31 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.41 155.59 77.02 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.218 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 49' ' ' SER . 31.5 Cg_exo -57.75 146.68 84.44 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 121.866 1.711 . . . . 0.0 112.168 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -40.6 166.15 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.921 179.665 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -77.35 54.59 4.75 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.029 2.486 . . . . 0.0 113.02 -179.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t 64.62 114.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.896 0.379 . . . . 0.0 111.24 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.521 ' HE ' ' CB ' ' A' ' 31' ' ' LYS . 16.0 ptp180 -53.56 145.73 14.42 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.127 0.489 . . . . 0.0 111.705 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.99 -134.12 3.16 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -121.15 130.17 53.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.915 0.357 . . . . 0.0 110.19 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mm -96.46 119.56 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.1 t -77.13 -52.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.148 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -166.18 161.74 17.15 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.464 -178.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.5 tt -91.11 107.19 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.579 0.704 . . . . 0.0 109.78 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.8 tp -75.09 -32.2 61.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.857 -178.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.9 146.93 43.58 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.382 0.61 . . . . 0.0 112.123 -179.02 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.683 ' H ' ' NE2' ' A' ' 64' ' ' GLN . 95.8 mtt180 -122.06 161.32 23.24 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.927 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -56.5 142.29 39.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.678 -179.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.85 4.21 57.92 Favored Glycine 0 N--CA 1.473 1.127 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.237 178.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.683 ' NE2' ' H ' ' A' ' 61' ' ' ARG . 74.1 mt-30 -98.04 131.69 44.24 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.428 0.632 . . . . 0.0 111.668 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -122.49 122.75 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.758 179.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 t -148.95 138.87 12.97 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.834 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.21 142.92 44.35 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 121.473 1.449 . . . . 0.0 112.414 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.97 128.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.013 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.39 51.41 0.04 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.045 179.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -166.85 169.47 13.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.227 0.514 . . . . 0.0 111.323 179.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 71' ' ' THR . 15.2 t -103.7 120.42 40.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.868 179.727 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -88.89 -7.88 55.28 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.182 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.426 HD12 ' H ' ' A' ' 74' ' ' GLN . 5.8 tp -157.16 144.43 18.69 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.426 ' H ' HD12 ' A' ' 73' ' ' LEU . 28.4 mp0 -104.19 132.99 49.86 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.554 0.216 . . . . 0.0 111.039 -179.205 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.8 mt -131.72 130.03 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.43 . . . . 0.0 111.957 -179.426 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -100.88 113.82 27.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.078 178.341 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.822 -1.085 . . . . 0.0 110.328 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 ttp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -89.36 132.88 34.75 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 52.9 mp0 -95.22 121.99 37.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.076 -179.043 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -91.46 113.01 25.16 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.169 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -115.47 146.27 41.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.599 -179.62 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.41 ' C ' ' CD2' ' A' ' 6' ' ' LEU . 4.9 tt -58.67 110.56 2.71 Favored Pre-proline 0 N--CA 1.469 0.516 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.448 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo . . . . . 0 N--CA 1.497 1.682 0 CA-C-N 120.21 1.111 . . . . 0.0 112.455 -179.779 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.646 0.26 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.14 119.27 6.1 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -178.94 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -125.67 133.46 52.16 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.022 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 mm -103.15 122.23 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.634 -178.821 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 9.9 p -90.89 -44.8 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.536 179.595 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.419 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 84.1 mtt85 -146.13 147.44 31.54 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.062 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -115.22 136.86 52.65 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 176.346 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 7.8 p-10 -106.0 1.1 26.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.201 -0.312 . . . . 0.0 111.73 -179.443 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.62 159.63 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.681 0.277 . . . . 0.0 110.943 -179.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -136.91 153.02 50.85 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.076 0.465 . . . . 0.0 110.123 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -57.54 141.99 45.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.766 179.876 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.39 8.34 59.94 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.48 179.057 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 28' ' ' MET . 65.9 t0 -130.58 135.36 47.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.611 0.706 . . . . 0.0 110.847 -179.691 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.486 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 65.9 mtt -81.45 150.2 28.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.193 -179.43 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 p -143.46 147.64 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.001 0.429 . . . . 0.0 110.593 179.605 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -102.65 162.1 13.2 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.841 -178.453 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.07 137.85 50.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.497 -179.067 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 59.81 45.22 12.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.436 179.902 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.437 ' O ' ' CG ' ' A' ' 34' ' ' ASP . 59.3 tt0 -147.03 88.45 1.74 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.524 179.086 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.54 ' OD2' ' NH2' ' A' ' 52' ' ' ARG . 11.8 m-20 170.43 148.65 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.776 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.503 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 74.6 mt -121.03 102.14 8.14 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.646 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.74 131.32 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.216 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -117.46 127.41 53.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.031 -179.831 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.57 129.08 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.795 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.8 ttp -108.55 131.19 55.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.566 -179.864 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.405 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -114.5 -84.89 0.61 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.328 -179.838 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.405 ' N ' ' OG1' ' A' ' 40' ' ' THR . 42.8 p-10 -98.16 51.06 1.02 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.482 179.827 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 65.56 34.66 7.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.132 -178.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.4 t -127.54 135.84 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.9 m -98.13 117.97 33.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.581 -179.574 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.72 131.45 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.298 179.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -93.57 136.17 34.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.212 -179.57 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.1 mt -140.95 95.51 7.61 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.6 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.54 144.75 91.54 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 121.985 1.79 . . . . 0.0 111.35 179.321 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.579 ' CB ' ' NE ' ' A' ' 52' ' ' ARG . 8.0 t -64.81 113.06 9.48 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.546 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.18 -24.64 44.08 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 120.932 1.088 . . . . 0.0 113.943 -178.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.0 125.07 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.579 ' NE ' ' CB ' ' A' ' 49' ' ' SER . 24.6 mmt180 -134.15 155.28 50.38 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.917 0.389 . . . . 0.0 110.873 -179.631 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.92 -84.71 0.06 OUTLIER Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.455 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -130.19 136.79 49.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.8 0.333 . . . . 0.0 110.565 179.379 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.444 HG22 HD12 ' A' ' 55' ' ' ILE . 9.4 mm -104.43 118.84 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.266 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.2 t -87.31 -52.36 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.318 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -160.83 154.36 22.07 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.752 -178.249 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.455 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.4 tt -108.17 122.18 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.503 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.3 mt -97.54 -17.61 19.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.189 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -107.28 141.8 38.04 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.93 0.395 . . . . 0.0 110.747 -179.243 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.495 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 89.4 mtm-85 -122.65 162.19 22.4 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.512 179.926 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -53.62 134.96 41.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.112 -179.067 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.62 6.27 83.4 Favored Glycine 0 N--CA 1.471 0.992 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.679 177.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 80.4 mt-30 -85.86 134.15 33.92 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.109 0.954 . . . . 0.0 111.467 -179.472 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.13 124.43 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.234 179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 t -148.83 136.93 11.46 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.696 -179.53 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.97 152.47 58.13 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 C-N-CA 121.924 1.75 . . . . 0.0 112.243 178.289 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.8 t -53.87 133.21 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.691 179.648 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.86 51.81 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.804 179.229 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.7 m -153.99 169.08 24.35 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.354 -179.723 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -104.07 111.76 24.47 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.44 -45.3 55.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.541 -179.795 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 74' ' ' GLN . 2.8 tt -152.96 147.66 26.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.939 -177.772 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.466 ' N ' ' CD2' ' A' ' 73' ' ' LEU . 52.4 tt0 -103.21 133.42 48.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.115 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 56.8 mt -126.73 129.2 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.205 0.526 . . . . 0.0 111.891 -177.395 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -96.02 111.63 23.59 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.951 178.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.353 -179.664 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -85.73 126.24 33.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.665 -179.553 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 52.6 mp0 -92.86 134.4 35.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.736 -179.472 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -109.49 108.53 19.05 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.784 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -114.17 141.2 47.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.043 -179.64 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.1 tt -69.26 112.12 10.8 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.413 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.5 1.875 0 C-N-CA 121.8 1.667 . . . . 0.0 112.875 -178.251 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 54.8 mp0 . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.826 0.346 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.36 124.8 5.25 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 10.1 tm-20 -128.02 137.8 52.34 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.128 0.464 . . . . 0.0 110.58 -179.309 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -102.13 114.44 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 9.4 p -85.17 -42.56 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.445 179.342 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.412 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 82.2 mtp180 -140.88 147.05 38.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.82 0.343 . . . . 0.0 111.258 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -109.04 137.73 46.5 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.252 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.3 p-10 -72.77 -40.89 65.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.296 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.12 165.58 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.551 -178.193 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 99.4 mttt -119.27 149.69 41.36 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.933 -179.592 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 56' ' ' VAL . 85.7 tt0 -45.31 139.61 3.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.32 7.25 62.23 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.567 -0.574 . . . . 0.0 113.341 178.59 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 24' ' ' LYS . 40.4 p-10 -135.44 153.06 51.9 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.371 1.086 . . . . 0.0 111.226 179.759 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.0 mtp -78.52 155.19 29.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.777 -178.79 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.23 152.77 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -113.38 147.4 37.79 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.937 0.399 . . . . 0.0 110.83 -179.623 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -85.06 84.45 7.7 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.108 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' ASP . 43.8 p30 -165.97 81.37 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.552 179.204 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 62.97 -66.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.048 179.493 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 32' ' ' ASP . 29.0 t0 62.78 -167.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.311 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.43 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 83.4 mt -126.54 75.75 1.57 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.183 0.516 . . . . 0.0 111.55 -179.768 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.06 128.14 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.51 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -124.73 128.68 49.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.114 -178.616 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.52 133.6 64.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.226 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.3 ttp -119.1 113.41 20.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.381 -179.024 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.7 p -62.75 -52.05 64.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.108 0.48 . . . . 0.0 109.908 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.8 t70 -146.87 -48.22 0.19 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.32 179.123 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -161.51 51.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.271 179.05 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.88 160.06 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.431 -179.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.5 m -110.25 114.79 28.54 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.32 117.1 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.354 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -97.76 136.42 38.12 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.646 178.959 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.5 mt -139.33 139.95 24.38 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 119.303 -0.38 . . . . 0.0 110.529 -178.744 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 49' ' ' SER . 52.8 Cg_exo -53.17 145.66 42.4 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.386 1.39 . . . . 0.0 111.725 178.195 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -47.34 179.19 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.858 -179.322 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 49' ' ' SER . 78.8 Cg_endo -87.86 49.67 1.74 Allowed 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.776 2.317 . . . . 0.0 113.855 -178.363 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.0 t 66.19 121.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 120.823 0.344 . . . . 0.0 111.599 178.759 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -50.23 136.38 19.79 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.524 -179.928 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.62 -141.63 5.75 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.371 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -126.05 126.67 44.62 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.811 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -91.74 119.23 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.676 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.4 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 37.7 t -101.41 -41.52 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.222 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -145.16 154.89 42.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.557 -177.677 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.5 tt -127.78 127.27 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.205 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.8 tp -100.26 -21.18 15.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.211 -179.492 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -106.08 141.93 36.64 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.225 0.536 . . . . 0.0 111.383 -178.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -122.18 165.74 15.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.143 179.371 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.0 mp0 -53.39 128.24 27.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.455 -179.463 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.72 5.95 85.98 Favored Glycine 0 N--CA 1.468 0.818 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.374 178.539 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -79.4 135.52 36.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.42 0.61 . . . . 0.0 110.71 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.76 131.52 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.611 179.624 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -149.47 137.54 11.77 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.785 -178.78 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.92 137.48 52.38 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.077 1.185 . . . . 0.0 112.344 177.942 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -56.22 129.16 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.721 179.774 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.68 49.3 0.08 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.113 178.985 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.3 p -164.62 165.99 20.54 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.345 0.572 . . . . 0.0 110.858 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 t -98.98 122.15 41.87 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.057 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.556 ' N ' ' CD1' ' A' ' 72' ' ' LEU . 3.0 mp -90.57 -5.38 56.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.686 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.416 HD21 ' N ' ' A' ' 74' ' ' GLN . 2.1 tt -162.34 142.43 9.83 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.101 -178.866 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.539 ' N ' ' OE1' ' A' ' 74' ' ' GLN . 2.3 mp0 -104.03 124.37 48.9 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.247 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.7 mt -122.89 127.48 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.47 0.652 . . . . 0.0 111.57 -177.7 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -98.12 111.36 23.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.219 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.77 -179.47 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -125.88 149.26 48.82 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.924 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.66 128.34 53.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.819 0.342 . . . . 0.0 110.384 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -87.08 126.13 34.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.058 -179.931 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -119.6 133.73 55.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.191 -179.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.0 123.3 79.58 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.821 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 C-N-CA 121.598 1.532 . . . . 0.0 111.781 -179.41 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 16' ' ' GLY . 13.4 tm-20 . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 111.377 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.47 ' N ' ' CD ' ' A' ' 15' ' ' GLU . . . -121.2 119.29 4.06 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.356 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -118.98 136.26 54.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 117.165 0.482 . . . . 0.0 110.658 -179.763 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -101.35 119.97 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.125 -179.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 10.0 p -89.9 -45.89 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.841 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 99.7 mtt180 -143.41 148.46 36.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.192 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -118.25 144.54 45.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.432 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.3 m-20 -124.48 12.94 8.75 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.136 0.426 . . . . 0.0 111.655 179.395 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.77 154.93 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.962 0.41 . . . . 0.0 110.764 179.605 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -121.9 153.68 38.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.096 -179.822 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -64.15 129.54 40.38 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.303 -179.955 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.04 5.66 63.88 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 36.5 p-10 -101.86 151.93 21.5 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.066 0.433 . . . . 0.0 110.665 179.536 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.2 mmm -90.85 148.85 22.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.537 -179.791 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.66 141.07 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.174 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -109.57 159.97 16.64 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.818 0.342 . . . . 0.0 111.272 -178.714 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -59.73 136.4 57.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.184 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 58.92 29.64 19.15 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.209 -179.559 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.69 79.56 1.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.573 0.225 . . . . 0.0 110.42 179.332 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 46.0 t0 -173.73 -178.56 1.61 Allowed 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.534 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.527 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 37.3 tp -153.95 97.84 2.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.922 0.391 . . . . 0.0 110.562 179.458 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.0 130.56 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.9 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.4 mp0 -114.66 120.71 41.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.926 178.759 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.6 m -119.98 134.37 63.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.008 -179.805 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.9 ptm -130.13 129.41 43.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.344 -179.58 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -43.07 61.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.325 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -154.78 -67.21 0.13 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.323 -179.648 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -132.67 37.15 3.49 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.228 179.523 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.1 t -133.82 136.01 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.901 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 m -116.26 120.61 39.48 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.516 -179.666 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.94 155.61 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.362 179.546 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -115.23 135.63 53.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.276 -179.782 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.1 mt -134.27 130.84 20.35 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.11 179.945 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.46 146.17 27.36 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.419 2.079 . . . . 0.0 112.626 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -60.59 110.91 3.32 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.29 -19.76 37.94 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.612 1.541 . . . . 0.0 114.951 -177.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.89 124.03 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 118.459 0.572 . . . . 0.0 111.606 -179.084 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -91.14 152.13 20.7 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.107 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.39 -133.34 2.39 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.214 179.49 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -125.05 143.33 50.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.688 0.28 . . . . 0.0 110.327 -179.371 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.4 mm -103.73 118.72 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.682 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.8 t -89.25 -55.36 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.097 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -143.52 153.5 42.65 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.289 0.566 . . . . 0.0 111.814 -178.364 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.7 tt -101.57 114.38 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.148 178.884 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.75 -17.68 20.12 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.827 -179.648 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -109.3 142.21 40.5 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.083 0.468 . . . . 0.0 110.756 -179.225 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -126.0 166.25 17.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.429 179.851 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.43 144.5 50.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.006 -179.391 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.03 5.8 87.27 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 179.259 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -70.76 133.44 46.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.593 0.711 . . . . 0.0 111.355 -179.01 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.46 118.67 40.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 114.33 -1.304 . . . . 0.0 107.5 178.604 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.56 154.79 35.82 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.006 -178.472 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.12 140.33 41.06 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.739 2.293 . . . . 0.0 111.676 179.087 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.12 124.61 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.774 179.412 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.1 53.31 0.06 OUTLIER Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.0 t -162.51 168.27 22.16 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.961 0.38 . . . . 0.0 110.807 -179.889 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.8 t -105.45 128.41 53.52 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.738 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.683 ' CD2' ' H ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -64.16 -41.81 97.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.182 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -161.27 177.28 10.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.757 -179.495 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -107.03 127.19 53.24 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.717 0.294 . . . . 0.0 110.889 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.47 125.29 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.25 0.548 . . . . 0.0 111.346 -179.323 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -90.27 140.49 29.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.8 178.913 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.449 179.792 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -79.61 129.17 34.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.839 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 57.1 mp0 -105.87 118.77 37.45 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -95.86 122.28 38.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.218 0.532 . . . . 0.0 110.733 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.63 145.22 49.09 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.66 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 tt -68.73 113.4 15.7 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.045 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.54 151.65 29.12 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.59 1.527 . . . . 0.0 112.008 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -91.02 89.27 7.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.712 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.411 HD12 HG22 ' A' ' 9' ' ' ILE . 96.1 mt -63.64 -43.46 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.96 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 11' ' ' GLU . . . -89.35 -164.93 40.63 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 10' ' ' GLY . 16.8 pt-20 -53.29 -166.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.672 0.272 . . . . 0.0 110.405 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -38.08 -72.49 0.18 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 12' ' ' GLY . 1.6 t 57.81 117.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 p -124.34 76.83 1.51 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.748 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.482 ' OE2' ' CG2' ' A' ' 65' ' ' VAL . 30.8 tp10 -170.44 143.27 2.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.322 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.92 110.45 0.72 Allowed Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -126.27 131.91 51.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 110.355 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -102.37 119.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.17 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 7.6 p -93.08 -43.81 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.426 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 83.2 mtp180 -139.57 145.07 38.15 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.808 0.337 . . . . 0.0 111.243 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -111.68 139.84 46.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.91 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 18.2 p-10 -101.36 -6.51 23.98 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.37 159.95 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.027 0.441 . . . . 0.0 111.4 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.33 149.99 49.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.7 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -59.55 138.63 57.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.257 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.64 8.87 76.16 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.604 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -121.98 149.84 42.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 117.431 0.616 . . . . 0.0 111.156 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.2 mtm -86.59 154.19 21.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.265 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.9 152.61 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.937 0.399 . . . . 0.0 110.515 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -117.44 157.23 26.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.012 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -67.55 65.6 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.962 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -176.11 73.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.531 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -147.1 122.09 10.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.409 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -128.14 39.45 3.84 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.454 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.8 mt -110.51 33.67 4.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.107 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.11 128.15 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -116.85 123.91 48.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.533 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.92 130.16 72.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.375 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.3 ttm -109.7 126.4 53.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.287 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -95.1 -77.28 0.47 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.054 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.424 ' N ' ' OG1' ' A' ' 40' ' ' THR . 62.1 t0 -95.99 -74.24 0.57 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.269 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -151.37 50.71 0.83 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.334 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.03 149.34 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.897 0.379 . . . . 0.0 110.75 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.8 m -107.97 118.82 37.75 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.957 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.96 133.79 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -95.51 135.5 37.08 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.426 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.4 mt -135.75 133.57 20.15 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.36 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.3 147.69 33.18 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.175 1.917 . . . . 0.0 111.162 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -96.98 107.89 40.28 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 111.371 0.137 . . . . 0.0 111.371 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -86.59 41.78 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.373 2.049 . . . . 0.0 111.358 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.39 156.2 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.716 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -154.33 149.07 26.51 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.276 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.29 -132.93 2.94 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.84 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -130.3 135.76 48.43 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -91.87 120.18 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.147 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.5 t -84.53 -50.07 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -164.16 157.06 17.61 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.898 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.0 tt -116.07 121.96 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.446 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.55 -16.88 18.97 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.21 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.543 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 17.8 m-85 -107.31 144.4 34.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.291 0.567 . . . . 0.0 111.58 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -123.83 161.48 25.21 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.86 137.02 57.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.45 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.41 4.99 85.5 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.492 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.52 ' OE1' ' CD2' ' A' ' 60' ' ' TYR . 55.3 tt0 -89.32 137.39 32.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.414 0.607 . . . . 0.0 110.563 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.482 ' CG2' ' OE2' ' A' ' 15' ' ' GLU . 3.4 p -124.42 131.21 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.375 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 t -148.3 140.86 14.89 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.249 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.19 148.17 32.69 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.501 1.467 . . . . 0.0 112.661 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.08 132.83 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.456 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.99 49.44 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.014 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.7 p -160.33 162.84 33.59 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.399 0.6 . . . . 0.0 111.355 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -96.37 120.99 37.68 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.2 mm? -82.45 -4.32 57.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.553 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.8 142.45 2.45 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.58 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -104.84 122.39 45.67 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.35 127.51 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.095 0.474 . . . . 0.0 111.081 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -88.0 141.32 28.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.087 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.493 179.825 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -82.84 130.12 35.09 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 51.0 mp0 -93.79 138.7 31.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.95 101.79 11.82 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 6' ' ' LEU . 68.6 mttm -108.28 105.19 14.77 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 5' ' ' LYS . 5.6 mt -29.23 93.84 0.06 OUTLIER Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 123.845 0.716 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' LYS . 92.0 Cg_endo -77.98 154.78 29.77 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.644 1.563 . . . . 0.0 112.127 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -84.75 86.89 7.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.813 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.9 pt -142.41 154.08 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.709 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.84 -28.91 3.1 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -172.68 -92.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.595 0.236 . . . . 0.0 110.37 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.94 159.85 24.5 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.423 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -145.21 95.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 110.437 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 p -66.52 -36.02 81.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.269 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -146.57 151.62 37.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.65 109.92 3.54 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -121.78 127.35 50.52 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 mm -100.92 117.94 46.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.05 0.452 . . . . 0.0 111.565 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.7 p -91.74 -41.85 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.583 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -143.37 141.88 31.07 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -111.93 145.4 39.62 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 35' ' ' LEU . 87.7 m-20 -128.54 20.85 6.1 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.43 0.559 . . . . 0.0 111.255 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.9 m -136.33 154.63 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 68.4 mttm -135.05 137.13 42.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.448 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -44.25 135.75 4.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.91 5.94 70.29 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 43.9 p-10 -104.19 150.88 23.98 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.806 0.303 . . . . 0.0 110.222 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.2 mtp -90.06 145.74 24.85 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.86 0.362 . . . . 0.0 110.645 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.9 t -126.42 132.85 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.478 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -105.7 158.2 16.88 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -62.88 136.4 57.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.639 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 58.66 36.46 25.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.141 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -141.81 89.76 2.22 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 51.4 t0 -172.91 158.16 3.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.901 0.382 . . . . 0.0 110.455 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.47 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 92.7 mt -135.22 86.35 2.24 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.322 0.582 . . . . 0.0 110.009 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.71 136.69 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.565 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.1 mp0 -123.06 128.14 49.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.056 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 p -128.15 130.0 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.0 ttp -109.3 133.49 52.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.547 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -99.65 -92.38 0.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.492 ' N ' ' OG1' ' A' ' 40' ' ' THR . 14.3 p-10 -83.69 -52.73 6.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.356 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -174.45 57.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.612 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -159.33 151.83 6.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.901 0.382 . . . . 0.0 110.417 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -103.87 117.53 34.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.284 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.88 132.59 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.064 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -92.53 135.71 33.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.954 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.94 90.8 13.8 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.55 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.08 147.73 92.04 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 122.638 2.225 . . . . 0.0 112.018 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.5 m -60.65 111.27 3.82 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 119.51 -0.281 . . . . 0.0 110.7 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.56 -16.81 30.39 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.413 1.409 . . . . 0.0 114.521 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.89 124.58 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.245 0.475 . . . . 0.0 111.084 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -89.74 151.49 21.8 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.415 0.15 . . . . 0.0 110.827 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.77 -145.47 7.97 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -114.46 133.74 55.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.85 0.325 . . . . 0.0 110.845 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -87.91 120.22 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 t -88.99 -52.63 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -156.27 160.74 40.04 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.186 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.445 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.0 tt -106.0 123.37 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.618 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.1 tp -101.11 -18.32 16.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.068 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -111.15 146.82 36.18 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.217 0.532 . . . . 0.0 111.053 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.516 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 99.8 mtt180 -122.5 167.3 13.52 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.111 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -62.37 140.54 58.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.838 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.52 5.02 82.6 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.382 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.516 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 83.5 mt-30 -85.61 135.17 33.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.488 0.644 . . . . 0.0 111.955 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 p -128.46 126.5 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.733 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.5 t -149.52 135.93 10.49 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.746 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.39 141.96 59.46 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.377 1.385 . . . . 0.0 111.905 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 p -52.98 128.32 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.849 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.03 48.24 0.06 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.187 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.4 p -164.17 162.24 22.65 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 117.407 0.604 . . . . 0.0 110.926 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 t -88.96 126.48 35.42 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.2 mt -97.36 -5.48 36.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.402 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 74' ' ' GLN . 3.4 tt -170.51 149.08 3.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.424 ' N ' HD22 ' A' ' 73' ' ' LEU . 66.7 mt-30 -103.17 125.52 49.9 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.8 mt -126.45 128.55 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.199 0.523 . . . . 0.0 111.723 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 18.6 p-10 -97.09 115.66 27.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.543 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.591 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -106.78 137.52 44.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.147 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.33 130.51 40.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.125 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -108.64 120.46 42.53 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.203 0.525 . . . . 0.0 110.331 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -127.18 153.34 46.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.955 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 tp -71.52 117.87 61.16 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.742 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.98 151.76 31.18 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.664 1.576 . . . . 0.0 111.886 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -83.41 107.44 15.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.247 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.4 pt -129.78 156.85 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.289 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.63 -169.39 47.83 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -127.93 137.65 52.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.708 0.289 . . . . 0.0 110.355 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.59 74.29 1.2 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.84 111.27 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.402 ' H ' ' HG1' ' A' ' 14' ' ' THR . 16.7 p -108.44 -14.1 14.73 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.279 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -173.38 149.65 1.75 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.988 0.423 . . . . 0.0 111.176 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.54 150.81 18.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -137.16 146.56 45.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.954 0.377 . . . . 0.0 110.262 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.89 115.93 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.37 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 10.7 p -86.04 -43.62 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.373 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.404 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 83.6 mtp180 -139.54 147.37 41.11 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.724 0.297 . . . . 0.0 111.264 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -111.95 141.84 45.1 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.46 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 16.5 p-10 -105.56 -3.51 22.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.542 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -134.59 160.35 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 120.891 0.377 . . . . 0.0 111.36 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.22 147.17 45.64 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.56 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.34 134.23 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.619 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.75 8.53 85.84 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.322 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -117.07 129.13 55.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.068 0.434 . . . . 0.0 111.431 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.1 ptp -59.54 150.25 27.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.843 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 30' ' ' GLU . 52.9 t -123.25 159.06 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.019 0.438 . . . . 0.0 110.138 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.2 mp0 -135.1 149.59 50.07 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.57 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 87.9 tttt -65.29 137.6 57.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.138 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 9.9 m-20 94.21 76.03 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.817 0.698 . . . . 0.0 110.704 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -146.16 95.66 2.66 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.594 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -104.1 52.35 0.76 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.653 0.263 . . . . 0.0 110.916 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -117.87 30.53 7.2 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.239 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.93 128.28 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -121.86 126.64 49.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.644 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.0 129.89 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.6 ttp -103.95 110.98 23.33 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.831 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 p -61.91 -48.13 81.85 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -146.31 -67.45 0.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.432 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -142.11 41.38 1.65 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.842 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.3 t -136.33 155.85 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -109.17 118.2 36.13 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.76 120.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.06 138.57 31.4 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -136.42 109.84 9.62 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.08 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.69 145.27 60.78 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.67 1.58 . . . . 0.0 111.369 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.5 m -105.04 99.62 20.35 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.08 44.44 1.28 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.295 1.997 . . . . 0.0 110.432 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.76 154.68 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -161.47 131.82 5.02 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.713 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.02 -136.49 3.85 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.855 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -124.44 132.13 53.5 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.88 0.34 . . . . 0.0 110.242 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 mm -91.77 121.33 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.8 t -87.46 -51.81 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -155.29 161.42 41.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.681 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.428 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.6 tt -122.0 123.78 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.695 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.06 -16.48 17.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -107.15 143.9 34.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.15 0.5 . . . . 0.0 111.375 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -123.61 164.99 17.95 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.272 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -59.34 134.4 56.97 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.631 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.98 5.64 90.01 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.009 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -82.15 137.39 34.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.041 0.42 . . . . 0.0 110.823 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.84 133.03 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.605 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.7 t -148.63 141.28 15.16 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.691 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.16 146.11 61.5 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.317 1.345 . . . . 0.0 111.373 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.6 p -64.89 130.2 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.018 0.437 . . . . 0.0 110.713 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.55 53.15 0.08 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.2 m -160.41 170.3 21.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.054 0.427 . . . . 0.0 111.255 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.2 m -99.43 112.5 24.68 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.838 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.52 -43.4 76.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.161 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 74' ' ' GLN . 2.2 tt -151.38 145.74 25.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.072 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.463 ' H ' HD23 ' A' ' 73' ' ' LEU . 39.1 mt-30 -104.11 130.73 51.84 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.9 mt -131.71 127.34 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.142 0.496 . . . . 0.0 111.536 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.76 140.97 29.28 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.918 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.568 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 1' ' ' MET . 4.4 mpp? . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -97.65 127.87 43.93 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 37.6 mp0 -107.74 111.72 24.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.131 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -75.55 100.94 4.72 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -112.55 147.16 37.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.554 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.3 tt -66.35 113.35 12.21 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -54.92 141.29 78.41 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 120.499 1.214 . . . . 0.0 112.09 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -94.19 108.45 20.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.812 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.2 pt -126.53 150.76 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.629 0.252 . . . . 0.0 110.582 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.83 -135.5 42.57 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 11' ' ' GLU . 1.2 pm0 -155.17 6.42 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.26 5.94 74.52 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.2 t -124.67 129.21 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.876 0.369 . . . . 0.0 110.107 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.2 p -141.0 -8.31 1.03 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.534 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -144.29 150.67 38.25 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.004 0.431 . . . . 0.0 111.016 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.14 132.38 8.05 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -133.84 142.03 47.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.96 0.41 . . . . 0.0 110.101 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -100.01 121.66 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.048 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 11.5 p -88.18 -45.69 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.167 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.42 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 63.0 ttm-85 -146.76 139.31 25.02 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -108.19 143.94 36.31 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.2 m-20 -127.55 15.89 7.05 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.892 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.15 155.91 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -130.07 147.56 51.83 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.941 0.401 . . . . 0.0 111.063 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.59 139.47 58.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.238 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.92 7.97 73.42 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.843 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -117.92 148.99 41.63 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.865 0.333 . . . . 0.0 110.68 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 63.8 mtt -76.77 147.29 37.36 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.105 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.99 132.74 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -98.89 154.92 17.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.432 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -96.05 84.26 3.79 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.86 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 34' ' ' ASP . 46.5 p-10 -173.5 131.22 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 110.853 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' ASP . 96.7 mm-40 53.78 -80.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.609 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 32' ' ' ASP . 93.8 m-20 57.01 150.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.457 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 89.5 mt -122.12 76.68 1.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.283 0.563 . . . . 0.0 111.629 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.07 131.59 70.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -123.16 121.72 36.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.274 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.3 m -115.19 130.88 68.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 43' ' ' VAL . 5.4 tpp -91.83 152.18 20.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.896 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -156.66 -89.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.589 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.448 ' N ' ' OG1' ' A' ' 40' ' ' THR . 91.7 m-20 -76.16 44.84 0.34 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.286 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 58.37 37.72 25.85 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.61 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.452 ' O ' ' SD ' ' A' ' 39' ' ' MET . 30.6 m -147.54 158.98 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.67 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -100.17 118.49 36.61 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 110.727 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -119.59 130.45 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.543 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -94.98 138.78 32.26 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.28 92.99 34.2 Favored Pre-proline 0 N--CA 1.472 0.639 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.184 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' O ' ' OG ' ' A' ' 49' ' ' SER . 88.3 Cg_endo -80.03 143.87 16.45 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.227 1.951 . . . . 0.0 113.133 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 48' ' ' PRO . 6.0 p 81.7 69.68 0.12 Allowed Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.408 ' CD ' ' OD2' ' A' ' 34' ' ' ASP . 64.2 Cg_endo -88.87 26.94 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.953 2.435 . . . . 0.0 112.177 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t 69.76 115.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.142 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -79.83 147.65 31.68 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 112.064 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.24 -133.92 2.57 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -122.48 134.33 54.58 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.7 mm -92.98 119.62 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -79.37 -52.39 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -168.44 157.96 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.705 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.4 tt -104.01 122.68 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.009 0.433 . . . . 0.0 111.334 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -100.93 -17.17 16.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -106.73 142.54 36.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.97 0.414 . . . . 0.0 110.884 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -117.47 169.83 9.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.313 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.29 134.19 56.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.246 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.49 6.17 86.43 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.866 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -79.09 131.85 36.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.2 0.524 . . . . 0.0 111.324 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -127.03 132.21 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.596 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.87 140.31 15.53 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.609 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.94 147.2 15.12 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.038 1.159 . . . . 0.0 112.187 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.1 p -60.13 130.4 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.51 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.08 55.99 0.21 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.4 m -151.38 175.69 12.0 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.055 0.455 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 m -101.14 109.7 21.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.252 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.05 -45.52 70.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.089 0.471 . . . . 0.0 110.946 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 tt -152.72 147.16 25.76 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -103.56 128.18 50.84 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.403 HG23 HD11 ' A' ' 75' ' ' ILE . 91.5 mt -128.07 129.52 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.164 0.507 . . . . 0.0 111.118 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -95.69 112.05 23.86 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.099 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.1 m . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.618 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 75' ' ' ILE . 21.6 t80 -79.75 127.58 32.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 110.217 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 54.8 mp0 -88.29 133.7 33.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.311 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -101.69 113.29 26.31 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 6' ' ' LEU . 54.0 mtmt -120.1 113.77 20.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 5' ' ' LYS . 12.6 mt -32.89 97.22 0.11 Allowed Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.521 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 9' ' ' ILE . 33.5 Cg_exo -55.1 148.17 50.11 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.721 1.614 . . . . 0.0 111.957 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -69.95 37.81 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.974 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.543 ' H ' ' C ' ' A' ' 7' ' ' PRO . 68.9 mt -109.17 129.83 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.69 -172.42 28.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 12' ' ' GLY . 79.9 tt0 -89.42 83.01 6.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.614 0.245 . . . . 0.0 110.612 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLU . . . 57.84 123.59 0.01 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.29 131.38 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.512 ' H ' ' HG1' ' A' ' 40' ' ' THR . 16.8 p -115.8 -39.69 3.46 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.61 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -145.99 153.62 40.99 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.69 109.76 3.91 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -121.49 132.61 54.82 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -101.91 120.58 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.94 0.4 . . . . 0.0 111.193 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 8.7 p -92.95 -42.43 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.62 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.402 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 43.2 ttm180 -148.79 134.51 18.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -104.2 140.44 37.83 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -120.24 16.77 12.33 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.094 0.406 . . . . 0.0 111.279 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.38 157.66 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.922 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -131.8 136.47 47.55 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.546 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.68 140.18 36.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 0.0 111.042 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.96 6.96 74.89 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.88 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -116.21 149.6 38.87 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.879 0.339 . . . . 0.0 110.723 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.5 mmm -83.47 147.32 27.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.643 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.2 t -118.9 132.54 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.353 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE1' ' OE1' ' A' ' 33' ' ' GLN . 95.5 mt-10 -96.23 155.59 16.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.721 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -67.83 134.13 50.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.859 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 57.86 34.56 24.5 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.241 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.414 ' OE1' ' OE1' ' A' ' 30' ' ' GLU . 82.7 mt-30 -143.13 87.49 1.97 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.868 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -174.62 168.95 3.7 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -136.31 97.69 3.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.244 0.545 . . . . 0.0 110.683 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.53 132.63 67.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.186 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -125.12 126.17 44.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.329 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.84 125.89 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.232 0.539 . . . . 0.0 109.567 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.0 ttp -105.86 137.91 42.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.069 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.535 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.6 t -102.81 -121.34 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.92 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.535 ' N ' ' OG1' ' A' ' 40' ' ' THR . 63.8 t0 -63.78 -46.77 83.73 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -177.13 60.55 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -150.33 149.13 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.741 0.305 . . . . 0.0 110.305 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -101.88 117.73 35.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.85 117.08 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.871 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -97.1 134.53 40.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.77 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.0 mt -138.9 129.58 14.96 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.556 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.45 143.59 22.0 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.134 1.889 . . . . 0.0 112.464 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 p -47.76 106.9 0.65 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.3 -23.51 32.84 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.077 1.185 . . . . 0.0 114.745 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.76 123.53 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.401 0.546 . . . . 0.0 111.732 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -83.04 161.22 21.76 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.38 -142.35 7.99 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.091 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -119.47 134.52 55.18 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.836 0.35 . . . . 0.0 111.187 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.443 HG21 HD13 ' A' ' 55' ' ' ILE . 5.3 mm -95.93 117.74 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.64 -53.46 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -151.58 156.8 41.22 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.478 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.7 tt -108.84 120.35 60.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.004 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.47 -17.93 18.49 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.302 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.522 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 7.6 m-85 -111.42 144.62 40.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.44 0.638 . . . . 0.0 111.391 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.508 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 99.9 mtt180 -120.82 162.19 20.22 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.078 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -58.33 142.28 48.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.609 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.76 6.03 70.59 Favored Glycine 0 N--CA 1.469 0.869 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.508 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 85.9 mt-30 -94.13 132.06 39.04 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.364 0.602 . . . . 0.0 112.161 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.95 125.8 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.007 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 t -147.97 137.17 11.91 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.646 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -50.48 137.4 40.23 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.016 1.144 . . . . 0.0 112.213 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.58 126.44 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.469 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.08 49.32 0.04 OUTLIER Glycine 0 CA--C 1.531 1.034 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.956 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.8 p -159.75 160.46 34.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 117.182 0.491 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.496 ' O ' ' CG2' ' A' ' 71' ' ' THR . 5.2 t -91.66 104.27 16.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.803 0.811 . . . . 0.0 109.982 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.2 mm? -67.31 -39.91 85.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.483 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 74' ' ' GLN . 3.5 tt -141.55 148.63 39.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.467 ' N ' ' CD2' ' A' ' 73' ' ' LEU . 57.5 tt0 -102.6 130.22 49.41 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 75' ' ' ILE . 96.3 mt -127.41 127.91 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.247 0.546 . . . . 0.0 111.398 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -102.1 114.9 29.42 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.167 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.114 -0.946 . . . . 0.0 110.599 179.825 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' OD1' ' A' ' 76' ' ' ASP . 97.8 mmm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -148.02 147.97 30.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.398 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -126.69 138.72 53.44 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.08 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.35 113.89 27.56 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.317 0.58 . . . . 0.0 110.573 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 6' ' ' LEU . 98.9 mttt -119.49 112.83 19.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.172 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.413 ' CD2' ' C ' ' A' ' 6' ' ' LEU . 3.7 tt -35.93 99.53 0.18 Allowed Pre-proline 0 N--CA 1.475 0.798 0 O-C-N 123.342 0.401 . . . . 0.0 110.446 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.18 154.52 25.22 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.702 1.601 . . . . 0.0 112.061 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -88.44 84.95 6.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.429 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.9 mt -123.82 135.23 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.933 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.24 -127.62 24.26 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -50.79 137.7 19.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.29 143.63 43.1 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.6 t -131.42 117.7 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 p -110.33 -14.82 14.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.807 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -145.24 144.58 30.88 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.256 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.05 111.0 3.25 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -121.28 129.99 53.43 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -102.35 118.8 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.405 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 9.8 p -96.77 -47.48 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.831 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 82.4 mtp180 -141.53 145.49 35.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.8 m95 -117.03 139.51 50.6 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.549 ' CG ' HH22 ' A' ' 52' ' ' ARG . 7.7 p-10 -108.09 5.15 25.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.492 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 3.8 m -133.84 157.2 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.626 0.251 . . . . 0.0 110.535 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.86 145.11 51.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.846 0.355 . . . . 0.0 110.496 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -61.54 138.5 58.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.196 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.07 8.01 65.2 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.913 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 28' ' ' MET . 68.1 t0 -117.32 135.95 53.48 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.926 0.363 . . . . 0.0 111.365 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.495 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 2.5 mpt? -90.48 131.69 36.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.047 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.17 146.0 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.743 0.306 . . . . 0.0 110.675 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.3 mm-40 -92.85 160.08 15.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.436 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -52.12 129.77 28.44 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.196 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 30' ' ' GLU . 2.5 p30 168.79 133.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.647 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -67.09 80.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.627 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 68.0 t0 -63.45 -43.2 98.07 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.363 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.523 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 1.4 mt 154.87 86.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.036 0.835 . . . . 0.0 110.824 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.47 126.05 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -121.13 123.09 41.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.467 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.93 130.42 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.418 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 25.1 ptm -128.12 152.05 48.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -94.71 -114.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.317 178.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.543 ' N ' ' OG1' ' A' ' 40' ' ' THR . 69.7 m-20 -65.03 -45.24 86.29 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -176.1 57.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.779 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 39' ' ' MET . 48.7 t -137.42 139.47 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -95.9 116.93 29.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.484 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.23 119.39 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -92.44 132.13 37.03 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 57.3 mt -141.26 138.04 17.31 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.466 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -52.3 141.64 49.28 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 CA-C-N 120.178 1.099 . . . . 0.0 111.083 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.494 ' CB ' ' HE ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -46.6 162.94 0.24 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.017 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 51' ' ' VAL . 95.4 Cg_endo -78.16 54.81 5.09 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 123.23 2.62 . . . . 0.0 112.991 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 50' ' ' PRO . 4.1 t 59.12 109.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.144 -0.623 . . . . 0.0 109.52 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.549 HH22 ' CG ' ' A' ' 22' ' ' ASP . 95.9 mtt180 -102.81 146.07 28.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 111.828 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.45 -85.84 0.06 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -125.11 114.04 18.52 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mm -91.54 120.02 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.0 t -79.44 -52.83 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -169.88 157.37 6.72 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.084 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.458 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 2.1 tt -110.33 119.26 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.439 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.21 -17.6 20.67 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.569 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.429 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 28.2 m-85 -110.2 141.76 42.69 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.909 0.385 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -132.13 165.81 23.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.069 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.02 141.94 21.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.802 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.69 5.0 60.26 Favored Glycine 0 N--CA 1.471 0.995 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.235 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -99.51 131.25 45.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.494 0.664 . . . . 0.0 111.861 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.98 123.51 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.354 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.27 138.69 13.04 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.301 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -52.68 143.79 45.47 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.356 1.37 . . . . 0.0 112.394 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.6 p -52.03 128.95 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.601 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.28 52.76 0.08 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.738 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -156.48 161.8 40.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.033 0.417 . . . . 0.0 111.164 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.3 p -92.91 111.29 22.86 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.807 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.3 mm? -89.08 -6.98 56.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.086 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.427 HD21 ' H ' ' A' ' 74' ' ' GLN . 0.6 OUTLIER -176.45 142.54 0.45 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.196 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.427 ' H ' HD21 ' A' ' 73' ' ' LEU . 58.0 tt0 -104.37 126.48 51.5 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 57.7 mt -128.35 128.26 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.18 0.514 . . . . 0.0 111.474 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.507 ' OD1' ' SD ' ' A' ' 1' ' ' MET . 85.6 m-20 -101.28 111.06 23.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.131 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.351 180.0 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -75.31 142.71 43.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.724 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -112.03 135.95 52.01 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.289 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -101.21 117.16 34.43 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.312 0.577 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 6' ' ' LEU . 99.4 mttt -119.54 107.37 13.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.146 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 5' ' ' LYS . 16.2 tp -31.06 93.2 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.931 0 O-C-N 123.665 0.603 . . . . 0.0 110.886 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 5' ' ' LYS . 30.8 Cg_exo -59.15 150.04 76.28 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.214 1.943 . . . . 0.0 112.585 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -77.88 92.57 4.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.185 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.64 134.41 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.86 -158.95 45.29 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -137.5 158.45 44.37 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.78 42.37 4.46 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -124.77 129.01 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.8 p -128.52 -35.59 1.93 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.61 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -145.84 156.5 43.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.193 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.69 110.04 3.95 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -118.41 130.8 56.18 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.7 mm -100.12 120.15 49.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.107 0.48 . . . . 0.0 111.777 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 7.4 p -90.43 -45.61 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.467 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.449 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 99.6 mtt180 -147.7 149.33 32.23 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -114.79 140.62 48.77 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -121.74 12.23 10.59 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.004 0.365 . . . . 0.0 111.009 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.09 131.07 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.81 141.65 36.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.187 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -54.91 135.77 47.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.879 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.27 6.48 84.17 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.516 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 28' ' ' MET . 64.2 t0 -110.82 146.95 35.53 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.245 0.522 . . . . 0.0 110.872 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.539 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 77.2 mtm -87.65 149.38 24.31 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.738 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.23 137.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.799 0.333 . . . . 0.0 110.444 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -90.21 158.83 17.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.51 138.16 58.26 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.42 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 58.6 37.02 25.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.057 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.33 87.21 1.87 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.489 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -172.82 167.09 5.25 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.733 0.302 . . . . 0.0 110.452 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -136.05 88.56 2.4 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.229 0.538 . . . . 0.0 110.138 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.16 128.61 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.522 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -117.08 118.01 31.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.561 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -109.52 129.3 64.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.0 ttp -117.14 154.97 30.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.647 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.426 ' CG2' ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -140.16 -86.21 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.868 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.426 ' H ' ' CG2' ' A' ' 40' ' ' THR . 67.2 t0 -94.43 52.63 1.58 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.329 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 60.04 44.33 13.36 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 121.035 0.445 . . . . 0.0 110.835 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -130.1 138.32 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.748 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 m -94.89 118.13 31.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.215 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.83 117.54 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.148 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -93.1 128.84 39.16 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 110.467 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.7 mt -137.99 90.21 14.16 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.451 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.74 144.62 92.84 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.528 2.152 . . . . 0.0 112.413 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.8 m -51.06 108.63 1.09 Allowed Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.803 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.9 -15.35 23.72 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 121.638 1.559 . . . . 0.0 115.035 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.89 124.6 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.42 0.555 . . . . 0.0 111.779 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -89.16 149.01 23.35 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 120.689 0.28 . . . . 0.0 111.112 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.24 -138.42 4.89 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -122.31 144.14 49.19 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.958 0.409 . . . . 0.0 111.084 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mm -99.75 120.58 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.7 t -83.52 -50.96 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -158.86 154.69 26.46 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.592 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.2 tt -91.47 108.23 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.42 0.629 . . . . 0.0 109.513 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.4 tp -82.01 -27.65 32.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.803 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -117.15 145.33 43.89 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.366 0.603 . . . . 0.0 111.649 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.524 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 90.2 mtm-85 -120.48 168.41 11.36 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.952 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -62.73 146.85 51.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 111.968 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.32 5.08 85.63 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.182 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.524 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 86.0 mt-30 -89.22 132.1 35.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.444 0.64 . . . . 0.0 111.942 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.07 121.13 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.848 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.96 139.33 14.0 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.342 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.38 143.85 25.78 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.183 1.255 . . . . 0.0 112.246 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 p -61.68 129.2 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.162 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.35 52.54 0.07 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.452 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.4 t -167.05 153.65 8.42 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.991 0.396 . . . . 0.0 110.998 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.7 t -79.57 130.9 35.8 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.2 mt -105.52 0.07 26.31 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 74' ' ' GLN . 3.2 tp -173.13 143.35 1.12 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.423 ' H ' HD13 ' A' ' 73' ' ' LEU . 12.7 mm-40 -102.98 129.68 49.81 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.013 0.435 . . . . 0.0 110.47 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 83.1 mt -129.82 126.18 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.327 0.584 . . . . 0.0 111.611 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -89.78 138.75 31.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.653 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.329 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.526 ' H3 ' ' CB ' ' A' ' 77' ' ' THR . 22.5 ttm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.47 150.36 45.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.198 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -130.55 129.76 43.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.54 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.67 120.35 32.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -129.49 149.35 51.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.605 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 tt -95.16 106.46 25.89 Favored Pre-proline 0 N--CA 1.473 0.675 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.677 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.46 159.2 25.75 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.874 1.716 . . . . 0.0 111.892 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -76.92 88.54 3.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 110.74 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 9' ' ' ILE . 96.5 mt -63.39 -43.15 98.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.034 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.04 168.41 46.93 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.63 -37.02 83.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.775 0.322 . . . . 0.0 110.473 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.71 121.7 1.12 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.1 t -153.28 -52.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 110.218 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.8 p 42.93 72.26 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.202 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -174.3 144.66 0.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.637 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.57 110.52 0.5 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' OE1' ' CE ' ' A' ' 39' ' ' MET . 83.7 tt0 -122.87 135.88 54.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.842 0.353 . . . . 0.0 110.268 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 mm -102.56 121.24 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.931 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.5 p -92.63 -42.44 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.36 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.4 ttt-85 -142.31 137.51 30.64 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -109.27 141.05 42.12 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 10.8 p-10 -114.87 3.04 14.49 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.42 155.83 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.701 0.286 . . . . 0.0 110.684 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 99.0 mttt -135.11 150.54 50.23 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.221 0.534 . . . . 0.0 111.239 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -50.03 131.21 22.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.114 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.79 5.3 68.72 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.65 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 31.7 p-10 -106.67 150.06 26.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 117.52 0.66 . . . . 0.0 110.734 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.7 mmm -85.55 153.28 22.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.913 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.6 t -125.18 160.57 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.957 0.408 . . . . 0.0 110.807 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.1 mp0 -118.45 152.26 36.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.355 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -80.64 140.4 35.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.31 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.11 141.96 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.051 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 65.9 114.11 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.496 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 45.0 t0 -163.49 -173.03 3.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.516 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 84.8 mt -138.15 69.94 1.39 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.082 0.467 . . . . 0.0 111.341 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.88 131.06 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 57.3 mp0 -128.54 123.27 33.04 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 110.937 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.78 131.85 64.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.425 ' CE ' ' OE1' ' A' ' 17' ' ' GLU . 63.2 ttp -99.5 121.59 41.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.659 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -96.49 -86.26 0.32 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.248 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' N ' ' OG1' ' A' ' 40' ' ' THR . 99.7 m-20 -101.26 49.98 0.87 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.206 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.1 tttm 73.08 28.25 1.92 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.932 0.396 . . . . 0.0 110.304 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.27 137.46 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.534 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 m -94.48 117.16 29.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.914 0.388 . . . . 0.0 110.13 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.5 m -124.16 131.22 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.557 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -90.07 139.23 30.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.593 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.8 mt -133.5 137.41 28.91 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.322 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 49' ' ' SER . 53.1 Cg_exo -51.99 140.59 49.02 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 121.79 1.66 . . . . 0.0 112.862 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.441 ' OG ' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -40.67 165.71 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.21 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.29 42.57 1.36 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.079 2.52 . . . . 0.0 113.172 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.7 t 62.22 118.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.661 0.267 . . . . 0.0 110.974 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.5 ptt-85 -44.04 150.33 0.28 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.902 0.382 . . . . 0.0 111.756 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.04 -146.38 11.66 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -118.23 131.65 56.36 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.907 0.384 . . . . 0.0 110.383 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.419 HG22 HD13 ' A' ' 55' ' ' ILE . 8.1 mm -96.63 118.87 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.9 t -91.0 -52.5 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -150.49 156.9 42.33 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.109 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.435 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.7 tt -117.6 123.33 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.751 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.46 -16.85 16.69 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.172 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.516 ' CD2' ' OE1' ' A' ' 64' ' ' GLN . 15.6 m-85 -106.74 141.99 37.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.115 0.483 . . . . 0.0 111.161 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -122.2 168.92 11.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.204 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.22 134.65 57.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.833 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.91 4.9 90.4 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.704 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.516 ' OE1' ' CD2' ' A' ' 60' ' ' TYR . 49.7 tt0 -82.97 135.65 34.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.504 0.652 . . . . 0.0 110.919 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -126.93 131.92 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.08 140.65 15.13 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 119.328 -0.367 . . . . 0.0 111.083 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.3 148.88 48.6 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 121.42 1.413 . . . . 0.0 112.225 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -57.8 132.55 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.204 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.78 51.84 0.11 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.5 ' HG ' ' HH ' ' A' ' 60' ' ' TYR . 36.4 p -159.06 163.27 36.44 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.445 0.623 . . . . 0.0 111.617 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.7 m -93.34 109.32 20.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.154 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.75 -46.04 87.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.406 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 74' ' ' GLN . 2.9 tt -152.55 146.47 25.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.492 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.46 ' N ' ' CD2' ' A' ' 73' ' ' LEU . 55.2 tt0 -102.95 130.06 49.89 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.6 mt -125.23 127.69 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.159 0.504 . . . . 0.0 111.342 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -91.92 137.27 32.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.526 ' CB ' ' H3 ' ' A' ' 1' ' ' MET . 19.1 m . . . . . 0 C--O 1.222 -0.392 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.252 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -139.78 149.9 44.09 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.92 133.78 50.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.265 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -88.23 112.82 23.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 109.933 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -117.64 117.57 29.73 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.697 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 tt -47.26 107.66 0.75 Allowed Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.77 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.39 148.72 23.9 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.543 1.496 . . . . 0.0 111.55 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 21.8 p-10 -79.77 105.21 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.47 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.4 pt -127.84 157.06 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.896 0.379 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.99 -132.73 43.23 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -66.42 -35.78 81.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.504 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.06 170.55 13.31 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -133.12 110.81 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.455 ' OG1' ' OE1' ' A' ' 15' ' ' GLU . 12.2 p -72.38 -39.08 68.3 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.89 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.455 ' OE1' ' OG1' ' A' ' 14' ' ' THR . 57.0 mp0 -144.6 149.77 36.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.815 0.34 . . . . 0.0 110.266 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.99 117.81 5.94 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -123.27 131.98 53.86 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.58 120.67 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.031 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 7.7 p -92.18 -43.12 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.72 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' NH2' ' OE1' ' A' ' 37' ' ' GLU . 86.2 mtm180 -144.92 151.4 38.61 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -118.68 140.98 49.04 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -116.64 9.06 14.0 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.1 0.409 . . . . 0.0 111.847 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.61 156.74 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.676 0.274 . . . . 0.0 110.342 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 62.6 mttp -115.34 142.34 46.81 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.275 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -57.33 134.64 56.17 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.36 6.43 66.32 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 40.1 p-10 -102.36 151.72 21.93 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.026 0.441 . . . . 0.0 110.86 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.9 mtm -81.64 144.61 31.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.199 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.0 t -122.54 133.61 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.389 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -104.03 159.94 15.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.114 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.87 133.46 54.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.279 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.1 37.96 26.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.522 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -139.43 81.46 1.83 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.727 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 68.0 t0 -177.67 132.17 0.16 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 41.5 tp -111.02 96.77 6.35 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.148 0.499 . . . . 0.0 109.99 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.77 124.03 72.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.542 ' OE1' ' NH2' ' A' ' 20' ' ' ARG . 76.0 tt0 -106.06 120.24 41.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.045 0.45 . . . . 0.0 110.6 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.32 131.55 67.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.678 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 43' ' ' VAL . 6.0 tpp -114.72 145.43 42.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.363 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 2.6 t -115.4 -131.35 0.32 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.027 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.532 ' N ' ' OG1' ' A' ' 40' ' ' THR . 67.3 t0 -65.13 -43.77 90.82 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.458 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -173.13 53.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.786 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.506 ' O ' ' SD ' ' A' ' 39' ' ' MET . 5.1 t -145.01 133.69 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.253 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -101.2 119.47 38.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.62 157.76 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.547 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -125.57 135.65 52.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.239 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.3 mt -133.58 88.26 34.52 Favored Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.503 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.18 142.53 97.26 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 122.409 2.072 . . . . 0.0 112.302 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.2 m -41.55 102.45 0.27 Allowed Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.203 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.32 -23.12 38.86 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.081 1.188 . . . . 0.0 114.466 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.83 126.4 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 118.246 0.476 . . . . 0.0 111.32 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.5 ptt-85 -84.75 146.01 27.61 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 120.514 0.197 . . . . 0.0 110.897 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.23 -145.94 7.2 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.698 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -115.94 135.51 53.91 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.641 0.258 . . . . 0.0 110.392 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 55' ' ' ILE . 7.5 mm -95.59 119.8 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.19 -53.27 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.531 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -164.1 157.73 18.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.727 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.471 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.7 tt -89.35 114.84 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.179 0.514 . . . . 0.0 110.691 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.94 -25.17 24.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.352 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.37 145.98 39.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.096 0.474 . . . . 0.0 111.192 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -123.23 165.65 16.55 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.017 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.4 142.39 48.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.417 0.627 . . . . 0.0 112.159 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.37 4.95 90.33 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.075 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -86.69 130.18 34.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 111.499 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.75 129.65 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.544 -0.753 . . . . 0.0 108.972 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.79 140.41 14.68 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 119.374 -0.346 . . . . 0.0 110.575 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.92 146.22 47.78 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.326 1.351 . . . . 0.0 112.584 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -56.12 130.47 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.09 49.78 0.15 Allowed Glycine 0 N--CA 1.47 0.903 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 p -160.52 164.52 32.02 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.135 0.467 . . . . 0.0 111.03 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.4 p -87.65 127.72 35.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.221 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 74.9 mt -93.58 -4.56 50.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.321 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 74' ' ' GLN . 2.0 tp 174.76 149.55 0.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.446 ' H ' HD12 ' A' ' 73' ' ' LEU . 58.2 tt0 -104.76 128.12 52.77 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.922 0.392 . . . . 0.0 111.394 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.3 mt -126.56 128.01 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.094 0.473 . . . . 0.0 110.976 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -96.9 110.97 23.37 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.068 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.506 -179.763 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.638 ' H1 ' ' H ' ' A' ' 77' ' ' THR . 28.3 ttt . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -126.77 148.87 49.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.739 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -124.62 135.42 53.08 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.281 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -100.76 119.74 39.07 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.33 147.24 48.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.917 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 tt -76.24 116.68 58.19 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.686 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.82 155.3 39.16 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.949 1.766 . . . . 0.0 112.812 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -84.15 91.08 7.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.347 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.0 pt -97.45 -0.16 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.041 0.448 . . . . 0.0 110.324 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.24 127.29 4.12 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -65.94 -36.77 84.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.546 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.91 79.34 1.25 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.5 t -129.48 130.99 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 m -127.16 -20.27 4.16 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.177 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -171.08 146.04 2.36 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.362 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.09 168.31 13.74 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -156.68 142.78 18.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.482 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 mm -102.87 121.33 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.462 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -92.35 -45.4 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.434 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -139.77 146.83 39.98 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.26 0.552 . . . . 0.0 112.077 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -114.57 142.99 45.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.263 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -118.17 8.34 12.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.451 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.21 156.06 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.792 0.33 . . . . 0.0 110.73 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.86 146.55 39.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.275 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.31 138.75 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.907 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.21 7.91 69.34 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.601 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 28' ' ' MET . 60.7 t0 -120.8 148.09 44.47 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.93 0.395 . . . . 0.0 111.038 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.537 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 96.9 mtp -83.94 150.13 25.87 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.561 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.4 t -119.73 133.59 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.807 0.337 . . . . 0.0 110.321 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.3 mp0 -101.96 155.41 18.18 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.443 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -71.34 140.8 50.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.024 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 t0 80.61 64.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.766 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -140.36 87.58 2.15 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -98.01 89.28 4.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.724 0.297 . . . . 0.0 111.354 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.9 mt -140.92 27.16 2.01 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 m -116.61 135.81 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -122.7 126.24 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.598 0.237 . . . . 0.0 110.602 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.33 155.74 34.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 110.464 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 43' ' ' VAL . 28.0 tpp -106.71 125.42 50.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.624 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.69 -49.77 3.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.974 0.416 . . . . 0.0 110.079 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.423 ' OD1' ' CG2' ' A' ' 43' ' ' VAL . 47.8 p-10 -139.23 49.72 1.83 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.438 ' C ' ' SD ' ' A' ' 39' ' ' MET . 48.5 tttm 72.76 23.8 2.84 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.589 ' N ' ' SD ' ' A' ' 39' ' ' MET . 47.6 t -123.69 134.57 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.754 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.3 m -95.68 118.74 32.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.661 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.12 155.11 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.251 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -109.67 135.1 51.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.711 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.32 157.88 75.73 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 49' ' ' SER . 37.2 Cg_exo -55.2 147.24 55.87 Favored 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 121.914 1.743 . . . . 0.0 112.452 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -48.4 179.9 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.352 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 49' ' ' SER . 88.0 Cg_endo -89.31 44.91 0.77 Allowed 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 123.094 2.529 . . . . 0.0 113.056 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.1 t 62.79 117.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 120.682 0.277 . . . . 0.0 111.745 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -39.26 147.12 0.07 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.695 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.53 -147.14 12.85 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.27 139.1 51.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.963 0.382 . . . . 0.0 110.309 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mm -103.31 119.02 51.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -93.6 -51.62 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -147.17 157.5 43.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.441 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.4 tt -116.94 124.24 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.376 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.22 -16.42 15.21 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 8.1 m-85 -109.89 145.51 36.71 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.269 0.557 . . . . 0.0 111.751 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -124.87 161.8 25.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.254 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -56.11 138.52 49.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.558 0.694 . . . . 0.0 112.33 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.85 5.67 89.91 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.202 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -81.2 133.83 35.52 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.332 -0.51 . . . . 0.0 110.832 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.9 t -118.02 128.62 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.157 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 t -149.84 139.38 13.17 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.513 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.04 143.28 83.92 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.205 1.27 . . . . 0.0 111.746 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.21 130.95 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.73 50.13 0.05 OUTLIER Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.975 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -166.65 164.07 16.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.388 0.594 . . . . 0.0 111.451 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.459 ' O ' ' CG2' ' A' ' 71' ' ' THR . 7.8 t -94.71 114.43 26.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.188 0.518 . . . . 0.0 109.628 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.533 ' CD1' ' CD2' ' A' ' 60' ' ' TYR . 2.9 mm? -64.72 -40.32 95.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.334 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD2' ' N ' ' A' ' 74' ' ' GLN . 2.9 tt -142.62 147.7 36.24 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.462 ' N ' ' CD2' ' A' ' 73' ' ' LEU . 55.5 tt0 -102.74 130.7 49.78 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.0 mt -128.3 127.78 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.982 0.42 . . . . 0.0 111.296 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -96.0 116.37 28.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.47 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.638 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 17.7 m . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.108 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -80.32 141.05 35.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.66 138.51 51.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.737 0.303 . . . . 0.0 110.756 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -101.36 106.02 17.13 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -114.84 120.81 41.27 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.066 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.416 ' C ' ' CD2' ' A' ' 6' ' ' LEU . 4.4 tt -47.11 107.64 0.75 Allowed Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -54.27 144.65 59.09 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.533 1.488 . . . . 0.0 112.332 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -79.23 19.08 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.373 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.4 pt -121.59 147.02 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.036 0.446 . . . . 0.0 110.568 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.94 -162.35 29.69 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.33 -40.2 95.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.227 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.89 111.66 0.25 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.7 t -128.29 127.17 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.3 p -125.09 -14.44 6.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.916 0.388 . . . . 0.0 110.675 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -159.4 153.27 23.15 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.69 144.59 17.31 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -157.06 126.7 6.16 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.4 mm -102.54 120.09 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.802 0.334 . . . . 0.0 111.65 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 9.1 p -87.27 -47.45 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.851 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 99.8 mtt180 -142.77 147.77 36.09 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -113.24 136.17 53.03 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 22.3 p-10 -99.69 -7.12 26.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.8 m -145.37 161.12 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.48 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 99.0 mttt -139.36 155.44 47.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.151 0.501 . . . . 0.0 111.215 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -46.78 142.31 3.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.389 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.9 8.53 67.08 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.137 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 47.2 p-10 -129.65 149.47 51.39 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.015 0.908 . . . . 0.0 111.659 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.5 mtt -84.94 151.39 24.27 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.54 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.18 147.1 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.093 0.473 . . . . 0.0 110.309 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 97.6 mt-10 -140.56 152.77 45.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.068 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 30' ' ' GLU . 33.7 tptt 94.59 124.11 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.955 0.784 . . . . 0.0 110.707 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 49' ' ' SER . 9.0 p-10 -72.75 -3.32 24.57 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.469 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -132.49 87.27 2.4 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.621 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 53.1 p-10 -97.82 -112.32 0.15 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.621 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 54.5 tp -166.84 80.51 0.23 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.275 0.559 . . . . 0.0 110.714 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.64 132.35 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -109.27 123.77 49.82 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 110.582 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.76 128.23 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.621 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttm -109.2 155.94 20.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.03 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.5 t -132.21 -118.33 0.21 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.629 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.536 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.2 p-10 -66.73 -46.33 75.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.941 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.46 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 30.8 ttmt -174.64 56.2 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.485 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -162.21 151.76 3.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.826 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 m -117.09 122.49 44.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.065 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.59 157.31 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.055 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.26 134.44 51.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.0 mt -118.53 137.63 24.99 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.92 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 49' ' ' SER . 50.2 Cg_exo -51.11 142.07 36.26 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.442 1.428 . . . . 0.0 112.467 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -36.58 157.44 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.37 44.93 1.72 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.496 2.131 . . . . 0.0 112.578 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.8 t 63.62 117.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -50.25 146.7 4.85 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.933 0.396 . . . . 0.0 111.704 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.73 -136.59 4.33 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -127.04 143.84 51.18 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.033 0.416 . . . . 0.0 110.239 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -104.0 117.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.3 t -91.18 -50.72 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -149.97 157.17 42.89 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.427 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 tt -132.02 126.84 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.766 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.13 -16.11 20.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.914 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.516 ' CZ ' ' CD2' ' A' ' 72' ' ' LEU . 25.2 m-85 -102.01 134.65 44.9 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.36 0.6 . . . . 0.0 111.782 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.81 178.99 4.28 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.987 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.69 128.16 35.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.781 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.46 5.88 81.56 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.527 177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -83.72 139.49 32.71 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.198 0.999 . . . . 0.0 111.743 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 p -125.73 132.63 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.378 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -147.99 137.59 12.24 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.032 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.51 150.6 41.99 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 121.472 1.448 . . . . 0.0 112.439 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.37 130.6 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.307 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.7 48.15 0.11 Allowed Glycine 0 N--CA 1.471 1.018 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.247 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.3 p -163.12 162.89 25.88 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 117.376 0.588 . . . . 0.0 111.171 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -90.28 130.79 36.35 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.516 ' CD2' ' CZ ' ' A' ' 60' ' ' TYR . 78.3 mt -89.27 -12.36 40.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.469 HD21 ' N ' ' A' ' 74' ' ' GLN . 2.3 tt -169.59 146.78 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.976 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.469 ' N ' HD21 ' A' ' 73' ' ' LEU . 2.7 tm0? -102.81 122.31 44.26 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.421 HG21 HD12 ' A' ' 75' ' ' ILE . 90.0 mt -124.97 128.73 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.398 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -98.54 111.26 23.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.229 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.56 -179.951 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -80.68 137.22 36.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -114.02 126.64 55.35 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -96.97 113.65 25.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.211 0.529 . . . . 0.0 110.161 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -117.71 139.42 51.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.023 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -71.51 113.15 17.25 Favored Pre-proline 0 N--CA 1.47 0.549 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.546 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -81.64 154.43 18.02 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.057 1.838 . . . . 0.0 111.929 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -69.67 138.67 53.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.3 pt -109.88 1.55 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.759 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.28 166.2 39.09 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -89.45 146.33 24.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.861 0.362 . . . . 0.0 110.414 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.44 25.24 66.11 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.9 t -123.49 130.88 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 p -152.73 70.08 0.88 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.475 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -162.14 143.63 10.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.43 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.22 110.22 0.79 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -123.23 137.04 54.97 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.03 121.42 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 112.056 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 9.8 p -87.19 -46.56 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.609 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.467 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 72.2 ttt180 -149.16 137.28 20.71 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -100.84 145.6 28.36 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 11.5 p-10 -121.3 8.89 10.3 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.31 155.68 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.075 0.464 . . . . 0.0 111.018 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -134.74 147.57 50.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 56' ' ' VAL . 24.0 tp10 -60.11 135.25 57.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.167 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.77 8.06 70.39 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.224 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -118.4 156.33 29.16 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.125 0.463 . . . . 0.0 111.322 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.2 mmt -96.4 150.96 20.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -138.32 154.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.809 0.337 . . . . 0.0 110.405 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 30' ' ' GLU . 1.3 pm0 -109.98 155.19 22.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.974 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -83.8 92.75 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.765 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -178.61 75.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.99 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 38.74 91.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.957 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.45 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 27.4 t70 -84.67 11.97 8.02 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.339 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.9 mt 66.0 66.33 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.918 0.761 . . . . 0.0 110.859 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.06 128.93 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.413 ' OE2' ' NZ ' ' A' ' 46' ' ' LYS . 95.9 mt-10 -120.56 125.54 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.14 0.495 . . . . 0.0 111.091 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.5 m -121.04 133.57 67.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.265 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.9 ttp -103.88 109.54 21.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.413 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -51.96 62.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.201 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -138.49 -65.48 0.5 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.545 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -149.47 43.83 0.93 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.701 0.286 . . . . 0.0 110.37 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.0 p -150.87 149.71 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.951 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 m -102.19 118.86 37.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.516 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.64 133.54 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.482 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' NZ ' ' OE2' ' A' ' 37' ' ' GLU . 68.2 mttm -94.24 137.45 33.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.745 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.2 mt -132.03 139.15 34.11 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.059 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 49' ' ' SER . 50.4 Cg_exo -52.97 142.74 52.24 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.356 1.371 . . . . 0.0 112.379 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.93 164.85 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.551 -179.218 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.28 44.55 1.63 Allowed 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.149 2.566 . . . . 0.0 112.663 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t 64.38 116.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.732 0.301 . . . . 0.0 110.901 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -49.78 146.93 4.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 111.665 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 167.3 -134.57 3.31 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.0 139.55 53.34 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.87 0.335 . . . . 0.0 110.192 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -99.01 120.25 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.464 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 21.4 t -87.05 -54.76 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -154.13 158.76 40.89 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.302 0.572 . . . . 0.0 112.038 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.464 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.4 tt -116.87 119.54 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.198 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 74.3 mt -100.17 -18.22 17.02 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.3 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -115.17 142.75 46.23 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -123.7 165.92 16.42 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.142 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.42 150.25 11.99 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.014 0.435 . . . . 0.0 111.983 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.55 6.47 77.17 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.303 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -101.72 129.97 48.01 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 112.071 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.95 128.94 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 t -147.08 140.43 14.94 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.783 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.48 140.82 63.7 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.239 1.293 . . . . 0.0 112.05 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.2 p -59.43 131.75 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.555 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.28 50.48 0.12 Allowed Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.014 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.1 p -156.36 164.55 38.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.269 0.535 . . . . 0.0 111.304 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.4 m -88.26 121.06 30.22 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.88 -27.69 13.48 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 74' ' ' GLN . 1.7 tt -156.12 141.71 17.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.431 ' N ' ' CD2' ' A' ' 73' ' ' LEU . 52.2 tt0 -104.25 132.81 50.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.86 0.362 . . . . 0.0 110.205 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.7 mt -130.99 127.47 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.191 0.519 . . . . 0.0 111.34 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -87.46 142.95 27.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.717 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 83.9 m . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.299 179.535 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -116.26 141.49 48.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -114.6 126.41 54.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.88 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -99.62 118.69 36.71 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.21 0.528 . . . . 0.0 110.503 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -124.65 140.91 52.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.882 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.81 114.75 12.21 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.98 153.98 37.63 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.622 1.548 . . . . 0.0 112.662 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -90.16 106.39 18.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.587 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.5 pt -127.03 143.71 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.47 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.43 -5.52 43.86 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 52.96 171.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.78 28.67 64.56 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.67 128.95 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.0 p -135.52 -7.26 2.22 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.291 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -142.06 148.71 38.87 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.768 0.318 . . . . 0.0 110.619 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.82 135.71 8.83 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.38 137.88 54.72 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 mm -102.66 121.18 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.688 0.28 . . . . 0.0 111.616 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 t -101.53 -34.65 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.751 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -153.49 133.21 13.06 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.88 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -105.37 130.48 53.47 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 16.8 p-10 -98.98 3.66 47.05 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.719 0.295 . . . . 0.0 111.086 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.46 157.64 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.792 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -132.33 145.7 51.45 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.32 0.581 . . . . 0.0 111.402 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -58.39 140.48 53.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.919 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.71 6.89 65.26 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -121.48 126.6 49.65 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.082 0.441 . . . . 0.0 111.225 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -71.34 141.17 50.44 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.2 t -142.1 161.5 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 1.6 pm0 -127.66 152.1 48.11 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.055 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 30' ' ' GLU . 52.4 pttt -26.8 145.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.583 0.552 . . . . 0.0 111.752 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.5 ' O ' ' O ' ' A' ' 33' ' ' GLN . 94.6 m-20 61.69 58.31 2.03 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.227 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.66 ' NE2' ' H ' ' A' ' 49' ' ' SER . 1.4 pm0 -43.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.488 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.485 ' H ' ' CG ' ' A' ' 33' ' ' GLN . 66.4 t0 -153.4 61.17 0.76 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.036 0.446 . . . . 0.0 110.672 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 34' ' ' ASP . 19.3 mt 55.73 124.62 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.999 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.73 131.78 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -92.87 120.53 33.31 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.331 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -129.22 134.93 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.967 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.0 ttp -116.43 153.15 32.6 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.723 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.412 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -135.31 -82.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' N ' ' OG1' ' A' ' 40' ' ' THR . 99.0 m-20 -91.6 44.43 1.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.0 tttt 68.46 38.06 2.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.79 0.328 . . . . 0.0 110.443 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.3 t -132.31 136.95 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -94.22 113.78 25.77 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.03 0.443 . . . . 0.0 110.012 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.39 133.75 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.822 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -93.53 125.26 38.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.31 0.576 . . . . 0.0 110.58 179.368 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 47' ' ' ILE . 80.4 mt -135.46 85.68 31.27 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.471 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.09 145.02 99.07 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 122.483 2.122 . . . . 0.0 111.722 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.66 ' H ' ' NE2' ' A' ' 33' ' ' GLN . 1.2 m -74.69 131.9 78.87 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.754 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.89 -15.45 40.33 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.816 1.677 . . . . 0.0 113.749 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -136.97 155.51 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.769 0.319 . . . . 0.0 111.424 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.18 160.02 9.4 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.42 -82.63 0.05 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -124.63 124.13 41.55 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -97.76 115.66 38.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.68 -54.07 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -165.36 152.64 10.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.514 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.445 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 2.8 tt -105.62 121.12 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.542 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -95.24 -17.48 21.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.077 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.407 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 12.3 m-85 -109.8 142.78 40.57 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.216 0.531 . . . . 0.0 111.261 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.435 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 60.7 ttm-85 -126.69 162.54 25.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.757 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -55.0 147.2 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.212 0.53 . . . . 0.0 111.875 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.44 6.48 87.56 Favored Glycine 0 N--CA 1.47 0.919 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.945 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.435 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 86.8 mt-30 -98.76 133.32 43.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.368 0.604 . . . . 0.0 111.715 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.81 129.14 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.29 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.9 t -147.64 141.04 15.29 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.722 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.04 142.47 34.39 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.466 1.444 . . . . 0.0 112.332 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -60.8 133.82 26.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.822 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.53 51.81 0.16 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 m -153.02 159.43 42.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 117.457 0.629 . . . . 0.0 111.561 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.2 m -88.04 98.08 11.33 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.867 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 3.1 mm? -65.21 -41.63 94.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.641 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.512 HD22 ' H ' ' A' ' 74' ' ' GLN . 1.8 tt -146.39 148.6 32.5 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.512 ' H ' HD22 ' A' ' 73' ' ' LEU . 54.3 mt-30 -103.26 127.18 50.66 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 mt -126.08 127.86 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.1 0.476 . . . . 0.0 111.575 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -101.83 114.16 28.0 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.961 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.4 -179.935 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 ttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -85.54 147.15 26.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.897 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -121.33 135.72 55.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.325 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -99.55 118.51 36.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -121.54 146.44 46.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.293 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.19 115.99 17.14 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -49.3 138.05 30.13 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.391 1.394 . . . . 0.0 113.291 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -81.53 12.72 3.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.339 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 pt -124.56 148.93 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.796 0.331 . . . . 0.0 110.489 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.82 -166.8 32.52 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -65.72 -37.1 85.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.37 . . . . 0.0 110.462 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASP . . . 170.81 134.78 1.81 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.98 129.44 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.815 0.34 . . . . 0.0 110.276 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 p -123.18 -26.81 4.26 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.354 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -173.77 156.41 2.85 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.373 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.11 122.61 6.97 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -131.63 135.19 46.75 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 mm -102.7 120.0 51.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.185 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 m -92.37 -43.58 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.719 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -142.93 145.52 33.11 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -118.22 140.28 50.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.1 m-20 -119.8 13.47 12.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.781 0.324 . . . . 0.0 110.82 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.35 158.92 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 26.4 pttm -138.94 144.36 39.0 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 110.574 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 26' ' ' GLY . 13.1 tm-20 -47.78 138.88 8.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.725 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' N ' ' CD ' ' A' ' 25' ' ' GLU . . . 87.56 6.82 76.61 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.451 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 42.4 p-10 -106.93 150.01 26.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.206 0.503 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.6 mtp -90.31 142.69 27.48 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.091 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.9 t -120.01 133.38 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.672 0.272 . . . . 0.0 110.705 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -101.47 156.49 17.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.238 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.39 135.9 55.83 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.704 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 57.9 34.4 24.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.303 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -144.43 88.27 1.92 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.76 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -172.67 170.87 4.63 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.938 0.399 . . . . 0.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.442 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 81.0 mt -140.14 88.42 2.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.61 133.38 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.444 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -123.1 124.91 44.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.189 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.04 154.64 26.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.215 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.6 ttp -106.84 152.4 23.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.216 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.65 -42.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.479 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 91.9 m-20 -136.0 49.0 2.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.92 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 56.81 43.46 25.0 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.066 0.46 . . . . 0.0 109.961 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.43 152.1 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.25 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.6 m -95.9 118.29 32.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.612 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.74 131.38 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.193 0.52 . . . . 0.0 110.769 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -92.03 139.24 30.84 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.086 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.3 mt -134.73 135.2 22.95 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.078 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 49' ' ' SER . 43.0 Cg_exo -51.6 146.17 27.42 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 121.689 1.593 . . . . 0.0 112.308 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.26 166.31 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.466 -179.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.71 49.85 3.32 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 123.044 2.496 . . . . 0.0 113.082 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t 68.29 119.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.838 0.351 . . . . 0.0 111.492 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -47.41 135.9 10.25 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.753 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.15 -141.52 6.51 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -123.59 144.98 49.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.021 0.411 . . . . 0.0 110.559 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.2 mm -100.96 120.76 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.2 t -92.43 -51.13 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -154.6 159.15 40.67 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.761 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.1 tt -106.95 132.76 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.221 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.44 -24.6 10.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.459 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -108.4 141.41 40.29 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.035 0.445 . . . . 0.0 111.418 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.494 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 90.4 mtm180 -120.2 162.62 19.05 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.39 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -56.17 134.83 53.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.174 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.75 4.98 84.62 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.929 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.494 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 79.8 mt-30 -83.27 135.53 34.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.688 0.744 . . . . 0.0 111.875 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.3 t -120.11 126.84 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 t -148.67 132.5 8.53 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -56.47 149.65 55.86 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.459 1.439 . . . . 0.0 112.106 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.89 128.56 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.783 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.52 49.72 0.05 OUTLIER Glycine 0 CA--C 1.531 1.078 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.131 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m -163.92 166.97 21.18 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.388 0.594 . . . . 0.0 111.165 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.454 ' O ' ' CG2' ' A' ' 71' ' ' THR . 6.3 t -95.4 115.92 28.09 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.99 -42.98 89.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.291 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.457 HD21 ' N ' ' A' ' 74' ' ' GLN . 4.0 tt -144.01 151.28 39.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.457 ' N ' HD21 ' A' ' 73' ' ' LEU . 36.8 mt-30 -102.62 121.12 41.77 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.9 127.19 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.965 0.412 . . . . 0.0 111.827 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.56 136.95 32.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.482 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.397 -179.872 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtm . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -111.77 143.65 42.34 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.328 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -139.49 114.31 9.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.017 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -88.87 122.44 32.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.135 0.493 . . . . 0.0 110.633 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -121.76 157.85 30.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.178 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 8' ' ' ASP . 10.4 tp -44.43 126.24 4.76 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.92 13.19 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.186 1.257 . . . . 0.0 112.539 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 6' ' ' LEU . 99.1 m-20 46.17 82.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.773 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.424 HG22 HD13 ' A' ' 9' ' ' ILE . 96.3 mt -62.38 -43.16 97.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.89 -168.88 41.79 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 57.96 77.16 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.019 0.438 . . . . 0.0 110.559 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.88 54.82 34.76 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.9 t -128.71 131.05 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 120.866 0.365 . . . . 0.0 110.274 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -163.47 46.59 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.234 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -169.17 154.09 5.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.896 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.79 137.09 10.29 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -151.97 133.47 14.63 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.921 0.391 . . . . 0.0 109.986 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -102.77 124.34 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.561 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.58 -44.24 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.527 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -151.61 137.87 18.42 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -107.75 136.9 46.72 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.1 m-20 -108.16 0.46 21.56 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.665 0.269 . . . . 0.0 110.766 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.5 m -133.54 158.49 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -137.5 154.33 49.89 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -54.73 143.21 25.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.059 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.51 7.13 76.29 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.762 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 28' ' ' MET . 62.0 t0 -123.19 150.57 43.2 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.602 0.701 . . . . 0.0 111.089 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.553 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 76.5 mtm -78.07 149.09 33.99 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -121.8 133.93 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.69 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.86 157.41 17.22 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.348 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.05 94.48 6.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' ASP . 8.0 p30 173.12 113.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.936 0.398 . . . . 0.0 111.381 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 53.67 -82.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.829 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' ASP . 9.7 t0 74.88 13.14 3.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.864 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.3 mt 21.08 84.48 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.761 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.93 130.33 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.6 mp0 -116.37 124.38 49.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.475 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.56 135.14 58.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.637 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.7 ttp -124.83 151.46 45.21 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.675 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -104.27 -51.83 3.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.742 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' OG1' ' A' ' 40' ' ' THR . 94.7 m-20 -138.01 -62.5 0.59 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.327 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -146.31 39.19 1.08 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.855 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.6 t -129.87 133.33 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.798 0.332 . . . . 0.0 110.134 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.5 m -114.96 115.79 27.45 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.09 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.0 m -129.46 131.13 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.852 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -95.2 133.35 39.15 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.095 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mt -128.85 134.48 26.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.993 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.35 144.23 50.27 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.678 1.586 . . . . 0.0 111.219 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.1 m -99.0 104.01 23.14 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.22 48.43 2.49 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.186 1.924 . . . . 0.0 110.663 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.61 158.91 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -160.36 144.98 14.45 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.128 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.01 -137.05 4.98 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.07 141.72 51.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.902 0.351 . . . . 0.0 110.087 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -97.09 119.97 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.33 -49.61 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -158.26 158.43 34.43 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.734 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 4.4 tt -123.96 122.8 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.255 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.3 mt -99.15 -18.02 17.88 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.668 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.54 ' HH ' ' HG ' ' A' ' 70' ' ' SER . 21.3 m-85 -105.43 136.5 44.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.156 0.503 . . . . 0.0 110.827 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -121.06 -176.45 3.27 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.031 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -64.57 126.78 28.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.59 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.47 5.57 86.79 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.22 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -70.48 133.97 47.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.802 0.801 . . . . 0.0 110.835 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.71 126.9 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.3 t -149.17 139.49 13.44 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.189 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.91 150.34 64.25 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.034 1.156 . . . . 0.0 111.707 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.0 p -64.05 127.66 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.347 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.74 52.38 0.07 OUTLIER Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.027 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.54 ' HG ' ' HH ' ' A' ' 60' ' ' TYR . 29.7 p -162.84 163.45 26.51 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 117.289 0.545 . . . . 0.0 111.38 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.441 ' H ' ' HG1' ' A' ' 71' ' ' THR . 1.8 p -89.76 113.09 24.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.156 0.503 . . . . 0.0 110.182 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.19 -39.14 86.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.559 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.57 144.91 24.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.606 -177.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -103.38 125.91 50.25 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.4 mt -132.63 128.77 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.222 0.535 . . . . 0.0 111.333 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -100.65 136.08 41.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.838 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.431 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.595 ' SD ' ' NE2' ' A' ' 74' ' ' GLN . 14.3 ptp . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -101.71 134.69 44.48 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 40.5 mp0 -111.51 116.87 31.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.747 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -76.93 100.56 5.62 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -105.83 155.75 19.0 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.108 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.9 mt -93.33 108.25 31.98 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.87 157.67 24.2 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.847 1.698 . . . . 0.0 112.169 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -91.04 110.32 21.58 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.142 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.5 tt -174.25 -21.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 110.408 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.71 -35.52 0.28 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.95 -37.33 81.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 0.0 110.501 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -143.96 133.06 5.16 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 15' ' ' GLU . 1.2 p -155.0 151.82 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 13' ' ' VAL . 11.6 p 53.64 -72.86 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.245 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER -139.07 144.72 38.9 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.075 -0.391 . . . . 0.0 111.126 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.63 123.63 7.74 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -126.14 140.05 52.88 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 117.334 0.567 . . . . 0.0 110.158 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.54 121.8 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.29 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.96 -42.74 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.762 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -155.89 133.84 11.28 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -102.01 134.41 45.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 24.0 p-10 -106.21 -0.52 24.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.662 0.268 . . . . 0.0 111.149 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.63 160.37 37.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -139.6 155.78 47.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -50.87 135.72 23.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.079 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.17 4.61 66.49 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.858 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 36.7 p-10 -114.46 154.06 28.84 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.628 0.714 . . . . 0.0 110.908 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.9 mtm -114.12 148.73 36.71 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.01 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -139.43 150.4 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.92 0.391 . . . . 0.0 110.706 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -90.06 159.35 16.88 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.54 136.62 58.08 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.986 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 60.0 36.43 21.5 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.821 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -145.4 86.32 1.75 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 17.3 t0 -176.27 161.06 2.24 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.531 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 76.6 mt -134.55 88.63 2.46 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.107 0.479 . . . . 0.0 109.882 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.38 130.09 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -111.92 124.63 52.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.582 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.5 m -121.91 131.21 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.1 ttm -101.93 123.31 45.62 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.692 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -88.1 -90.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.418 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 42' ' ' LYS . 23.0 p-10 -96.03 -68.98 0.77 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.726 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.53 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 25.0 pttm -149.2 43.17 0.95 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.73 0.3 . . . . 0.0 110.977 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.19 151.21 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.909 0.385 . . . . 0.0 110.598 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 m -99.63 117.78 34.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.069 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.9 m -118.0 134.02 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.239 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.43 134.18 41.03 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.928 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.0 mt -137.23 85.41 21.98 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.732 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -55.74 141.43 84.51 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.705 2.27 . . . . 0.0 112.333 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.9 t -36.23 100.27 0.19 Allowed Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.589 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.92 -21.92 36.82 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.073 1.182 . . . . 0.0 113.843 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.19 120.96 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 122.104 -0.372 . . . . 0.0 111.212 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.48 152.94 33.95 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 121.167 -0.213 . . . . 0.0 110.547 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.2 -134.29 3.04 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.31 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -136.93 134.03 36.32 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.741 0.305 . . . . 0.0 110.234 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 55' ' ' ILE . 7.0 mm -90.77 118.44 36.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.95 -51.47 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -146.17 156.74 43.63 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.885 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.438 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 5.6 tt -121.79 122.77 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.362 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.15 -18.88 16.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.639 0.257 . . . . 0.0 110.933 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -105.98 141.08 37.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.17 0.509 . . . . 0.0 111.406 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.05 162.89 25.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.313 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.03 140.78 42.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.545 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.55 6.09 81.03 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.388 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -99.43 134.81 41.77 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.347 0.594 . . . . 0.0 111.854 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -126.38 129.2 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.566 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 t -147.79 138.03 12.65 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.38 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.15 140.95 70.73 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.43 1.42 . . . . 0.0 112.426 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 m -53.23 144.65 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.703 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.48 50.28 0.42 Allowed Glycine 0 N--CA 1.471 1.014 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.5 p -156.64 162.59 39.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 117.012 0.406 . . . . 0.0 111.024 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 m -82.33 100.61 10.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.005 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.19 -42.43 93.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.8 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 74' ' ' GLN . 3.3 tt -158.27 148.32 19.98 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.595 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 56.8 tt0 -103.05 128.24 49.99 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 86.8 mt -126.05 127.21 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.072 0.463 . . . . 0.0 111.262 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -98.56 111.98 24.17 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.212 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.182 179.771 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.39 141.01 40.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 33.8 mp0 -111.14 120.39 42.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.435 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -88.65 105.1 17.45 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 6' ' ' LEU . 67.9 tttt -111.85 173.08 6.53 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.137 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.403 ' H ' ' HG2' ' A' ' 5' ' ' LYS . 2.5 tt -106.42 82.97 1.06 Allowed Pre-proline 0 N--CA 1.471 0.594 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.77 155.04 49.15 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.473 1.449 . . . . 0.0 111.854 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -80.29 107.43 13.09 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.103 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.4 pt -103.0 -0.13 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.127 0.489 . . . . 0.0 110.163 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.28 177.56 46.27 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 11' ' ' GLU . 57.8 mp0 -83.77 172.56 12.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 110.217 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.44 8.51 61.05 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -127.33 130.26 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.978 0.418 . . . . 0.0 110.019 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 p -144.73 -16.49 0.53 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.593 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -145.04 151.17 38.12 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.362 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.59 110.74 3.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -125.14 134.01 52.6 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 mm -102.6 119.05 50.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.659 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 8.8 p -90.1 -43.58 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.405 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.405 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 99.7 mtt180 -140.9 144.58 35.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.878 0.37 . . . . 0.0 111.405 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -109.36 136.89 48.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 18.7 p-10 -93.76 -11.66 30.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.731 0.301 . . . . 0.0 110.522 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.78 159.89 7.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.263 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 73.8 mmtt -129.52 144.73 51.39 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -46.51 138.3 5.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.914 0.388 . . . . 0.0 111.339 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.18 7.55 58.31 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.445 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 24' ' ' LYS . 50.0 p-10 -129.07 151.26 49.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.603 0.702 . . . . 0.0 111.212 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.3 mtt -103.08 150.32 23.72 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.496 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.462 ' CG2' ' OE1' ' A' ' 33' ' ' GLN . 3.5 p -138.34 154.26 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.343 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -102.82 160.84 14.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.801 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 86.4 tttt -65.65 137.17 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.055 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 8.9 m-20 92.63 81.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.676 0.61 . . . . 0.0 111.575 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.462 ' OE1' ' CG2' ' A' ' 29' ' ' VAL . 57.2 tt0 -153.56 98.73 2.26 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.887 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -96.49 77.12 2.93 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -141.25 25.84 2.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.926 0.393 . . . . 0.0 110.295 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.23 131.61 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.9 131.04 53.51 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.232 0.539 . . . . 0.0 111.557 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.2 124.28 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.176 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.3 ttp -110.78 157.39 19.84 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.911 0.386 . . . . 0.0 110.83 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.3 t -136.31 -118.08 0.16 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.034 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.521 ' N ' ' OG1' ' A' ' 40' ' ' THR . 87.5 m-20 -64.02 -49.41 72.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.793 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -175.46 56.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.503 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.52 150.22 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.977 0.417 . . . . 0.0 110.894 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -109.77 120.09 41.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.853 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.37 118.47 58.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.951 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -88.28 133.94 33.93 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mt -145.69 117.63 5.1 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.318 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.34 142.94 19.25 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.947 1.765 . . . . 0.0 111.586 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 m -46.57 106.64 0.6 Allowed Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.86 -25.72 45.16 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.338 1.359 . . . . 0.0 114.539 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.5 123.35 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 118.066 0.394 . . . . 0.0 111.607 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -85.53 149.89 25.06 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.65 -134.56 2.59 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.179 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -126.29 131.22 51.92 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.003 0.402 . . . . 0.0 110.828 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 mm -93.9 119.08 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.8 t -93.08 -49.39 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.463 ' O ' ' CD2' ' A' ' 73' ' ' LEU . 60.6 pttt -148.86 150.28 32.73 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.5 tt -127.64 128.86 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.187 0.518 . . . . 0.0 110.968 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.5 mt -98.31 -17.36 18.94 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.141 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -94.5 142.72 27.11 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.311 0.577 . . . . 0.0 111.404 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -125.82 159.83 31.42 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.491 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.86 128.99 39.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.526 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.06 3.54 88.98 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.638 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -77.28 132.33 38.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.179 0.514 . . . . 0.0 111.079 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.94 128.54 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.764 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.34 135.84 10.79 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 119.499 -0.286 . . . . 0.0 110.579 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.63 146.7 42.56 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.388 1.392 . . . . 0.0 112.305 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 p -58.68 126.97 17.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.682 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.32 51.65 0.08 OUTLIER Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.3 m -153.83 159.73 41.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.131 0.465 . . . . 0.0 110.749 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.8 m -84.63 112.4 20.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.033 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.95 -43.84 82.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.991 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.7 OUTLIER -159.69 149.81 18.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.175 -177.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.465 ' H ' HD23 ' A' ' 73' ' ' LEU . 12.7 mm-40 -103.5 118.45 36.78 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.3 mt -118.18 128.68 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.486 0.66 . . . . 0.0 111.572 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -95.19 115.48 27.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.335 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.777 -179.715 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -84.13 131.56 34.77 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 51.9 mp0 -102.73 113.28 26.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.184 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -79.85 101.14 8.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.726 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.514 ' NZ ' ' OG1' ' A' ' 71' ' ' THR . 68.5 mttm -112.4 145.8 39.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.2 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -63.04 111.9 5.81 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -58.44 146.68 89.36 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.061 1.174 . . . . 0.0 112.013 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -79.1 16.26 0.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.189 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.1 pt -127.56 154.36 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.53 -154.85 26.05 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.88 -37.77 88.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.906 0.384 . . . . 0.0 110.071 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.06 117.04 0.53 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.78 130.34 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.819 0.343 . . . . 0.0 110.2 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.3 p -135.39 -15.03 1.93 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.323 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -163.56 152.09 13.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.169 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.79 139.46 14.5 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -152.48 116.05 4.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.1 118.27 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.897 0.379 . . . . 0.0 111.668 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.0 p -92.65 -40.02 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.398 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -144.73 137.37 26.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -110.63 146.55 35.96 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 56.7 t0 -130.69 26.84 5.0 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.948 0.34 . . . . 0.0 111.304 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.89 155.01 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.848 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -141.98 147.47 37.01 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.02 0.438 . . . . 0.0 111.158 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.18 140.48 38.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.938 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.3 88.08 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.233 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -108.38 125.75 52.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.116 0.458 . . . . 0.0 111.356 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.9 mtm -85.61 129.42 34.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.108 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.77 135.46 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.313 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -90.99 156.3 18.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.961 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 88.5 tttt -61.24 130.32 45.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 16.2 t0 94.87 69.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.057 0.848 . . . . 0.0 110.802 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 34' ' ' ASP . 52.2 tt0 -176.93 -118.58 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 33' ' ' GLN . 67.1 t0 29.49 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.8 tp -84.51 94.72 8.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.19 134.01 62.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.883 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.42 113.18 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.315 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.7 132.56 59.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.2 ttp -118.87 124.39 47.02 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.54 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.451 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -90.25 -86.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.54 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 18.4 p-10 -86.07 -59.18 2.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.625 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 7.5 tmtt? -172.83 57.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 p -153.39 151.3 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.353 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -94.3 116.11 28.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.155 0.503 . . . . 0.0 109.987 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.66 117.33 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.876 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' CD ' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -98.35 132.96 43.39 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.046 0.45 . . . . 0.0 111.316 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mt -138.63 85.29 17.43 Favored Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.588 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -87.35 53.82 2.66 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.516 2.144 . . . . 0.0 113.511 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 51' ' ' VAL . 59.6 p -170.51 47.52 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.038 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 49' ' ' SER . 71.5 Cg_endo -73.26 25.12 0.31 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.36 2.04 . . . . 0.0 111.457 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 49' ' ' SER . 4.5 t 66.79 67.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.229 0.537 . . . . 0.0 109.799 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -76.79 150.2 36.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.44 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.94 -92.99 0.09 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -122.36 133.78 54.64 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mm -104.69 120.31 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.3 t -87.55 -51.19 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -155.65 159.98 40.03 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.278 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.487 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.7 tt -98.04 116.04 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.873 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -99.16 -16.81 18.45 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.679 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -119.79 143.83 47.64 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.524 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 83.4 mtp180 -120.88 166.98 13.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.656 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.36 143.99 57.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.005 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 5.98 89.49 Favored Glycine 0 N--CA 1.466 0.693 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.168 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.524 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 24.5 mt-30 -82.34 126.88 32.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.268 0.556 . . . . 0.0 111.275 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.0 124.16 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.11 155.14 37.35 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.299 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.04 151.85 62.15 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.721 2.281 . . . . 0.0 111.685 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -59.83 129.52 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.259 0.552 . . . . 0.0 110.999 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.82 55.01 0.12 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.825 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.6 m -154.68 166.2 34.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.978 0.418 . . . . 0.0 111.272 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.514 ' OG1' ' NZ ' ' A' ' 5' ' ' LYS . 19.3 m -94.59 114.17 26.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.285 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.07 -46.9 61.04 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.513 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.472 HD13 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -160.99 158.01 27.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.715 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.472 ' H ' HD13 ' A' ' 73' ' ' LEU . 58.7 tt0 -103.35 128.03 50.55 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.07 -0.394 . . . . 0.0 111.079 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.2 mt -127.12 128.71 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.215 0.531 . . . . 0.0 112.302 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -100.24 115.74 30.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.38 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.275 179.549 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.484 ' H3 ' ' CB ' ' A' ' 77' ' ' THR . 63.4 ttp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' ILE . 2.1 t80 -122.73 149.85 43.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.737 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -132.23 134.59 45.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.322 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -96.36 113.32 24.89 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -115.65 153.91 30.45 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.914 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tt -102.81 92.67 3.68 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.85 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.2 152.76 40.23 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.531 1.487 . . . . 0.0 111.98 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -67.53 137.77 56.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.512 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.9 pt -135.1 153.61 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.176 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.67 -130.67 51.36 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -161.39 154.31 20.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.694 0.283 . . . . 0.0 110.328 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.04 59.84 1.92 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.7 t -126.7 131.2 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 p -106.67 -54.26 2.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.404 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -143.81 157.47 44.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.505 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.46 145.82 18.22 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -145.32 138.11 26.14 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.509 0.654 . . . . 0.0 110.995 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -100.63 122.11 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.509 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 p -90.22 -44.76 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.234 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -143.89 148.44 35.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -118.84 143.57 46.88 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 34' ' ' ASP . 1.1 m-20 -128.42 18.38 6.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.222 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.49 159.31 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.44 142.24 51.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.827 0.346 . . . . 0.0 110.414 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.2 137.27 58.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.083 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.67 7.23 71.9 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 28' ' ' MET . 58.0 t0 -114.55 142.34 46.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.045 0.45 . . . . 0.0 111.084 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.543 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 94.9 mtp -79.94 152.33 29.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.432 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -126.89 160.82 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.363 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -123.53 152.0 42.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.896 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -57.9 90.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.2 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 63.7 t0 -178.95 134.01 0.13 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.078 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 4.2 pp0? -45.06 124.91 4.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.663 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' ASP . 89.7 m-20 -95.07 9.44 39.51 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 32.8 tp 63.1 73.85 0.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.235 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 m -117.32 134.57 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -119.12 137.81 53.34 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.603 0.716 . . . . 0.0 110.999 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 p -131.89 128.94 60.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.309 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.1 ttp -101.41 109.34 21.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.812 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -48.9 78.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.209 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 23.8 p-10 -152.4 -45.92 0.1 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.33 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -165.22 52.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.956 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -160.89 155.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 110.367 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -95.22 117.85 30.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.161 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.22 118.26 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.135 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -98.54 133.59 42.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.797 0.332 . . . . 0.0 110.365 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.1 mt -135.95 137.37 25.01 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 49' ' ' SER . 38.3 Cg_exo -54.59 147.48 48.52 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.325 1.35 . . . . 0.0 111.408 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -40.48 166.61 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 120.746 0.308 . . . . 0.0 111.133 -179.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.99 47.92 2.69 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.752 2.301 . . . . 0.0 113.42 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t 64.39 119.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.943 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -49.76 150.51 2.09 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.912 0.387 . . . . 0.0 111.76 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.65 -143.55 8.95 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -113.16 132.7 55.37 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 122.569 -0.371 . . . . 0.0 110.64 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mm -95.33 115.6 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.4 t -70.57 -50.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -173.84 155.03 2.52 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.667 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.502 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.7 tt -89.31 110.83 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.407 0.622 . . . . 0.0 110.633 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.6 -27.51 34.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.237 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.622 ' HH ' ' HG ' ' A' ' 70' ' ' SER . 5.0 m-85 -110.37 145.86 36.81 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.27 0.557 . . . . 0.0 112.002 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -115.24 169.21 9.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.353 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.63 133.29 53.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.591 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.11 6.26 88.99 Favored Glycine 0 N--CA 1.466 0.672 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.994 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -80.62 133.26 35.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.849 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 p -124.76 127.96 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.927 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 t -148.54 137.33 11.86 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.316 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.2 137.27 46.17 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.155 1.237 . . . . 0.0 111.66 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.5 m -52.37 144.1 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.774 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.29 50.74 0.28 Allowed Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.622 ' HG ' ' HH ' ' A' ' 60' ' ' TYR . 37.0 p -161.4 164.05 30.18 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 p -91.29 108.28 19.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.122 0.487 . . . . 0.0 110.544 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 3.7 mm? -63.85 -38.81 92.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.522 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 74' ' ' GLN . 4.0 tp -155.04 143.96 20.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.413 ' H ' HD12 ' A' ' 73' ' ' LEU . 53.3 tt0 -104.5 131.92 51.34 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.87 0.366 . . . . 0.0 111.173 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' ' 2' ' ' TYR . 92.8 mt -128.12 127.78 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -93.65 134.8 35.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.032 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.484 ' CB ' ' H3 ' ' A' ' 1' ' ' MET . 20.2 m . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.363 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.549 ' N ' ' H ' ' A' ' 77' ' ' THR . 5.0 ptt? . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -79.6 147.12 32.2 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.95 125.47 50.49 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -95.05 112.33 24.04 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -119.11 148.88 42.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.927 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.33 159.08 86.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.49 140.19 74.72 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 121.573 1.516 . . . . 0.0 113.467 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -105.11 70.1 0.88 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.24 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 12' ' ' GLY . 79.4 mt -119.28 132.23 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.71 -40.93 89.98 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -66.36 -50.54 63.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 111.522 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' ILE . . . -101.35 168.42 19.83 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.2 t 56.61 105.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.6 p -120.02 -7.15 9.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.042 0.449 . . . . 0.0 109.911 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.459 ' OE2' ' CG2' ' A' ' 65' ' ' VAL . 43.6 tt0 -168.4 156.21 8.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.861 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.17 114.08 3.1 Favored Glycine 0 N--CA 1.468 0.795 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -130.28 127.46 39.57 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -102.02 121.32 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.738 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.07 -42.3 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.293 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -142.31 140.72 32.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.747 0.308 . . . . 0.0 110.613 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.567 ' C ' ' H ' ' A' ' 23' ' ' VAL . 14.5 m95 -101.81 -18.28 15.83 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.289 0.566 . . . . 0.0 109.71 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 35' ' ' LEU . 19.5 m-20 43.51 3.32 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.671 -1.15 . . . . 0.0 113.89 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 21' ' ' TRP . 3.7 m -140.18 156.54 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -126.26 136.6 52.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -45.99 142.09 2.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.039 0.447 . . . . 0.0 111.091 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.17 69.47 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.048 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 51.4 p-10 -107.74 149.67 27.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.0 0.4 . . . . 0.0 110.732 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.6 mtt -83.85 144.15 29.44 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.553 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.1 t -121.07 132.8 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -109.92 154.29 23.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.036 0.446 . . . . 0.0 111.202 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -69.13 138.97 54.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.633 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t0 70.01 23.53 5.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.303 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -149.62 86.35 1.46 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.411 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -173.64 141.87 0.89 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.131 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 76.5 mt -137.16 92.2 2.69 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.17 131.8 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.511 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 58.6 mp0 -106.78 124.89 50.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.179 0.514 . . . . 0.0 111.224 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.15 132.06 70.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.768 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.6 ttp -116.46 117.53 30.16 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.207 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -64.83 -49.72 69.5 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.048 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -151.72 -64.7 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.686 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -138.23 36.87 2.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.122 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.34 133.76 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.635 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.6 m -102.36 118.22 36.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.77 162.21 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.784 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -134.77 134.95 41.47 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.926 0.393 . . . . 0.0 110.792 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.8 mt -123.78 85.62 53.49 Favored Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.448 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 49' ' ' SER . 92.0 Cg_endo -80.35 147.19 17.95 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.674 2.25 . . . . 0.0 112.482 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 48' ' ' PRO . 1.2 t 89.72 61.19 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.02 28.83 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.732 2.288 . . . . 0.0 111.343 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t 72.25 111.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.151 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -59.73 146.52 41.15 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.785 0.326 . . . . 0.0 111.775 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.04 -141.3 6.24 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -125.17 136.8 53.95 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 55' ' ' ILE . 7.1 mm -91.85 118.58 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -79.0 -50.74 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -171.07 158.76 5.72 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.92 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.6 tt -108.96 123.61 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.869 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.0 mt -97.78 -17.92 19.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.919 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.494 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 6.3 m-85 -108.9 144.24 37.06 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.886 0.374 . . . . 0.0 110.696 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -117.0 160.84 20.33 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.281 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 -57.24 140.58 49.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.698 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.32 4.97 90.35 Favored Glycine 0 N--CA 1.468 0.78 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.965 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -84.71 134.91 34.33 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.516 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' CG2' ' OE2' ' A' ' 15' ' ' GLU . 4.4 p -125.92 129.01 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.774 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.1 t -148.94 139.83 13.79 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.02 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.64 145.55 81.05 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.12 1.213 . . . . 0.0 111.378 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -55.33 125.94 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.088 0.471 . . . . 0.0 111.379 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.42 49.06 0.04 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.231 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.9 p -160.68 162.38 32.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.972 0.386 . . . . 0.0 111.091 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -94.55 107.8 19.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.199 0.523 . . . . 0.0 109.993 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.8 mm? -67.18 -39.28 86.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.813 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.502 HD22 ' H ' ' A' ' 74' ' ' GLN . 1.7 tt -153.19 145.72 24.15 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.332 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.502 ' H ' HD22 ' A' ' 73' ' ' LEU . 66.3 mt-30 -104.15 130.31 51.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.402 HG22 HD13 ' A' ' 75' ' ' ILE . 83.3 mt -127.73 126.62 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.279 0.561 . . . . 0.0 111.738 -177.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -86.65 143.11 27.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.727 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.549 ' H ' ' N ' ' A' ' 1' ' ' MET . 8.9 t . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.127 -0.939 . . . . 0.0 110.017 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -88.53 129.56 35.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 52.9 mp0 -112.28 125.43 54.15 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -92.12 123.46 35.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.237 0.541 . . . . 0.0 110.745 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -122.14 145.79 47.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.286 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.78 115.63 20.28 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.807 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.21 -7.4 18.94 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.881 1.721 . . . . 0.0 112.3 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.5 m-20 52.25 34.6 14.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.368 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.499 ' CG2' ' O ' ' A' ' 9' ' ' ILE . 90.7 mt 44.29 19.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.362 0.601 . . . . 0.0 109.966 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . 88.14 -178.8 46.6 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 56.98 -88.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.666 0.269 . . . . 0.0 110.292 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 10' ' ' GLY . . . 142.79 160.35 8.33 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.441 ' O ' ' OG1' ' A' ' 14' ' ' THR . 55.9 t -145.93 -7.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 13' ' ' VAL . 68.7 p 53.92 55.84 7.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.362 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -174.99 141.69 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.567 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.79 109.87 0.44 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -123.4 142.64 50.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.017 0.436 . . . . 0.0 110.164 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 mt -102.0 121.85 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.545 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 9.8 p -101.29 -48.16 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 61.3 ttt85 -146.9 136.64 23.1 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -109.76 137.62 47.29 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.61 177.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 8.0 p-10 -101.86 -5.04 25.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.018 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.25 160.18 32.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.371 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 43.8 mmtm -129.22 153.29 47.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.842 0.353 . . . . 0.0 110.683 -179.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -53.09 142.44 20.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.37 6.69 66.05 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.859 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 53.0 p30 -123.41 151.98 42.05 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.901 0.85 . . . . 0.0 111.466 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -86.09 154.56 21.3 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.862 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.1 p -138.11 147.08 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.806 0.336 . . . . 0.0 110.203 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -107.33 155.47 19.95 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.492 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -62.3 138.07 58.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.273 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 t0 66.79 20.13 10.65 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.19 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -137.0 81.54 1.88 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 35.3 t70 -173.6 104.46 0.12 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.437 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.552 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 51.0 tp -84.06 99.38 10.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.688 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.63 130.01 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -115.74 123.76 49.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.842 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.82 137.03 59.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.955 0.407 . . . . 0.0 110.397 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.4 ptm -115.22 142.01 47.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.141 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -103.19 -64.35 1.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.817 0.341 . . . . 0.0 110.468 -179.595 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.529 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.4 t70 -128.39 56.08 1.65 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.4 tttp 73.71 47.46 0.17 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.9 t -133.69 159.57 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.946 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.1 m -121.75 113.83 20.24 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.915 0.388 . . . . 0.0 110.404 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -132.84 130.63 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.972 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.4 ' HZ3' ' CD1' ' A' ' 35' ' ' LEU . 52.5 tttp -92.2 136.29 33.3 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.98 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -136.25 96.36 12.63 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.098 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.77 146.6 76.89 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.343 2.029 . . . . 0.0 111.505 178.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.5 m -85.36 112.87 47.2 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.442 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.48 24.94 0.72 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.191 1.928 . . . . 0.0 111.052 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.55 155.96 37.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.68 -177.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -145.91 146.95 31.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.297 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.59 -132.38 2.56 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -129.37 148.41 51.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.694 0.283 . . . . 0.0 110.309 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mm -99.56 120.37 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.7 t -78.55 -50.93 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -172.84 154.25 2.87 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.312 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.482 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.7 tt -101.72 114.92 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.194 0.521 . . . . 0.0 110.331 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.27 -41.61 89.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.771 -179.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.461 ' CG ' ' NE2' ' A' ' 64' ' ' GLN . 5.5 m-85 -139.72 150.21 44.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.279 -178.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -109.93 -166.53 1.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.678 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -53.62 150.96 6.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.734 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.47 6.3 57.54 Favored Glycine 0 N--CA 1.474 1.231 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.461 ' NE2' ' CG ' ' A' ' 60' ' ' TYR . 49.7 tt0 -98.81 135.23 40.57 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 p -142.91 116.83 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -148.53 142.62 16.46 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.03 146.21 70.65 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.456 1.438 . . . . 0.0 112.162 177.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.9 p -48.79 131.27 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.587 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.29 51.2 0.06 OUTLIER Glycine 0 CA--C 1.527 0.785 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.809 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.8 t -165.18 157.56 15.68 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.779 179.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.7 p -89.92 131.01 36.05 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.117 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.45 -15.63 24.09 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.543 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.559 HD22 ' H ' ' A' ' 74' ' ' GLN . 0.8 OUTLIER -171.32 145.73 2.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.014 -0.674 . . . . 0.0 110.746 -179.218 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.559 ' H ' HD22 ' A' ' 73' ' ' LEU . 56.7 mt-30 -104.7 127.59 52.52 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.1 mt -129.25 126.95 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.311 0.577 . . . . 0.0 111.784 -177.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -88.0 135.98 33.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.825 178.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.6 m . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.541 -179.986 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttp . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -76.83 143.29 39.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.62 136.65 54.3 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.795 0.331 . . . . 0.0 110.181 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.14 118.46 36.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.721 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -118.52 134.85 54.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.42 -179.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.95 126.1 91.92 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.8 148.77 59.07 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.198 1.265 . . . . 0.0 112.192 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.74 112.08 15.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.19 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.8 pt -126.42 157.34 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.776 0.322 . . . . 0.0 110.577 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.61 -167.68 50.55 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.42 -101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.778 0.323 . . . . 0.0 110.579 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.8 122.96 7.38 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.79 131.11 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.3 p -148.71 5.97 0.71 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.93 0.395 . . . . 0.0 110.852 -179.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -138.28 144.43 40.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.584 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.46 151.08 17.49 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -153.39 128.29 9.56 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.265 0.533 . . . . 0.0 110.984 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 mm -102.22 119.75 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.36 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.5 m -93.55 -40.06 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.729 178.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.8 149.06 43.06 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.013 0.435 . . . . 0.0 111.836 -178.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -116.1 145.36 43.09 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.769 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 51.7 t0 -109.33 -6.6 15.44 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.461 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.25 159.54 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.87 0.367 . . . . 0.0 111.574 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -136.38 155.74 49.61 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.582 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -66.07 141.91 57.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.514 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.3 7.72 86.26 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.556 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -118.18 143.46 46.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.31 0.555 . . . . 0.0 111.621 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.7 mtm -87.87 147.13 25.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.563 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.09 151.4 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.032 0.444 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 32' ' ' ASP . 93.9 mt-10 -112.05 154.9 24.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.442 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.05 80.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.562 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' GLU . 68.0 t0 -179.44 94.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.17 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -142.27 151.89 42.49 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.155 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 63.8 t0 -165.74 24.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.976 0.417 . . . . 0.0 110.206 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.7 mt -121.99 27.84 7.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.689 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.42 129.24 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.07 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.453 ' OE2' ' N ' ' A' ' 45' ' ' VAL . 3.8 tm-20 -127.13 128.33 46.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.611 -179.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.36 141.52 43.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.046 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.9 ttp -126.16 136.59 53.04 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 -72.55 0.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.833 0.349 . . . . 0.0 110.421 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -97.56 41.12 1.13 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.525 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 tttp 71.22 37.76 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.402 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.5 t -127.17 134.68 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.5 m -96.64 116.66 29.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.142 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.453 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 34.3 m -133.27 132.64 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.052 0.453 . . . . 0.0 111.642 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -94.04 139.22 31.23 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.948 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mt -138.89 121.6 10.6 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 119.605 -0.235 . . . . 0.0 110.645 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.28 143.17 19.59 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.33 2.02 . . . . 0.0 112.081 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 82.1 p -69.7 114.13 22.38 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.394 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.71 8.43 4.63 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.947 1.765 . . . . 0.0 113.553 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -140.3 157.32 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.157 0.503 . . . . 0.0 111.841 -177.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -143.32 149.79 38.28 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.734 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.87 -134.94 2.91 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -118.37 131.34 56.31 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 117.224 0.512 . . . . 0.0 109.986 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 55' ' ' ILE . 5.1 mm -94.57 118.71 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.2 t -97.03 -48.91 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -143.36 157.17 44.69 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -177.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.0 tt -125.32 122.01 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.573 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.8 mt -98.86 -17.42 18.43 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.62 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -104.13 138.65 40.33 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.165 0.507 . . . . 0.0 111.288 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -122.05 166.29 14.73 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.077 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.87 130.48 44.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.979 0.418 . . . . 0.0 111.214 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.22 5.58 89.62 Favored Glycine 0 N--CA 1.467 0.755 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.882 179.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -79.22 140.49 37.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.979 0.419 . . . . 0.0 110.898 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.4 t -117.92 130.62 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.752 -179.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.5 t -148.96 138.15 12.39 Favored Pre-proline 0 N--CA 1.474 0.769 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.332 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -54.13 139.6 71.51 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.394 1.396 . . . . 0.0 112.069 177.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.9 t -65.14 131.84 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.45 51.05 0.13 Allowed Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.7 p -159.82 162.79 34.81 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 122.508 -0.407 . . . . 0.0 111.31 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.458 ' O ' ' CG2' ' A' ' 71' ' ' THR . 4.9 t -84.53 114.25 21.82 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.482 0.658 . . . . 0.0 109.953 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.83 -42.16 90.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.487 -178.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 74' ' ' GLN . 2.5 tt -143.77 146.85 33.42 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -177.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.444 ' N ' HD22 ' A' ' 73' ' ' LEU . 57.5 tt0 -101.74 123.51 45.84 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.26 129.53 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.495 -177.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -100.33 111.16 23.41 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.62 179.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.222 -0.358 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.021 -179.721 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OE2' ' A' ' 3' ' ' GLU . 68.4 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -77.43 133.9 38.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.917 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.545 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 54.4 mp0 -109.83 128.64 55.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.206 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -92.64 117.32 29.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -119.7 147.16 44.91 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.014 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mt -67.9 113.7 16.19 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 32.1 Cg_exo -56.63 145.67 80.26 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 120.985 1.124 . . . . 0.0 112.14 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 7' ' ' PRO . 22.1 t0 93.04 113.91 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.188 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.1 pt -123.7 154.98 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 110.519 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.02 -121.75 19.73 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -60.59 145.49 48.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.987 0.422 . . . . 0.0 110.589 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.25 -52.61 1.85 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 179.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.3 t -127.93 129.42 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.3 p -131.86 -11.36 3.41 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.461 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -164.77 144.13 7.07 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.505 -179.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.77 153.19 21.27 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -138.28 142.87 39.81 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.82 121.39 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.876 0.369 . . . . 0.0 111.992 -178.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -94.27 -40.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.492 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -139.6 146.79 40.24 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -119.45 140.79 49.87 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.618 179.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 9.1 p-10 -114.87 5.52 15.16 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -135.24 156.72 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.513 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -142.52 149.09 38.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.406 0.622 . . . . 0.0 111.516 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -56.62 140.11 47.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.489 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.93 9.14 78.07 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 116.328 -0.396 . . . . 0.0 112.695 178.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 28' ' ' MET . 67.3 t0 -121.86 135.85 54.91 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.184 0.492 . . . . 0.0 111.705 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.531 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 62.9 ttp -94.2 127.54 40.11 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.456 179.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 p -129.82 136.88 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.203 0.525 . . . . 0.0 111.956 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 56.5 mp0 -83.86 157.19 22.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.584 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 37.0 ttpt -81.45 130.54 35.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.72 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 52.7 t0 130.5 122.02 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.433 1.083 . . . . 0.0 110.19 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.447 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 60.8 tp60 58.29 103.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.458 178.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 33' ' ' GLN . 97.3 m-20 -143.08 141.18 31.2 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.1 tp -101.73 79.44 1.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.198 0.523 . . . . 0.0 111.441 -178.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.61 126.06 74.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -118.34 118.58 32.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.741 -179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 m -125.57 132.79 70.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.927 0.394 . . . . 0.0 110.26 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.9 ttp -96.35 123.69 40.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.258 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.1 p -89.53 -64.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.729 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 40' ' ' THR . 68.3 t0 -137.57 60.14 1.65 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.246 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 35.5 tttp 74.69 21.89 2.09 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.51 139.59 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 m -94.69 115.74 27.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.794 0.33 . . . . 0.0 110.269 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 m -125.69 131.04 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.898 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -99.67 135.02 41.71 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -131.76 85.27 52.03 Favored Pre-proline 0 N--CA 1.471 0.6 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.844 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.483 ' O ' ' OG ' ' A' ' 49' ' ' SER . 91.2 Cg_endo -80.44 151.22 19.89 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.571 2.181 . . . . 0.0 113.201 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 48' ' ' PRO . 6.0 p 80.74 67.6 0.14 Allowed Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.08 37.85 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.857 2.372 . . . . 0.0 112.755 178.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 t 63.25 114.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.725 0.298 . . . . 0.0 111.24 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -77.37 152.77 34.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.475 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.72 -140.36 6.04 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -112.17 129.76 56.14 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.37 0.585 . . . . 0.0 110.465 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -93.9 119.89 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.1 t -93.31 -52.74 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -151.87 158.65 43.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.902 -177.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.7 tt -112.25 121.76 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.027 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.6 mt -99.3 -17.15 18.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.19 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -109.25 143.35 38.83 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.062 0.458 . . . . 0.0 111.004 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -120.58 164.42 16.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.084 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.38 127.09 30.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.171 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.2 5.4 89.02 Favored Glycine 0 N--CA 1.468 0.785 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 178.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -76.7 136.53 39.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.648 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.74 132.92 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.698 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.78 140.68 14.56 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.777 -178.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.03 147.17 76.56 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.265 1.31 . . . . 0.0 110.596 176.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.02 126.67 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.246 0.546 . . . . 0.0 110.997 -179.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 146.0 48.56 0.03 OUTLIER Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.388 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 p -164.97 166.41 19.41 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.268 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.456 ' O ' ' CG2' ' A' ' 71' ' ' THR . 6.6 t -88.98 117.43 27.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.776 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.46 -43.36 97.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.277 0.561 . . . . 0.0 110.428 -179.29 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.419 HD21 ' N ' ' A' ' 74' ' ' GLN . 3.8 tt -145.99 146.32 30.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.419 ' N ' HD21 ' A' ' 73' ' ' LEU . 37.4 tp60 -101.91 124.89 48.31 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.2 mt -127.2 127.3 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.223 -178.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -87.52 142.54 27.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.46 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.216 -179.886 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 75' ' ' ILE . 24.1 t80 -74.72 131.88 41.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 43.1 mp0 -95.95 125.9 40.82 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.697 -179.149 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -94.71 109.24 21.2 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.19 150.22 26.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.078 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.45 116.37 39.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.89 147.37 43.86 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.774 1.649 . . . . 0.0 112.985 -178.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -86.37 18.41 3.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.921 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.53 -23.34 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.949 0.404 . . . . 0.0 110.085 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.98 168.28 19.69 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -179.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.66 -39.64 85.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 0.0 110.404 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -173.87 154.82 20.58 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.8 t -153.06 89.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.03 0.443 . . . . 0.0 110.448 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 m -65.19 -31.7 73.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.992 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -164.4 153.88 13.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.85 111.43 4.23 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -118.38 125.01 49.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.069 0.461 . . . . 0.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 mm -102.41 120.35 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.232 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -107.92 -25.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -141.72 129.96 22.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.03 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -112.44 139.59 47.88 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 17.8 p-10 -111.49 2.09 17.27 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.3 m -135.5 161.23 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.81 0.338 . . . . 0.0 110.696 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.46 153.02 50.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.046 -178.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -52.74 140.76 22.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.376 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.71 8.33 76.89 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.374 177.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 41.7 p-10 -113.98 150.01 34.48 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.822 0.811 . . . . 0.0 110.691 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.6 mtm -97.63 149.63 22.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.284 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -145.16 140.12 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.906 0.384 . . . . 0.0 111.118 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 32' ' ' ASP . 95.7 mt-10 -87.03 163.93 16.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.869 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.36 74.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.235 0.541 . . . . 0.0 110.435 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 30' ' ' GLU . 11.5 p-10 170.07 78.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.518 ' HB2' ' H ' ' A' ' 49' ' ' SER . 18.1 tp60 -46.98 167.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.35 -179.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 99.0 m-20 -87.77 -34.48 18.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.529 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 0.9 OUTLIER 159.62 106.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.784 0.678 . . . . 0.0 110.734 179.511 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.62 131.73 69.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -117.98 123.3 45.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.989 0.424 . . . . 0.0 111.459 -178.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.74 128.49 71.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.503 ' SD ' ' N ' ' A' ' 41' ' ' ASP . 10.6 tmm? -133.48 127.82 34.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.564 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -46.23 64.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.503 ' N ' ' SD ' ' A' ' 39' ' ' MET . 24.5 p-10 -152.47 -54.73 0.12 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.551 -179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.423 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 59.8 pttt -145.74 42.07 1.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.148 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.83 137.91 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.168 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -103.33 119.24 38.51 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.89 119.02 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.756 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.53 112.9 24.79 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 mt -129.99 109.78 16.89 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.63 147.66 17.61 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.37 2.047 . . . . 0.0 111.744 179.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.518 ' H ' ' HB2' ' A' ' 33' ' ' GLN . 6.9 t -58.39 120.39 43.94 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.17 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.96 -3.05 13.35 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 122.088 1.859 . . . . 0.0 114.218 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.23 125.45 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.027 0.376 . . . . 0.0 110.927 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -97.04 153.54 17.86 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.634 0.254 . . . . 0.0 111.037 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.89 -129.71 1.75 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.612 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -126.76 133.59 50.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.708 0.289 . . . . 0.0 110.408 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 mm -86.74 123.59 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 t -82.94 -52.17 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.679 -178.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -164.25 158.88 19.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.801 -178.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.481 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.2 tt -91.14 114.54 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.281 0.562 . . . . 0.0 110.481 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -90.94 -24.36 20.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -113.2 140.21 48.13 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.284 0.564 . . . . 0.0 111.154 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.511 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 86.8 mtm-85 -114.42 166.52 11.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.636 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -62.16 129.34 40.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.861 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.26 69.38 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.808 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.511 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 78.5 mt-30 -80.99 134.68 35.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.616 0.708 . . . . 0.0 111.174 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.95 124.07 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.465 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 t -147.29 138.61 13.27 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 -179.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -55.07 148.81 46.61 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.138 1.225 . . . . 0.0 111.809 179.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.8 p -59.27 129.68 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.169 0.509 . . . . 0.0 111.112 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.09 49.16 0.09 OUTLIER Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.068 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.9 p -159.84 163.78 34.15 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 117.299 0.549 . . . . 0.0 110.846 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.465 ' O ' ' CG2' ' A' ' 71' ' ' THR . 8.5 t -86.75 114.21 23.24 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.261 0.553 . . . . 0.0 110.391 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -65.55 -41.4 93.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.442 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.438 HD11 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -152.37 153.99 34.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.369 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.438 ' H ' HD11 ' A' ' 73' ' ' LEU . 50.7 tt0 -103.11 129.4 49.95 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.171 0.51 . . . . 0.0 110.992 -178.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 75' ' ' ILE . 89.7 mt -128.7 129.15 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.665 -178.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -96.24 114.44 26.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.699 178.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.665 179.904 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -95.71 142.74 27.64 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -118.55 135.6 54.32 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.951 0.405 . . . . 0.0 110.638 -179.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -88.7 116.31 26.87 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.096 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -116.87 132.01 56.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.888 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.94 115.69 42.86 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.729 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.36 153.0 27.25 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.314 1.343 . . . . 0.0 111.977 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -87.16 85.78 7.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.614 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.2 mt -68.37 -42.97 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.101 179.226 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.19 137.13 13.18 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.475 ' OE1' ' N ' ' A' ' 11' ' ' GLU . 56.8 mp0 -82.19 147.52 28.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.633 0.254 . . . . 0.0 110.617 179.657 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.02 21.28 65.85 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.2 t -126.66 133.09 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.1 p -148.55 80.13 1.44 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.937 0.398 . . . . 0.0 110.612 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -169.36 144.21 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.015 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.77 123.18 3.42 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -134.89 139.85 45.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.975 0.417 . . . . 0.0 110.174 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.43 119.02 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.554 -179.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.3 p -92.27 -41.98 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -144.83 138.47 27.07 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -110.86 140.19 45.52 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 34' ' ' ASP . 4.4 p30 -108.02 -4.05 18.18 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.01 162.69 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.959 0.409 . . . . 0.0 111.383 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.2 151.91 35.9 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.842 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -61.06 138.37 58.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.883 0.373 . . . . 0.0 111.219 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.78 64.21 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.682 179.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 41.9 p-10 -117.73 152.22 35.69 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.399 0.6 . . . . 0.0 111.021 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -81.35 151.22 28.09 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.041 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -140.28 140.32 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.195 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -95.76 152.41 18.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.723 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 52' ' ' ARG . 64.2 tttm -82.04 89.39 6.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.343 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 33' ' ' GLN . 62.6 t0 -176.3 78.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.188 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 32' ' ' ASP . 4.7 tp-100 37.08 93.02 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.047 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 31.8 t0 -90.17 15.33 10.49 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.0 mt 62.19 66.84 0.77 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.398 -179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.57 130.25 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -110.15 123.38 49.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.332 0.587 . . . . 0.0 110.647 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 m -124.23 137.62 56.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.886 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 39' ' ' MET . 3.4 ppp? -121.92 147.44 46.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.148 0.499 . . . . 0.0 110.837 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -109.41 -59.41 1.91 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.415 -179.542 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.517 ' N ' ' OG1' ' A' ' 40' ' ' THR . 55.7 t0 -135.95 68.55 1.44 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.96 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 62.67 38.83 11.78 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.71 138.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.074 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.0 m -114.86 116.11 28.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.213 0.53 . . . . 0.0 110.758 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.71 157.81 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.431 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -100.72 136.16 41.03 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.925 179.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.5 tt -127.26 135.11 26.93 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.446 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 49' ' ' SER . 33.9 Cg_exo -54.69 144.32 65.47 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 121.516 1.477 . . . . 0.0 112.226 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -41.32 164.46 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.649 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -81.45 47.12 2.44 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.772 2.315 . . . . 0.0 113.45 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 t 67.04 117.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.922 0.391 . . . . 0.0 111.417 179.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 73.7 ttt-85 -48.25 135.68 13.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.425 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.16 -145.45 8.11 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -118.51 133.91 55.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.033 0.417 . . . . 0.0 110.182 -179.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -95.05 121.38 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 t -81.63 -51.18 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -164.55 155.61 15.15 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.437 -178.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.7 tt -90.51 118.27 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.584 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -93.86 -18.24 22.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.716 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -119.08 140.58 49.84 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.089 0.471 . . . . 0.0 110.909 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -115.97 167.32 11.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.234 0.54 . . . . 0.0 111.523 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -62.57 132.65 53.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.902 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.01 3.38 90.59 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -80.63 134.49 35.9 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.308 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.76 131.47 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.761 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 t -146.62 139.09 13.97 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.526 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.68 149.04 25.97 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.387 1.391 . . . . 0.0 111.626 178.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 p -59.35 133.61 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.723 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.46 48.03 0.12 Allowed Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.1 p -162.63 165.08 26.26 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 117.43 0.615 . . . . 0.0 111.367 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.449 ' O ' ' CG2' ' A' ' 71' ' ' THR . 14.7 t -96.95 118.16 32.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.985 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.671 ' CD2' ' H ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -66.26 -36.13 82.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.919 -179.188 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 74' ' ' GLN . 2.1 tp -151.18 149.97 30.07 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.458 ' H ' HD13 ' A' ' 73' ' ' LEU . 3.7 tm0? -103.78 131.97 50.47 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 -179.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.5 mt -130.17 129.24 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.138 0.494 . . . . 0.0 111.958 -178.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -97.11 117.2 30.77 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.985 178.287 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.679 -179.527 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mmm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -74.39 130.38 39.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.131 -179.131 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 42.9 mp0 -102.51 125.19 49.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.174 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -86.4 116.26 24.44 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.28 147.27 49.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.791 -179.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.8 tt -75.68 111.51 14.83 Favored Pre-proline 0 N--CA 1.471 0.604 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 9' ' ' ILE . 33.2 Cg_exo -58.36 143.46 97.49 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 CA-C-N 120.492 1.212 . . . . 0.0 112.388 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -77.55 22.14 0.26 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.598 179.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.458 ' H ' ' C ' ' A' ' 7' ' ' PRO . 79.9 mt -112.1 131.18 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.946 0.403 . . . . 0.0 110.14 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 12' ' ' GLY . . . 163.55 -164.82 36.47 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 11' ' ' GLU . 58.0 mp0 -75.67 37.9 0.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.595 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 89.23 97.34 1.05 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.65 120.42 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.6 p -131.2 -2.89 3.94 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -141.32 143.73 34.21 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.806 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.55 133.38 8.88 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -140.03 133.07 29.48 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.973 0.416 . . . . 0.0 109.892 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.7 mm -102.81 119.62 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.879 -178.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 p -98.8 -37.37 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.03 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -141.01 133.43 28.36 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -110.55 144.85 38.79 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.08 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -128.65 19.91 6.13 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.094 0.407 . . . . 0.0 111.275 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.53 155.41 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -128.16 145.13 51.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.038 0.447 . . . . 0.0 110.512 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.79 137.86 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.054 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.56 7.75 71.53 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.133 179.452 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -116.73 147.82 41.67 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.121 0.461 . . . . 0.0 111.103 -179.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.4 mmm -84.37 147.71 27.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.4 133.98 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.252 179.019 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -91.61 158.31 16.49 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.193 -179.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.78 137.67 57.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.51 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.408 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 94.3 m-20 60.57 37.07 19.68 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.543 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 32' ' ' ASP . 99.4 mm-40 -143.44 86.78 1.91 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -174.36 162.73 3.63 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -134.06 89.74 2.61 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.233 0.539 . . . . 0.0 109.825 178.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.54 130.94 70.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.175 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.9 119.89 37.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.891 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.1 m -117.33 133.17 64.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.068 0.461 . . . . 0.0 109.975 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.0 ttp -113.55 132.57 55.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -116.77 -88.71 0.59 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.658 -179.663 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.445 ' N ' ' OG1' ' A' ' 40' ' ' THR . 23.2 p-10 -90.06 50.72 1.91 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.214 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 62.22 43.79 8.22 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.3 t -131.7 158.25 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.735 178.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.6 m -111.28 116.17 30.56 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.095 179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.34 135.33 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.958 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -101.23 134.7 43.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.949 0.404 . . . . 0.0 110.808 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.8 mt -136.54 87.72 20.97 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.696 179.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.55 145.66 94.05 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 122.85 2.366 . . . . 0.0 112.543 179.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.9 m -51.65 108.41 1.06 Allowed Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.329 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.23 -14.72 28.6 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.461 1.441 . . . . 0.0 114.638 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.5 126.0 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 118.511 0.596 . . . . 0.0 111.228 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -92.01 150.44 20.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.574 0.226 . . . . 0.0 110.714 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.26 -134.33 2.89 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -119.29 147.26 44.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.944 0.372 . . . . 0.0 110.38 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mm -103.91 119.29 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.9 t -77.76 -52.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.874 -179.018 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -169.24 154.85 6.1 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.158 -178.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.1 tt -81.77 115.75 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.292 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.4 mt -93.99 -19.23 21.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.653 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -117.58 143.07 46.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.239 0.543 . . . . 0.0 111.192 -179.681 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -112.13 163.37 14.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.752 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.65 139.78 58.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.504 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.08 5.33 89.66 Favored Glycine 0 N--CA 1.468 0.79 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.86 179.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -79.01 133.63 36.82 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.227 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.45 127.75 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.18 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -149.35 136.19 10.75 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.45 148.97 69.01 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 121.615 1.543 . . . . 0.0 112.17 177.046 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -48.48 147.73 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.734 179.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.11 47.98 0.63 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.503 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.5 p -162.02 163.16 28.99 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.634 179.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.446 ' O ' ' CG2' ' A' ' 71' ' ' THR . 15.0 t -103.1 118.96 37.98 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.097 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.635 ' CD2' ' H ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -66.86 -35.75 80.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.891 -179.678 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.424 HD13 ' H ' ' A' ' 74' ' ' GLN . 1.8 tp -149.98 149.47 30.43 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.424 ' H ' HD13 ' A' ' 73' ' ' LEU . 57.9 tt0 -104.03 131.81 50.91 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.709 0.29 . . . . 0.0 110.793 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 87.5 mt -127.37 128.74 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.388 0.613 . . . . 0.0 112.036 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -94.54 140.93 29.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.915 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.472 179.389 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -116.38 147.16 41.91 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.13 134.12 47.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -93.94 118.04 30.93 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.542 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -125.98 145.52 50.25 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tp -82.29 113.75 46.21 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.74 149.75 30.18 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.841 1.694 . . . . 0.0 112.963 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 12' ' ' GLY . 53.2 m-20 -63.51 -33.18 75.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.984 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.7 pt -93.0 116.91 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 121.789 -0.57 . . . . 0.0 110.815 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 12' ' ' GLY . . . 60.03 152.17 0.01 OUTLIER Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 54.37 5.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.517 0.199 . . . . 0.0 111.206 179.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 177.01 162.21 27.06 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.424 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 61.3 t -150.06 -97.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.477 0.179 . . . . 0.0 110.562 179.43 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 p -121.48 7.85 10.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -152.18 150.18 29.56 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.045 0.45 . . . . 0.0 111.321 -179.408 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.67 110.51 0.93 Allowed Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' OE1' ' CE ' ' A' ' 39' ' ' MET . 79.1 tt0 -115.81 129.59 56.5 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.632 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.0 mm -102.17 119.62 50.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.329 -178.152 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.8 m -109.37 -38.83 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -138.22 148.94 45.31 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -132.98 141.42 48.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.641 -1.163 . . . . 0.0 107.919 177.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -128.46 16.45 6.53 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.41 160.8 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.98 143.47 51.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.826 0.346 . . . . 0.0 110.812 -179.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -61.26 140.55 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.162 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.21 7.19 77.29 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.889 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -118.41 149.54 41.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.975 0.417 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.0 mtm -81.95 151.15 27.33 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.908 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -135.47 145.64 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.965 179.334 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -110.49 132.13 54.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.587 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 64.4 tttm -52.83 137.48 31.8 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.561 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 3.7 m-20 83.61 -11.7 0.88 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.408 0.442 . . . . 0.0 111.795 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -115.43 76.78 1.03 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.572 0.225 . . . . 0.0 110.42 179.229 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 57.2 t0 -176.66 137.73 0.27 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.245 179.559 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.477 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 81.2 mt -119.45 108.25 14.31 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.558 0.694 . . . . 0.0 110.598 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.21 133.1 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.631 179.576 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.462 ' OE2' ' CG2' ' A' ' 44' ' ' THR . 44.2 tt0 -116.57 120.0 37.33 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 110.397 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.21 140.85 46.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.539 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.444 ' CE ' ' OE1' ' A' ' 17' ' ' GLU . 66.0 ttp -124.71 144.46 50.21 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.832 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -129.18 -85.96 0.55 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.952 179.355 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.453 ' N ' ' OG1' ' A' ' 40' ' ' THR . 67.3 t0 -82.86 47.01 1.15 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.801 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 61.8 38.88 14.52 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.335 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.26 135.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.462 ' CG2' ' OE2' ' A' ' 37' ' ' GLU . 6.9 m -95.61 119.38 34.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.121 -179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.52 153.88 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 110.734 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -119.26 133.49 55.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.773 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.4 mt -125.63 137.97 30.99 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.088 -179.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' SER . 31.2 Cg_exo -52.49 153.97 12.72 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 121.54 1.493 . . . . 0.0 111.557 178.159 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.33 164.39 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.952 0.406 . . . . 0.0 111.304 -179.514 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.1 49.07 3.1 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.946 2.431 . . . . 0.0 113.669 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 t 69.93 117.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 120.889 0.376 . . . . 0.0 111.693 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -46.81 135.84 8.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.2 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.5 -143.41 7.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.26 144.76 48.44 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.084 0.442 . . . . 0.0 110.545 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 55' ' ' ILE . 7.2 mm -102.02 121.57 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.1 t -80.25 -52.14 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.54 -179.024 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -167.54 156.99 10.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.932 -179.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.463 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.6 tt -85.87 116.37 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.085 0.469 . . . . 0.0 110.398 -179.688 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.71 -29.68 22.24 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.8 -179.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' ' CB ' ' A' ' 70' ' ' SER . 15.4 m-85 -119.15 145.8 45.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.072 0.463 . . . . 0.0 111.387 -179.649 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -126.62 172.54 10.18 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.962 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.5 145.92 55.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.407 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.99 6.13 82.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.761 178.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -100.41 124.4 45.87 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.46 0.648 . . . . 0.0 112.059 -179.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 p -125.01 126.74 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.515 178.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 t -148.67 140.54 14.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.555 -177.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.09 148.45 48.61 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.164 1.242 . . . . 0.0 111.325 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.29 130.33 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 111.127 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.72 52.86 0.07 OUTLIER Glycine 0 CA--C 1.528 0.863 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.921 179.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.459 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 8.5 m -156.54 164.57 38.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.195 0.498 . . . . 0.0 111.077 179.608 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 p -96.07 111.85 23.75 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.56 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 72' ' ' LEU . 5.8 mp -64.01 -41.03 97.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.357 179.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.42 HD13 ' H ' ' A' ' 74' ' ' GLN . 2.3 tp -162.45 146.26 11.73 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.138 -178.614 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' H ' HD13 ' A' ' 73' ' ' LEU . 3.2 tm0? -103.09 130.54 50.26 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.921 0.391 . . . . 0.0 110.741 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.2 mt -128.2 128.92 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.301 0.572 . . . . 0.0 111.923 -178.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -95.82 139.98 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.686 178.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.439 179.932 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -80.16 148.08 31.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.824 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.79 118.92 29.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -83.37 104.28 13.4 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -102.34 148.22 25.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.477 -179.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.38 117.32 59.48 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.288 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.23 157.6 33.55 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.939 1.76 . . . . 0.0 111.597 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.65 78.54 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.257 0.551 . . . . 0.0 110.159 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.73 -43.24 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.116 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.21 155.29 20.63 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.45 -37.98 83.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.151 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.11 114.74 1.71 Allowed Glycine 0 N--CA 1.464 0.507 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.8 t -131.09 133.29 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.55 ' HG1' ' H ' ' A' ' 15' ' ' GLU . 39.3 p -89.17 -64.17 1.18 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.286 179.71 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.55 ' H ' ' HG1' ' A' ' 14' ' ' THR . 43.9 mp0 -142.22 156.79 45.33 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.237 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.01 162.62 26.3 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -155.11 135.97 13.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.199 0.5 . . . . 0.0 110.55 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.3 mm -102.64 121.44 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.484 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.6 p -91.72 -44.53 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.407 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -140.86 138.53 34.02 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.054 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.0 m95 -112.45 141.57 46.03 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 34' ' ' ASP . 15.4 p-10 -125.59 18.43 8.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.13 0.423 . . . . 0.0 111.555 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.79 156.24 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.86 139.9 51.94 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.49 140.93 53.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.045 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.78 5.71 68.31 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.821 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 28' ' ' MET . 43.9 t0 -110.11 -174.39 2.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 117.02 0.41 . . . . 0.0 110.676 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.536 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 94.9 mtp -120.22 151.95 38.42 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.0 t -128.63 161.26 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.088 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -130.85 156.01 45.75 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.684 -179.402 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.73 140.37 58.44 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.382 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 59.62 32.44 21.55 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.437 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -147.43 87.67 1.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.312 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 65.8 t0 -171.83 130.33 0.66 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.258 -178.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.5 mt -108.93 84.01 1.85 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.423 0.63 . . . . 0.0 110.34 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.48 132.83 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.494 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -111.1 116.54 31.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.635 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 m -113.25 131.99 63.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 110.568 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.8 ttp -111.18 112.68 24.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 p -63.0 -47.87 81.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.175 0.512 . . . . 0.0 110.001 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -149.56 -68.1 0.21 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.67 -179.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -138.64 35.23 2.22 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.264 179.503 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.36 137.58 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 m -103.47 118.0 35.73 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.12 156.85 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.24 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -99.71 138.34 36.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.177 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 47' ' ' ILE . 19.8 tt -133.48 113.95 13.27 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.484 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.29 142.98 17.16 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.003 1.802 . . . . 0.0 112.289 -179.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.0 p -58.38 109.46 1.85 Allowed Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.15 -23.13 39.86 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.057 1.172 . . . . 0.0 114.705 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.99 127.46 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.253 0.479 . . . . 0.0 111.34 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -92.86 148.82 21.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.672 0.272 . . . . 0.0 110.849 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.11 -131.48 1.7 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.9 146.87 49.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.015 0.408 . . . . 0.0 110.448 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.9 mm -103.58 119.89 52.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.139 -179.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 t -79.28 -52.42 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.908 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -163.68 158.39 20.36 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.167 -179.203 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.5 tt -88.73 118.28 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.054 0.454 . . . . 0.0 111.253 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.4 mt -96.92 -17.87 19.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.167 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.24 146.61 39.05 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.018 0.437 . . . . 0.0 110.586 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -124.08 160.88 26.76 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.816 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.79 138.03 58.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.03 5.35 90.2 Favored Glycine 0 N--CA 1.467 0.735 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.543 178.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -75.69 129.18 36.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.209 0.528 . . . . 0.0 111.174 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.9 t -119.7 127.64 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.31 154.92 36.67 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.499 -178.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.25 145.7 55.03 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.84 2.36 . . . . 0.0 112.238 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -55.4 130.42 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.193 0.521 . . . . 0.0 110.421 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.13 55.49 0.25 Allowed Glycine 0 N--CA 1.467 0.736 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -149.71 173.18 13.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.18 0.514 . . . . 0.0 111.07 -179.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -102.05 114.29 28.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.935 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.68 -47.46 69.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.914 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD13 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -159.01 159.4 34.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.806 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.489 ' H ' HD13 ' A' ' 73' ' ' LEU . 51.3 tt0 -104.5 127.91 52.31 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.834 0.349 . . . . 0.0 111.412 -178.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.6 mt -128.86 128.73 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.189 0.519 . . . . 0.0 111.757 -179.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -100.05 119.05 37.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.359 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.819 -179.832 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OE2' ' A' ' 3' ' ' GLU . 99.3 mtp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -80.99 131.45 35.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 56.0 mp0 -113.52 123.78 50.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -95.85 122.16 38.34 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -128.72 129.46 45.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.973 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 tp -45.62 105.9 0.51 Allowed Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.0 145.41 85.8 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.351 1.367 . . . . 0.0 111.989 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' A' ' 10' ' ' GLY . 38.5 p-10 -69.59 -2.61 11.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.707 -179.398 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 95.7 mt 52.85 3.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.581 0.229 . . . . 0.0 111.184 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 8' ' ' ASP . . . 76.54 23.45 70.28 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.293 178.582 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -146.71 157.07 43.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.915 0.357 . . . . 0.0 110.34 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.95 135.79 32.59 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.49 130.24 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.806 0.336 . . . . 0.0 110.61 -179.468 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 p -76.13 -46.86 26.68 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.442 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -170.26 156.27 5.69 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.846 179.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.85 154.18 17.07 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -141.05 140.72 34.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.968 0.413 . . . . 0.0 110.096 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.4 mm -102.64 124.25 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.992 -178.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.45 -44.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.91 142.71 40.62 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -121.2 135.83 55.08 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -106.99 -3.8 19.71 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.686 0.279 . . . . 0.0 111.186 179.053 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.08 159.17 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -144.99 161.12 40.18 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.065 0.46 . . . . 0.0 111.53 -178.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -56.78 139.78 49.84 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.371 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.76 8.05 62.41 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.28 -0.486 . . . . 0.0 112.943 178.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -128.02 155.01 44.99 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.543 0.672 . . . . 0.0 111.837 -179.307 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.0 mtp -88.75 154.62 20.13 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.016 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -134.64 150.84 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.007 0.432 . . . . 0.0 110.624 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.63 159.66 17.97 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.147 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -71.43 87.79 0.88 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.034 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 34' ' ' ASP . 38.0 t0 -174.46 159.71 3.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.663 178.63 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -44.78 95.5 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.553 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' ASP . 79.4 m-20 -72.33 -3.65 25.16 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.588 0.709 . . . . 0.0 109.131 179.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.412 ' O ' ' CG ' ' A' ' 22' ' ' ASP . 35.6 tp 60.79 80.48 0.21 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.337 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.11 131.81 70.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.268 178.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -111.26 121.75 46.08 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.52 138.23 54.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.741 -178.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 52.0 ttp -103.82 108.98 20.53 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.27 -46.14 74.55 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.246 -0.581 . . . . 0.0 110.903 -179.221 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 42' ' ' LYS . 18.9 p-10 -139.69 -63.83 0.5 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.156 -179.588 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.541 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 64.9 mttp -150.96 45.2 0.83 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.921 0.391 . . . . 0.0 110.624 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -158.71 146.01 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.311 178.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -98.84 120.94 40.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.274 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.47 156.53 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.64 135.47 52.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.902 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.9 mt -127.11 112.63 21.69 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.891 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.46 150.95 39.87 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.33 1.353 . . . . 0.0 110.954 178.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.7 m -104.29 97.72 12.48 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -88.12 41.97 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.675 2.25 . . . . 0.0 111.576 178.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.3 m -129.76 156.55 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.812 0.339 . . . . 0.0 111.508 -177.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.485 ' CD ' ' N ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -151.12 148.06 27.82 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.469 179.874 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.55 -137.52 5.5 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -131.14 147.53 52.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 mm -97.88 118.07 43.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.15 -47.5 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -152.55 157.01 40.45 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -177.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.9 tt -131.68 126.06 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.256 178.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.3 mt -104.46 -15.48 15.36 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.98 -178.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.536 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 8.5 m-85 -108.71 144.03 37.04 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.281 0.563 . . . . 0.0 111.581 -178.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.487 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 84.9 mtt85 -131.39 166.25 21.69 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.149 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.58 138.66 51.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.581 -179.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.35 5.33 67.43 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.117 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 61' ' ' ARG . 34.9 mt-30 -96.11 131.26 42.73 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.234 0.54 . . . . 0.0 111.505 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.72 127.91 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 t -147.02 140.44 14.97 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.23 146.31 61.13 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.154 1.236 . . . . 0.0 111.275 177.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.6 p -62.66 129.49 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.204 0.526 . . . . 0.0 110.811 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.69 51.18 0.06 OUTLIER Glycine 0 CA--C 1.53 1.03 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.595 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 p -160.55 162.23 32.87 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 122.424 -0.456 . . . . 0.0 111.25 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 p -92.75 116.8 29.35 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.314 179.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.4 mm? -83.72 -18.23 38.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.589 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.55 144.16 4.27 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.05 -178.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -106.81 119.49 39.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 176.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.3 mt -126.79 127.54 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.267 0.556 . . . . 0.0 112.156 -177.031 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -85.15 145.68 27.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.738 179.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.537 179.785 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -110.98 142.48 43.05 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.32 130.83 55.58 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -96.0 118.67 33.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.06 0.457 . . . . 0.0 110.116 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -122.34 138.79 54.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.891 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 tp -64.1 115.25 17.86 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.05 158.89 41.77 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.967 1.778 . . . . 0.0 112.41 -178.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -87.17 108.35 18.87 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.137 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.7 mt -65.15 -41.88 92.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.075 0.464 . . . . 0.0 109.755 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 8.13 31.73 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -64.75 -37.71 88.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.706 0.289 . . . . 0.0 110.364 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . 164.73 -43.32 0.3 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER 57.42 145.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.251 0.548 . . . . 0.0 110.987 179.648 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 p -151.44 -36.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.598 179.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -173.48 159.23 3.62 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.946 179.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.19 119.2 6.21 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -134.25 138.2 44.88 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.34 0.57 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.4 mm -103.45 121.8 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.749 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.59 -40.75 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -138.69 147.93 43.37 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -128.2 141.58 51.42 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 54.9 t0 -125.46 22.65 7.66 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.79 0.329 . . . . 0.0 111.076 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.0 156.08 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.2 135.33 55.16 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -58.69 138.2 57.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.46 6.8 76.99 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -114.79 156.48 24.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.716 0.293 . . . . 0.0 110.402 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.6 mtt -80.34 148.15 30.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.719 -179.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.4 t -121.36 135.42 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.458 -178.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -109.56 137.6 47.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.763 179.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.521 ' CB ' ' HE ' ' A' ' 52' ' ' ARG . 37.1 ttmt -68.08 137.64 55.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 6.6 t0 84.73 -11.78 0.78 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.585 179.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -118.87 82.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.654 0.264 . . . . 0.0 110.478 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 67.5 t0 -169.81 139.22 1.91 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.831 0.348 . . . . 0.0 110.423 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 69.4 mt -113.31 89.2 3.02 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.285 0.564 . . . . 0.0 109.919 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.64 130.92 71.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.43 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -121.29 126.36 49.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.821 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.93 149.88 32.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.9 ttp -118.41 134.86 54.72 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.384 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -110.99 -58.91 2.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.49 -179.58 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.482 ' N ' ' OG1' ' A' ' 40' ' ' THR . 51.9 p-10 -131.49 61.63 1.64 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.081 -179.41 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt 61.02 33.96 19.46 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 121.208 0.527 . . . . 0.0 110.119 -178.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.8 t -127.51 136.36 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.32 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 m -106.67 120.33 41.69 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.831 0.348 . . . . 0.0 110.139 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.89 156.59 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 121.244 0.545 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.55 135.74 53.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.31 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.41 155.59 77.02 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.218 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 49' ' ' SER . 31.5 Cg_exo -57.75 146.68 84.44 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 121.866 1.711 . . . . 0.0 112.168 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -40.6 166.15 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.921 179.665 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -77.35 54.59 4.75 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.029 2.486 . . . . 0.0 113.02 -179.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t 64.62 114.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.896 0.379 . . . . 0.0 111.24 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.521 ' HE ' ' CB ' ' A' ' 31' ' ' LYS . 16.0 ptp180 -53.56 145.73 14.42 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.127 0.489 . . . . 0.0 111.705 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.99 -134.12 3.16 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -121.15 130.17 53.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.915 0.357 . . . . 0.0 110.19 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mm -96.46 119.56 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.1 t -77.13 -52.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.148 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -166.18 161.74 17.15 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.464 -178.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.5 tt -91.11 107.19 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.579 0.704 . . . . 0.0 109.78 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.8 tp -75.09 -32.2 61.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.857 -178.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.9 146.93 43.58 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.382 0.61 . . . . 0.0 112.123 -179.02 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.683 ' H ' ' NE2' ' A' ' 64' ' ' GLN . 95.8 mtt180 -122.06 161.32 23.24 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.927 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -56.5 142.29 39.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.678 -179.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.85 4.21 57.92 Favored Glycine 0 N--CA 1.473 1.127 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.237 178.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.683 ' NE2' ' H ' ' A' ' 61' ' ' ARG . 74.1 mt-30 -98.04 131.69 44.24 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.428 0.632 . . . . 0.0 111.668 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -122.49 122.75 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.758 179.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 t -148.95 138.87 12.97 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.834 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.21 142.92 44.35 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 121.473 1.449 . . . . 0.0 112.414 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.97 128.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.013 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.39 51.41 0.04 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.045 179.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -166.85 169.47 13.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.227 0.514 . . . . 0.0 111.323 179.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 71' ' ' THR . 15.2 t -103.7 120.42 40.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.868 179.727 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -88.89 -7.88 55.28 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.182 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.426 HD12 ' H ' ' A' ' 74' ' ' GLN . 5.8 tp -157.16 144.43 18.69 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.426 ' H ' HD12 ' A' ' 73' ' ' LEU . 28.4 mp0 -104.19 132.99 49.86 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.554 0.216 . . . . 0.0 111.039 -179.205 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.8 mt -131.72 130.03 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.43 . . . . 0.0 111.957 -179.426 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -100.88 113.82 27.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.078 178.341 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.822 -1.085 . . . . 0.0 110.328 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 ttp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -89.36 132.88 34.75 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 52.9 mp0 -95.22 121.99 37.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.076 -179.043 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -91.46 113.01 25.16 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.169 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -115.47 146.27 41.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.599 -179.62 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.41 ' C ' ' CD2' ' A' ' 6' ' ' LEU . 4.9 tt -58.67 110.56 2.71 Favored Pre-proline 0 N--CA 1.469 0.516 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.448 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -54.87 141.27 77.86 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 120.21 1.111 . . . . 0.0 112.455 -179.779 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -81.76 22.43 0.75 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.092 -179.877 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.1 mt -106.46 130.21 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.904 0.383 . . . . 0.0 110.415 -179.346 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.76 -175.76 34.24 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -67.27 -40.44 86.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.058 0.456 . . . . 0.0 110.065 179.651 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.05 158.28 19.96 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.669 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.8 t -151.93 85.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.328 179.867 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -65.1 -24.99 67.59 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.314 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -173.24 153.69 2.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.37 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.14 119.27 6.1 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -178.94 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -125.67 133.46 52.16 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.022 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 mm -103.15 122.23 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.634 -178.821 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 9.9 p -90.89 -44.8 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.536 179.595 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.419 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 84.1 mtt85 -146.13 147.44 31.54 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.062 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -115.22 136.86 52.65 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 176.346 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 7.8 p-10 -106.0 1.1 26.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.201 -0.312 . . . . 0.0 111.73 -179.443 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.0 m -136.62 159.63 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.681 0.277 . . . . 0.0 110.943 -179.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -136.91 153.02 50.85 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.076 0.465 . . . . 0.0 110.123 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -57.54 141.99 45.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.766 179.876 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.39 8.34 59.94 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.48 179.057 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 28' ' ' MET . 65.9 t0 -130.58 135.36 47.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.611 0.706 . . . . 0.0 110.847 -179.691 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.486 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 65.9 mtt -81.45 150.2 28.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.193 -179.43 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 p -143.46 147.64 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.001 0.429 . . . . 0.0 110.593 179.605 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -102.65 162.1 13.2 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.841 -178.453 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.07 137.85 50.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.497 -179.067 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 59.81 45.22 12.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.436 179.902 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.437 ' O ' ' CG ' ' A' ' 34' ' ' ASP . 59.3 tt0 -147.03 88.45 1.74 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.524 179.086 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.54 ' OD2' ' NH2' ' A' ' 52' ' ' ARG . 11.8 m-20 170.43 148.65 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.776 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.503 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 74.6 mt -121.03 102.14 8.14 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.646 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.74 131.32 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.216 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -117.46 127.41 53.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.031 -179.831 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.57 129.08 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.795 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.8 ttp -108.55 131.19 55.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.566 -179.864 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.405 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -114.5 -84.89 0.61 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.328 -179.838 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.405 ' N ' ' OG1' ' A' ' 40' ' ' THR . 42.8 p-10 -98.16 51.06 1.02 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.482 179.827 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 65.56 34.66 7.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.132 -178.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.4 t -127.54 135.84 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.9 m -98.13 117.97 33.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.581 -179.574 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.72 131.45 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.298 179.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -93.57 136.17 34.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.212 -179.57 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.1 mt -140.95 95.51 7.61 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.6 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.54 144.75 91.54 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 121.985 1.79 . . . . 0.0 111.35 179.321 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.579 ' CB ' ' NE ' ' A' ' 52' ' ' ARG . 8.0 t -64.81 113.06 9.48 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.546 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.18 -24.64 44.08 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 120.932 1.088 . . . . 0.0 113.943 -178.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.0 125.07 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.579 ' NE ' ' CB ' ' A' ' 49' ' ' SER . 24.6 mmt180 -134.15 155.28 50.38 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.917 0.389 . . . . 0.0 110.873 -179.631 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.92 -84.71 0.06 OUTLIER Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.455 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -130.19 136.79 49.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.8 0.333 . . . . 0.0 110.565 179.379 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.444 HG22 HD12 ' A' ' 55' ' ' ILE . 9.4 mm -104.43 118.84 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.266 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.2 t -87.31 -52.36 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.318 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -160.83 154.36 22.07 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.752 -178.249 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.455 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.4 tt -108.17 122.18 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.503 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.3 mt -97.54 -17.61 19.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.189 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -107.28 141.8 38.04 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.93 0.395 . . . . 0.0 110.747 -179.243 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.495 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 89.4 mtm-85 -122.65 162.19 22.4 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.512 179.926 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -53.62 134.96 41.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.112 -179.067 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.62 6.27 83.4 Favored Glycine 0 N--CA 1.471 0.992 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.679 177.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 80.4 mt-30 -85.86 134.15 33.92 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.109 0.954 . . . . 0.0 111.467 -179.472 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 p -122.13 124.43 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.234 179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 t -148.83 136.93 11.46 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.696 -179.53 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.97 152.47 58.13 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 C-N-CA 121.924 1.75 . . . . 0.0 112.243 178.289 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.8 t -53.87 133.21 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.691 179.648 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.86 51.81 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.804 179.229 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.7 m -153.99 169.08 24.35 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.354 -179.723 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -104.07 111.76 24.47 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.44 -45.3 55.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.541 -179.795 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 74' ' ' GLN . 2.8 tt -152.96 147.66 26.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.939 -177.772 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.466 ' N ' ' CD2' ' A' ' 73' ' ' LEU . 52.4 tt0 -103.21 133.42 48.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.115 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 56.8 mt -126.73 129.2 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.205 0.526 . . . . 0.0 111.891 -177.395 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -96.02 111.63 23.59 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.951 178.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.353 -179.664 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -85.73 126.24 33.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.665 -179.553 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 52.6 mp0 -92.86 134.4 35.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.736 -179.472 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -109.49 108.53 19.05 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.784 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -114.17 141.2 47.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.043 -179.64 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.1 tt -69.26 112.12 10.8 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.413 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.45 156.27 58.57 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.8 1.667 . . . . 0.0 112.875 -178.251 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -74.52 99.15 3.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.586 -179.566 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.08 -42.4 95.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.509 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.38 161.69 29.87 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.869 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 13' ' ' VAL . 58.0 mp0 -66.19 -31.13 71.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.723 0.296 . . . . 0.0 110.836 -179.39 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.5 26.91 0.36 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -179.836 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.531 ' H ' ' C ' ' A' ' 11' ' ' GLU . 53.4 t -127.67 124.99 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.459 ' OG1' ' OE1' ' A' ' 15' ' ' GLU . 27.3 p -138.31 -1.18 1.94 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.119 -179.873 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 54.8 mp0 -140.54 144.01 35.7 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.826 0.346 . . . . 0.0 110.765 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.36 124.8 5.25 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 10.1 tm-20 -128.02 137.8 52.34 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.128 0.464 . . . . 0.0 110.58 -179.309 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -102.13 114.44 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 9.4 p -85.17 -42.56 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.445 179.342 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.412 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 82.2 mtp180 -140.88 147.05 38.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.82 0.343 . . . . 0.0 111.258 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -109.04 137.73 46.5 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.252 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.3 p-10 -72.77 -40.89 65.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.296 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.12 165.58 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.551 -178.193 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 99.4 mttt -119.27 149.69 41.36 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.933 -179.592 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 56' ' ' VAL . 85.7 tt0 -45.31 139.61 3.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.32 7.25 62.23 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.567 -0.574 . . . . 0.0 113.341 178.59 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 24' ' ' LYS . 40.4 p-10 -135.44 153.06 51.9 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.371 1.086 . . . . 0.0 111.226 179.759 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.0 mtp -78.52 155.19 29.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.777 -178.79 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.23 152.77 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -113.38 147.4 37.79 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.937 0.399 . . . . 0.0 110.83 -179.623 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -85.06 84.45 7.7 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.108 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' ASP . 43.8 p30 -165.97 81.37 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.552 179.204 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 62.97 -66.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.048 179.493 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 32' ' ' ASP . 29.0 t0 62.78 -167.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.311 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 83.4 mt -126.54 75.75 1.57 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.183 0.516 . . . . 0.0 111.55 -179.768 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.06 128.14 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.51 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -124.73 128.68 49.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.114 -178.616 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.52 133.6 64.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.226 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.3 ttp -119.1 113.41 20.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.381 -179.024 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.7 p -62.75 -52.05 64.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.108 0.48 . . . . 0.0 109.908 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.8 t70 -146.87 -48.22 0.19 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.32 179.123 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -161.51 51.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.271 179.05 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.3 t -135.88 160.06 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.431 -179.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.5 m -110.25 114.79 28.54 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.32 117.1 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.354 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -97.76 136.42 38.12 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.646 178.959 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.5 mt -139.33 139.95 24.38 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 119.303 -0.38 . . . . 0.0 110.529 -178.744 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 49' ' ' SER . 52.8 Cg_exo -53.17 145.66 42.4 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.386 1.39 . . . . 0.0 111.725 178.195 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -47.34 179.19 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.858 -179.322 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 49' ' ' SER . 78.8 Cg_endo -87.86 49.67 1.74 Allowed 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.776 2.317 . . . . 0.0 113.855 -178.363 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.0 t 66.19 121.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 120.823 0.344 . . . . 0.0 111.599 178.759 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -50.23 136.38 19.79 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.524 -179.928 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.62 -141.63 5.75 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.371 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -126.05 126.67 44.62 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.811 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -91.74 119.23 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.676 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.4 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 37.7 t -101.41 -41.52 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.222 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -145.16 154.89 42.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.557 -177.677 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.5 tt -127.78 127.27 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.205 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.8 tp -100.26 -21.18 15.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.211 -179.492 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -106.08 141.93 36.64 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.225 0.536 . . . . 0.0 111.383 -178.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -122.18 165.74 15.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.143 179.371 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.0 mp0 -53.39 128.24 27.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.455 -179.463 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.72 5.95 85.98 Favored Glycine 0 N--CA 1.468 0.818 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.374 178.539 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -79.4 135.52 36.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.42 0.61 . . . . 0.0 110.71 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.76 131.52 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.611 179.624 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -149.47 137.54 11.77 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.785 -178.78 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.92 137.48 52.38 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.077 1.185 . . . . 0.0 112.344 177.942 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -56.22 129.16 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.721 179.774 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.68 49.3 0.08 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.113 178.985 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.3 p -164.62 165.99 20.54 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.345 0.572 . . . . 0.0 110.858 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 t -98.98 122.15 41.87 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.057 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.556 ' N ' ' CD1' ' A' ' 72' ' ' LEU . 3.0 mp -90.57 -5.38 56.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.686 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.416 HD21 ' N ' ' A' ' 74' ' ' GLN . 2.1 tt -162.34 142.43 9.83 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.101 -178.866 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.539 ' N ' ' OE1' ' A' ' 74' ' ' GLN . 2.3 mp0 -104.03 124.37 48.9 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.247 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.7 mt -122.89 127.48 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.47 0.652 . . . . 0.0 111.57 -177.7 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -98.12 111.36 23.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.219 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.77 -179.47 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -125.88 149.26 48.82 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.924 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.66 128.34 53.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.819 0.342 . . . . 0.0 110.384 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -87.08 126.13 34.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.058 -179.931 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -119.6 133.73 55.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.191 -179.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.0 123.3 79.58 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.821 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.08 148.39 44.63 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.598 1.532 . . . . 0.0 111.781 -179.41 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -67.79 123.5 20.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.399 -179.56 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 75.5 mt -119.77 133.51 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.9 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.99 -174.42 20.73 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.805 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -88.92 147.38 24.37 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -179.704 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.31 -112.15 4.34 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 t 59.73 106.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.501 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -124.42 11.88 8.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.539 -179.049 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.47 ' CD ' ' N ' ' A' ' 16' ' ' GLY . 13.4 tm-20 -145.84 142.87 29.24 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 111.377 179.951 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.47 ' N ' ' CD ' ' A' ' 15' ' ' GLU . . . -121.2 119.29 4.06 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.356 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -118.98 136.26 54.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 117.165 0.482 . . . . 0.0 110.658 -179.763 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mm -101.35 119.97 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.125 -179.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 20' ' ' ARG . 10.0 p -89.9 -45.89 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.841 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' N ' ' CG1' ' A' ' 19' ' ' VAL . 99.7 mtt180 -143.41 148.46 36.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.192 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -118.25 144.54 45.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.432 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.3 m-20 -124.48 12.94 8.75 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.136 0.426 . . . . 0.0 111.655 179.395 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.77 154.93 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.962 0.41 . . . . 0.0 110.764 179.605 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -121.9 153.68 38.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.096 -179.822 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -64.15 129.54 40.38 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.303 -179.955 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.04 5.66 63.88 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 36.5 p-10 -101.86 151.93 21.5 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.066 0.433 . . . . 0.0 110.665 179.536 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.2 mmm -90.85 148.85 22.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.537 -179.791 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.66 141.07 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.174 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -109.57 159.97 16.64 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.818 0.342 . . . . 0.0 111.272 -178.714 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -59.73 136.4 57.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.184 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 58.92 29.64 19.15 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.209 -179.559 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.69 79.56 1.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.573 0.225 . . . . 0.0 110.42 179.332 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 46.0 t0 -173.73 -178.56 1.61 Allowed 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.534 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.527 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 37.3 tp -153.95 97.84 2.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.922 0.391 . . . . 0.0 110.562 179.458 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.0 130.56 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.9 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.4 mp0 -114.66 120.71 41.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.926 178.759 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.6 m -119.98 134.37 63.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.008 -179.805 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.9 ptm -130.13 129.41 43.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.344 -179.58 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -43.07 61.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.325 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -154.78 -67.21 0.13 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.323 -179.648 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -132.67 37.15 3.49 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.228 179.523 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.1 t -133.82 136.01 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.901 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 m -116.26 120.61 39.48 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.516 -179.666 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.94 155.61 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.362 179.546 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -115.23 135.63 53.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.276 -179.782 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.1 mt -134.27 130.84 20.35 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.11 179.945 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.46 146.17 27.36 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.419 2.079 . . . . 0.0 112.626 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -60.59 110.91 3.32 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.29 -19.76 37.94 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.612 1.541 . . . . 0.0 114.951 -177.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.89 124.03 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 118.459 0.572 . . . . 0.0 111.606 -179.084 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -91.14 152.13 20.7 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.107 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.39 -133.34 2.39 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.214 179.49 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -125.05 143.33 50.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.688 0.28 . . . . 0.0 110.327 -179.371 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.4 mm -103.73 118.72 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.682 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.8 t -89.25 -55.36 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.097 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -143.52 153.5 42.65 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.289 0.566 . . . . 0.0 111.814 -178.364 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.7 tt -101.57 114.38 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.148 178.884 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.75 -17.68 20.12 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.827 -179.648 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -109.3 142.21 40.5 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.083 0.468 . . . . 0.0 110.756 -179.225 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -126.0 166.25 17.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.429 179.851 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.43 144.5 50.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.006 -179.391 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.03 5.8 87.27 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 179.259 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -70.76 133.44 46.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.593 0.711 . . . . 0.0 111.355 -179.01 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.46 118.67 40.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 114.33 -1.304 . . . . 0.0 107.5 178.604 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.56 154.79 35.82 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.006 -178.472 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.12 140.33 41.06 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.739 2.293 . . . . 0.0 111.676 179.087 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.12 124.61 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.774 179.412 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.1 53.31 0.06 OUTLIER Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.0 t -162.51 168.27 22.16 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.961 0.38 . . . . 0.0 110.807 -179.889 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.8 t -105.45 128.41 53.52 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.738 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.683 ' CD2' ' H ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -64.16 -41.81 97.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.182 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -161.27 177.28 10.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.757 -179.495 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -107.03 127.19 53.24 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.717 0.294 . . . . 0.0 110.889 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.47 125.29 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.25 0.548 . . . . 0.0 111.346 -179.323 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -90.27 140.49 29.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.8 178.913 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.449 179.792 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -79.61 129.17 34.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.839 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 57.1 mp0 -105.87 118.77 37.45 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -95.86 122.28 38.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.218 0.532 . . . . 0.0 110.733 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.63 145.22 49.09 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.66 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 tt -68.73 113.4 15.7 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.045 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 N--CA 1.491 1.381 0 C-N-CA 121.59 1.527 . . . . 0.0 112.008 -179.322 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.482 ' OE2' ' CG2' ' A' ' 65' ' ' VAL . 30.8 tp10 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.92 110.45 0.72 Allowed Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -126.27 131.91 51.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 110.355 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -102.37 119.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.17 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.6 p -93.08 -43.81 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.519 ' N ' HG13 ' A' ' 19' ' ' VAL . 83.2 mtp180 -139.57 145.07 38.15 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.808 0.337 . . . . 0.0 111.243 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -111.68 139.84 46.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.91 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 18.2 p-10 -101.36 -6.51 23.98 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.37 159.95 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.027 0.441 . . . . 0.0 111.4 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.33 149.99 49.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.7 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -59.55 138.63 57.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.257 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.64 8.87 76.16 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.604 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -121.98 149.84 42.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 117.431 0.616 . . . . 0.0 111.156 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.2 mtm -86.59 154.19 21.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.265 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.474 HG23 ' NE2' ' A' ' 33' ' ' GLN . 2.6 p -138.9 152.61 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.937 0.399 . . . . 0.0 110.515 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -117.44 157.23 26.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.012 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -67.55 65.6 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.962 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -176.11 73.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.531 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.474 ' NE2' HG23 ' A' ' 29' ' ' VAL . 85.1 mt-30 -147.1 122.09 10.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.409 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -128.14 39.45 3.84 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.454 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.8 mt -110.51 33.67 4.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.107 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.11 128.15 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -116.85 123.91 48.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.533 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.92 130.16 72.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.375 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.3 ttm -109.7 126.4 53.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.287 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -95.1 -77.28 0.47 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.054 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.424 ' N ' ' OG1' ' A' ' 40' ' ' THR . 62.1 t0 -95.99 -74.24 0.57 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.269 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -151.37 50.71 0.83 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.334 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.03 149.34 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.897 0.379 . . . . 0.0 110.75 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.8 m -107.97 118.82 37.75 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.957 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.96 133.79 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -95.51 135.5 37.08 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.426 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.4 mt -135.75 133.57 20.15 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.36 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.3 147.69 33.18 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.175 1.917 . . . . 0.0 111.162 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -96.98 107.89 40.28 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 111.371 0.137 . . . . 0.0 111.371 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -86.59 41.78 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.373 2.049 . . . . 0.0 111.358 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.39 156.2 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.716 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -154.33 149.07 26.51 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.276 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.29 -132.93 2.94 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.84 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -130.3 135.76 48.43 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -91.87 120.18 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.147 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.5 t -84.53 -50.07 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -164.16 157.06 17.61 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.898 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 58' ' ' ILE . 3.0 tt -116.07 121.96 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.446 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.55 -16.88 18.97 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.21 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.543 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 17.8 m-85 -107.31 144.4 34.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.291 0.567 . . . . 0.0 111.58 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -123.83 161.48 25.21 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.86 137.02 57.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.45 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.41 4.99 85.5 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.492 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.52 ' OE1' ' CD2' ' A' ' 60' ' ' TYR . 55.3 tt0 -89.32 137.39 32.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.414 0.607 . . . . 0.0 110.563 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.482 ' CG2' ' OE2' ' A' ' 15' ' ' GLU . 3.4 p -124.42 131.21 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.375 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 t -148.3 140.86 14.89 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.249 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.19 148.17 32.69 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.501 1.467 . . . . 0.0 112.661 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 68' ' ' VAL . 9.8 p -62.08 132.83 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.456 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.99 49.44 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.014 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.7 p -160.33 162.84 33.59 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.399 0.6 . . . . 0.0 111.355 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 71' ' ' THR . 5.3 t -96.37 120.99 37.68 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.2 mm? -82.45 -4.32 57.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.553 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.8 142.45 2.45 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.58 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -104.84 122.39 45.67 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.35 127.51 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.095 0.474 . . . . 0.0 111.081 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -88.0 141.32 28.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.087 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.493 179.825 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -82.84 130.12 35.09 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 51.0 mp0 -93.79 138.7 31.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.95 101.79 11.82 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 6' ' ' LEU . 68.6 mttm -108.28 105.19 14.77 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 5' ' ' LYS . 5.6 mt -29.23 93.84 0.06 OUTLIER Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 123.845 0.716 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' LYS . 92.0 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 C-N-CA 121.644 1.563 . . . . 0.0 112.127 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.65 109.92 3.54 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -121.78 127.35 50.52 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.409 HG21 ' NE1' ' A' ' 21' ' ' TRP . 7.2 mm -100.92 117.94 46.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.05 0.452 . . . . 0.0 111.565 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 20' ' ' ARG . 10.7 p -91.74 -41.85 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.583 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.488 ' N ' HG13 ' A' ' 19' ' ' VAL . 95.1 mtt-85 -143.37 141.88 31.07 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.409 ' NE1' HG21 ' A' ' 18' ' ' ILE . 37.3 m95 -111.93 145.4 39.62 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 35' ' ' LEU . 87.7 m-20 -128.54 20.85 6.1 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.43 0.559 . . . . 0.0 111.255 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.9 m -136.33 154.63 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 68.4 mttm -135.05 137.13 42.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.448 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -44.25 135.75 4.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.91 5.94 70.29 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 43.9 p-10 -104.19 150.88 23.98 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.806 0.303 . . . . 0.0 110.222 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.2 mtp -90.06 145.74 24.85 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.86 0.362 . . . . 0.0 110.645 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.9 t -126.42 132.85 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.478 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -105.7 158.2 16.88 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -62.88 136.4 57.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.639 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 58.66 36.46 25.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.141 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -141.81 89.76 2.22 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 51.4 t0 -172.91 158.16 3.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.901 0.382 . . . . 0.0 110.455 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.47 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 92.7 mt -135.22 86.35 2.24 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.322 0.582 . . . . 0.0 110.009 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.71 136.69 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.565 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.1 mp0 -123.06 128.14 49.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.056 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 p -128.15 130.0 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.0 ttp -109.3 133.49 52.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.547 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -99.65 -92.38 0.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.492 ' N ' ' OG1' ' A' ' 40' ' ' THR . 14.3 p-10 -83.69 -52.73 6.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.356 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -174.45 57.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.612 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -159.33 151.83 6.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.901 0.382 . . . . 0.0 110.417 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -103.87 117.53 34.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.284 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.88 132.59 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.064 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -92.53 135.71 33.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.954 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.94 90.8 13.8 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.55 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.08 147.73 92.04 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 122.638 2.225 . . . . 0.0 112.018 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.5 m -60.65 111.27 3.82 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 119.51 -0.281 . . . . 0.0 110.7 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.56 -16.81 30.39 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.413 1.409 . . . . 0.0 114.521 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.89 124.58 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.245 0.475 . . . . 0.0 111.084 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -89.74 151.49 21.8 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.415 0.15 . . . . 0.0 110.827 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.77 -145.47 7.97 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -114.46 133.74 55.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.85 0.325 . . . . 0.0 110.845 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.487 HG23 HD21 ' A' ' 73' ' ' LEU . 5.8 mm -87.91 120.22 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 t -88.99 -52.63 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -156.27 160.74 40.04 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.186 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.481 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.0 tt -106.0 123.37 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.618 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.1 tp -101.11 -18.32 16.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.068 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.436 ' CE2' HD22 ' A' ' 72' ' ' LEU . 5.8 m-85 -111.15 146.82 36.18 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.217 0.532 . . . . 0.0 111.053 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.574 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 99.8 mtt180 -122.5 167.3 13.52 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.111 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -62.37 140.54 58.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.838 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.52 5.02 82.6 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.382 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.574 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 83.5 mt-30 -85.61 135.17 33.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.488 0.644 . . . . 0.0 111.955 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 p -128.46 126.5 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.733 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.5 t -149.52 135.93 10.49 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.746 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.39 141.96 59.46 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.377 1.385 . . . . 0.0 111.905 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 p -52.98 128.32 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.849 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.03 48.24 0.06 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.187 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.4 p -164.17 162.24 22.65 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 117.407 0.604 . . . . 0.0 110.926 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 71' ' ' THR . 6.0 t -88.96 126.48 35.42 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.436 HD22 ' CE2' ' A' ' 60' ' ' TYR . 42.2 mt -97.36 -5.48 36.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.402 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.4 tt -170.51 149.08 3.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.507 ' N ' HD23 ' A' ' 73' ' ' LEU . 66.7 mt-30 -103.17 125.52 49.9 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.8 mt -126.45 128.55 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.199 0.523 . . . . 0.0 111.723 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 18.6 p-10 -97.09 115.66 27.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.543 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.591 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -106.78 137.52 44.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.147 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.33 130.51 40.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.125 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -108.64 120.46 42.53 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.203 0.525 . . . . 0.0 110.331 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -127.18 153.34 46.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.955 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 tp -71.52 117.87 61.16 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.742 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 C-N-CA 121.664 1.576 . . . . 0.0 111.886 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.988 0.423 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.54 150.81 18.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -137.16 146.56 45.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.954 0.377 . . . . 0.0 110.262 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.89 115.93 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.37 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 20' ' ' ARG . 10.7 p -86.04 -43.62 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.373 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.503 ' N ' HG13 ' A' ' 19' ' ' VAL . 83.6 mtp180 -139.54 147.37 41.11 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.724 0.297 . . . . 0.0 111.264 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -111.95 141.84 45.1 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.46 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 16.5 p-10 -105.56 -3.51 22.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.542 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -134.59 160.35 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 120.891 0.377 . . . . 0.0 111.36 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.22 147.17 45.64 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.56 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.432 ' OE1' HG22 ' A' ' 58' ' ' ILE . 82.6 tt0 -63.34 134.23 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.619 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.75 8.53 85.84 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.322 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -117.07 129.13 55.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.068 0.434 . . . . 0.0 111.431 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.1 ptp -59.54 150.25 27.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.843 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 30' ' ' GLU . 52.9 t -123.25 159.06 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.019 0.438 . . . . 0.0 110.138 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 57.2 mp0 -135.1 149.59 50.07 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.57 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 87.9 tttt -65.29 137.6 57.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.138 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 9.9 m-20 94.21 76.03 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.817 0.698 . . . . 0.0 110.704 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -146.16 95.66 2.66 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.594 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -104.1 52.35 0.76 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.653 0.263 . . . . 0.0 110.916 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -117.87 30.53 7.2 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.239 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.93 128.28 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -121.86 126.64 49.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.644 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.0 129.89 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.6 ttp -103.95 110.98 23.33 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.831 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.453 ' H ' HG23 ' A' ' 40' ' ' THR . 1.1 p -61.91 -48.13 81.85 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -146.31 -67.45 0.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.432 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -142.11 41.38 1.65 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.842 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 44' ' ' THR . 48.3 t -136.33 155.85 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.416 ' N ' HG12 ' A' ' 43' ' ' VAL . 5.0 m -109.17 118.2 36.13 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.76 120.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.06 138.57 31.4 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -136.42 109.84 9.62 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.08 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.69 145.27 60.78 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.67 1.58 . . . . 0.0 111.369 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.5 m -105.04 99.62 20.35 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.08 44.44 1.28 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.295 1.997 . . . . 0.0 110.432 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.76 154.68 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -161.47 131.82 5.02 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.713 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.02 -136.49 3.85 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.855 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -124.44 132.13 53.5 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.88 0.34 . . . . 0.0 110.242 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.429 ' N ' HD13 ' A' ' 55' ' ' ILE . 4.2 mm -91.77 121.33 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.8 t -87.46 -51.81 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -155.29 161.42 41.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.681 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.575 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.6 tt -122.0 123.78 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.695 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.06 -16.48 17.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -107.15 143.9 34.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.15 0.5 . . . . 0.0 111.375 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -123.61 164.99 17.95 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.272 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -59.34 134.4 56.97 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.631 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.98 5.64 90.01 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.009 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -82.15 137.39 34.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.041 0.42 . . . . 0.0 110.823 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.84 133.03 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.605 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.7 t -148.63 141.28 15.16 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.691 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.16 146.11 61.5 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.317 1.345 . . . . 0.0 111.373 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.451 ' H ' HG12 ' A' ' 68' ' ' VAL . 1.6 p -64.89 130.2 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.018 0.437 . . . . 0.0 110.713 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.55 53.15 0.08 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.2 m -160.41 170.3 21.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.054 0.427 . . . . 0.0 111.255 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.2 m -99.43 112.5 24.68 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.838 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.52 -43.4 76.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.161 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.2 tt -151.38 145.74 25.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.072 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.84 ' N ' HD23 ' A' ' 73' ' ' LEU . 39.1 mt-30 -104.11 130.73 51.84 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.9 mt -131.71 127.34 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.142 0.496 . . . . 0.0 111.536 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.76 140.97 29.28 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.918 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.568 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -97.65 127.87 43.93 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 37.6 mp0 -107.74 111.72 24.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.131 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -75.55 100.94 4.72 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -112.55 147.16 37.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.554 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 7' ' ' PRO . 7.3 tt -66.35 113.35 12.21 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.455 ' O ' HD23 ' A' ' 6' ' ' LEU . 45.6 Cg_exo . . . . . 0 N--CA 1.494 1.532 0 CA-C-N 120.499 1.214 . . . . 0.0 112.09 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 121.004 0.431 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.14 132.38 8.05 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -133.84 142.03 47.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.96 0.41 . . . . 0.0 110.101 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -100.01 121.66 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.048 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.545 HG13 ' N ' ' A' ' 20' ' ' ARG . 11.5 p -88.18 -45.69 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.167 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.545 ' N ' HG13 ' A' ' 19' ' ' VAL . 63.0 ttm-85 -146.76 139.31 25.02 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -108.19 143.94 36.31 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.2 m-20 -127.55 15.89 7.05 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.892 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.15 155.91 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -130.07 147.56 51.83 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.941 0.401 . . . . 0.0 111.063 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.435 ' OE1' HG22 ' A' ' 58' ' ' ILE . 10.3 pt-20 -62.59 139.47 58.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.92 7.97 73.42 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.843 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -117.92 148.99 41.63 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.865 0.333 . . . . 0.0 110.68 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 63.8 mtt -76.77 147.29 37.36 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.105 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.99 132.74 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -98.89 154.92 17.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.432 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -96.05 84.26 3.79 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.86 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 34' ' ' ASP . 46.5 p-10 -173.5 131.22 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 110.853 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' ASP . 96.7 mm-40 53.78 -80.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.609 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 32' ' ' ASP . 93.8 m-20 57.01 150.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.457 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 89.5 mt -122.12 76.68 1.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.283 0.563 . . . . 0.0 111.629 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.07 131.59 70.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -123.16 121.72 36.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.274 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.3 m -115.19 130.88 68.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 43' ' ' VAL . 5.4 tpp -91.83 152.18 20.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.896 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.487 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -156.66 -89.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.589 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.487 ' H ' HG23 ' A' ' 40' ' ' THR . 91.7 m-20 -76.16 44.84 0.34 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.286 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 58.37 37.72 25.85 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.61 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.452 ' O ' ' SD ' ' A' ' 39' ' ' MET . 30.6 m -147.54 158.98 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.67 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -100.17 118.49 36.61 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 110.727 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -119.59 130.45 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.543 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -94.98 138.78 32.26 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.28 92.99 34.2 Favored Pre-proline 0 N--CA 1.472 0.639 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.184 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.461 ' O ' ' OG ' ' A' ' 49' ' ' SER . 88.3 Cg_endo -80.03 143.87 16.45 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.227 1.951 . . . . 0.0 113.133 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 49' ' ' SER . 6.0 p 81.7 69.68 0.12 Allowed Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.408 ' CD ' ' OD2' ' A' ' 34' ' ' ASP . 64.2 Cg_endo -88.87 26.94 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.953 2.435 . . . . 0.0 112.177 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t 69.76 115.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.142 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -79.83 147.65 31.68 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 112.064 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.24 -133.92 2.57 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -122.48 134.33 54.58 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.487 HG23 HD21 ' A' ' 73' ' ' LEU . 7.7 mm -92.98 119.62 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -79.37 -52.39 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -168.44 157.96 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.705 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.4 tt -104.01 122.68 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.009 0.433 . . . . 0.0 111.334 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -100.93 -17.17 16.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -106.73 142.54 36.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.97 0.414 . . . . 0.0 110.884 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -117.47 169.83 9.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.313 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.29 134.19 56.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.246 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.49 6.17 86.43 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.866 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -79.09 131.85 36.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.2 0.524 . . . . 0.0 111.324 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -127.03 132.21 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.596 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.87 140.31 15.53 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.609 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.94 147.2 15.12 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.038 1.159 . . . . 0.0 112.187 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.1 p -60.13 130.4 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.51 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.08 55.99 0.21 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.4 m -151.38 175.69 12.0 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.055 0.455 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 m -101.14 109.7 21.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.252 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.05 -45.52 70.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.089 0.471 . . . . 0.0 110.946 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.487 HD21 HG23 ' A' ' 55' ' ' ILE . 3.9 tt -152.72 147.16 25.76 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.485 ' N ' HD23 ' A' ' 73' ' ' LEU . 58.3 tt0 -103.56 128.18 50.84 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.5 mt -128.07 129.52 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.164 0.507 . . . . 0.0 111.118 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -95.69 112.05 23.86 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.099 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.1 m . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.618 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 75' ' ' ILE . 21.6 t80 -79.75 127.58 32.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 110.217 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 54.8 mp0 -88.29 133.7 33.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.311 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -101.69 113.29 26.31 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 6' ' ' LEU . 54.0 mtmt -120.1 113.77 20.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 5' ' ' LYS . 12.6 mt -32.89 97.22 0.11 Allowed Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.521 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo . . . . . 0 N--CA 1.492 1.4 0 C-N-CA 121.721 1.614 . . . . 0.0 111.957 -179.918 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.69 109.76 3.91 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -121.49 132.61 54.82 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -101.91 120.58 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.94 0.4 . . . . 0.0 111.193 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.502 HG13 ' N ' ' A' ' 20' ' ' ARG . 8.7 p -92.95 -42.43 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.62 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.502 ' N ' HG13 ' A' ' 19' ' ' VAL . 43.2 ttm180 -148.79 134.51 18.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -104.2 140.44 37.83 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -120.24 16.77 12.33 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.094 0.406 . . . . 0.0 111.279 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.38 157.66 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.922 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -131.8 136.47 47.55 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.546 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.68 140.18 36.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 0.0 111.042 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.96 6.96 74.89 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.88 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -116.21 149.6 38.87 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.879 0.339 . . . . 0.0 110.723 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.5 mmm -83.47 147.32 27.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.643 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.2 t -118.9 132.54 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.353 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE1' ' OE1' ' A' ' 33' ' ' GLN . 95.5 mt-10 -96.23 155.59 16.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.721 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -67.83 134.13 50.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.859 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 57.86 34.56 24.5 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.241 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.414 ' OE1' ' OE1' ' A' ' 30' ' ' GLU . 82.7 mt-30 -143.13 87.49 1.97 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.868 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -174.62 168.95 3.7 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -136.31 97.69 3.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.244 0.545 . . . . 0.0 110.683 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.53 132.63 67.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.186 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -125.12 126.17 44.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.329 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.84 125.89 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.232 0.539 . . . . 0.0 109.567 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.0 ttp -105.86 137.91 42.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.069 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.535 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.6 t -102.81 -121.34 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.92 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.535 ' N ' ' OG1' ' A' ' 40' ' ' THR . 63.8 t0 -63.78 -46.77 83.73 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -177.13 60.55 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -150.33 149.13 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.741 0.305 . . . . 0.0 110.305 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -101.88 117.73 35.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.85 117.08 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.871 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -97.1 134.53 40.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.77 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.0 mt -138.9 129.58 14.96 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.556 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.45 143.59 22.0 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.134 1.889 . . . . 0.0 112.464 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 p -47.76 106.9 0.65 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.3 -23.51 32.84 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.077 1.185 . . . . 0.0 114.745 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.76 123.53 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.401 0.546 . . . . 0.0 111.732 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -83.04 161.22 21.76 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.38 -142.35 7.99 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.091 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -119.47 134.52 55.18 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.836 0.35 . . . . 0.0 111.187 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mm -95.93 117.74 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.64 -53.46 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -151.58 156.8 41.22 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.478 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.7 tt -108.84 120.35 60.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.004 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.47 -17.93 18.49 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.302 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.522 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 7.6 m-85 -111.42 144.62 40.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.44 0.638 . . . . 0.0 111.391 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.552 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 99.9 mtt180 -120.82 162.19 20.22 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.078 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -58.33 142.28 48.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.609 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.76 6.03 70.59 Favored Glycine 0 N--CA 1.469 0.869 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.552 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 85.9 mt-30 -94.13 132.06 39.04 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.364 0.602 . . . . 0.0 112.161 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.95 125.8 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.007 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 t -147.97 137.17 11.91 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.646 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -50.48 137.4 40.23 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.016 1.144 . . . . 0.0 112.213 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.58 126.44 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.469 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.08 49.32 0.04 OUTLIER Glycine 0 CA--C 1.531 1.034 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.956 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.8 p -159.75 160.46 34.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 117.182 0.491 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 71' ' ' THR . 5.2 t -91.66 104.27 16.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.803 0.811 . . . . 0.0 109.982 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 72' ' ' LEU . 2.2 mm? -67.31 -39.91 85.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.483 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.908 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.5 tt -141.55 148.63 39.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.908 ' N ' HD23 ' A' ' 73' ' ' LEU . 57.5 tt0 -102.6 130.22 49.41 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 2' ' ' TYR . 96.3 mt -127.41 127.91 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.247 0.546 . . . . 0.0 111.398 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -102.1 114.9 29.42 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.167 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.114 -0.946 . . . . 0.0 110.599 179.825 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' OD1' ' A' ' 76' ' ' ASP . 97.8 mmm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -148.02 147.97 30.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.398 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -126.69 138.72 53.44 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.08 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.35 113.89 27.56 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.317 0.58 . . . . 0.0 110.573 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 6' ' ' LEU . 98.9 mttt -119.49 112.83 19.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.172 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.576 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.7 tt -35.93 99.53 0.18 Allowed Pre-proline 0 N--CA 1.475 0.798 0 O-C-N 123.342 0.401 . . . . 0.0 110.446 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 N--CA 1.493 1.445 0 C-N-CA 121.702 1.601 . . . . 0.0 112.061 -179.024 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.751 0.31 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.05 111.0 3.25 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -121.28 129.99 53.43 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.426 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.6 mm -102.35 118.8 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.405 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.8 p -96.77 -47.48 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.831 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.575 ' N ' HG13 ' A' ' 19' ' ' VAL . 82.4 mtp180 -141.53 145.49 35.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.426 ' NE1' HG21 ' A' ' 18' ' ' ILE . 31.8 m95 -117.03 139.51 50.6 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.565 ' CG ' HH22 ' A' ' 52' ' ' ARG . 7.7 p-10 -108.09 5.15 25.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.492 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 3.8 m -133.84 157.2 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.626 0.251 . . . . 0.0 110.535 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.86 145.11 51.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.846 0.355 . . . . 0.0 110.496 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -61.54 138.5 58.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.196 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.07 8.01 65.2 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.913 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 28' ' ' MET . 68.1 t0 -117.32 135.95 53.48 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.926 0.363 . . . . 0.0 111.365 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.495 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 2.5 mpt? -90.48 131.69 36.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.047 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.17 146.0 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.743 0.306 . . . . 0.0 110.675 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.3 mm-40 -92.85 160.08 15.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.436 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -52.12 129.77 28.44 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.196 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 30' ' ' GLU . 2.5 p30 168.79 133.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.647 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -67.09 80.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.627 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 68.0 t0 -63.45 -43.2 98.07 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.363 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.523 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 1.4 mt 154.87 86.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.036 0.835 . . . . 0.0 110.824 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -117.47 126.05 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -121.13 123.09 41.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.467 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.93 130.42 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.418 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 25.1 ptm -128.12 152.05 48.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -94.71 -114.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.317 178.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.543 ' N ' ' OG1' ' A' ' 40' ' ' THR . 69.7 m-20 -65.03 -45.24 86.29 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -176.1 57.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.779 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 39' ' ' MET . 48.7 t -137.42 139.47 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -95.9 116.93 29.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.484 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.23 119.39 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -92.44 132.13 37.03 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 36' ' ' VAL . 57.3 mt -141.26 138.04 17.31 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.466 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -52.3 141.64 49.28 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 CA-C-N 120.178 1.099 . . . . 0.0 111.083 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.517 ' CB ' ' HE ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -46.6 162.94 0.24 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.017 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 51' ' ' VAL . 95.4 Cg_endo -78.16 54.81 5.09 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 123.23 2.62 . . . . 0.0 112.991 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 50' ' ' PRO . 4.1 t 59.12 109.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.144 -0.623 . . . . 0.0 109.52 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.565 HH22 ' CG ' ' A' ' 22' ' ' ASP . 95.9 mtt180 -102.81 146.07 28.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 111.828 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.45 -85.84 0.06 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -125.11 114.04 18.52 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mm -91.54 120.02 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.0 t -79.44 -52.83 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -169.88 157.37 6.72 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.084 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.1 tt -110.33 119.26 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.439 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.21 -17.6 20.67 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.569 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.429 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 28.2 m-85 -110.2 141.76 42.69 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.909 0.385 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -132.13 165.81 23.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.069 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.02 141.94 21.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.802 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.69 5.0 60.26 Favored Glycine 0 N--CA 1.471 0.995 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.235 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -99.51 131.25 45.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.494 0.664 . . . . 0.0 111.861 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.98 123.51 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.354 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.27 138.69 13.04 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.301 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -52.68 143.79 45.47 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.356 1.37 . . . . 0.0 112.394 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.6 p -52.03 128.95 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.601 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.28 52.76 0.08 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.738 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -156.48 161.8 40.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.033 0.417 . . . . 0.0 111.164 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.3 p -92.91 111.29 22.86 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.807 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.711 HD22 ' N ' ' A' ' 72' ' ' LEU . 2.3 mm? -89.08 -6.98 56.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.086 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.6 OUTLIER -176.45 142.54 0.45 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.196 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.473 ' H ' HD23 ' A' ' 73' ' ' LEU . 58.0 tt0 -104.37 126.48 51.5 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 57.7 mt -128.35 128.26 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.18 0.514 . . . . 0.0 111.474 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.507 ' OD1' ' SD ' ' A' ' 1' ' ' MET . 85.6 m-20 -101.28 111.06 23.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.131 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.351 180.0 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -75.31 142.71 43.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.724 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -112.03 135.95 52.01 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.289 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -101.21 117.16 34.43 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.312 0.577 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 6' ' ' LEU . 99.4 mttt -119.54 107.37 13.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.146 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 5' ' ' LYS . 16.2 tp -31.06 93.2 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.931 0 O-C-N 123.665 0.603 . . . . 0.0 110.886 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 5' ' ' LYS . 30.8 Cg_exo . . . . . 0 N--CA 1.498 1.756 0 C-N-CA 122.214 1.943 . . . . 0.0 112.585 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.69 110.04 3.95 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -118.41 130.8 56.18 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.418 HG21 ' NE1' ' A' ' 21' ' ' TRP . 10.7 mm -100.12 120.15 49.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.107 0.48 . . . . 0.0 111.777 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.4 p -90.43 -45.61 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.467 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.6 mtt180 -147.7 149.33 32.23 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.418 ' NE1' HG21 ' A' ' 18' ' ' ILE . 69.5 m95 -114.79 140.62 48.77 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -121.74 12.23 10.59 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.004 0.365 . . . . 0.0 111.009 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 23' ' ' VAL . 5.3 m -126.09 131.07 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.81 141.65 36.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.187 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -54.91 135.77 47.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.879 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.27 6.48 84.17 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.516 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 28' ' ' MET . 64.2 t0 -110.82 146.95 35.53 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.245 0.522 . . . . 0.0 110.872 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.539 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 77.2 mtm -87.65 149.38 24.31 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.738 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.23 137.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.799 0.333 . . . . 0.0 110.444 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -90.21 158.83 17.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.51 138.16 58.26 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.42 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 58.6 37.02 25.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.057 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.33 87.21 1.87 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.489 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -172.82 167.09 5.25 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.733 0.302 . . . . 0.0 110.452 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -136.05 88.56 2.4 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.229 0.538 . . . . 0.0 110.138 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.16 128.61 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.522 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -117.08 118.01 31.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.561 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -109.52 129.3 64.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.0 ttp -117.14 154.97 30.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.647 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.59 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -140.16 -86.21 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.868 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.59 ' H ' HG23 ' A' ' 40' ' ' THR . 67.2 t0 -94.43 52.63 1.58 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.329 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 60.04 44.33 13.36 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 121.035 0.445 . . . . 0.0 110.835 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -130.1 138.32 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.748 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 m -94.89 118.13 31.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.215 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.83 117.54 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.148 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -93.1 128.84 39.16 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 110.467 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.7 mt -137.99 90.21 14.16 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.451 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.74 144.62 92.84 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.528 2.152 . . . . 0.0 112.413 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.8 m -51.06 108.63 1.09 Allowed Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.803 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.9 -15.35 23.72 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 121.638 1.559 . . . . 0.0 115.035 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.89 124.6 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.42 0.555 . . . . 0.0 111.779 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -89.16 149.01 23.35 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 120.689 0.28 . . . . 0.0 111.112 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.24 -138.42 4.89 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -122.31 144.14 49.19 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.958 0.409 . . . . 0.0 111.084 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 73' ' ' LEU . 7.8 mm -99.75 120.58 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.7 t -83.52 -50.96 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -158.86 154.69 26.46 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.592 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.58 ' O ' HG23 ' A' ' 58' ' ' ILE . 3.2 tt -91.47 108.23 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.42 0.629 . . . . 0.0 109.513 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.4 tp -82.01 -27.65 32.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.803 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' CE2' HD22 ' A' ' 72' ' ' LEU . 4.2 m-85 -117.15 145.33 43.89 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.366 0.603 . . . . 0.0 111.649 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.568 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 90.2 mtm-85 -120.48 168.41 11.36 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.952 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -62.73 146.85 51.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 111.968 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.32 5.08 85.63 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.182 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.568 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 86.0 mt-30 -89.22 132.1 35.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.444 0.64 . . . . 0.0 111.942 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.07 121.13 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.848 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.96 139.33 14.0 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.342 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.38 143.85 25.78 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.183 1.255 . . . . 0.0 112.246 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 p -61.68 129.2 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.162 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.35 52.54 0.07 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.452 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.4 t -167.05 153.65 8.42 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.991 0.396 . . . . 0.0 110.998 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.7 t -79.57 130.9 35.8 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.411 HD22 ' CE2' ' A' ' 60' ' ' TYR . 26.2 mt -105.52 0.07 26.31 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 74' ' ' GLN . 3.2 tp -173.13 143.35 1.12 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.661 ' N ' HD12 ' A' ' 73' ' ' LEU . 12.7 mm-40 -102.98 129.68 49.81 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.013 0.435 . . . . 0.0 110.47 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 83.1 mt -129.82 126.18 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.327 0.584 . . . . 0.0 111.611 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -89.78 138.75 31.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.653 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.329 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.402 ' H2 ' ' CB ' ' A' ' 77' ' ' THR . 22.5 ttm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.47 150.36 45.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.198 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -130.55 129.76 43.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.54 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CE2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -91.67 120.35 32.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -129.49 149.35 51.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.605 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.515 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.2 tt -95.16 106.46 25.89 Favored Pre-proline 0 N--CA 1.473 0.675 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.677 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 N--CA 1.492 1.427 0 C-N-CA 121.874 1.716 . . . . 0.0 111.892 179.482 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.7 0.286 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.57 110.52 0.5 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' OE1' ' CE ' ' A' ' 39' ' ' MET . 83.7 tt0 -122.87 135.88 54.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.842 0.353 . . . . 0.0 110.268 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 mm -102.56 121.24 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.931 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 20' ' ' ARG . 11.5 p -92.63 -42.44 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.36 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.515 ' N ' HG13 ' A' ' 19' ' ' VAL . 79.4 ttt-85 -142.31 137.51 30.64 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -109.27 141.05 42.12 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 10.8 p-10 -114.87 3.04 14.49 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.42 155.83 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.701 0.286 . . . . 0.0 110.684 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 99.0 mttt -135.11 150.54 50.23 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.221 0.534 . . . . 0.0 111.239 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -50.03 131.21 22.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.114 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.79 5.3 68.72 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.65 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 31.7 p-10 -106.67 150.06 26.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 117.52 0.66 . . . . 0.0 110.734 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.7 mmm -85.55 153.28 22.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.913 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 30' ' ' GLU . 26.6 t -125.18 160.57 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.957 0.408 . . . . 0.0 110.807 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 57.1 mp0 -118.45 152.26 36.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.355 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HB2' HH11 ' A' ' 52' ' ' ARG . 65.1 tttm -80.64 140.4 35.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.31 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.11 141.96 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.051 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 65.9 114.11 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.496 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 45.0 t0 -163.49 -173.03 3.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.489 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 84.8 mt -138.15 69.94 1.39 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.082 0.467 . . . . 0.0 111.341 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.88 131.06 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 57.3 mp0 -128.54 123.27 33.04 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 110.937 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.78 131.85 64.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.425 ' CE ' ' OE1' ' A' ' 17' ' ' GLU . 63.2 ttp -99.5 121.59 41.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.659 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -96.49 -86.26 0.32 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.248 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' N ' ' OG1' ' A' ' 40' ' ' THR . 99.7 m-20 -101.26 49.98 0.87 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.206 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.1 tttm 73.08 28.25 1.92 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.932 0.396 . . . . 0.0 110.304 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.27 137.46 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.534 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 m -94.48 117.16 29.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.914 0.388 . . . . 0.0 110.13 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.5 m -124.16 131.22 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.557 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -90.07 139.23 30.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.593 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.8 mt -133.5 137.41 28.91 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.322 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 49' ' ' SER . 53.1 Cg_exo -51.99 140.59 49.02 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 121.79 1.66 . . . . 0.0 112.862 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.43 ' OG ' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -40.67 165.71 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.21 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.29 42.57 1.36 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.079 2.52 . . . . 0.0 113.172 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.7 t 62.22 118.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.661 0.267 . . . . 0.0 110.974 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.401 HH11 ' HB2' ' A' ' 31' ' ' LYS . 35.5 ptt-85 -44.04 150.33 0.28 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.902 0.382 . . . . 0.0 111.756 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.04 -146.38 11.66 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -118.23 131.65 56.36 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.907 0.384 . . . . 0.0 110.383 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.415 ' CG2' HD11 ' A' ' 73' ' ' LEU . 8.1 mm -96.63 118.87 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.9 t -91.0 -52.5 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -150.49 156.9 42.33 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.109 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.7 tt -117.6 123.33 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.751 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.46 -16.85 16.69 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.172 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.516 ' CD2' ' OE1' ' A' ' 64' ' ' GLN . 15.6 m-85 -106.74 141.99 37.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.115 0.483 . . . . 0.0 111.161 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -122.2 168.92 11.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.204 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.22 134.65 57.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.833 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.91 4.9 90.4 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.704 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.516 ' OE1' ' CD2' ' A' ' 60' ' ' TYR . 49.7 tt0 -82.97 135.65 34.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.504 0.652 . . . . 0.0 110.919 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -126.93 131.92 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.08 140.65 15.13 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 119.328 -0.367 . . . . 0.0 111.083 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.3 148.88 48.6 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 121.42 1.413 . . . . 0.0 112.225 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 68' ' ' VAL . 7.5 p -57.8 132.55 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.204 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.78 51.84 0.11 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.4 p -159.06 163.27 36.44 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.445 0.623 . . . . 0.0 111.617 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.7 m -93.34 109.32 20.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.154 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.435 HD12 ' CE2' ' A' ' 4' ' ' PHE . 97.1 mt -63.75 -46.04 87.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.406 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.879 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.9 tt -152.55 146.47 25.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.492 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.879 ' N ' HD23 ' A' ' 73' ' ' LEU . 55.2 tt0 -102.95 130.06 49.89 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.6 mt -125.23 127.69 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.159 0.504 . . . . 0.0 111.342 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -91.92 137.27 32.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.402 ' CB ' ' H2 ' ' A' ' 1' ' ' MET . 19.1 m . . . . . 0 C--O 1.222 -0.392 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.252 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -139.78 149.9 44.09 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.92 133.78 50.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.265 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.423 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -88.23 112.82 23.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 109.933 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -117.64 117.57 29.73 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.697 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.49 ' C ' HD23 ' A' ' 6' ' ' LEU . 4.0 tt -47.26 107.66 0.75 Allowed Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.77 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 N--CA 1.492 1.421 0 C-N-CA 121.543 1.496 . . . . 0.0 111.55 -179.711 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 57.0 mp0 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 120.815 0.34 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.99 117.81 5.94 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -123.27 131.98 53.86 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.435 HG21 ' NE1' ' A' ' 21' ' ' TRP . 9.0 mm -102.58 120.67 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.031 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.517 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.7 p -92.18 -43.12 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.72 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' NH2' ' OE1' ' A' ' 37' ' ' GLU . 86.2 mtm180 -144.92 151.4 38.61 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.435 ' NE1' HG21 ' A' ' 18' ' ' ILE . 68.2 m95 -118.68 140.98 49.04 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -116.64 9.06 14.0 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.1 0.409 . . . . 0.0 111.847 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.61 156.74 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.676 0.274 . . . . 0.0 110.342 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 62.6 mttp -115.34 142.34 46.81 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.275 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -57.33 134.64 56.17 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.36 6.43 66.32 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 40.1 p-10 -102.36 151.72 21.93 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.026 0.441 . . . . 0.0 110.86 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.9 mtm -81.64 144.61 31.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.199 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.0 t -122.54 133.61 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.389 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -104.03 159.94 15.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.114 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' HH11 ' A' ' 52' ' ' ARG . 87.9 tttt -62.87 133.46 54.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.279 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.1 37.96 26.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.522 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -139.43 81.46 1.83 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.727 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 49' ' ' SER . 68.0 t0 -177.67 132.17 0.16 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.43 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 41.5 tp -111.02 96.77 6.35 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.148 0.499 . . . . 0.0 109.99 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.77 124.03 72.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.542 ' OE1' ' NH2' ' A' ' 20' ' ' ARG . 76.0 tt0 -106.06 120.24 41.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.045 0.45 . . . . 0.0 110.6 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.32 131.55 67.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.678 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 43' ' ' VAL . 6.0 tpp -114.72 145.43 42.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.363 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 2.6 t -115.4 -131.35 0.32 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.027 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.532 ' N ' ' OG1' ' A' ' 40' ' ' THR . 67.3 t0 -65.13 -43.77 90.82 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.458 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -173.13 53.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.786 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.506 ' O ' ' SD ' ' A' ' 39' ' ' MET . 5.1 t -145.01 133.69 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.253 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -101.2 119.47 38.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.62 157.76 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.547 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -125.57 135.65 52.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.239 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.3 mt -133.58 88.26 34.52 Favored Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.503 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.18 142.53 97.26 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 122.409 2.072 . . . . 0.0 112.302 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.445 ' H ' ' HB3' ' A' ' 34' ' ' ASP . 74.2 m -41.55 102.45 0.27 Allowed Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.203 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.32 -23.12 38.86 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.081 1.188 . . . . 0.0 114.466 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.83 126.4 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 118.246 0.476 . . . . 0.0 111.32 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.402 HH11 ' HB2' ' A' ' 31' ' ' LYS . 33.5 ptt-85 -84.75 146.01 27.61 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 120.514 0.197 . . . . 0.0 110.897 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.23 -145.94 7.2 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.698 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -115.94 135.51 53.91 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.641 0.258 . . . . 0.0 110.392 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.5 mm -95.59 119.8 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.19 -53.27 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.531 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -164.1 157.73 18.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.727 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.7 tt -89.35 114.84 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.179 0.514 . . . . 0.0 110.691 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.94 -25.17 24.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.352 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.37 145.98 39.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.096 0.474 . . . . 0.0 111.192 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -123.23 165.65 16.55 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.017 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.4 142.39 48.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.417 0.627 . . . . 0.0 112.159 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.37 4.95 90.33 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.075 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -86.69 130.18 34.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 111.499 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.75 129.65 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.544 -0.753 . . . . 0.0 108.972 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.79 140.41 14.68 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 119.374 -0.346 . . . . 0.0 110.575 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.92 146.22 47.78 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.326 1.351 . . . . 0.0 112.584 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -56.12 130.47 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.09 49.78 0.15 Allowed Glycine 0 N--CA 1.47 0.903 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 p -160.52 164.52 32.02 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.135 0.467 . . . . 0.0 111.03 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.4 p -87.65 127.72 35.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.221 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 74.9 mt -93.58 -4.56 50.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.321 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.733 HD12 ' H ' ' A' ' 74' ' ' GLN . 2.0 tp 174.76 149.55 0.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.733 ' H ' HD12 ' A' ' 73' ' ' LEU . 58.2 tt0 -104.76 128.12 52.77 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.922 0.392 . . . . 0.0 111.394 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.3 mt -126.56 128.01 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.094 0.473 . . . . 0.0 110.976 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -96.9 110.97 23.37 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.068 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.506 -179.763 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -126.77 148.87 49.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.739 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -124.62 135.42 53.08 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.281 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -100.76 119.74 39.07 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.33 147.24 48.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.917 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 tt -76.24 116.68 58.19 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.686 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo . . . . . 0 N--CA 1.496 1.621 0 C-N-CA 121.949 1.766 . . . . 0.0 112.812 -179.268 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.657 0.265 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.09 168.31 13.74 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -156.68 142.78 18.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.482 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 mm -102.87 121.33 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.462 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 20' ' ' ARG . 27.0 m -92.35 -45.4 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.434 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' N ' HG23 ' A' ' 19' ' ' VAL . 95.7 mtt-85 -139.77 146.83 39.98 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.26 0.552 . . . . 0.0 112.077 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -114.57 142.99 45.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.263 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -118.17 8.34 12.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.451 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.21 156.06 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.792 0.33 . . . . 0.0 110.73 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.86 146.55 39.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.275 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.31 138.75 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.907 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.21 7.91 69.34 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.601 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 28' ' ' MET . 60.7 t0 -120.8 148.09 44.47 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.93 0.395 . . . . 0.0 111.038 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.537 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 96.9 mtp -83.94 150.13 25.87 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.561 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.4 t -119.73 133.59 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.807 0.337 . . . . 0.0 110.321 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 57.3 mp0 -101.96 155.41 18.18 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.443 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -71.34 140.8 50.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.024 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 t0 80.61 64.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.766 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -140.36 87.58 2.15 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -98.01 89.28 4.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.724 0.297 . . . . 0.0 111.354 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.9 mt -140.92 27.16 2.01 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 m -116.61 135.81 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -122.7 126.24 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.598 0.237 . . . . 0.0 110.602 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.33 155.74 34.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 110.464 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 43' ' ' VAL . 28.0 tpp -106.71 125.42 50.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.624 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.69 -49.77 3.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.974 0.416 . . . . 0.0 110.079 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' OD1' HG23 ' A' ' 43' ' ' VAL . 47.8 p-10 -139.23 49.72 1.83 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.438 ' C ' ' SD ' ' A' ' 39' ' ' MET . 48.5 tttm 72.76 23.8 2.84 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.589 ' N ' ' SD ' ' A' ' 39' ' ' MET . 47.6 t -123.69 134.57 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.754 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.3 m -95.68 118.74 32.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.661 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.12 155.11 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.251 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -109.67 135.1 51.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.711 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.32 157.88 75.73 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 49' ' ' SER . 37.2 Cg_exo -55.2 147.24 55.87 Favored 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 121.914 1.743 . . . . 0.0 112.452 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -48.4 179.9 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.352 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 49' ' ' SER . 88.0 Cg_endo -89.31 44.91 0.77 Allowed 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 123.094 2.529 . . . . 0.0 113.056 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.1 t 62.79 117.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 120.682 0.277 . . . . 0.0 111.745 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -39.26 147.12 0.07 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.695 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.53 -147.14 12.85 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.27 139.1 51.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.963 0.382 . . . . 0.0 110.309 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mm -103.31 119.02 51.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -93.6 -51.62 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -147.17 157.5 43.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.4 tt -116.94 124.24 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.376 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.22 -16.42 15.21 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 8.1 m-85 -109.89 145.51 36.71 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.269 0.557 . . . . 0.0 111.751 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -124.87 161.8 25.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.254 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -56.11 138.52 49.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.558 0.694 . . . . 0.0 112.33 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.85 5.67 89.91 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.202 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -81.2 133.83 35.52 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.332 -0.51 . . . . 0.0 110.832 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.9 t -118.02 128.62 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.157 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 t -149.84 139.38 13.17 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.513 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.04 143.28 83.92 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.205 1.27 . . . . 0.0 111.746 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.21 130.95 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.73 50.13 0.05 OUTLIER Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.975 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -166.65 164.07 16.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.388 0.594 . . . . 0.0 111.451 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 71' ' ' THR . 7.8 t -94.71 114.43 26.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.188 0.518 . . . . 0.0 109.628 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.533 ' CD1' ' CD2' ' A' ' 60' ' ' TYR . 2.9 mm? -64.72 -40.32 95.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.334 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.9 tt -142.62 147.7 36.24 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.873 ' N ' HD23 ' A' ' 73' ' ' LEU . 55.5 tt0 -102.74 130.7 49.78 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.0 mt -128.3 127.78 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.982 0.42 . . . . 0.0 111.296 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -96.0 116.37 28.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.47 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.108 -179.82 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -80.32 141.05 35.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.66 138.51 51.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.737 0.303 . . . . 0.0 110.756 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -101.36 106.02 17.13 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -114.84 120.81 41.27 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.066 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.58 ' C ' HD23 ' A' ' 6' ' ' LEU . 4.4 tt -47.11 107.64 0.75 Allowed Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.447 ' N ' HD23 ' A' ' 6' ' ' LEU . 44.6 Cg_exo . . . . . 0 N--CA 1.496 1.633 0 C-N-CA 121.533 1.488 . . . . 0.0 112.332 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.451 ' OE2' HG22 ' A' ' 65' ' ' VAL . 74.8 tt0 . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -98.69 144.59 17.31 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -157.06 126.7 6.16 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.417 HG21 ' NE1' ' A' ' 21' ' ' TRP . 5.4 mm -102.54 120.09 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.802 0.334 . . . . 0.0 111.65 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.1 p -87.27 -47.45 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.851 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.565 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.8 mtt180 -142.77 147.77 36.09 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.417 ' NE1' HG21 ' A' ' 18' ' ' ILE . 42.1 m95 -113.24 136.17 53.03 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 22.3 p-10 -99.69 -7.12 26.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.8 m -145.37 161.12 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.48 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 99.0 mttt -139.36 155.44 47.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.151 0.501 . . . . 0.0 111.215 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -46.78 142.31 3.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.389 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.9 8.53 67.08 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.137 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 47.2 p-10 -129.65 149.47 51.39 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.015 0.908 . . . . 0.0 111.659 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.5 mtt -84.94 151.39 24.27 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.54 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.18 147.1 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.093 0.473 . . . . 0.0 110.309 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 97.6 mt-10 -140.56 152.77 45.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.068 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 30' ' ' GLU . 33.7 tptt 94.59 124.11 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.955 0.784 . . . . 0.0 110.707 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 49' ' ' SER . 9.0 p-10 -72.75 -3.32 24.57 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.469 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -132.49 87.27 2.4 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.6 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 53.1 p-10 -97.82 -112.32 0.15 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.6 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 54.5 tp -166.84 80.51 0.23 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.275 0.559 . . . . 0.0 110.714 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.64 132.35 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -109.27 123.77 49.82 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 110.582 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.76 128.23 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.621 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttm -109.2 155.94 20.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.03 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.5 t -132.21 -118.33 0.21 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.629 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.536 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.2 p-10 -66.73 -46.33 75.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.941 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.488 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 30.8 ttmt -174.64 56.2 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.485 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -162.21 151.76 3.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.826 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 m -117.09 122.49 44.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.065 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.59 157.31 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.055 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.26 134.44 51.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.0 mt -118.53 137.63 24.99 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.92 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 49' ' ' SER . 50.2 Cg_exo -51.11 142.07 36.26 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.442 1.428 . . . . 0.0 112.467 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -36.58 157.44 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.37 44.93 1.72 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.496 2.131 . . . . 0.0 112.578 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.8 t 63.62 117.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -50.25 146.7 4.85 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.933 0.396 . . . . 0.0 111.704 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.73 -136.59 4.33 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -127.04 143.84 51.18 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.033 0.416 . . . . 0.0 110.239 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.474 HG23 HD21 ' A' ' 73' ' ' LEU . 7.3 mm -104.0 117.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.3 t -91.18 -50.72 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -149.97 157.17 42.89 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.427 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 58' ' ' ILE . 15.5 tt -132.02 126.84 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.766 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.13 -16.11 20.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.914 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.587 ' CE1' HD23 ' A' ' 72' ' ' LEU . 25.2 m-85 -102.01 134.65 44.9 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.36 0.6 . . . . 0.0 111.782 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.81 178.99 4.28 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.987 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.69 128.16 35.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.781 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.46 5.88 81.56 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.527 177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -83.72 139.49 32.71 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.198 0.999 . . . . 0.0 111.743 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 16' ' ' GLY . 12.9 p -125.73 132.63 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.378 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -147.99 137.59 12.24 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.032 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.51 150.6 41.99 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 121.472 1.448 . . . . 0.0 112.439 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.37 130.6 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.307 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.7 48.15 0.11 Allowed Glycine 0 N--CA 1.471 1.018 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.247 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.3 p -163.12 162.89 25.88 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 117.376 0.588 . . . . 0.0 111.171 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -90.28 130.79 36.35 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.587 HD23 ' CE1' ' A' ' 60' ' ' TYR . 78.3 mt -89.27 -12.36 40.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.3 tt -169.59 146.78 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.976 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.502 ' N ' HD23 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -102.81 122.31 44.26 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.139 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.0 mt -124.97 128.73 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.398 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -98.54 111.26 23.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.229 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.56 -179.951 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -80.68 137.22 36.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -114.02 126.64 55.35 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -96.97 113.65 25.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.211 0.529 . . . . 0.0 110.161 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -117.71 139.42 51.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.023 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -71.51 113.15 17.25 Favored Pre-proline 0 N--CA 1.47 0.549 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.546 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 N--CA 1.492 1.401 0 C-N-CA 122.057 1.838 . . . . 0.0 111.929 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.22 110.22 0.79 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -123.23 137.04 54.97 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.03 121.42 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 112.056 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.8 p -87.19 -46.56 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.609 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' N ' HG13 ' A' ' 19' ' ' VAL . 72.2 ttt180 -149.16 137.28 20.71 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -100.84 145.6 28.36 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 11.5 p-10 -121.3 8.89 10.3 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.31 155.68 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.075 0.464 . . . . 0.0 111.018 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -134.74 147.57 50.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 56' ' ' VAL . 24.0 tp10 -60.11 135.25 57.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.167 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.77 8.06 70.39 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.224 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -118.4 156.33 29.16 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.125 0.463 . . . . 0.0 111.322 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.2 mmt -96.4 150.96 20.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 30' ' ' GLU . 3.4 p -138.32 154.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.809 0.337 . . . . 0.0 110.405 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 1.3 pm0 -109.98 155.19 22.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.974 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -83.8 92.75 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.765 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -178.61 75.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.99 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 38.74 91.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.957 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.45 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 27.4 t70 -84.67 11.97 8.02 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.339 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.9 mt 66.0 66.33 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.918 0.761 . . . . 0.0 110.859 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.06 128.93 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -120.56 125.54 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.14 0.495 . . . . 0.0 111.091 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.5 m -121.04 133.57 67.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.265 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.9 ttp -103.88 109.54 21.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.413 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 40' ' ' THR . 0.2 OUTLIER -63.67 -51.96 62.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.201 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -138.49 -65.48 0.5 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.545 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -149.47 43.83 0.93 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.701 0.286 . . . . 0.0 110.37 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.0 p -150.87 149.71 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.951 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 m -102.19 118.86 37.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.516 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.64 133.54 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.482 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -94.24 137.45 33.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.745 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.2 mt -132.03 139.15 34.11 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.059 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 49' ' ' SER . 50.4 Cg_exo -52.97 142.74 52.24 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.356 1.371 . . . . 0.0 112.379 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.93 164.85 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.551 -179.218 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.28 44.55 1.63 Allowed 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.149 2.566 . . . . 0.0 112.663 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t 64.38 116.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.732 0.301 . . . . 0.0 110.901 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -49.78 146.93 4.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 111.665 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 167.3 -134.57 3.31 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.0 139.55 53.34 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.87 0.335 . . . . 0.0 110.192 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -99.01 120.25 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.464 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 21.4 t -87.05 -54.76 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -154.13 158.76 40.89 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.302 0.572 . . . . 0.0 112.038 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.4 tt -116.87 119.54 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.198 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 74.3 mt -100.17 -18.22 17.02 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.3 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -115.17 142.75 46.23 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -123.7 165.92 16.42 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.142 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.42 150.25 11.99 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.014 0.435 . . . . 0.0 111.983 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.55 6.47 77.17 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.303 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -101.72 129.97 48.01 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 112.071 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.95 128.94 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 t -147.08 140.43 14.94 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.783 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.48 140.82 63.7 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.239 1.293 . . . . 0.0 112.05 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 68' ' ' VAL . 10.2 p -59.43 131.75 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.555 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.28 50.48 0.12 Allowed Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.014 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.1 p -156.36 164.55 38.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.269 0.535 . . . . 0.0 111.304 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.4 m -88.26 121.06 30.22 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.88 -27.69 13.48 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 74' ' ' GLN . 1.7 tt -156.12 141.71 17.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.796 ' N ' HD23 ' A' ' 73' ' ' LEU . 52.2 tt0 -104.25 132.81 50.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.86 0.362 . . . . 0.0 110.205 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.7 mt -130.99 127.47 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.191 0.519 . . . . 0.0 111.34 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -87.46 142.95 27.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.717 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 83.9 m . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.299 179.535 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -116.26 141.49 48.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -114.6 126.41 54.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.88 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -99.62 118.69 36.71 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.21 0.528 . . . . 0.0 110.503 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -124.65 140.91 52.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.882 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.81 114.75 12.21 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo . . . . . 0 N--CA 1.493 1.484 0 C-N-CA 121.622 1.548 . . . . 0.0 112.662 -178.914 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 120.768 0.318 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.82 135.71 8.83 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.38 137.88 54.72 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.411 HG21 ' NE1' ' A' ' 21' ' ' TRP . 8.9 mm -102.66 121.18 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.688 0.28 . . . . 0.0 111.616 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 t -101.53 -34.65 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.751 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -153.49 133.21 13.06 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.88 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.411 ' NE1' HG21 ' A' ' 18' ' ' ILE . 67.6 m95 -105.37 130.48 53.47 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 16.8 p-10 -98.98 3.66 47.05 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.719 0.295 . . . . 0.0 111.086 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.46 157.64 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.792 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -132.33 145.7 51.45 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.32 0.581 . . . . 0.0 111.402 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -58.39 140.48 53.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.919 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.71 6.89 65.26 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -121.48 126.6 49.65 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.082 0.441 . . . . 0.0 111.225 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -71.34 141.17 50.44 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 30' ' ' GLU . 11.2 t -142.1 161.5 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 1.6 pm0 -127.66 152.1 48.11 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.055 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 30' ' ' GLU . 52.4 pttt -26.8 145.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.583 0.552 . . . . 0.0 111.752 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.5 ' O ' ' O ' ' A' ' 33' ' ' GLN . 94.6 m-20 61.69 58.31 2.03 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.227 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.699 ' NE2' ' H ' ' A' ' 49' ' ' SER . 1.4 pm0 -43.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.488 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' H ' ' CG ' ' A' ' 33' ' ' GLN . 66.4 t0 -153.4 61.17 0.76 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.036 0.446 . . . . 0.0 110.672 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 34' ' ' ASP . 19.3 mt 55.73 124.62 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.999 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.73 131.78 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -92.87 120.53 33.31 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.331 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -129.22 134.93 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.967 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.0 ttp -116.43 153.15 32.6 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.723 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -135.31 -82.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 40' ' ' THR . 99.0 m-20 -91.6 44.43 1.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.0 tttt 68.46 38.06 2.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.79 0.328 . . . . 0.0 110.443 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.3 t -132.31 136.95 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -94.22 113.78 25.77 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.03 0.443 . . . . 0.0 110.012 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.39 133.75 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.822 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -93.53 125.26 38.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.31 0.576 . . . . 0.0 110.58 179.368 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.4 mt -135.46 85.68 31.27 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.471 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.09 145.02 99.07 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 122.483 2.122 . . . . 0.0 111.722 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.699 ' H ' ' NE2' ' A' ' 33' ' ' GLN . 1.2 m -74.69 131.9 78.87 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.754 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.89 -15.45 40.33 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.816 1.677 . . . . 0.0 113.749 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -136.97 155.51 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.769 0.319 . . . . 0.0 111.424 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.18 160.02 9.4 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.42 -82.63 0.05 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -124.63 124.13 41.55 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -97.76 115.66 38.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.68 -54.07 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -165.36 152.64 10.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.514 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.8 tt -105.62 121.12 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.542 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -95.24 -17.48 21.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.077 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.529 ' CD1' HD13 ' A' ' 72' ' ' LEU . 12.3 m-85 -109.8 142.78 40.57 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.216 0.531 . . . . 0.0 111.261 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.493 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 60.7 ttm-85 -126.69 162.54 25.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.757 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -55.0 147.2 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.212 0.53 . . . . 0.0 111.875 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.44 6.48 87.56 Favored Glycine 0 N--CA 1.47 0.919 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.945 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.493 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 86.8 mt-30 -98.76 133.32 43.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.368 0.604 . . . . 0.0 111.715 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.81 129.14 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.29 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.9 t -147.64 141.04 15.29 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.722 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.04 142.47 34.39 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.466 1.444 . . . . 0.0 112.332 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -60.8 133.82 26.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.822 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.53 51.81 0.16 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 m -153.02 159.43 42.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 117.457 0.629 . . . . 0.0 111.561 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.2 m -88.04 98.08 11.33 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.867 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.535 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 3.1 mm? -65.21 -41.63 94.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.641 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.846 HD23 ' N ' ' A' ' 74' ' ' GLN . 1.8 tt -146.39 148.6 32.5 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.846 ' N ' HD23 ' A' ' 73' ' ' LEU . 54.3 mt-30 -103.26 127.18 50.66 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 mt -126.08 127.86 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.1 0.476 . . . . 0.0 111.575 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -101.83 114.16 28.0 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.961 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.4 -179.935 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 ttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -85.54 147.15 26.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.897 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -121.33 135.72 55.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.325 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.436 ' CE2' HD12 ' A' ' 72' ' ' LEU . 1.3 t80 -99.55 118.51 36.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -121.54 146.44 46.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.293 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.19 115.99 17.14 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo . . . . . 0 N--CA 1.495 1.616 0 C-N-CA 121.391 1.394 . . . . 0.0 113.291 -179.211 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.653 0.263 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.11 122.61 6.97 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -131.63 135.19 46.75 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.436 HG21 ' NE1' ' A' ' 21' ' ' TRP . 8.4 mm -102.7 120.0 51.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.185 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 m -92.37 -43.58 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.719 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -142.93 145.52 33.11 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.436 ' NE1' HG21 ' A' ' 18' ' ' ILE . 46.3 m95 -118.22 140.28 50.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.1 m-20 -119.8 13.47 12.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.781 0.324 . . . . 0.0 110.82 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.35 158.92 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 26.4 pttm -138.94 144.36 39.0 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 110.574 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 26' ' ' GLY . 13.1 tm-20 -47.78 138.88 8.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.725 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' N ' ' CD ' ' A' ' 25' ' ' GLU . . . 87.56 6.82 76.61 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.451 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 42.4 p-10 -106.93 150.01 26.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.206 0.503 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.6 mtp -90.31 142.69 27.48 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.091 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.9 t -120.01 133.38 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.672 0.272 . . . . 0.0 110.705 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -101.47 156.49 17.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.238 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.39 135.9 55.83 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.704 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 57.9 34.4 24.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.303 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -144.43 88.27 1.92 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.76 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -172.67 170.87 4.63 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.938 0.399 . . . . 0.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.452 HD23 ' NZ ' ' A' ' 46' ' ' LYS . 81.0 mt -140.14 88.42 2.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.61 133.38 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.444 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -123.1 124.91 44.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.189 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.04 154.64 26.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.215 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.6 ttp -106.84 152.4 23.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.216 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.65 -42.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.479 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -136.0 49.0 2.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.92 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 56.81 43.46 25.0 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.066 0.46 . . . . 0.0 109.961 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.43 152.1 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.25 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.6 m -95.9 118.29 32.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.612 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.74 131.38 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.193 0.52 . . . . 0.0 110.769 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.452 ' NZ ' HD23 ' A' ' 35' ' ' LEU . 54.0 tttp -92.03 139.24 30.84 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.086 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.3 mt -134.73 135.2 22.95 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.078 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 49' ' ' SER . 43.0 Cg_exo -51.6 146.17 27.42 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 121.689 1.593 . . . . 0.0 112.308 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.26 166.31 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.466 -179.272 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.71 49.85 3.32 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 123.044 2.496 . . . . 0.0 113.082 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t 68.29 119.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.838 0.351 . . . . 0.0 111.492 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -47.41 135.9 10.25 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.753 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.15 -141.52 6.51 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -123.59 144.98 49.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.021 0.411 . . . . 0.0 110.559 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.409 HG23 HD21 ' A' ' 73' ' ' LEU . 8.2 mm -100.96 120.76 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.2 t -92.43 -51.13 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -154.6 159.15 40.67 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.761 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.1 tt -106.95 132.76 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.221 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.44 -24.6 10.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.459 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -108.4 141.41 40.29 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.035 0.445 . . . . 0.0 111.418 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.554 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 90.4 mtm180 -120.2 162.62 19.05 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.39 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 56.2 mp0 -56.17 134.83 53.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.174 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.75 4.98 84.62 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.929 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.554 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 79.8 mt-30 -83.27 135.53 34.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.688 0.744 . . . . 0.0 111.875 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.3 t -120.11 126.84 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 t -148.67 132.5 8.53 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -56.47 149.65 55.86 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.459 1.439 . . . . 0.0 112.106 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 68' ' ' VAL . 1.4 p -58.89 128.56 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.783 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.52 49.72 0.05 OUTLIER Glycine 0 CA--C 1.531 1.078 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.131 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m -163.92 166.97 21.18 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.388 0.594 . . . . 0.0 111.165 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 71' ' ' THR . 6.3 t -95.4 115.92 28.09 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.436 HD12 ' CE2' ' A' ' 4' ' ' PHE . 92.1 mt -65.99 -42.98 89.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.291 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.532 HD23 ' N ' ' A' ' 74' ' ' GLN . 4.0 tt -144.01 151.28 39.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.532 ' N ' HD23 ' A' ' 73' ' ' LEU . 36.8 mt-30 -102.62 121.12 41.77 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.9 127.19 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.965 0.412 . . . . 0.0 111.827 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.56 136.95 32.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.482 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.397 -179.872 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtm . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -111.77 143.65 42.34 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.328 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -139.49 114.31 9.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.017 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -88.87 122.44 32.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.135 0.493 . . . . 0.0 110.633 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -121.76 157.85 30.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.178 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 tp -44.43 126.24 4.76 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.495 1.611 0 C-N-CA 121.186 1.257 . . . . 0.0 112.539 -178.449 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 C--O 1.232 0.15 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.79 137.09 10.29 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -151.97 133.47 14.63 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.921 0.391 . . . . 0.0 109.986 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.404 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.6 mm -102.77 124.34 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.561 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.5 p -91.58 -44.24 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.527 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.514 ' N ' HG13 ' A' ' 19' ' ' VAL . 71.3 ttt180 -151.61 137.87 18.42 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.404 ' NE1' HG21 ' A' ' 18' ' ' ILE . 60.9 m95 -107.75 136.9 46.72 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.1 m-20 -108.16 0.46 21.56 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.665 0.269 . . . . 0.0 110.766 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.5 m -133.54 158.49 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -137.5 154.33 49.89 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -54.73 143.21 25.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.059 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.51 7.13 76.29 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.762 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 28' ' ' MET . 62.0 t0 -123.19 150.57 43.2 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.602 0.701 . . . . 0.0 111.089 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.553 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 76.5 mtm -78.07 149.09 33.99 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -121.8 133.93 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.69 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.86 157.41 17.22 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.348 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.05 94.48 6.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' ASP . 8.0 p30 173.12 113.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.936 0.398 . . . . 0.0 111.381 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 53.67 -82.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.829 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' ASP . 9.7 t0 74.88 13.14 3.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.864 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.3 mt 21.08 84.48 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.761 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.93 130.33 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.6 mp0 -116.37 124.38 49.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.475 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.56 135.14 58.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.637 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.7 ttp -124.83 151.46 45.21 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.675 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -104.27 -51.83 3.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.742 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' OG1' ' A' ' 40' ' ' THR . 94.7 m-20 -138.01 -62.5 0.59 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.327 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -146.31 39.19 1.08 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.855 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.6 t -129.87 133.33 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.798 0.332 . . . . 0.0 110.134 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.5 m -114.96 115.79 27.45 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.09 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.0 m -129.46 131.13 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.852 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -95.2 133.35 39.15 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.095 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mt -128.85 134.48 26.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.993 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.35 144.23 50.27 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.678 1.586 . . . . 0.0 111.219 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.1 m -99.0 104.01 23.14 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.22 48.43 2.49 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.186 1.924 . . . . 0.0 110.663 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.61 158.91 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -160.36 144.98 14.45 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.128 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.01 -137.05 4.98 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.07 141.72 51.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.902 0.351 . . . . 0.0 110.087 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -97.09 119.97 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.33 -49.61 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -158.26 158.43 34.43 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.734 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 58' ' ' ILE . 4.4 tt -123.96 122.8 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.255 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.3 mt -99.15 -18.02 17.88 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.668 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CE1' HD23 ' A' ' 72' ' ' LEU . 21.3 m-85 -105.43 136.5 44.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.156 0.503 . . . . 0.0 110.827 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -121.06 -176.45 3.27 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.031 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -64.57 126.78 28.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.59 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.47 5.57 86.79 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.22 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -70.48 133.97 47.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.802 0.801 . . . . 0.0 110.835 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.71 126.9 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.3 t -149.17 139.49 13.44 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.189 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.91 150.34 64.25 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.034 1.156 . . . . 0.0 111.707 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.0 p -64.05 127.66 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.347 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.74 52.38 0.07 OUTLIER Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.027 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.7 p -162.84 163.45 26.51 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 117.289 0.545 . . . . 0.0 111.38 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 p -89.76 113.09 24.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.156 0.503 . . . . 0.0 110.182 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.46 HD23 ' CE1' ' A' ' 60' ' ' TYR . 96.2 mt -67.19 -39.14 86.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.559 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 74' ' ' GLN . 0.8 OUTLIER -151.57 144.91 24.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.606 -177.391 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.469 ' N ' HD23 ' A' ' 73' ' ' LEU . 52.4 tt0 -103.38 125.91 50.25 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.4 mt -132.63 128.77 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.222 0.535 . . . . 0.0 111.333 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -100.65 136.08 41.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.838 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.431 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.442 ' SD ' ' OE1' ' A' ' 74' ' ' GLN . 14.3 ptp . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -101.71 134.69 44.48 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 40.5 mp0 -111.51 116.87 31.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.747 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -76.93 100.56 5.62 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -105.83 155.75 19.0 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.108 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.9 mt -93.33 108.25 31.98 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 N--CA 1.497 1.686 0 C-N-CA 121.847 1.698 . . . . 0.0 112.169 -179.674 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.765 0.317 . . . . 0.0 111.126 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.63 123.63 7.74 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -126.14 140.05 52.88 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 117.334 0.567 . . . . 0.0 110.158 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.54 121.8 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.29 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 20' ' ' ARG . 12.1 p -92.96 -42.74 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.762 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.482 ' N ' HG13 ' A' ' 19' ' ' VAL . 72.3 ttt180 -155.89 133.84 11.28 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -102.01 134.41 45.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 24.0 p-10 -106.21 -0.52 24.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.662 0.268 . . . . 0.0 111.149 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.63 160.37 37.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -139.6 155.78 47.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -50.87 135.72 23.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.079 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.17 4.61 66.49 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.858 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 36.7 p-10 -114.46 154.06 28.84 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.628 0.714 . . . . 0.0 110.908 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.9 mtm -114.12 148.73 36.71 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.01 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -139.43 150.4 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.92 0.391 . . . . 0.0 110.706 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -90.06 159.35 16.88 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.54 136.62 58.08 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.986 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 60.0 36.43 21.5 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.821 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -145.4 86.32 1.75 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 17.3 t0 -176.27 161.06 2.24 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.531 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 76.6 mt -134.55 88.63 2.46 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.107 0.479 . . . . 0.0 109.882 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.38 130.09 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -111.92 124.63 52.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.582 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.5 m -121.91 131.21 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.1 ttm -101.93 123.31 45.62 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.692 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -88.1 -90.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.418 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 42' ' ' LYS . 23.0 p-10 -96.03 -68.98 0.77 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.726 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.502 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 25.0 pttm -149.2 43.17 0.95 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.73 0.3 . . . . 0.0 110.977 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.19 151.21 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.909 0.385 . . . . 0.0 110.598 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 m -99.63 117.78 34.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.069 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.9 m -118.0 134.02 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.239 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.43 134.18 41.03 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.928 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.0 mt -137.23 85.41 21.98 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.732 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -55.74 141.43 84.51 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.705 2.27 . . . . 0.0 112.333 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.9 t -36.23 100.27 0.19 Allowed Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.589 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.92 -21.92 36.82 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.073 1.182 . . . . 0.0 113.843 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.19 120.96 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 122.104 -0.372 . . . . 0.0 111.212 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.48 152.94 33.95 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 121.167 -0.213 . . . . 0.0 110.547 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.2 -134.29 3.04 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.31 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -136.93 134.03 36.32 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.741 0.305 . . . . 0.0 110.234 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.0 mm -90.77 118.44 36.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.95 -51.47 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -146.17 156.74 43.63 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.885 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.529 ' O ' HG23 ' A' ' 58' ' ' ILE . 5.6 tt -121.79 122.77 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.362 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.15 -18.88 16.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.639 0.257 . . . . 0.0 110.933 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -105.98 141.08 37.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.17 0.509 . . . . 0.0 111.406 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.05 162.89 25.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.313 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.03 140.78 42.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.545 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.55 6.09 81.03 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.388 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -99.43 134.81 41.77 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.347 0.594 . . . . 0.0 111.854 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -126.38 129.2 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.566 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 t -147.79 138.03 12.65 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.38 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.15 140.95 70.73 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.43 1.42 . . . . 0.0 112.426 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 m -53.23 144.65 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.703 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.48 50.28 0.42 Allowed Glycine 0 N--CA 1.471 1.014 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.5 p -156.64 162.59 39.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 117.012 0.406 . . . . 0.0 111.024 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 m -82.33 100.61 10.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.005 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.19 -42.43 93.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.8 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.896 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.3 tt -158.27 148.32 19.98 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.896 ' N ' HD23 ' A' ' 73' ' ' LEU . 6.7 tt0 -103.05 128.24 49.99 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 86.8 mt -126.05 127.21 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.072 0.463 . . . . 0.0 111.262 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -98.56 111.98 24.17 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.212 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.182 179.771 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.39 141.01 40.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 33.8 mp0 -111.14 120.39 42.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.435 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -88.65 105.1 17.45 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -111.85 173.08 6.53 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.137 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.5 tt -106.42 82.97 1.06 Allowed Pre-proline 0 N--CA 1.471 0.594 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.493 1.495 0 C-N-CA 121.473 1.449 . . . . 0.0 111.854 -179.948 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 120.829 0.347 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.59 110.74 3.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -125.14 134.01 52.6 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 mm -102.6 119.05 50.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.659 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 20' ' ' ARG . 8.8 p -90.1 -43.58 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.405 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.501 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.7 mtt180 -140.9 144.58 35.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.878 0.37 . . . . 0.0 111.405 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -109.36 136.89 48.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 18.7 p-10 -93.76 -11.66 30.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.731 0.301 . . . . 0.0 110.522 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.78 159.89 7.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.263 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 73.8 mmtt -129.52 144.73 51.39 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -46.51 138.3 5.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.914 0.388 . . . . 0.0 111.339 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.18 7.55 58.31 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.445 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 24' ' ' LYS . 50.0 p-10 -129.07 151.26 49.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.603 0.702 . . . . 0.0 111.212 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.3 mtt -103.08 150.32 23.72 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.496 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.462 ' CG2' ' OE1' ' A' ' 33' ' ' GLN . 3.5 p -138.34 154.26 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.343 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -102.82 160.84 14.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.801 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 86.4 tttt -65.65 137.17 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.055 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 8.9 m-20 92.63 81.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.676 0.61 . . . . 0.0 111.575 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.462 ' OE1' ' CG2' ' A' ' 29' ' ' VAL . 57.2 tt0 -153.56 98.73 2.26 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.887 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -96.49 77.12 2.93 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 35' ' ' LEU . 87.0 mt -141.25 25.84 2.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.926 0.393 . . . . 0.0 110.295 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.23 131.61 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.9 131.04 53.51 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.232 0.539 . . . . 0.0 111.557 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.2 124.28 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.176 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.3 ttp -110.78 157.39 19.84 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.911 0.386 . . . . 0.0 110.83 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.3 t -136.31 -118.08 0.16 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.034 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.521 ' N ' ' OG1' ' A' ' 40' ' ' THR . 87.5 m-20 -64.02 -49.41 72.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.793 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -175.46 56.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.503 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.52 150.22 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.977 0.417 . . . . 0.0 110.894 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -109.77 120.09 41.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.853 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.37 118.47 58.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.951 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -88.28 133.94 33.93 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mt -145.69 117.63 5.1 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.318 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.34 142.94 19.25 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.947 1.765 . . . . 0.0 111.586 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 m -46.57 106.64 0.6 Allowed Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.86 -25.72 45.16 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.338 1.359 . . . . 0.0 114.539 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.5 123.35 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 118.066 0.394 . . . . 0.0 111.607 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 52.8 ptt85 -85.53 149.89 25.06 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.65 -134.56 2.59 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.179 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -126.29 131.22 51.92 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.003 0.402 . . . . 0.0 110.828 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 mm -93.9 119.08 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.8 t -93.08 -49.39 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.463 ' O ' ' CD2' ' A' ' 73' ' ' LEU . 60.6 pttt -148.86 150.28 32.73 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 58' ' ' ILE . 10.5 tt -127.64 128.86 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.187 0.518 . . . . 0.0 110.968 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.5 mt -98.31 -17.36 18.94 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.141 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.54 ' CE1' HD23 ' A' ' 72' ' ' LEU . 30.1 m-85 -94.5 142.72 27.11 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.311 0.577 . . . . 0.0 111.404 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -125.82 159.83 31.42 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.491 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.86 128.99 39.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.526 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.06 3.54 88.98 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.638 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -77.28 132.33 38.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.179 0.514 . . . . 0.0 111.079 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.94 128.54 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.764 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.34 135.84 10.79 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 119.499 -0.286 . . . . 0.0 110.579 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.63 146.7 42.56 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.388 1.392 . . . . 0.0 112.305 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 p -58.68 126.97 17.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.682 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.32 51.65 0.08 OUTLIER Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.3 m -153.83 159.73 41.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.131 0.465 . . . . 0.0 110.749 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.8 m -84.63 112.4 20.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.033 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.54 HD23 ' CE1' ' A' ' 60' ' ' TYR . 85.4 mt -66.95 -43.84 82.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.991 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.7 OUTLIER -159.69 149.81 18.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.175 -177.534 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.475 ' H ' HD23 ' A' ' 73' ' ' LEU . 12.7 mm-40 -103.5 118.45 36.78 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.3 mt -118.18 128.68 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.486 0.66 . . . . 0.0 111.572 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -95.19 115.48 27.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.335 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.777 -179.715 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -84.13 131.56 34.77 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 51.9 mp0 -102.73 113.28 26.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.184 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -79.85 101.14 8.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.726 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.433 ' NZ ' ' OG1' ' A' ' 71' ' ' THR . 68.5 mttm -112.4 145.8 39.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.2 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -63.04 111.9 5.81 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo . . . . . 0 N--CA 1.498 1.77 0 C-N-CA 121.061 1.174 . . . . 0.0 112.013 179.462 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.79 139.46 14.5 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -152.48 116.05 4.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.1 118.27 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.897 0.379 . . . . 0.0 111.668 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 20' ' ' ARG . 12.0 p -92.65 -40.02 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.398 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.464 ' N ' HG13 ' A' ' 19' ' ' VAL . 62.8 ttm-85 -144.73 137.37 26.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -110.63 146.55 35.96 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 56.7 t0 -130.69 26.84 5.0 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.948 0.34 . . . . 0.0 111.304 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.89 155.01 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.848 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -141.98 147.47 37.01 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.02 0.438 . . . . 0.0 111.158 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.18 140.48 38.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.938 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.3 88.08 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.233 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -108.38 125.75 52.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.116 0.458 . . . . 0.0 111.356 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.9 mtm -85.61 129.42 34.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.108 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.77 135.46 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.313 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -90.99 156.3 18.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.961 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 88.5 tttt -61.24 130.32 45.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 16.2 t0 94.87 69.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.057 0.848 . . . . 0.0 110.802 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 34' ' ' ASP . 52.2 tt0 -176.93 -118.58 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 33' ' ' GLN . 67.1 t0 29.49 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.8 tp -84.51 94.72 8.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.19 134.01 62.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.883 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.42 113.18 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.315 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.7 132.56 59.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.2 ttp -118.87 124.39 47.02 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.54 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -90.25 -86.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.54 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 18.4 p-10 -86.07 -59.18 2.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.625 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 7.5 tmtt? -172.83 57.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 p -153.39 151.3 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.353 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -94.3 116.11 28.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.155 0.503 . . . . 0.0 109.987 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.66 117.33 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.876 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.569 ' CD ' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -98.35 132.96 43.39 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.046 0.45 . . . . 0.0 111.316 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mt -138.63 85.29 17.43 Favored Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.588 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -87.35 53.82 2.66 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.516 2.144 . . . . 0.0 113.511 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.482 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 59.6 p -170.51 47.52 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.038 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 49' ' ' SER . 71.5 Cg_endo -73.26 25.12 0.31 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.36 2.04 . . . . 0.0 111.457 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.456 ' H ' ' C ' ' A' ' 49' ' ' SER . 4.5 t 66.79 67.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.229 0.537 . . . . 0.0 109.799 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -76.79 150.2 36.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.44 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.94 -92.99 0.09 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -122.36 133.78 54.64 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mm -104.69 120.31 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.3 t -87.55 -51.19 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -155.65 159.98 40.03 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.278 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.529 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.7 tt -98.04 116.04 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.873 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -99.16 -16.81 18.45 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.679 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -119.79 143.83 47.64 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 83.4 mtp180 -120.88 166.98 13.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.656 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.36 143.99 57.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.005 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 5.98 89.49 Favored Glycine 0 N--CA 1.466 0.693 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.168 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.584 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 77.2 mt-30 -82.34 126.88 32.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.268 0.556 . . . . 0.0 111.275 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.0 124.16 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.11 155.14 37.35 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.299 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.04 151.85 62.15 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.721 2.281 . . . . 0.0 111.685 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -59.83 129.52 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.259 0.552 . . . . 0.0 110.999 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.82 55.01 0.12 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.825 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.6 m -154.68 166.2 34.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.978 0.418 . . . . 0.0 111.272 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.433 ' OG1' ' NZ ' ' A' ' 5' ' ' LYS . 19.3 m -94.59 114.17 26.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.285 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.07 -46.9 61.04 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.513 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.65 HD12 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -160.99 158.01 27.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.715 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.65 ' H ' HD12 ' A' ' 73' ' ' LEU . 58.7 tt0 -103.35 128.03 50.55 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.07 -0.394 . . . . 0.0 111.079 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.2 mt -127.12 128.71 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.215 0.531 . . . . 0.0 112.302 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -100.24 115.74 30.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.38 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.275 179.549 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.452 ' H2 ' ' CB ' ' A' ' 77' ' ' THR . 63.4 ttp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' ILE . 2.1 t80 -122.73 149.85 43.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.737 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -132.23 134.59 45.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.322 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -96.36 113.32 24.89 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -115.65 153.91 30.45 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.914 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.438 ' C ' HD23 ' A' ' 6' ' ' LEU . 1.5 tt -102.81 92.67 3.68 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.85 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.494 1.55 0 C-N-CA 121.531 1.487 . . . . 0.0 111.98 -179.835 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.46 145.82 18.22 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -145.32 138.11 26.14 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.509 0.654 . . . . 0.0 110.995 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -100.63 122.11 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.509 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.1 p -90.22 -44.76 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.234 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' N ' HG13 ' A' ' 19' ' ' VAL . 89.4 mtm180 -143.89 148.44 35.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -118.84 143.57 46.88 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 34' ' ' ASP . 1.1 m-20 -128.42 18.38 6.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.222 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.49 159.31 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.44 142.24 51.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.827 0.346 . . . . 0.0 110.414 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.2 137.27 58.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.083 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.67 7.23 71.9 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 28' ' ' MET . 58.0 t0 -114.55 142.34 46.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.045 0.45 . . . . 0.0 111.084 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.543 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 94.9 mtp -79.94 152.33 29.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.432 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 30' ' ' GLU . 21.4 t -126.89 160.82 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.363 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 29' ' ' VAL . 80.1 mm-40 -123.53 152.0 42.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.896 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -57.9 90.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.2 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 63.7 t0 -178.95 134.01 0.13 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.078 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 4.2 pp0? -45.06 124.91 4.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.663 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' ASP . 89.7 m-20 -95.07 9.44 39.51 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 32.8 tp 63.1 73.85 0.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.235 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 m -117.32 134.57 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -119.12 137.81 53.34 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.603 0.716 . . . . 0.0 110.999 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 p -131.89 128.94 60.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.309 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.1 ttp -101.41 109.34 21.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.812 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 40' ' ' THR . 0.5 OUTLIER -62.0 -48.9 78.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.209 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 23.8 p-10 -152.4 -45.92 0.1 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.33 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -165.22 52.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.956 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 44' ' ' THR . 13.6 p -160.89 155.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 110.367 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 43' ' ' VAL . 5.9 m -95.22 117.85 30.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.161 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.22 118.26 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.135 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -98.54 133.59 42.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.797 0.332 . . . . 0.0 110.365 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.1 mt -135.95 137.37 25.01 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 49' ' ' SER . 38.3 Cg_exo -54.59 147.48 48.52 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.325 1.35 . . . . 0.0 111.408 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -40.48 166.61 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 120.746 0.308 . . . . 0.0 111.133 -179.549 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.99 47.92 2.69 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.752 2.301 . . . . 0.0 113.42 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t 64.39 119.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.943 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -49.76 150.51 2.09 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.912 0.387 . . . . 0.0 111.76 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.65 -143.55 8.95 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -113.16 132.7 55.37 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 122.569 -0.371 . . . . 0.0 110.64 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mm -95.33 115.6 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.4 t -70.57 -50.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -173.84 155.03 2.52 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.667 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.7 tt -89.31 110.83 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.407 0.622 . . . . 0.0 110.633 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 71' ' ' THR . 36.2 tp -81.6 -27.51 34.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.237 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.49 ' CG ' HD13 ' A' ' 72' ' ' LEU . 5.0 m-85 -110.37 145.86 36.81 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.27 0.557 . . . . 0.0 112.002 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -115.24 169.21 9.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.353 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.63 133.29 53.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.591 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.11 6.26 88.99 Favored Glycine 0 N--CA 1.466 0.672 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.994 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -80.62 133.26 35.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.849 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 p -124.76 127.96 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.927 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 t -148.54 137.33 11.86 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.316 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.2 137.27 46.17 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.155 1.237 . . . . 0.0 111.66 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.5 m -52.37 144.1 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.774 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.29 50.74 0.28 Allowed Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.0 p -161.4 164.05 30.18 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.482 ' O ' HD23 ' A' ' 59' ' ' LEU . 5.7 p -91.29 108.28 19.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.122 0.487 . . . . 0.0 110.544 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.7 mm? -63.85 -38.81 92.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.522 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 74' ' ' GLN . 4.0 tp -155.04 143.96 20.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.645 ' N ' HD12 ' A' ' 73' ' ' LEU . 53.3 tt0 -104.5 131.92 51.34 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.87 0.366 . . . . 0.0 111.173 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' ' 2' ' ' TYR . 92.8 mt -128.12 127.78 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -93.65 134.8 35.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.032 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.452 ' CB ' ' H2 ' ' A' ' 1' ' ' MET . 20.2 m . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.363 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.566 ' N ' ' H ' ' A' ' 77' ' ' THR . 5.0 ptt? . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -79.6 147.12 32.2 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.95 125.47 50.49 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -95.05 112.33 24.04 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -119.11 148.88 42.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.927 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.33 159.08 86.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.5 1.895 0 C-N-CA 121.573 1.516 . . . . 0.0 113.467 -179.316 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.459 ' OE2' ' CG2' ' A' ' 65' ' ' VAL . 43.6 tt0 . . . . . 0 C--O 1.232 0.159 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.17 114.08 3.1 Favored Glycine 0 N--CA 1.468 0.795 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -130.28 127.46 39.57 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -102.02 121.32 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.738 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.2 p -94.07 -42.3 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.293 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.464 ' N ' HG13 ' A' ' 19' ' ' VAL . 82.6 mtp180 -142.31 140.72 32.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.747 0.308 . . . . 0.0 110.613 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.566 ' O ' ' N ' ' A' ' 23' ' ' VAL . 14.5 m95 -101.81 -18.28 15.83 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.289 0.566 . . . . 0.0 109.71 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 35' ' ' LEU . 19.5 m-20 43.51 3.32 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.671 -1.15 . . . . 0.0 113.89 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 21' ' ' TRP . 3.7 m -140.18 156.54 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -126.26 136.6 52.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -45.99 142.09 2.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.039 0.447 . . . . 0.0 111.091 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.17 69.47 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.048 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 51.4 p-10 -107.74 149.67 27.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.0 0.4 . . . . 0.0 110.732 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.6 mtt -83.85 144.15 29.44 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.553 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.1 t -121.07 132.8 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -109.92 154.29 23.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.036 0.446 . . . . 0.0 111.202 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -69.13 138.97 54.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.633 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t0 70.01 23.53 5.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.303 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -149.62 86.35 1.46 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.411 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -173.64 141.87 0.89 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.131 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 76.5 mt -137.16 92.2 2.69 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.17 131.8 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.511 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 58.6 mp0 -106.78 124.89 50.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.179 0.514 . . . . 0.0 111.224 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.15 132.06 70.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.768 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.6 ttp -116.46 117.53 30.16 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.207 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 40' ' ' THR . 1.7 p -64.83 -49.72 69.5 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.048 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -151.72 -64.7 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.686 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -138.23 36.87 2.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.122 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.34 133.76 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.635 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.6 m -102.36 118.22 36.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.77 162.21 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.784 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -134.77 134.95 41.47 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.926 0.393 . . . . 0.0 110.792 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.8 mt -123.78 85.62 53.49 Favored Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.448 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 49' ' ' SER . 92.0 Cg_endo -80.35 147.19 17.95 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.674 2.25 . . . . 0.0 112.482 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 48' ' ' PRO . 1.2 t 89.72 61.19 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.02 28.83 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.732 2.288 . . . . 0.0 111.343 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t 72.25 111.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.151 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -59.73 146.52 41.15 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.785 0.326 . . . . 0.0 111.775 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.04 -141.3 6.24 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -125.17 136.8 53.95 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.1 mm -91.85 118.58 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -79.0 -50.74 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -171.07 158.76 5.72 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.92 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.6 tt -108.96 123.61 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.869 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.0 mt -97.78 -17.92 19.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.919 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.494 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 6.3 m-85 -108.9 144.24 37.06 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.886 0.374 . . . . 0.0 110.696 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -117.0 160.84 20.33 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.281 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 -57.24 140.58 49.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.698 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.32 4.97 90.35 Favored Glycine 0 N--CA 1.468 0.78 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.965 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -84.71 134.91 34.33 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.516 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' CG2' ' OE2' ' A' ' 15' ' ' GLU . 4.4 p -125.92 129.01 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.774 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.1 t -148.94 139.83 13.79 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.02 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.64 145.55 81.05 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.12 1.213 . . . . 0.0 111.378 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -55.33 125.94 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.088 0.471 . . . . 0.0 111.379 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.42 49.06 0.04 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.231 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.9 p -160.68 162.38 32.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.972 0.386 . . . . 0.0 111.091 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -94.55 107.8 19.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.199 0.523 . . . . 0.0 109.993 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 72' ' ' LEU . 2.8 mm? -67.18 -39.28 86.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.813 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.815 HD23 ' N ' ' A' ' 74' ' ' GLN . 1.7 tt -153.19 145.72 24.15 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.332 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.815 ' N ' HD23 ' A' ' 73' ' ' LEU . 66.3 mt-30 -104.15 130.31 51.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 83.3 mt -127.73 126.62 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.279 0.561 . . . . 0.0 111.738 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -86.65 143.11 27.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.727 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.566 ' H ' ' N ' ' A' ' 1' ' ' MET . 8.9 t . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.127 -0.939 . . . . 0.0 110.017 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -88.53 129.56 35.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 52.9 mp0 -112.28 125.43 54.15 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -92.12 123.46 35.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.237 0.541 . . . . 0.0 110.745 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -122.14 145.79 47.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.286 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.78 115.63 20.28 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.807 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.494 1.53 0 C-N-CA 121.881 1.721 . . . . 0.0 112.3 -179.124 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.79 109.87 0.44 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -123.4 142.64 50.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.017 0.436 . . . . 0.0 110.164 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 mt -102.0 121.85 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.545 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.8 p -101.29 -48.16 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.571 ' N ' HG13 ' A' ' 19' ' ' VAL . 61.3 ttt85 -146.9 136.64 23.1 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -109.76 137.62 47.29 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.61 177.44 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 8.0 p-10 -101.86 -5.04 25.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.018 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.25 160.18 32.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.371 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 43.8 mmtm -129.22 153.29 47.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.842 0.353 . . . . 0.0 110.683 -179.271 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' OE1' HG22 ' A' ' 58' ' ' ILE . 16.5 pt-20 -53.09 142.44 20.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.37 6.69 66.05 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.859 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 53.0 p30 -123.41 151.98 42.05 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.901 0.85 . . . . 0.0 111.466 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -86.09 154.56 21.3 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.862 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.1 p -138.11 147.08 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.806 0.336 . . . . 0.0 110.203 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -107.33 155.47 19.95 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.492 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -62.3 138.07 58.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.273 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 t0 66.79 20.13 10.65 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.19 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -137.0 81.54 1.88 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 35.3 t70 -173.6 104.46 0.12 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.437 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.552 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 51.0 tp -84.06 99.38 10.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.688 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.63 130.01 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.42 ' OE2' HG23 ' A' ' 44' ' ' THR . 77.0 tt0 -115.74 123.76 49.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.842 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.82 137.03 59.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.955 0.407 . . . . 0.0 110.397 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.4 ptm -115.22 142.01 47.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.141 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -103.19 -64.35 1.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.817 0.341 . . . . 0.0 110.468 -179.595 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.529 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.4 t70 -128.39 56.08 1.65 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.4 tttp 73.71 47.46 0.17 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 44' ' ' THR . 16.9 t -133.69 159.57 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.946 -179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.435 ' N ' HG12 ' A' ' 43' ' ' VAL . 28.1 m -121.75 113.83 20.24 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.915 0.388 . . . . 0.0 110.404 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -132.84 130.63 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.972 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.477 ' HZ2' HD12 ' A' ' 35' ' ' LEU . 52.5 tttp -92.2 136.29 33.3 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.98 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -136.25 96.36 12.63 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.098 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.77 146.6 76.89 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.343 2.029 . . . . 0.0 111.505 178.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.5 m -85.36 112.87 47.2 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.442 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.48 24.94 0.72 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.191 1.928 . . . . 0.0 111.052 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.55 155.96 37.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.68 -177.357 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -145.91 146.95 31.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.297 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.59 -132.38 2.56 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -129.37 148.41 51.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.694 0.283 . . . . 0.0 110.309 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mm -99.56 120.37 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.7 t -78.55 -50.93 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.012 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -172.84 154.25 2.87 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.312 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.7 tt -101.72 114.92 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.194 0.521 . . . . 0.0 110.331 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.27 -41.61 89.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.771 -179.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.461 ' CG ' ' NE2' ' A' ' 64' ' ' GLN . 5.5 m-85 -139.72 150.21 44.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.279 -178.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -109.93 -166.53 1.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.678 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -53.62 150.96 6.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.734 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.47 6.3 57.54 Favored Glycine 0 N--CA 1.474 1.231 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.461 ' NE2' ' CG ' ' A' ' 60' ' ' TYR . 49.7 tt0 -98.81 135.23 40.57 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.466 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 p -142.91 116.83 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -148.53 142.62 16.46 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.03 146.21 70.65 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.456 1.438 . . . . 0.0 112.162 177.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 68' ' ' VAL . 12.9 p -48.79 131.27 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.587 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.29 51.2 0.06 OUTLIER Glycine 0 CA--C 1.527 0.785 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.809 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.8 t -165.18 157.56 15.68 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.779 179.148 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.7 p -89.92 131.01 36.05 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.117 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.45 -15.63 24.09 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.543 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.815 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.8 OUTLIER -171.32 145.73 2.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.014 -0.674 . . . . 0.0 110.746 -179.218 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.815 ' H ' HD23 ' A' ' 73' ' ' LEU . 56.7 mt-30 -104.7 127.59 52.52 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.1 mt -129.25 126.95 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.311 0.577 . . . . 0.0 111.784 -177.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -88.0 135.98 33.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.825 178.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.6 m . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.541 -179.986 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttp . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -76.83 143.29 39.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.62 136.65 54.3 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.795 0.331 . . . . 0.0 110.181 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.568 ' CE2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -104.14 118.46 36.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.721 179.753 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -118.52 134.85 54.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.42 -179.046 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.95 126.1 91.92 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.491 1.335 0 C-N-CA 121.198 1.265 . . . . 0.0 112.192 -179.484 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.532 0.206 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.46 151.08 17.49 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.476 ' OE1' HG22 ' A' ' 65' ' ' VAL . 40.5 tp10 -153.39 128.29 9.56 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.265 0.533 . . . . 0.0 110.984 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 mm -102.22 119.75 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.36 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.5 m -93.55 -40.06 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.729 178.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.8 149.06 43.06 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.013 0.435 . . . . 0.0 111.836 -178.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -116.1 145.36 43.09 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.769 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 51.7 t0 -109.33 -6.6 15.44 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.461 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.25 159.54 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.87 0.367 . . . . 0.0 111.574 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -136.38 155.74 49.61 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.582 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -66.07 141.91 57.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.514 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.3 7.72 86.26 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.556 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -118.18 143.46 46.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.31 0.555 . . . . 0.0 111.621 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.7 mtm -87.87 147.13 25.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.563 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.09 151.4 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.032 0.444 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 32' ' ' ASP . 93.9 mt-10 -112.05 154.9 24.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.442 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.05 80.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.562 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' GLU . 68.0 t0 -179.44 94.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.17 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.408 ' HB2' ' H ' ' A' ' 49' ' ' SER . 37.4 mt-30 -142.27 151.89 42.49 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.155 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 63.8 t0 -165.74 24.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.976 0.417 . . . . 0.0 110.206 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.7 mt -121.99 27.84 7.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.689 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.42 129.24 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.07 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.453 ' OE2' ' N ' ' A' ' 45' ' ' VAL . 3.8 tm-20 -127.13 128.33 46.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.611 -179.398 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.36 141.52 43.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.046 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.9 ttp -126.16 136.59 53.04 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 -72.55 0.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.833 0.349 . . . . 0.0 110.421 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -97.56 41.12 1.13 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.525 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 tttp 71.22 37.76 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.402 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.5 t -127.17 134.68 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.5 m -96.64 116.66 29.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.142 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.453 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 34.3 m -133.27 132.64 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.052 0.453 . . . . 0.0 111.642 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -94.04 139.22 31.23 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.948 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mt -138.89 121.6 10.6 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 119.605 -0.235 . . . . 0.0 110.645 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.28 143.17 19.59 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.33 2.02 . . . . 0.0 112.081 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.408 ' H ' ' HB2' ' A' ' 33' ' ' GLN . 82.1 p -69.7 114.13 22.38 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.394 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.71 8.43 4.63 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.947 1.765 . . . . 0.0 113.553 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -140.3 157.32 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.157 0.503 . . . . 0.0 111.841 -177.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -143.32 149.79 38.28 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.734 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.87 -134.94 2.91 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -118.37 131.34 56.31 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 117.224 0.512 . . . . 0.0 109.986 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mm -94.57 118.71 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.2 t -97.03 -48.91 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -143.36 157.17 44.69 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -177.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.575 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.0 tt -125.32 122.01 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.573 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.8 mt -98.86 -17.42 18.43 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.62 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.524 ' CE1' HD23 ' A' ' 72' ' ' LEU . 9.5 m-85 -104.13 138.65 40.33 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.165 0.507 . . . . 0.0 111.288 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -122.05 166.29 14.73 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.077 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.87 130.48 44.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.979 0.418 . . . . 0.0 111.214 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.22 5.58 89.62 Favored Glycine 0 N--CA 1.467 0.755 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.882 179.129 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -79.22 140.49 37.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.979 0.419 . . . . 0.0 110.898 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.476 HG22 ' OE1' ' A' ' 17' ' ' GLU . 77.4 t -117.92 130.62 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.752 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.5 t -148.96 138.15 12.39 Favored Pre-proline 0 N--CA 1.474 0.769 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.332 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -54.13 139.6 71.51 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.394 1.396 . . . . 0.0 112.069 177.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.9 t -65.14 131.84 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.45 51.05 0.13 Allowed Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.7 p -159.82 162.79 34.81 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 122.508 -0.407 . . . . 0.0 111.31 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 71' ' ' THR . 4.9 t -84.53 114.25 21.82 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.482 0.658 . . . . 0.0 109.953 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.568 HD12 ' CE2' ' A' ' 4' ' ' PHE . 94.9 mt -65.83 -42.16 90.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.487 -178.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.5 tt -143.77 146.85 33.42 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -177.004 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.471 ' N ' HD23 ' A' ' 73' ' ' LEU . 57.5 tt0 -101.74 123.51 45.84 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.803 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.26 129.53 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.495 -177.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -100.33 111.16 23.41 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.62 179.06 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.222 -0.358 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.021 -179.721 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OE2' ' A' ' 3' ' ' GLU . 68.4 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -77.43 133.9 38.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.917 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.545 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 54.4 mp0 -109.83 128.64 55.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.206 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -92.64 117.32 29.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.432 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -119.7 147.16 44.91 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.014 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mt -67.9 113.7 16.19 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.497 1.694 0 C-N-CA 120.985 1.124 . . . . 0.0 112.14 179.149 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 CA--C 1.523 -0.078 0 CA-C-O 120.633 0.254 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.77 153.19 21.27 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -138.28 142.87 39.81 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.421 HG21 ' NE1' ' A' ' 21' ' ' TRP . 5.9 mm -102.82 121.39 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.876 0.369 . . . . 0.0 111.992 -178.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 20' ' ' ARG . 31.4 m -94.27 -40.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.492 179.128 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.423 ' N ' HG23 ' A' ' 19' ' ' VAL . 95.9 mtt-85 -139.6 146.79 40.24 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.482 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.421 ' NE1' HG21 ' A' ' 18' ' ' ILE . 19.0 m95 -119.45 140.79 49.87 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.618 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 9.1 p-10 -114.87 5.52 15.16 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -135.24 156.72 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.513 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -142.52 149.09 38.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.406 0.622 . . . . 0.0 111.516 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -56.62 140.11 47.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.489 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.93 9.14 78.07 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 116.328 -0.396 . . . . 0.0 112.695 178.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 28' ' ' MET . 67.3 t0 -121.86 135.85 54.91 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.184 0.492 . . . . 0.0 111.705 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.531 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 62.9 ttp -94.2 127.54 40.11 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.456 179.027 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 p -129.82 136.88 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.203 0.525 . . . . 0.0 111.956 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 56.5 mp0 -83.86 157.19 22.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.584 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 37.0 ttpt -81.45 130.54 35.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.72 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 52.7 t0 130.5 122.02 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.433 1.083 . . . . 0.0 110.19 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.447 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 60.8 tp60 58.29 103.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.458 178.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 33' ' ' GLN . 97.3 m-20 -143.08 141.18 31.2 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.41 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.1 tp -101.73 79.44 1.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.198 0.523 . . . . 0.0 111.441 -178.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.61 126.06 74.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.752 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -118.34 118.58 32.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.741 -179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 m -125.57 132.79 70.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.927 0.394 . . . . 0.0 110.26 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.9 ttp -96.35 123.69 40.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.258 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.1 p -89.53 -64.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.729 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 40' ' ' THR . 68.3 t0 -137.57 60.14 1.65 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.246 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 35.5 tttp 74.69 21.89 2.09 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.51 139.59 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 m -94.69 115.74 27.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.794 0.33 . . . . 0.0 110.269 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 m -125.69 131.04 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.898 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -99.67 135.02 41.71 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -131.76 85.27 52.03 Favored Pre-proline 0 N--CA 1.471 0.6 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.844 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.459 ' O ' ' OG ' ' A' ' 49' ' ' SER . 91.2 Cg_endo -80.44 151.22 19.89 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.571 2.181 . . . . 0.0 113.201 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 48' ' ' PRO . 6.0 p 80.74 67.6 0.14 Allowed Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.08 37.85 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.857 2.372 . . . . 0.0 112.755 178.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 t 63.25 114.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.725 0.298 . . . . 0.0 111.24 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB3' ' N ' ' A' ' 31' ' ' LYS . 32.2 ptt180 -77.37 152.77 34.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.475 179.643 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.72 -140.36 6.04 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -112.17 129.76 56.14 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.37 0.585 . . . . 0.0 110.465 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.422 HG23 HD21 ' A' ' 73' ' ' LEU . 5.8 mm -93.9 119.89 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.1 t -93.31 -52.74 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -151.87 158.65 43.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.902 -177.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.7 tt -112.25 121.76 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.027 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.6 mt -99.3 -17.15 18.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.19 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.421 ' CZ ' HD23 ' A' ' 72' ' ' LEU . 11.1 m-85 -109.25 143.35 38.83 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.062 0.458 . . . . 0.0 111.004 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -120.58 164.42 16.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.084 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.38 127.09 30.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.171 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.2 5.4 89.02 Favored Glycine 0 N--CA 1.468 0.785 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 178.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -76.7 136.53 39.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.648 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.74 132.92 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.698 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.78 140.68 14.56 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.777 -178.375 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.03 147.17 76.56 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.265 1.31 . . . . 0.0 110.596 176.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.02 126.67 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.246 0.546 . . . . 0.0 110.997 -179.352 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 146.0 48.56 0.03 OUTLIER Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.388 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 p -164.97 166.41 19.41 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.268 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 71' ' ' THR . 6.6 t -88.98 117.43 27.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.776 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.495 HD12 ' CE2' ' A' ' 4' ' ' PHE . 95.9 mt -63.46 -43.36 97.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.277 0.561 . . . . 0.0 110.428 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.8 tt -145.99 146.32 30.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.462 ' N ' HD23 ' A' ' 73' ' ' LEU . 37.4 tp60 -101.91 124.89 48.31 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.2 mt -127.2 127.3 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.223 -178.285 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -87.52 142.54 27.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.46 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.216 -179.886 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 75' ' ' ILE . 24.1 t80 -74.72 131.88 41.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 43.1 mp0 -95.95 125.9 40.82 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.697 -179.149 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -94.71 109.24 21.2 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.19 150.22 26.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.078 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.45 116.37 39.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.495 1.606 0 C-N-CA 121.774 1.649 . . . . 0.0 112.985 -178.402 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 . . . . . 0 C--O 1.232 0.156 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.85 111.43 4.23 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -118.38 125.01 49.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.069 0.461 . . . . 0.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.452 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.1 mm -102.41 120.35 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.232 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -107.92 -25.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -141.72 129.96 22.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.03 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.452 ' NE1' HG21 ' A' ' 18' ' ' ILE . 46.5 m95 -112.44 139.59 47.88 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.59 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 17.8 p-10 -111.49 2.09 17.27 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.54 HG11 ' NE2' ' A' ' 33' ' ' GLN . 33.3 m -135.5 161.23 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.81 0.338 . . . . 0.0 110.696 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.46 153.02 50.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.046 -178.558 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -52.74 140.76 22.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.376 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.71 8.33 76.89 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.374 177.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 41.7 p-10 -113.98 150.01 34.48 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.822 0.811 . . . . 0.0 110.691 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.6 mtm -97.63 149.63 22.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.284 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -145.16 140.12 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.906 0.384 . . . . 0.0 111.118 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 32' ' ' ASP . 95.7 mt-10 -87.03 163.93 16.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.869 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' N ' ' HB3' ' A' ' 52' ' ' ARG . 88.9 tttt -58.36 74.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.235 0.541 . . . . 0.0 110.435 -179.236 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 30' ' ' GLU . 11.5 p-10 170.07 78.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB2' ' H ' ' A' ' 49' ' ' SER . 18.1 tp60 -46.98 167.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.35 -179.538 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 99.0 m-20 -87.77 -34.48 18.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.529 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 0.9 OUTLIER 159.62 106.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.784 0.678 . . . . 0.0 110.734 179.511 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.62 131.73 69.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -117.98 123.3 45.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.989 0.424 . . . . 0.0 111.459 -178.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.74 128.49 71.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.503 ' SD ' ' N ' ' A' ' 41' ' ' ASP . 10.6 tmm? -133.48 127.82 34.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.564 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 40' ' ' THR . 0.3 OUTLIER -70.5 -46.23 64.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.773 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.503 ' N ' ' SD ' ' A' ' 39' ' ' MET . 24.5 p-10 -152.47 -54.73 0.12 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.551 -179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.423 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 59.8 pttt -145.74 42.07 1.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.148 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.473 ' H ' ' HG2' ' A' ' 39' ' ' MET . 46.5 t -137.83 137.91 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.168 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -103.33 119.24 38.51 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.89 119.02 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.756 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.53 112.9 24.79 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 mt -129.99 109.78 16.89 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.63 147.66 17.61 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.37 2.047 . . . . 0.0 111.744 179.11 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.555 ' H ' ' HB2' ' A' ' 33' ' ' GLN . 6.9 t -58.39 120.39 43.94 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.17 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.96 -3.05 13.35 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 122.088 1.859 . . . . 0.0 114.218 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.23 125.45 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.027 0.376 . . . . 0.0 110.927 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HB3' ' N ' ' A' ' 31' ' ' LYS . 40.2 ptt180 -97.04 153.54 17.86 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.634 0.254 . . . . 0.0 111.037 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.89 -129.71 1.75 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.612 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -126.76 133.59 50.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.708 0.289 . . . . 0.0 110.408 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 mm -86.74 123.59 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 t -82.94 -52.17 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.679 -178.79 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -164.25 158.88 19.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.801 -178.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 58' ' ' ILE . 3.2 tt -91.14 114.54 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.281 0.562 . . . . 0.0 110.481 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -90.94 -24.36 20.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -113.2 140.21 48.13 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.284 0.564 . . . . 0.0 111.154 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.565 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 86.8 mtm-85 -114.42 166.52 11.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.636 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -62.16 129.34 40.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.861 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.26 69.38 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.808 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.565 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 78.5 mt-30 -80.99 134.68 35.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.616 0.708 . . . . 0.0 111.174 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.95 124.07 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.465 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 t -147.29 138.61 13.27 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 -179.128 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -55.07 148.81 46.61 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.138 1.225 . . . . 0.0 111.809 179.082 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.8 p -59.27 129.68 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.169 0.509 . . . . 0.0 111.112 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.09 49.16 0.09 OUTLIER Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.068 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.9 p -159.84 163.78 34.15 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 117.299 0.549 . . . . 0.0 110.846 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 71' ' ' THR . 8.5 t -86.75 114.21 23.24 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.261 0.553 . . . . 0.0 110.391 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -65.55 -41.4 93.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.442 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -152.37 153.99 34.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.369 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.616 ' H ' HD12 ' A' ' 73' ' ' LEU . 50.7 tt0 -103.11 129.4 49.95 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.171 0.51 . . . . 0.0 110.992 -178.529 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 2' ' ' TYR . 89.7 mt -128.7 129.15 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.665 -178.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -96.24 114.44 26.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.699 178.802 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.665 179.904 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -95.71 142.74 27.64 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -118.55 135.6 54.32 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.951 0.405 . . . . 0.0 110.638 -179.382 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.449 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -88.7 116.31 26.87 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.096 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -116.87 132.01 56.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.888 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.94 115.69 42.86 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.729 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo . . . . . 0 N--CA 1.492 1.427 0 C-N-CA 121.314 1.343 . . . . 0.0 111.977 179.608 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.77 123.18 3.42 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -134.89 139.85 45.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.975 0.417 . . . . 0.0 110.174 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.43 119.02 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.554 -179.616 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.3 p -92.27 -41.98 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' N ' HG13 ' A' ' 19' ' ' VAL . 77.7 ttt180 -144.83 138.47 27.07 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.415 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -110.86 140.19 45.52 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 34' ' ' ASP . 4.4 p30 -108.02 -4.05 18.18 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.01 162.69 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.959 0.409 . . . . 0.0 111.383 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.2 151.91 35.9 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.842 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -61.06 138.37 58.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.883 0.373 . . . . 0.0 111.219 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.78 64.21 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.682 179.262 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 41.9 p-10 -117.73 152.22 35.69 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.399 0.6 . . . . 0.0 111.021 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -81.35 151.22 28.09 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.041 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -140.28 140.32 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.195 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -95.76 152.41 18.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.723 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HB2' ' H ' ' A' ' 52' ' ' ARG . 64.2 tttm -82.04 89.39 6.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.343 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 33' ' ' GLN . 62.6 t0 -176.3 78.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.188 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 32' ' ' ASP . 4.7 tp-100 37.08 93.02 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.047 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 31.8 t0 -90.17 15.33 10.49 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.0 mt 62.19 66.84 0.77 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.398 -179.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.57 130.25 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -110.15 123.38 49.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.332 0.587 . . . . 0.0 110.647 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 m -124.23 137.62 56.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.886 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 39' ' ' MET . 3.4 ppp? -121.92 147.44 46.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.148 0.499 . . . . 0.0 110.837 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -109.41 -59.41 1.91 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.415 -179.542 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.517 ' N ' ' OG1' ' A' ' 40' ' ' THR . 55.7 t0 -135.95 68.55 1.44 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.96 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 62.67 38.83 11.78 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.71 138.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.074 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.0 m -114.86 116.11 28.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.213 0.53 . . . . 0.0 110.758 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.71 157.81 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.431 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -100.72 136.16 41.03 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.925 179.207 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 47' ' ' ILE . 12.5 tt -127.26 135.11 26.93 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.446 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 49' ' ' SER . 33.9 Cg_exo -54.69 144.32 65.47 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 121.516 1.477 . . . . 0.0 112.226 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -41.32 164.46 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.649 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -81.45 47.12 2.44 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.772 2.315 . . . . 0.0 113.45 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 t 67.04 117.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.922 0.391 . . . . 0.0 111.417 179.551 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.473 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 73.7 ttt-85 -48.25 135.68 13.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.425 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.16 -145.45 8.11 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -118.51 133.91 55.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.033 0.417 . . . . 0.0 110.182 -179.078 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -95.05 121.38 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 t -81.63 -51.18 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -164.55 155.61 15.15 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.437 -178.69 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.7 tt -90.51 118.27 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.584 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -93.86 -18.24 22.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.716 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -119.08 140.58 49.84 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.089 0.471 . . . . 0.0 110.909 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -115.97 167.32 11.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.234 0.54 . . . . 0.0 111.523 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -62.57 132.65 53.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.902 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.01 3.38 90.59 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -80.63 134.49 35.9 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.308 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.76 131.47 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.761 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 t -146.62 139.09 13.97 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.526 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.68 149.04 25.97 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.387 1.391 . . . . 0.0 111.626 178.459 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 p -59.35 133.61 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.723 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.46 48.03 0.12 Allowed Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.1 p -162.63 165.08 26.26 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 117.43 0.615 . . . . 0.0 111.367 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 71' ' ' THR . 14.7 t -96.95 118.16 32.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.985 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.052 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -66.26 -36.13 82.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.919 -179.188 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.69 HD12 ' H ' ' A' ' 74' ' ' GLN . 2.1 tp -151.18 149.97 30.07 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.536 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.69 ' H ' HD12 ' A' ' 73' ' ' LEU . 0.7 OUTLIER -103.78 131.97 50.47 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 -179.706 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.5 mt -130.17 129.24 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.138 0.494 . . . . 0.0 111.958 -178.707 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -97.11 117.2 30.77 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.985 178.287 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.679 -179.527 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mmm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -74.39 130.38 39.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.131 -179.131 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 42.9 mp0 -102.51 125.19 49.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.174 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -86.4 116.26 24.44 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.28 147.27 49.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.791 -179.102 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 6' ' ' LEU . 4.8 tt -75.68 111.51 14.83 Favored Pre-proline 0 N--CA 1.471 0.604 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.001 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.438 ' N ' HD23 ' A' ' 6' ' ' LEU . 33.2 Cg_exo . . . . . 0 N--CA 1.496 1.665 0 CA-C-N 120.492 1.212 . . . . 0.0 112.388 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.55 133.38 8.88 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -140.03 133.07 29.48 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.973 0.416 . . . . 0.0 109.892 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.427 HG21 ' NE1' ' A' ' 21' ' ' TRP . 5.7 mm -102.81 119.62 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.879 -178.891 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 p -98.8 -37.37 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.03 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -141.01 133.43 28.36 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.372 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.427 ' NE1' HG21 ' A' ' 18' ' ' ILE . 33.5 m95 -110.55 144.85 38.79 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.08 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -128.65 19.91 6.13 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.094 0.407 . . . . 0.0 111.275 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.53 155.41 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -128.16 145.13 51.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.038 0.447 . . . . 0.0 110.512 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.79 137.86 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.054 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.56 7.75 71.53 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.133 179.452 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -116.73 147.82 41.67 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.121 0.461 . . . . 0.0 111.103 -179.784 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.4 mmm -84.37 147.71 27.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.4 133.98 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.252 179.019 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -91.61 158.31 16.49 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.193 -179.337 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.78 137.67 57.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.51 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 60.57 37.07 19.68 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.543 179.855 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -143.44 86.78 1.91 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.739 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -174.36 162.73 3.63 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -134.06 89.74 2.61 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.233 0.539 . . . . 0.0 109.825 178.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.54 130.94 70.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.175 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.9 119.89 37.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.891 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.1 m -117.33 133.17 64.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.068 0.461 . . . . 0.0 109.975 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.0 ttp -113.55 132.57 55.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -116.77 -88.71 0.59 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.658 -179.663 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.601 ' H ' HG23 ' A' ' 40' ' ' THR . 23.2 p-10 -90.06 50.72 1.91 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.214 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 62.22 43.79 8.22 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 44' ' ' THR . 35.3 t -131.7 158.25 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.735 178.839 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.48 ' N ' HG12 ' A' ' 43' ' ' VAL . 5.6 m -111.28 116.17 30.56 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.095 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.34 135.33 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.958 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -101.23 134.7 43.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.949 0.404 . . . . 0.0 110.808 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.8 mt -136.54 87.72 20.97 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.696 179.882 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.55 145.66 94.05 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 122.85 2.366 . . . . 0.0 112.543 179.638 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.9 m -51.65 108.41 1.06 Allowed Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.329 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.23 -14.72 28.6 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.461 1.441 . . . . 0.0 114.638 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.5 126.0 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 118.511 0.596 . . . . 0.0 111.228 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -92.01 150.44 20.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.574 0.226 . . . . 0.0 110.714 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.26 -134.33 2.89 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -119.29 147.26 44.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.944 0.372 . . . . 0.0 110.38 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mm -103.91 119.29 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.9 t -77.76 -52.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.874 -179.018 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -169.24 154.85 6.1 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.158 -178.887 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.1 tt -81.77 115.75 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.292 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.4 mt -93.99 -19.23 21.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.653 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -117.58 143.07 46.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.239 0.543 . . . . 0.0 111.192 -179.681 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -112.13 163.37 14.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.752 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.65 139.78 58.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.504 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.08 5.33 89.66 Favored Glycine 0 N--CA 1.468 0.79 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.86 179.103 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -79.01 133.63 36.82 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.227 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.45 127.75 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.18 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -149.35 136.19 10.75 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.418 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.45 148.97 69.01 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 121.615 1.543 . . . . 0.0 112.17 177.046 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -48.48 147.73 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.734 179.64 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.11 47.98 0.63 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.503 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.5 p -162.02 163.16 28.99 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.634 179.186 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 71' ' ' THR . 15.0 t -103.1 118.96 37.98 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.097 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.035 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -66.86 -35.75 80.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.891 -179.678 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.648 HD12 ' H ' ' A' ' 74' ' ' GLN . 1.8 tp -149.98 149.47 30.43 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.727 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.648 ' H ' HD12 ' A' ' 73' ' ' LEU . 57.9 tt0 -104.03 131.81 50.91 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.709 0.29 . . . . 0.0 110.793 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 87.5 mt -127.37 128.74 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.388 0.613 . . . . 0.0 112.036 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -94.54 140.93 29.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.915 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.472 179.389 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -116.38 147.16 41.91 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.456 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.13 134.12 47.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -93.94 118.04 30.93 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.542 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -125.98 145.52 50.25 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tp -82.29 113.75 46.21 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 N--CA 1.494 1.554 0 C-N-CA 121.841 1.694 . . . . 0.0 112.963 -179.566 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 121.045 0.45 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.67 110.51 0.93 Allowed Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' OE1' ' CE ' ' A' ' 39' ' ' MET . 79.1 tt0 -115.81 129.59 56.5 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.632 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 ' HE1' ' A' ' 21' ' ' TRP . 18.0 mm -102.17 119.62 50.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.329 -178.152 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.8 m -109.37 -38.83 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -138.22 148.94 45.31 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.544 ' HE1' HG21 ' A' ' 18' ' ' ILE . 79.5 m95 -132.98 141.42 48.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.641 -1.163 . . . . 0.0 107.919 177.436 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -128.46 16.45 6.53 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.41 160.8 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.456 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.98 143.47 51.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.826 0.346 . . . . 0.0 110.812 -179.033 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -61.26 140.55 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.162 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.21 7.19 77.29 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.889 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -118.41 149.54 41.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.975 0.417 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.0 mtm -81.95 151.15 27.33 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.908 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -135.47 145.64 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.965 179.334 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -110.49 132.13 54.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.587 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 64.4 tttm -52.83 137.48 31.8 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.561 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 3.7 m-20 83.61 -11.7 0.88 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.408 0.442 . . . . 0.0 111.795 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -115.43 76.78 1.03 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.572 0.225 . . . . 0.0 110.42 179.229 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 57.2 t0 -176.66 137.73 0.27 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.245 179.559 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.477 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 81.2 mt -119.45 108.25 14.31 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.558 0.694 . . . . 0.0 110.598 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.21 133.1 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.631 179.576 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.462 ' OE2' ' CG2' ' A' ' 44' ' ' THR . 44.2 tt0 -116.57 120.0 37.33 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 110.397 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.21 140.85 46.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.539 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.444 ' CE ' ' OE1' ' A' ' 17' ' ' GLU . 66.0 ttp -124.71 144.46 50.21 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.832 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -129.18 -85.96 0.55 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.952 179.355 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.485 ' H ' HG23 ' A' ' 40' ' ' THR . 67.3 t0 -82.86 47.01 1.15 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.801 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 61.8 38.88 14.52 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.335 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.26 135.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.462 ' CG2' ' OE2' ' A' ' 37' ' ' GLU . 6.9 m -95.61 119.38 34.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.121 -179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.52 153.88 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 110.734 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -119.26 133.49 55.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.773 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.4 mt -125.63 137.97 30.99 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.088 -179.203 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' SER . 31.2 Cg_exo -52.49 153.97 12.72 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 121.54 1.493 . . . . 0.0 111.557 178.159 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.33 164.39 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.952 0.406 . . . . 0.0 111.304 -179.514 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.1 49.07 3.1 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.946 2.431 . . . . 0.0 113.669 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 t 69.93 117.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 120.889 0.376 . . . . 0.0 111.693 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -46.81 135.84 8.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.2 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.5 -143.41 7.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.26 144.76 48.44 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.084 0.442 . . . . 0.0 110.545 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.02 121.57 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.1 t -80.25 -52.14 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.54 -179.024 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -167.54 156.99 10.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.932 -179.181 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.463 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.6 tt -85.87 116.37 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.085 0.469 . . . . 0.0 110.398 -179.688 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.71 -29.68 22.24 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.8 -179.342 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' ' CB ' ' A' ' 70' ' ' SER . 15.4 m-85 -119.15 145.8 45.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.072 0.463 . . . . 0.0 111.387 -179.649 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -126.62 172.54 10.18 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.962 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.5 145.92 55.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.407 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.99 6.13 82.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.761 178.927 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -100.41 124.4 45.87 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.46 0.648 . . . . 0.0 112.059 -179.312 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 p -125.01 126.74 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.515 178.653 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 t -148.67 140.54 14.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.555 -177.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.09 148.45 48.61 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.164 1.242 . . . . 0.0 111.325 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.29 130.33 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 111.127 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.72 52.86 0.07 OUTLIER Glycine 0 CA--C 1.528 0.863 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.921 179.067 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.459 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 8.5 m -156.54 164.57 38.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.195 0.498 . . . . 0.0 111.077 179.608 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 p -96.07 111.85 23.75 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.56 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 72' ' ' LEU . 5.8 mp -64.01 -41.03 97.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.357 179.772 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 74' ' ' GLN . 2.3 tp -162.45 146.26 11.73 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.138 -178.614 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.633 ' N ' HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -103.09 130.54 50.26 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.921 0.391 . . . . 0.0 110.741 -179.414 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.2 mt -128.2 128.92 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.301 0.572 . . . . 0.0 111.923 -178.427 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -95.82 139.98 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.686 178.607 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.42 ' H ' HG22 ' A' ' 77' ' ' THR . 1.3 t . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.439 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -80.16 148.08 31.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.824 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.79 118.92 29.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE2' HD12 ' A' ' 72' ' ' LEU . 3.4 t80 -83.37 104.28 13.4 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -102.34 148.22 25.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.477 -179.066 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.38 117.32 59.48 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.288 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo . . . . . 0 N--CA 1.498 1.75 0 C-N-CA 121.939 1.76 . . . . 0.0 111.597 179.641 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 43.9 mp0 . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.01 162.62 26.3 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -155.11 135.97 13.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.199 0.5 . . . . 0.0 110.55 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.413 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.3 mm -102.64 121.44 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.484 -179.781 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 20' ' ' ARG . 12.6 p -91.72 -44.53 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.407 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.49 ' N ' HG13 ' A' ' 19' ' ' VAL . 61.2 ttp180 -140.86 138.53 34.02 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.054 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.413 ' NE1' HG21 ' A' ' 18' ' ' ILE . 30.0 m95 -112.45 141.57 46.03 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 34' ' ' ASP . 15.4 p-10 -125.59 18.43 8.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.13 0.423 . . . . 0.0 111.555 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.79 156.24 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.86 139.9 51.94 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.771 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.49 140.93 53.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.045 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.78 5.71 68.31 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.821 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 28' ' ' MET . 43.9 t0 -110.11 -174.39 2.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 117.02 0.41 . . . . 0.0 110.676 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.511 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 94.9 mtp -120.22 151.95 38.42 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 30' ' ' GLU . 13.0 t -128.63 161.26 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.436 ' N ' HG12 ' A' ' 29' ' ' VAL . 80.8 mm-40 -130.85 156.01 45.75 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.684 -179.402 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.73 140.37 58.44 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.382 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 59.62 32.44 21.55 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.437 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -147.43 87.67 1.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.312 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 65.8 t0 -171.83 130.33 0.66 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.258 -178.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.5 mt -108.93 84.01 1.85 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.423 0.63 . . . . 0.0 110.34 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.48 132.83 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.494 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -111.1 116.54 31.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.635 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 m -113.25 131.99 63.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 110.568 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.8 ttp -111.18 112.68 24.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.461 ' H ' HG23 ' A' ' 40' ' ' THR . 1.1 p -63.0 -47.87 81.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.175 0.512 . . . . 0.0 110.001 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -149.56 -68.1 0.21 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.67 -179.669 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -138.64 35.23 2.22 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.264 179.503 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.36 137.58 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 m -103.47 118.0 35.73 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.12 156.85 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.24 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -99.71 138.34 36.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.177 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 47' ' ' ILE . 19.8 tt -133.48 113.95 13.27 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.484 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.29 142.98 17.16 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.003 1.802 . . . . 0.0 112.289 -179.768 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.0 p -58.38 109.46 1.85 Allowed Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.556 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.15 -23.13 39.86 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.057 1.172 . . . . 0.0 114.705 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.99 127.46 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.253 0.479 . . . . 0.0 111.34 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -92.86 148.82 21.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.672 0.272 . . . . 0.0 110.849 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.11 -131.48 1.7 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.9 146.87 49.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.015 0.408 . . . . 0.0 110.448 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.9 mm -103.58 119.89 52.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.139 -179.221 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 t -79.28 -52.42 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.908 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -163.68 158.39 20.36 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.167 -179.203 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 58' ' ' ILE . 3.5 tt -88.73 118.28 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.054 0.454 . . . . 0.0 111.253 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.4 mt -96.92 -17.87 19.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.167 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.412 ' CE2' HD23 ' A' ' 72' ' ' LEU . 3.8 m-85 -113.24 146.61 39.05 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.018 0.437 . . . . 0.0 110.586 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -124.08 160.88 26.76 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.816 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.79 138.03 58.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.069 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.03 5.35 90.2 Favored Glycine 0 N--CA 1.467 0.735 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.543 178.803 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -75.69 129.18 36.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.209 0.528 . . . . 0.0 111.174 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.9 t -119.7 127.64 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.904 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.31 154.92 36.67 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.499 -178.877 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.25 145.7 55.03 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.84 2.36 . . . . 0.0 112.238 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -55.4 130.42 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.193 0.521 . . . . 0.0 110.421 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.13 55.49 0.25 Allowed Glycine 0 N--CA 1.467 0.736 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -149.71 173.18 13.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.18 0.514 . . . . 0.0 111.07 -179.656 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -102.05 114.29 28.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.935 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.451 HD12 ' CE2' ' A' ' 4' ' ' PHE . 95.1 mt -67.68 -47.46 69.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.914 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.701 HD12 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -159.01 159.4 34.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.806 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.701 ' H ' HD12 ' A' ' 73' ' ' LEU . 51.3 tt0 -104.5 127.91 52.31 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.834 0.349 . . . . 0.0 111.412 -178.653 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.6 mt -128.86 128.73 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.189 0.519 . . . . 0.0 111.757 -179.603 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -100.05 119.05 37.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.359 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.819 -179.832 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OE2' ' A' ' 3' ' ' GLU . 99.3 mtp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -80.99 131.45 35.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.762 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 56.0 mp0 -113.52 123.78 50.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -95.85 122.16 38.34 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.362 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -128.72 129.46 45.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.973 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 tp -45.62 105.9 0.51 Allowed Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.498 1.764 0 C-N-CA 121.351 1.367 . . . . 0.0 111.989 -179.796 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.622 0.248 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.85 154.18 17.07 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -141.05 140.72 34.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.968 0.413 . . . . 0.0 110.096 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.468 HG21 ' NE1' ' A' ' 21' ' ' TRP . 7.4 mm -102.64 124.25 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.992 -178.795 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.45 -44.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.56 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.91 142.71 40.62 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.135 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.468 ' NE1' HG21 ' A' ' 18' ' ' ILE . 63.1 m95 -121.2 135.83 55.08 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.179 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -106.99 -3.8 19.71 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.686 0.279 . . . . 0.0 111.186 179.053 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.08 159.17 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.73 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -144.99 161.12 40.18 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.065 0.46 . . . . 0.0 111.53 -178.62 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -56.78 139.78 49.84 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.371 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.76 8.05 62.41 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.28 -0.486 . . . . 0.0 112.943 178.286 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -128.02 155.01 44.99 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.543 0.672 . . . . 0.0 111.837 -179.307 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.0 mtp -88.75 154.62 20.13 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.016 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -134.64 150.84 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.007 0.432 . . . . 0.0 110.624 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.63 159.66 17.97 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.147 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -71.43 87.79 0.88 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.034 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 34' ' ' ASP . 38.0 t0 -174.46 159.71 3.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.663 178.63 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -44.78 95.5 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.553 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' ASP . 79.4 m-20 -72.33 -3.65 25.16 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.588 0.709 . . . . 0.0 109.131 179.488 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.412 ' O ' ' CG ' ' A' ' 22' ' ' ASP . 35.6 tp 60.79 80.48 0.21 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.337 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.11 131.81 70.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.268 178.806 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -111.26 121.75 46.08 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.179 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.52 138.23 54.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.741 -178.739 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.405 ' HG3' ' H ' ' A' ' 43' ' ' VAL . 52.0 ttp -103.82 108.98 20.53 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.27 -46.14 74.55 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.246 -0.581 . . . . 0.0 110.903 -179.221 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 42' ' ' LYS . 18.9 p-10 -139.69 -63.83 0.5 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.156 -179.588 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.504 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 64.9 mttp -150.96 45.2 0.83 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.921 0.391 . . . . 0.0 110.624 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' H ' ' HG3' ' A' ' 39' ' ' MET . 7.4 p -158.71 146.01 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.311 178.747 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -98.84 120.94 40.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.274 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.47 156.53 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.64 135.47 52.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.902 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.9 mt -127.11 112.63 21.69 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.891 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.46 150.95 39.87 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.33 1.353 . . . . 0.0 110.954 178.576 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.7 m -104.29 97.72 12.48 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -88.12 41.97 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.675 2.25 . . . . 0.0 111.576 178.887 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.3 m -129.76 156.55 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.812 0.339 . . . . 0.0 111.508 -177.512 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.485 ' CD ' ' N ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -151.12 148.06 27.82 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.469 179.874 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.55 -137.52 5.5 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -131.14 147.53 52.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 mm -97.88 118.07 43.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.15 -47.5 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.871 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -152.55 157.01 40.45 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -177.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 58' ' ' ILE . 19.9 tt -131.68 126.06 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.256 178.884 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.3 mt -104.46 -15.48 15.36 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.98 -178.359 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.536 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 8.5 m-85 -108.71 144.03 37.04 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.281 0.563 . . . . 0.0 111.581 -178.881 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.487 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 84.9 mtt85 -131.39 166.25 21.69 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.149 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.58 138.66 51.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.581 -179.124 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.35 5.33 67.43 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.117 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 61' ' ' ARG . 34.9 mt-30 -96.11 131.26 42.73 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.234 0.54 . . . . 0.0 111.505 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.72 127.91 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.889 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 t -147.02 140.44 14.97 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.23 146.31 61.13 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.154 1.236 . . . . 0.0 111.275 177.255 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 68' ' ' VAL . 1.6 p -62.66 129.49 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.204 0.526 . . . . 0.0 110.811 -179.564 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.69 51.18 0.06 OUTLIER Glycine 0 CA--C 1.53 1.03 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.595 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 p -160.55 162.23 32.87 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 122.424 -0.456 . . . . 0.0 111.25 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 p -92.75 116.8 29.35 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.314 179.551 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.4 mm? -83.72 -18.23 38.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.589 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.55 144.16 4.27 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.05 -178.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -106.81 119.49 39.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 176.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.3 mt -126.79 127.54 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.267 0.556 . . . . 0.0 112.156 -177.031 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -85.15 145.68 27.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.738 179.209 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.537 179.785 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -110.98 142.48 43.05 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.32 130.83 55.58 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -96.0 118.67 33.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.06 0.457 . . . . 0.0 110.116 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -122.34 138.79 54.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.891 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 tp -64.1 115.25 17.86 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.495 1.608 0 C-N-CA 121.967 1.778 . . . . 0.0 112.41 -178.989 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.19 119.2 6.21 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.669 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -134.25 138.2 44.88 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.34 0.57 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.45 HG21 ' NE1' ' A' ' 21' ' ' TRP . 7.4 mm -103.45 121.8 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.749 -179.382 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.59 -40.75 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -138.69 147.93 43.37 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.45 ' NE1' HG21 ' A' ' 18' ' ' ILE . 54.4 m95 -128.2 141.58 51.42 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.736 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 54.9 t0 -125.46 22.65 7.66 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.79 0.329 . . . . 0.0 111.076 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.0 156.08 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.178 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.2 135.33 55.16 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -58.69 138.2 57.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.46 6.8 76.99 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -114.79 156.48 24.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.716 0.293 . . . . 0.0 110.402 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.6 mtt -80.34 148.15 30.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.719 -179.647 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.4 t -121.36 135.42 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.458 -178.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -109.56 137.6 47.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.763 179.292 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.569 ' H ' ' HE ' ' A' ' 52' ' ' ARG . 37.1 ttmt -68.08 137.64 55.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 6.6 t0 84.73 -11.78 0.78 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.585 179.732 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -118.87 82.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.654 0.264 . . . . 0.0 110.478 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 67.5 t0 -169.81 139.22 1.91 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.831 0.348 . . . . 0.0 110.423 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 69.4 mt -113.31 89.2 3.02 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.285 0.564 . . . . 0.0 109.919 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.64 130.92 71.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.43 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -121.29 126.36 49.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.821 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.93 149.88 32.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.9 ttp -118.41 134.86 54.72 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.384 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -110.99 -58.91 2.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.49 -179.58 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.482 ' N ' ' OG1' ' A' ' 40' ' ' THR . 51.9 p-10 -131.49 61.63 1.64 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.081 -179.41 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt 61.02 33.96 19.46 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 121.208 0.527 . . . . 0.0 110.119 -178.641 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.8 t -127.51 136.36 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.32 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 m -106.67 120.33 41.69 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.831 0.348 . . . . 0.0 110.139 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.89 156.59 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 121.244 0.545 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.55 135.74 53.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.31 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.41 155.59 77.02 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.218 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 49' ' ' SER . 31.5 Cg_exo -57.75 146.68 84.44 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 121.866 1.711 . . . . 0.0 112.168 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -40.6 166.15 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.921 179.665 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -77.35 54.59 4.75 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.029 2.486 . . . . 0.0 113.02 -179.396 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t 64.62 114.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.896 0.379 . . . . 0.0 111.24 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.569 ' HE ' ' H ' ' A' ' 31' ' ' LYS . 16.0 ptp180 -53.56 145.73 14.42 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.127 0.489 . . . . 0.0 111.705 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.99 -134.12 3.16 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -121.15 130.17 53.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.915 0.357 . . . . 0.0 110.19 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 73' ' ' LEU . 7.4 mm -96.46 119.56 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.1 t -77.13 -52.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.148 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -166.18 161.74 17.15 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.464 -178.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.5 tt -91.11 107.19 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.579 0.704 . . . . 0.0 109.78 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.505 HD22 HE22 ' A' ' 74' ' ' GLN . 54.8 tp -75.09 -32.2 61.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.857 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.521 ' CD2' ' NE2' ' A' ' 64' ' ' GLN . 17.1 m-85 -117.9 146.93 43.58 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.382 0.61 . . . . 0.0 112.123 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -122.06 161.32 23.24 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.927 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -56.5 142.29 39.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.678 -179.074 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.85 4.21 57.92 Favored Glycine 0 N--CA 1.473 1.127 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.237 178.515 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.521 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 32.5 mt-30 -98.04 131.69 44.24 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.428 0.632 . . . . 0.0 111.668 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -122.49 122.75 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.758 179.0 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 t -148.95 138.87 12.97 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.834 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.21 142.92 44.35 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 121.473 1.449 . . . . 0.0 112.414 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.97 128.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.013 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.39 51.41 0.04 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.045 179.07 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -166.85 169.47 13.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.227 0.514 . . . . 0.0 111.323 179.51 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.585 ' O ' HG23 ' A' ' 71' ' ' THR . 15.2 t -103.7 120.42 40.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.868 179.727 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -88.89 -7.88 55.28 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.182 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.671 HD12 ' H ' ' A' ' 74' ' ' GLN . 5.8 tp -157.16 144.43 18.69 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.671 ' H ' HD12 ' A' ' 73' ' ' LEU . 28.4 mp0 -104.19 132.99 49.86 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.554 0.216 . . . . 0.0 111.039 -179.205 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.8 mt -131.72 130.03 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.43 . . . . 0.0 111.957 -179.426 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -100.88 113.82 27.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.078 178.341 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.411 ' H ' HG22 ' A' ' 77' ' ' THR . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.822 -1.085 . . . . 0.0 110.328 179.984 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 ttp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -89.36 132.88 34.75 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 52.9 mp0 -95.22 121.99 37.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.076 -179.043 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -91.46 113.01 25.16 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.169 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -115.47 146.27 41.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.599 -179.62 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.588 ' C ' HD23 ' A' ' 6' ' ' LEU . 4.9 tt -58.67 110.56 2.71 Favored Pre-proline 0 N--CA 1.469 0.516 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.448 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.486 ' N ' HD23 ' A' ' 6' ' ' LEU . 46.8 Cg_exo . . . . . 0 N--CA 1.497 1.682 0 CA-C-N 120.21 1.111 . . . . 0.0 112.455 -179.779 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.646 0.26 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.14 119.27 6.1 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -178.94 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -125.67 133.46 52.16 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.022 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.402 HG21 ' NE1' ' A' ' 21' ' ' TRP . 9.1 mm -103.15 122.23 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.634 -178.821 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.9 p -90.89 -44.8 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.536 179.595 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' N ' HG13 ' A' ' 19' ' ' VAL . 84.1 mtt85 -146.13 147.44 31.54 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.062 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.402 ' NE1' HG21 ' A' ' 18' ' ' ILE . 62.4 m95 -115.22 136.86 52.65 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 176.346 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 7.8 p-10 -106.0 1.1 26.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.201 -0.312 . . . . 0.0 111.73 -179.443 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG11 ' OD2' ' A' ' 34' ' ' ASP . 32.0 m -136.62 159.63 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.681 0.277 . . . . 0.0 110.943 -179.739 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -136.91 153.02 50.85 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.076 0.465 . . . . 0.0 110.123 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -57.54 141.99 45.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.766 179.876 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.39 8.34 59.94 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.48 179.057 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 28' ' ' MET . 65.9 t0 -130.58 135.36 47.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.611 0.706 . . . . 0.0 110.847 -179.691 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.486 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 65.9 mtt -81.45 150.2 28.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.193 -179.43 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 p -143.46 147.64 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.001 0.429 . . . . 0.0 110.593 179.605 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -102.65 162.1 13.2 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.841 -178.453 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.07 137.85 50.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.497 -179.067 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 59.81 45.22 12.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.436 179.902 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.437 ' O ' ' CG ' ' A' ' 34' ' ' ASP . 59.3 tt0 -147.03 88.45 1.74 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.524 179.086 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.54 ' OD2' ' NH2' ' A' ' 52' ' ' ARG . 11.8 m-20 170.43 148.65 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.776 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.51 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 74.6 mt -121.03 102.14 8.14 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.646 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.74 131.32 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.216 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -117.46 127.41 53.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.031 -179.831 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.57 129.08 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.795 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.8 ttp -108.55 131.19 55.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.566 -179.864 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -114.5 -84.89 0.61 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.328 -179.838 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' H ' HG23 ' A' ' 40' ' ' THR . 42.8 p-10 -98.16 51.06 1.02 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.482 179.827 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 65.56 34.66 7.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.132 -178.714 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.4 t -127.54 135.84 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.9 m -98.13 117.97 33.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.581 -179.574 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.72 131.45 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.298 179.519 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -93.57 136.17 34.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.212 -179.57 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.1 mt -140.95 95.51 7.61 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.6 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.54 144.75 91.54 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 121.985 1.79 . . . . 0.0 111.35 179.321 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.579 ' CB ' ' NE ' ' A' ' 52' ' ' ARG . 8.0 t -64.81 113.06 9.48 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.546 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.18 -24.64 44.08 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 120.932 1.088 . . . . 0.0 113.943 -178.933 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.0 125.07 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.111 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.579 ' NE ' ' CB ' ' A' ' 49' ' ' SER . 24.6 mmt180 -134.15 155.28 50.38 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.917 0.389 . . . . 0.0 110.873 -179.631 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.92 -84.71 0.06 OUTLIER Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.455 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -130.19 136.79 49.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.8 0.333 . . . . 0.0 110.565 179.379 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.401 ' CG2' HD11 ' A' ' 73' ' ' LEU . 9.4 mm -104.43 118.84 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.266 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.2 t -87.31 -52.36 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.318 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -160.83 154.36 22.07 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.752 -178.249 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.4 tt -108.17 122.18 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.503 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.3 mt -97.54 -17.61 19.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.189 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -107.28 141.8 38.04 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.93 0.395 . . . . 0.0 110.747 -179.243 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.551 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 89.4 mtm-85 -122.65 162.19 22.4 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.512 179.926 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 56.2 mp0 -53.62 134.96 41.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.112 -179.067 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.62 6.27 83.4 Favored Glycine 0 N--CA 1.471 0.992 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.679 177.969 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.551 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 80.4 mt-30 -85.86 134.15 33.92 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.109 0.954 . . . . 0.0 111.467 -179.472 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.5 p -122.13 124.43 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.234 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 t -148.83 136.93 11.46 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.696 -179.53 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.97 152.47 58.13 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 C-N-CA 121.924 1.75 . . . . 0.0 112.243 178.289 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.8 t -53.87 133.21 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.691 179.648 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.86 51.81 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.804 179.229 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.7 m -153.99 169.08 24.35 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.354 -179.723 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -104.07 111.76 24.47 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.191 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.44 -45.3 55.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.541 -179.795 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.875 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.8 tt -152.96 147.66 26.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.939 -177.772 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.875 ' N ' HD23 ' A' ' 73' ' ' LEU . 18.9 tt0 -103.21 133.42 48.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.115 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 56.8 mt -126.73 129.2 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.205 0.526 . . . . 0.0 111.891 -177.395 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -96.02 111.63 23.59 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.951 178.885 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.353 -179.664 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -85.73 126.24 33.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.665 -179.553 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 52.6 mp0 -92.86 134.4 35.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.736 -179.472 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -109.49 108.53 19.05 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.784 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -114.17 141.2 47.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.043 -179.64 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.544 ' C ' HD23 ' A' ' 6' ' ' LEU . 5.1 tt -69.26 112.12 10.8 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.413 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' N ' HD23 ' A' ' 6' ' ' LEU . 73.2 Cg_endo . . . . . 0 N--CA 1.5 1.875 0 C-N-CA 121.8 1.667 . . . . 0.0 112.875 -178.251 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 54.8 mp0 . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.826 0.346 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.36 124.8 5.25 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' OE1' ' C ' ' A' ' 17' ' ' GLU . 10.1 tm-20 -128.02 137.8 52.34 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.128 0.464 . . . . 0.0 110.58 -179.309 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -102.13 114.44 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.51 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.4 p -85.17 -42.56 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.445 179.342 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.51 ' N ' HG13 ' A' ' 19' ' ' VAL . 82.2 mtp180 -140.88 147.05 38.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.82 0.343 . . . . 0.0 111.258 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -109.04 137.73 46.5 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.252 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.3 p-10 -72.77 -40.89 65.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.296 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.12 165.58 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.551 -178.193 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 99.4 mttt -119.27 149.69 41.36 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.933 -179.592 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 56' ' ' VAL . 85.7 tt0 -45.31 139.61 3.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.32 7.25 62.23 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.567 -0.574 . . . . 0.0 113.341 178.59 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 24' ' ' LYS . 40.4 p-10 -135.44 153.06 51.9 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.371 1.086 . . . . 0.0 111.226 179.759 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.0 mtp -78.52 155.19 29.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.777 -178.79 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.23 152.77 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.926 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -113.38 147.4 37.79 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.937 0.399 . . . . 0.0 110.83 -179.623 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.454 ' HB2' ' H ' ' A' ' 52' ' ' ARG . 50.3 tttp -85.06 84.45 7.7 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.108 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' ASP . 43.8 p30 -165.97 81.37 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.552 179.204 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 62.97 -66.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.048 179.493 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 32' ' ' ASP . 29.0 t0 62.78 -167.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.311 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.4 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 83.4 mt -126.54 75.75 1.57 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.183 0.516 . . . . 0.0 111.55 -179.768 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.06 128.14 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.51 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -124.73 128.68 49.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.114 -178.616 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.52 133.6 64.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.226 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.44 ' HG3' ' H ' ' A' ' 43' ' ' VAL . 65.3 ttp -119.1 113.41 20.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.381 -179.024 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 40' ' ' THR . 1.7 p -62.75 -52.05 64.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.108 0.48 . . . . 0.0 109.908 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.8 t70 -146.87 -48.22 0.19 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.32 179.123 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -161.51 51.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.271 179.05 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 44' ' ' THR . 46.3 t -135.88 160.06 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.431 -179.792 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.502 ' N ' HG12 ' A' ' 43' ' ' VAL . 18.5 m -110.25 114.79 28.54 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.296 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.32 117.1 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.354 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -97.76 136.42 38.12 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.646 178.959 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.5 mt -139.33 139.95 24.38 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 119.303 -0.38 . . . . 0.0 110.529 -178.744 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 49' ' ' SER . 52.8 Cg_exo -53.17 145.66 42.4 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.386 1.39 . . . . 0.0 111.725 178.195 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -47.34 179.19 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.858 -179.322 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 49' ' ' SER . 78.8 Cg_endo -87.86 49.67 1.74 Allowed 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.776 2.317 . . . . 0.0 113.855 -178.363 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.0 t 66.19 121.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 120.823 0.344 . . . . 0.0 111.599 178.759 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 42.2 ttm180 -50.23 136.38 19.79 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.524 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.62 -141.63 5.75 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.371 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -126.05 126.67 44.62 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.811 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.566 HG23 HD21 ' A' ' 73' ' ' LEU . 5.8 mm -91.74 119.23 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.676 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.4 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 37.7 t -101.41 -41.52 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.222 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -145.16 154.89 42.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.557 -177.677 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 58' ' ' ILE . 12.5 tt -127.78 127.27 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.205 -179.824 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.8 tp -100.26 -21.18 15.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.211 -179.492 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.506 ' CD2' HD23 ' A' ' 72' ' ' LEU . 6.4 m-85 -106.08 141.93 36.64 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.225 0.536 . . . . 0.0 111.383 -178.951 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -122.18 165.74 15.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.143 179.371 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.0 mp0 -53.39 128.24 27.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.455 -179.463 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.72 5.95 85.98 Favored Glycine 0 N--CA 1.468 0.818 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.374 178.539 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -79.4 135.52 36.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.42 0.61 . . . . 0.0 110.71 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.76 131.52 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.611 179.624 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -149.47 137.54 11.77 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.785 -178.78 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.92 137.48 52.38 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.077 1.185 . . . . 0.0 112.344 177.942 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -56.22 129.16 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.721 179.774 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.68 49.3 0.08 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.113 178.985 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.3 p -164.62 165.99 20.54 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.345 0.572 . . . . 0.0 110.858 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 71' ' ' THR . 14.9 t -98.98 122.15 41.87 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.057 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 72' ' ' LEU . 3.0 mp -90.57 -5.38 56.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.686 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.566 HD21 HG23 ' A' ' 55' ' ' ILE . 2.1 tt -162.34 142.43 9.83 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.101 -178.866 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.539 ' OE1' ' N ' ' A' ' 74' ' ' GLN . 2.3 mp0 -104.03 124.37 48.9 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.247 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.7 mt -122.89 127.48 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.47 0.652 . . . . 0.0 111.57 -177.7 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -98.12 111.36 23.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.219 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.77 -179.47 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -125.88 149.26 48.82 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.924 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.66 128.34 53.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.819 0.342 . . . . 0.0 110.384 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.831 ' CD2' HD23 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -87.08 126.13 34.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.058 -179.931 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -119.6 133.73 55.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.191 -179.425 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.0 123.3 79.58 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.821 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 C-N-CA 121.598 1.532 . . . . 0.0 111.781 -179.41 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.58 ' OE2' HG13 ' A' ' 65' ' ' VAL . 13.4 tm-20 . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 111.377 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.47 ' N ' ' CD ' ' A' ' 15' ' ' GLU . . . -121.2 119.29 4.06 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.356 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -118.98 136.26 54.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 117.165 0.482 . . . . 0.0 110.658 -179.763 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.401 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.9 mm -101.35 119.97 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.125 -179.678 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 20' ' ' ARG . 10.0 p -89.9 -45.89 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.841 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.53 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.7 mtt180 -143.41 148.46 36.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.192 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.401 ' NE1' HG21 ' A' ' 18' ' ' ILE . 36.3 m95 -118.25 144.54 45.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.432 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.3 m-20 -124.48 12.94 8.75 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.136 0.426 . . . . 0.0 111.655 179.395 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.77 154.93 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.962 0.41 . . . . 0.0 110.764 179.605 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -121.9 153.68 38.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.096 -179.822 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -64.15 129.54 40.38 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.303 -179.955 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.04 5.66 63.88 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.502 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 36.5 p-10 -101.86 151.93 21.5 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.066 0.433 . . . . 0.0 110.665 179.536 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.2 mmm -90.85 148.85 22.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.537 -179.791 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.66 141.07 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.174 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -109.57 159.97 16.64 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.818 0.342 . . . . 0.0 111.272 -178.714 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -59.73 136.4 57.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.184 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 58.92 29.64 19.15 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.209 -179.559 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.69 79.56 1.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.573 0.225 . . . . 0.0 110.42 179.332 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 46.0 t0 -173.73 -178.56 1.61 Allowed 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.534 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.487 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 37.3 tp -153.95 97.84 2.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.922 0.391 . . . . 0.0 110.562 179.458 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.0 130.56 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.9 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.4 mp0 -114.66 120.71 41.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.926 178.759 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.6 m -119.98 134.37 63.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.008 -179.805 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.9 ptm -130.13 129.41 43.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.344 -179.58 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -73.25 -43.07 61.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.325 179.922 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -154.78 -67.21 0.13 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.323 -179.648 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -132.67 37.15 3.49 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.228 179.523 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.1 t -133.82 136.01 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.901 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 m -116.26 120.61 39.48 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.516 -179.666 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.94 155.61 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.362 179.546 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -115.23 135.63 53.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.276 -179.782 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.1 mt -134.27 130.84 20.35 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.11 179.945 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.46 146.17 27.36 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.419 2.079 . . . . 0.0 112.626 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -60.59 110.91 3.32 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.806 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.29 -19.76 37.94 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.612 1.541 . . . . 0.0 114.951 -177.856 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.89 124.03 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 118.459 0.572 . . . . 0.0 111.606 -179.084 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -91.14 152.13 20.7 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.107 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.39 -133.34 2.39 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.214 179.49 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -125.05 143.33 50.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.688 0.28 . . . . 0.0 110.327 -179.371 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.4 mm -103.73 118.72 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.682 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.8 t -89.25 -55.36 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.097 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -143.52 153.5 42.65 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.289 0.566 . . . . 0.0 111.814 -178.364 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.6 ' O ' HG23 ' A' ' 58' ' ' ILE . 3.7 tt -101.57 114.38 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.148 178.884 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.75 -17.68 20.12 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.827 -179.648 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -109.3 142.21 40.5 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.083 0.468 . . . . 0.0 110.756 -179.225 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.416 ' H ' ' HG3' ' A' ' 64' ' ' GLN . 11.2 ptp85 -126.0 166.25 17.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.429 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.43 144.5 50.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.006 -179.391 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.03 5.8 87.27 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 179.259 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 61' ' ' ARG . 22.4 mm-40 -70.76 133.44 46.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.593 0.711 . . . . 0.0 111.355 -179.01 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.58 HG13 ' OE2' ' A' ' 15' ' ' GLU . 40.0 t -131.46 118.67 40.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 114.33 -1.304 . . . . 0.0 107.5 178.604 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.56 154.79 35.82 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.006 -178.472 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.12 140.33 41.06 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.739 2.293 . . . . 0.0 111.676 179.087 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.12 124.61 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.774 179.412 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.1 53.31 0.06 OUTLIER Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.0 t -162.51 168.27 22.16 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.961 0.38 . . . . 0.0 110.807 -179.889 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 71' ' ' THR . 14.8 t -105.45 128.41 53.52 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.039 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -64.16 -41.81 97.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.182 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -161.27 177.28 10.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.757 -179.495 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -107.03 127.19 53.24 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.717 0.294 . . . . 0.0 110.889 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.47 125.29 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.25 0.548 . . . . 0.0 111.346 -179.323 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -90.27 140.49 29.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.8 178.913 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.449 179.792 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -79.61 129.17 34.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.839 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 57.1 mp0 -105.87 118.77 37.45 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -95.86 122.28 38.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.218 0.532 . . . . 0.0 110.733 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.63 145.22 49.09 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.66 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 tt -68.73 113.4 15.7 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.045 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.54 151.65 29.12 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.59 1.527 . . . . 0.0 112.008 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -91.02 89.27 7.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.712 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.64 -43.46 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.96 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 11' ' ' GLU . . . -89.35 -164.93 40.63 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 10' ' ' GLY . 16.8 pt-20 -53.29 -166.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.672 0.272 . . . . 0.0 110.405 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -38.08 -72.49 0.18 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 12' ' ' GLY . 1.6 t 57.81 117.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 p -124.34 76.83 1.51 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.748 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.482 ' OE2' ' CG2' ' A' ' 65' ' ' VAL . 30.8 tp10 -170.44 143.27 2.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.322 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.92 110.45 0.72 Allowed Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -126.27 131.91 51.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 110.355 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -102.37 119.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.17 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.6 p -93.08 -43.81 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.519 ' N ' HG13 ' A' ' 19' ' ' VAL . 83.2 mtp180 -139.57 145.07 38.15 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.808 0.337 . . . . 0.0 111.243 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -111.68 139.84 46.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.91 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 18.2 p-10 -101.36 -6.51 23.98 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.37 159.95 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.027 0.441 . . . . 0.0 111.4 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.33 149.99 49.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.7 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -59.55 138.63 57.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.257 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.64 8.87 76.16 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.604 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -121.98 149.84 42.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 117.431 0.616 . . . . 0.0 111.156 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.2 mtm -86.59 154.19 21.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.265 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.474 HG23 ' NE2' ' A' ' 33' ' ' GLN . 2.6 p -138.9 152.61 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.937 0.399 . . . . 0.0 110.515 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -117.44 157.23 26.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.012 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -67.55 65.6 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.962 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -176.11 73.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.531 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' NE2' HG23 ' A' ' 29' ' ' VAL . 85.1 mt-30 -147.1 122.09 10.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.409 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -128.14 39.45 3.84 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.454 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.8 mt -110.51 33.67 4.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.107 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.11 128.15 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -116.85 123.91 48.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.533 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.92 130.16 72.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.375 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.3 ttm -109.7 126.4 53.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.287 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -95.1 -77.28 0.47 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.054 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.424 ' N ' ' OG1' ' A' ' 40' ' ' THR . 62.1 t0 -95.99 -74.24 0.57 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.269 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -151.37 50.71 0.83 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.334 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.03 149.34 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.897 0.379 . . . . 0.0 110.75 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.8 m -107.97 118.82 37.75 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.957 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.96 133.79 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -95.51 135.5 37.08 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.426 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.4 mt -135.75 133.57 20.15 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.36 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.3 147.69 33.18 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.175 1.917 . . . . 0.0 111.162 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -96.98 107.89 40.28 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 111.371 0.137 . . . . 0.0 111.371 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -86.59 41.78 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.373 2.049 . . . . 0.0 111.358 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.39 156.2 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.716 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -154.33 149.07 26.51 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.276 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.29 -132.93 2.94 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.84 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -130.3 135.76 48.43 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -91.87 120.18 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.147 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.5 t -84.53 -50.07 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -164.16 157.06 17.61 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.898 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 58' ' ' ILE . 3.0 tt -116.07 121.96 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.446 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.55 -16.88 18.97 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.21 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.543 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 17.8 m-85 -107.31 144.4 34.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.291 0.567 . . . . 0.0 111.58 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -123.83 161.48 25.21 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.86 137.02 57.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.45 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.41 4.99 85.5 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.492 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.52 ' OE1' ' CD2' ' A' ' 60' ' ' TYR . 55.3 tt0 -89.32 137.39 32.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.414 0.607 . . . . 0.0 110.563 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.482 ' CG2' ' OE2' ' A' ' 15' ' ' GLU . 3.4 p -124.42 131.21 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.375 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 t -148.3 140.86 14.89 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.249 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.19 148.17 32.69 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.501 1.467 . . . . 0.0 112.661 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 68' ' ' VAL . 9.8 p -62.08 132.83 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.456 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.99 49.44 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.014 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.7 p -160.33 162.84 33.59 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.399 0.6 . . . . 0.0 111.355 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 71' ' ' THR . 5.3 t -96.37 120.99 37.68 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.2 mm? -82.45 -4.32 57.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.553 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.8 142.45 2.45 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.58 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -104.84 122.39 45.67 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.35 127.51 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.095 0.474 . . . . 0.0 111.081 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -88.0 141.32 28.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.087 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.493 179.825 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -82.84 130.12 35.09 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 51.0 mp0 -93.79 138.7 31.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.95 101.79 11.82 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 6' ' ' LEU . 68.6 mttm -108.28 105.19 14.77 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 5' ' ' LYS . 5.6 mt -29.23 93.84 0.06 OUTLIER Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 123.845 0.716 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' LYS . 92.0 Cg_endo -77.98 154.78 29.77 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.644 1.563 . . . . 0.0 112.127 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -84.75 86.89 7.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.813 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.9 pt -142.41 154.08 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.709 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.84 -28.91 3.1 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -172.68 -92.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.595 0.236 . . . . 0.0 110.37 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.94 159.85 24.5 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.423 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -145.21 95.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 110.437 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 p -66.52 -36.02 81.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.269 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -146.57 151.62 37.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.65 109.92 3.54 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -121.78 127.35 50.52 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.409 HG21 ' NE1' ' A' ' 21' ' ' TRP . 7.2 mm -100.92 117.94 46.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.05 0.452 . . . . 0.0 111.565 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 20' ' ' ARG . 10.7 p -91.74 -41.85 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.583 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.488 ' N ' HG13 ' A' ' 19' ' ' VAL . 95.1 mtt-85 -143.37 141.88 31.07 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.409 ' NE1' HG21 ' A' ' 18' ' ' ILE . 37.3 m95 -111.93 145.4 39.62 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 35' ' ' LEU . 87.7 m-20 -128.54 20.85 6.1 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.43 0.559 . . . . 0.0 111.255 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.9 m -136.33 154.63 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 68.4 mttm -135.05 137.13 42.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.448 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -44.25 135.75 4.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.91 5.94 70.29 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 43.9 p-10 -104.19 150.88 23.98 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.806 0.303 . . . . 0.0 110.222 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.2 mtp -90.06 145.74 24.85 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.86 0.362 . . . . 0.0 110.645 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.9 t -126.42 132.85 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.478 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -105.7 158.2 16.88 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -62.88 136.4 57.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.639 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 58.66 36.46 25.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.141 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -141.81 89.76 2.22 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 51.4 t0 -172.91 158.16 3.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.901 0.382 . . . . 0.0 110.455 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.47 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 92.7 mt -135.22 86.35 2.24 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.322 0.582 . . . . 0.0 110.009 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.71 136.69 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.565 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.1 mp0 -123.06 128.14 49.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.056 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 p -128.15 130.0 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.0 ttp -109.3 133.49 52.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.547 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -99.65 -92.38 0.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.492 ' N ' ' OG1' ' A' ' 40' ' ' THR . 14.3 p-10 -83.69 -52.73 6.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.356 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -174.45 57.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.612 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -159.33 151.83 6.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.901 0.382 . . . . 0.0 110.417 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -103.87 117.53 34.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.284 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.88 132.59 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.064 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -92.53 135.71 33.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.954 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.94 90.8 13.8 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.55 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.08 147.73 92.04 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 122.638 2.225 . . . . 0.0 112.018 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.5 m -60.65 111.27 3.82 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 119.51 -0.281 . . . . 0.0 110.7 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.56 -16.81 30.39 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.413 1.409 . . . . 0.0 114.521 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.89 124.58 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.245 0.475 . . . . 0.0 111.084 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -89.74 151.49 21.8 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.415 0.15 . . . . 0.0 110.827 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.77 -145.47 7.97 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -114.46 133.74 55.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.85 0.325 . . . . 0.0 110.845 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.487 HG23 HD21 ' A' ' 73' ' ' LEU . 5.8 mm -87.91 120.22 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 t -88.99 -52.63 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -156.27 160.74 40.04 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.186 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.481 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.0 tt -106.0 123.37 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.618 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.1 tp -101.11 -18.32 16.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.068 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.436 ' CE2' HD22 ' A' ' 72' ' ' LEU . 5.8 m-85 -111.15 146.82 36.18 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.217 0.532 . . . . 0.0 111.053 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.574 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 99.8 mtt180 -122.5 167.3 13.52 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.111 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -62.37 140.54 58.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.838 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.52 5.02 82.6 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.382 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.574 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 83.5 mt-30 -85.61 135.17 33.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.488 0.644 . . . . 0.0 111.955 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 p -128.46 126.5 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.733 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.5 t -149.52 135.93 10.49 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.746 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.39 141.96 59.46 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.377 1.385 . . . . 0.0 111.905 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 p -52.98 128.32 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.849 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.03 48.24 0.06 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.187 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.4 p -164.17 162.24 22.65 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 117.407 0.604 . . . . 0.0 110.926 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 71' ' ' THR . 6.0 t -88.96 126.48 35.42 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.436 HD22 ' CE2' ' A' ' 60' ' ' TYR . 42.2 mt -97.36 -5.48 36.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.402 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.4 tt -170.51 149.08 3.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.507 ' N ' HD23 ' A' ' 73' ' ' LEU . 66.7 mt-30 -103.17 125.52 49.9 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.8 mt -126.45 128.55 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.199 0.523 . . . . 0.0 111.723 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 18.6 p-10 -97.09 115.66 27.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.543 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.591 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -106.78 137.52 44.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.147 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.33 130.51 40.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.125 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -108.64 120.46 42.53 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.203 0.525 . . . . 0.0 110.331 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -127.18 153.34 46.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.955 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 tp -71.52 117.87 61.16 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.742 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.98 151.76 31.18 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.664 1.576 . . . . 0.0 111.886 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -83.41 107.44 15.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.247 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.4 pt -129.78 156.85 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.289 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.63 -169.39 47.83 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -127.93 137.65 52.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.708 0.289 . . . . 0.0 110.355 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.59 74.29 1.2 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.84 111.27 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.7 p -108.44 -14.1 14.73 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.279 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -173.38 149.65 1.75 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.988 0.423 . . . . 0.0 111.176 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.54 150.81 18.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -137.16 146.56 45.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.954 0.377 . . . . 0.0 110.262 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.89 115.93 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.37 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 20' ' ' ARG . 10.7 p -86.04 -43.62 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.373 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.503 ' N ' HG13 ' A' ' 19' ' ' VAL . 83.6 mtp180 -139.54 147.37 41.11 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.724 0.297 . . . . 0.0 111.264 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -111.95 141.84 45.1 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.46 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 16.5 p-10 -105.56 -3.51 22.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.542 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -134.59 160.35 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 120.891 0.377 . . . . 0.0 111.36 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.22 147.17 45.64 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.56 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.432 ' OE1' HG22 ' A' ' 58' ' ' ILE . 82.6 tt0 -63.34 134.23 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.619 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.75 8.53 85.84 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.322 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -117.07 129.13 55.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.068 0.434 . . . . 0.0 111.431 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.1 ptp -59.54 150.25 27.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.843 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 30' ' ' GLU . 52.9 t -123.25 159.06 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.019 0.438 . . . . 0.0 110.138 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 57.2 mp0 -135.1 149.59 50.07 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.57 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 87.9 tttt -65.29 137.6 57.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.138 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 9.9 m-20 94.21 76.03 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.817 0.698 . . . . 0.0 110.704 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -146.16 95.66 2.66 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.594 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -104.1 52.35 0.76 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.653 0.263 . . . . 0.0 110.916 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -117.87 30.53 7.2 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.239 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.93 128.28 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -121.86 126.64 49.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.644 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.0 129.89 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.6 ttp -103.95 110.98 23.33 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.831 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.453 ' H ' HG23 ' A' ' 40' ' ' THR . 1.1 p -61.91 -48.13 81.85 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -146.31 -67.45 0.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.432 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -142.11 41.38 1.65 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.842 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 44' ' ' THR . 48.3 t -136.33 155.85 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.416 ' N ' HG12 ' A' ' 43' ' ' VAL . 5.0 m -109.17 118.2 36.13 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.76 120.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.06 138.57 31.4 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -136.42 109.84 9.62 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.08 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.69 145.27 60.78 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.67 1.58 . . . . 0.0 111.369 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.5 m -105.04 99.62 20.35 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.08 44.44 1.28 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.295 1.997 . . . . 0.0 110.432 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.76 154.68 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -161.47 131.82 5.02 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.713 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.02 -136.49 3.85 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.855 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -124.44 132.13 53.5 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.88 0.34 . . . . 0.0 110.242 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.429 ' N ' HD13 ' A' ' 55' ' ' ILE . 4.2 mm -91.77 121.33 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.8 t -87.46 -51.81 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -155.29 161.42 41.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.681 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.575 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.6 tt -122.0 123.78 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.695 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.06 -16.48 17.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -107.15 143.9 34.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.15 0.5 . . . . 0.0 111.375 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -123.61 164.99 17.95 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.272 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -59.34 134.4 56.97 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.631 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.98 5.64 90.01 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.009 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -82.15 137.39 34.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.041 0.42 . . . . 0.0 110.823 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.84 133.03 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.605 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.7 t -148.63 141.28 15.16 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.691 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.16 146.11 61.5 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.317 1.345 . . . . 0.0 111.373 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.451 ' H ' HG12 ' A' ' 68' ' ' VAL . 1.6 p -64.89 130.2 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.018 0.437 . . . . 0.0 110.713 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.55 53.15 0.08 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.2 m -160.41 170.3 21.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.054 0.427 . . . . 0.0 111.255 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.2 m -99.43 112.5 24.68 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.838 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.52 -43.4 76.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.161 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.2 tt -151.38 145.74 25.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.072 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.84 ' N ' HD23 ' A' ' 73' ' ' LEU . 39.1 mt-30 -104.11 130.73 51.84 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.9 mt -131.71 127.34 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.142 0.496 . . . . 0.0 111.536 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.76 140.97 29.28 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.918 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.568 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -97.65 127.87 43.93 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 37.6 mp0 -107.74 111.72 24.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.131 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -75.55 100.94 4.72 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -112.55 147.16 37.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.554 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 7' ' ' PRO . 7.3 tt -66.35 113.35 12.21 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.455 ' O ' HD23 ' A' ' 6' ' ' LEU . 45.6 Cg_exo -54.92 141.29 78.41 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 120.499 1.214 . . . . 0.0 112.09 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -94.19 108.45 20.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.812 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.2 pt -126.53 150.76 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.629 0.252 . . . . 0.0 110.582 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.83 -135.5 42.57 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.489 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.2 pm0 -155.17 6.42 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.26 5.94 74.52 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.2 t -124.67 129.21 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.876 0.369 . . . . 0.0 110.107 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.2 p -141.0 -8.31 1.03 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.534 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -144.29 150.67 38.25 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.004 0.431 . . . . 0.0 111.016 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.14 132.38 8.05 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -133.84 142.03 47.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.96 0.41 . . . . 0.0 110.101 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -100.01 121.66 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.048 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.545 HG13 ' N ' ' A' ' 20' ' ' ARG . 11.5 p -88.18 -45.69 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.167 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.545 ' N ' HG13 ' A' ' 19' ' ' VAL . 63.0 ttm-85 -146.76 139.31 25.02 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -108.19 143.94 36.31 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.2 m-20 -127.55 15.89 7.05 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.892 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.15 155.91 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -130.07 147.56 51.83 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.941 0.401 . . . . 0.0 111.063 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.435 ' OE1' HG22 ' A' ' 58' ' ' ILE . 10.3 pt-20 -62.59 139.47 58.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.92 7.97 73.42 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.843 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -117.92 148.99 41.63 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.865 0.333 . . . . 0.0 110.68 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 63.8 mtt -76.77 147.29 37.36 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.105 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.99 132.74 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -98.89 154.92 17.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.432 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -96.05 84.26 3.79 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.86 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 34' ' ' ASP . 46.5 p-10 -173.5 131.22 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 110.853 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' ASP . 96.7 mm-40 53.78 -80.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.609 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 32' ' ' ASP . 93.8 m-20 57.01 150.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.457 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 89.5 mt -122.12 76.68 1.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.283 0.563 . . . . 0.0 111.629 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.07 131.59 70.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -123.16 121.72 36.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.274 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.3 m -115.19 130.88 68.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 43' ' ' VAL . 5.4 tpp -91.83 152.18 20.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.896 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.487 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -156.66 -89.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.589 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.487 ' H ' HG23 ' A' ' 40' ' ' THR . 91.7 m-20 -76.16 44.84 0.34 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.286 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 58.37 37.72 25.85 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.61 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.452 ' O ' ' SD ' ' A' ' 39' ' ' MET . 30.6 m -147.54 158.98 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.67 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -100.17 118.49 36.61 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 110.727 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -119.59 130.45 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.543 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -94.98 138.78 32.26 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.28 92.99 34.2 Favored Pre-proline 0 N--CA 1.472 0.639 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.184 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.461 ' O ' ' OG ' ' A' ' 49' ' ' SER . 88.3 Cg_endo -80.03 143.87 16.45 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.227 1.951 . . . . 0.0 113.133 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 49' ' ' SER . 6.0 p 81.7 69.68 0.12 Allowed Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.408 ' CD ' ' OD2' ' A' ' 34' ' ' ASP . 64.2 Cg_endo -88.87 26.94 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.953 2.435 . . . . 0.0 112.177 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t 69.76 115.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.142 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -79.83 147.65 31.68 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 112.064 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.24 -133.92 2.57 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -122.48 134.33 54.58 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.487 HG23 HD21 ' A' ' 73' ' ' LEU . 7.7 mm -92.98 119.62 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -79.37 -52.39 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -168.44 157.96 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.705 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.4 tt -104.01 122.68 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.009 0.433 . . . . 0.0 111.334 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -100.93 -17.17 16.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -106.73 142.54 36.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.97 0.414 . . . . 0.0 110.884 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -117.47 169.83 9.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.313 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.29 134.19 56.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.246 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.49 6.17 86.43 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.866 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -79.09 131.85 36.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.2 0.524 . . . . 0.0 111.324 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -127.03 132.21 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.596 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.87 140.31 15.53 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.609 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.94 147.2 15.12 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.038 1.159 . . . . 0.0 112.187 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.1 p -60.13 130.4 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.51 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.08 55.99 0.21 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.4 m -151.38 175.69 12.0 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.055 0.455 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 m -101.14 109.7 21.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.252 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.05 -45.52 70.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.089 0.471 . . . . 0.0 110.946 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.487 HD21 HG23 ' A' ' 55' ' ' ILE . 3.9 tt -152.72 147.16 25.76 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.485 ' N ' HD23 ' A' ' 73' ' ' LEU . 58.3 tt0 -103.56 128.18 50.84 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.5 mt -128.07 129.52 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.164 0.507 . . . . 0.0 111.118 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -95.69 112.05 23.86 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.099 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.1 m . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.618 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 75' ' ' ILE . 21.6 t80 -79.75 127.58 32.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 110.217 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 54.8 mp0 -88.29 133.7 33.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.311 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -101.69 113.29 26.31 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 6' ' ' LEU . 54.0 mtmt -120.1 113.77 20.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 5' ' ' LYS . 12.6 mt -32.89 97.22 0.11 Allowed Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.521 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 9' ' ' ILE . 33.5 Cg_exo -55.1 148.17 50.11 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.721 1.614 . . . . 0.0 111.957 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -69.95 37.81 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.974 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.506 ' H ' ' C ' ' A' ' 7' ' ' PRO . 68.9 mt -109.17 129.83 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.69 -172.42 28.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 12' ' ' GLY . 79.9 tt0 -89.42 83.01 6.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.614 0.245 . . . . 0.0 110.612 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLU . . . 57.84 123.59 0.01 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.29 131.38 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.8 p -115.8 -39.69 3.46 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.61 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -145.99 153.62 40.99 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.69 109.76 3.91 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -121.49 132.61 54.82 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -101.91 120.58 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.94 0.4 . . . . 0.0 111.193 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.502 HG13 ' N ' ' A' ' 20' ' ' ARG . 8.7 p -92.95 -42.43 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.62 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.502 ' N ' HG13 ' A' ' 19' ' ' VAL . 43.2 ttm180 -148.79 134.51 18.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -104.2 140.44 37.83 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -120.24 16.77 12.33 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.094 0.406 . . . . 0.0 111.279 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.38 157.66 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.922 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -131.8 136.47 47.55 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.546 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.68 140.18 36.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 0.0 111.042 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.96 6.96 74.89 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.88 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -116.21 149.6 38.87 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.879 0.339 . . . . 0.0 110.723 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.5 mmm -83.47 147.32 27.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.643 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.2 t -118.9 132.54 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.353 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE1' ' OE1' ' A' ' 33' ' ' GLN . 95.5 mt-10 -96.23 155.59 16.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.721 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -67.83 134.13 50.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.859 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 57.86 34.56 24.5 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.241 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.414 ' OE1' ' OE1' ' A' ' 30' ' ' GLU . 82.7 mt-30 -143.13 87.49 1.97 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.868 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -174.62 168.95 3.7 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -136.31 97.69 3.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.244 0.545 . . . . 0.0 110.683 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.53 132.63 67.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.186 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -125.12 126.17 44.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.329 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.84 125.89 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.232 0.539 . . . . 0.0 109.567 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.0 ttp -105.86 137.91 42.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.069 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.535 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.6 t -102.81 -121.34 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.92 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.535 ' N ' ' OG1' ' A' ' 40' ' ' THR . 63.8 t0 -63.78 -46.77 83.73 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -177.13 60.55 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -150.33 149.13 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.741 0.305 . . . . 0.0 110.305 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -101.88 117.73 35.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.85 117.08 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.871 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -97.1 134.53 40.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.77 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.0 mt -138.9 129.58 14.96 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.556 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.45 143.59 22.0 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.134 1.889 . . . . 0.0 112.464 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 p -47.76 106.9 0.65 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.3 -23.51 32.84 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.077 1.185 . . . . 0.0 114.745 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.76 123.53 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.401 0.546 . . . . 0.0 111.732 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -83.04 161.22 21.76 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.38 -142.35 7.99 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.091 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -119.47 134.52 55.18 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.836 0.35 . . . . 0.0 111.187 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mm -95.93 117.74 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.64 -53.46 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -151.58 156.8 41.22 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.478 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.7 tt -108.84 120.35 60.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.004 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.47 -17.93 18.49 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.302 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.522 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 7.6 m-85 -111.42 144.62 40.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.44 0.638 . . . . 0.0 111.391 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.552 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 99.9 mtt180 -120.82 162.19 20.22 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.078 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -58.33 142.28 48.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.609 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.76 6.03 70.59 Favored Glycine 0 N--CA 1.469 0.869 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.552 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 85.9 mt-30 -94.13 132.06 39.04 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.364 0.602 . . . . 0.0 112.161 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.95 125.8 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.007 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 t -147.97 137.17 11.91 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.646 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -50.48 137.4 40.23 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.016 1.144 . . . . 0.0 112.213 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.58 126.44 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.469 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.08 49.32 0.04 OUTLIER Glycine 0 CA--C 1.531 1.034 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.956 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.8 p -159.75 160.46 34.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 117.182 0.491 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 71' ' ' THR . 5.2 t -91.66 104.27 16.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.803 0.811 . . . . 0.0 109.982 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 72' ' ' LEU . 2.2 mm? -67.31 -39.91 85.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.483 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.908 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.5 tt -141.55 148.63 39.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.908 ' N ' HD23 ' A' ' 73' ' ' LEU . 57.5 tt0 -102.6 130.22 49.41 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 2' ' ' TYR . 96.3 mt -127.41 127.91 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.247 0.546 . . . . 0.0 111.398 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -102.1 114.9 29.42 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.167 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.114 -0.946 . . . . 0.0 110.599 179.825 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' OD1' ' A' ' 76' ' ' ASP . 97.8 mmm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -148.02 147.97 30.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.398 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -126.69 138.72 53.44 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.08 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.35 113.89 27.56 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.317 0.58 . . . . 0.0 110.573 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 6' ' ' LEU . 98.9 mttt -119.49 112.83 19.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.172 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.576 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.7 tt -35.93 99.53 0.18 Allowed Pre-proline 0 N--CA 1.475 0.798 0 O-C-N 123.342 0.401 . . . . 0.0 110.446 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.18 154.52 25.22 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.702 1.601 . . . . 0.0 112.061 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -88.44 84.95 6.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.429 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.9 mt -123.82 135.23 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.933 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.24 -127.62 24.26 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -50.79 137.7 19.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.29 143.63 43.1 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.6 t -131.42 117.7 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 p -110.33 -14.82 14.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.807 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -145.24 144.58 30.88 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.256 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.05 111.0 3.25 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -121.28 129.99 53.43 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.426 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.6 mm -102.35 118.8 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.405 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.8 p -96.77 -47.48 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.831 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.575 ' N ' HG13 ' A' ' 19' ' ' VAL . 82.4 mtp180 -141.53 145.49 35.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.426 ' NE1' HG21 ' A' ' 18' ' ' ILE . 31.8 m95 -117.03 139.51 50.6 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.565 ' CG ' HH22 ' A' ' 52' ' ' ARG . 7.7 p-10 -108.09 5.15 25.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.492 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 3.8 m -133.84 157.2 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.626 0.251 . . . . 0.0 110.535 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.86 145.11 51.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.846 0.355 . . . . 0.0 110.496 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -61.54 138.5 58.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.196 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.07 8.01 65.2 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.913 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 28' ' ' MET . 68.1 t0 -117.32 135.95 53.48 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.926 0.363 . . . . 0.0 111.365 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.495 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 2.5 mpt? -90.48 131.69 36.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.047 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.17 146.0 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.743 0.306 . . . . 0.0 110.675 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.3 mm-40 -92.85 160.08 15.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.436 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -52.12 129.77 28.44 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.196 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 30' ' ' GLU . 2.5 p30 168.79 133.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.647 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -67.09 80.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.627 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 68.0 t0 -63.45 -43.2 98.07 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.363 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.523 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 1.4 mt 154.87 86.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.036 0.835 . . . . 0.0 110.824 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -117.47 126.05 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -121.13 123.09 41.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.467 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.93 130.42 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.418 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 25.1 ptm -128.12 152.05 48.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -94.71 -114.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.317 178.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.543 ' N ' ' OG1' ' A' ' 40' ' ' THR . 69.7 m-20 -65.03 -45.24 86.29 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -176.1 57.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.779 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 39' ' ' MET . 48.7 t -137.42 139.47 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -95.9 116.93 29.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.484 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.23 119.39 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -92.44 132.13 37.03 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 36' ' ' VAL . 57.3 mt -141.26 138.04 17.31 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.466 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -52.3 141.64 49.28 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 CA-C-N 120.178 1.099 . . . . 0.0 111.083 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.517 ' CB ' ' HE ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -46.6 162.94 0.24 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.017 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 51' ' ' VAL . 95.4 Cg_endo -78.16 54.81 5.09 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 123.23 2.62 . . . . 0.0 112.991 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 50' ' ' PRO . 4.1 t 59.12 109.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.144 -0.623 . . . . 0.0 109.52 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.565 HH22 ' CG ' ' A' ' 22' ' ' ASP . 95.9 mtt180 -102.81 146.07 28.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 111.828 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.45 -85.84 0.06 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -125.11 114.04 18.52 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mm -91.54 120.02 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.0 t -79.44 -52.83 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -169.88 157.37 6.72 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.084 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.1 tt -110.33 119.26 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.439 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.21 -17.6 20.67 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.569 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.429 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 28.2 m-85 -110.2 141.76 42.69 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.909 0.385 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -132.13 165.81 23.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.069 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.02 141.94 21.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.802 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.69 5.0 60.26 Favored Glycine 0 N--CA 1.471 0.995 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.235 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -99.51 131.25 45.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.494 0.664 . . . . 0.0 111.861 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.98 123.51 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.354 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.27 138.69 13.04 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.301 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -52.68 143.79 45.47 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.356 1.37 . . . . 0.0 112.394 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.6 p -52.03 128.95 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.601 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.28 52.76 0.08 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.738 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -156.48 161.8 40.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.033 0.417 . . . . 0.0 111.164 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.3 p -92.91 111.29 22.86 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.807 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.711 HD22 ' N ' ' A' ' 72' ' ' LEU . 2.3 mm? -89.08 -6.98 56.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.086 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.6 OUTLIER -176.45 142.54 0.45 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.196 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.473 ' H ' HD23 ' A' ' 73' ' ' LEU . 58.0 tt0 -104.37 126.48 51.5 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 57.7 mt -128.35 128.26 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.18 0.514 . . . . 0.0 111.474 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.507 ' OD1' ' SD ' ' A' ' 1' ' ' MET . 85.6 m-20 -101.28 111.06 23.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.131 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.351 180.0 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -75.31 142.71 43.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.724 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -112.03 135.95 52.01 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.289 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -101.21 117.16 34.43 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.312 0.577 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 6' ' ' LEU . 99.4 mttt -119.54 107.37 13.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.146 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 5' ' ' LYS . 16.2 tp -31.06 93.2 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.931 0 O-C-N 123.665 0.603 . . . . 0.0 110.886 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 5' ' ' LYS . 30.8 Cg_exo -59.15 150.04 76.28 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.214 1.943 . . . . 0.0 112.585 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -77.88 92.57 4.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.185 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.64 134.41 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.86 -158.95 45.29 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -137.5 158.45 44.37 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.78 42.37 4.46 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -124.77 129.01 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.8 p -128.52 -35.59 1.93 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.61 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -145.84 156.5 43.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.193 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.69 110.04 3.95 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -118.41 130.8 56.18 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.418 HG21 ' NE1' ' A' ' 21' ' ' TRP . 10.7 mm -100.12 120.15 49.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.107 0.48 . . . . 0.0 111.777 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.4 p -90.43 -45.61 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.467 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.6 mtt180 -147.7 149.33 32.23 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.418 ' NE1' HG21 ' A' ' 18' ' ' ILE . 69.5 m95 -114.79 140.62 48.77 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -121.74 12.23 10.59 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.004 0.365 . . . . 0.0 111.009 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 23' ' ' VAL . 5.3 m -126.09 131.07 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.81 141.65 36.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.187 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -54.91 135.77 47.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.879 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.27 6.48 84.17 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.516 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 28' ' ' MET . 64.2 t0 -110.82 146.95 35.53 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.245 0.522 . . . . 0.0 110.872 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.539 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 77.2 mtm -87.65 149.38 24.31 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.738 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.23 137.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.799 0.333 . . . . 0.0 110.444 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -90.21 158.83 17.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.51 138.16 58.26 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.42 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 58.6 37.02 25.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.057 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.33 87.21 1.87 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.489 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -172.82 167.09 5.25 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.733 0.302 . . . . 0.0 110.452 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -136.05 88.56 2.4 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.229 0.538 . . . . 0.0 110.138 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.16 128.61 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.522 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -117.08 118.01 31.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.561 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -109.52 129.3 64.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.0 ttp -117.14 154.97 30.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.647 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.59 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -140.16 -86.21 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.868 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.59 ' H ' HG23 ' A' ' 40' ' ' THR . 67.2 t0 -94.43 52.63 1.58 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.329 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 60.04 44.33 13.36 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 121.035 0.445 . . . . 0.0 110.835 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -130.1 138.32 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.748 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 m -94.89 118.13 31.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.215 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.83 117.54 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.148 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -93.1 128.84 39.16 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 110.467 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.7 mt -137.99 90.21 14.16 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.451 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.74 144.62 92.84 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.528 2.152 . . . . 0.0 112.413 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.8 m -51.06 108.63 1.09 Allowed Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.803 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.9 -15.35 23.72 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 121.638 1.559 . . . . 0.0 115.035 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.89 124.6 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.42 0.555 . . . . 0.0 111.779 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -89.16 149.01 23.35 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 120.689 0.28 . . . . 0.0 111.112 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.24 -138.42 4.89 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -122.31 144.14 49.19 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.958 0.409 . . . . 0.0 111.084 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 73' ' ' LEU . 7.8 mm -99.75 120.58 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.7 t -83.52 -50.96 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -158.86 154.69 26.46 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.592 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.58 ' O ' HG23 ' A' ' 58' ' ' ILE . 3.2 tt -91.47 108.23 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.42 0.629 . . . . 0.0 109.513 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.4 tp -82.01 -27.65 32.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.803 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' CE2' HD22 ' A' ' 72' ' ' LEU . 4.2 m-85 -117.15 145.33 43.89 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.366 0.603 . . . . 0.0 111.649 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.568 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 90.2 mtm-85 -120.48 168.41 11.36 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.952 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -62.73 146.85 51.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 111.968 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.32 5.08 85.63 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.182 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.568 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 86.0 mt-30 -89.22 132.1 35.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.444 0.64 . . . . 0.0 111.942 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.07 121.13 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.848 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.96 139.33 14.0 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.342 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.38 143.85 25.78 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.183 1.255 . . . . 0.0 112.246 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 p -61.68 129.2 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.162 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.35 52.54 0.07 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.452 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.4 t -167.05 153.65 8.42 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.991 0.396 . . . . 0.0 110.998 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.7 t -79.57 130.9 35.8 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.411 HD22 ' CE2' ' A' ' 60' ' ' TYR . 26.2 mt -105.52 0.07 26.31 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 74' ' ' GLN . 3.2 tp -173.13 143.35 1.12 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.661 ' N ' HD12 ' A' ' 73' ' ' LEU . 12.7 mm-40 -102.98 129.68 49.81 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.013 0.435 . . . . 0.0 110.47 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 83.1 mt -129.82 126.18 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.327 0.584 . . . . 0.0 111.611 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -89.78 138.75 31.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.653 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.329 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.402 ' H2 ' ' CB ' ' A' ' 77' ' ' THR . 22.5 ttm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.47 150.36 45.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.198 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -130.55 129.76 43.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.54 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CE2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -91.67 120.35 32.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -129.49 149.35 51.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.605 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.515 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.2 tt -95.16 106.46 25.89 Favored Pre-proline 0 N--CA 1.473 0.675 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.677 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.46 159.2 25.75 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.874 1.716 . . . . 0.0 111.892 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -76.92 88.54 3.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 110.74 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.39 -43.15 98.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.034 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.04 168.41 46.93 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.63 -37.02 83.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.775 0.322 . . . . 0.0 110.473 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.71 121.7 1.12 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.1 t -153.28 -52.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 110.218 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.8 p 42.93 72.26 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.202 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -174.3 144.66 0.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.637 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.57 110.52 0.5 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' OE1' ' CE ' ' A' ' 39' ' ' MET . 83.7 tt0 -122.87 135.88 54.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.842 0.353 . . . . 0.0 110.268 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 mm -102.56 121.24 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.931 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 20' ' ' ARG . 11.5 p -92.63 -42.44 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.36 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.515 ' N ' HG13 ' A' ' 19' ' ' VAL . 79.4 ttt-85 -142.31 137.51 30.64 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -109.27 141.05 42.12 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 10.8 p-10 -114.87 3.04 14.49 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.42 155.83 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.701 0.286 . . . . 0.0 110.684 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 99.0 mttt -135.11 150.54 50.23 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.221 0.534 . . . . 0.0 111.239 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -50.03 131.21 22.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.114 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.79 5.3 68.72 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.65 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 31.7 p-10 -106.67 150.06 26.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 117.52 0.66 . . . . 0.0 110.734 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.7 mmm -85.55 153.28 22.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.913 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 30' ' ' GLU . 26.6 t -125.18 160.57 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.957 0.408 . . . . 0.0 110.807 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 57.1 mp0 -118.45 152.26 36.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.355 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HB2' HH11 ' A' ' 52' ' ' ARG . 65.1 tttm -80.64 140.4 35.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.31 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.11 141.96 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.051 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 65.9 114.11 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.496 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 45.0 t0 -163.49 -173.03 3.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.489 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 84.8 mt -138.15 69.94 1.39 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.082 0.467 . . . . 0.0 111.341 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.88 131.06 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.478 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 57.3 mp0 -128.54 123.27 33.04 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 110.937 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.78 131.85 64.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.425 ' CE ' ' OE1' ' A' ' 17' ' ' GLU . 63.2 ttp -99.5 121.59 41.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.659 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -96.49 -86.26 0.32 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.248 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' N ' ' OG1' ' A' ' 40' ' ' THR . 99.7 m-20 -101.26 49.98 0.87 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.206 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.1 tttm 73.08 28.25 1.92 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.932 0.396 . . . . 0.0 110.304 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.27 137.46 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.534 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 m -94.48 117.16 29.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.914 0.388 . . . . 0.0 110.13 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.5 m -124.16 131.22 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.557 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -90.07 139.23 30.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.593 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.8 mt -133.5 137.41 28.91 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.322 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 49' ' ' SER . 53.1 Cg_exo -51.99 140.59 49.02 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 121.79 1.66 . . . . 0.0 112.862 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.43 ' OG ' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -40.67 165.71 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.21 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.29 42.57 1.36 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.079 2.52 . . . . 0.0 113.172 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.7 t 62.22 118.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.661 0.267 . . . . 0.0 110.974 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.401 HH11 ' HB2' ' A' ' 31' ' ' LYS . 35.5 ptt-85 -44.04 150.33 0.28 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.902 0.382 . . . . 0.0 111.756 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.04 -146.38 11.66 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -118.23 131.65 56.36 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.907 0.384 . . . . 0.0 110.383 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.415 ' CG2' HD11 ' A' ' 73' ' ' LEU . 8.1 mm -96.63 118.87 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.9 t -91.0 -52.5 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -150.49 156.9 42.33 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.109 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.7 tt -117.6 123.33 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.751 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.46 -16.85 16.69 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.172 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.516 ' CD2' ' OE1' ' A' ' 64' ' ' GLN . 15.6 m-85 -106.74 141.99 37.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.115 0.483 . . . . 0.0 111.161 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -122.2 168.92 11.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.204 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.22 134.65 57.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.833 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.91 4.9 90.4 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.704 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.516 ' OE1' ' CD2' ' A' ' 60' ' ' TYR . 49.7 tt0 -82.97 135.65 34.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.504 0.652 . . . . 0.0 110.919 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -126.93 131.92 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.08 140.65 15.13 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 119.328 -0.367 . . . . 0.0 111.083 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.3 148.88 48.6 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 121.42 1.413 . . . . 0.0 112.225 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 68' ' ' VAL . 7.5 p -57.8 132.55 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.204 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.78 51.84 0.11 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.4 p -159.06 163.27 36.44 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.445 0.623 . . . . 0.0 111.617 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.7 m -93.34 109.32 20.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.154 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.435 HD12 ' CE2' ' A' ' 4' ' ' PHE . 97.1 mt -63.75 -46.04 87.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.406 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.879 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.9 tt -152.55 146.47 25.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.492 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.879 ' N ' HD23 ' A' ' 73' ' ' LEU . 55.2 tt0 -102.95 130.06 49.89 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.6 mt -125.23 127.69 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.159 0.504 . . . . 0.0 111.342 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -91.92 137.27 32.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.402 ' CB ' ' H2 ' ' A' ' 1' ' ' MET . 19.1 m . . . . . 0 C--O 1.222 -0.392 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.252 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -139.78 149.9 44.09 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.92 133.78 50.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.265 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -88.23 112.82 23.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 109.933 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -117.64 117.57 29.73 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.697 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.49 ' C ' HD23 ' A' ' 6' ' ' LEU . 4.0 tt -47.26 107.66 0.75 Allowed Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.77 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.39 148.72 23.9 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.543 1.496 . . . . 0.0 111.55 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 21.8 p-10 -79.77 105.21 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.47 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.4 pt -127.84 157.06 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.896 0.379 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.99 -132.73 43.23 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -66.42 -35.78 81.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.504 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.06 170.55 13.31 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -133.12 110.81 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.445 ' OG1' ' OE1' ' A' ' 15' ' ' GLU . 12.2 p -72.38 -39.08 68.3 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.89 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.445 ' OE1' ' OG1' ' A' ' 14' ' ' THR . 57.0 mp0 -144.6 149.77 36.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.815 0.34 . . . . 0.0 110.266 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.99 117.81 5.94 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -123.27 131.98 53.86 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.435 HG21 ' NE1' ' A' ' 21' ' ' TRP . 9.0 mm -102.58 120.67 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.031 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.517 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.7 p -92.18 -43.12 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.72 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' NH2' ' OE1' ' A' ' 37' ' ' GLU . 86.2 mtm180 -144.92 151.4 38.61 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.435 ' NE1' HG21 ' A' ' 18' ' ' ILE . 68.2 m95 -118.68 140.98 49.04 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -116.64 9.06 14.0 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.1 0.409 . . . . 0.0 111.847 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.61 156.74 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.676 0.274 . . . . 0.0 110.342 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 62.6 mttp -115.34 142.34 46.81 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.275 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -57.33 134.64 56.17 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.36 6.43 66.32 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 40.1 p-10 -102.36 151.72 21.93 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.026 0.441 . . . . 0.0 110.86 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.9 mtm -81.64 144.61 31.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.199 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.0 t -122.54 133.61 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.389 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -104.03 159.94 15.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.114 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' HH11 ' A' ' 52' ' ' ARG . 87.9 tttt -62.87 133.46 54.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.279 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.1 37.96 26.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.522 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -139.43 81.46 1.83 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.727 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 49' ' ' SER . 68.0 t0 -177.67 132.17 0.16 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 41.5 tp -111.02 96.77 6.35 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.148 0.499 . . . . 0.0 109.99 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.77 124.03 72.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.542 ' OE1' ' NH2' ' A' ' 20' ' ' ARG . 76.0 tt0 -106.06 120.24 41.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.045 0.45 . . . . 0.0 110.6 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.32 131.55 67.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.678 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 43' ' ' VAL . 6.0 tpp -114.72 145.43 42.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.363 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 2.6 t -115.4 -131.35 0.32 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.027 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.532 ' N ' ' OG1' ' A' ' 40' ' ' THR . 67.3 t0 -65.13 -43.77 90.82 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.458 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -173.13 53.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.786 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.506 ' O ' ' SD ' ' A' ' 39' ' ' MET . 5.1 t -145.01 133.69 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.253 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -101.2 119.47 38.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.62 157.76 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.547 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -125.57 135.65 52.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.239 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.3 mt -133.58 88.26 34.52 Favored Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.503 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.18 142.53 97.26 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 122.409 2.072 . . . . 0.0 112.302 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.445 ' H ' ' HB3' ' A' ' 34' ' ' ASP . 74.2 m -41.55 102.45 0.27 Allowed Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.203 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.32 -23.12 38.86 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.081 1.188 . . . . 0.0 114.466 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.83 126.4 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 118.246 0.476 . . . . 0.0 111.32 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.402 HH11 ' HB2' ' A' ' 31' ' ' LYS . 33.5 ptt-85 -84.75 146.01 27.61 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 120.514 0.197 . . . . 0.0 110.897 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.23 -145.94 7.2 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.698 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -115.94 135.51 53.91 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.641 0.258 . . . . 0.0 110.392 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.5 mm -95.59 119.8 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.19 -53.27 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.531 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -164.1 157.73 18.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.727 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.7 tt -89.35 114.84 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.179 0.514 . . . . 0.0 110.691 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.94 -25.17 24.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.352 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.37 145.98 39.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.096 0.474 . . . . 0.0 111.192 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -123.23 165.65 16.55 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.017 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.4 142.39 48.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.417 0.627 . . . . 0.0 112.159 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.37 4.95 90.33 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.075 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -86.69 130.18 34.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 111.499 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.75 129.65 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.544 -0.753 . . . . 0.0 108.972 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.79 140.41 14.68 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 119.374 -0.346 . . . . 0.0 110.575 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.92 146.22 47.78 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.326 1.351 . . . . 0.0 112.584 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -56.12 130.47 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.09 49.78 0.15 Allowed Glycine 0 N--CA 1.47 0.903 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 p -160.52 164.52 32.02 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.135 0.467 . . . . 0.0 111.03 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.4 p -87.65 127.72 35.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.221 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 74.9 mt -93.58 -4.56 50.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.321 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.733 HD12 ' H ' ' A' ' 74' ' ' GLN . 2.0 tp 174.76 149.55 0.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.733 ' H ' HD12 ' A' ' 73' ' ' LEU . 58.2 tt0 -104.76 128.12 52.77 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.922 0.392 . . . . 0.0 111.394 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.3 mt -126.56 128.01 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.094 0.473 . . . . 0.0 110.976 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -96.9 110.97 23.37 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.068 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.506 -179.763 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -126.77 148.87 49.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.739 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -124.62 135.42 53.08 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.281 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -100.76 119.74 39.07 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.33 147.24 48.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.917 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 tt -76.24 116.68 58.19 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.686 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.82 155.3 39.16 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.949 1.766 . . . . 0.0 112.812 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -84.15 91.08 7.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.347 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.0 pt -97.45 -0.16 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.041 0.448 . . . . 0.0 110.324 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.24 127.29 4.12 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -65.94 -36.77 84.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.546 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.91 79.34 1.25 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.5 t -129.48 130.99 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 m -127.16 -20.27 4.16 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.177 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -171.08 146.04 2.36 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.362 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.09 168.31 13.74 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -156.68 142.78 18.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.482 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 mm -102.87 121.33 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.462 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 20' ' ' ARG . 27.0 m -92.35 -45.4 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.434 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' N ' HG23 ' A' ' 19' ' ' VAL . 95.7 mtt-85 -139.77 146.83 39.98 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.26 0.552 . . . . 0.0 112.077 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -114.57 142.99 45.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.263 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -118.17 8.34 12.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.451 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.21 156.06 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.792 0.33 . . . . 0.0 110.73 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.86 146.55 39.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.275 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.31 138.75 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.907 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.21 7.91 69.34 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.601 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 28' ' ' MET . 60.7 t0 -120.8 148.09 44.47 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.93 0.395 . . . . 0.0 111.038 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.537 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 96.9 mtp -83.94 150.13 25.87 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.561 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.4 t -119.73 133.59 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.807 0.337 . . . . 0.0 110.321 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 57.3 mp0 -101.96 155.41 18.18 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.443 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -71.34 140.8 50.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.024 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 t0 80.61 64.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.766 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -140.36 87.58 2.15 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -98.01 89.28 4.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.724 0.297 . . . . 0.0 111.354 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.9 mt -140.92 27.16 2.01 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 m -116.61 135.81 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -122.7 126.24 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.598 0.237 . . . . 0.0 110.602 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.33 155.74 34.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 110.464 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 43' ' ' VAL . 28.0 tpp -106.71 125.42 50.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.624 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.69 -49.77 3.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.974 0.416 . . . . 0.0 110.079 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' OD1' HG23 ' A' ' 43' ' ' VAL . 47.8 p-10 -139.23 49.72 1.83 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.438 ' C ' ' SD ' ' A' ' 39' ' ' MET . 48.5 tttm 72.76 23.8 2.84 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.589 ' N ' ' SD ' ' A' ' 39' ' ' MET . 47.6 t -123.69 134.57 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.754 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.3 m -95.68 118.74 32.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.661 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.12 155.11 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.251 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -109.67 135.1 51.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.711 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.32 157.88 75.73 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 49' ' ' SER . 37.2 Cg_exo -55.2 147.24 55.87 Favored 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 121.914 1.743 . . . . 0.0 112.452 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -48.4 179.9 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.352 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 49' ' ' SER . 88.0 Cg_endo -89.31 44.91 0.77 Allowed 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 123.094 2.529 . . . . 0.0 113.056 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.1 t 62.79 117.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 120.682 0.277 . . . . 0.0 111.745 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -39.26 147.12 0.07 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.695 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.53 -147.14 12.85 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.27 139.1 51.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.963 0.382 . . . . 0.0 110.309 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mm -103.31 119.02 51.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -93.6 -51.62 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -147.17 157.5 43.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.52 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.4 tt -116.94 124.24 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.376 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.22 -16.42 15.21 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 8.1 m-85 -109.89 145.51 36.71 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.269 0.557 . . . . 0.0 111.751 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -124.87 161.8 25.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.254 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -56.11 138.52 49.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.558 0.694 . . . . 0.0 112.33 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.85 5.67 89.91 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.202 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -81.2 133.83 35.52 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.332 -0.51 . . . . 0.0 110.832 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.9 t -118.02 128.62 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.157 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 t -149.84 139.38 13.17 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.513 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.04 143.28 83.92 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.205 1.27 . . . . 0.0 111.746 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.21 130.95 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.73 50.13 0.05 OUTLIER Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.975 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -166.65 164.07 16.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.388 0.594 . . . . 0.0 111.451 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 71' ' ' THR . 7.8 t -94.71 114.43 26.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.188 0.518 . . . . 0.0 109.628 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.533 ' CD1' ' CD2' ' A' ' 60' ' ' TYR . 2.9 mm? -64.72 -40.32 95.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.334 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.9 tt -142.62 147.7 36.24 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.873 ' N ' HD23 ' A' ' 73' ' ' LEU . 55.5 tt0 -102.74 130.7 49.78 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.0 mt -128.3 127.78 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.982 0.42 . . . . 0.0 111.296 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -96.0 116.37 28.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.47 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.108 -179.82 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -80.32 141.05 35.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.66 138.51 51.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.737 0.303 . . . . 0.0 110.756 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -101.36 106.02 17.13 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -114.84 120.81 41.27 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.066 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.58 ' C ' HD23 ' A' ' 6' ' ' LEU . 4.4 tt -47.11 107.64 0.75 Allowed Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.447 ' N ' HD23 ' A' ' 6' ' ' LEU . 44.6 Cg_exo -54.27 144.65 59.09 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.533 1.488 . . . . 0.0 112.332 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -79.23 19.08 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.373 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.4 pt -121.59 147.02 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.036 0.446 . . . . 0.0 110.568 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.94 -162.35 29.69 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.33 -40.2 95.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.227 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.89 111.66 0.25 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.7 t -128.29 127.17 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.3 p -125.09 -14.44 6.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.916 0.388 . . . . 0.0 110.675 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.451 ' OE2' HG22 ' A' ' 65' ' ' VAL . 74.8 tt0 -159.4 153.27 23.15 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -98.69 144.59 17.31 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -157.06 126.7 6.16 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.417 HG21 ' NE1' ' A' ' 21' ' ' TRP . 5.4 mm -102.54 120.09 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.802 0.334 . . . . 0.0 111.65 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.1 p -87.27 -47.45 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.851 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.565 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.8 mtt180 -142.77 147.77 36.09 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.417 ' NE1' HG21 ' A' ' 18' ' ' ILE . 42.1 m95 -113.24 136.17 53.03 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 22.3 p-10 -99.69 -7.12 26.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.8 m -145.37 161.12 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.48 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 99.0 mttt -139.36 155.44 47.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.151 0.501 . . . . 0.0 111.215 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -46.78 142.31 3.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.389 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.9 8.53 67.08 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.137 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 47.2 p-10 -129.65 149.47 51.39 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.015 0.908 . . . . 0.0 111.659 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.5 mtt -84.94 151.39 24.27 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.54 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.18 147.1 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.093 0.473 . . . . 0.0 110.309 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 97.6 mt-10 -140.56 152.77 45.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.068 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 30' ' ' GLU . 33.7 tptt 94.59 124.11 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.955 0.784 . . . . 0.0 110.707 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 49' ' ' SER . 9.0 p-10 -72.75 -3.32 24.57 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.469 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -132.49 87.27 2.4 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.6 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 53.1 p-10 -97.82 -112.32 0.15 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.6 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 54.5 tp -166.84 80.51 0.23 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.275 0.559 . . . . 0.0 110.714 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.64 132.35 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -109.27 123.77 49.82 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 110.582 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.76 128.23 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.621 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttm -109.2 155.94 20.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.03 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.5 t -132.21 -118.33 0.21 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.629 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.536 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.2 p-10 -66.73 -46.33 75.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.941 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.488 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 30.8 ttmt -174.64 56.2 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.485 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -162.21 151.76 3.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.826 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 m -117.09 122.49 44.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.065 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.59 157.31 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.055 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.26 134.44 51.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.0 mt -118.53 137.63 24.99 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.92 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 49' ' ' SER . 50.2 Cg_exo -51.11 142.07 36.26 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.442 1.428 . . . . 0.0 112.467 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -36.58 157.44 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.37 44.93 1.72 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.496 2.131 . . . . 0.0 112.578 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.8 t 63.62 117.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -50.25 146.7 4.85 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.933 0.396 . . . . 0.0 111.704 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.73 -136.59 4.33 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -127.04 143.84 51.18 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.033 0.416 . . . . 0.0 110.239 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.474 HG23 HD21 ' A' ' 73' ' ' LEU . 7.3 mm -104.0 117.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.3 t -91.18 -50.72 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -149.97 157.17 42.89 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.427 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 58' ' ' ILE . 15.5 tt -132.02 126.84 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.766 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.13 -16.11 20.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.914 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.587 ' CE1' HD23 ' A' ' 72' ' ' LEU . 25.2 m-85 -102.01 134.65 44.9 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.36 0.6 . . . . 0.0 111.782 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.81 178.99 4.28 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.987 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.69 128.16 35.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.781 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.46 5.88 81.56 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.527 177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -83.72 139.49 32.71 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.198 0.999 . . . . 0.0 111.743 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 16' ' ' GLY . 12.9 p -125.73 132.63 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.378 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -147.99 137.59 12.24 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.032 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.51 150.6 41.99 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 121.472 1.448 . . . . 0.0 112.439 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.37 130.6 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.307 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.7 48.15 0.11 Allowed Glycine 0 N--CA 1.471 1.018 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.247 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.3 p -163.12 162.89 25.88 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 117.376 0.588 . . . . 0.0 111.171 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -90.28 130.79 36.35 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.587 HD23 ' CE1' ' A' ' 60' ' ' TYR . 78.3 mt -89.27 -12.36 40.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.3 tt -169.59 146.78 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.976 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.502 ' N ' HD23 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -102.81 122.31 44.26 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.139 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.0 mt -124.97 128.73 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.398 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -98.54 111.26 23.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.229 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.56 -179.951 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -80.68 137.22 36.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -114.02 126.64 55.35 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -96.97 113.65 25.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.211 0.529 . . . . 0.0 110.161 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -117.71 139.42 51.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.023 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -71.51 113.15 17.25 Favored Pre-proline 0 N--CA 1.47 0.549 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.546 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -81.64 154.43 18.02 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.057 1.838 . . . . 0.0 111.929 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -69.67 138.67 53.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.3 pt -109.88 1.55 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.759 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.28 166.2 39.09 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -89.45 146.33 24.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.861 0.362 . . . . 0.0 110.414 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.44 25.24 66.11 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.9 t -123.49 130.88 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 p -152.73 70.08 0.88 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.475 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -162.14 143.63 10.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.43 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.22 110.22 0.79 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -123.23 137.04 54.97 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.03 121.42 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 112.056 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.8 p -87.19 -46.56 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.609 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' N ' HG13 ' A' ' 19' ' ' VAL . 72.2 ttt180 -149.16 137.28 20.71 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -100.84 145.6 28.36 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 11.5 p-10 -121.3 8.89 10.3 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.31 155.68 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.075 0.464 . . . . 0.0 111.018 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -134.74 147.57 50.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 56' ' ' VAL . 24.0 tp10 -60.11 135.25 57.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.167 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.77 8.06 70.39 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.224 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -118.4 156.33 29.16 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.125 0.463 . . . . 0.0 111.322 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.2 mmt -96.4 150.96 20.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 30' ' ' GLU . 3.4 p -138.32 154.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.809 0.337 . . . . 0.0 110.405 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 1.3 pm0 -109.98 155.19 22.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.974 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -83.8 92.75 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.765 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -178.61 75.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.99 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 38.74 91.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.957 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.45 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 27.4 t70 -84.67 11.97 8.02 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.339 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.9 mt 66.0 66.33 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.918 0.761 . . . . 0.0 110.859 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.06 128.93 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -120.56 125.54 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.14 0.495 . . . . 0.0 111.091 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.5 m -121.04 133.57 67.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.265 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.9 ttp -103.88 109.54 21.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.413 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 40' ' ' THR . 0.2 OUTLIER -63.67 -51.96 62.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.201 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -138.49 -65.48 0.5 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.545 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -149.47 43.83 0.93 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.701 0.286 . . . . 0.0 110.37 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.0 p -150.87 149.71 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.951 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 m -102.19 118.86 37.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.516 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.64 133.54 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.482 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -94.24 137.45 33.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.745 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.2 mt -132.03 139.15 34.11 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.059 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 49' ' ' SER . 50.4 Cg_exo -52.97 142.74 52.24 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.356 1.371 . . . . 0.0 112.379 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.93 164.85 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.551 -179.218 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.28 44.55 1.63 Allowed 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.149 2.566 . . . . 0.0 112.663 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t 64.38 116.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.732 0.301 . . . . 0.0 110.901 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -49.78 146.93 4.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 111.665 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 167.3 -134.57 3.31 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.0 139.55 53.34 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.87 0.335 . . . . 0.0 110.192 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -99.01 120.25 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.464 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 21.4 t -87.05 -54.76 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -154.13 158.76 40.89 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.302 0.572 . . . . 0.0 112.038 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.4 tt -116.87 119.54 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.198 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 74.3 mt -100.17 -18.22 17.02 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.3 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -115.17 142.75 46.23 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -123.7 165.92 16.42 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.142 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.42 150.25 11.99 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.014 0.435 . . . . 0.0 111.983 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.55 6.47 77.17 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.303 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -101.72 129.97 48.01 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 112.071 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.95 128.94 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 t -147.08 140.43 14.94 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.783 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.48 140.82 63.7 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.239 1.293 . . . . 0.0 112.05 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 68' ' ' VAL . 10.2 p -59.43 131.75 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.555 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.28 50.48 0.12 Allowed Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.014 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.1 p -156.36 164.55 38.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.269 0.535 . . . . 0.0 111.304 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.4 m -88.26 121.06 30.22 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.88 -27.69 13.48 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 74' ' ' GLN . 1.7 tt -156.12 141.71 17.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.796 ' N ' HD23 ' A' ' 73' ' ' LEU . 52.2 tt0 -104.25 132.81 50.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.86 0.362 . . . . 0.0 110.205 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.7 mt -130.99 127.47 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.191 0.519 . . . . 0.0 111.34 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -87.46 142.95 27.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.717 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 83.9 m . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.299 179.535 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -116.26 141.49 48.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -114.6 126.41 54.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.88 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -99.62 118.69 36.71 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.21 0.528 . . . . 0.0 110.503 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -124.65 140.91 52.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.882 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.81 114.75 12.21 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.98 153.98 37.63 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.622 1.548 . . . . 0.0 112.662 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -90.16 106.39 18.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.587 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.5 pt -127.03 143.71 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.47 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.43 -5.52 43.86 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 52.96 171.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.78 28.67 64.56 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.518 HG22 ' OG1' ' A' ' 40' ' ' THR . 59.8 t -123.67 128.95 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.0 p -135.52 -7.26 2.22 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.291 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -142.06 148.71 38.87 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.768 0.318 . . . . 0.0 110.619 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.82 135.71 8.83 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.38 137.88 54.72 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.411 HG21 ' NE1' ' A' ' 21' ' ' TRP . 8.9 mm -102.66 121.18 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.688 0.28 . . . . 0.0 111.616 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 t -101.53 -34.65 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.751 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -153.49 133.21 13.06 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.88 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.411 ' NE1' HG21 ' A' ' 18' ' ' ILE . 67.6 m95 -105.37 130.48 53.47 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 16.8 p-10 -98.98 3.66 47.05 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.719 0.295 . . . . 0.0 111.086 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.46 157.64 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.792 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -132.33 145.7 51.45 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.32 0.581 . . . . 0.0 111.402 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -58.39 140.48 53.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.919 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.71 6.89 65.26 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -121.48 126.6 49.65 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.082 0.441 . . . . 0.0 111.225 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -71.34 141.17 50.44 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 30' ' ' GLU . 11.2 t -142.1 161.5 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 1.6 pm0 -127.66 152.1 48.11 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.055 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 30' ' ' GLU . 52.4 pttt -26.8 145.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.583 0.552 . . . . 0.0 111.752 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.5 ' O ' ' O ' ' A' ' 33' ' ' GLN . 94.6 m-20 61.69 58.31 2.03 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.227 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.699 ' NE2' ' H ' ' A' ' 49' ' ' SER . 1.4 pm0 -43.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.488 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' H ' ' CG ' ' A' ' 33' ' ' GLN . 66.4 t0 -153.4 61.17 0.76 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.036 0.446 . . . . 0.0 110.672 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 34' ' ' ASP . 19.3 mt 55.73 124.62 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.999 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.73 131.78 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -92.87 120.53 33.31 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.331 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -129.22 134.93 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.967 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.0 ttp -116.43 153.15 32.6 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.723 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.518 ' OG1' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -135.31 -82.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 40' ' ' THR . 99.0 m-20 -91.6 44.43 1.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.0 tttt 68.46 38.06 2.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.79 0.328 . . . . 0.0 110.443 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.3 t -132.31 136.95 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -94.22 113.78 25.77 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.03 0.443 . . . . 0.0 110.012 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.39 133.75 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.822 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -93.53 125.26 38.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.31 0.576 . . . . 0.0 110.58 179.368 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.4 mt -135.46 85.68 31.27 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.471 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.09 145.02 99.07 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 122.483 2.122 . . . . 0.0 111.722 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.699 ' H ' ' NE2' ' A' ' 33' ' ' GLN . 1.2 m -74.69 131.9 78.87 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.754 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.89 -15.45 40.33 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.816 1.677 . . . . 0.0 113.749 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -136.97 155.51 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.769 0.319 . . . . 0.0 111.424 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.18 160.02 9.4 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.42 -82.63 0.05 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -124.63 124.13 41.55 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -97.76 115.66 38.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.68 -54.07 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -165.36 152.64 10.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.514 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.8 tt -105.62 121.12 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.542 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -95.24 -17.48 21.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.077 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.529 ' CD1' HD13 ' A' ' 72' ' ' LEU . 12.3 m-85 -109.8 142.78 40.57 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.216 0.531 . . . . 0.0 111.261 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.493 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 60.7 ttm-85 -126.69 162.54 25.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.757 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -55.0 147.2 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.212 0.53 . . . . 0.0 111.875 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.44 6.48 87.56 Favored Glycine 0 N--CA 1.47 0.919 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.945 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.493 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 86.8 mt-30 -98.76 133.32 43.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.368 0.604 . . . . 0.0 111.715 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.81 129.14 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.29 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.9 t -147.64 141.04 15.29 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.722 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.04 142.47 34.39 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.466 1.444 . . . . 0.0 112.332 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -60.8 133.82 26.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.822 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.53 51.81 0.16 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 m -153.02 159.43 42.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 117.457 0.629 . . . . 0.0 111.561 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.2 m -88.04 98.08 11.33 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.867 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.535 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 3.1 mm? -65.21 -41.63 94.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.641 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.846 HD23 ' N ' ' A' ' 74' ' ' GLN . 1.8 tt -146.39 148.6 32.5 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.846 ' N ' HD23 ' A' ' 73' ' ' LEU . 54.3 mt-30 -103.26 127.18 50.66 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 mt -126.08 127.86 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.1 0.476 . . . . 0.0 111.575 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -101.83 114.16 28.0 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.961 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.4 -179.935 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 ttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -85.54 147.15 26.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.897 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -121.33 135.72 55.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.325 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.436 ' CE2' HD12 ' A' ' 72' ' ' LEU . 1.3 t80 -99.55 118.51 36.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -121.54 146.44 46.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.293 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.19 115.99 17.14 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -49.3 138.05 30.13 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.391 1.394 . . . . 0.0 113.291 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -81.53 12.72 3.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.339 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 pt -124.56 148.93 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.796 0.331 . . . . 0.0 110.489 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.82 -166.8 32.52 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -65.72 -37.1 85.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.37 . . . . 0.0 110.462 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASP . . . 170.81 134.78 1.81 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.98 129.44 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.815 0.34 . . . . 0.0 110.276 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 p -123.18 -26.81 4.26 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.354 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -173.77 156.41 2.85 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.373 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.11 122.61 6.97 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -131.63 135.19 46.75 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.436 HG21 ' NE1' ' A' ' 21' ' ' TRP . 8.4 mm -102.7 120.0 51.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.185 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 m -92.37 -43.58 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.719 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -142.93 145.52 33.11 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.436 ' NE1' HG21 ' A' ' 18' ' ' ILE . 46.3 m95 -118.22 140.28 50.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.1 m-20 -119.8 13.47 12.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.781 0.324 . . . . 0.0 110.82 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.35 158.92 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 26.4 pttm -138.94 144.36 39.0 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 110.574 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 26' ' ' GLY . 13.1 tm-20 -47.78 138.88 8.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.725 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' N ' ' CD ' ' A' ' 25' ' ' GLU . . . 87.56 6.82 76.61 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.451 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 42.4 p-10 -106.93 150.01 26.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.206 0.503 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.6 mtp -90.31 142.69 27.48 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.091 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.9 t -120.01 133.38 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.672 0.272 . . . . 0.0 110.705 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -101.47 156.49 17.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.238 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.39 135.9 55.83 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.704 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 57.9 34.4 24.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.303 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -144.43 88.27 1.92 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.76 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -172.67 170.87 4.63 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.938 0.399 . . . . 0.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.452 HD23 ' NZ ' ' A' ' 46' ' ' LYS . 81.0 mt -140.14 88.42 2.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.61 133.38 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.444 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -123.1 124.91 44.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.189 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.04 154.64 26.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.215 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.6 ttp -106.84 152.4 23.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.216 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.65 -42.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.479 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 91.9 m-20 -136.0 49.0 2.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.92 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 56.81 43.46 25.0 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.066 0.46 . . . . 0.0 109.961 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.43 152.1 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.25 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.6 m -95.9 118.29 32.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.612 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.74 131.38 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.193 0.52 . . . . 0.0 110.769 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.452 ' NZ ' HD23 ' A' ' 35' ' ' LEU . 54.0 tttp -92.03 139.24 30.84 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.086 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.3 mt -134.73 135.2 22.95 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.078 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 49' ' ' SER . 43.0 Cg_exo -51.6 146.17 27.42 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 121.689 1.593 . . . . 0.0 112.308 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.26 166.31 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.466 -179.272 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.71 49.85 3.32 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 123.044 2.496 . . . . 0.0 113.082 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t 68.29 119.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.838 0.351 . . . . 0.0 111.492 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -47.41 135.9 10.25 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.753 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.15 -141.52 6.51 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -123.59 144.98 49.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.021 0.411 . . . . 0.0 110.559 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.409 HG23 HD21 ' A' ' 73' ' ' LEU . 8.2 mm -100.96 120.76 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.2 t -92.43 -51.13 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -154.6 159.15 40.67 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.761 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.1 tt -106.95 132.76 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.221 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.44 -24.6 10.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.459 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -108.4 141.41 40.29 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.035 0.445 . . . . 0.0 111.418 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.554 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 90.4 mtm180 -120.2 162.62 19.05 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.39 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 56.2 mp0 -56.17 134.83 53.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.174 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.75 4.98 84.62 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.929 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.554 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 79.8 mt-30 -83.27 135.53 34.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.688 0.744 . . . . 0.0 111.875 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.3 t -120.11 126.84 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 t -148.67 132.5 8.53 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -56.47 149.65 55.86 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.459 1.439 . . . . 0.0 112.106 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 68' ' ' VAL . 1.4 p -58.89 128.56 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.783 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.52 49.72 0.05 OUTLIER Glycine 0 CA--C 1.531 1.078 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.131 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m -163.92 166.97 21.18 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.388 0.594 . . . . 0.0 111.165 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 71' ' ' THR . 6.3 t -95.4 115.92 28.09 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.436 HD12 ' CE2' ' A' ' 4' ' ' PHE . 92.1 mt -65.99 -42.98 89.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.291 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.532 HD23 ' N ' ' A' ' 74' ' ' GLN . 4.0 tt -144.01 151.28 39.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.532 ' N ' HD23 ' A' ' 73' ' ' LEU . 36.8 mt-30 -102.62 121.12 41.77 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.9 127.19 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.965 0.412 . . . . 0.0 111.827 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.56 136.95 32.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.482 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.397 -179.872 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtm . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -111.77 143.65 42.34 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.328 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -139.49 114.31 9.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.017 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -88.87 122.44 32.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.135 0.493 . . . . 0.0 110.633 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -121.76 157.85 30.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.178 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 8' ' ' ASP . 10.4 tp -44.43 126.24 4.76 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.92 13.19 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.186 1.257 . . . . 0.0 112.539 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 6' ' ' LEU . 99.1 m-20 46.17 82.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.773 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.38 -43.16 97.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.89 -168.88 41.79 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 57.96 77.16 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.019 0.438 . . . . 0.0 110.559 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.88 54.82 34.76 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.9 t -128.71 131.05 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 120.866 0.365 . . . . 0.0 110.274 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -163.47 46.59 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.234 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -169.17 154.09 5.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.896 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.79 137.09 10.29 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -151.97 133.47 14.63 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.921 0.391 . . . . 0.0 109.986 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.404 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.6 mm -102.77 124.34 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.561 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.5 p -91.58 -44.24 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.527 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.514 ' N ' HG13 ' A' ' 19' ' ' VAL . 71.3 ttt180 -151.61 137.87 18.42 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.404 ' NE1' HG21 ' A' ' 18' ' ' ILE . 60.9 m95 -107.75 136.9 46.72 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.1 m-20 -108.16 0.46 21.56 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.665 0.269 . . . . 0.0 110.766 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.5 m -133.54 158.49 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -137.5 154.33 49.89 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -54.73 143.21 25.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.059 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.51 7.13 76.29 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.762 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 28' ' ' MET . 62.0 t0 -123.19 150.57 43.2 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.602 0.701 . . . . 0.0 111.089 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.553 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 76.5 mtm -78.07 149.09 33.99 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -121.8 133.93 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.69 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.86 157.41 17.22 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.348 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.05 94.48 6.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' ASP . 8.0 p30 173.12 113.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.936 0.398 . . . . 0.0 111.381 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 53.67 -82.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.829 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' ASP . 9.7 t0 74.88 13.14 3.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.864 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.3 mt 21.08 84.48 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.761 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.93 130.33 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.6 mp0 -116.37 124.38 49.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.475 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.56 135.14 58.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.637 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.7 ttp -124.83 151.46 45.21 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.675 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -104.27 -51.83 3.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.742 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' OG1' ' A' ' 40' ' ' THR . 94.7 m-20 -138.01 -62.5 0.59 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.327 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -146.31 39.19 1.08 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.855 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.6 t -129.87 133.33 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.798 0.332 . . . . 0.0 110.134 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.5 m -114.96 115.79 27.45 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.09 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.0 m -129.46 131.13 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.852 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -95.2 133.35 39.15 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.095 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mt -128.85 134.48 26.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.993 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.35 144.23 50.27 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.678 1.586 . . . . 0.0 111.219 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.1 m -99.0 104.01 23.14 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.22 48.43 2.49 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.186 1.924 . . . . 0.0 110.663 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.61 158.91 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -160.36 144.98 14.45 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.128 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.01 -137.05 4.98 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.07 141.72 51.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.902 0.351 . . . . 0.0 110.087 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -97.09 119.97 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.33 -49.61 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -158.26 158.43 34.43 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.734 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 58' ' ' ILE . 4.4 tt -123.96 122.8 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.255 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.3 mt -99.15 -18.02 17.88 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.668 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CE1' HD23 ' A' ' 72' ' ' LEU . 21.3 m-85 -105.43 136.5 44.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.156 0.503 . . . . 0.0 110.827 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -121.06 -176.45 3.27 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.031 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -64.57 126.78 28.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.59 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.47 5.57 86.79 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.22 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -70.48 133.97 47.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.802 0.801 . . . . 0.0 110.835 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.71 126.9 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.3 t -149.17 139.49 13.44 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.189 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.91 150.34 64.25 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.034 1.156 . . . . 0.0 111.707 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.0 p -64.05 127.66 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.347 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.74 52.38 0.07 OUTLIER Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.027 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.7 p -162.84 163.45 26.51 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 117.289 0.545 . . . . 0.0 111.38 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 p -89.76 113.09 24.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.156 0.503 . . . . 0.0 110.182 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.46 HD23 ' CE1' ' A' ' 60' ' ' TYR . 96.2 mt -67.19 -39.14 86.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.559 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 74' ' ' GLN . 0.8 OUTLIER -151.57 144.91 24.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.606 -177.391 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.469 ' N ' HD23 ' A' ' 73' ' ' LEU . 52.4 tt0 -103.38 125.91 50.25 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.4 mt -132.63 128.77 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.222 0.535 . . . . 0.0 111.333 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -100.65 136.08 41.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.838 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.431 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.442 ' SD ' ' OE1' ' A' ' 74' ' ' GLN . 14.3 ptp . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -101.71 134.69 44.48 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 40.5 mp0 -111.51 116.87 31.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.747 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -76.93 100.56 5.62 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -105.83 155.75 19.0 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.108 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.9 mt -93.33 108.25 31.98 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.87 157.67 24.2 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.847 1.698 . . . . 0.0 112.169 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.455 ' OD1' HG21 ' A' ' 68' ' ' VAL . 90.1 m-20 -91.04 110.32 21.58 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.142 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 9' ' ' ILE . 14.5 tt -174.25 -21.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 110.408 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.71 -35.52 0.28 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.95 -37.33 81.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 0.0 110.501 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -143.96 133.06 5.16 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 15' ' ' GLU . 1.2 p -155.0 151.82 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 13' ' ' VAL . 11.6 p 53.64 -72.86 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.245 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER -139.07 144.72 38.9 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.075 -0.391 . . . . 0.0 111.126 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.63 123.63 7.74 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -126.14 140.05 52.88 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 117.334 0.567 . . . . 0.0 110.158 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.54 121.8 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.29 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 20' ' ' ARG . 12.1 p -92.96 -42.74 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.762 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.482 ' N ' HG13 ' A' ' 19' ' ' VAL . 72.3 ttt180 -155.89 133.84 11.28 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -102.01 134.41 45.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 24.0 p-10 -106.21 -0.52 24.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.662 0.268 . . . . 0.0 111.149 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.63 160.37 37.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -139.6 155.78 47.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -50.87 135.72 23.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.079 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.17 4.61 66.49 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.858 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 36.7 p-10 -114.46 154.06 28.84 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.628 0.714 . . . . 0.0 110.908 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.9 mtm -114.12 148.73 36.71 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.01 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -139.43 150.4 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.92 0.391 . . . . 0.0 110.706 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -90.06 159.35 16.88 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.54 136.62 58.08 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.986 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 60.0 36.43 21.5 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.821 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -145.4 86.32 1.75 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 17.3 t0 -176.27 161.06 2.24 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.531 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 76.6 mt -134.55 88.63 2.46 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.107 0.479 . . . . 0.0 109.882 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.38 130.09 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -111.92 124.63 52.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.582 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.5 m -121.91 131.21 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.1 ttm -101.93 123.31 45.62 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.692 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -88.1 -90.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.418 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 42' ' ' LYS . 23.0 p-10 -96.03 -68.98 0.77 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.726 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.502 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 25.0 pttm -149.2 43.17 0.95 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.73 0.3 . . . . 0.0 110.977 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.19 151.21 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.909 0.385 . . . . 0.0 110.598 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 m -99.63 117.78 34.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.069 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.9 m -118.0 134.02 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.239 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.43 134.18 41.03 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.928 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.0 mt -137.23 85.41 21.98 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.732 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -55.74 141.43 84.51 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.705 2.27 . . . . 0.0 112.333 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.9 t -36.23 100.27 0.19 Allowed Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.589 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.92 -21.92 36.82 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.073 1.182 . . . . 0.0 113.843 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.19 120.96 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 122.104 -0.372 . . . . 0.0 111.212 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.48 152.94 33.95 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 121.167 -0.213 . . . . 0.0 110.547 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.2 -134.29 3.04 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.31 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -136.93 134.03 36.32 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.741 0.305 . . . . 0.0 110.234 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.0 mm -90.77 118.44 36.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.95 -51.47 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -146.17 156.74 43.63 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.885 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.529 ' O ' HG23 ' A' ' 58' ' ' ILE . 5.6 tt -121.79 122.77 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.362 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.15 -18.88 16.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.639 0.257 . . . . 0.0 110.933 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -105.98 141.08 37.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.17 0.509 . . . . 0.0 111.406 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.05 162.89 25.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.313 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.03 140.78 42.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.545 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.55 6.09 81.03 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.388 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -99.43 134.81 41.77 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.347 0.594 . . . . 0.0 111.854 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -126.38 129.2 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.566 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 t -147.79 138.03 12.65 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.38 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.15 140.95 70.73 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.43 1.42 . . . . 0.0 112.426 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.455 HG21 ' OD1' ' A' ' 8' ' ' ASP . 17.5 m -53.23 144.65 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.703 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.48 50.28 0.42 Allowed Glycine 0 N--CA 1.471 1.014 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.5 p -156.64 162.59 39.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 117.012 0.406 . . . . 0.0 111.024 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 m -82.33 100.61 10.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.005 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.19 -42.43 93.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.8 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.896 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.3 tt -158.27 148.32 19.98 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.896 ' N ' HD23 ' A' ' 73' ' ' LEU . 6.7 tt0 -103.05 128.24 49.99 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 86.8 mt -126.05 127.21 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.072 0.463 . . . . 0.0 111.262 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -98.56 111.98 24.17 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.212 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.182 179.771 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.39 141.01 40.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 33.8 mp0 -111.14 120.39 42.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.435 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -88.65 105.1 17.45 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -111.85 173.08 6.53 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.137 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.5 tt -106.42 82.97 1.06 Allowed Pre-proline 0 N--CA 1.471 0.594 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.77 155.04 49.15 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.473 1.449 . . . . 0.0 111.854 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -80.29 107.43 13.09 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.103 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 9' ' ' ILE . 11.4 pt -103.0 -0.13 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.127 0.489 . . . . 0.0 110.163 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.28 177.56 46.27 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 11' ' ' GLU . 57.8 mp0 -83.77 172.56 12.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 110.217 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.44 8.51 61.05 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -127.33 130.26 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.978 0.418 . . . . 0.0 110.019 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 p -144.73 -16.49 0.53 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.593 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -145.04 151.17 38.12 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.362 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.59 110.74 3.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -125.14 134.01 52.6 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 mm -102.6 119.05 50.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.659 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 20' ' ' ARG . 8.8 p -90.1 -43.58 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.405 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.501 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.7 mtt180 -140.9 144.58 35.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.878 0.37 . . . . 0.0 111.405 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -109.36 136.89 48.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 18.7 p-10 -93.76 -11.66 30.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.731 0.301 . . . . 0.0 110.522 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.78 159.89 7.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.263 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 73.8 mmtt -129.52 144.73 51.39 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -46.51 138.3 5.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.914 0.388 . . . . 0.0 111.339 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.18 7.55 58.31 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.445 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 24' ' ' LYS . 50.0 p-10 -129.07 151.26 49.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.603 0.702 . . . . 0.0 111.212 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.3 mtt -103.08 150.32 23.72 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.496 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.462 ' CG2' ' OE1' ' A' ' 33' ' ' GLN . 3.5 p -138.34 154.26 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.343 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -102.82 160.84 14.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.801 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 86.4 tttt -65.65 137.17 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.055 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 8.9 m-20 92.63 81.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.676 0.61 . . . . 0.0 111.575 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.462 ' OE1' ' CG2' ' A' ' 29' ' ' VAL . 57.2 tt0 -153.56 98.73 2.26 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.887 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -96.49 77.12 2.93 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 35' ' ' LEU . 87.0 mt -141.25 25.84 2.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.926 0.393 . . . . 0.0 110.295 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.23 131.61 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.9 131.04 53.51 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.232 0.539 . . . . 0.0 111.557 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.2 124.28 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.176 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.3 ttp -110.78 157.39 19.84 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.911 0.386 . . . . 0.0 110.83 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.3 t -136.31 -118.08 0.16 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.034 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.521 ' N ' ' OG1' ' A' ' 40' ' ' THR . 87.5 m-20 -64.02 -49.41 72.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.793 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -175.46 56.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.503 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.52 150.22 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.977 0.417 . . . . 0.0 110.894 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -109.77 120.09 41.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.853 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.37 118.47 58.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.951 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -88.28 133.94 33.93 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mt -145.69 117.63 5.1 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.318 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.34 142.94 19.25 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.947 1.765 . . . . 0.0 111.586 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 m -46.57 106.64 0.6 Allowed Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.86 -25.72 45.16 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.338 1.359 . . . . 0.0 114.539 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.5 123.35 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 118.066 0.394 . . . . 0.0 111.607 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 52.8 ptt85 -85.53 149.89 25.06 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.65 -134.56 2.59 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.179 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -126.29 131.22 51.92 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.003 0.402 . . . . 0.0 110.828 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 mm -93.9 119.08 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.8 t -93.08 -49.39 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.463 ' O ' ' CD2' ' A' ' 73' ' ' LEU . 60.6 pttt -148.86 150.28 32.73 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 58' ' ' ILE . 10.5 tt -127.64 128.86 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.187 0.518 . . . . 0.0 110.968 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.5 mt -98.31 -17.36 18.94 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.141 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.54 ' CE1' HD23 ' A' ' 72' ' ' LEU . 30.1 m-85 -94.5 142.72 27.11 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.311 0.577 . . . . 0.0 111.404 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -125.82 159.83 31.42 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.491 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.86 128.99 39.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.526 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.06 3.54 88.98 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.638 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -77.28 132.33 38.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.179 0.514 . . . . 0.0 111.079 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.94 128.54 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.764 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.34 135.84 10.79 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 119.499 -0.286 . . . . 0.0 110.579 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.63 146.7 42.56 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.388 1.392 . . . . 0.0 112.305 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 p -58.68 126.97 17.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.682 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.32 51.65 0.08 OUTLIER Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.3 m -153.83 159.73 41.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.131 0.465 . . . . 0.0 110.749 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.8 m -84.63 112.4 20.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.033 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.54 HD23 ' CE1' ' A' ' 60' ' ' TYR . 85.4 mt -66.95 -43.84 82.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.991 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.7 OUTLIER -159.69 149.81 18.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.175 -177.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.475 ' H ' HD23 ' A' ' 73' ' ' LEU . 12.7 mm-40 -103.5 118.45 36.78 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.3 mt -118.18 128.68 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.486 0.66 . . . . 0.0 111.572 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -95.19 115.48 27.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.335 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.777 -179.715 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -84.13 131.56 34.77 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 51.9 mp0 -102.73 113.28 26.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.184 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -79.85 101.14 8.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.726 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.433 ' NZ ' ' OG1' ' A' ' 71' ' ' THR . 68.5 mttm -112.4 145.8 39.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.2 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -63.04 111.9 5.81 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -58.44 146.68 89.36 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.061 1.174 . . . . 0.0 112.013 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -79.1 16.26 0.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.189 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.1 pt -127.56 154.36 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.53 -154.85 26.05 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.88 -37.77 88.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.906 0.384 . . . . 0.0 110.071 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.06 117.04 0.53 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.78 130.34 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.819 0.343 . . . . 0.0 110.2 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.3 p -135.39 -15.03 1.93 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.323 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -163.56 152.09 13.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.169 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.79 139.46 14.5 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -152.48 116.05 4.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.1 118.27 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.897 0.379 . . . . 0.0 111.668 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 20' ' ' ARG . 12.0 p -92.65 -40.02 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.398 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.464 ' N ' HG13 ' A' ' 19' ' ' VAL . 62.8 ttm-85 -144.73 137.37 26.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -110.63 146.55 35.96 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 56.7 t0 -130.69 26.84 5.0 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.948 0.34 . . . . 0.0 111.304 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.89 155.01 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.848 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -141.98 147.47 37.01 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.02 0.438 . . . . 0.0 111.158 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.18 140.48 38.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.938 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.3 88.08 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.233 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -108.38 125.75 52.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.116 0.458 . . . . 0.0 111.356 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.9 mtm -85.61 129.42 34.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.108 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.77 135.46 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.313 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -90.99 156.3 18.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.961 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 88.5 tttt -61.24 130.32 45.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 16.2 t0 94.87 69.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.057 0.848 . . . . 0.0 110.802 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 34' ' ' ASP . 52.2 tt0 -176.93 -118.58 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 33' ' ' GLN . 67.1 t0 29.49 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.8 tp -84.51 94.72 8.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.19 134.01 62.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.883 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.42 113.18 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.315 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.7 132.56 59.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.2 ttp -118.87 124.39 47.02 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.54 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -90.25 -86.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.54 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 18.4 p-10 -86.07 -59.18 2.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.625 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 7.5 tmtt? -172.83 57.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 p -153.39 151.3 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.353 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -94.3 116.11 28.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.155 0.503 . . . . 0.0 109.987 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.66 117.33 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.876 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.569 ' CD ' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -98.35 132.96 43.39 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.046 0.45 . . . . 0.0 111.316 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mt -138.63 85.29 17.43 Favored Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.588 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -87.35 53.82 2.66 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.516 2.144 . . . . 0.0 113.511 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.482 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 59.6 p -170.51 47.52 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.038 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 49' ' ' SER . 71.5 Cg_endo -73.26 25.12 0.31 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.36 2.04 . . . . 0.0 111.457 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.456 ' H ' ' C ' ' A' ' 49' ' ' SER . 4.5 t 66.79 67.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.229 0.537 . . . . 0.0 109.799 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -76.79 150.2 36.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.44 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.94 -92.99 0.09 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -122.36 133.78 54.64 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mm -104.69 120.31 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.3 t -87.55 -51.19 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -155.65 159.98 40.03 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.278 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.529 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.7 tt -98.04 116.04 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.873 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -99.16 -16.81 18.45 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.679 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -119.79 143.83 47.64 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 83.4 mtp180 -120.88 166.98 13.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.656 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.36 143.99 57.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.005 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 5.98 89.49 Favored Glycine 0 N--CA 1.466 0.693 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.168 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.584 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 77.2 mt-30 -82.34 126.88 32.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.268 0.556 . . . . 0.0 111.275 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.0 124.16 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.11 155.14 37.35 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.299 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.04 151.85 62.15 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.721 2.281 . . . . 0.0 111.685 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -59.83 129.52 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.259 0.552 . . . . 0.0 110.999 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.82 55.01 0.12 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.825 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.6 m -154.68 166.2 34.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.978 0.418 . . . . 0.0 111.272 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.433 ' OG1' ' NZ ' ' A' ' 5' ' ' LYS . 19.3 m -94.59 114.17 26.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.285 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.07 -46.9 61.04 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.513 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.65 HD12 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -160.99 158.01 27.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.715 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.65 ' H ' HD12 ' A' ' 73' ' ' LEU . 58.7 tt0 -103.35 128.03 50.55 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.07 -0.394 . . . . 0.0 111.079 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.2 mt -127.12 128.71 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.215 0.531 . . . . 0.0 112.302 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -100.24 115.74 30.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.38 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.275 179.549 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' H2 ' ' CB ' ' A' ' 77' ' ' THR . 63.4 ttp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' ILE . 2.1 t80 -122.73 149.85 43.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.737 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -132.23 134.59 45.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.322 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -96.36 113.32 24.89 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -115.65 153.91 30.45 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.914 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.438 ' C ' HD23 ' A' ' 6' ' ' LEU . 1.5 tt -102.81 92.67 3.68 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.85 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.2 152.76 40.23 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.531 1.487 . . . . 0.0 111.98 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -67.53 137.77 56.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.512 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.9 pt -135.1 153.61 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.176 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.67 -130.67 51.36 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -161.39 154.31 20.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.694 0.283 . . . . 0.0 110.328 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.04 59.84 1.92 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.7 t -126.7 131.2 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 p -106.67 -54.26 2.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.404 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -143.81 157.47 44.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.505 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.46 145.82 18.22 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -145.32 138.11 26.14 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.509 0.654 . . . . 0.0 110.995 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -100.63 122.11 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.509 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.1 p -90.22 -44.76 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.234 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' N ' HG13 ' A' ' 19' ' ' VAL . 89.4 mtm180 -143.89 148.44 35.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -118.84 143.57 46.88 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 34' ' ' ASP . 1.1 m-20 -128.42 18.38 6.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.222 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.49 159.31 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.44 142.24 51.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.827 0.346 . . . . 0.0 110.414 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.2 137.27 58.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.083 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.67 7.23 71.9 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 28' ' ' MET . 58.0 t0 -114.55 142.34 46.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.045 0.45 . . . . 0.0 111.084 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.543 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 94.9 mtp -79.94 152.33 29.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.432 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 30' ' ' GLU . 21.4 t -126.89 160.82 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.363 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 29' ' ' VAL . 80.1 mm-40 -123.53 152.0 42.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.896 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -57.9 90.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.2 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 63.7 t0 -178.95 134.01 0.13 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.078 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 4.2 pp0? -45.06 124.91 4.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.663 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' ASP . 89.7 m-20 -95.07 9.44 39.51 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 32.8 tp 63.1 73.85 0.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.235 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 m -117.32 134.57 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -119.12 137.81 53.34 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.603 0.716 . . . . 0.0 110.999 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 p -131.89 128.94 60.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.309 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.1 ttp -101.41 109.34 21.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.812 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 40' ' ' THR . 0.5 OUTLIER -62.0 -48.9 78.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.209 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 23.8 p-10 -152.4 -45.92 0.1 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.33 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -165.22 52.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.956 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 44' ' ' THR . 13.6 p -160.89 155.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 110.367 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 43' ' ' VAL . 5.9 m -95.22 117.85 30.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.161 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.22 118.26 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.135 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -98.54 133.59 42.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.797 0.332 . . . . 0.0 110.365 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.1 mt -135.95 137.37 25.01 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 49' ' ' SER . 38.3 Cg_exo -54.59 147.48 48.52 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.325 1.35 . . . . 0.0 111.408 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -40.48 166.61 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 120.746 0.308 . . . . 0.0 111.133 -179.549 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.99 47.92 2.69 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.752 2.301 . . . . 0.0 113.42 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t 64.39 119.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.943 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -49.76 150.51 2.09 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.912 0.387 . . . . 0.0 111.76 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.65 -143.55 8.95 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -113.16 132.7 55.37 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 122.569 -0.371 . . . . 0.0 110.64 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mm -95.33 115.6 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.4 t -70.57 -50.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -173.84 155.03 2.52 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.667 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.7 tt -89.31 110.83 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.407 0.622 . . . . 0.0 110.633 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 71' ' ' THR . 36.2 tp -81.6 -27.51 34.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.237 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.49 ' CG ' HD13 ' A' ' 72' ' ' LEU . 5.0 m-85 -110.37 145.86 36.81 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.27 0.557 . . . . 0.0 112.002 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -115.24 169.21 9.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.353 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.63 133.29 53.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.591 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.11 6.26 88.99 Favored Glycine 0 N--CA 1.466 0.672 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.994 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -80.62 133.26 35.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.849 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 p -124.76 127.96 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.927 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 t -148.54 137.33 11.86 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.316 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.2 137.27 46.17 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.155 1.237 . . . . 0.0 111.66 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.5 m -52.37 144.1 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.774 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.29 50.74 0.28 Allowed Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.0 p -161.4 164.05 30.18 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.482 ' O ' HD23 ' A' ' 59' ' ' LEU . 5.7 p -91.29 108.28 19.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.122 0.487 . . . . 0.0 110.544 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.7 mm? -63.85 -38.81 92.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.522 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 74' ' ' GLN . 4.0 tp -155.04 143.96 20.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.645 ' N ' HD12 ' A' ' 73' ' ' LEU . 53.3 tt0 -104.5 131.92 51.34 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.87 0.366 . . . . 0.0 111.173 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' ' 2' ' ' TYR . 92.8 mt -128.12 127.78 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -93.65 134.8 35.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.032 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.452 ' CB ' ' H2 ' ' A' ' 1' ' ' MET . 20.2 m . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.363 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.566 ' N ' ' H ' ' A' ' 77' ' ' THR . 5.0 ptt? . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -79.6 147.12 32.2 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.95 125.47 50.49 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -95.05 112.33 24.04 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -119.11 148.88 42.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.927 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.33 159.08 86.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.49 140.19 74.72 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 121.573 1.516 . . . . 0.0 113.467 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -105.11 70.1 0.88 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.24 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 12' ' ' GLY . 79.4 mt -119.28 132.23 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.71 -40.93 89.98 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -66.36 -50.54 63.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 111.522 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' ILE . . . -101.35 168.42 19.83 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.2 t 56.61 105.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.6 p -120.02 -7.15 9.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.042 0.449 . . . . 0.0 109.911 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.459 ' OE2' ' CG2' ' A' ' 65' ' ' VAL . 43.6 tt0 -168.4 156.21 8.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.861 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.17 114.08 3.1 Favored Glycine 0 N--CA 1.468 0.795 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -130.28 127.46 39.57 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -102.02 121.32 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.738 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.2 p -94.07 -42.3 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.293 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.464 ' N ' HG13 ' A' ' 19' ' ' VAL . 82.6 mtp180 -142.31 140.72 32.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.747 0.308 . . . . 0.0 110.613 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.566 ' O ' ' N ' ' A' ' 23' ' ' VAL . 14.5 m95 -101.81 -18.28 15.83 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.289 0.566 . . . . 0.0 109.71 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 35' ' ' LEU . 19.5 m-20 43.51 3.32 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.671 -1.15 . . . . 0.0 113.89 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 21' ' ' TRP . 3.7 m -140.18 156.54 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -126.26 136.6 52.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -45.99 142.09 2.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.039 0.447 . . . . 0.0 111.091 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.17 69.47 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.048 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 51.4 p-10 -107.74 149.67 27.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.0 0.4 . . . . 0.0 110.732 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.6 mtt -83.85 144.15 29.44 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.553 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.1 t -121.07 132.8 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -109.92 154.29 23.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.036 0.446 . . . . 0.0 111.202 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -69.13 138.97 54.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.633 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t0 70.01 23.53 5.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.303 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -149.62 86.35 1.46 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.411 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -173.64 141.87 0.89 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.131 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 76.5 mt -137.16 92.2 2.69 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.17 131.8 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.511 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 58.6 mp0 -106.78 124.89 50.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.179 0.514 . . . . 0.0 111.224 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.15 132.06 70.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.768 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.6 ttp -116.46 117.53 30.16 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.207 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 40' ' ' THR . 1.7 p -64.83 -49.72 69.5 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.048 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -151.72 -64.7 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.686 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -138.23 36.87 2.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.122 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.34 133.76 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.635 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.6 m -102.36 118.22 36.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.77 162.21 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.784 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -134.77 134.95 41.47 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.926 0.393 . . . . 0.0 110.792 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.8 mt -123.78 85.62 53.49 Favored Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.448 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 49' ' ' SER . 92.0 Cg_endo -80.35 147.19 17.95 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.674 2.25 . . . . 0.0 112.482 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 48' ' ' PRO . 1.2 t 89.72 61.19 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.02 28.83 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.732 2.288 . . . . 0.0 111.343 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t 72.25 111.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.151 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -59.73 146.52 41.15 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.785 0.326 . . . . 0.0 111.775 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.04 -141.3 6.24 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -125.17 136.8 53.95 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.1 mm -91.85 118.58 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -79.0 -50.74 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -171.07 158.76 5.72 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.92 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.6 tt -108.96 123.61 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.869 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.0 mt -97.78 -17.92 19.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.919 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.494 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 6.3 m-85 -108.9 144.24 37.06 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.886 0.374 . . . . 0.0 110.696 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -117.0 160.84 20.33 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.281 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 -57.24 140.58 49.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.698 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.32 4.97 90.35 Favored Glycine 0 N--CA 1.468 0.78 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.965 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -84.71 134.91 34.33 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.516 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' CG2' ' OE2' ' A' ' 15' ' ' GLU . 4.4 p -125.92 129.01 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.774 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.1 t -148.94 139.83 13.79 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.02 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.64 145.55 81.05 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.12 1.213 . . . . 0.0 111.378 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -55.33 125.94 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.088 0.471 . . . . 0.0 111.379 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.42 49.06 0.04 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.231 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.9 p -160.68 162.38 32.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.972 0.386 . . . . 0.0 111.091 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -94.55 107.8 19.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.199 0.523 . . . . 0.0 109.993 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 72' ' ' LEU . 2.8 mm? -67.18 -39.28 86.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.813 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.815 HD23 ' N ' ' A' ' 74' ' ' GLN . 1.7 tt -153.19 145.72 24.15 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.332 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.815 ' N ' HD23 ' A' ' 73' ' ' LEU . 66.3 mt-30 -104.15 130.31 51.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 83.3 mt -127.73 126.62 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.279 0.561 . . . . 0.0 111.738 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -86.65 143.11 27.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.727 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.566 ' H ' ' N ' ' A' ' 1' ' ' MET . 8.9 t . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.127 -0.939 . . . . 0.0 110.017 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -88.53 129.56 35.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 52.9 mp0 -112.28 125.43 54.15 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -92.12 123.46 35.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.237 0.541 . . . . 0.0 110.745 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -122.14 145.79 47.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.286 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 8' ' ' ASP . 9.9 tp -63.78 115.63 20.28 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.807 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.21 -7.4 18.94 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.881 1.721 . . . . 0.0 112.3 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.5 m-20 52.25 34.6 14.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.368 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 9' ' ' ILE . 90.7 mt 44.29 19.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.362 0.601 . . . . 0.0 109.966 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . 88.14 -178.8 46.6 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 56.98 -88.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.666 0.269 . . . . 0.0 110.292 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 10' ' ' GLY . . . 142.79 160.35 8.33 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 13' ' ' VAL . 55.9 t -145.93 -7.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 13' ' ' VAL . 68.7 p 53.92 55.84 7.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.362 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -174.99 141.69 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.567 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.79 109.87 0.44 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -123.4 142.64 50.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.017 0.436 . . . . 0.0 110.164 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 mt -102.0 121.85 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.545 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.8 p -101.29 -48.16 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.571 ' N ' HG13 ' A' ' 19' ' ' VAL . 61.3 ttt85 -146.9 136.64 23.1 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -109.76 137.62 47.29 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.61 177.44 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 8.0 p-10 -101.86 -5.04 25.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.018 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.25 160.18 32.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.371 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 43.8 mmtm -129.22 153.29 47.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.842 0.353 . . . . 0.0 110.683 -179.271 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' OE1' HG22 ' A' ' 58' ' ' ILE . 16.5 pt-20 -53.09 142.44 20.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.37 6.69 66.05 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.859 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 53.0 p30 -123.41 151.98 42.05 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.901 0.85 . . . . 0.0 111.466 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -86.09 154.56 21.3 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.862 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.1 p -138.11 147.08 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.806 0.336 . . . . 0.0 110.203 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -107.33 155.47 19.95 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.492 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -62.3 138.07 58.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.273 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 t0 66.79 20.13 10.65 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.19 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -137.0 81.54 1.88 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 35.3 t70 -173.6 104.46 0.12 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.437 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.552 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 51.0 tp -84.06 99.38 10.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.688 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.63 130.01 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.42 ' OE2' HG23 ' A' ' 44' ' ' THR . 77.0 tt0 -115.74 123.76 49.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.842 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.82 137.03 59.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.955 0.407 . . . . 0.0 110.397 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.4 ptm -115.22 142.01 47.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.141 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -103.19 -64.35 1.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.817 0.341 . . . . 0.0 110.468 -179.595 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.529 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.4 t70 -128.39 56.08 1.65 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.4 tttp 73.71 47.46 0.17 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 44' ' ' THR . 16.9 t -133.69 159.57 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.946 -179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.435 ' N ' HG12 ' A' ' 43' ' ' VAL . 28.1 m -121.75 113.83 20.24 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.915 0.388 . . . . 0.0 110.404 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -132.84 130.63 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.972 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.477 ' HZ2' HD12 ' A' ' 35' ' ' LEU . 52.5 tttp -92.2 136.29 33.3 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.98 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -136.25 96.36 12.63 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.098 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.77 146.6 76.89 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.343 2.029 . . . . 0.0 111.505 178.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.5 m -85.36 112.87 47.2 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.442 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.48 24.94 0.72 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.191 1.928 . . . . 0.0 111.052 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.55 155.96 37.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.68 -177.357 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -145.91 146.95 31.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.297 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.59 -132.38 2.56 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -129.37 148.41 51.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.694 0.283 . . . . 0.0 110.309 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mm -99.56 120.37 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.7 t -78.55 -50.93 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -172.84 154.25 2.87 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.312 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.7 tt -101.72 114.92 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.194 0.521 . . . . 0.0 110.331 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.27 -41.61 89.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.771 -179.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.461 ' CG ' ' NE2' ' A' ' 64' ' ' GLN . 5.5 m-85 -139.72 150.21 44.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.279 -178.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -109.93 -166.53 1.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.678 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -53.62 150.96 6.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.734 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.47 6.3 57.54 Favored Glycine 0 N--CA 1.474 1.231 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.461 ' NE2' ' CG ' ' A' ' 60' ' ' TYR . 49.7 tt0 -98.81 135.23 40.57 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.466 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 p -142.91 116.83 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -148.53 142.62 16.46 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.03 146.21 70.65 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.456 1.438 . . . . 0.0 112.162 177.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 68' ' ' VAL . 12.9 p -48.79 131.27 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.587 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.29 51.2 0.06 OUTLIER Glycine 0 CA--C 1.527 0.785 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.809 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.8 t -165.18 157.56 15.68 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.779 179.148 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.7 p -89.92 131.01 36.05 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.117 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.45 -15.63 24.09 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.543 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.815 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.8 OUTLIER -171.32 145.73 2.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.014 -0.674 . . . . 0.0 110.746 -179.218 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.815 ' H ' HD23 ' A' ' 73' ' ' LEU . 56.7 mt-30 -104.7 127.59 52.52 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.1 mt -129.25 126.95 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.311 0.577 . . . . 0.0 111.784 -177.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -88.0 135.98 33.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.825 178.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.6 m . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.541 -179.986 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttp . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -76.83 143.29 39.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.62 136.65 54.3 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.795 0.331 . . . . 0.0 110.181 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.568 ' CE2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -104.14 118.46 36.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.721 179.753 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -118.52 134.85 54.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.42 -179.046 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.95 126.1 91.92 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.8 148.77 59.07 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.198 1.265 . . . . 0.0 112.192 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.74 112.08 15.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.19 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.8 pt -126.42 157.34 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.776 0.322 . . . . 0.0 110.577 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.61 -167.68 50.55 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.42 -101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.778 0.323 . . . . 0.0 110.579 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.8 122.96 7.38 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.79 131.11 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.3 p -148.71 5.97 0.71 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.93 0.395 . . . . 0.0 110.852 -179.254 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -138.28 144.43 40.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.584 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.46 151.08 17.49 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.476 ' OE1' HG22 ' A' ' 65' ' ' VAL . 40.5 tp10 -153.39 128.29 9.56 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.265 0.533 . . . . 0.0 110.984 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 mm -102.22 119.75 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.36 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.5 m -93.55 -40.06 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.729 178.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.8 149.06 43.06 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.013 0.435 . . . . 0.0 111.836 -178.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -116.1 145.36 43.09 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.769 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 51.7 t0 -109.33 -6.6 15.44 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.461 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.25 159.54 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.87 0.367 . . . . 0.0 111.574 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -136.38 155.74 49.61 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.582 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -66.07 141.91 57.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.514 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.3 7.72 86.26 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.556 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -118.18 143.46 46.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.31 0.555 . . . . 0.0 111.621 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.7 mtm -87.87 147.13 25.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.563 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.09 151.4 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.032 0.444 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 32' ' ' ASP . 93.9 mt-10 -112.05 154.9 24.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.442 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.05 80.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.562 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' GLU . 68.0 t0 -179.44 94.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.17 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.408 ' HB2' ' H ' ' A' ' 49' ' ' SER . 37.4 mt-30 -142.27 151.89 42.49 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.155 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 63.8 t0 -165.74 24.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.976 0.417 . . . . 0.0 110.206 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.7 mt -121.99 27.84 7.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.689 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.42 129.24 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.07 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.453 ' OE2' ' N ' ' A' ' 45' ' ' VAL . 3.8 tm-20 -127.13 128.33 46.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.611 -179.398 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.36 141.52 43.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.046 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.9 ttp -126.16 136.59 53.04 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 -72.55 0.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.833 0.349 . . . . 0.0 110.421 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -97.56 41.12 1.13 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.525 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 tttp 71.22 37.76 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.402 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.5 t -127.17 134.68 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.5 m -96.64 116.66 29.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.142 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.453 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 34.3 m -133.27 132.64 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.052 0.453 . . . . 0.0 111.642 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -94.04 139.22 31.23 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.948 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mt -138.89 121.6 10.6 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 119.605 -0.235 . . . . 0.0 110.645 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.28 143.17 19.59 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.33 2.02 . . . . 0.0 112.081 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.408 ' H ' ' HB2' ' A' ' 33' ' ' GLN . 82.1 p -69.7 114.13 22.38 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.394 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.71 8.43 4.63 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.947 1.765 . . . . 0.0 113.553 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -140.3 157.32 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.157 0.503 . . . . 0.0 111.841 -177.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -143.32 149.79 38.28 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.734 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.87 -134.94 2.91 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -118.37 131.34 56.31 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 117.224 0.512 . . . . 0.0 109.986 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mm -94.57 118.71 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.2 t -97.03 -48.91 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -143.36 157.17 44.69 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -177.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.575 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.0 tt -125.32 122.01 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.573 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.8 mt -98.86 -17.42 18.43 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.62 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.524 ' CE1' HD23 ' A' ' 72' ' ' LEU . 9.5 m-85 -104.13 138.65 40.33 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.165 0.507 . . . . 0.0 111.288 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -122.05 166.29 14.73 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.077 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.87 130.48 44.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.979 0.418 . . . . 0.0 111.214 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.22 5.58 89.62 Favored Glycine 0 N--CA 1.467 0.755 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.882 179.129 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -79.22 140.49 37.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.979 0.419 . . . . 0.0 110.898 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.476 HG22 ' OE1' ' A' ' 17' ' ' GLU . 77.4 t -117.92 130.62 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.752 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.5 t -148.96 138.15 12.39 Favored Pre-proline 0 N--CA 1.474 0.769 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.332 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -54.13 139.6 71.51 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.394 1.396 . . . . 0.0 112.069 177.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.9 t -65.14 131.84 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.45 51.05 0.13 Allowed Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.7 p -159.82 162.79 34.81 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 122.508 -0.407 . . . . 0.0 111.31 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 71' ' ' THR . 4.9 t -84.53 114.25 21.82 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.482 0.658 . . . . 0.0 109.953 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.568 HD12 ' CE2' ' A' ' 4' ' ' PHE . 94.9 mt -65.83 -42.16 90.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.487 -178.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.5 tt -143.77 146.85 33.42 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -177.004 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.471 ' N ' HD23 ' A' ' 73' ' ' LEU . 57.5 tt0 -101.74 123.51 45.84 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.26 129.53 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.495 -177.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -100.33 111.16 23.41 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.62 179.06 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.222 -0.358 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.021 -179.721 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OE2' ' A' ' 3' ' ' GLU . 68.4 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -77.43 133.9 38.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.917 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.545 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 54.4 mp0 -109.83 128.64 55.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.206 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -92.64 117.32 29.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.432 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -119.7 147.16 44.91 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.014 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mt -67.9 113.7 16.19 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 32.1 Cg_exo -56.63 145.67 80.26 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 120.985 1.124 . . . . 0.0 112.14 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 7' ' ' PRO . 22.1 t0 93.04 113.91 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.188 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.1 pt -123.7 154.98 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 110.519 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.02 -121.75 19.73 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -60.59 145.49 48.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.987 0.422 . . . . 0.0 110.589 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.25 -52.61 1.85 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 179.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.3 t -127.93 129.42 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.3 p -131.86 -11.36 3.41 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.461 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -164.77 144.13 7.07 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.505 -179.113 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.77 153.19 21.27 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -138.28 142.87 39.81 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.421 HG21 ' NE1' ' A' ' 21' ' ' TRP . 5.9 mm -102.82 121.39 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.876 0.369 . . . . 0.0 111.992 -178.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 20' ' ' ARG . 31.4 m -94.27 -40.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.492 179.128 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.423 ' N ' HG23 ' A' ' 19' ' ' VAL . 95.9 mtt-85 -139.6 146.79 40.24 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.482 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.421 ' NE1' HG21 ' A' ' 18' ' ' ILE . 19.0 m95 -119.45 140.79 49.87 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.618 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 9.1 p-10 -114.87 5.52 15.16 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -135.24 156.72 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.513 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -142.52 149.09 38.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.406 0.622 . . . . 0.0 111.516 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -56.62 140.11 47.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.489 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.93 9.14 78.07 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 116.328 -0.396 . . . . 0.0 112.695 178.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 28' ' ' MET . 67.3 t0 -121.86 135.85 54.91 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.184 0.492 . . . . 0.0 111.705 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.531 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 62.9 ttp -94.2 127.54 40.11 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.456 179.027 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 p -129.82 136.88 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.203 0.525 . . . . 0.0 111.956 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 56.5 mp0 -83.86 157.19 22.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.584 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 37.0 ttpt -81.45 130.54 35.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.72 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 52.7 t0 130.5 122.02 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.433 1.083 . . . . 0.0 110.19 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.447 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 60.8 tp60 58.29 103.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.458 178.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 33' ' ' GLN . 97.3 m-20 -143.08 141.18 31.2 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.41 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.1 tp -101.73 79.44 1.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.198 0.523 . . . . 0.0 111.441 -178.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.61 126.06 74.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -118.34 118.58 32.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.741 -179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 m -125.57 132.79 70.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.927 0.394 . . . . 0.0 110.26 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.9 ttp -96.35 123.69 40.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.258 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.1 p -89.53 -64.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.729 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 40' ' ' THR . 68.3 t0 -137.57 60.14 1.65 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.246 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 35.5 tttp 74.69 21.89 2.09 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.51 139.59 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 m -94.69 115.74 27.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.794 0.33 . . . . 0.0 110.269 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 m -125.69 131.04 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.898 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -99.67 135.02 41.71 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -131.76 85.27 52.03 Favored Pre-proline 0 N--CA 1.471 0.6 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.844 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.459 ' O ' ' OG ' ' A' ' 49' ' ' SER . 91.2 Cg_endo -80.44 151.22 19.89 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.571 2.181 . . . . 0.0 113.201 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 48' ' ' PRO . 6.0 p 80.74 67.6 0.14 Allowed Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.08 37.85 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.857 2.372 . . . . 0.0 112.755 178.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 t 63.25 114.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.725 0.298 . . . . 0.0 111.24 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB3' ' N ' ' A' ' 31' ' ' LYS . 32.2 ptt180 -77.37 152.77 34.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.475 179.643 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.72 -140.36 6.04 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -112.17 129.76 56.14 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.37 0.585 . . . . 0.0 110.465 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.422 HG23 HD21 ' A' ' 73' ' ' LEU . 5.8 mm -93.9 119.89 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.1 t -93.31 -52.74 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -151.87 158.65 43.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.902 -177.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.7 tt -112.25 121.76 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.027 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.6 mt -99.3 -17.15 18.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.19 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.421 ' CZ ' HD23 ' A' ' 72' ' ' LEU . 11.1 m-85 -109.25 143.35 38.83 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.062 0.458 . . . . 0.0 111.004 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -120.58 164.42 16.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.084 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.38 127.09 30.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.171 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.2 5.4 89.02 Favored Glycine 0 N--CA 1.468 0.785 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 178.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -76.7 136.53 39.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.648 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.74 132.92 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.698 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.78 140.68 14.56 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.777 -178.375 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.03 147.17 76.56 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.265 1.31 . . . . 0.0 110.596 176.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.02 126.67 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.246 0.546 . . . . 0.0 110.997 -179.352 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 146.0 48.56 0.03 OUTLIER Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.388 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 p -164.97 166.41 19.41 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.268 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 71' ' ' THR . 6.6 t -88.98 117.43 27.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.776 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.495 HD12 ' CE2' ' A' ' 4' ' ' PHE . 95.9 mt -63.46 -43.36 97.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.277 0.561 . . . . 0.0 110.428 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.8 tt -145.99 146.32 30.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.462 ' N ' HD23 ' A' ' 73' ' ' LEU . 37.4 tp60 -101.91 124.89 48.31 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.2 mt -127.2 127.3 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.223 -178.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -87.52 142.54 27.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.46 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.216 -179.886 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 75' ' ' ILE . 24.1 t80 -74.72 131.88 41.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 43.1 mp0 -95.95 125.9 40.82 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.697 -179.149 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -94.71 109.24 21.2 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.19 150.22 26.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.078 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.45 116.37 39.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.89 147.37 43.86 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.774 1.649 . . . . 0.0 112.985 -178.402 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -86.37 18.41 3.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.921 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.53 -23.34 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.949 0.404 . . . . 0.0 110.085 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.98 168.28 19.69 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -179.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.66 -39.64 85.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 0.0 110.404 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -173.87 154.82 20.58 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.8 t -153.06 89.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.03 0.443 . . . . 0.0 110.448 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 m -65.19 -31.7 73.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.992 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -164.4 153.88 13.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.85 111.43 4.23 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -118.38 125.01 49.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.069 0.461 . . . . 0.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.452 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.1 mm -102.41 120.35 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.232 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -107.92 -25.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -141.72 129.96 22.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.03 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.452 ' NE1' HG21 ' A' ' 18' ' ' ILE . 46.5 m95 -112.44 139.59 47.88 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 17.8 p-10 -111.49 2.09 17.27 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.54 HG11 ' NE2' ' A' ' 33' ' ' GLN . 33.3 m -135.5 161.23 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.81 0.338 . . . . 0.0 110.696 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.46 153.02 50.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.046 -178.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -52.74 140.76 22.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.376 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.71 8.33 76.89 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.374 177.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 41.7 p-10 -113.98 150.01 34.48 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.822 0.811 . . . . 0.0 110.691 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.6 mtm -97.63 149.63 22.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.284 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -145.16 140.12 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.906 0.384 . . . . 0.0 111.118 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 32' ' ' ASP . 95.7 mt-10 -87.03 163.93 16.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.869 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' N ' ' HB3' ' A' ' 52' ' ' ARG . 88.9 tttt -58.36 74.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.235 0.541 . . . . 0.0 110.435 -179.236 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 30' ' ' GLU . 11.5 p-10 170.07 78.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB2' ' H ' ' A' ' 49' ' ' SER . 18.1 tp60 -46.98 167.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.35 -179.538 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 99.0 m-20 -87.77 -34.48 18.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.529 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 0.9 OUTLIER 159.62 106.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.784 0.678 . . . . 0.0 110.734 179.511 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.62 131.73 69.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -117.98 123.3 45.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.989 0.424 . . . . 0.0 111.459 -178.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.74 128.49 71.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.503 ' SD ' ' N ' ' A' ' 41' ' ' ASP . 10.6 tmm? -133.48 127.82 34.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.564 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 40' ' ' THR . 0.3 OUTLIER -70.5 -46.23 64.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.773 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.503 ' N ' ' SD ' ' A' ' 39' ' ' MET . 24.5 p-10 -152.47 -54.73 0.12 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.551 -179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.423 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 59.8 pttt -145.74 42.07 1.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.148 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.473 ' H ' ' HG2' ' A' ' 39' ' ' MET . 46.5 t -137.83 137.91 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.168 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -103.33 119.24 38.51 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.89 119.02 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.756 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.53 112.9 24.79 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 mt -129.99 109.78 16.89 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.63 147.66 17.61 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.37 2.047 . . . . 0.0 111.744 179.11 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.555 ' H ' ' HB2' ' A' ' 33' ' ' GLN . 6.9 t -58.39 120.39 43.94 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.17 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.96 -3.05 13.35 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 122.088 1.859 . . . . 0.0 114.218 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.23 125.45 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.027 0.376 . . . . 0.0 110.927 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HB3' ' N ' ' A' ' 31' ' ' LYS . 40.2 ptt180 -97.04 153.54 17.86 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.634 0.254 . . . . 0.0 111.037 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.89 -129.71 1.75 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.612 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -126.76 133.59 50.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.708 0.289 . . . . 0.0 110.408 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 mm -86.74 123.59 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 t -82.94 -52.17 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.679 -178.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -164.25 158.88 19.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.801 -178.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 58' ' ' ILE . 3.2 tt -91.14 114.54 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.281 0.562 . . . . 0.0 110.481 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -90.94 -24.36 20.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -113.2 140.21 48.13 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.284 0.564 . . . . 0.0 111.154 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.565 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 86.8 mtm-85 -114.42 166.52 11.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.636 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -62.16 129.34 40.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.861 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.26 69.38 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.808 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.565 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 78.5 mt-30 -80.99 134.68 35.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.616 0.708 . . . . 0.0 111.174 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.95 124.07 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.465 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 t -147.29 138.61 13.27 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 -179.128 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -55.07 148.81 46.61 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.138 1.225 . . . . 0.0 111.809 179.082 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.8 p -59.27 129.68 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.169 0.509 . . . . 0.0 111.112 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.09 49.16 0.09 OUTLIER Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.068 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.9 p -159.84 163.78 34.15 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 117.299 0.549 . . . . 0.0 110.846 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 71' ' ' THR . 8.5 t -86.75 114.21 23.24 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.261 0.553 . . . . 0.0 110.391 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -65.55 -41.4 93.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.442 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -152.37 153.99 34.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.369 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.616 ' H ' HD12 ' A' ' 73' ' ' LEU . 50.7 tt0 -103.11 129.4 49.95 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.171 0.51 . . . . 0.0 110.992 -178.529 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 2' ' ' TYR . 89.7 mt -128.7 129.15 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.665 -178.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -96.24 114.44 26.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.699 178.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.665 179.904 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -95.71 142.74 27.64 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -118.55 135.6 54.32 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.951 0.405 . . . . 0.0 110.638 -179.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -88.7 116.31 26.87 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.096 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -116.87 132.01 56.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.888 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.94 115.69 42.86 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.729 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.36 153.0 27.25 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.314 1.343 . . . . 0.0 111.977 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -87.16 85.78 7.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.614 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.2 mt -68.37 -42.97 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.101 179.226 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.19 137.13 13.18 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.475 ' OE1' ' N ' ' A' ' 11' ' ' GLU . 56.8 mp0 -82.19 147.52 28.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.633 0.254 . . . . 0.0 110.617 179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.02 21.28 65.85 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.2 t -126.66 133.09 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.1 p -148.55 80.13 1.44 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.937 0.398 . . . . 0.0 110.612 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -169.36 144.21 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.015 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.77 123.18 3.42 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -134.89 139.85 45.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.975 0.417 . . . . 0.0 110.174 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.43 119.02 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.554 -179.616 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.3 p -92.27 -41.98 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' N ' HG13 ' A' ' 19' ' ' VAL . 77.7 ttt180 -144.83 138.47 27.07 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.415 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -110.86 140.19 45.52 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 34' ' ' ASP . 4.4 p30 -108.02 -4.05 18.18 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.01 162.69 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.959 0.409 . . . . 0.0 111.383 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.2 151.91 35.9 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.842 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -61.06 138.37 58.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.883 0.373 . . . . 0.0 111.219 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.78 64.21 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.682 179.262 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 41.9 p-10 -117.73 152.22 35.69 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.399 0.6 . . . . 0.0 111.021 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -81.35 151.22 28.09 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.041 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -140.28 140.32 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.195 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -95.76 152.41 18.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.723 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HB2' ' H ' ' A' ' 52' ' ' ARG . 64.2 tttm -82.04 89.39 6.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.343 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 33' ' ' GLN . 62.6 t0 -176.3 78.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.188 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 32' ' ' ASP . 4.7 tp-100 37.08 93.02 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.047 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 31.8 t0 -90.17 15.33 10.49 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.0 mt 62.19 66.84 0.77 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.398 -179.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.57 130.25 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -110.15 123.38 49.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.332 0.587 . . . . 0.0 110.647 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 m -124.23 137.62 56.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.886 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 39' ' ' MET . 3.4 ppp? -121.92 147.44 46.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.148 0.499 . . . . 0.0 110.837 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -109.41 -59.41 1.91 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.415 -179.542 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.517 ' N ' ' OG1' ' A' ' 40' ' ' THR . 55.7 t0 -135.95 68.55 1.44 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.96 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 62.67 38.83 11.78 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.71 138.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.074 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.0 m -114.86 116.11 28.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.213 0.53 . . . . 0.0 110.758 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.71 157.81 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.431 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -100.72 136.16 41.03 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.925 179.207 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 47' ' ' ILE . 12.5 tt -127.26 135.11 26.93 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.446 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 49' ' ' SER . 33.9 Cg_exo -54.69 144.32 65.47 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 121.516 1.477 . . . . 0.0 112.226 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -41.32 164.46 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.649 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -81.45 47.12 2.44 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.772 2.315 . . . . 0.0 113.45 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 t 67.04 117.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.922 0.391 . . . . 0.0 111.417 179.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.473 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 73.7 ttt-85 -48.25 135.68 13.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.425 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.16 -145.45 8.11 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -118.51 133.91 55.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.033 0.417 . . . . 0.0 110.182 -179.078 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -95.05 121.38 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 t -81.63 -51.18 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -164.55 155.61 15.15 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.437 -178.69 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.7 tt -90.51 118.27 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.584 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -93.86 -18.24 22.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.716 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -119.08 140.58 49.84 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.089 0.471 . . . . 0.0 110.909 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -115.97 167.32 11.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.234 0.54 . . . . 0.0 111.523 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -62.57 132.65 53.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.902 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.01 3.38 90.59 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -80.63 134.49 35.9 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.308 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.76 131.47 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.761 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 t -146.62 139.09 13.97 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.526 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.68 149.04 25.97 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.387 1.391 . . . . 0.0 111.626 178.459 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 p -59.35 133.61 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.723 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.46 48.03 0.12 Allowed Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.1 p -162.63 165.08 26.26 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 117.43 0.615 . . . . 0.0 111.367 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 71' ' ' THR . 14.7 t -96.95 118.16 32.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.985 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.052 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -66.26 -36.13 82.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.919 -179.188 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.69 HD12 ' H ' ' A' ' 74' ' ' GLN . 2.1 tp -151.18 149.97 30.07 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.536 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.69 ' H ' HD12 ' A' ' 73' ' ' LEU . 0.7 OUTLIER -103.78 131.97 50.47 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 -179.706 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.5 mt -130.17 129.24 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.138 0.494 . . . . 0.0 111.958 -178.707 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -97.11 117.2 30.77 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.985 178.287 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.679 -179.527 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mmm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -74.39 130.38 39.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.131 -179.131 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 42.9 mp0 -102.51 125.19 49.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.174 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -86.4 116.26 24.44 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.28 147.27 49.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.791 -179.102 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 6' ' ' LEU . 4.8 tt -75.68 111.51 14.83 Favored Pre-proline 0 N--CA 1.471 0.604 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.001 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.438 ' N ' HD23 ' A' ' 6' ' ' LEU . 33.2 Cg_exo -58.36 143.46 97.49 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 CA-C-N 120.492 1.212 . . . . 0.0 112.388 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -77.55 22.14 0.26 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.598 179.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 7' ' ' PRO . 79.9 mt -112.1 131.18 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.946 0.403 . . . . 0.0 110.14 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' GLY . . . 163.55 -164.82 36.47 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 11' ' ' GLU . 58.0 mp0 -75.67 37.9 0.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.595 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 89.23 97.34 1.05 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.669 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.65 120.42 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.629 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.6 p -131.2 -2.89 3.94 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -141.32 143.73 34.21 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.806 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.55 133.38 8.88 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.787 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -140.03 133.07 29.48 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.973 0.416 . . . . 0.0 109.892 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.427 HG21 ' NE1' ' A' ' 21' ' ' TRP . 5.7 mm -102.81 119.62 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.879 -178.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 p -98.8 -37.37 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.03 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -141.01 133.43 28.36 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.372 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.427 ' NE1' HG21 ' A' ' 18' ' ' ILE . 33.5 m95 -110.55 144.85 38.79 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.08 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -128.65 19.91 6.13 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.094 0.407 . . . . 0.0 111.275 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.53 155.41 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -128.16 145.13 51.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.038 0.447 . . . . 0.0 110.512 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.79 137.86 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.054 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.56 7.75 71.53 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.133 179.452 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -116.73 147.82 41.67 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.121 0.461 . . . . 0.0 111.103 -179.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.4 mmm -84.37 147.71 27.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.4 133.98 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.252 179.019 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -91.61 158.31 16.49 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.193 -179.337 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.78 137.67 57.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.51 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 60.57 37.07 19.68 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.543 179.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -143.44 86.78 1.91 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.739 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -174.36 162.73 3.63 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -134.06 89.74 2.61 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.233 0.539 . . . . 0.0 109.825 178.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.54 130.94 70.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.175 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.9 119.89 37.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.891 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.1 m -117.33 133.17 64.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.068 0.461 . . . . 0.0 109.975 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.0 ttp -113.55 132.57 55.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -116.77 -88.71 0.59 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.658 -179.663 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.601 ' H ' HG23 ' A' ' 40' ' ' THR . 23.2 p-10 -90.06 50.72 1.91 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.214 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 62.22 43.79 8.22 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 44' ' ' THR . 35.3 t -131.7 158.25 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.735 178.839 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.48 ' N ' HG12 ' A' ' 43' ' ' VAL . 5.6 m -111.28 116.17 30.56 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.095 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.34 135.33 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.958 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -101.23 134.7 43.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.949 0.404 . . . . 0.0 110.808 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.8 mt -136.54 87.72 20.97 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.696 179.882 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.55 145.66 94.05 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 122.85 2.366 . . . . 0.0 112.543 179.638 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.9 m -51.65 108.41 1.06 Allowed Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.329 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.23 -14.72 28.6 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.461 1.441 . . . . 0.0 114.638 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.5 126.0 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 118.511 0.596 . . . . 0.0 111.228 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -92.01 150.44 20.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.574 0.226 . . . . 0.0 110.714 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.26 -134.33 2.89 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -119.29 147.26 44.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.944 0.372 . . . . 0.0 110.38 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mm -103.91 119.29 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.9 t -77.76 -52.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.874 -179.018 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -169.24 154.85 6.1 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.158 -178.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.483 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.1 tt -81.77 115.75 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.292 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.4 mt -93.99 -19.23 21.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.653 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -117.58 143.07 46.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.239 0.543 . . . . 0.0 111.192 -179.681 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -112.13 163.37 14.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.752 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.65 139.78 58.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.504 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.08 5.33 89.66 Favored Glycine 0 N--CA 1.468 0.79 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.86 179.103 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -79.01 133.63 36.82 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.227 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.45 127.75 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.18 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -149.35 136.19 10.75 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.418 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.45 148.97 69.01 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 121.615 1.543 . . . . 0.0 112.17 177.046 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -48.48 147.73 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.734 179.64 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.11 47.98 0.63 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.503 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.5 p -162.02 163.16 28.99 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.634 179.186 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 71' ' ' THR . 15.0 t -103.1 118.96 37.98 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.097 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.035 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -66.86 -35.75 80.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.891 -179.678 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.648 HD12 ' H ' ' A' ' 74' ' ' GLN . 1.8 tp -149.98 149.47 30.43 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.727 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.648 ' H ' HD12 ' A' ' 73' ' ' LEU . 57.9 tt0 -104.03 131.81 50.91 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.709 0.29 . . . . 0.0 110.793 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 87.5 mt -127.37 128.74 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.388 0.613 . . . . 0.0 112.036 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -94.54 140.93 29.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.915 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.472 179.389 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -116.38 147.16 41.91 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.456 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.13 134.12 47.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -93.94 118.04 30.93 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.542 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -125.98 145.52 50.25 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tp -82.29 113.75 46.21 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.74 149.75 30.18 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.841 1.694 . . . . 0.0 112.963 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 12' ' ' GLY . 53.2 m-20 -63.51 -33.18 75.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.984 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.7 pt -93.0 116.91 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 121.789 -0.57 . . . . 0.0 110.815 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 12' ' ' GLY . . . 60.03 152.17 0.01 OUTLIER Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 54.37 5.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.517 0.199 . . . . 0.0 111.206 179.397 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 177.01 162.21 27.06 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 14' ' ' THR . 61.3 t -150.06 -97.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.477 0.179 . . . . 0.0 110.562 179.43 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.429 ' N ' HG12 ' A' ' 13' ' ' VAL . 19.9 p -121.48 7.85 10.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.083 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -152.18 150.18 29.56 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.045 0.45 . . . . 0.0 111.321 -179.408 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.67 110.51 0.93 Allowed Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' OE1' ' CE ' ' A' ' 39' ' ' MET . 79.1 tt0 -115.81 129.59 56.5 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.632 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 ' HE1' ' A' ' 21' ' ' TRP . 18.0 mm -102.17 119.62 50.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.329 -178.152 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.8 m -109.37 -38.83 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -138.22 148.94 45.31 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.544 ' HE1' HG21 ' A' ' 18' ' ' ILE . 79.5 m95 -132.98 141.42 48.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.641 -1.163 . . . . 0.0 107.919 177.436 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -128.46 16.45 6.53 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.41 160.8 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.456 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.98 143.47 51.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.826 0.346 . . . . 0.0 110.812 -179.033 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -61.26 140.55 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.162 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.21 7.19 77.29 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.889 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -118.41 149.54 41.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.975 0.417 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.0 mtm -81.95 151.15 27.33 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.908 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -135.47 145.64 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.965 179.334 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -110.49 132.13 54.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.587 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 64.4 tttm -52.83 137.48 31.8 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.561 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 3.7 m-20 83.61 -11.7 0.88 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.408 0.442 . . . . 0.0 111.795 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -115.43 76.78 1.03 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.572 0.225 . . . . 0.0 110.42 179.229 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 57.2 t0 -176.66 137.73 0.27 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.245 179.559 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.477 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 81.2 mt -119.45 108.25 14.31 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.558 0.694 . . . . 0.0 110.598 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.21 133.1 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.631 179.576 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.462 ' OE2' ' CG2' ' A' ' 44' ' ' THR . 44.2 tt0 -116.57 120.0 37.33 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 110.397 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.21 140.85 46.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.539 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.444 ' CE ' ' OE1' ' A' ' 17' ' ' GLU . 66.0 ttp -124.71 144.46 50.21 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.832 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -129.18 -85.96 0.55 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.952 179.355 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.485 ' H ' HG23 ' A' ' 40' ' ' THR . 67.3 t0 -82.86 47.01 1.15 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.801 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 61.8 38.88 14.52 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.335 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.26 135.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.462 ' CG2' ' OE2' ' A' ' 37' ' ' GLU . 6.9 m -95.61 119.38 34.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.121 -179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.52 153.88 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 110.734 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -119.26 133.49 55.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.773 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.4 mt -125.63 137.97 30.99 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.088 -179.203 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' SER . 31.2 Cg_exo -52.49 153.97 12.72 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 121.54 1.493 . . . . 0.0 111.557 178.159 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.33 164.39 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.952 0.406 . . . . 0.0 111.304 -179.514 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.1 49.07 3.1 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.946 2.431 . . . . 0.0 113.669 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 t 69.93 117.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 120.889 0.376 . . . . 0.0 111.693 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -46.81 135.84 8.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.2 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.5 -143.41 7.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.26 144.76 48.44 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.084 0.442 . . . . 0.0 110.545 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.02 121.57 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.1 t -80.25 -52.14 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.54 -179.024 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -167.54 156.99 10.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.932 -179.181 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.463 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.6 tt -85.87 116.37 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.085 0.469 . . . . 0.0 110.398 -179.688 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.71 -29.68 22.24 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.8 -179.342 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' ' CB ' ' A' ' 70' ' ' SER . 15.4 m-85 -119.15 145.8 45.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.072 0.463 . . . . 0.0 111.387 -179.649 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -126.62 172.54 10.18 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.962 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.5 145.92 55.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.407 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.99 6.13 82.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.761 178.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -100.41 124.4 45.87 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.46 0.648 . . . . 0.0 112.059 -179.312 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 p -125.01 126.74 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.515 178.653 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 t -148.67 140.54 14.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.555 -177.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.09 148.45 48.61 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.164 1.242 . . . . 0.0 111.325 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.29 130.33 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 111.127 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.72 52.86 0.07 OUTLIER Glycine 0 CA--C 1.528 0.863 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.921 179.067 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.459 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 8.5 m -156.54 164.57 38.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.195 0.498 . . . . 0.0 111.077 179.608 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 p -96.07 111.85 23.75 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.56 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 72' ' ' LEU . 5.8 mp -64.01 -41.03 97.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.357 179.772 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 74' ' ' GLN . 2.3 tp -162.45 146.26 11.73 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.138 -178.614 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.633 ' N ' HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -103.09 130.54 50.26 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.921 0.391 . . . . 0.0 110.741 -179.414 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.2 mt -128.2 128.92 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.301 0.572 . . . . 0.0 111.923 -178.427 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -95.82 139.98 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.686 178.607 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.42 ' H ' HG22 ' A' ' 77' ' ' THR . 1.3 t . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.439 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -80.16 148.08 31.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.824 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.79 118.92 29.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE2' HD12 ' A' ' 72' ' ' LEU . 3.4 t80 -83.37 104.28 13.4 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -102.34 148.22 25.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.477 -179.066 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.38 117.32 59.48 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.288 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.23 157.6 33.55 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.939 1.76 . . . . 0.0 111.597 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.65 78.54 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.257 0.551 . . . . 0.0 110.159 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.73 -43.24 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.116 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.21 155.29 20.63 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.536 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.45 -37.98 83.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.151 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.11 114.74 1.71 Allowed Glycine 0 N--CA 1.464 0.507 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.8 t -131.09 133.29 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.3 p -89.17 -64.17 1.18 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.286 179.71 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 43.9 mp0 -142.22 156.79 45.33 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.237 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.01 162.62 26.3 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -155.11 135.97 13.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.199 0.5 . . . . 0.0 110.55 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.413 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.3 mm -102.64 121.44 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.484 -179.781 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 20' ' ' ARG . 12.6 p -91.72 -44.53 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.407 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.49 ' N ' HG13 ' A' ' 19' ' ' VAL . 61.2 ttp180 -140.86 138.53 34.02 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.054 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.413 ' NE1' HG21 ' A' ' 18' ' ' ILE . 30.0 m95 -112.45 141.57 46.03 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 34' ' ' ASP . 15.4 p-10 -125.59 18.43 8.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.13 0.423 . . . . 0.0 111.555 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.79 156.24 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.86 139.9 51.94 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.771 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.49 140.93 53.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.045 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.78 5.71 68.31 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.821 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 28' ' ' MET . 43.9 t0 -110.11 -174.39 2.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 117.02 0.41 . . . . 0.0 110.676 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.511 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 94.9 mtp -120.22 151.95 38.42 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 30' ' ' GLU . 13.0 t -128.63 161.26 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.436 ' N ' HG12 ' A' ' 29' ' ' VAL . 80.8 mm-40 -130.85 156.01 45.75 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.684 -179.402 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.73 140.37 58.44 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.382 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 59.62 32.44 21.55 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.437 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -147.43 87.67 1.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.312 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 65.8 t0 -171.83 130.33 0.66 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.258 -178.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.5 mt -108.93 84.01 1.85 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.423 0.63 . . . . 0.0 110.34 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.48 132.83 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.494 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -111.1 116.54 31.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.635 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 m -113.25 131.99 63.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 110.568 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.8 ttp -111.18 112.68 24.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.461 ' H ' HG23 ' A' ' 40' ' ' THR . 1.1 p -63.0 -47.87 81.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.175 0.512 . . . . 0.0 110.001 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -149.56 -68.1 0.21 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.67 -179.669 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -138.64 35.23 2.22 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.264 179.503 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.36 137.58 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 m -103.47 118.0 35.73 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.12 156.85 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.24 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -99.71 138.34 36.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.177 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 47' ' ' ILE . 19.8 tt -133.48 113.95 13.27 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.484 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.29 142.98 17.16 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.003 1.802 . . . . 0.0 112.289 -179.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.0 p -58.38 109.46 1.85 Allowed Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.556 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.15 -23.13 39.86 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.057 1.172 . . . . 0.0 114.705 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.99 127.46 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.253 0.479 . . . . 0.0 111.34 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -92.86 148.82 21.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.672 0.272 . . . . 0.0 110.849 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.11 -131.48 1.7 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.9 146.87 49.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.015 0.408 . . . . 0.0 110.448 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.9 mm -103.58 119.89 52.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.139 -179.221 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 t -79.28 -52.42 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.908 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -163.68 158.39 20.36 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.167 -179.203 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 58' ' ' ILE . 3.5 tt -88.73 118.28 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.054 0.454 . . . . 0.0 111.253 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.4 mt -96.92 -17.87 19.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.167 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.412 ' CE2' HD23 ' A' ' 72' ' ' LEU . 3.8 m-85 -113.24 146.61 39.05 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.018 0.437 . . . . 0.0 110.586 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -124.08 160.88 26.76 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.816 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.79 138.03 58.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.069 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.03 5.35 90.2 Favored Glycine 0 N--CA 1.467 0.735 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.543 178.803 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -75.69 129.18 36.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.209 0.528 . . . . 0.0 111.174 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.9 t -119.7 127.64 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.31 154.92 36.67 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.499 -178.877 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.25 145.7 55.03 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.84 2.36 . . . . 0.0 112.238 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -55.4 130.42 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.193 0.521 . . . . 0.0 110.421 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.13 55.49 0.25 Allowed Glycine 0 N--CA 1.467 0.736 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -149.71 173.18 13.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.18 0.514 . . . . 0.0 111.07 -179.656 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -102.05 114.29 28.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.935 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.451 HD12 ' CE2' ' A' ' 4' ' ' PHE . 95.1 mt -67.68 -47.46 69.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.914 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.701 HD12 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -159.01 159.4 34.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.806 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.701 ' H ' HD12 ' A' ' 73' ' ' LEU . 51.3 tt0 -104.5 127.91 52.31 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.834 0.349 . . . . 0.0 111.412 -178.653 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.6 mt -128.86 128.73 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.189 0.519 . . . . 0.0 111.757 -179.603 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -100.05 119.05 37.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.359 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.819 -179.832 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OE2' ' A' ' 3' ' ' GLU . 99.3 mtp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -80.99 131.45 35.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.762 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 56.0 mp0 -113.52 123.78 50.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -95.85 122.16 38.34 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.362 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -128.72 129.46 45.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.973 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 tp -45.62 105.9 0.51 Allowed Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.0 145.41 85.8 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.351 1.367 . . . . 0.0 111.989 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 10' ' ' GLY . 38.5 p-10 -69.59 -2.61 11.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.707 -179.398 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 9' ' ' ILE . 95.7 mt 52.85 3.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.581 0.229 . . . . 0.0 111.184 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 8' ' ' ASP . . . 76.54 23.45 70.28 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.293 178.582 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -146.71 157.07 43.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.915 0.357 . . . . 0.0 110.34 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.95 135.79 32.59 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.49 130.24 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.806 0.336 . . . . 0.0 110.61 -179.468 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 p -76.13 -46.86 26.68 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.442 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -170.26 156.27 5.69 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.846 179.635 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.85 154.18 17.07 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -141.05 140.72 34.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.968 0.413 . . . . 0.0 110.096 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.468 HG21 ' NE1' ' A' ' 21' ' ' TRP . 7.4 mm -102.64 124.25 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.992 -178.795 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.45 -44.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.56 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.91 142.71 40.62 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.135 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.468 ' NE1' HG21 ' A' ' 18' ' ' ILE . 63.1 m95 -121.2 135.83 55.08 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.179 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -106.99 -3.8 19.71 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.686 0.279 . . . . 0.0 111.186 179.053 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.08 159.17 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.73 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -144.99 161.12 40.18 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.065 0.46 . . . . 0.0 111.53 -178.62 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -56.78 139.78 49.84 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.371 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.76 8.05 62.41 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.28 -0.486 . . . . 0.0 112.943 178.286 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -128.02 155.01 44.99 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.543 0.672 . . . . 0.0 111.837 -179.307 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.0 mtp -88.75 154.62 20.13 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.016 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -134.64 150.84 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.007 0.432 . . . . 0.0 110.624 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.63 159.66 17.97 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.147 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -71.43 87.79 0.88 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.034 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 34' ' ' ASP . 38.0 t0 -174.46 159.71 3.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.663 178.63 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -44.78 95.5 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.553 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' ASP . 79.4 m-20 -72.33 -3.65 25.16 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.588 0.709 . . . . 0.0 109.131 179.488 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.412 ' O ' ' CG ' ' A' ' 22' ' ' ASP . 35.6 tp 60.79 80.48 0.21 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.337 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.11 131.81 70.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.268 178.806 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -111.26 121.75 46.08 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.179 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.52 138.23 54.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.741 -178.739 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.405 ' HG3' ' H ' ' A' ' 43' ' ' VAL . 52.0 ttp -103.82 108.98 20.53 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.27 -46.14 74.55 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.246 -0.581 . . . . 0.0 110.903 -179.221 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 42' ' ' LYS . 18.9 p-10 -139.69 -63.83 0.5 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.156 -179.588 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.504 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 64.9 mttp -150.96 45.2 0.83 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.921 0.391 . . . . 0.0 110.624 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' H ' ' HG3' ' A' ' 39' ' ' MET . 7.4 p -158.71 146.01 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.311 178.747 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -98.84 120.94 40.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.274 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.47 156.53 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.64 135.47 52.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.902 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.9 mt -127.11 112.63 21.69 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.891 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.46 150.95 39.87 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.33 1.353 . . . . 0.0 110.954 178.576 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.7 m -104.29 97.72 12.48 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -88.12 41.97 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.675 2.25 . . . . 0.0 111.576 178.887 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.3 m -129.76 156.55 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.812 0.339 . . . . 0.0 111.508 -177.512 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.485 ' N ' ' CD ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -151.12 148.06 27.82 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.469 179.874 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.55 -137.52 5.5 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -131.14 147.53 52.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 mm -97.88 118.07 43.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.15 -47.5 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.871 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -152.55 157.01 40.45 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -177.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 58' ' ' ILE . 19.9 tt -131.68 126.06 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.256 178.884 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.3 mt -104.46 -15.48 15.36 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.98 -178.359 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.536 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 8.5 m-85 -108.71 144.03 37.04 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.281 0.563 . . . . 0.0 111.581 -178.881 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.487 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 84.9 mtt85 -131.39 166.25 21.69 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.149 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.58 138.66 51.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.581 -179.124 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.35 5.33 67.43 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.117 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 61' ' ' ARG . 34.9 mt-30 -96.11 131.26 42.73 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.234 0.54 . . . . 0.0 111.505 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.72 127.91 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 t -147.02 140.44 14.97 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.23 146.31 61.13 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.154 1.236 . . . . 0.0 111.275 177.255 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 68' ' ' VAL . 1.6 p -62.66 129.49 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.204 0.526 . . . . 0.0 110.811 -179.564 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.69 51.18 0.06 OUTLIER Glycine 0 CA--C 1.53 1.03 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.595 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 p -160.55 162.23 32.87 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 122.424 -0.456 . . . . 0.0 111.25 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 p -92.75 116.8 29.35 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.314 179.551 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 2.4 mm? -83.72 -18.23 38.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.589 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.55 144.16 4.27 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.05 -178.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -106.81 119.49 39.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 176.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.3 mt -126.79 127.54 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.267 0.556 . . . . 0.0 112.156 -177.031 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -85.15 145.68 27.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.738 179.209 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.537 179.785 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -110.98 142.48 43.05 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.32 130.83 55.58 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -96.0 118.67 33.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.06 0.457 . . . . 0.0 110.116 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -122.34 138.79 54.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.891 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 tp -64.1 115.25 17.86 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.05 158.89 41.77 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.967 1.778 . . . . 0.0 112.41 -178.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -87.17 108.35 18.87 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.137 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.7 mt -65.15 -41.88 92.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.075 0.464 . . . . 0.0 109.755 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 8.13 31.73 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -64.75 -37.71 88.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.706 0.289 . . . . 0.0 110.364 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . 164.73 -43.32 0.3 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER 57.42 145.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.251 0.548 . . . . 0.0 110.987 179.648 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 p -151.44 -36.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.598 179.087 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -173.48 159.23 3.62 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.946 179.054 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.19 119.2 6.21 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.669 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -134.25 138.2 44.88 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.34 0.57 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.45 HG21 ' NE1' ' A' ' 21' ' ' TRP . 7.4 mm -103.45 121.8 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.749 -179.382 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.59 -40.75 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -138.69 147.93 43.37 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.45 ' NE1' HG21 ' A' ' 18' ' ' ILE . 54.4 m95 -128.2 141.58 51.42 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 54.9 t0 -125.46 22.65 7.66 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.79 0.329 . . . . 0.0 111.076 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.0 156.08 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.178 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.2 135.33 55.16 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -58.69 138.2 57.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.46 6.8 76.99 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -114.79 156.48 24.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.716 0.293 . . . . 0.0 110.402 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.6 mtt -80.34 148.15 30.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.719 -179.647 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.4 t -121.36 135.42 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.458 -178.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -109.56 137.6 47.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.763 179.292 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.569 ' H ' ' HE ' ' A' ' 52' ' ' ARG . 37.1 ttmt -68.08 137.64 55.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 6.6 t0 84.73 -11.78 0.78 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.585 179.732 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -118.87 82.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.654 0.264 . . . . 0.0 110.478 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 67.5 t0 -169.81 139.22 1.91 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.831 0.348 . . . . 0.0 110.423 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 69.4 mt -113.31 89.2 3.02 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.285 0.564 . . . . 0.0 109.919 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.64 130.92 71.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.43 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -121.29 126.36 49.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.821 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.93 149.88 32.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.9 ttp -118.41 134.86 54.72 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.384 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -110.99 -58.91 2.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.49 -179.58 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.482 ' N ' ' OG1' ' A' ' 40' ' ' THR . 51.9 p-10 -131.49 61.63 1.64 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.081 -179.41 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt 61.02 33.96 19.46 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 121.208 0.527 . . . . 0.0 110.119 -178.641 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.8 t -127.51 136.36 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.32 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 m -106.67 120.33 41.69 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.831 0.348 . . . . 0.0 110.139 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.89 156.59 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 121.244 0.545 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.55 135.74 53.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.31 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.41 155.59 77.02 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.218 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 49' ' ' SER . 31.5 Cg_exo -57.75 146.68 84.44 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 121.866 1.711 . . . . 0.0 112.168 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -40.6 166.15 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.921 179.665 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -77.35 54.59 4.75 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.029 2.486 . . . . 0.0 113.02 -179.396 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t 64.62 114.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.896 0.379 . . . . 0.0 111.24 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.569 ' HE ' ' H ' ' A' ' 31' ' ' LYS . 16.0 ptp180 -53.56 145.73 14.42 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.127 0.489 . . . . 0.0 111.705 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.99 -134.12 3.16 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -121.15 130.17 53.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.915 0.357 . . . . 0.0 110.19 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 73' ' ' LEU . 7.4 mm -96.46 119.56 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.1 t -77.13 -52.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.148 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -166.18 161.74 17.15 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.464 -178.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.5 tt -91.11 107.19 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.579 0.704 . . . . 0.0 109.78 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.505 HD22 HE22 ' A' ' 74' ' ' GLN . 54.8 tp -75.09 -32.2 61.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.857 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.521 ' CD2' ' NE2' ' A' ' 64' ' ' GLN . 17.1 m-85 -117.9 146.93 43.58 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.382 0.61 . . . . 0.0 112.123 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -122.06 161.32 23.24 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.927 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -56.5 142.29 39.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.678 -179.074 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.85 4.21 57.92 Favored Glycine 0 N--CA 1.473 1.127 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.237 178.515 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.521 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 32.5 mt-30 -98.04 131.69 44.24 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.428 0.632 . . . . 0.0 111.668 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -122.49 122.75 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.758 179.0 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 t -148.95 138.87 12.97 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.834 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.21 142.92 44.35 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 121.473 1.449 . . . . 0.0 112.414 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.97 128.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.013 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.39 51.41 0.04 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.045 179.07 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -166.85 169.47 13.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.227 0.514 . . . . 0.0 111.323 179.51 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.585 ' O ' HG23 ' A' ' 71' ' ' THR . 15.2 t -103.7 120.42 40.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.868 179.727 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -88.89 -7.88 55.28 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.182 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.671 HD12 ' H ' ' A' ' 74' ' ' GLN . 5.8 tp -157.16 144.43 18.69 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.671 ' H ' HD12 ' A' ' 73' ' ' LEU . 28.4 mp0 -104.19 132.99 49.86 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.554 0.216 . . . . 0.0 111.039 -179.205 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.8 mt -131.72 130.03 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.43 . . . . 0.0 111.957 -179.426 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -100.88 113.82 27.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.078 178.341 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.411 ' H ' HG22 ' A' ' 77' ' ' THR . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.822 -1.085 . . . . 0.0 110.328 179.984 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 ttp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -89.36 132.88 34.75 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 52.9 mp0 -95.22 121.99 37.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.076 -179.043 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -91.46 113.01 25.16 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.169 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -115.47 146.27 41.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.599 -179.62 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.588 ' C ' HD23 ' A' ' 6' ' ' LEU . 4.9 tt -58.67 110.56 2.71 Favored Pre-proline 0 N--CA 1.469 0.516 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.448 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.486 ' N ' HD23 ' A' ' 6' ' ' LEU . 46.8 Cg_exo -54.87 141.27 77.86 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 120.21 1.111 . . . . 0.0 112.455 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -81.76 22.43 0.75 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.092 -179.877 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.1 mt -106.46 130.21 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.904 0.383 . . . . 0.0 110.415 -179.346 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.76 -175.76 34.24 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -67.27 -40.44 86.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.058 0.456 . . . . 0.0 110.065 179.651 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.05 158.28 19.96 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.669 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.8 t -151.93 85.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.328 179.867 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -65.1 -24.99 67.59 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.314 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -173.24 153.69 2.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.37 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.14 119.27 6.1 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -178.94 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -125.67 133.46 52.16 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.022 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.402 HG21 ' NE1' ' A' ' 21' ' ' TRP . 9.1 mm -103.15 122.23 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.634 -178.821 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.9 p -90.89 -44.8 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.536 179.595 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' N ' HG13 ' A' ' 19' ' ' VAL . 84.1 mtt85 -146.13 147.44 31.54 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.062 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.402 ' NE1' HG21 ' A' ' 18' ' ' ILE . 62.4 m95 -115.22 136.86 52.65 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 176.346 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 7.8 p-10 -106.0 1.1 26.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.201 -0.312 . . . . 0.0 111.73 -179.443 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG11 ' OD2' ' A' ' 34' ' ' ASP . 32.0 m -136.62 159.63 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.681 0.277 . . . . 0.0 110.943 -179.739 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -136.91 153.02 50.85 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.076 0.465 . . . . 0.0 110.123 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -57.54 141.99 45.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.766 179.876 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.39 8.34 59.94 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.48 179.057 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 28' ' ' MET . 65.9 t0 -130.58 135.36 47.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.611 0.706 . . . . 0.0 110.847 -179.691 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.486 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 65.9 mtt -81.45 150.2 28.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.193 -179.43 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 p -143.46 147.64 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.001 0.429 . . . . 0.0 110.593 179.605 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -102.65 162.1 13.2 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.841 -178.453 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.07 137.85 50.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.497 -179.067 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 59.81 45.22 12.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.436 179.902 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.437 ' O ' ' CG ' ' A' ' 34' ' ' ASP . 59.3 tt0 -147.03 88.45 1.74 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.524 179.086 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.54 ' OD2' ' NH2' ' A' ' 52' ' ' ARG . 11.8 m-20 170.43 148.65 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.776 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.51 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 74.6 mt -121.03 102.14 8.14 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.646 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.74 131.32 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.216 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -117.46 127.41 53.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.031 -179.831 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.57 129.08 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.795 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.8 ttp -108.55 131.19 55.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.566 -179.864 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -114.5 -84.89 0.61 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.328 -179.838 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' H ' HG23 ' A' ' 40' ' ' THR . 42.8 p-10 -98.16 51.06 1.02 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.482 179.827 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 65.56 34.66 7.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.132 -178.714 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.4 t -127.54 135.84 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.9 m -98.13 117.97 33.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.581 -179.574 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.72 131.45 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.298 179.519 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -93.57 136.17 34.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.212 -179.57 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.1 mt -140.95 95.51 7.61 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.6 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.54 144.75 91.54 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 121.985 1.79 . . . . 0.0 111.35 179.321 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.579 ' CB ' ' NE ' ' A' ' 52' ' ' ARG . 8.0 t -64.81 113.06 9.48 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.546 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.18 -24.64 44.08 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 120.932 1.088 . . . . 0.0 113.943 -178.933 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.0 125.07 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.111 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.579 ' NE ' ' CB ' ' A' ' 49' ' ' SER . 24.6 mmt180 -134.15 155.28 50.38 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.917 0.389 . . . . 0.0 110.873 -179.631 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.92 -84.71 0.06 OUTLIER Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.455 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -130.19 136.79 49.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.8 0.333 . . . . 0.0 110.565 179.379 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.401 ' CG2' HD11 ' A' ' 73' ' ' LEU . 9.4 mm -104.43 118.84 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.266 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.2 t -87.31 -52.36 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.318 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -160.83 154.36 22.07 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.752 -178.249 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.4 tt -108.17 122.18 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.503 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.3 mt -97.54 -17.61 19.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.189 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -107.28 141.8 38.04 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.93 0.395 . . . . 0.0 110.747 -179.243 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.551 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 89.4 mtm-85 -122.65 162.19 22.4 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.512 179.926 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 56.2 mp0 -53.62 134.96 41.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.112 -179.067 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.62 6.27 83.4 Favored Glycine 0 N--CA 1.471 0.992 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.679 177.969 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.551 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 80.4 mt-30 -85.86 134.15 33.92 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.109 0.954 . . . . 0.0 111.467 -179.472 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.5 p -122.13 124.43 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.234 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 t -148.83 136.93 11.46 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.696 -179.53 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.97 152.47 58.13 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 C-N-CA 121.924 1.75 . . . . 0.0 112.243 178.289 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.8 t -53.87 133.21 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.691 179.648 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.86 51.81 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.804 179.229 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.7 m -153.99 169.08 24.35 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.354 -179.723 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -104.07 111.76 24.47 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.191 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.44 -45.3 55.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.541 -179.795 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.875 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.8 tt -152.96 147.66 26.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.939 -177.772 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.875 ' N ' HD23 ' A' ' 73' ' ' LEU . 18.9 tt0 -103.21 133.42 48.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.115 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 56.8 mt -126.73 129.2 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.205 0.526 . . . . 0.0 111.891 -177.395 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -96.02 111.63 23.59 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.951 178.885 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.353 -179.664 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -85.73 126.24 33.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.665 -179.553 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 52.6 mp0 -92.86 134.4 35.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.736 -179.472 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -109.49 108.53 19.05 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.784 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -114.17 141.2 47.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.043 -179.64 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.544 ' C ' HD23 ' A' ' 6' ' ' LEU . 5.1 tt -69.26 112.12 10.8 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.413 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' N ' HD23 ' A' ' 6' ' ' LEU . 73.2 Cg_endo -71.45 156.27 58.57 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.8 1.667 . . . . 0.0 112.875 -178.251 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.407 ' OD1' HG11 ' A' ' 68' ' ' VAL . 81.2 m-20 -74.52 99.15 3.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.586 -179.566 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.08 -42.4 95.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.509 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.38 161.69 29.87 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.869 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' VAL . 58.0 mp0 -66.19 -31.13 71.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.723 0.296 . . . . 0.0 110.836 -179.39 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.5 26.91 0.36 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -179.836 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' GLU . 53.4 t -127.67 124.99 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.457 ' OG1' ' OE1' ' A' ' 15' ' ' GLU . 27.3 p -138.31 -1.18 1.94 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.119 -179.873 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 54.8 mp0 -140.54 144.01 35.7 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.826 0.346 . . . . 0.0 110.765 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.36 124.8 5.25 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' OE1' ' C ' ' A' ' 17' ' ' GLU . 10.1 tm-20 -128.02 137.8 52.34 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.128 0.464 . . . . 0.0 110.58 -179.309 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -102.13 114.44 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.51 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.4 p -85.17 -42.56 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.445 179.342 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.51 ' N ' HG13 ' A' ' 19' ' ' VAL . 82.2 mtp180 -140.88 147.05 38.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.82 0.343 . . . . 0.0 111.258 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -109.04 137.73 46.5 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.252 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.3 p-10 -72.77 -40.89 65.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.296 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.12 165.58 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.551 -178.193 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 99.4 mttt -119.27 149.69 41.36 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.933 -179.592 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 56' ' ' VAL . 85.7 tt0 -45.31 139.61 3.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.32 7.25 62.23 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.567 -0.574 . . . . 0.0 113.341 178.59 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 24' ' ' LYS . 40.4 p-10 -135.44 153.06 51.9 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.371 1.086 . . . . 0.0 111.226 179.759 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.0 mtp -78.52 155.19 29.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.777 -178.79 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.23 152.77 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.926 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -113.38 147.4 37.79 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.937 0.399 . . . . 0.0 110.83 -179.623 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.454 ' HB2' ' H ' ' A' ' 52' ' ' ARG . 50.3 tttp -85.06 84.45 7.7 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.108 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' ASP . 43.8 p30 -165.97 81.37 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.552 179.204 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 62.97 -66.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.048 179.493 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 32' ' ' ASP . 29.0 t0 62.78 -167.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.311 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.4 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 83.4 mt -126.54 75.75 1.57 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.183 0.516 . . . . 0.0 111.55 -179.768 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.06 128.14 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.51 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -124.73 128.68 49.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.114 -178.616 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.52 133.6 64.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.226 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.44 ' HG3' ' H ' ' A' ' 43' ' ' VAL . 65.3 ttp -119.1 113.41 20.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.381 -179.024 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 40' ' ' THR . 1.7 p -62.75 -52.05 64.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.108 0.48 . . . . 0.0 109.908 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.8 t70 -146.87 -48.22 0.19 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.32 179.123 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -161.51 51.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.271 179.05 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 44' ' ' THR . 46.3 t -135.88 160.06 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.431 -179.792 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.502 ' N ' HG12 ' A' ' 43' ' ' VAL . 18.5 m -110.25 114.79 28.54 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.296 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.32 117.1 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.354 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -97.76 136.42 38.12 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.646 178.959 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.5 mt -139.33 139.95 24.38 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 119.303 -0.38 . . . . 0.0 110.529 -178.744 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 49' ' ' SER . 52.8 Cg_exo -53.17 145.66 42.4 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.386 1.39 . . . . 0.0 111.725 178.195 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -47.34 179.19 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.858 -179.322 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 49' ' ' SER . 78.8 Cg_endo -87.86 49.67 1.74 Allowed 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.776 2.317 . . . . 0.0 113.855 -178.363 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.0 t 66.19 121.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 120.823 0.344 . . . . 0.0 111.599 178.759 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 42.2 ttm180 -50.23 136.38 19.79 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.524 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.62 -141.63 5.75 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.371 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -126.05 126.67 44.62 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.811 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.566 HG23 HD21 ' A' ' 73' ' ' LEU . 5.8 mm -91.74 119.23 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.676 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.4 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 37.7 t -101.41 -41.52 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.222 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -145.16 154.89 42.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.557 -177.677 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 58' ' ' ILE . 12.5 tt -127.78 127.27 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.205 -179.824 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.8 tp -100.26 -21.18 15.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.211 -179.492 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.506 ' CD2' HD23 ' A' ' 72' ' ' LEU . 6.4 m-85 -106.08 141.93 36.64 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.225 0.536 . . . . 0.0 111.383 -178.951 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -122.18 165.74 15.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.143 179.371 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.0 mp0 -53.39 128.24 27.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.455 -179.463 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.72 5.95 85.98 Favored Glycine 0 N--CA 1.468 0.818 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.374 178.539 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -79.4 135.52 36.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.42 0.61 . . . . 0.0 110.71 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.76 131.52 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.611 179.624 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -149.47 137.54 11.77 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.785 -178.78 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.92 137.48 52.38 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.077 1.185 . . . . 0.0 112.344 177.942 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.407 HG11 ' OD1' ' A' ' 8' ' ' ASP . 48.9 t -56.22 129.16 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.721 179.774 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.68 49.3 0.08 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.113 178.985 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.3 p -164.62 165.99 20.54 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.345 0.572 . . . . 0.0 110.858 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 71' ' ' THR . 14.9 t -98.98 122.15 41.87 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.057 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 72' ' ' LEU . 3.0 mp -90.57 -5.38 56.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.686 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.566 HD21 HG23 ' A' ' 55' ' ' ILE . 2.1 tt -162.34 142.43 9.83 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.101 -178.866 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.539 ' OE1' ' N ' ' A' ' 74' ' ' GLN . 2.3 mp0 -104.03 124.37 48.9 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.247 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.7 mt -122.89 127.48 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.47 0.652 . . . . 0.0 111.57 -177.7 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -98.12 111.36 23.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.219 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.77 -179.47 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -125.88 149.26 48.82 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.924 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.66 128.34 53.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.819 0.342 . . . . 0.0 110.384 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.831 ' CD2' HD23 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -87.08 126.13 34.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.058 -179.931 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -119.6 133.73 55.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.191 -179.425 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.0 123.3 79.58 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.821 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.08 148.39 44.63 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.598 1.532 . . . . 0.0 111.781 -179.41 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -67.79 123.5 20.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.399 -179.56 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 75.5 mt -119.77 133.51 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.9 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.99 -174.42 20.73 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.805 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -88.92 147.38 24.37 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -179.704 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.31 -112.15 4.34 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 t 59.73 106.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.501 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -124.42 11.88 8.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.539 -179.049 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.58 ' OE2' HG13 ' A' ' 65' ' ' VAL . 13.4 tm-20 -145.84 142.87 29.24 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 111.377 179.951 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.47 ' N ' ' CD ' ' A' ' 15' ' ' GLU . . . -121.2 119.29 4.06 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.356 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -118.98 136.26 54.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 117.165 0.482 . . . . 0.0 110.658 -179.763 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.401 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.9 mm -101.35 119.97 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.125 -179.678 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 20' ' ' ARG . 10.0 p -89.9 -45.89 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.841 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.53 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.7 mtt180 -143.41 148.46 36.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.192 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.401 ' NE1' HG21 ' A' ' 18' ' ' ILE . 36.3 m95 -118.25 144.54 45.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.432 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.3 m-20 -124.48 12.94 8.75 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.136 0.426 . . . . 0.0 111.655 179.395 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.77 154.93 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.962 0.41 . . . . 0.0 110.764 179.605 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -121.9 153.68 38.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.096 -179.822 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -64.15 129.54 40.38 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.303 -179.955 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.04 5.66 63.88 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.502 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 36.5 p-10 -101.86 151.93 21.5 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.066 0.433 . . . . 0.0 110.665 179.536 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.2 mmm -90.85 148.85 22.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.537 -179.791 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.66 141.07 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.174 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -109.57 159.97 16.64 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.818 0.342 . . . . 0.0 111.272 -178.714 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -59.73 136.4 57.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.184 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 58.92 29.64 19.15 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.209 -179.559 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.69 79.56 1.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.573 0.225 . . . . 0.0 110.42 179.332 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 46.0 t0 -173.73 -178.56 1.61 Allowed 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.534 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.487 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 37.3 tp -153.95 97.84 2.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.922 0.391 . . . . 0.0 110.562 179.458 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.0 130.56 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.9 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.4 mp0 -114.66 120.71 41.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.926 178.759 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.6 m -119.98 134.37 63.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.008 -179.805 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.9 ptm -130.13 129.41 43.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.344 -179.58 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -73.25 -43.07 61.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.325 179.922 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -154.78 -67.21 0.13 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.323 -179.648 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -132.67 37.15 3.49 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.228 179.523 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.1 t -133.82 136.01 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.901 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 m -116.26 120.61 39.48 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.516 -179.666 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.94 155.61 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.362 179.546 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -115.23 135.63 53.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.276 -179.782 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.1 mt -134.27 130.84 20.35 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.11 179.945 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.46 146.17 27.36 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.419 2.079 . . . . 0.0 112.626 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -60.59 110.91 3.32 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.806 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.29 -19.76 37.94 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.612 1.541 . . . . 0.0 114.951 -177.856 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.89 124.03 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 118.459 0.572 . . . . 0.0 111.606 -179.084 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -91.14 152.13 20.7 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.107 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.39 -133.34 2.39 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.214 179.49 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -125.05 143.33 50.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.688 0.28 . . . . 0.0 110.327 -179.371 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.4 mm -103.73 118.72 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.682 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.8 t -89.25 -55.36 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.097 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -143.52 153.5 42.65 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.289 0.566 . . . . 0.0 111.814 -178.364 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.6 ' O ' HG23 ' A' ' 58' ' ' ILE . 3.7 tt -101.57 114.38 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.148 178.884 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.75 -17.68 20.12 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.827 -179.648 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -109.3 142.21 40.5 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.083 0.468 . . . . 0.0 110.756 -179.225 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.416 ' H ' ' HG3' ' A' ' 64' ' ' GLN . 11.2 ptp85 -126.0 166.25 17.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.429 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.43 144.5 50.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.006 -179.391 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.03 5.8 87.27 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 179.259 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 61' ' ' ARG . 22.4 mm-40 -70.76 133.44 46.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.593 0.711 . . . . 0.0 111.355 -179.01 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.58 HG13 ' OE2' ' A' ' 15' ' ' GLU . 40.0 t -131.46 118.67 40.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 114.33 -1.304 . . . . 0.0 107.5 178.604 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.56 154.79 35.82 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.006 -178.472 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.12 140.33 41.06 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.739 2.293 . . . . 0.0 111.676 179.087 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.12 124.61 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.774 179.412 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.1 53.31 0.06 OUTLIER Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.0 t -162.51 168.27 22.16 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.961 0.38 . . . . 0.0 110.807 -179.889 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 71' ' ' THR . 14.8 t -105.45 128.41 53.52 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.039 ' H ' HD22 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -64.16 -41.81 97.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.182 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -161.27 177.28 10.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.757 -179.495 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -107.03 127.19 53.24 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.717 0.294 . . . . 0.0 110.889 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.47 125.29 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.25 0.548 . . . . 0.0 111.346 -179.323 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -90.27 140.49 29.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.8 178.913 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.449 179.792 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -79.61 129.17 34.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.839 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 57.1 mp0 -105.87 118.77 37.45 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -95.86 122.28 38.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.218 0.532 . . . . 0.0 110.733 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.63 145.22 49.09 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.66 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 tt -68.73 113.4 15.7 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.045 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 N--CA 1.491 1.381 0 C-N-CA 121.59 1.527 . . . . 0.0 112.008 -179.322 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.482 ' OE2' ' CG2' ' A' ' 65' ' ' VAL . 30.8 tp10 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.92 110.45 0.72 Allowed Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -126.27 131.91 51.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 110.355 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -102.37 119.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.17 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.6 p -93.08 -43.81 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.519 ' N ' HG13 ' A' ' 19' ' ' VAL . 83.2 mtp180 -139.57 145.07 38.15 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.808 0.337 . . . . 0.0 111.243 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -111.68 139.84 46.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.91 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 18.2 p-10 -101.36 -6.51 23.98 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.37 159.95 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.027 0.441 . . . . 0.0 111.4 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.33 149.99 49.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.7 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -59.55 138.63 57.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.257 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.64 8.87 76.16 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.604 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -121.98 149.84 42.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 117.431 0.616 . . . . 0.0 111.156 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.2 mtm -86.59 154.19 21.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.265 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.474 HG23 ' NE2' ' A' ' 33' ' ' GLN . 2.6 p -138.9 152.61 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.937 0.399 . . . . 0.0 110.515 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -117.44 157.23 26.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.012 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -67.55 65.6 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.962 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -176.11 73.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.531 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.474 ' NE2' HG23 ' A' ' 29' ' ' VAL . 85.1 mt-30 -147.1 122.09 10.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.409 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -128.14 39.45 3.84 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.454 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.8 mt -110.51 33.67 4.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.107 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.11 128.15 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -116.85 123.91 48.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.533 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.92 130.16 72.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.375 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.3 ttm -109.7 126.4 53.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.287 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -95.1 -77.28 0.47 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.054 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.424 ' N ' ' OG1' ' A' ' 40' ' ' THR . 62.1 t0 -95.99 -74.24 0.57 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.269 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -151.37 50.71 0.83 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.334 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.03 149.34 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.897 0.379 . . . . 0.0 110.75 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.8 m -107.97 118.82 37.75 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.957 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.96 133.79 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -95.51 135.5 37.08 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.426 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.4 mt -135.75 133.57 20.15 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.36 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.3 147.69 33.18 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.175 1.917 . . . . 0.0 111.162 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -96.98 107.89 40.28 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 111.371 0.137 . . . . 0.0 111.371 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -86.59 41.78 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.373 2.049 . . . . 0.0 111.358 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.39 156.2 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.716 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -154.33 149.07 26.51 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.276 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.29 -132.93 2.94 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.84 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -130.3 135.76 48.43 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -91.87 120.18 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.147 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.5 t -84.53 -50.07 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -164.16 157.06 17.61 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.898 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 58' ' ' ILE . 3.0 tt -116.07 121.96 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.446 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.55 -16.88 18.97 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.21 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.543 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 17.8 m-85 -107.31 144.4 34.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.291 0.567 . . . . 0.0 111.58 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -123.83 161.48 25.21 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.86 137.02 57.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.45 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.41 4.99 85.5 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.492 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.52 ' OE1' ' CD2' ' A' ' 60' ' ' TYR . 55.3 tt0 -89.32 137.39 32.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.414 0.607 . . . . 0.0 110.563 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.482 ' CG2' ' OE2' ' A' ' 15' ' ' GLU . 3.4 p -124.42 131.21 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.375 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 t -148.3 140.86 14.89 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.249 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.19 148.17 32.69 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.501 1.467 . . . . 0.0 112.661 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 68' ' ' VAL . 9.8 p -62.08 132.83 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.456 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.99 49.44 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.014 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.7 p -160.33 162.84 33.59 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.399 0.6 . . . . 0.0 111.355 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 71' ' ' THR . 5.3 t -96.37 120.99 37.68 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.2 mm? -82.45 -4.32 57.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.553 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.8 142.45 2.45 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.58 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -104.84 122.39 45.67 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.35 127.51 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.095 0.474 . . . . 0.0 111.081 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -88.0 141.32 28.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.087 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.493 179.825 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -82.84 130.12 35.09 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 51.0 mp0 -93.79 138.7 31.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.95 101.79 11.82 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 6' ' ' LEU . 68.6 mttm -108.28 105.19 14.77 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 5' ' ' LYS . 5.6 mt -29.23 93.84 0.06 OUTLIER Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 123.845 0.716 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' LYS . 92.0 Cg_endo . . . . . 0 N--CA 1.489 1.229 0 C-N-CA 121.644 1.563 . . . . 0.0 112.127 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 . . . . . 0 N--CA 1.465 0.307 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.65 109.92 3.54 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -121.78 127.35 50.52 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.409 HG21 ' NE1' ' A' ' 21' ' ' TRP . 7.2 mm -100.92 117.94 46.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.05 0.452 . . . . 0.0 111.565 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 20' ' ' ARG . 10.7 p -91.74 -41.85 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.583 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.488 ' N ' HG13 ' A' ' 19' ' ' VAL . 95.1 mtt-85 -143.37 141.88 31.07 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.409 ' NE1' HG21 ' A' ' 18' ' ' ILE . 37.3 m95 -111.93 145.4 39.62 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 35' ' ' LEU . 87.7 m-20 -128.54 20.85 6.1 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.43 0.559 . . . . 0.0 111.255 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.9 m -136.33 154.63 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 68.4 mttm -135.05 137.13 42.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.448 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -44.25 135.75 4.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.91 5.94 70.29 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 43.9 p-10 -104.19 150.88 23.98 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.806 0.303 . . . . 0.0 110.222 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.2 mtp -90.06 145.74 24.85 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.86 0.362 . . . . 0.0 110.645 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.9 t -126.42 132.85 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.478 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -105.7 158.2 16.88 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -62.88 136.4 57.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.639 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 58.66 36.46 25.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.141 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -141.81 89.76 2.22 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 51.4 t0 -172.91 158.16 3.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.901 0.382 . . . . 0.0 110.455 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.47 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 92.7 mt -135.22 86.35 2.24 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.322 0.582 . . . . 0.0 110.009 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.71 136.69 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.565 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.1 mp0 -123.06 128.14 49.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.056 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 p -128.15 130.0 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.0 ttp -109.3 133.49 52.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.547 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -99.65 -92.38 0.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.492 ' N ' ' OG1' ' A' ' 40' ' ' THR . 14.3 p-10 -83.69 -52.73 6.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.356 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -174.45 57.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.612 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -159.33 151.83 6.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.901 0.382 . . . . 0.0 110.417 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -103.87 117.53 34.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.284 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.88 132.59 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.064 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -92.53 135.71 33.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.954 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.94 90.8 13.8 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.55 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.08 147.73 92.04 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 122.638 2.225 . . . . 0.0 112.018 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.5 m -60.65 111.27 3.82 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 119.51 -0.281 . . . . 0.0 110.7 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.56 -16.81 30.39 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.413 1.409 . . . . 0.0 114.521 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.89 124.58 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.245 0.475 . . . . 0.0 111.084 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -89.74 151.49 21.8 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.415 0.15 . . . . 0.0 110.827 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.77 -145.47 7.97 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -114.46 133.74 55.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.85 0.325 . . . . 0.0 110.845 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.487 HG23 HD21 ' A' ' 73' ' ' LEU . 5.8 mm -87.91 120.22 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 t -88.99 -52.63 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -156.27 160.74 40.04 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.186 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.0 tt -106.0 123.37 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.618 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.1 tp -101.11 -18.32 16.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.068 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.436 ' CE2' HD22 ' A' ' 72' ' ' LEU . 5.8 m-85 -111.15 146.82 36.18 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.217 0.532 . . . . 0.0 111.053 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.574 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 99.8 mtt180 -122.5 167.3 13.52 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.111 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -62.37 140.54 58.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.838 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.52 5.02 82.6 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.382 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.574 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 83.5 mt-30 -85.61 135.17 33.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.488 0.644 . . . . 0.0 111.955 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 p -128.46 126.5 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.733 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.5 t -149.52 135.93 10.49 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.746 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.39 141.96 59.46 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.377 1.385 . . . . 0.0 111.905 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 p -52.98 128.32 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.849 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.03 48.24 0.06 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.187 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.4 p -164.17 162.24 22.65 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 117.407 0.604 . . . . 0.0 110.926 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 71' ' ' THR . 6.0 t -88.96 126.48 35.42 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.436 HD22 ' CE2' ' A' ' 60' ' ' TYR . 42.2 mt -97.36 -5.48 36.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.402 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.4 tt -170.51 149.08 3.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.507 ' N ' HD23 ' A' ' 73' ' ' LEU . 66.7 mt-30 -103.17 125.52 49.9 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.8 mt -126.45 128.55 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.199 0.523 . . . . 0.0 111.723 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 18.6 p-10 -97.09 115.66 27.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.543 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.591 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -106.78 137.52 44.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.147 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.33 130.51 40.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.125 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -108.64 120.46 42.53 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.203 0.525 . . . . 0.0 110.331 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -127.18 153.34 46.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.955 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 tp -71.52 117.87 61.16 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.742 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 C-N-CA 121.664 1.576 . . . . 0.0 111.886 -179.87 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.988 0.423 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.54 150.81 18.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -137.16 146.56 45.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.954 0.377 . . . . 0.0 110.262 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.89 115.93 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.37 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 20' ' ' ARG . 10.7 p -86.04 -43.62 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.373 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.503 ' N ' HG13 ' A' ' 19' ' ' VAL . 83.6 mtp180 -139.54 147.37 41.11 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.724 0.297 . . . . 0.0 111.264 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -111.95 141.84 45.1 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.46 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 16.5 p-10 -105.56 -3.51 22.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.542 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -134.59 160.35 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 120.891 0.377 . . . . 0.0 111.36 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.22 147.17 45.64 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.56 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.432 ' OE1' HG22 ' A' ' 58' ' ' ILE . 82.6 tt0 -63.34 134.23 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.619 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.75 8.53 85.84 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.322 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -117.07 129.13 55.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.068 0.434 . . . . 0.0 111.431 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.1 ptp -59.54 150.25 27.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.843 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 30' ' ' GLU . 52.9 t -123.25 159.06 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.019 0.438 . . . . 0.0 110.138 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.2 mp0 -135.1 149.59 50.07 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.57 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 87.9 tttt -65.29 137.6 57.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.138 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 9.9 m-20 94.21 76.03 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.817 0.698 . . . . 0.0 110.704 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -146.16 95.66 2.66 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.594 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -104.1 52.35 0.76 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.653 0.263 . . . . 0.0 110.916 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -117.87 30.53 7.2 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.239 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.93 128.28 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -121.86 126.64 49.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.644 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.0 129.89 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.6 ttp -103.95 110.98 23.33 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.831 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.453 ' H ' HG23 ' A' ' 40' ' ' THR . 1.1 p -61.91 -48.13 81.85 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -146.31 -67.45 0.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.432 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -142.11 41.38 1.65 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.842 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 44' ' ' THR . 48.3 t -136.33 155.85 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.416 ' N ' HG12 ' A' ' 43' ' ' VAL . 5.0 m -109.17 118.2 36.13 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.76 120.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.06 138.57 31.4 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -136.42 109.84 9.62 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.08 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.69 145.27 60.78 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.67 1.58 . . . . 0.0 111.369 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.5 m -105.04 99.62 20.35 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.08 44.44 1.28 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.295 1.997 . . . . 0.0 110.432 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.76 154.68 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -161.47 131.82 5.02 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.713 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.02 -136.49 3.85 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.855 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -124.44 132.13 53.5 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.88 0.34 . . . . 0.0 110.242 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 55' ' ' ILE . 4.2 mm -91.77 121.33 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.8 t -87.46 -51.81 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -155.29 161.42 41.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.681 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.6 tt -122.0 123.78 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.695 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.06 -16.48 17.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -107.15 143.9 34.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.15 0.5 . . . . 0.0 111.375 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -123.61 164.99 17.95 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.272 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -59.34 134.4 56.97 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.631 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.98 5.64 90.01 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.009 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -82.15 137.39 34.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.041 0.42 . . . . 0.0 110.823 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.84 133.03 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.605 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.7 t -148.63 141.28 15.16 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.691 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.16 146.11 61.5 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.317 1.345 . . . . 0.0 111.373 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.451 ' H ' HG12 ' A' ' 68' ' ' VAL . 1.6 p -64.89 130.2 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.018 0.437 . . . . 0.0 110.713 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.55 53.15 0.08 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.2 m -160.41 170.3 21.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.054 0.427 . . . . 0.0 111.255 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.2 m -99.43 112.5 24.68 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.838 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.52 -43.4 76.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.161 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.2 tt -151.38 145.74 25.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.072 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.84 ' N ' HD23 ' A' ' 73' ' ' LEU . 39.1 mt-30 -104.11 130.73 51.84 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.9 mt -131.71 127.34 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.142 0.496 . . . . 0.0 111.536 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.76 140.97 29.28 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.918 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.568 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -97.65 127.87 43.93 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 37.6 mp0 -107.74 111.72 24.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.131 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -75.55 100.94 4.72 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -112.55 147.16 37.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.554 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 7' ' ' PRO . 7.3 tt -66.35 113.35 12.21 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.455 ' O ' HD23 ' A' ' 6' ' ' LEU . 45.6 Cg_exo . . . . . 0 N--CA 1.494 1.532 0 CA-C-N 120.499 1.214 . . . . 0.0 112.09 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 121.004 0.431 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.14 132.38 8.05 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -133.84 142.03 47.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.96 0.41 . . . . 0.0 110.101 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -100.01 121.66 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.048 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.545 HG13 ' N ' ' A' ' 20' ' ' ARG . 11.5 p -88.18 -45.69 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.167 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.545 ' N ' HG13 ' A' ' 19' ' ' VAL . 63.0 ttm-85 -146.76 139.31 25.02 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -108.19 143.94 36.31 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.2 m-20 -127.55 15.89 7.05 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.892 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.15 155.91 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -130.07 147.56 51.83 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.941 0.401 . . . . 0.0 111.063 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.435 ' OE1' HG22 ' A' ' 58' ' ' ILE . 10.3 pt-20 -62.59 139.47 58.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.92 7.97 73.42 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.843 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -117.92 148.99 41.63 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.865 0.333 . . . . 0.0 110.68 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 63.8 mtt -76.77 147.29 37.36 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.105 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.99 132.74 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -98.89 154.92 17.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.432 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -96.05 84.26 3.79 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.86 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 34' ' ' ASP . 46.5 p-10 -173.5 131.22 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 110.853 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' ASP . 96.7 mm-40 53.78 -80.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.609 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 32' ' ' ASP . 93.8 m-20 57.01 150.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.457 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 89.5 mt -122.12 76.68 1.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.283 0.563 . . . . 0.0 111.629 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.07 131.59 70.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -123.16 121.72 36.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.274 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.3 m -115.19 130.88 68.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 43' ' ' VAL . 5.4 tpp -91.83 152.18 20.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.896 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.487 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -156.66 -89.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.589 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.487 ' H ' HG23 ' A' ' 40' ' ' THR . 91.7 m-20 -76.16 44.84 0.34 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.286 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 58.37 37.72 25.85 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.61 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.452 ' O ' ' SD ' ' A' ' 39' ' ' MET . 30.6 m -147.54 158.98 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.67 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -100.17 118.49 36.61 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 110.727 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -119.59 130.45 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.543 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -94.98 138.78 32.26 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.28 92.99 34.2 Favored Pre-proline 0 N--CA 1.472 0.639 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.184 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.461 ' O ' ' OG ' ' A' ' 49' ' ' SER . 88.3 Cg_endo -80.03 143.87 16.45 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.227 1.951 . . . . 0.0 113.133 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 49' ' ' SER . 6.0 p 81.7 69.68 0.12 Allowed Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.408 ' CD ' ' OD2' ' A' ' 34' ' ' ASP . 64.2 Cg_endo -88.87 26.94 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.953 2.435 . . . . 0.0 112.177 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t 69.76 115.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.142 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -79.83 147.65 31.68 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 112.064 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.24 -133.92 2.57 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -122.48 134.33 54.58 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.487 HG23 HD21 ' A' ' 73' ' ' LEU . 7.7 mm -92.98 119.62 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -79.37 -52.39 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -168.44 157.96 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.705 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.4 tt -104.01 122.68 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.009 0.433 . . . . 0.0 111.334 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -100.93 -17.17 16.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -106.73 142.54 36.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.97 0.414 . . . . 0.0 110.884 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -117.47 169.83 9.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.313 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.29 134.19 56.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.246 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.49 6.17 86.43 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.866 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -79.09 131.85 36.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.2 0.524 . . . . 0.0 111.324 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -127.03 132.21 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.596 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.87 140.31 15.53 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.609 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.94 147.2 15.12 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.038 1.159 . . . . 0.0 112.187 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.1 p -60.13 130.4 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.51 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.08 55.99 0.21 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.4 m -151.38 175.69 12.0 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.055 0.455 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 m -101.14 109.7 21.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.252 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.05 -45.52 70.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.089 0.471 . . . . 0.0 110.946 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.487 HD21 HG23 ' A' ' 55' ' ' ILE . 3.9 tt -152.72 147.16 25.76 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.485 ' N ' HD23 ' A' ' 73' ' ' LEU . 58.3 tt0 -103.56 128.18 50.84 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.5 mt -128.07 129.52 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.164 0.507 . . . . 0.0 111.118 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -95.69 112.05 23.86 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.099 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.1 m . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.618 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 75' ' ' ILE . 21.6 t80 -79.75 127.58 32.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 110.217 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 54.8 mp0 -88.29 133.7 33.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.311 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -101.69 113.29 26.31 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 6' ' ' LEU . 54.0 mtmt -120.1 113.77 20.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 5' ' ' LYS . 12.6 mt -32.89 97.22 0.11 Allowed Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.521 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo . . . . . 0 N--CA 1.492 1.4 0 C-N-CA 121.721 1.614 . . . . 0.0 111.957 -179.918 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.69 109.76 3.91 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -121.49 132.61 54.82 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -101.91 120.58 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.94 0.4 . . . . 0.0 111.193 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.502 HG13 ' N ' ' A' ' 20' ' ' ARG . 8.7 p -92.95 -42.43 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.62 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.502 ' N ' HG13 ' A' ' 19' ' ' VAL . 43.2 ttm180 -148.79 134.51 18.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -104.2 140.44 37.83 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -120.24 16.77 12.33 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.094 0.406 . . . . 0.0 111.279 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.38 157.66 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.922 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -131.8 136.47 47.55 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.546 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.68 140.18 36.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 0.0 111.042 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.96 6.96 74.89 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.88 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -116.21 149.6 38.87 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.879 0.339 . . . . 0.0 110.723 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.5 mmm -83.47 147.32 27.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.643 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.2 t -118.9 132.54 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.353 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE1' ' OE1' ' A' ' 33' ' ' GLN . 95.5 mt-10 -96.23 155.59 16.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.721 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -67.83 134.13 50.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.859 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 57.86 34.56 24.5 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.241 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.414 ' OE1' ' OE1' ' A' ' 30' ' ' GLU . 82.7 mt-30 -143.13 87.49 1.97 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.868 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -174.62 168.95 3.7 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -136.31 97.69 3.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.244 0.545 . . . . 0.0 110.683 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.53 132.63 67.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.186 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -125.12 126.17 44.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.329 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.84 125.89 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.232 0.539 . . . . 0.0 109.567 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.0 ttp -105.86 137.91 42.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.069 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.535 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.6 t -102.81 -121.34 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.92 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.535 ' N ' ' OG1' ' A' ' 40' ' ' THR . 63.8 t0 -63.78 -46.77 83.73 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -177.13 60.55 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -150.33 149.13 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.741 0.305 . . . . 0.0 110.305 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -101.88 117.73 35.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.85 117.08 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.871 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -97.1 134.53 40.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.77 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.0 mt -138.9 129.58 14.96 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.556 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.45 143.59 22.0 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.134 1.889 . . . . 0.0 112.464 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 p -47.76 106.9 0.65 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.3 -23.51 32.84 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.077 1.185 . . . . 0.0 114.745 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.76 123.53 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.401 0.546 . . . . 0.0 111.732 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -83.04 161.22 21.76 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.38 -142.35 7.99 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.091 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -119.47 134.52 55.18 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.836 0.35 . . . . 0.0 111.187 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mm -95.93 117.74 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.64 -53.46 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -151.58 156.8 41.22 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.478 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.52 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.7 tt -108.84 120.35 60.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.004 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.47 -17.93 18.49 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.302 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.522 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 7.6 m-85 -111.42 144.62 40.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.44 0.638 . . . . 0.0 111.391 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.552 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 99.9 mtt180 -120.82 162.19 20.22 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.078 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -58.33 142.28 48.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.609 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.76 6.03 70.59 Favored Glycine 0 N--CA 1.469 0.869 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.552 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 85.9 mt-30 -94.13 132.06 39.04 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.364 0.602 . . . . 0.0 112.161 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.95 125.8 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.007 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 t -147.97 137.17 11.91 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.646 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -50.48 137.4 40.23 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.016 1.144 . . . . 0.0 112.213 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.58 126.44 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.469 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.08 49.32 0.04 OUTLIER Glycine 0 CA--C 1.531 1.034 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.956 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.8 p -159.75 160.46 34.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 117.182 0.491 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 71' ' ' THR . 5.2 t -91.66 104.27 16.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.803 0.811 . . . . 0.0 109.982 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 72' ' ' LEU . 2.2 mm? -67.31 -39.91 85.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.483 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.908 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.5 tt -141.55 148.63 39.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.908 ' N ' HD23 ' A' ' 73' ' ' LEU . 57.5 tt0 -102.6 130.22 49.41 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 2' ' ' TYR . 96.3 mt -127.41 127.91 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.247 0.546 . . . . 0.0 111.398 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -102.1 114.9 29.42 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.167 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.114 -0.946 . . . . 0.0 110.599 179.825 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' OD1' ' A' ' 76' ' ' ASP . 97.8 mmm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -148.02 147.97 30.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.398 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -126.69 138.72 53.44 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.08 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.35 113.89 27.56 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.317 0.58 . . . . 0.0 110.573 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 6' ' ' LEU . 98.9 mttt -119.49 112.83 19.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.172 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 6' ' ' LEU . 3.7 tt -35.93 99.53 0.18 Allowed Pre-proline 0 N--CA 1.475 0.798 0 O-C-N 123.342 0.401 . . . . 0.0 110.446 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo . . . . . 0 N--CA 1.493 1.445 0 C-N-CA 121.702 1.601 . . . . 0.0 112.061 -179.024 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.751 0.31 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.05 111.0 3.25 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -121.28 129.99 53.43 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.426 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.6 mm -102.35 118.8 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.405 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.8 p -96.77 -47.48 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.831 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.575 ' N ' HG13 ' A' ' 19' ' ' VAL . 82.4 mtp180 -141.53 145.49 35.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.426 ' NE1' HG21 ' A' ' 18' ' ' ILE . 31.8 m95 -117.03 139.51 50.6 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.565 ' CG ' HH22 ' A' ' 52' ' ' ARG . 7.7 p-10 -108.09 5.15 25.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.492 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 3.8 m -133.84 157.2 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.626 0.251 . . . . 0.0 110.535 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.86 145.11 51.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.846 0.355 . . . . 0.0 110.496 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -61.54 138.5 58.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.196 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.07 8.01 65.2 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.913 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 28' ' ' MET . 68.1 t0 -117.32 135.95 53.48 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.926 0.363 . . . . 0.0 111.365 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.495 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 2.5 mpt? -90.48 131.69 36.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.047 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.17 146.0 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.743 0.306 . . . . 0.0 110.675 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.3 mm-40 -92.85 160.08 15.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.436 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -52.12 129.77 28.44 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.196 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 30' ' ' GLU . 2.5 p30 168.79 133.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.647 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -67.09 80.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.627 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 68.0 t0 -63.45 -43.2 98.07 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.363 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.523 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 1.4 mt 154.87 86.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.036 0.835 . . . . 0.0 110.824 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -117.47 126.05 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -121.13 123.09 41.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.467 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.93 130.42 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.418 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 25.1 ptm -128.12 152.05 48.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -94.71 -114.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.317 178.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.543 ' N ' ' OG1' ' A' ' 40' ' ' THR . 69.7 m-20 -65.03 -45.24 86.29 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -176.1 57.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.779 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 39' ' ' MET . 48.7 t -137.42 139.47 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -95.9 116.93 29.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.484 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.23 119.39 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -92.44 132.13 37.03 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 36' ' ' VAL . 57.3 mt -141.26 138.04 17.31 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.466 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -52.3 141.64 49.28 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 CA-C-N 120.178 1.099 . . . . 0.0 111.083 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.517 ' CB ' ' HE ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -46.6 162.94 0.24 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.017 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 51' ' ' VAL . 95.4 Cg_endo -78.16 54.81 5.09 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 123.23 2.62 . . . . 0.0 112.991 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 50' ' ' PRO . 4.1 t 59.12 109.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.144 -0.623 . . . . 0.0 109.52 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.565 HH22 ' CG ' ' A' ' 22' ' ' ASP . 95.9 mtt180 -102.81 146.07 28.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 111.828 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.45 -85.84 0.06 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -125.11 114.04 18.52 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mm -91.54 120.02 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.0 t -79.44 -52.83 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -169.88 157.37 6.72 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.084 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.1 tt -110.33 119.26 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.439 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.21 -17.6 20.67 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.569 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.429 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 28.2 m-85 -110.2 141.76 42.69 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.909 0.385 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -132.13 165.81 23.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.069 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.02 141.94 21.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.802 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.69 5.0 60.26 Favored Glycine 0 N--CA 1.471 0.995 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.235 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -99.51 131.25 45.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.494 0.664 . . . . 0.0 111.861 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.98 123.51 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.354 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.27 138.69 13.04 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.301 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -52.68 143.79 45.47 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.356 1.37 . . . . 0.0 112.394 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.6 p -52.03 128.95 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.601 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.28 52.76 0.08 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.738 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -156.48 161.8 40.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.033 0.417 . . . . 0.0 111.164 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.3 p -92.91 111.29 22.86 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.807 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.711 HD22 ' N ' ' A' ' 72' ' ' LEU . 2.3 mm? -89.08 -6.98 56.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.086 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.6 OUTLIER -176.45 142.54 0.45 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.196 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.473 ' H ' HD23 ' A' ' 73' ' ' LEU . 58.0 tt0 -104.37 126.48 51.5 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 57.7 mt -128.35 128.26 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.18 0.514 . . . . 0.0 111.474 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.507 ' OD1' ' SD ' ' A' ' 1' ' ' MET . 85.6 m-20 -101.28 111.06 23.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.131 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.351 180.0 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -75.31 142.71 43.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.724 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -112.03 135.95 52.01 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.289 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -101.21 117.16 34.43 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.312 0.577 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 6' ' ' LEU . 99.4 mttt -119.54 107.37 13.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.146 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 5' ' ' LYS . 16.2 tp -31.06 93.2 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.931 0 O-C-N 123.665 0.603 . . . . 0.0 110.886 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 5' ' ' LYS . 30.8 Cg_exo . . . . . 0 N--CA 1.498 1.756 0 C-N-CA 122.214 1.943 . . . . 0.0 112.585 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.69 110.04 3.95 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -118.41 130.8 56.18 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.418 HG21 ' NE1' ' A' ' 21' ' ' TRP . 10.7 mm -100.12 120.15 49.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.107 0.48 . . . . 0.0 111.777 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.4 p -90.43 -45.61 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.467 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.6 mtt180 -147.7 149.33 32.23 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.418 ' NE1' HG21 ' A' ' 18' ' ' ILE . 69.5 m95 -114.79 140.62 48.77 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -121.74 12.23 10.59 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.004 0.365 . . . . 0.0 111.009 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 23' ' ' VAL . 5.3 m -126.09 131.07 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.81 141.65 36.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.187 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -54.91 135.77 47.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.879 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.27 6.48 84.17 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.516 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 28' ' ' MET . 64.2 t0 -110.82 146.95 35.53 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.245 0.522 . . . . 0.0 110.872 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.539 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 77.2 mtm -87.65 149.38 24.31 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.738 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.23 137.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.799 0.333 . . . . 0.0 110.444 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -90.21 158.83 17.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.51 138.16 58.26 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.42 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 58.6 37.02 25.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.057 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.33 87.21 1.87 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.489 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -172.82 167.09 5.25 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.733 0.302 . . . . 0.0 110.452 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -136.05 88.56 2.4 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.229 0.538 . . . . 0.0 110.138 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.16 128.61 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.522 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -117.08 118.01 31.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.561 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -109.52 129.3 64.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.0 ttp -117.14 154.97 30.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.647 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.59 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -140.16 -86.21 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.868 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.59 ' H ' HG23 ' A' ' 40' ' ' THR . 67.2 t0 -94.43 52.63 1.58 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.329 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 60.04 44.33 13.36 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 121.035 0.445 . . . . 0.0 110.835 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -130.1 138.32 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.748 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 m -94.89 118.13 31.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.215 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.83 117.54 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.148 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -93.1 128.84 39.16 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 110.467 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.7 mt -137.99 90.21 14.16 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.451 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.74 144.62 92.84 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.528 2.152 . . . . 0.0 112.413 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.8 m -51.06 108.63 1.09 Allowed Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.803 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.9 -15.35 23.72 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 121.638 1.559 . . . . 0.0 115.035 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.89 124.6 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.42 0.555 . . . . 0.0 111.779 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -89.16 149.01 23.35 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 120.689 0.28 . . . . 0.0 111.112 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.24 -138.42 4.89 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -122.31 144.14 49.19 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.958 0.409 . . . . 0.0 111.084 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 73' ' ' LEU . 7.8 mm -99.75 120.58 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.7 t -83.52 -50.96 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -158.86 154.69 26.46 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.592 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 58' ' ' ILE . 3.2 tt -91.47 108.23 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.42 0.629 . . . . 0.0 109.513 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.4 tp -82.01 -27.65 32.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.803 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' CE2' HD22 ' A' ' 72' ' ' LEU . 4.2 m-85 -117.15 145.33 43.89 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.366 0.603 . . . . 0.0 111.649 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.568 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 90.2 mtm-85 -120.48 168.41 11.36 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.952 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -62.73 146.85 51.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 111.968 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.32 5.08 85.63 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.182 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.568 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 86.0 mt-30 -89.22 132.1 35.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.444 0.64 . . . . 0.0 111.942 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.07 121.13 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.848 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.96 139.33 14.0 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.342 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.38 143.85 25.78 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.183 1.255 . . . . 0.0 112.246 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 p -61.68 129.2 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.162 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.35 52.54 0.07 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.452 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.4 t -167.05 153.65 8.42 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.991 0.396 . . . . 0.0 110.998 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.7 t -79.57 130.9 35.8 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.411 HD22 ' CE2' ' A' ' 60' ' ' TYR . 26.2 mt -105.52 0.07 26.31 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 74' ' ' GLN . 3.2 tp -173.13 143.35 1.12 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.661 ' N ' HD12 ' A' ' 73' ' ' LEU . 12.7 mm-40 -102.98 129.68 49.81 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.013 0.435 . . . . 0.0 110.47 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 83.1 mt -129.82 126.18 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.327 0.584 . . . . 0.0 111.611 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -89.78 138.75 31.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.653 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.329 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.402 ' H2 ' ' CB ' ' A' ' 77' ' ' THR . 22.5 ttm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.47 150.36 45.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.198 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -130.55 129.76 43.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.54 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CE2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -91.67 120.35 32.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -129.49 149.35 51.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.605 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.515 HD23 ' C ' ' A' ' 6' ' ' LEU . 3.2 tt -95.16 106.46 25.89 Favored Pre-proline 0 N--CA 1.473 0.675 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.677 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 N--CA 1.492 1.427 0 C-N-CA 121.874 1.716 . . . . 0.0 111.892 179.482 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.7 0.286 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.57 110.52 0.5 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' OE1' ' CE ' ' A' ' 39' ' ' MET . 83.7 tt0 -122.87 135.88 54.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.842 0.353 . . . . 0.0 110.268 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 mm -102.56 121.24 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.931 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 20' ' ' ARG . 11.5 p -92.63 -42.44 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.36 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.515 ' N ' HG13 ' A' ' 19' ' ' VAL . 79.4 ttt-85 -142.31 137.51 30.64 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -109.27 141.05 42.12 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 10.8 p-10 -114.87 3.04 14.49 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.42 155.83 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.701 0.286 . . . . 0.0 110.684 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 99.0 mttt -135.11 150.54 50.23 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.221 0.534 . . . . 0.0 111.239 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -50.03 131.21 22.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.114 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.79 5.3 68.72 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.65 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 31.7 p-10 -106.67 150.06 26.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 117.52 0.66 . . . . 0.0 110.734 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.7 mmm -85.55 153.28 22.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.913 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 30' ' ' GLU . 26.6 t -125.18 160.57 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.957 0.408 . . . . 0.0 110.807 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.1 mp0 -118.45 152.26 36.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.355 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HB2' HH11 ' A' ' 52' ' ' ARG . 65.1 tttm -80.64 140.4 35.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.31 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.11 141.96 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.051 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 65.9 114.11 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.496 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 45.0 t0 -163.49 -173.03 3.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.489 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 84.8 mt -138.15 69.94 1.39 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.082 0.467 . . . . 0.0 111.341 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.88 131.06 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 37' ' ' GLU . 57.3 mp0 -128.54 123.27 33.04 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 110.937 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.78 131.85 64.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.425 ' CE ' ' OE1' ' A' ' 17' ' ' GLU . 63.2 ttp -99.5 121.59 41.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.659 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -96.49 -86.26 0.32 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.248 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' N ' ' OG1' ' A' ' 40' ' ' THR . 99.7 m-20 -101.26 49.98 0.87 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.206 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.1 tttm 73.08 28.25 1.92 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.932 0.396 . . . . 0.0 110.304 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.27 137.46 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.534 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 m -94.48 117.16 29.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.914 0.388 . . . . 0.0 110.13 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.5 m -124.16 131.22 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.557 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -90.07 139.23 30.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.593 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.8 mt -133.5 137.41 28.91 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.322 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 49' ' ' SER . 53.1 Cg_exo -51.99 140.59 49.02 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 121.79 1.66 . . . . 0.0 112.862 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.43 ' OG ' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -40.67 165.71 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.21 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.29 42.57 1.36 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.079 2.52 . . . . 0.0 113.172 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.7 t 62.22 118.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.661 0.267 . . . . 0.0 110.974 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.401 HH11 ' HB2' ' A' ' 31' ' ' LYS . 35.5 ptt-85 -44.04 150.33 0.28 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.902 0.382 . . . . 0.0 111.756 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.04 -146.38 11.66 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -118.23 131.65 56.36 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.907 0.384 . . . . 0.0 110.383 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.415 ' CG2' HD11 ' A' ' 73' ' ' LEU . 8.1 mm -96.63 118.87 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.9 t -91.0 -52.5 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -150.49 156.9 42.33 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.109 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.511 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.7 tt -117.6 123.33 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.751 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.46 -16.85 16.69 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.172 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.516 ' CD2' ' OE1' ' A' ' 64' ' ' GLN . 15.6 m-85 -106.74 141.99 37.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.115 0.483 . . . . 0.0 111.161 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -122.2 168.92 11.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.204 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.22 134.65 57.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.833 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.91 4.9 90.4 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.704 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.516 ' OE1' ' CD2' ' A' ' 60' ' ' TYR . 49.7 tt0 -82.97 135.65 34.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.504 0.652 . . . . 0.0 110.919 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -126.93 131.92 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.08 140.65 15.13 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 119.328 -0.367 . . . . 0.0 111.083 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.3 148.88 48.6 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 121.42 1.413 . . . . 0.0 112.225 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 68' ' ' VAL . 7.5 p -57.8 132.55 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.204 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.78 51.84 0.11 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.4 p -159.06 163.27 36.44 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.445 0.623 . . . . 0.0 111.617 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.7 m -93.34 109.32 20.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.154 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.435 HD12 ' CE2' ' A' ' 4' ' ' PHE . 97.1 mt -63.75 -46.04 87.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.406 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.879 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.9 tt -152.55 146.47 25.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.492 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.879 ' N ' HD23 ' A' ' 73' ' ' LEU . 55.2 tt0 -102.95 130.06 49.89 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.6 mt -125.23 127.69 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.159 0.504 . . . . 0.0 111.342 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -91.92 137.27 32.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.402 ' CB ' ' H2 ' ' A' ' 1' ' ' MET . 19.1 m . . . . . 0 C--O 1.222 -0.392 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.252 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -139.78 149.9 44.09 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.92 133.78 50.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.265 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.423 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -88.23 112.82 23.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 109.933 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -117.64 117.57 29.73 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.697 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 6' ' ' LEU . 4.0 tt -47.26 107.66 0.75 Allowed Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.77 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 N--CA 1.492 1.421 0 C-N-CA 121.543 1.496 . . . . 0.0 111.55 -179.711 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 57.0 mp0 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 120.815 0.34 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.99 117.81 5.94 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -123.27 131.98 53.86 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.435 HG21 ' NE1' ' A' ' 21' ' ' TRP . 9.0 mm -102.58 120.67 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.031 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.517 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.7 p -92.18 -43.12 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.72 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' NH2' ' OE1' ' A' ' 37' ' ' GLU . 86.2 mtm180 -144.92 151.4 38.61 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.435 ' NE1' HG21 ' A' ' 18' ' ' ILE . 68.2 m95 -118.68 140.98 49.04 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -116.64 9.06 14.0 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.1 0.409 . . . . 0.0 111.847 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.61 156.74 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.676 0.274 . . . . 0.0 110.342 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 62.6 mttp -115.34 142.34 46.81 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.275 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -57.33 134.64 56.17 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.36 6.43 66.32 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 40.1 p-10 -102.36 151.72 21.93 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.026 0.441 . . . . 0.0 110.86 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.9 mtm -81.64 144.61 31.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.199 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.0 t -122.54 133.61 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.389 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -104.03 159.94 15.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.114 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' HH11 ' A' ' 52' ' ' ARG . 87.9 tttt -62.87 133.46 54.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.279 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.1 37.96 26.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.522 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -139.43 81.46 1.83 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.727 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 49' ' ' SER . 68.0 t0 -177.67 132.17 0.16 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.43 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 41.5 tp -111.02 96.77 6.35 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.148 0.499 . . . . 0.0 109.99 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.77 124.03 72.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.542 ' OE1' ' NH2' ' A' ' 20' ' ' ARG . 76.0 tt0 -106.06 120.24 41.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.045 0.45 . . . . 0.0 110.6 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.32 131.55 67.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.678 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 43' ' ' VAL . 6.0 tpp -114.72 145.43 42.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.363 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 2.6 t -115.4 -131.35 0.32 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.027 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.532 ' N ' ' OG1' ' A' ' 40' ' ' THR . 67.3 t0 -65.13 -43.77 90.82 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.458 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -173.13 53.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.786 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.506 ' O ' ' SD ' ' A' ' 39' ' ' MET . 5.1 t -145.01 133.69 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.253 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -101.2 119.47 38.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.62 157.76 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.547 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -125.57 135.65 52.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.239 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.3 mt -133.58 88.26 34.52 Favored Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.503 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.18 142.53 97.26 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 122.409 2.072 . . . . 0.0 112.302 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.445 ' H ' ' HB3' ' A' ' 34' ' ' ASP . 74.2 m -41.55 102.45 0.27 Allowed Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.203 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.32 -23.12 38.86 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.081 1.188 . . . . 0.0 114.466 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.83 126.4 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 118.246 0.476 . . . . 0.0 111.32 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.402 HH11 ' HB2' ' A' ' 31' ' ' LYS . 33.5 ptt-85 -84.75 146.01 27.61 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 120.514 0.197 . . . . 0.0 110.897 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.23 -145.94 7.2 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.698 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -115.94 135.51 53.91 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.641 0.258 . . . . 0.0 110.392 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.5 mm -95.59 119.8 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.19 -53.27 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.531 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -164.1 157.73 18.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.727 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.7 tt -89.35 114.84 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.179 0.514 . . . . 0.0 110.691 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.94 -25.17 24.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.352 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.37 145.98 39.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.096 0.474 . . . . 0.0 111.192 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -123.23 165.65 16.55 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.017 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.4 142.39 48.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.417 0.627 . . . . 0.0 112.159 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.37 4.95 90.33 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.075 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -86.69 130.18 34.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 111.499 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.75 129.65 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.544 -0.753 . . . . 0.0 108.972 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.79 140.41 14.68 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 119.374 -0.346 . . . . 0.0 110.575 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.92 146.22 47.78 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.326 1.351 . . . . 0.0 112.584 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -56.12 130.47 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.09 49.78 0.15 Allowed Glycine 0 N--CA 1.47 0.903 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 p -160.52 164.52 32.02 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.135 0.467 . . . . 0.0 111.03 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.4 p -87.65 127.72 35.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.221 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 74.9 mt -93.58 -4.56 50.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.321 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.733 HD12 ' H ' ' A' ' 74' ' ' GLN . 2.0 tp 174.76 149.55 0.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.733 ' H ' HD12 ' A' ' 73' ' ' LEU . 58.2 tt0 -104.76 128.12 52.77 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.922 0.392 . . . . 0.0 111.394 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.3 mt -126.56 128.01 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.094 0.473 . . . . 0.0 110.976 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -96.9 110.97 23.37 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.068 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.506 -179.763 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -126.77 148.87 49.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.739 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -124.62 135.42 53.08 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.281 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -100.76 119.74 39.07 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.33 147.24 48.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.917 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 tt -76.24 116.68 58.19 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.686 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo . . . . . 0 N--CA 1.496 1.621 0 C-N-CA 121.949 1.766 . . . . 0.0 112.812 -179.268 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.657 0.265 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.09 168.31 13.74 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -156.68 142.78 18.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.482 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 mm -102.87 121.33 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.462 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 20' ' ' ARG . 27.0 m -92.35 -45.4 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.434 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' N ' HG23 ' A' ' 19' ' ' VAL . 95.7 mtt-85 -139.77 146.83 39.98 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.26 0.552 . . . . 0.0 112.077 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -114.57 142.99 45.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.263 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -118.17 8.34 12.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.451 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.21 156.06 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.792 0.33 . . . . 0.0 110.73 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.86 146.55 39.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.275 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.31 138.75 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.907 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.21 7.91 69.34 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.601 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 28' ' ' MET . 60.7 t0 -120.8 148.09 44.47 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.93 0.395 . . . . 0.0 111.038 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.537 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 96.9 mtp -83.94 150.13 25.87 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.561 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.4 t -119.73 133.59 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.807 0.337 . . . . 0.0 110.321 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.3 mp0 -101.96 155.41 18.18 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.443 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -71.34 140.8 50.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.024 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 t0 80.61 64.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.766 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -140.36 87.58 2.15 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -98.01 89.28 4.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.724 0.297 . . . . 0.0 111.354 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.9 mt -140.92 27.16 2.01 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 m -116.61 135.81 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -122.7 126.24 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.598 0.237 . . . . 0.0 110.602 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.33 155.74 34.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 110.464 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 43' ' ' VAL . 28.0 tpp -106.71 125.42 50.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.624 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.69 -49.77 3.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.974 0.416 . . . . 0.0 110.079 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' OD1' HG23 ' A' ' 43' ' ' VAL . 47.8 p-10 -139.23 49.72 1.83 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.438 ' C ' ' SD ' ' A' ' 39' ' ' MET . 48.5 tttm 72.76 23.8 2.84 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.589 ' N ' ' SD ' ' A' ' 39' ' ' MET . 47.6 t -123.69 134.57 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.754 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.3 m -95.68 118.74 32.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.661 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.12 155.11 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.251 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -109.67 135.1 51.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.711 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.32 157.88 75.73 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 49' ' ' SER . 37.2 Cg_exo -55.2 147.24 55.87 Favored 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 121.914 1.743 . . . . 0.0 112.452 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -48.4 179.9 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.352 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 49' ' ' SER . 88.0 Cg_endo -89.31 44.91 0.77 Allowed 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 123.094 2.529 . . . . 0.0 113.056 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.1 t 62.79 117.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 120.682 0.277 . . . . 0.0 111.745 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -39.26 147.12 0.07 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.695 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.53 -147.14 12.85 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.27 139.1 51.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.963 0.382 . . . . 0.0 110.309 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mm -103.31 119.02 51.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -93.6 -51.62 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -147.17 157.5 43.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.52 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.4 tt -116.94 124.24 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.376 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.22 -16.42 15.21 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 8.1 m-85 -109.89 145.51 36.71 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.269 0.557 . . . . 0.0 111.751 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -124.87 161.8 25.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.254 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -56.11 138.52 49.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.558 0.694 . . . . 0.0 112.33 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.85 5.67 89.91 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.202 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -81.2 133.83 35.52 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.332 -0.51 . . . . 0.0 110.832 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.9 t -118.02 128.62 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.157 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 t -149.84 139.38 13.17 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.513 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.04 143.28 83.92 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.205 1.27 . . . . 0.0 111.746 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.21 130.95 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.73 50.13 0.05 OUTLIER Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.975 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -166.65 164.07 16.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.388 0.594 . . . . 0.0 111.451 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 71' ' ' THR . 7.8 t -94.71 114.43 26.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.188 0.518 . . . . 0.0 109.628 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.533 ' CD1' ' CD2' ' A' ' 60' ' ' TYR . 2.9 mm? -64.72 -40.32 95.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.334 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.9 tt -142.62 147.7 36.24 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.873 ' N ' HD23 ' A' ' 73' ' ' LEU . 55.5 tt0 -102.74 130.7 49.78 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.0 mt -128.3 127.78 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.982 0.42 . . . . 0.0 111.296 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -96.0 116.37 28.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.47 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.108 -179.82 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -80.32 141.05 35.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.66 138.51 51.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.737 0.303 . . . . 0.0 110.756 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -101.36 106.02 17.13 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -114.84 120.81 41.27 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.066 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.58 HD23 ' C ' ' A' ' 6' ' ' LEU . 4.4 tt -47.11 107.64 0.75 Allowed Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.447 ' N ' HD23 ' A' ' 6' ' ' LEU . 44.6 Cg_exo . . . . . 0 N--CA 1.496 1.633 0 C-N-CA 121.533 1.488 . . . . 0.0 112.332 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.451 ' OE2' HG22 ' A' ' 65' ' ' VAL . 74.8 tt0 . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -98.69 144.59 17.31 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -157.06 126.7 6.16 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.417 HG21 ' NE1' ' A' ' 21' ' ' TRP . 5.4 mm -102.54 120.09 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.802 0.334 . . . . 0.0 111.65 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.1 p -87.27 -47.45 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.851 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.565 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.8 mtt180 -142.77 147.77 36.09 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.417 ' NE1' HG21 ' A' ' 18' ' ' ILE . 42.1 m95 -113.24 136.17 53.03 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 22.3 p-10 -99.69 -7.12 26.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.8 m -145.37 161.12 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.48 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 99.0 mttt -139.36 155.44 47.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.151 0.501 . . . . 0.0 111.215 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -46.78 142.31 3.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.389 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.9 8.53 67.08 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.137 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 47.2 p-10 -129.65 149.47 51.39 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.015 0.908 . . . . 0.0 111.659 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.5 mtt -84.94 151.39 24.27 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.54 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.18 147.1 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.093 0.473 . . . . 0.0 110.309 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 97.6 mt-10 -140.56 152.77 45.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.068 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 30' ' ' GLU . 33.7 tptt 94.59 124.11 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.955 0.784 . . . . 0.0 110.707 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 49' ' ' SER . 9.0 p-10 -72.75 -3.32 24.57 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.469 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -132.49 87.27 2.4 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.6 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 53.1 p-10 -97.82 -112.32 0.15 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.6 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 54.5 tp -166.84 80.51 0.23 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.275 0.559 . . . . 0.0 110.714 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.64 132.35 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -109.27 123.77 49.82 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 110.582 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.76 128.23 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.621 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttm -109.2 155.94 20.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.03 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.5 t -132.21 -118.33 0.21 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.629 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.536 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.2 p-10 -66.73 -46.33 75.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.941 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.488 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 30.8 ttmt -174.64 56.2 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.485 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -162.21 151.76 3.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.826 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 m -117.09 122.49 44.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.065 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.59 157.31 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.055 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.26 134.44 51.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.0 mt -118.53 137.63 24.99 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.92 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 49' ' ' SER . 50.2 Cg_exo -51.11 142.07 36.26 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.442 1.428 . . . . 0.0 112.467 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -36.58 157.44 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.37 44.93 1.72 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.496 2.131 . . . . 0.0 112.578 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.8 t 63.62 117.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -50.25 146.7 4.85 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.933 0.396 . . . . 0.0 111.704 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.73 -136.59 4.33 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -127.04 143.84 51.18 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.033 0.416 . . . . 0.0 110.239 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.474 HG23 HD21 ' A' ' 73' ' ' LEU . 7.3 mm -104.0 117.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.3 t -91.18 -50.72 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -149.97 157.17 42.89 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.427 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ILE . 15.5 tt -132.02 126.84 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.766 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.13 -16.11 20.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.914 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.587 ' CE1' HD23 ' A' ' 72' ' ' LEU . 25.2 m-85 -102.01 134.65 44.9 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.36 0.6 . . . . 0.0 111.782 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.81 178.99 4.28 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.987 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.69 128.16 35.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.781 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.46 5.88 81.56 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.527 177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -83.72 139.49 32.71 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.198 0.999 . . . . 0.0 111.743 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 16' ' ' GLY . 12.9 p -125.73 132.63 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.378 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -147.99 137.59 12.24 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.032 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.51 150.6 41.99 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 121.472 1.448 . . . . 0.0 112.439 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.37 130.6 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.307 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.7 48.15 0.11 Allowed Glycine 0 N--CA 1.471 1.018 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.247 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.3 p -163.12 162.89 25.88 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 117.376 0.588 . . . . 0.0 111.171 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -90.28 130.79 36.35 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.587 HD23 ' CE1' ' A' ' 60' ' ' TYR . 78.3 mt -89.27 -12.36 40.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.3 tt -169.59 146.78 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.976 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.502 ' N ' HD23 ' A' ' 73' ' ' LEU . 2.7 tm0? -102.81 122.31 44.26 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.0 mt -124.97 128.73 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.398 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -98.54 111.26 23.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.229 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.56 -179.951 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -80.68 137.22 36.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -114.02 126.64 55.35 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -96.97 113.65 25.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.211 0.529 . . . . 0.0 110.161 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -117.71 139.42 51.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.023 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -71.51 113.15 17.25 Favored Pre-proline 0 N--CA 1.47 0.549 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.546 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 N--CA 1.492 1.401 0 C-N-CA 122.057 1.838 . . . . 0.0 111.929 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.22 110.22 0.79 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -123.23 137.04 54.97 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.03 121.42 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 112.056 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.8 p -87.19 -46.56 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.609 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' N ' HG13 ' A' ' 19' ' ' VAL . 72.2 ttt180 -149.16 137.28 20.71 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -100.84 145.6 28.36 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 11.5 p-10 -121.3 8.89 10.3 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.31 155.68 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.075 0.464 . . . . 0.0 111.018 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -134.74 147.57 50.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 56' ' ' VAL . 24.0 tp10 -60.11 135.25 57.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.167 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.77 8.06 70.39 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.224 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -118.4 156.33 29.16 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.125 0.463 . . . . 0.0 111.322 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.2 mmt -96.4 150.96 20.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 30' ' ' GLU . 3.4 p -138.32 154.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.809 0.337 . . . . 0.0 110.405 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 30' ' ' GLU . 1.3 pm0 -109.98 155.19 22.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.974 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -83.8 92.75 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.765 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -178.61 75.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.99 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 38.74 91.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.957 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.45 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 27.4 t70 -84.67 11.97 8.02 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.339 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.9 mt 66.0 66.33 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.918 0.761 . . . . 0.0 110.859 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.06 128.93 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -120.56 125.54 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.14 0.495 . . . . 0.0 111.091 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.5 m -121.04 133.57 67.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.265 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.9 ttp -103.88 109.54 21.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.413 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 40' ' ' THR . 0.2 OUTLIER -63.67 -51.96 62.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.201 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -138.49 -65.48 0.5 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.545 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -149.47 43.83 0.93 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.701 0.286 . . . . 0.0 110.37 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.0 p -150.87 149.71 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.951 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 m -102.19 118.86 37.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.516 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.64 133.54 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.482 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -94.24 137.45 33.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.745 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.2 mt -132.03 139.15 34.11 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.059 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 49' ' ' SER . 50.4 Cg_exo -52.97 142.74 52.24 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.356 1.371 . . . . 0.0 112.379 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.93 164.85 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.551 -179.218 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.28 44.55 1.63 Allowed 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.149 2.566 . . . . 0.0 112.663 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t 64.38 116.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.732 0.301 . . . . 0.0 110.901 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -49.78 146.93 4.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 111.665 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 167.3 -134.57 3.31 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.0 139.55 53.34 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.87 0.335 . . . . 0.0 110.192 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -99.01 120.25 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.464 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 21.4 t -87.05 -54.76 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -154.13 158.76 40.89 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.302 0.572 . . . . 0.0 112.038 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.4 tt -116.87 119.54 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.198 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 74.3 mt -100.17 -18.22 17.02 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.3 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -115.17 142.75 46.23 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -123.7 165.92 16.42 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.142 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.42 150.25 11.99 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.014 0.435 . . . . 0.0 111.983 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.55 6.47 77.17 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.303 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -101.72 129.97 48.01 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 112.071 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.95 128.94 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 t -147.08 140.43 14.94 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.783 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.48 140.82 63.7 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.239 1.293 . . . . 0.0 112.05 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 68' ' ' VAL . 10.2 p -59.43 131.75 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.555 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.28 50.48 0.12 Allowed Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.014 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.1 p -156.36 164.55 38.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.269 0.535 . . . . 0.0 111.304 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.4 m -88.26 121.06 30.22 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.88 -27.69 13.48 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 74' ' ' GLN . 1.7 tt -156.12 141.71 17.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.796 ' N ' HD23 ' A' ' 73' ' ' LEU . 52.2 tt0 -104.25 132.81 50.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.86 0.362 . . . . 0.0 110.205 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.7 mt -130.99 127.47 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.191 0.519 . . . . 0.0 111.34 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -87.46 142.95 27.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.717 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 83.9 m . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.299 179.535 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -116.26 141.49 48.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -114.6 126.41 54.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.88 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -99.62 118.69 36.71 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.21 0.528 . . . . 0.0 110.503 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -124.65 140.91 52.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.882 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.81 114.75 12.21 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo . . . . . 0 N--CA 1.493 1.484 0 C-N-CA 121.622 1.548 . . . . 0.0 112.662 -178.914 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 120.768 0.318 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.82 135.71 8.83 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.38 137.88 54.72 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.411 HG21 ' NE1' ' A' ' 21' ' ' TRP . 8.9 mm -102.66 121.18 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.688 0.28 . . . . 0.0 111.616 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 t -101.53 -34.65 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.751 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -153.49 133.21 13.06 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.88 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.411 ' NE1' HG21 ' A' ' 18' ' ' ILE . 67.6 m95 -105.37 130.48 53.47 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 16.8 p-10 -98.98 3.66 47.05 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.719 0.295 . . . . 0.0 111.086 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.46 157.64 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.792 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -132.33 145.7 51.45 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.32 0.581 . . . . 0.0 111.402 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -58.39 140.48 53.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.919 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.71 6.89 65.26 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -121.48 126.6 49.65 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.082 0.441 . . . . 0.0 111.225 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -71.34 141.17 50.44 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 30' ' ' GLU . 11.2 t -142.1 161.5 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 1.6 pm0 -127.66 152.1 48.11 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.055 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 30' ' ' GLU . 52.4 pttt -26.8 145.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.583 0.552 . . . . 0.0 111.752 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.5 ' O ' ' O ' ' A' ' 33' ' ' GLN . 94.6 m-20 61.69 58.31 2.03 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.227 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.699 ' NE2' ' H ' ' A' ' 49' ' ' SER . 1.4 pm0 -43.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.488 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' H ' ' CG ' ' A' ' 33' ' ' GLN . 66.4 t0 -153.4 61.17 0.76 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.036 0.446 . . . . 0.0 110.672 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 34' ' ' ASP . 19.3 mt 55.73 124.62 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.999 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.73 131.78 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -92.87 120.53 33.31 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.331 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -129.22 134.93 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.967 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.0 ttp -116.43 153.15 32.6 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.723 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -135.31 -82.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 40' ' ' THR . 99.0 m-20 -91.6 44.43 1.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.0 tttt 68.46 38.06 2.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.79 0.328 . . . . 0.0 110.443 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.3 t -132.31 136.95 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -94.22 113.78 25.77 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.03 0.443 . . . . 0.0 110.012 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.39 133.75 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.822 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -93.53 125.26 38.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.31 0.576 . . . . 0.0 110.58 179.368 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.4 mt -135.46 85.68 31.27 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.471 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.09 145.02 99.07 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 122.483 2.122 . . . . 0.0 111.722 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.699 ' H ' ' NE2' ' A' ' 33' ' ' GLN . 1.2 m -74.69 131.9 78.87 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.754 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.89 -15.45 40.33 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.816 1.677 . . . . 0.0 113.749 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -136.97 155.51 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.769 0.319 . . . . 0.0 111.424 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.18 160.02 9.4 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.42 -82.63 0.05 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -124.63 124.13 41.55 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -97.76 115.66 38.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.68 -54.07 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -165.36 152.64 10.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.514 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.8 tt -105.62 121.12 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.542 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -95.24 -17.48 21.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.077 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.529 ' CD1' HD13 ' A' ' 72' ' ' LEU . 12.3 m-85 -109.8 142.78 40.57 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.216 0.531 . . . . 0.0 111.261 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.493 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 60.7 ttm-85 -126.69 162.54 25.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.757 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -55.0 147.2 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.212 0.53 . . . . 0.0 111.875 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.44 6.48 87.56 Favored Glycine 0 N--CA 1.47 0.919 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.945 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.493 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 86.8 mt-30 -98.76 133.32 43.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.368 0.604 . . . . 0.0 111.715 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.81 129.14 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.29 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.9 t -147.64 141.04 15.29 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.722 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.04 142.47 34.39 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.466 1.444 . . . . 0.0 112.332 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -60.8 133.82 26.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.822 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.53 51.81 0.16 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 m -153.02 159.43 42.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 117.457 0.629 . . . . 0.0 111.561 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.2 m -88.04 98.08 11.33 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.867 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 3.1 mm? -65.21 -41.63 94.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.641 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.846 HD23 ' N ' ' A' ' 74' ' ' GLN . 1.8 tt -146.39 148.6 32.5 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.846 ' N ' HD23 ' A' ' 73' ' ' LEU . 54.3 mt-30 -103.26 127.18 50.66 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 mt -126.08 127.86 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.1 0.476 . . . . 0.0 111.575 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -101.83 114.16 28.0 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.961 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.4 -179.935 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 ttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -85.54 147.15 26.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.897 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -121.33 135.72 55.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.325 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.436 ' CE2' HD12 ' A' ' 72' ' ' LEU . 1.3 t80 -99.55 118.51 36.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -121.54 146.44 46.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.293 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.19 115.99 17.14 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo . . . . . 0 N--CA 1.495 1.616 0 C-N-CA 121.391 1.394 . . . . 0.0 113.291 -179.211 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.653 0.263 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.11 122.61 6.97 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -131.63 135.19 46.75 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.436 HG21 ' NE1' ' A' ' 21' ' ' TRP . 8.4 mm -102.7 120.0 51.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.185 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 m -92.37 -43.58 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.719 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -142.93 145.52 33.11 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.436 ' NE1' HG21 ' A' ' 18' ' ' ILE . 46.3 m95 -118.22 140.28 50.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.1 m-20 -119.8 13.47 12.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.781 0.324 . . . . 0.0 110.82 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.35 158.92 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 26.4 pttm -138.94 144.36 39.0 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 110.574 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 26' ' ' GLY . 13.1 tm-20 -47.78 138.88 8.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.725 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' N ' ' CD ' ' A' ' 25' ' ' GLU . . . 87.56 6.82 76.61 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.451 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 42.4 p-10 -106.93 150.01 26.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.206 0.503 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.6 mtp -90.31 142.69 27.48 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.091 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.9 t -120.01 133.38 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.672 0.272 . . . . 0.0 110.705 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -101.47 156.49 17.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.238 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.39 135.9 55.83 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.704 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 57.9 34.4 24.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.303 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -144.43 88.27 1.92 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.76 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -172.67 170.87 4.63 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.938 0.399 . . . . 0.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.452 HD23 ' NZ ' ' A' ' 46' ' ' LYS . 81.0 mt -140.14 88.42 2.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.61 133.38 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.444 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -123.1 124.91 44.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.189 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.04 154.64 26.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.215 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.6 ttp -106.84 152.4 23.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.216 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.65 -42.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.479 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -136.0 49.0 2.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.92 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 56.81 43.46 25.0 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.066 0.46 . . . . 0.0 109.961 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.43 152.1 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.25 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.6 m -95.9 118.29 32.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.612 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.74 131.38 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.193 0.52 . . . . 0.0 110.769 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.452 ' NZ ' HD23 ' A' ' 35' ' ' LEU . 54.0 tttp -92.03 139.24 30.84 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.086 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.3 mt -134.73 135.2 22.95 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.078 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 49' ' ' SER . 43.0 Cg_exo -51.6 146.17 27.42 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 121.689 1.593 . . . . 0.0 112.308 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.26 166.31 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.466 -179.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.71 49.85 3.32 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 123.044 2.496 . . . . 0.0 113.082 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t 68.29 119.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.838 0.351 . . . . 0.0 111.492 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -47.41 135.9 10.25 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.753 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.15 -141.52 6.51 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -123.59 144.98 49.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.021 0.411 . . . . 0.0 110.559 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.409 HG23 HD21 ' A' ' 73' ' ' LEU . 8.2 mm -100.96 120.76 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.2 t -92.43 -51.13 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -154.6 159.15 40.67 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.761 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.1 tt -106.95 132.76 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.221 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.44 -24.6 10.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.459 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -108.4 141.41 40.29 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.035 0.445 . . . . 0.0 111.418 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.554 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 90.4 mtm180 -120.2 162.62 19.05 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.39 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 56.2 mp0 -56.17 134.83 53.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.174 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.75 4.98 84.62 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.929 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.554 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 79.8 mt-30 -83.27 135.53 34.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.688 0.744 . . . . 0.0 111.875 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.3 t -120.11 126.84 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 t -148.67 132.5 8.53 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -56.47 149.65 55.86 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.459 1.439 . . . . 0.0 112.106 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 68' ' ' VAL . 1.4 p -58.89 128.56 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.783 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.52 49.72 0.05 OUTLIER Glycine 0 CA--C 1.531 1.078 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.131 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m -163.92 166.97 21.18 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.388 0.594 . . . . 0.0 111.165 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 71' ' ' THR . 6.3 t -95.4 115.92 28.09 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.436 HD12 ' CE2' ' A' ' 4' ' ' PHE . 92.1 mt -65.99 -42.98 89.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.291 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.532 HD23 ' N ' ' A' ' 74' ' ' GLN . 4.0 tt -144.01 151.28 39.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.532 ' N ' HD23 ' A' ' 73' ' ' LEU . 36.8 mt-30 -102.62 121.12 41.77 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.9 127.19 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.965 0.412 . . . . 0.0 111.827 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.56 136.95 32.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.482 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.397 -179.872 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtm . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -111.77 143.65 42.34 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.328 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -139.49 114.31 9.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.017 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -88.87 122.44 32.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.135 0.493 . . . . 0.0 110.633 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -121.76 157.85 30.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.178 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 tp -44.43 126.24 4.76 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.495 1.611 0 C-N-CA 121.186 1.257 . . . . 0.0 112.539 -178.449 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 C--O 1.232 0.15 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.79 137.09 10.29 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -151.97 133.47 14.63 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.921 0.391 . . . . 0.0 109.986 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.404 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.6 mm -102.77 124.34 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.561 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.5 p -91.58 -44.24 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.527 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.514 ' N ' HG13 ' A' ' 19' ' ' VAL . 71.3 ttt180 -151.61 137.87 18.42 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.404 ' NE1' HG21 ' A' ' 18' ' ' ILE . 60.9 m95 -107.75 136.9 46.72 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.1 m-20 -108.16 0.46 21.56 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.665 0.269 . . . . 0.0 110.766 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.5 m -133.54 158.49 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -137.5 154.33 49.89 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -54.73 143.21 25.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.059 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.51 7.13 76.29 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.762 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 28' ' ' MET . 62.0 t0 -123.19 150.57 43.2 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.602 0.701 . . . . 0.0 111.089 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.553 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 76.5 mtm -78.07 149.09 33.99 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -121.8 133.93 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.69 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.86 157.41 17.22 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.348 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.05 94.48 6.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' ASP . 8.0 p30 173.12 113.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.936 0.398 . . . . 0.0 111.381 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 53.67 -82.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.829 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' ASP . 9.7 t0 74.88 13.14 3.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.864 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.3 mt 21.08 84.48 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.761 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.93 130.33 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.6 mp0 -116.37 124.38 49.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.475 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.56 135.14 58.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.637 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.7 ttp -124.83 151.46 45.21 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.675 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -104.27 -51.83 3.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.742 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' OG1' ' A' ' 40' ' ' THR . 94.7 m-20 -138.01 -62.5 0.59 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.327 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -146.31 39.19 1.08 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.855 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.6 t -129.87 133.33 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.798 0.332 . . . . 0.0 110.134 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.5 m -114.96 115.79 27.45 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.09 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.0 m -129.46 131.13 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.852 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -95.2 133.35 39.15 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.095 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mt -128.85 134.48 26.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.993 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.35 144.23 50.27 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.678 1.586 . . . . 0.0 111.219 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.1 m -99.0 104.01 23.14 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.22 48.43 2.49 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.186 1.924 . . . . 0.0 110.663 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.61 158.91 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -160.36 144.98 14.45 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.128 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.01 -137.05 4.98 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.07 141.72 51.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.902 0.351 . . . . 0.0 110.087 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -97.09 119.97 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.33 -49.61 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -158.26 158.43 34.43 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.734 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 58' ' ' ILE . 4.4 tt -123.96 122.8 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.255 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.3 mt -99.15 -18.02 17.88 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.668 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CE1' HD23 ' A' ' 72' ' ' LEU . 21.3 m-85 -105.43 136.5 44.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.156 0.503 . . . . 0.0 110.827 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -121.06 -176.45 3.27 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.031 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -64.57 126.78 28.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.59 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.47 5.57 86.79 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.22 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -70.48 133.97 47.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.802 0.801 . . . . 0.0 110.835 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.71 126.9 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.3 t -149.17 139.49 13.44 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.189 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.91 150.34 64.25 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.034 1.156 . . . . 0.0 111.707 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.0 p -64.05 127.66 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.347 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.74 52.38 0.07 OUTLIER Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.027 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.7 p -162.84 163.45 26.51 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 117.289 0.545 . . . . 0.0 111.38 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 p -89.76 113.09 24.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.156 0.503 . . . . 0.0 110.182 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.46 HD23 ' CE1' ' A' ' 60' ' ' TYR . 96.2 mt -67.19 -39.14 86.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.559 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 74' ' ' GLN . 0.8 OUTLIER -151.57 144.91 24.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.606 -177.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.469 ' N ' HD23 ' A' ' 73' ' ' LEU . 52.4 tt0 -103.38 125.91 50.25 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.4 mt -132.63 128.77 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.222 0.535 . . . . 0.0 111.333 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -100.65 136.08 41.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.838 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.431 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.595 ' SD ' ' NE2' ' A' ' 74' ' ' GLN . 14.3 ptp . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -101.71 134.69 44.48 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 40.5 mp0 -111.51 116.87 31.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.747 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -76.93 100.56 5.62 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -105.83 155.75 19.0 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.108 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.9 mt -93.33 108.25 31.98 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 N--CA 1.497 1.686 0 C-N-CA 121.847 1.698 . . . . 0.0 112.169 -179.674 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.765 0.317 . . . . 0.0 111.126 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.63 123.63 7.74 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -126.14 140.05 52.88 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 117.334 0.567 . . . . 0.0 110.158 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.54 121.8 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.29 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 20' ' ' ARG . 12.1 p -92.96 -42.74 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.762 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.482 ' N ' HG13 ' A' ' 19' ' ' VAL . 72.3 ttt180 -155.89 133.84 11.28 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -102.01 134.41 45.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 24.0 p-10 -106.21 -0.52 24.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.662 0.268 . . . . 0.0 111.149 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.63 160.37 37.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -139.6 155.78 47.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -50.87 135.72 23.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.079 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.17 4.61 66.49 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.858 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 36.7 p-10 -114.46 154.06 28.84 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.628 0.714 . . . . 0.0 110.908 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.9 mtm -114.12 148.73 36.71 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.01 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -139.43 150.4 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.92 0.391 . . . . 0.0 110.706 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -90.06 159.35 16.88 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.54 136.62 58.08 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.986 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 60.0 36.43 21.5 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.821 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -145.4 86.32 1.75 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 17.3 t0 -176.27 161.06 2.24 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.531 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 76.6 mt -134.55 88.63 2.46 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.107 0.479 . . . . 0.0 109.882 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.38 130.09 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -111.92 124.63 52.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.582 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.5 m -121.91 131.21 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.1 ttm -101.93 123.31 45.62 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.692 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -88.1 -90.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.418 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 42' ' ' LYS . 23.0 p-10 -96.03 -68.98 0.77 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.726 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.502 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 25.0 pttm -149.2 43.17 0.95 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.73 0.3 . . . . 0.0 110.977 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.19 151.21 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.909 0.385 . . . . 0.0 110.598 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 m -99.63 117.78 34.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.069 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.9 m -118.0 134.02 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.239 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.43 134.18 41.03 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.928 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.0 mt -137.23 85.41 21.98 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.732 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -55.74 141.43 84.51 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.705 2.27 . . . . 0.0 112.333 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.9 t -36.23 100.27 0.19 Allowed Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.589 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.92 -21.92 36.82 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.073 1.182 . . . . 0.0 113.843 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.19 120.96 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 122.104 -0.372 . . . . 0.0 111.212 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.48 152.94 33.95 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 121.167 -0.213 . . . . 0.0 110.547 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.2 -134.29 3.04 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.31 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -136.93 134.03 36.32 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.741 0.305 . . . . 0.0 110.234 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.0 mm -90.77 118.44 36.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.95 -51.47 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -146.17 156.74 43.63 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.885 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 58' ' ' ILE . 5.6 tt -121.79 122.77 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.362 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.15 -18.88 16.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.639 0.257 . . . . 0.0 110.933 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -105.98 141.08 37.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.17 0.509 . . . . 0.0 111.406 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.05 162.89 25.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.313 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.03 140.78 42.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.545 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.55 6.09 81.03 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.388 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -99.43 134.81 41.77 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.347 0.594 . . . . 0.0 111.854 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -126.38 129.2 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.566 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 t -147.79 138.03 12.65 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.38 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.15 140.95 70.73 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.43 1.42 . . . . 0.0 112.426 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 m -53.23 144.65 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.703 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.48 50.28 0.42 Allowed Glycine 0 N--CA 1.471 1.014 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.5 p -156.64 162.59 39.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 117.012 0.406 . . . . 0.0 111.024 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 m -82.33 100.61 10.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.005 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.19 -42.43 93.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.8 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.896 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.3 tt -158.27 148.32 19.98 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.896 ' N ' HD23 ' A' ' 73' ' ' LEU . 56.8 tt0 -103.05 128.24 49.99 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 86.8 mt -126.05 127.21 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.072 0.463 . . . . 0.0 111.262 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -98.56 111.98 24.17 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.212 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.182 179.771 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.39 141.01 40.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 33.8 mp0 -111.14 120.39 42.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.435 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -88.65 105.1 17.45 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -111.85 173.08 6.53 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.137 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.461 HD23 ' C ' ' A' ' 6' ' ' LEU . 2.5 tt -106.42 82.97 1.06 Allowed Pre-proline 0 N--CA 1.471 0.594 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.493 1.495 0 C-N-CA 121.473 1.449 . . . . 0.0 111.854 -179.948 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 120.829 0.347 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.59 110.74 3.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -125.14 134.01 52.6 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 mm -102.6 119.05 50.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.659 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 20' ' ' ARG . 8.8 p -90.1 -43.58 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.405 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.501 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.7 mtt180 -140.9 144.58 35.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.878 0.37 . . . . 0.0 111.405 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -109.36 136.89 48.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 18.7 p-10 -93.76 -11.66 30.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.731 0.301 . . . . 0.0 110.522 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.78 159.89 7.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.263 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 73.8 mmtt -129.52 144.73 51.39 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -46.51 138.3 5.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.914 0.388 . . . . 0.0 111.339 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.18 7.55 58.31 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.445 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 24' ' ' LYS . 50.0 p-10 -129.07 151.26 49.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.603 0.702 . . . . 0.0 111.212 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.3 mtt -103.08 150.32 23.72 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.496 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.462 ' CG2' ' OE1' ' A' ' 33' ' ' GLN . 3.5 p -138.34 154.26 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.343 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -102.82 160.84 14.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.801 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 86.4 tttt -65.65 137.17 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.055 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 8.9 m-20 92.63 81.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.676 0.61 . . . . 0.0 111.575 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.462 ' OE1' ' CG2' ' A' ' 29' ' ' VAL . 57.2 tt0 -153.56 98.73 2.26 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.887 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -96.49 77.12 2.93 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 35' ' ' LEU . 87.0 mt -141.25 25.84 2.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.926 0.393 . . . . 0.0 110.295 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.23 131.61 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.9 131.04 53.51 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.232 0.539 . . . . 0.0 111.557 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.2 124.28 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.176 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.3 ttp -110.78 157.39 19.84 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.911 0.386 . . . . 0.0 110.83 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.3 t -136.31 -118.08 0.16 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.034 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.521 ' N ' ' OG1' ' A' ' 40' ' ' THR . 87.5 m-20 -64.02 -49.41 72.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.793 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -175.46 56.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.503 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.52 150.22 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.977 0.417 . . . . 0.0 110.894 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -109.77 120.09 41.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.853 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.37 118.47 58.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.951 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -88.28 133.94 33.93 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mt -145.69 117.63 5.1 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.318 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.34 142.94 19.25 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.947 1.765 . . . . 0.0 111.586 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 m -46.57 106.64 0.6 Allowed Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.86 -25.72 45.16 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.338 1.359 . . . . 0.0 114.539 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.5 123.35 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 118.066 0.394 . . . . 0.0 111.607 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 52.8 ptt85 -85.53 149.89 25.06 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.65 -134.56 2.59 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.179 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -126.29 131.22 51.92 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.003 0.402 . . . . 0.0 110.828 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 mm -93.9 119.08 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.8 t -93.08 -49.39 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.463 ' O ' ' CD2' ' A' ' 73' ' ' LEU . 60.6 pttt -148.86 150.28 32.73 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 58' ' ' ILE . 10.5 tt -127.64 128.86 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.187 0.518 . . . . 0.0 110.968 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.5 mt -98.31 -17.36 18.94 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.141 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.54 ' CE1' HD23 ' A' ' 72' ' ' LEU . 30.1 m-85 -94.5 142.72 27.11 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.311 0.577 . . . . 0.0 111.404 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -125.82 159.83 31.42 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.491 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.86 128.99 39.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.526 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.06 3.54 88.98 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.638 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -77.28 132.33 38.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.179 0.514 . . . . 0.0 111.079 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.94 128.54 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.764 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.34 135.84 10.79 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 119.499 -0.286 . . . . 0.0 110.579 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.63 146.7 42.56 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.388 1.392 . . . . 0.0 112.305 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 p -58.68 126.97 17.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.682 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.32 51.65 0.08 OUTLIER Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.3 m -153.83 159.73 41.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.131 0.465 . . . . 0.0 110.749 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.8 m -84.63 112.4 20.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.033 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.54 HD23 ' CE1' ' A' ' 60' ' ' TYR . 85.4 mt -66.95 -43.84 82.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.991 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.7 OUTLIER -159.69 149.81 18.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.175 -177.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.475 ' H ' HD23 ' A' ' 73' ' ' LEU . 12.7 mm-40 -103.5 118.45 36.78 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.3 mt -118.18 128.68 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.486 0.66 . . . . 0.0 111.572 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -95.19 115.48 27.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.335 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.777 -179.715 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -84.13 131.56 34.77 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 51.9 mp0 -102.73 113.28 26.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.184 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -79.85 101.14 8.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.726 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.433 ' NZ ' ' OG1' ' A' ' 71' ' ' THR . 68.5 mttm -112.4 145.8 39.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.2 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -63.04 111.9 5.81 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo . . . . . 0 N--CA 1.498 1.77 0 C-N-CA 121.061 1.174 . . . . 0.0 112.013 179.462 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.79 139.46 14.5 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -152.48 116.05 4.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.1 118.27 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.897 0.379 . . . . 0.0 111.668 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 20' ' ' ARG . 12.0 p -92.65 -40.02 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.398 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.464 ' N ' HG13 ' A' ' 19' ' ' VAL . 62.8 ttm-85 -144.73 137.37 26.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -110.63 146.55 35.96 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 56.7 t0 -130.69 26.84 5.0 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.948 0.34 . . . . 0.0 111.304 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.89 155.01 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.848 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -141.98 147.47 37.01 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.02 0.438 . . . . 0.0 111.158 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.18 140.48 38.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.938 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.3 88.08 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.233 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -108.38 125.75 52.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.116 0.458 . . . . 0.0 111.356 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.9 mtm -85.61 129.42 34.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.108 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.77 135.46 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.313 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -90.99 156.3 18.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.961 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 88.5 tttt -61.24 130.32 45.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 16.2 t0 94.87 69.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.057 0.848 . . . . 0.0 110.802 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 34' ' ' ASP . 52.2 tt0 -176.93 -118.58 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 33' ' ' GLN . 67.1 t0 29.49 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.8 tp -84.51 94.72 8.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.19 134.01 62.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.883 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.42 113.18 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.315 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.7 132.56 59.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.2 ttp -118.87 124.39 47.02 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.54 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -90.25 -86.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.54 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 18.4 p-10 -86.07 -59.18 2.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.625 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 7.5 tmtt? -172.83 57.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 p -153.39 151.3 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.353 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -94.3 116.11 28.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.155 0.503 . . . . 0.0 109.987 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.66 117.33 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.876 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.569 ' H ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -98.35 132.96 43.39 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.046 0.45 . . . . 0.0 111.316 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mt -138.63 85.29 17.43 Favored Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.588 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -87.35 53.82 2.66 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.516 2.144 . . . . 0.0 113.511 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.482 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 59.6 p -170.51 47.52 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.038 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 49' ' ' SER . 71.5 Cg_endo -73.26 25.12 0.31 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.36 2.04 . . . . 0.0 111.457 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.456 ' H ' ' C ' ' A' ' 49' ' ' SER . 4.5 t 66.79 67.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.229 0.537 . . . . 0.0 109.799 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -76.79 150.2 36.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.44 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.94 -92.99 0.09 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -122.36 133.78 54.64 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mm -104.69 120.31 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.3 t -87.55 -51.19 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -155.65 159.98 40.03 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.278 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.7 tt -98.04 116.04 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.873 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -99.16 -16.81 18.45 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.679 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -119.79 143.83 47.64 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 83.4 mtp180 -120.88 166.98 13.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.656 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.36 143.99 57.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.005 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 5.98 89.49 Favored Glycine 0 N--CA 1.466 0.693 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.168 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.584 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 24.5 mt-30 -82.34 126.88 32.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.268 0.556 . . . . 0.0 111.275 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.0 124.16 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.11 155.14 37.35 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.299 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.04 151.85 62.15 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.721 2.281 . . . . 0.0 111.685 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -59.83 129.52 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.259 0.552 . . . . 0.0 110.999 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.82 55.01 0.12 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.825 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.6 m -154.68 166.2 34.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.978 0.418 . . . . 0.0 111.272 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.433 ' OG1' ' NZ ' ' A' ' 5' ' ' LYS . 19.3 m -94.59 114.17 26.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.285 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.07 -46.9 61.04 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.513 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.65 HD12 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -160.99 158.01 27.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.65 ' H ' HD12 ' A' ' 73' ' ' LEU . 58.7 tt0 -103.35 128.03 50.55 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.07 -0.394 . . . . 0.0 111.079 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.2 mt -127.12 128.71 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.215 0.531 . . . . 0.0 112.302 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -100.24 115.74 30.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.38 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.275 179.549 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.452 ' H2 ' ' CB ' ' A' ' 77' ' ' THR . 63.4 ttp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' ILE . 2.1 t80 -122.73 149.85 43.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.737 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -132.23 134.59 45.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.322 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -96.36 113.32 24.89 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -115.65 153.91 30.45 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.914 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 6' ' ' LEU . 1.5 tt -102.81 92.67 3.68 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.85 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.494 1.55 0 C-N-CA 121.531 1.487 . . . . 0.0 111.98 -179.835 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.46 145.82 18.22 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -145.32 138.11 26.14 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.509 0.654 . . . . 0.0 110.995 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -100.63 122.11 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.509 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.1 p -90.22 -44.76 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.234 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' N ' HG13 ' A' ' 19' ' ' VAL . 89.4 mtm180 -143.89 148.44 35.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -118.84 143.57 46.88 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 34' ' ' ASP . 1.1 m-20 -128.42 18.38 6.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.222 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.49 159.31 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.44 142.24 51.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.827 0.346 . . . . 0.0 110.414 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.2 137.27 58.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.083 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.67 7.23 71.9 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 28' ' ' MET . 58.0 t0 -114.55 142.34 46.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.045 0.45 . . . . 0.0 111.084 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.543 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 94.9 mtp -79.94 152.33 29.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.432 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 30' ' ' GLU . 21.4 t -126.89 160.82 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.363 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 29' ' ' VAL . 80.1 mm-40 -123.53 152.0 42.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.896 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -57.9 90.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.2 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 63.7 t0 -178.95 134.01 0.13 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.078 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 4.2 pp0? -45.06 124.91 4.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.663 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' ASP . 89.7 m-20 -95.07 9.44 39.51 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 32.8 tp 63.1 73.85 0.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.235 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 m -117.32 134.57 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -119.12 137.81 53.34 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.603 0.716 . . . . 0.0 110.999 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 p -131.89 128.94 60.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.309 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.1 ttp -101.41 109.34 21.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.812 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 40' ' ' THR . 0.5 OUTLIER -62.0 -48.9 78.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.209 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 23.8 p-10 -152.4 -45.92 0.1 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.33 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -165.22 52.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.956 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 44' ' ' THR . 13.6 p -160.89 155.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 110.367 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 43' ' ' VAL . 5.9 m -95.22 117.85 30.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.161 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.22 118.26 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.135 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -98.54 133.59 42.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.797 0.332 . . . . 0.0 110.365 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.1 mt -135.95 137.37 25.01 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 49' ' ' SER . 38.3 Cg_exo -54.59 147.48 48.52 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.325 1.35 . . . . 0.0 111.408 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -40.48 166.61 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 120.746 0.308 . . . . 0.0 111.133 -179.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.99 47.92 2.69 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.752 2.301 . . . . 0.0 113.42 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t 64.39 119.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.943 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -49.76 150.51 2.09 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.912 0.387 . . . . 0.0 111.76 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.65 -143.55 8.95 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -113.16 132.7 55.37 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 122.569 -0.371 . . . . 0.0 110.64 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mm -95.33 115.6 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.4 t -70.57 -50.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -173.84 155.03 2.52 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.667 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.7 tt -89.31 110.83 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.407 0.622 . . . . 0.0 110.633 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 71' ' ' THR . 36.2 tp -81.6 -27.51 34.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.237 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.49 ' CG ' HD13 ' A' ' 72' ' ' LEU . 5.0 m-85 -110.37 145.86 36.81 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.27 0.557 . . . . 0.0 112.002 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -115.24 169.21 9.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.353 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.63 133.29 53.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.591 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.11 6.26 88.99 Favored Glycine 0 N--CA 1.466 0.672 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.994 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -80.62 133.26 35.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.849 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 p -124.76 127.96 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.927 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 t -148.54 137.33 11.86 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.316 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.2 137.27 46.17 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.155 1.237 . . . . 0.0 111.66 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.5 m -52.37 144.1 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.774 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.29 50.74 0.28 Allowed Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.0 p -161.4 164.05 30.18 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.482 ' O ' HD23 ' A' ' 59' ' ' LEU . 5.7 p -91.29 108.28 19.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.122 0.487 . . . . 0.0 110.544 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.7 mm? -63.85 -38.81 92.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.522 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 74' ' ' GLN . 4.0 tp -155.04 143.96 20.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.645 ' N ' HD12 ' A' ' 73' ' ' LEU . 53.3 tt0 -104.5 131.92 51.34 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.87 0.366 . . . . 0.0 111.173 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' ' 2' ' ' TYR . 92.8 mt -128.12 127.78 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -93.65 134.8 35.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.032 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.452 ' CB ' ' H2 ' ' A' ' 1' ' ' MET . 20.2 m . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.363 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.566 ' N ' ' H ' ' A' ' 77' ' ' THR . 5.0 ptt? . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -79.6 147.12 32.2 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.95 125.47 50.49 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -95.05 112.33 24.04 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -119.11 148.88 42.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.927 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.33 159.08 86.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.5 1.895 0 C-N-CA 121.573 1.516 . . . . 0.0 113.467 -179.316 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.459 ' OE2' ' CG2' ' A' ' 65' ' ' VAL . 43.6 tt0 . . . . . 0 C--O 1.232 0.159 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.17 114.08 3.1 Favored Glycine 0 N--CA 1.468 0.795 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -130.28 127.46 39.57 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -102.02 121.32 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.738 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.2 p -94.07 -42.3 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.293 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.464 ' N ' HG13 ' A' ' 19' ' ' VAL . 82.6 mtp180 -142.31 140.72 32.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.747 0.308 . . . . 0.0 110.613 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.566 ' O ' ' N ' ' A' ' 23' ' ' VAL . 14.5 m95 -101.81 -18.28 15.83 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.289 0.566 . . . . 0.0 109.71 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 35' ' ' LEU . 19.5 m-20 43.51 3.32 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.671 -1.15 . . . . 0.0 113.89 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 21' ' ' TRP . 3.7 m -140.18 156.54 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -126.26 136.6 52.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -45.99 142.09 2.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.039 0.447 . . . . 0.0 111.091 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.17 69.47 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.048 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 51.4 p-10 -107.74 149.67 27.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.0 0.4 . . . . 0.0 110.732 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.6 mtt -83.85 144.15 29.44 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.553 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.1 t -121.07 132.8 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -109.92 154.29 23.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.036 0.446 . . . . 0.0 111.202 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -69.13 138.97 54.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.633 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t0 70.01 23.53 5.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.303 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -149.62 86.35 1.46 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.411 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -173.64 141.87 0.89 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.131 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 76.5 mt -137.16 92.2 2.69 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.17 131.8 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 37' ' ' GLU . 58.6 mp0 -106.78 124.89 50.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.179 0.514 . . . . 0.0 111.224 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.15 132.06 70.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.768 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.6 ttp -116.46 117.53 30.16 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.207 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 40' ' ' THR . 1.7 p -64.83 -49.72 69.5 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.048 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -151.72 -64.7 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.686 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -138.23 36.87 2.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.122 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.34 133.76 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.635 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.6 m -102.36 118.22 36.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.77 162.21 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.784 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -134.77 134.95 41.47 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.926 0.393 . . . . 0.0 110.792 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.8 mt -123.78 85.62 53.49 Favored Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.448 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 49' ' ' SER . 92.0 Cg_endo -80.35 147.19 17.95 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.674 2.25 . . . . 0.0 112.482 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 48' ' ' PRO . 1.2 t 89.72 61.19 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.02 28.83 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.732 2.288 . . . . 0.0 111.343 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t 72.25 111.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.151 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -59.73 146.52 41.15 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.785 0.326 . . . . 0.0 111.775 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.04 -141.3 6.24 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -125.17 136.8 53.95 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.1 mm -91.85 118.58 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -79.0 -50.74 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -171.07 158.76 5.72 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.92 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.6 tt -108.96 123.61 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.869 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.0 mt -97.78 -17.92 19.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.919 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.494 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 6.3 m-85 -108.9 144.24 37.06 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.886 0.374 . . . . 0.0 110.696 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -117.0 160.84 20.33 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.281 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 -57.24 140.58 49.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.698 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.32 4.97 90.35 Favored Glycine 0 N--CA 1.468 0.78 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.965 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -84.71 134.91 34.33 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.516 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' CG2' ' OE2' ' A' ' 15' ' ' GLU . 4.4 p -125.92 129.01 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.774 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.1 t -148.94 139.83 13.79 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.02 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.64 145.55 81.05 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.12 1.213 . . . . 0.0 111.378 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -55.33 125.94 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.088 0.471 . . . . 0.0 111.379 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.42 49.06 0.04 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.231 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.9 p -160.68 162.38 32.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.972 0.386 . . . . 0.0 111.091 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -94.55 107.8 19.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.199 0.523 . . . . 0.0 109.993 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 72' ' ' LEU . 2.8 mm? -67.18 -39.28 86.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.813 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.815 HD23 ' N ' ' A' ' 74' ' ' GLN . 1.7 tt -153.19 145.72 24.15 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.332 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.815 ' N ' HD23 ' A' ' 73' ' ' LEU . 66.3 mt-30 -104.15 130.31 51.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 83.3 mt -127.73 126.62 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.279 0.561 . . . . 0.0 111.738 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -86.65 143.11 27.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.727 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.566 ' H ' ' N ' ' A' ' 1' ' ' MET . 8.9 t . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.127 -0.939 . . . . 0.0 110.017 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -88.53 129.56 35.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 52.9 mp0 -112.28 125.43 54.15 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -92.12 123.46 35.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.237 0.541 . . . . 0.0 110.745 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -122.14 145.79 47.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.286 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.78 115.63 20.28 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.807 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.494 1.53 0 C-N-CA 121.881 1.721 . . . . 0.0 112.3 -179.124 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.79 109.87 0.44 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -123.4 142.64 50.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.017 0.436 . . . . 0.0 110.164 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 mt -102.0 121.85 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.545 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.8 p -101.29 -48.16 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.571 ' N ' HG13 ' A' ' 19' ' ' VAL . 61.3 ttt85 -146.9 136.64 23.1 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -109.76 137.62 47.29 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.61 177.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 8.0 p-10 -101.86 -5.04 25.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.018 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.25 160.18 32.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.371 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 43.8 mmtm -129.22 153.29 47.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.842 0.353 . . . . 0.0 110.683 -179.271 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' OE1' HG22 ' A' ' 58' ' ' ILE . 16.5 pt-20 -53.09 142.44 20.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.37 6.69 66.05 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.859 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 53.0 p30 -123.41 151.98 42.05 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.901 0.85 . . . . 0.0 111.466 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -86.09 154.56 21.3 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.862 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.1 p -138.11 147.08 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.806 0.336 . . . . 0.0 110.203 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -107.33 155.47 19.95 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.492 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -62.3 138.07 58.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.273 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 t0 66.79 20.13 10.65 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.19 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -137.0 81.54 1.88 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 35.3 t70 -173.6 104.46 0.12 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.437 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.552 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 51.0 tp -84.06 99.38 10.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.688 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.63 130.01 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.42 ' OE2' HG23 ' A' ' 44' ' ' THR . 77.0 tt0 -115.74 123.76 49.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.842 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.82 137.03 59.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.955 0.407 . . . . 0.0 110.397 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.4 ptm -115.22 142.01 47.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.141 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -103.19 -64.35 1.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.817 0.341 . . . . 0.0 110.468 -179.595 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.529 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.4 t70 -128.39 56.08 1.65 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.4 tttp 73.71 47.46 0.17 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 44' ' ' THR . 16.9 t -133.69 159.57 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.946 -179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.435 ' N ' HG12 ' A' ' 43' ' ' VAL . 28.1 m -121.75 113.83 20.24 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.915 0.388 . . . . 0.0 110.404 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -132.84 130.63 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.972 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.477 ' HZ2' HD12 ' A' ' 35' ' ' LEU . 52.5 tttp -92.2 136.29 33.3 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.98 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -136.25 96.36 12.63 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.098 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.77 146.6 76.89 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.343 2.029 . . . . 0.0 111.505 178.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.5 m -85.36 112.87 47.2 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.442 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.48 24.94 0.72 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.191 1.928 . . . . 0.0 111.052 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.55 155.96 37.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.68 -177.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -145.91 146.95 31.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.297 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.59 -132.38 2.56 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -129.37 148.41 51.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.694 0.283 . . . . 0.0 110.309 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mm -99.56 120.37 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.7 t -78.55 -50.93 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -172.84 154.25 2.87 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.312 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.582 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.7 tt -101.72 114.92 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.194 0.521 . . . . 0.0 110.331 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.27 -41.61 89.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.771 -179.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.461 ' CG ' ' NE2' ' A' ' 64' ' ' GLN . 5.5 m-85 -139.72 150.21 44.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.279 -178.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -109.93 -166.53 1.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.678 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -53.62 150.96 6.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.734 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.47 6.3 57.54 Favored Glycine 0 N--CA 1.474 1.231 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.461 ' NE2' ' CG ' ' A' ' 60' ' ' TYR . 49.7 tt0 -98.81 135.23 40.57 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 p -142.91 116.83 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -148.53 142.62 16.46 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.03 146.21 70.65 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.456 1.438 . . . . 0.0 112.162 177.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 68' ' ' VAL . 12.9 p -48.79 131.27 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.587 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.29 51.2 0.06 OUTLIER Glycine 0 CA--C 1.527 0.785 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.809 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.8 t -165.18 157.56 15.68 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.779 179.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.7 p -89.92 131.01 36.05 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.117 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.45 -15.63 24.09 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.543 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.815 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.8 OUTLIER -171.32 145.73 2.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.014 -0.674 . . . . 0.0 110.746 -179.218 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.815 ' H ' HD23 ' A' ' 73' ' ' LEU . 56.7 mt-30 -104.7 127.59 52.52 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.1 mt -129.25 126.95 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.311 0.577 . . . . 0.0 111.784 -177.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -88.0 135.98 33.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.825 178.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.6 m . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.541 -179.986 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttp . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -76.83 143.29 39.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.62 136.65 54.3 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.795 0.331 . . . . 0.0 110.181 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.568 ' CE2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -104.14 118.46 36.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.721 179.753 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -118.52 134.85 54.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.42 -179.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.95 126.1 91.92 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.491 1.335 0 C-N-CA 121.198 1.265 . . . . 0.0 112.192 -179.484 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.532 0.206 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.46 151.08 17.49 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.476 ' OE1' HG22 ' A' ' 65' ' ' VAL . 40.5 tp10 -153.39 128.29 9.56 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.265 0.533 . . . . 0.0 110.984 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 mm -102.22 119.75 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.36 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.5 m -93.55 -40.06 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.729 178.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.8 149.06 43.06 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.013 0.435 . . . . 0.0 111.836 -178.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -116.1 145.36 43.09 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.769 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 51.7 t0 -109.33 -6.6 15.44 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.461 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.25 159.54 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.87 0.367 . . . . 0.0 111.574 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -136.38 155.74 49.61 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.582 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -66.07 141.91 57.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.514 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.3 7.72 86.26 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.556 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -118.18 143.46 46.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.31 0.555 . . . . 0.0 111.621 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.7 mtm -87.87 147.13 25.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.563 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.09 151.4 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.032 0.444 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 32' ' ' ASP . 93.9 mt-10 -112.05 154.9 24.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.442 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.05 80.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.562 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' GLU . 68.0 t0 -179.44 94.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.17 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.408 ' HB2' ' H ' ' A' ' 49' ' ' SER . 37.4 mt-30 -142.27 151.89 42.49 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.155 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 63.8 t0 -165.74 24.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.976 0.417 . . . . 0.0 110.206 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.7 mt -121.99 27.84 7.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.689 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.42 129.24 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.07 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.453 ' OE2' ' N ' ' A' ' 45' ' ' VAL . 3.8 tm-20 -127.13 128.33 46.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.611 -179.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.36 141.52 43.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.046 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.9 ttp -126.16 136.59 53.04 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 -72.55 0.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.833 0.349 . . . . 0.0 110.421 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -97.56 41.12 1.13 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.525 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 tttp 71.22 37.76 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.402 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.5 t -127.17 134.68 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.5 m -96.64 116.66 29.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.142 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.453 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 34.3 m -133.27 132.64 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.052 0.453 . . . . 0.0 111.642 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -94.04 139.22 31.23 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.948 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mt -138.89 121.6 10.6 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 119.605 -0.235 . . . . 0.0 110.645 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.28 143.17 19.59 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.33 2.02 . . . . 0.0 112.081 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.408 ' H ' ' HB2' ' A' ' 33' ' ' GLN . 82.1 p -69.7 114.13 22.38 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.394 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.71 8.43 4.63 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.947 1.765 . . . . 0.0 113.553 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -140.3 157.32 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.157 0.503 . . . . 0.0 111.841 -177.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -143.32 149.79 38.28 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.734 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.87 -134.94 2.91 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -118.37 131.34 56.31 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 117.224 0.512 . . . . 0.0 109.986 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mm -94.57 118.71 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.2 t -97.03 -48.91 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -143.36 157.17 44.69 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -177.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.0 tt -125.32 122.01 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.573 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.8 mt -98.86 -17.42 18.43 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.62 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.524 ' CE1' HD23 ' A' ' 72' ' ' LEU . 9.5 m-85 -104.13 138.65 40.33 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.165 0.507 . . . . 0.0 111.288 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -122.05 166.29 14.73 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.077 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.87 130.48 44.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.979 0.418 . . . . 0.0 111.214 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.22 5.58 89.62 Favored Glycine 0 N--CA 1.467 0.755 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.882 179.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -79.22 140.49 37.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.979 0.419 . . . . 0.0 110.898 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.476 HG22 ' OE1' ' A' ' 17' ' ' GLU . 77.4 t -117.92 130.62 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.752 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.5 t -148.96 138.15 12.39 Favored Pre-proline 0 N--CA 1.474 0.769 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.332 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -54.13 139.6 71.51 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.394 1.396 . . . . 0.0 112.069 177.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.9 t -65.14 131.84 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.45 51.05 0.13 Allowed Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.7 p -159.82 162.79 34.81 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 122.508 -0.407 . . . . 0.0 111.31 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 71' ' ' THR . 4.9 t -84.53 114.25 21.82 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.482 0.658 . . . . 0.0 109.953 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.568 HD12 ' CE2' ' A' ' 4' ' ' PHE . 94.9 mt -65.83 -42.16 90.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.487 -178.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.5 tt -143.77 146.85 33.42 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -177.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.471 ' N ' HD23 ' A' ' 73' ' ' LEU . 57.5 tt0 -101.74 123.51 45.84 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.26 129.53 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.495 -177.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -100.33 111.16 23.41 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.62 179.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.222 -0.358 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.021 -179.721 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OE2' ' A' ' 3' ' ' GLU . 68.4 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -77.43 133.9 38.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.917 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 54.4 mp0 -109.83 128.64 55.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.206 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -92.64 117.32 29.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.432 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -119.7 147.16 44.91 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.014 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mt -67.9 113.7 16.19 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.497 1.694 0 C-N-CA 120.985 1.124 . . . . 0.0 112.14 179.149 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 CA--C 1.523 -0.078 0 CA-C-O 120.633 0.254 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.77 153.19 21.27 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -138.28 142.87 39.81 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.421 HG21 ' NE1' ' A' ' 21' ' ' TRP . 5.9 mm -102.82 121.39 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.876 0.369 . . . . 0.0 111.992 -178.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 20' ' ' ARG . 31.4 m -94.27 -40.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.492 179.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.423 ' N ' HG23 ' A' ' 19' ' ' VAL . 95.9 mtt-85 -139.6 146.79 40.24 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.421 ' NE1' HG21 ' A' ' 18' ' ' ILE . 19.0 m95 -119.45 140.79 49.87 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.618 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 9.1 p-10 -114.87 5.52 15.16 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -135.24 156.72 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.513 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -142.52 149.09 38.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.406 0.622 . . . . 0.0 111.516 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -56.62 140.11 47.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.489 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.93 9.14 78.07 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 116.328 -0.396 . . . . 0.0 112.695 178.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 28' ' ' MET . 67.3 t0 -121.86 135.85 54.91 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.184 0.492 . . . . 0.0 111.705 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.531 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 62.9 ttp -94.2 127.54 40.11 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.456 179.027 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 p -129.82 136.88 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.203 0.525 . . . . 0.0 111.956 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 56.5 mp0 -83.86 157.19 22.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.584 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 37.0 ttpt -81.45 130.54 35.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.72 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 52.7 t0 130.5 122.02 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.433 1.083 . . . . 0.0 110.19 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.447 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 60.8 tp60 58.29 103.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.458 178.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 33' ' ' GLN . 97.3 m-20 -143.08 141.18 31.2 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.1 tp -101.73 79.44 1.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.198 0.523 . . . . 0.0 111.441 -178.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.61 126.06 74.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -118.34 118.58 32.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.741 -179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 m -125.57 132.79 70.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.927 0.394 . . . . 0.0 110.26 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.9 ttp -96.35 123.69 40.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.258 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.1 p -89.53 -64.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.729 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 40' ' ' THR . 68.3 t0 -137.57 60.14 1.65 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.246 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 35.5 tttp 74.69 21.89 2.09 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.51 139.59 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 m -94.69 115.74 27.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.794 0.33 . . . . 0.0 110.269 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 m -125.69 131.04 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.898 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -99.67 135.02 41.71 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -131.76 85.27 52.03 Favored Pre-proline 0 N--CA 1.471 0.6 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.844 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.459 ' O ' ' OG ' ' A' ' 49' ' ' SER . 91.2 Cg_endo -80.44 151.22 19.89 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.571 2.181 . . . . 0.0 113.201 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 48' ' ' PRO . 6.0 p 80.74 67.6 0.14 Allowed Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.08 37.85 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.857 2.372 . . . . 0.0 112.755 178.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 t 63.25 114.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.725 0.298 . . . . 0.0 111.24 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB3' ' N ' ' A' ' 31' ' ' LYS . 32.2 ptt180 -77.37 152.77 34.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.475 179.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.72 -140.36 6.04 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -112.17 129.76 56.14 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.37 0.585 . . . . 0.0 110.465 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.422 HG23 HD21 ' A' ' 73' ' ' LEU . 5.8 mm -93.9 119.89 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.1 t -93.31 -52.74 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -151.87 158.65 43.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.902 -177.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.7 tt -112.25 121.76 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.027 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.6 mt -99.3 -17.15 18.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.19 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.421 ' CZ ' HD23 ' A' ' 72' ' ' LEU . 11.1 m-85 -109.25 143.35 38.83 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.062 0.458 . . . . 0.0 111.004 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -120.58 164.42 16.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.084 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.38 127.09 30.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.171 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.2 5.4 89.02 Favored Glycine 0 N--CA 1.468 0.785 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 178.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -76.7 136.53 39.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.648 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.74 132.92 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.698 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.78 140.68 14.56 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.777 -178.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.03 147.17 76.56 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.265 1.31 . . . . 0.0 110.596 176.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.02 126.67 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.246 0.546 . . . . 0.0 110.997 -179.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 146.0 48.56 0.03 OUTLIER Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.388 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 p -164.97 166.41 19.41 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.268 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 71' ' ' THR . 6.6 t -88.98 117.43 27.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.776 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.495 HD12 ' CE2' ' A' ' 4' ' ' PHE . 95.9 mt -63.46 -43.36 97.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.277 0.561 . . . . 0.0 110.428 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.8 tt -145.99 146.32 30.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.462 ' N ' HD23 ' A' ' 73' ' ' LEU . 37.4 tp60 -101.91 124.89 48.31 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.2 mt -127.2 127.3 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.223 -178.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -87.52 142.54 27.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.46 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.216 -179.886 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 75' ' ' ILE . 24.1 t80 -74.72 131.88 41.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 43.1 mp0 -95.95 125.9 40.82 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.697 -179.149 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -94.71 109.24 21.2 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.19 150.22 26.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.078 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.45 116.37 39.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.495 1.606 0 C-N-CA 121.774 1.649 . . . . 0.0 112.985 -178.402 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 . . . . . 0 C--O 1.232 0.156 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.85 111.43 4.23 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -118.38 125.01 49.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.069 0.461 . . . . 0.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.452 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.1 mm -102.41 120.35 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.232 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -107.92 -25.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -141.72 129.96 22.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.03 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.452 ' NE1' HG21 ' A' ' 18' ' ' ILE . 46.5 m95 -112.44 139.59 47.88 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 17.8 p-10 -111.49 2.09 17.27 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.54 HG11 ' NE2' ' A' ' 33' ' ' GLN . 33.3 m -135.5 161.23 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.81 0.338 . . . . 0.0 110.696 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.46 153.02 50.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.046 -178.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -52.74 140.76 22.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.376 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.71 8.33 76.89 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.374 177.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 41.7 p-10 -113.98 150.01 34.48 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.822 0.811 . . . . 0.0 110.691 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.6 mtm -97.63 149.63 22.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.284 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -145.16 140.12 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.906 0.384 . . . . 0.0 111.118 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 32' ' ' ASP . 95.7 mt-10 -87.03 163.93 16.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.869 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' N ' ' HB3' ' A' ' 52' ' ' ARG . 88.9 tttt -58.36 74.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.235 0.541 . . . . 0.0 110.435 -179.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 30' ' ' GLU . 11.5 p-10 170.07 78.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB2' ' H ' ' A' ' 49' ' ' SER . 18.1 tp60 -46.98 167.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.35 -179.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 99.0 m-20 -87.77 -34.48 18.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.529 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 0.9 OUTLIER 159.62 106.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.784 0.678 . . . . 0.0 110.734 179.511 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.62 131.73 69.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -117.98 123.3 45.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.989 0.424 . . . . 0.0 111.459 -178.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.74 128.49 71.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.503 ' SD ' ' N ' ' A' ' 41' ' ' ASP . 10.6 tmm? -133.48 127.82 34.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.564 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 40' ' ' THR . 0.3 OUTLIER -70.5 -46.23 64.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.773 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.503 ' N ' ' SD ' ' A' ' 39' ' ' MET . 24.5 p-10 -152.47 -54.73 0.12 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.551 -179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.423 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 59.8 pttt -145.74 42.07 1.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.148 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.473 ' H ' ' HG2' ' A' ' 39' ' ' MET . 46.5 t -137.83 137.91 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.168 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -103.33 119.24 38.51 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.89 119.02 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.756 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.53 112.9 24.79 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 mt -129.99 109.78 16.89 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.63 147.66 17.61 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.37 2.047 . . . . 0.0 111.744 179.11 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.555 ' H ' ' HB2' ' A' ' 33' ' ' GLN . 6.9 t -58.39 120.39 43.94 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.17 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.96 -3.05 13.35 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 122.088 1.859 . . . . 0.0 114.218 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.23 125.45 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.027 0.376 . . . . 0.0 110.927 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HB3' ' N ' ' A' ' 31' ' ' LYS . 40.2 ptt180 -97.04 153.54 17.86 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.634 0.254 . . . . 0.0 111.037 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.89 -129.71 1.75 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.612 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -126.76 133.59 50.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.708 0.289 . . . . 0.0 110.408 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 mm -86.74 123.59 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 t -82.94 -52.17 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.679 -178.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -164.25 158.88 19.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.801 -178.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 58' ' ' ILE . 3.2 tt -91.14 114.54 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.281 0.562 . . . . 0.0 110.481 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -90.94 -24.36 20.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -113.2 140.21 48.13 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.284 0.564 . . . . 0.0 111.154 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.565 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 86.8 mtm-85 -114.42 166.52 11.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.636 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -62.16 129.34 40.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.861 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.26 69.38 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.808 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.565 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 78.5 mt-30 -80.99 134.68 35.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.616 0.708 . . . . 0.0 111.174 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.95 124.07 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.465 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 t -147.29 138.61 13.27 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 -179.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -55.07 148.81 46.61 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.138 1.225 . . . . 0.0 111.809 179.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.8 p -59.27 129.68 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.169 0.509 . . . . 0.0 111.112 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.09 49.16 0.09 OUTLIER Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.068 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.9 p -159.84 163.78 34.15 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 117.299 0.549 . . . . 0.0 110.846 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 71' ' ' THR . 8.5 t -86.75 114.21 23.24 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.261 0.553 . . . . 0.0 110.391 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -65.55 -41.4 93.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.442 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -152.37 153.99 34.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.616 ' H ' HD12 ' A' ' 73' ' ' LEU . 50.7 tt0 -103.11 129.4 49.95 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.171 0.51 . . . . 0.0 110.992 -178.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 2' ' ' TYR . 89.7 mt -128.7 129.15 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.665 -178.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -96.24 114.44 26.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.699 178.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.665 179.904 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -95.71 142.74 27.64 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -118.55 135.6 54.32 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.951 0.405 . . . . 0.0 110.638 -179.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -88.7 116.31 26.87 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.096 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -116.87 132.01 56.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.888 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.94 115.69 42.86 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.729 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo . . . . . 0 N--CA 1.492 1.427 0 C-N-CA 121.314 1.343 . . . . 0.0 111.977 179.608 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.77 123.18 3.42 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -134.89 139.85 45.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.975 0.417 . . . . 0.0 110.174 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.43 119.02 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.554 -179.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.3 p -92.27 -41.98 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' N ' HG13 ' A' ' 19' ' ' VAL . 77.7 ttt180 -144.83 138.47 27.07 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -110.86 140.19 45.52 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 34' ' ' ASP . 4.4 p30 -108.02 -4.05 18.18 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.01 162.69 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.959 0.409 . . . . 0.0 111.383 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.2 151.91 35.9 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.842 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -61.06 138.37 58.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.883 0.373 . . . . 0.0 111.219 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.78 64.21 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.682 179.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 41.9 p-10 -117.73 152.22 35.69 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.399 0.6 . . . . 0.0 111.021 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -81.35 151.22 28.09 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.041 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -140.28 140.32 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.195 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -95.76 152.41 18.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.723 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HB2' ' H ' ' A' ' 52' ' ' ARG . 64.2 tttm -82.04 89.39 6.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.343 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 33' ' ' GLN . 62.6 t0 -176.3 78.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.188 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 32' ' ' ASP . 4.7 tp-100 37.08 93.02 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.047 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 31.8 t0 -90.17 15.33 10.49 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.0 mt 62.19 66.84 0.77 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.398 -179.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.57 130.25 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -110.15 123.38 49.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.332 0.587 . . . . 0.0 110.647 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 m -124.23 137.62 56.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.886 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 39' ' ' MET . 3.4 ppp? -121.92 147.44 46.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.148 0.499 . . . . 0.0 110.837 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -109.41 -59.41 1.91 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.415 -179.542 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.517 ' N ' ' OG1' ' A' ' 40' ' ' THR . 55.7 t0 -135.95 68.55 1.44 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.96 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 62.67 38.83 11.78 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.71 138.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.074 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.0 m -114.86 116.11 28.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.213 0.53 . . . . 0.0 110.758 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.71 157.81 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.431 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -100.72 136.16 41.03 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.925 179.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 47' ' ' ILE . 12.5 tt -127.26 135.11 26.93 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.446 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 49' ' ' SER . 33.9 Cg_exo -54.69 144.32 65.47 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 121.516 1.477 . . . . 0.0 112.226 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -41.32 164.46 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.649 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -81.45 47.12 2.44 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.772 2.315 . . . . 0.0 113.45 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 t 67.04 117.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.922 0.391 . . . . 0.0 111.417 179.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.473 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 73.7 ttt-85 -48.25 135.68 13.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.425 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.16 -145.45 8.11 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -118.51 133.91 55.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.033 0.417 . . . . 0.0 110.182 -179.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -95.05 121.38 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 t -81.63 -51.18 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -164.55 155.61 15.15 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.437 -178.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.7 tt -90.51 118.27 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.584 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -93.86 -18.24 22.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.716 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -119.08 140.58 49.84 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.089 0.471 . . . . 0.0 110.909 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -115.97 167.32 11.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.234 0.54 . . . . 0.0 111.523 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -62.57 132.65 53.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.902 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.01 3.38 90.59 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -80.63 134.49 35.9 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.308 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.76 131.47 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.761 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 t -146.62 139.09 13.97 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.526 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.68 149.04 25.97 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.387 1.391 . . . . 0.0 111.626 178.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 p -59.35 133.61 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.723 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.46 48.03 0.12 Allowed Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.1 p -162.63 165.08 26.26 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 117.43 0.615 . . . . 0.0 111.367 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 71' ' ' THR . 14.7 t -96.95 118.16 32.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.985 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.052 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -66.26 -36.13 82.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.919 -179.188 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.69 HD12 ' H ' ' A' ' 74' ' ' GLN . 2.1 tp -151.18 149.97 30.07 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.69 ' H ' HD12 ' A' ' 73' ' ' LEU . 3.7 tm0? -103.78 131.97 50.47 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 -179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.5 mt -130.17 129.24 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.138 0.494 . . . . 0.0 111.958 -178.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -97.11 117.2 30.77 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.985 178.287 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.679 -179.527 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mmm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -74.39 130.38 39.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.131 -179.131 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 42.9 mp0 -102.51 125.19 49.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.174 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -86.4 116.26 24.44 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.28 147.27 49.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.791 -179.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 6' ' ' LEU . 4.8 tt -75.68 111.51 14.83 Favored Pre-proline 0 N--CA 1.471 0.604 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.001 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.438 ' N ' HD23 ' A' ' 6' ' ' LEU . 33.2 Cg_exo . . . . . 0 N--CA 1.496 1.665 0 CA-C-N 120.492 1.212 . . . . 0.0 112.388 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.55 133.38 8.88 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -140.03 133.07 29.48 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.973 0.416 . . . . 0.0 109.892 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.427 HG21 ' NE1' ' A' ' 21' ' ' TRP . 5.7 mm -102.81 119.62 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.879 -178.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 p -98.8 -37.37 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.03 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -141.01 133.43 28.36 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.427 ' NE1' HG21 ' A' ' 18' ' ' ILE . 33.5 m95 -110.55 144.85 38.79 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.08 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -128.65 19.91 6.13 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.094 0.407 . . . . 0.0 111.275 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.53 155.41 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -128.16 145.13 51.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.038 0.447 . . . . 0.0 110.512 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.79 137.86 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.054 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.56 7.75 71.53 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.133 179.452 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -116.73 147.82 41.67 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.121 0.461 . . . . 0.0 111.103 -179.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.4 mmm -84.37 147.71 27.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.4 133.98 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.252 179.019 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -91.61 158.31 16.49 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.193 -179.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.78 137.67 57.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.51 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.408 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 94.3 m-20 60.57 37.07 19.68 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.543 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 32' ' ' ASP . 99.4 mm-40 -143.44 86.78 1.91 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -174.36 162.73 3.63 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -134.06 89.74 2.61 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.233 0.539 . . . . 0.0 109.825 178.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.54 130.94 70.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.175 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.9 119.89 37.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.891 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.1 m -117.33 133.17 64.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.068 0.461 . . . . 0.0 109.975 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.0 ttp -113.55 132.57 55.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -116.77 -88.71 0.59 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.658 -179.663 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.601 ' H ' HG23 ' A' ' 40' ' ' THR . 23.2 p-10 -90.06 50.72 1.91 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.214 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 62.22 43.79 8.22 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 44' ' ' THR . 35.3 t -131.7 158.25 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.735 178.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.48 ' N ' HG12 ' A' ' 43' ' ' VAL . 5.6 m -111.28 116.17 30.56 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.095 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.34 135.33 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.958 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -101.23 134.7 43.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.949 0.404 . . . . 0.0 110.808 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.8 mt -136.54 87.72 20.97 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.696 179.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.55 145.66 94.05 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 122.85 2.366 . . . . 0.0 112.543 179.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.9 m -51.65 108.41 1.06 Allowed Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.329 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.23 -14.72 28.6 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.461 1.441 . . . . 0.0 114.638 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.5 126.0 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 118.511 0.596 . . . . 0.0 111.228 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -92.01 150.44 20.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.574 0.226 . . . . 0.0 110.714 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.26 -134.33 2.89 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -119.29 147.26 44.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.944 0.372 . . . . 0.0 110.38 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mm -103.91 119.29 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.9 t -77.76 -52.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.874 -179.018 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -169.24 154.85 6.1 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.158 -178.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.1 tt -81.77 115.75 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.292 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.4 mt -93.99 -19.23 21.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.653 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -117.58 143.07 46.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.239 0.543 . . . . 0.0 111.192 -179.681 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -112.13 163.37 14.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.752 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.65 139.78 58.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.504 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.08 5.33 89.66 Favored Glycine 0 N--CA 1.468 0.79 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.86 179.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -79.01 133.63 36.82 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.227 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.45 127.75 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.18 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -149.35 136.19 10.75 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.45 148.97 69.01 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 121.615 1.543 . . . . 0.0 112.17 177.046 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -48.48 147.73 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.734 179.64 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.11 47.98 0.63 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.503 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.5 p -162.02 163.16 28.99 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.634 179.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 71' ' ' THR . 15.0 t -103.1 118.96 37.98 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.097 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.035 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -66.86 -35.75 80.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.891 -179.678 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.648 HD12 ' H ' ' A' ' 74' ' ' GLN . 1.8 tp -149.98 149.47 30.43 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.648 ' H ' HD12 ' A' ' 73' ' ' LEU . 57.9 tt0 -104.03 131.81 50.91 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.709 0.29 . . . . 0.0 110.793 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 87.5 mt -127.37 128.74 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.388 0.613 . . . . 0.0 112.036 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -94.54 140.93 29.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.915 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.472 179.389 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -116.38 147.16 41.91 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.13 134.12 47.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -93.94 118.04 30.93 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.542 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -125.98 145.52 50.25 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tp -82.29 113.75 46.21 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 N--CA 1.494 1.554 0 C-N-CA 121.841 1.694 . . . . 0.0 112.963 -179.566 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 121.045 0.45 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.67 110.51 0.93 Allowed Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' OE1' ' CE ' ' A' ' 39' ' ' MET . 79.1 tt0 -115.81 129.59 56.5 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 ' HE1' ' A' ' 21' ' ' TRP . 18.0 mm -102.17 119.62 50.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.329 -178.152 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.8 m -109.37 -38.83 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -138.22 148.94 45.31 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.544 ' HE1' HG21 ' A' ' 18' ' ' ILE . 79.5 m95 -132.98 141.42 48.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.641 -1.163 . . . . 0.0 107.919 177.436 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -128.46 16.45 6.53 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.41 160.8 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.98 143.47 51.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.826 0.346 . . . . 0.0 110.812 -179.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -61.26 140.55 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.162 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.21 7.19 77.29 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.889 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -118.41 149.54 41.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.975 0.417 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.0 mtm -81.95 151.15 27.33 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.908 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -135.47 145.64 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.965 179.334 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -110.49 132.13 54.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.587 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 64.4 tttm -52.83 137.48 31.8 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.561 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 3.7 m-20 83.61 -11.7 0.88 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.408 0.442 . . . . 0.0 111.795 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -115.43 76.78 1.03 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.572 0.225 . . . . 0.0 110.42 179.229 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 57.2 t0 -176.66 137.73 0.27 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.245 179.559 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.477 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 81.2 mt -119.45 108.25 14.31 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.558 0.694 . . . . 0.0 110.598 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.21 133.1 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.631 179.576 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.462 ' OE2' ' CG2' ' A' ' 44' ' ' THR . 44.2 tt0 -116.57 120.0 37.33 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 110.397 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.21 140.85 46.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.539 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.444 ' CE ' ' OE1' ' A' ' 17' ' ' GLU . 66.0 ttp -124.71 144.46 50.21 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.832 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -129.18 -85.96 0.55 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.952 179.355 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.485 ' H ' HG23 ' A' ' 40' ' ' THR . 67.3 t0 -82.86 47.01 1.15 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.801 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 61.8 38.88 14.52 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.335 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.26 135.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.462 ' CG2' ' OE2' ' A' ' 37' ' ' GLU . 6.9 m -95.61 119.38 34.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.121 -179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.52 153.88 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 110.734 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -119.26 133.49 55.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.773 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.4 mt -125.63 137.97 30.99 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.088 -179.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' SER . 31.2 Cg_exo -52.49 153.97 12.72 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 121.54 1.493 . . . . 0.0 111.557 178.159 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.33 164.39 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.952 0.406 . . . . 0.0 111.304 -179.514 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.1 49.07 3.1 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.946 2.431 . . . . 0.0 113.669 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 t 69.93 117.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 120.889 0.376 . . . . 0.0 111.693 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -46.81 135.84 8.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.2 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.5 -143.41 7.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.26 144.76 48.44 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.084 0.442 . . . . 0.0 110.545 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.02 121.57 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.1 t -80.25 -52.14 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.54 -179.024 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -167.54 156.99 10.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.932 -179.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.463 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.6 tt -85.87 116.37 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.085 0.469 . . . . 0.0 110.398 -179.688 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.71 -29.68 22.24 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.8 -179.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' ' CB ' ' A' ' 70' ' ' SER . 15.4 m-85 -119.15 145.8 45.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.072 0.463 . . . . 0.0 111.387 -179.649 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -126.62 172.54 10.18 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.962 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.5 145.92 55.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.407 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.99 6.13 82.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.761 178.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -100.41 124.4 45.87 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.46 0.648 . . . . 0.0 112.059 -179.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 p -125.01 126.74 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.515 178.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 t -148.67 140.54 14.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.555 -177.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.09 148.45 48.61 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.164 1.242 . . . . 0.0 111.325 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.29 130.33 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 111.127 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.72 52.86 0.07 OUTLIER Glycine 0 CA--C 1.528 0.863 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.921 179.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.459 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 8.5 m -156.54 164.57 38.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.195 0.498 . . . . 0.0 111.077 179.608 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 p -96.07 111.85 23.75 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.56 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 72' ' ' LEU . 5.8 mp -64.01 -41.03 97.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.357 179.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 74' ' ' GLN . 2.3 tp -162.45 146.26 11.73 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.138 -178.614 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.633 ' N ' HD12 ' A' ' 73' ' ' LEU . 3.2 tm0? -103.09 130.54 50.26 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.921 0.391 . . . . 0.0 110.741 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.2 mt -128.2 128.92 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.301 0.572 . . . . 0.0 111.923 -178.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -95.82 139.98 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.686 178.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.42 ' H ' HG22 ' A' ' 77' ' ' THR . 1.3 t . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.439 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -80.16 148.08 31.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.824 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.79 118.92 29.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE2' HD12 ' A' ' 72' ' ' LEU . 3.4 t80 -83.37 104.28 13.4 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -102.34 148.22 25.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.477 -179.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.38 117.32 59.48 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.288 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo . . . . . 0 N--CA 1.498 1.75 0 C-N-CA 121.939 1.76 . . . . 0.0 111.597 179.641 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.403 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 43.9 mp0 . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.01 162.62 26.3 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -155.11 135.97 13.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.199 0.5 . . . . 0.0 110.55 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.413 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.3 mm -102.64 121.44 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.484 -179.781 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 20' ' ' ARG . 12.6 p -91.72 -44.53 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.407 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.49 ' N ' HG13 ' A' ' 19' ' ' VAL . 61.2 ttp180 -140.86 138.53 34.02 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.054 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.413 ' NE1' HG21 ' A' ' 18' ' ' ILE . 30.0 m95 -112.45 141.57 46.03 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 34' ' ' ASP . 15.4 p-10 -125.59 18.43 8.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.13 0.423 . . . . 0.0 111.555 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.79 156.24 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.86 139.9 51.94 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.771 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.49 140.93 53.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.045 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.78 5.71 68.31 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.821 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 28' ' ' MET . 43.9 t0 -110.11 -174.39 2.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 117.02 0.41 . . . . 0.0 110.676 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.511 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 94.9 mtp -120.22 151.95 38.42 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 30' ' ' GLU . 13.0 t -128.63 161.26 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.436 ' N ' HG12 ' A' ' 29' ' ' VAL . 80.8 mm-40 -130.85 156.01 45.75 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.684 -179.402 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.73 140.37 58.44 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.382 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 59.62 32.44 21.55 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.437 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -147.43 87.67 1.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.312 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 65.8 t0 -171.83 130.33 0.66 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.258 -178.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.5 mt -108.93 84.01 1.85 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.423 0.63 . . . . 0.0 110.34 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.48 132.83 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.494 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -111.1 116.54 31.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.635 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 m -113.25 131.99 63.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 110.568 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.8 ttp -111.18 112.68 24.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.461 ' H ' HG23 ' A' ' 40' ' ' THR . 1.1 p -63.0 -47.87 81.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.175 0.512 . . . . 0.0 110.001 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -149.56 -68.1 0.21 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.67 -179.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -138.64 35.23 2.22 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.264 179.503 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.36 137.58 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 m -103.47 118.0 35.73 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.12 156.85 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.24 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -99.71 138.34 36.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.177 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 47' ' ' ILE . 19.8 tt -133.48 113.95 13.27 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.484 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.29 142.98 17.16 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.003 1.802 . . . . 0.0 112.289 -179.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.0 p -58.38 109.46 1.85 Allowed Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.15 -23.13 39.86 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.057 1.172 . . . . 0.0 114.705 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.99 127.46 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.253 0.479 . . . . 0.0 111.34 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -92.86 148.82 21.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.672 0.272 . . . . 0.0 110.849 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.11 -131.48 1.7 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.9 146.87 49.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.015 0.408 . . . . 0.0 110.448 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.9 mm -103.58 119.89 52.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.139 -179.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 t -79.28 -52.42 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.908 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -163.68 158.39 20.36 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.167 -179.203 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 58' ' ' ILE . 3.5 tt -88.73 118.28 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.054 0.454 . . . . 0.0 111.253 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.4 mt -96.92 -17.87 19.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.167 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.412 ' CE2' HD23 ' A' ' 72' ' ' LEU . 3.8 m-85 -113.24 146.61 39.05 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.018 0.437 . . . . 0.0 110.586 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -124.08 160.88 26.76 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.816 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.79 138.03 58.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.03 5.35 90.2 Favored Glycine 0 N--CA 1.467 0.735 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.543 178.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -75.69 129.18 36.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.209 0.528 . . . . 0.0 111.174 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.9 t -119.7 127.64 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.31 154.92 36.67 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.499 -178.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.25 145.7 55.03 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.84 2.36 . . . . 0.0 112.238 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -55.4 130.42 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.193 0.521 . . . . 0.0 110.421 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.13 55.49 0.25 Allowed Glycine 0 N--CA 1.467 0.736 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -149.71 173.18 13.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.18 0.514 . . . . 0.0 111.07 -179.656 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -102.05 114.29 28.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.935 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.451 HD12 ' CE2' ' A' ' 4' ' ' PHE . 95.1 mt -67.68 -47.46 69.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.914 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.701 HD12 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -159.01 159.4 34.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.806 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.701 ' H ' HD12 ' A' ' 73' ' ' LEU . 51.3 tt0 -104.5 127.91 52.31 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.834 0.349 . . . . 0.0 111.412 -178.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.6 mt -128.86 128.73 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.189 0.519 . . . . 0.0 111.757 -179.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -100.05 119.05 37.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.359 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.819 -179.832 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OE2' ' A' ' 3' ' ' GLU . 99.3 mtp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -80.99 131.45 35.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 56.0 mp0 -113.52 123.78 50.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -95.85 122.16 38.34 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -128.72 129.46 45.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.973 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 tp -45.62 105.9 0.51 Allowed Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.498 1.764 0 C-N-CA 121.351 1.367 . . . . 0.0 111.989 -179.796 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.622 0.248 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.85 154.18 17.07 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -141.05 140.72 34.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.968 0.413 . . . . 0.0 110.096 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.468 HG21 ' NE1' ' A' ' 21' ' ' TRP . 7.4 mm -102.64 124.25 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.992 -178.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.45 -44.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.91 142.71 40.62 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.468 ' NE1' HG21 ' A' ' 18' ' ' ILE . 63.1 m95 -121.2 135.83 55.08 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.179 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -106.99 -3.8 19.71 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.686 0.279 . . . . 0.0 111.186 179.053 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.08 159.17 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -144.99 161.12 40.18 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.065 0.46 . . . . 0.0 111.53 -178.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -56.78 139.78 49.84 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.371 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.76 8.05 62.41 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.28 -0.486 . . . . 0.0 112.943 178.286 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -128.02 155.01 44.99 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.543 0.672 . . . . 0.0 111.837 -179.307 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.0 mtp -88.75 154.62 20.13 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.016 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -134.64 150.84 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.007 0.432 . . . . 0.0 110.624 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.63 159.66 17.97 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.147 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -71.43 87.79 0.88 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.034 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 34' ' ' ASP . 38.0 t0 -174.46 159.71 3.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.663 178.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -44.78 95.5 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.553 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' ASP . 79.4 m-20 -72.33 -3.65 25.16 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.588 0.709 . . . . 0.0 109.131 179.488 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.412 ' O ' ' CG ' ' A' ' 22' ' ' ASP . 35.6 tp 60.79 80.48 0.21 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.337 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.11 131.81 70.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.268 178.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -111.26 121.75 46.08 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.179 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.52 138.23 54.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.741 -178.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.405 ' HG3' ' H ' ' A' ' 43' ' ' VAL . 52.0 ttp -103.82 108.98 20.53 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.27 -46.14 74.55 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.246 -0.581 . . . . 0.0 110.903 -179.221 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 42' ' ' LYS . 18.9 p-10 -139.69 -63.83 0.5 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.156 -179.588 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.504 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 64.9 mttp -150.96 45.2 0.83 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.921 0.391 . . . . 0.0 110.624 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' H ' ' HG3' ' A' ' 39' ' ' MET . 7.4 p -158.71 146.01 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.311 178.747 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -98.84 120.94 40.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.274 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.47 156.53 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.64 135.47 52.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.902 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.9 mt -127.11 112.63 21.69 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.891 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.46 150.95 39.87 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.33 1.353 . . . . 0.0 110.954 178.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.7 m -104.29 97.72 12.48 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -88.12 41.97 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.675 2.25 . . . . 0.0 111.576 178.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.3 m -129.76 156.55 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.812 0.339 . . . . 0.0 111.508 -177.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.485 ' CD ' ' N ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -151.12 148.06 27.82 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.469 179.874 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.55 -137.52 5.5 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -131.14 147.53 52.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 mm -97.88 118.07 43.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.15 -47.5 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -152.55 157.01 40.45 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -177.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 58' ' ' ILE . 19.9 tt -131.68 126.06 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.256 178.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.3 mt -104.46 -15.48 15.36 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.98 -178.359 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.536 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 8.5 m-85 -108.71 144.03 37.04 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.281 0.563 . . . . 0.0 111.581 -178.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.487 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 84.9 mtt85 -131.39 166.25 21.69 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.149 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.58 138.66 51.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.581 -179.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.35 5.33 67.43 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.117 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 61' ' ' ARG . 34.9 mt-30 -96.11 131.26 42.73 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.234 0.54 . . . . 0.0 111.505 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.72 127.91 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 t -147.02 140.44 14.97 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.23 146.31 61.13 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.154 1.236 . . . . 0.0 111.275 177.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 68' ' ' VAL . 1.6 p -62.66 129.49 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.204 0.526 . . . . 0.0 110.811 -179.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.69 51.18 0.06 OUTLIER Glycine 0 CA--C 1.53 1.03 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.595 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 p -160.55 162.23 32.87 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 122.424 -0.456 . . . . 0.0 111.25 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 p -92.75 116.8 29.35 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.314 179.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.4 mm? -83.72 -18.23 38.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.589 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.55 144.16 4.27 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.05 -178.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -106.81 119.49 39.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 176.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.3 mt -126.79 127.54 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.267 0.556 . . . . 0.0 112.156 -177.031 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -85.15 145.68 27.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.738 179.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.537 179.785 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -110.98 142.48 43.05 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.32 130.83 55.58 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -96.0 118.67 33.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.06 0.457 . . . . 0.0 110.116 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -122.34 138.79 54.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.891 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 tp -64.1 115.25 17.86 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.495 1.608 0 C-N-CA 121.967 1.778 . . . . 0.0 112.41 -178.989 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.19 119.2 6.21 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -134.25 138.2 44.88 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.34 0.57 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.45 HG21 ' NE1' ' A' ' 21' ' ' TRP . 7.4 mm -103.45 121.8 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.749 -179.382 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.59 -40.75 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -138.69 147.93 43.37 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.45 ' NE1' HG21 ' A' ' 18' ' ' ILE . 54.4 m95 -128.2 141.58 51.42 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 54.9 t0 -125.46 22.65 7.66 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.79 0.329 . . . . 0.0 111.076 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.0 156.08 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.2 135.33 55.16 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -58.69 138.2 57.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.46 6.8 76.99 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -114.79 156.48 24.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.716 0.293 . . . . 0.0 110.402 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.6 mtt -80.34 148.15 30.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.719 -179.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.4 t -121.36 135.42 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.458 -178.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -109.56 137.6 47.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.763 179.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.569 ' H ' ' HE ' ' A' ' 52' ' ' ARG . 37.1 ttmt -68.08 137.64 55.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 6.6 t0 84.73 -11.78 0.78 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.585 179.732 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -118.87 82.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.654 0.264 . . . . 0.0 110.478 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 67.5 t0 -169.81 139.22 1.91 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.831 0.348 . . . . 0.0 110.423 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 69.4 mt -113.31 89.2 3.02 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.285 0.564 . . . . 0.0 109.919 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.64 130.92 71.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.43 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -121.29 126.36 49.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.821 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.93 149.88 32.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.9 ttp -118.41 134.86 54.72 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.384 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -110.99 -58.91 2.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.49 -179.58 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.482 ' N ' ' OG1' ' A' ' 40' ' ' THR . 51.9 p-10 -131.49 61.63 1.64 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.081 -179.41 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt 61.02 33.96 19.46 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 121.208 0.527 . . . . 0.0 110.119 -178.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.8 t -127.51 136.36 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.32 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 m -106.67 120.33 41.69 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.831 0.348 . . . . 0.0 110.139 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.89 156.59 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 121.244 0.545 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.55 135.74 53.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.31 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.41 155.59 77.02 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.218 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 49' ' ' SER . 31.5 Cg_exo -57.75 146.68 84.44 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 121.866 1.711 . . . . 0.0 112.168 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -40.6 166.15 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.921 179.665 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -77.35 54.59 4.75 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.029 2.486 . . . . 0.0 113.02 -179.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t 64.62 114.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.896 0.379 . . . . 0.0 111.24 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.569 ' HE ' ' H ' ' A' ' 31' ' ' LYS . 16.0 ptp180 -53.56 145.73 14.42 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.127 0.489 . . . . 0.0 111.705 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.99 -134.12 3.16 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -121.15 130.17 53.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.915 0.357 . . . . 0.0 110.19 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 73' ' ' LEU . 7.4 mm -96.46 119.56 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.1 t -77.13 -52.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.148 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -166.18 161.74 17.15 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.464 -178.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.5 tt -91.11 107.19 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.579 0.704 . . . . 0.0 109.78 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.505 HD22 HE22 ' A' ' 74' ' ' GLN . 54.8 tp -75.09 -32.2 61.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.857 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.9 146.93 43.58 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.382 0.61 . . . . 0.0 112.123 -179.02 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.746 ' H ' ' NE2' ' A' ' 64' ' ' GLN . 95.8 mtt180 -122.06 161.32 23.24 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.927 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -56.5 142.29 39.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.678 -179.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.85 4.21 57.92 Favored Glycine 0 N--CA 1.473 1.127 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.237 178.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.746 ' NE2' ' H ' ' A' ' 61' ' ' ARG . 74.1 mt-30 -98.04 131.69 44.24 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.428 0.632 . . . . 0.0 111.668 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -122.49 122.75 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.758 179.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 t -148.95 138.87 12.97 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.834 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.21 142.92 44.35 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 121.473 1.449 . . . . 0.0 112.414 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.97 128.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.013 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.39 51.41 0.04 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.045 179.07 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -166.85 169.47 13.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.227 0.514 . . . . 0.0 111.323 179.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.585 ' O ' HG23 ' A' ' 71' ' ' THR . 15.2 t -103.7 120.42 40.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.868 179.727 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -88.89 -7.88 55.28 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.182 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.671 HD12 ' H ' ' A' ' 74' ' ' GLN . 5.8 tp -157.16 144.43 18.69 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.671 ' H ' HD12 ' A' ' 73' ' ' LEU . 28.4 mp0 -104.19 132.99 49.86 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.554 0.216 . . . . 0.0 111.039 -179.205 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.8 mt -131.72 130.03 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.43 . . . . 0.0 111.957 -179.426 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -100.88 113.82 27.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.078 178.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.411 ' H ' HG22 ' A' ' 77' ' ' THR . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.822 -1.085 . . . . 0.0 110.328 179.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 ttp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -89.36 132.88 34.75 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.543 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 52.9 mp0 -95.22 121.99 37.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.076 -179.043 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -91.46 113.01 25.16 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.169 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -115.47 146.27 41.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.599 -179.62 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 6' ' ' LEU . 4.9 tt -58.67 110.56 2.71 Favored Pre-proline 0 N--CA 1.469 0.516 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.448 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.486 ' N ' HD23 ' A' ' 6' ' ' LEU . 46.8 Cg_exo . . . . . 0 N--CA 1.497 1.682 0 CA-C-N 120.21 1.111 . . . . 0.0 112.455 -179.779 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.646 0.26 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.14 119.27 6.1 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -178.94 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -125.67 133.46 52.16 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.022 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.402 HG21 ' NE1' ' A' ' 21' ' ' TRP . 9.1 mm -103.15 122.23 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.634 -178.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.9 p -90.89 -44.8 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.536 179.595 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' N ' HG13 ' A' ' 19' ' ' VAL . 84.1 mtt85 -146.13 147.44 31.54 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.062 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.402 ' NE1' HG21 ' A' ' 18' ' ' ILE . 62.4 m95 -115.22 136.86 52.65 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 176.346 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 7.8 p-10 -106.0 1.1 26.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.201 -0.312 . . . . 0.0 111.73 -179.443 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG11 ' OD2' ' A' ' 34' ' ' ASP . 32.0 m -136.62 159.63 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.681 0.277 . . . . 0.0 110.943 -179.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -136.91 153.02 50.85 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.076 0.465 . . . . 0.0 110.123 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -57.54 141.99 45.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.766 179.876 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.39 8.34 59.94 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.48 179.057 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 28' ' ' MET . 65.9 t0 -130.58 135.36 47.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.611 0.706 . . . . 0.0 110.847 -179.691 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.486 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 65.9 mtt -81.45 150.2 28.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.193 -179.43 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 p -143.46 147.64 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.001 0.429 . . . . 0.0 110.593 179.605 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -102.65 162.1 13.2 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.841 -178.453 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.07 137.85 50.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.497 -179.067 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 59.81 45.22 12.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.436 179.902 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.437 ' O ' ' CG ' ' A' ' 34' ' ' ASP . 59.3 tt0 -147.03 88.45 1.74 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.524 179.086 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.54 ' OD2' ' NH2' ' A' ' 52' ' ' ARG . 11.8 m-20 170.43 148.65 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.776 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.51 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 74.6 mt -121.03 102.14 8.14 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.646 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.74 131.32 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.216 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -117.46 127.41 53.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.031 -179.831 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.57 129.08 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.795 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.8 ttp -108.55 131.19 55.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.566 -179.864 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -114.5 -84.89 0.61 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.328 -179.838 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' H ' HG23 ' A' ' 40' ' ' THR . 42.8 p-10 -98.16 51.06 1.02 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.482 179.827 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 65.56 34.66 7.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.132 -178.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.4 t -127.54 135.84 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.9 m -98.13 117.97 33.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.581 -179.574 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.72 131.45 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.298 179.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -93.57 136.17 34.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.212 -179.57 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.1 mt -140.95 95.51 7.61 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.6 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.54 144.75 91.54 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 121.985 1.79 . . . . 0.0 111.35 179.321 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.579 ' CB ' ' NE ' ' A' ' 52' ' ' ARG . 8.0 t -64.81 113.06 9.48 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.546 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.18 -24.64 44.08 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 120.932 1.088 . . . . 0.0 113.943 -178.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.0 125.07 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.579 ' NE ' ' CB ' ' A' ' 49' ' ' SER . 24.6 mmt180 -134.15 155.28 50.38 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.917 0.389 . . . . 0.0 110.873 -179.631 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.92 -84.71 0.06 OUTLIER Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.455 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -130.19 136.79 49.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.8 0.333 . . . . 0.0 110.565 179.379 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.401 ' CG2' HD11 ' A' ' 73' ' ' LEU . 9.4 mm -104.43 118.84 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.266 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.2 t -87.31 -52.36 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.318 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -160.83 154.36 22.07 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.752 -178.249 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.4 tt -108.17 122.18 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.503 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.3 mt -97.54 -17.61 19.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.189 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -107.28 141.8 38.04 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.93 0.395 . . . . 0.0 110.747 -179.243 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.551 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 89.4 mtm-85 -122.65 162.19 22.4 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.512 179.926 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 56.2 mp0 -53.62 134.96 41.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.112 -179.067 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.62 6.27 83.4 Favored Glycine 0 N--CA 1.471 0.992 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.679 177.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.551 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 80.4 mt-30 -85.86 134.15 33.92 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.109 0.954 . . . . 0.0 111.467 -179.472 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.5 p -122.13 124.43 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.234 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 t -148.83 136.93 11.46 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.696 -179.53 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.97 152.47 58.13 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 C-N-CA 121.924 1.75 . . . . 0.0 112.243 178.289 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.8 t -53.87 133.21 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.691 179.648 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.86 51.81 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.804 179.229 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.7 m -153.99 169.08 24.35 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.354 -179.723 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -104.07 111.76 24.47 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.44 -45.3 55.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.541 -179.795 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.875 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.8 tt -152.96 147.66 26.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.939 -177.772 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.875 ' N ' HD23 ' A' ' 73' ' ' LEU . 52.4 tt0 -103.21 133.42 48.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.115 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 56.8 mt -126.73 129.2 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.205 0.526 . . . . 0.0 111.891 -177.395 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -96.02 111.63 23.59 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.951 178.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.353 -179.664 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -85.73 126.24 33.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.665 -179.553 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 52.6 mp0 -92.86 134.4 35.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.736 -179.472 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -109.49 108.53 19.05 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.784 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -114.17 141.2 47.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.043 -179.64 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.544 HD23 ' C ' ' A' ' 6' ' ' LEU . 5.1 tt -69.26 112.12 10.8 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.413 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' N ' HD23 ' A' ' 6' ' ' LEU . 73.2 Cg_endo . . . . . 0 N--CA 1.5 1.875 0 C-N-CA 121.8 1.667 . . . . 0.0 112.875 -178.251 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 54.8 mp0 . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.826 0.346 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.36 124.8 5.25 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 10.1 tm-20 -128.02 137.8 52.34 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.128 0.464 . . . . 0.0 110.58 -179.309 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -102.13 114.44 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.51 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.4 p -85.17 -42.56 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.445 179.342 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.51 ' N ' HG13 ' A' ' 19' ' ' VAL . 82.2 mtp180 -140.88 147.05 38.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.82 0.343 . . . . 0.0 111.258 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -109.04 137.73 46.5 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.252 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.3 p-10 -72.77 -40.89 65.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.296 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.12 165.58 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.551 -178.193 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 99.4 mttt -119.27 149.69 41.36 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.933 -179.592 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 56' ' ' VAL . 85.7 tt0 -45.31 139.61 3.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.32 7.25 62.23 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.567 -0.574 . . . . 0.0 113.341 178.59 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 24' ' ' LYS . 40.4 p-10 -135.44 153.06 51.9 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.371 1.086 . . . . 0.0 111.226 179.759 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.0 mtp -78.52 155.19 29.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.777 -178.79 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.23 152.77 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.926 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -113.38 147.4 37.79 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.937 0.399 . . . . 0.0 110.83 -179.623 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.454 ' HB2' ' H ' ' A' ' 52' ' ' ARG . 50.3 tttp -85.06 84.45 7.7 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.108 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' ASP . 43.8 p30 -165.97 81.37 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.552 179.204 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 62.97 -66.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.048 179.493 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 32' ' ' ASP . 29.0 t0 62.78 -167.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.311 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.4 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 83.4 mt -126.54 75.75 1.57 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.183 0.516 . . . . 0.0 111.55 -179.768 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.06 128.14 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.51 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -124.73 128.68 49.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.114 -178.616 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.52 133.6 64.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.226 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.44 ' HG3' ' H ' ' A' ' 43' ' ' VAL . 65.3 ttp -119.1 113.41 20.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.381 -179.024 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.46 ' H ' HG23 ' A' ' 40' ' ' THR . 1.7 p -62.75 -52.05 64.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.108 0.48 . . . . 0.0 109.908 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.8 t70 -146.87 -48.22 0.19 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.32 179.123 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -161.51 51.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.271 179.05 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 44' ' ' THR . 46.3 t -135.88 160.06 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.431 -179.792 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.502 ' N ' HG12 ' A' ' 43' ' ' VAL . 18.5 m -110.25 114.79 28.54 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.296 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.32 117.1 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.354 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -97.76 136.42 38.12 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.646 178.959 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.5 mt -139.33 139.95 24.38 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 119.303 -0.38 . . . . 0.0 110.529 -178.744 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 49' ' ' SER . 52.8 Cg_exo -53.17 145.66 42.4 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.386 1.39 . . . . 0.0 111.725 178.195 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -47.34 179.19 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.858 -179.322 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 49' ' ' SER . 78.8 Cg_endo -87.86 49.67 1.74 Allowed 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.776 2.317 . . . . 0.0 113.855 -178.363 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.0 t 66.19 121.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 120.823 0.344 . . . . 0.0 111.599 178.759 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 42.2 ttm180 -50.23 136.38 19.79 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.524 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.62 -141.63 5.75 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.371 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -126.05 126.67 44.62 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.811 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.566 HG23 HD21 ' A' ' 73' ' ' LEU . 5.8 mm -91.74 119.23 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.676 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.4 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 37.7 t -101.41 -41.52 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.222 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -145.16 154.89 42.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.557 -177.677 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 58' ' ' ILE . 12.5 tt -127.78 127.27 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.205 -179.824 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.8 tp -100.26 -21.18 15.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.211 -179.492 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.506 ' CD2' HD23 ' A' ' 72' ' ' LEU . 6.4 m-85 -106.08 141.93 36.64 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.225 0.536 . . . . 0.0 111.383 -178.951 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -122.18 165.74 15.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.143 179.371 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.0 mp0 -53.39 128.24 27.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.455 -179.463 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.72 5.95 85.98 Favored Glycine 0 N--CA 1.468 0.818 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.374 178.539 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -79.4 135.52 36.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.42 0.61 . . . . 0.0 110.71 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.76 131.52 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.611 179.624 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -149.47 137.54 11.77 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.785 -178.78 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.92 137.48 52.38 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.077 1.185 . . . . 0.0 112.344 177.942 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.9 t -56.22 129.16 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.721 179.774 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.68 49.3 0.08 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.113 178.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.3 p -164.62 165.99 20.54 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.345 0.572 . . . . 0.0 110.858 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 71' ' ' THR . 14.9 t -98.98 122.15 41.87 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.057 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.8 ' N ' HD12 ' A' ' 72' ' ' LEU . 3.0 mp -90.57 -5.38 56.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.686 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.566 HD21 HG23 ' A' ' 55' ' ' ILE . 2.1 tt -162.34 142.43 9.83 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.101 -178.866 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.539 ' OE1' ' N ' ' A' ' 74' ' ' GLN . 2.3 mp0 -104.03 124.37 48.9 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.247 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.7 mt -122.89 127.48 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.47 0.652 . . . . 0.0 111.57 -177.7 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -98.12 111.36 23.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.219 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.77 -179.47 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -125.88 149.26 48.82 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.924 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.66 128.34 53.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.819 0.342 . . . . 0.0 110.384 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.831 ' CD2' HD23 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -87.08 126.13 34.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.058 -179.931 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -119.6 133.73 55.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.191 -179.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.0 123.3 79.58 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.821 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 C-N-CA 121.598 1.532 . . . . 0.0 111.781 -179.41 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.58 ' OE2' HG13 ' A' ' 65' ' ' VAL . 13.4 tm-20 . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 111.377 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.47 ' N ' ' CD ' ' A' ' 15' ' ' GLU . . . -121.2 119.29 4.06 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.356 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -118.98 136.26 54.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 117.165 0.482 . . . . 0.0 110.658 -179.763 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.401 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.9 mm -101.35 119.97 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.125 -179.678 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 20' ' ' ARG . 10.0 p -89.9 -45.89 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.841 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.53 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.7 mtt180 -143.41 148.46 36.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.192 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.401 ' NE1' HG21 ' A' ' 18' ' ' ILE . 36.3 m95 -118.25 144.54 45.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.432 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.3 m-20 -124.48 12.94 8.75 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.136 0.426 . . . . 0.0 111.655 179.395 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.77 154.93 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.962 0.41 . . . . 0.0 110.764 179.605 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -121.9 153.68 38.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.096 -179.822 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -64.15 129.54 40.38 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.303 -179.955 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.04 5.66 63.88 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 36.5 p-10 -101.86 151.93 21.5 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.066 0.433 . . . . 0.0 110.665 179.536 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.2 mmm -90.85 148.85 22.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.537 -179.791 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.66 141.07 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.174 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -109.57 159.97 16.64 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.818 0.342 . . . . 0.0 111.272 -178.714 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -59.73 136.4 57.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.184 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 58.92 29.64 19.15 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.209 -179.559 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.69 79.56 1.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.573 0.225 . . . . 0.0 110.42 179.332 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 46.0 t0 -173.73 -178.56 1.61 Allowed 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.534 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.487 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 37.3 tp -153.95 97.84 2.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.922 0.391 . . . . 0.0 110.562 179.458 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.0 130.56 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.9 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.4 mp0 -114.66 120.71 41.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.926 178.759 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.6 m -119.98 134.37 63.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.008 -179.805 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.9 ptm -130.13 129.41 43.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.344 -179.58 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -73.25 -43.07 61.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.325 179.922 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -154.78 -67.21 0.13 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.323 -179.648 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -132.67 37.15 3.49 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.228 179.523 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.1 t -133.82 136.01 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.901 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 m -116.26 120.61 39.48 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.516 -179.666 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.94 155.61 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.362 179.546 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -115.23 135.63 53.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.276 -179.782 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.1 mt -134.27 130.84 20.35 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.11 179.945 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.46 146.17 27.36 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.419 2.079 . . . . 0.0 112.626 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -60.59 110.91 3.32 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.806 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.29 -19.76 37.94 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.612 1.541 . . . . 0.0 114.951 -177.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.89 124.03 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 118.459 0.572 . . . . 0.0 111.606 -179.084 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -91.14 152.13 20.7 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.107 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.39 -133.34 2.39 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.214 179.49 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -125.05 143.33 50.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.688 0.28 . . . . 0.0 110.327 -179.371 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.4 mm -103.73 118.72 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.682 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.8 t -89.25 -55.36 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.097 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -143.52 153.5 42.65 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.289 0.566 . . . . 0.0 111.814 -178.364 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 58' ' ' ILE . 3.7 tt -101.57 114.38 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.148 178.884 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.75 -17.68 20.12 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.827 -179.648 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -109.3 142.21 40.5 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.083 0.468 . . . . 0.0 110.756 -179.225 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.416 ' H ' ' HG3' ' A' ' 64' ' ' GLN . 11.2 ptp85 -126.0 166.25 17.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.429 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.43 144.5 50.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.006 -179.391 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.03 5.8 87.27 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 179.259 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 61' ' ' ARG . 22.4 mm-40 -70.76 133.44 46.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.593 0.711 . . . . 0.0 111.355 -179.01 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.58 HG13 ' OE2' ' A' ' 15' ' ' GLU . 40.0 t -131.46 118.67 40.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 114.33 -1.304 . . . . 0.0 107.5 178.604 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.56 154.79 35.82 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.006 -178.472 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.12 140.33 41.06 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.739 2.293 . . . . 0.0 111.676 179.087 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.12 124.61 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.774 179.412 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.1 53.31 0.06 OUTLIER Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.0 t -162.51 168.27 22.16 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.961 0.38 . . . . 0.0 110.807 -179.889 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 71' ' ' THR . 14.8 t -105.45 128.41 53.52 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.039 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -64.16 -41.81 97.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.182 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -161.27 177.28 10.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.757 -179.495 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -107.03 127.19 53.24 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.717 0.294 . . . . 0.0 110.889 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.47 125.29 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.25 0.548 . . . . 0.0 111.346 -179.323 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -90.27 140.49 29.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.8 178.913 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.449 179.792 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -79.61 129.17 34.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.839 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 57.1 mp0 -105.87 118.77 37.45 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -95.86 122.28 38.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.218 0.532 . . . . 0.0 110.733 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.63 145.22 49.09 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.66 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 tt -68.73 113.4 15.7 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.045 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -77.54 151.65 29.12 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.59 1.527 . . . . 0.0 112.008 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -91.02 89.27 7.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.712 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.64 -43.46 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.96 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 11' ' ' GLU . . . -89.35 -164.93 40.63 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 10' ' ' GLY . 16.8 pt-20 -53.29 -166.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.672 0.272 . . . . 0.0 110.405 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . -38.08 -72.49 0.18 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.451 ' O ' ' O ' ' A' ' 12' ' ' GLY . 1.6 t 57.81 117.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.4 p -124.34 76.83 1.51 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.748 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.482 ' OE2' ' CG2' ' A' ' 65' ' ' VAL . 30.8 tp10 -170.44 143.27 2.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.322 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.92 110.45 0.72 Allowed Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -126.27 131.91 51.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.917 0.389 . . . . 0.0 110.355 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -102.37 119.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.17 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.519 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.6 p -93.08 -43.81 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.519 ' N ' HG13 ' A' ' 19' ' ' VAL . 83.2 mtp180 -139.57 145.07 38.15 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.808 0.337 . . . . 0.0 111.243 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -111.68 139.84 46.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.91 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 18.2 p-10 -101.36 -6.51 23.98 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.37 159.95 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.027 0.441 . . . . 0.0 111.4 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.33 149.99 49.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.7 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -59.55 138.63 57.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.257 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.64 8.87 76.16 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.604 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -121.98 149.84 42.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 117.431 0.616 . . . . 0.0 111.156 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.2 mtm -86.59 154.19 21.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.265 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.474 HG23 ' NE2' ' A' ' 33' ' ' GLN . 2.6 p -138.9 152.61 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.937 0.399 . . . . 0.0 110.515 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -117.44 157.23 26.58 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.012 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -67.55 65.6 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.962 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -176.11 73.21 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.531 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' NE2' HG23 ' A' ' 29' ' ' VAL . 85.1 mt-30 -147.1 122.09 10.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.409 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -128.14 39.45 3.84 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.454 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.8 mt -110.51 33.67 4.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.107 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.11 128.15 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -116.85 123.91 48.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.533 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.92 130.16 72.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.375 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.3 ttm -109.7 126.4 53.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.287 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.424 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -95.1 -77.28 0.47 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.054 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.424 ' N ' ' OG1' ' A' ' 40' ' ' THR . 62.1 t0 -95.99 -74.24 0.57 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.269 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -151.37 50.71 0.83 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.334 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.03 149.34 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.897 0.379 . . . . 0.0 110.75 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.8 m -107.97 118.82 37.75 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.957 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.96 133.79 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -95.51 135.5 37.08 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.426 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.4 mt -135.75 133.57 20.15 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.36 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.3 147.69 33.18 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.175 1.917 . . . . 0.0 111.162 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -96.98 107.89 40.28 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 111.371 0.137 . . . . 0.0 111.371 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -86.59 41.78 0.83 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.373 2.049 . . . . 0.0 111.358 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.39 156.2 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.716 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -154.33 149.07 26.51 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.276 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.29 -132.93 2.94 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.84 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -130.3 135.76 48.43 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -91.87 120.18 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.147 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.5 t -84.53 -50.07 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -164.16 157.06 17.61 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.898 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 58' ' ' ILE . 3.0 tt -116.07 121.96 68.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.446 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt -98.55 -16.88 18.97 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.21 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.543 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 17.8 m-85 -107.31 144.4 34.21 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.291 0.567 . . . . 0.0 111.58 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -123.83 161.48 25.21 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.86 137.02 57.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.45 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.41 4.99 85.5 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.492 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.52 ' OE1' ' CD2' ' A' ' 60' ' ' TYR . 55.3 tt0 -89.32 137.39 32.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.414 0.607 . . . . 0.0 110.563 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.482 ' CG2' ' OE2' ' A' ' 15' ' ' GLU . 3.4 p -124.42 131.21 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.375 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 t -148.3 140.86 14.89 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-O 119.379 -0.343 . . . . 0.0 111.249 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.19 148.17 32.69 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.501 1.467 . . . . 0.0 112.661 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 68' ' ' VAL . 9.8 p -62.08 132.83 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.456 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.99 49.44 0.1 Allowed Glycine 0 CA--C 1.53 0.973 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.014 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.7 p -160.33 162.84 33.59 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.399 0.6 . . . . 0.0 111.355 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 71' ' ' THR . 5.3 t -96.37 120.99 37.68 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.2 mm? -82.45 -4.32 57.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.553 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -169.8 142.45 2.45 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.58 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -104.84 122.39 45.67 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.35 127.51 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.095 0.474 . . . . 0.0 111.081 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -88.0 141.32 28.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.087 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.493 179.825 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.4 mtp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -82.84 130.12 35.09 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 51.0 mp0 -93.79 138.7 31.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.93 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -102.95 101.79 11.82 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 6' ' ' LEU . 68.6 mttm -108.28 105.19 14.77 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 5' ' ' LYS . 5.6 mt -29.23 93.84 0.06 OUTLIER Pre-proline 0 N--CA 1.483 1.224 0 O-C-N 123.845 0.716 . . . . 0.0 110.667 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.403 ' N ' ' O ' ' A' ' 5' ' ' LYS . 92.0 Cg_endo -77.98 154.78 29.77 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.644 1.563 . . . . 0.0 112.127 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -84.75 86.89 7.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.813 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.9 pt -142.41 154.08 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.709 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.84 -28.91 3.1 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -172.68 -92.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.595 0.236 . . . . 0.0 110.37 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.94 159.85 24.5 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.423 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -145.21 95.31 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 120.965 0.412 . . . . 0.0 110.437 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 p -66.52 -36.02 81.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.269 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -146.57 151.62 37.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.65 109.92 3.54 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -121.78 127.35 50.52 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.409 HG21 ' NE1' ' A' ' 21' ' ' TRP . 7.2 mm -100.92 117.94 46.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.05 0.452 . . . . 0.0 111.565 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 20' ' ' ARG . 10.7 p -91.74 -41.85 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.583 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.488 ' N ' HG13 ' A' ' 19' ' ' VAL . 95.1 mtt-85 -143.37 141.88 31.07 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.409 ' NE1' HG21 ' A' ' 18' ' ' ILE . 37.3 m95 -111.93 145.4 39.62 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 35' ' ' LEU . 87.7 m-20 -128.54 20.85 6.1 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.43 0.559 . . . . 0.0 111.255 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.9 m -136.33 154.63 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 68.4 mttm -135.05 137.13 42.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.448 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -44.25 135.75 4.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.91 5.94 70.29 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 24' ' ' LYS . 43.9 p-10 -104.19 150.88 23.98 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.806 0.303 . . . . 0.0 110.222 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.2 mtp -90.06 145.74 24.85 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.86 0.362 . . . . 0.0 110.645 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.9 t -126.42 132.85 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.478 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -105.7 158.2 16.88 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -62.88 136.4 57.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.639 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 58.66 36.46 25.01 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.141 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -141.81 89.76 2.22 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 51.4 t0 -172.91 158.16 3.78 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.901 0.382 . . . . 0.0 110.455 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.47 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 92.7 mt -135.22 86.35 2.24 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.322 0.582 . . . . 0.0 110.009 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.71 136.69 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.565 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.1 mp0 -123.06 128.14 49.73 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.056 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.2 p -128.15 130.0 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.0 ttp -109.3 133.49 52.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.547 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -99.65 -92.38 0.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.492 ' N ' ' OG1' ' A' ' 40' ' ' THR . 14.3 p-10 -83.69 -52.73 6.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.356 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -174.45 57.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.612 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.0 p -159.33 151.83 6.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.901 0.382 . . . . 0.0 110.417 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -103.87 117.53 34.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.284 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.88 132.59 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.064 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -92.53 135.71 33.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.954 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.94 90.8 13.8 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.55 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.08 147.73 92.04 Favored 'Trans proline' 0 N--CA 1.503 2.081 0 C-N-CA 122.638 2.225 . . . . 0.0 112.018 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.5 m -60.65 111.27 3.82 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 119.51 -0.281 . . . . 0.0 110.7 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.56 -16.81 30.39 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.413 1.409 . . . . 0.0 114.521 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.89 124.58 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.245 0.475 . . . . 0.0 111.084 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -89.74 151.49 21.8 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.415 0.15 . . . . 0.0 110.827 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.77 -145.47 7.97 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -114.46 133.74 55.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.85 0.325 . . . . 0.0 110.845 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.487 HG23 HD21 ' A' ' 73' ' ' LEU . 5.8 mm -87.91 120.22 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 t -88.99 -52.63 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -156.27 160.74 40.04 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.186 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.0 tt -106.0 123.37 60.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.618 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.1 tp -101.11 -18.32 16.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.068 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.436 ' CE2' HD22 ' A' ' 72' ' ' LEU . 5.8 m-85 -111.15 146.82 36.18 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.217 0.532 . . . . 0.0 111.053 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.574 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 99.8 mtt180 -122.5 167.3 13.52 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.111 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -62.37 140.54 58.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.838 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.52 5.02 82.6 Favored Glycine 0 N--CA 1.469 0.889 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.382 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.574 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 83.5 mt-30 -85.61 135.17 33.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.488 0.644 . . . . 0.0 111.955 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 p -128.46 126.5 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.733 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.5 t -149.52 135.93 10.49 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.746 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.39 141.96 59.46 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.377 1.385 . . . . 0.0 111.905 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 p -52.98 128.32 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.849 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.03 48.24 0.06 OUTLIER Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.187 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.4 p -164.17 162.24 22.65 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 117.407 0.604 . . . . 0.0 110.926 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 71' ' ' THR . 6.0 t -88.96 126.48 35.42 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.436 HD22 ' CE2' ' A' ' 60' ' ' TYR . 42.2 mt -97.36 -5.48 36.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.402 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.4 tt -170.51 149.08 3.21 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.507 ' N ' HD23 ' A' ' 73' ' ' LEU . 66.7 mt-30 -103.17 125.52 49.9 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.8 mt -126.45 128.55 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.199 0.523 . . . . 0.0 111.723 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 18.6 p-10 -97.09 115.66 27.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.543 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.591 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -106.78 137.52 44.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.147 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -132.33 130.51 40.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.125 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -108.64 120.46 42.53 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.203 0.525 . . . . 0.0 110.331 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -127.18 153.34 46.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.955 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 tp -71.52 117.87 61.16 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.742 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.98 151.76 31.18 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.664 1.576 . . . . 0.0 111.886 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -83.41 107.44 15.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.247 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.4 pt -129.78 156.85 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.289 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.63 -169.39 47.83 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -127.93 137.65 52.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.708 0.289 . . . . 0.0 110.355 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.59 74.29 1.2 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.9 t -128.84 111.27 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.7 p -108.44 -14.1 14.73 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.279 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -173.38 149.65 1.75 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.988 0.423 . . . . 0.0 111.176 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.54 150.81 18.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -137.16 146.56 45.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.954 0.377 . . . . 0.0 110.262 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.8 mm -102.89 115.93 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.37 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 20' ' ' ARG . 10.7 p -86.04 -43.62 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.373 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.503 ' N ' HG13 ' A' ' 19' ' ' VAL . 83.6 mtp180 -139.54 147.37 41.11 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.724 0.297 . . . . 0.0 111.264 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -111.95 141.84 45.1 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.46 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 16.5 p-10 -105.56 -3.51 22.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.542 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -134.59 160.35 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 120.891 0.377 . . . . 0.0 111.36 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.22 147.17 45.64 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.56 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.432 ' OE1' HG22 ' A' ' 58' ' ' ILE . 82.6 tt0 -63.34 134.23 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.619 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.75 8.53 85.84 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.322 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -117.07 129.13 55.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.068 0.434 . . . . 0.0 111.431 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.1 ptp -59.54 150.25 27.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.843 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 30' ' ' GLU . 52.9 t -123.25 159.06 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.019 0.438 . . . . 0.0 110.138 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.2 mp0 -135.1 149.59 50.07 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.57 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 87.9 tttt -65.29 137.6 57.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.138 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 9.9 m-20 94.21 76.03 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.817 0.698 . . . . 0.0 110.704 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -146.16 95.66 2.66 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.594 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -104.1 52.35 0.76 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.653 0.263 . . . . 0.0 110.916 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.4 mt -117.87 30.53 7.2 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.239 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.93 128.28 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -121.86 126.64 49.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.644 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.0 129.89 71.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.6 ttp -103.95 110.98 23.33 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.831 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.453 ' H ' HG23 ' A' ' 40' ' ' THR . 1.1 p -61.91 -48.13 81.85 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -146.31 -67.45 0.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.432 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -142.11 41.38 1.65 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.842 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 44' ' ' THR . 48.3 t -136.33 155.85 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.416 ' N ' HG12 ' A' ' 43' ' ' VAL . 5.0 m -109.17 118.2 36.13 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.76 120.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.06 138.57 31.4 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -136.42 109.84 9.62 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.08 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.69 145.27 60.78 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 121.67 1.58 . . . . 0.0 111.369 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.5 m -105.04 99.62 20.35 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -86.08 44.44 1.28 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.295 1.997 . . . . 0.0 110.432 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.76 154.68 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -161.47 131.82 5.02 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.713 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.02 -136.49 3.85 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.855 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -124.44 132.13 53.5 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.88 0.34 . . . . 0.0 110.242 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 55' ' ' ILE . 4.2 mm -91.77 121.33 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.8 t -87.46 -51.81 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -155.29 161.42 41.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.681 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.6 tt -122.0 123.78 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.695 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.06 -16.48 17.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -107.15 143.9 34.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.15 0.5 . . . . 0.0 111.375 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -123.61 164.99 17.95 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.272 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -59.34 134.4 56.97 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.631 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.98 5.64 90.01 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.009 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -82.15 137.39 34.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.041 0.42 . . . . 0.0 110.823 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.84 133.03 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.605 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.7 t -148.63 141.28 15.16 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 119.485 -0.293 . . . . 0.0 111.691 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -55.16 146.11 61.5 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.317 1.345 . . . . 0.0 111.373 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.451 ' H ' HG12 ' A' ' 68' ' ' VAL . 1.6 p -64.89 130.2 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.018 0.437 . . . . 0.0 110.713 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.55 53.15 0.08 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.2 m -160.41 170.3 21.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.054 0.427 . . . . 0.0 111.255 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.2 m -99.43 112.5 24.68 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.838 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.52 -43.4 76.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.161 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.2 tt -151.38 145.74 25.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.072 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.84 ' N ' HD23 ' A' ' 73' ' ' LEU . 39.1 mt-30 -104.11 130.73 51.84 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.9 mt -131.71 127.34 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.142 0.496 . . . . 0.0 111.536 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -90.76 140.97 29.28 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.918 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.568 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -97.65 127.87 43.93 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 37.6 mp0 -107.74 111.72 24.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.131 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -75.55 100.94 4.72 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -112.55 147.16 37.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.554 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 7' ' ' PRO . 7.3 tt -66.35 113.35 12.21 Favored Pre-proline 0 N--CA 1.47 0.535 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.455 ' O ' HD23 ' A' ' 6' ' ' LEU . 45.6 Cg_exo -54.92 141.29 78.41 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 120.499 1.214 . . . . 0.0 112.09 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -94.19 108.45 20.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.812 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.2 pt -126.53 150.76 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.629 0.252 . . . . 0.0 110.582 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 53.83 -135.5 42.57 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.489 ' N ' ' CD ' ' A' ' 11' ' ' GLU . 1.2 pm0 -155.17 6.42 0.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.26 5.94 74.52 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.2 t -124.67 129.21 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.876 0.369 . . . . 0.0 110.107 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.2 p -141.0 -8.31 1.03 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.534 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -144.29 150.67 38.25 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.004 0.431 . . . . 0.0 111.016 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.14 132.38 8.05 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -133.84 142.03 47.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.96 0.41 . . . . 0.0 110.101 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -100.01 121.66 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.048 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.545 HG13 ' N ' ' A' ' 20' ' ' ARG . 11.5 p -88.18 -45.69 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.167 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.545 ' N ' HG13 ' A' ' 19' ' ' VAL . 63.0 ttm-85 -146.76 139.31 25.02 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -108.19 143.94 36.31 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.2 m-20 -127.55 15.89 7.05 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.892 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.15 155.91 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -130.07 147.56 51.83 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.941 0.401 . . . . 0.0 111.063 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.435 ' OE1' HG22 ' A' ' 58' ' ' ILE . 10.3 pt-20 -62.59 139.47 58.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.92 7.97 73.42 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.843 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -117.92 148.99 41.63 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.865 0.333 . . . . 0.0 110.68 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 63.8 mtt -76.77 147.29 37.36 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.105 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.99 132.74 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.818 0.342 . . . . 0.0 110.83 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -98.89 154.92 17.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.432 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -96.05 84.26 3.79 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.86 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 34' ' ' ASP . 46.5 p-10 -173.5 131.22 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 0.0 110.853 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' ASP . 96.7 mm-40 53.78 -80.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.609 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' A' ' 32' ' ' ASP . 93.8 m-20 57.01 150.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.457 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 89.5 mt -122.12 76.68 1.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.283 0.563 . . . . 0.0 111.629 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.07 131.59 70.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -123.16 121.72 36.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.274 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.3 m -115.19 130.88 68.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 43' ' ' VAL . 5.4 tpp -91.83 152.18 20.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.896 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.487 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -156.66 -89.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.589 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.487 ' H ' HG23 ' A' ' 40' ' ' THR . 91.7 m-20 -76.16 44.84 0.34 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.286 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 58.37 37.72 25.85 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.61 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.452 ' O ' ' SD ' ' A' ' 39' ' ' MET . 30.6 m -147.54 158.98 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.67 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -100.17 118.49 36.61 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.96 0.409 . . . . 0.0 110.727 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -119.59 130.45 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.543 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.4 tttm -94.98 138.78 32.26 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.28 92.99 34.2 Favored Pre-proline 0 N--CA 1.472 0.639 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.184 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.461 ' O ' ' OG ' ' A' ' 49' ' ' SER . 88.3 Cg_endo -80.03 143.87 16.45 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.227 1.951 . . . . 0.0 113.133 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 49' ' ' SER . 6.0 p 81.7 69.68 0.12 Allowed Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.408 ' CD ' ' OD2' ' A' ' 34' ' ' ASP . 64.2 Cg_endo -88.87 26.94 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.953 2.435 . . . . 0.0 112.177 178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t 69.76 115.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.142 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.1 ptt85 -79.83 147.65 31.68 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.077 0.465 . . . . 0.0 112.064 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.24 -133.92 2.57 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -122.48 134.33 54.58 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.487 HG23 HD21 ' A' ' 73' ' ' LEU . 7.7 mm -92.98 119.62 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -79.37 -52.39 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -168.44 157.96 9.32 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.705 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.4 tt -104.01 122.68 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.009 0.433 . . . . 0.0 111.334 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.2 mt -100.93 -17.17 16.93 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -106.73 142.54 36.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.97 0.414 . . . . 0.0 110.884 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -117.47 169.83 9.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.313 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.29 134.19 56.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.246 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.49 6.17 86.43 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.866 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -79.09 131.85 36.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.2 0.524 . . . . 0.0 111.324 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -127.03 132.21 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.596 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 t -145.87 140.31 15.53 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.609 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.94 147.2 15.12 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.038 1.159 . . . . 0.0 112.187 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.1 p -60.13 130.4 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.51 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.08 55.99 0.21 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.4 m -151.38 175.69 12.0 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.055 0.455 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 m -101.14 109.7 21.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.252 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.6 mt -69.05 -45.52 70.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.089 0.471 . . . . 0.0 110.946 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.487 HD21 HG23 ' A' ' 55' ' ' ILE . 3.9 tt -152.72 147.16 25.76 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.485 ' N ' HD23 ' A' ' 73' ' ' LEU . 58.3 tt0 -103.56 128.18 50.84 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.5 mt -128.07 129.52 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.164 0.507 . . . . 0.0 111.118 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -95.69 112.05 23.86 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.099 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.1 m . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.618 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 75' ' ' ILE . 21.6 t80 -79.75 127.58 32.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 110.217 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 54.8 mp0 -88.29 133.7 33.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.311 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -101.69 113.29 26.31 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 6' ' ' LEU . 54.0 mtmt -120.1 113.77 20.98 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.265 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 5' ' ' LYS . 12.6 mt -32.89 97.22 0.11 Allowed Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.521 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 9' ' ' ILE . 33.5 Cg_exo -55.1 148.17 50.11 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.721 1.614 . . . . 0.0 111.957 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -69.95 37.81 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.974 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.506 ' H ' ' C ' ' A' ' 7' ' ' PRO . 68.9 mt -109.17 129.83 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.69 -172.42 28.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 12' ' ' GLY . 79.9 tt0 -89.42 83.01 6.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.614 0.245 . . . . 0.0 110.612 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLU . . . 57.84 123.59 0.01 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.29 131.38 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.8 p -115.8 -39.69 3.46 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.61 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -145.99 153.62 40.99 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.69 109.76 3.91 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -121.49 132.61 54.82 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -101.91 120.58 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.94 0.4 . . . . 0.0 111.193 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.502 HG13 ' N ' ' A' ' 20' ' ' ARG . 8.7 p -92.95 -42.43 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.62 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.502 ' N ' HG13 ' A' ' 19' ' ' VAL . 43.2 ttm180 -148.79 134.51 18.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -104.2 140.44 37.83 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -120.24 16.77 12.33 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.094 0.406 . . . . 0.0 111.279 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.38 157.66 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.922 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -131.8 136.47 47.55 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.546 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.68 140.18 36.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.948 0.404 . . . . 0.0 111.042 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.96 6.96 74.89 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.88 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -116.21 149.6 38.87 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.879 0.339 . . . . 0.0 110.723 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.5 mmm -83.47 147.32 27.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.643 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.2 t -118.9 132.54 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.353 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE1' ' OE1' ' A' ' 33' ' ' GLN . 95.5 mt-10 -96.23 155.59 16.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.721 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -67.83 134.13 50.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.859 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 57.86 34.56 24.5 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.241 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.414 ' OE1' ' OE1' ' A' ' 30' ' ' GLU . 82.7 mt-30 -143.13 87.49 1.97 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.868 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -174.62 168.95 3.7 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 90.5 mt -136.31 97.69 3.65 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.244 0.545 . . . . 0.0 110.683 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.53 132.63 67.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.186 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -125.12 126.17 44.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.329 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.84 125.89 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.232 0.539 . . . . 0.0 109.567 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.0 ttp -105.86 137.91 42.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.069 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.535 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.6 t -102.81 -121.34 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.92 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.535 ' N ' ' OG1' ' A' ' 40' ' ' THR . 63.8 t0 -63.78 -46.77 83.73 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -177.13 60.55 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -150.33 149.13 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.741 0.305 . . . . 0.0 110.305 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -101.88 117.73 35.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.85 117.08 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.871 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -97.1 134.53 40.32 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.77 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.0 mt -138.9 129.58 14.96 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.556 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.45 143.59 22.0 Favored 'Trans proline' 0 N--CA 1.501 1.915 0 C-N-CA 122.134 1.889 . . . . 0.0 112.464 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 p -47.76 106.9 0.65 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.3 -23.51 32.84 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 121.077 1.185 . . . . 0.0 114.745 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.76 123.53 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.401 0.546 . . . . 0.0 111.732 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -83.04 161.22 21.76 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.38 -142.35 7.99 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.091 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -119.47 134.52 55.18 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.836 0.35 . . . . 0.0 111.187 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mm -95.93 117.74 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.64 -53.46 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -151.58 156.8 41.22 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 119.562 -0.855 . . . . 0.0 112.478 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.52 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.7 tt -108.84 120.35 60.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.004 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.47 -17.93 18.49 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.302 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.522 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 7.6 m-85 -111.42 144.62 40.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.44 0.638 . . . . 0.0 111.391 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.552 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 99.9 mtt180 -120.82 162.19 20.22 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.078 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -58.33 142.28 48.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.609 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.76 6.03 70.59 Favored Glycine 0 N--CA 1.469 0.869 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.552 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 85.9 mt-30 -94.13 132.06 39.04 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.364 0.602 . . . . 0.0 112.161 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.95 125.8 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.007 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.9 t -147.97 137.17 11.91 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.646 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -50.48 137.4 40.23 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.016 1.144 . . . . 0.0 112.213 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.5 p -52.58 126.44 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.469 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.08 49.32 0.04 OUTLIER Glycine 0 CA--C 1.531 1.034 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.956 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.8 p -159.75 160.46 34.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 117.182 0.491 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 71' ' ' THR . 5.2 t -91.66 104.27 16.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.803 0.811 . . . . 0.0 109.982 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 72' ' ' LEU . 2.2 mm? -67.31 -39.91 85.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.483 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.908 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.5 tt -141.55 148.63 39.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.908 ' N ' HD23 ' A' ' 73' ' ' LEU . 57.5 tt0 -102.6 130.22 49.41 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 2' ' ' TYR . 96.3 mt -127.41 127.91 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.247 0.546 . . . . 0.0 111.398 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -102.1 114.9 29.42 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.167 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.218 -0.562 0 CA-C-O 118.114 -0.946 . . . . 0.0 110.599 179.825 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' OD1' ' A' ' 76' ' ' ASP . 97.8 mmm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -148.02 147.97 30.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.398 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -126.69 138.72 53.44 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.08 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.35 113.89 27.56 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.317 0.58 . . . . 0.0 110.573 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 6' ' ' LEU . 98.9 mttt -119.49 112.83 19.87 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.172 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 6' ' ' LEU . 3.7 tt -35.93 99.53 0.18 Allowed Pre-proline 0 N--CA 1.475 0.798 0 O-C-N 123.342 0.401 . . . . 0.0 110.446 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.18 154.52 25.22 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.702 1.601 . . . . 0.0 112.061 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -88.44 84.95 6.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.429 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.9 mt -123.82 135.23 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.933 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.24 -127.62 24.26 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -50.79 137.7 19.93 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.29 143.63 43.1 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.6 t -131.42 117.7 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 p -110.33 -14.82 14.08 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.807 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -145.24 144.58 30.88 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.256 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.05 111.0 3.25 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -121.28 129.99 53.43 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.426 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.6 mm -102.35 118.8 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.405 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.8 p -96.77 -47.48 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.831 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.575 ' N ' HG13 ' A' ' 19' ' ' VAL . 82.4 mtp180 -141.53 145.49 35.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.426 ' NE1' HG21 ' A' ' 18' ' ' ILE . 31.8 m95 -117.03 139.51 50.6 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.565 ' CG ' HH22 ' A' ' 52' ' ' ARG . 7.7 p-10 -108.09 5.15 25.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.492 ' CG1' ' CZ ' ' A' ' 52' ' ' ARG . 3.8 m -133.84 157.2 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.626 0.251 . . . . 0.0 110.535 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.86 145.11 51.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.846 0.355 . . . . 0.0 110.496 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -61.54 138.5 58.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.196 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.07 8.01 65.2 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.913 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 28' ' ' MET . 68.1 t0 -117.32 135.95 53.48 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.926 0.363 . . . . 0.0 111.365 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.495 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 2.5 mpt? -90.48 131.69 36.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.047 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.17 146.0 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.743 0.306 . . . . 0.0 110.675 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.3 mm-40 -92.85 160.08 15.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.436 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -52.12 129.77 28.44 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.196 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 30' ' ' GLU . 2.5 p30 168.79 133.15 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.647 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -67.09 80.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.627 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 68.0 t0 -63.45 -43.2 98.07 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.363 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.523 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 1.4 mt 154.87 86.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.036 0.835 . . . . 0.0 110.824 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -117.47 126.05 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -121.13 123.09 41.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.467 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.93 130.42 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.418 ' CB ' ' O ' ' A' ' 43' ' ' VAL . 25.1 ptm -128.12 152.05 48.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -94.71 -114.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.317 178.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.543 ' N ' ' OG1' ' A' ' 40' ' ' THR . 69.7 m-20 -65.03 -45.24 86.29 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -176.1 57.7 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.779 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 39' ' ' MET . 48.7 t -137.42 139.47 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -95.9 116.93 29.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.484 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.23 119.39 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -92.44 132.13 37.03 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 36' ' ' VAL . 57.3 mt -141.26 138.04 17.31 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.466 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -52.3 141.64 49.28 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 CA-C-N 120.178 1.099 . . . . 0.0 111.083 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.517 ' CB ' ' HE ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -46.6 162.94 0.24 Allowed Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.017 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 51' ' ' VAL . 95.4 Cg_endo -78.16 54.81 5.09 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 123.23 2.62 . . . . 0.0 112.991 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 50' ' ' PRO . 4.1 t 59.12 109.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 120.144 -0.623 . . . . 0.0 109.52 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.565 HH22 ' CG ' ' A' ' 22' ' ' ASP . 95.9 mtt180 -102.81 146.07 28.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.408 0.623 . . . . 0.0 111.828 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.45 -85.84 0.06 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -125.11 114.04 18.52 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mm -91.54 120.02 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.0 t -79.44 -52.83 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -169.88 157.37 6.72 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.084 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.1 tt -110.33 119.26 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.439 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.21 -17.6 20.67 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.569 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.429 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 28.2 m-85 -110.2 141.76 42.69 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.909 0.385 . . . . 0.0 110.9 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -132.13 165.81 23.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.069 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.02 141.94 21.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.802 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.69 5.0 60.26 Favored Glycine 0 N--CA 1.471 0.995 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.235 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -99.51 131.25 45.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.494 0.664 . . . . 0.0 111.861 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.98 123.51 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.354 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.5 t -148.27 138.69 13.04 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.301 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -52.68 143.79 45.47 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.356 1.37 . . . . 0.0 112.394 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.6 p -52.03 128.95 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.601 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.28 52.76 0.08 OUTLIER Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.738 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -156.48 161.8 40.01 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.033 0.417 . . . . 0.0 111.164 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.3 p -92.91 111.29 22.86 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.807 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.711 HD22 ' N ' ' A' ' 72' ' ' LEU . 2.3 mm? -89.08 -6.98 56.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.086 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.6 OUTLIER -176.45 142.54 0.45 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.196 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.473 ' H ' HD23 ' A' ' 73' ' ' LEU . 58.0 tt0 -104.37 126.48 51.5 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 57.7 mt -128.35 128.26 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.18 0.514 . . . . 0.0 111.474 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.507 ' OD1' ' SD ' ' A' ' 1' ' ' MET . 85.6 m-20 -101.28 111.06 23.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.131 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.351 180.0 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -75.31 142.71 43.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.724 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -112.03 135.95 52.01 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.289 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -101.21 117.16 34.43 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.312 0.577 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 6' ' ' LEU . 99.4 mttt -119.54 107.37 13.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.146 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 5' ' ' LYS . 16.2 tp -31.06 93.2 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.931 0 O-C-N 123.665 0.603 . . . . 0.0 110.886 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 5' ' ' LYS . 30.8 Cg_exo -59.15 150.04 76.28 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.214 1.943 . . . . 0.0 112.585 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -77.88 92.57 4.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.185 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.0 mt -119.64 134.41 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.86 -158.95 45.29 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -137.5 158.45 44.37 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.78 42.37 4.46 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.6 t -124.77 129.01 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.8 p -128.52 -35.59 1.93 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.61 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -145.84 156.5 43.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.193 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.69 110.04 3.95 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -118.41 130.8 56.18 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.418 HG21 ' NE1' ' A' ' 21' ' ' TRP . 10.7 mm -100.12 120.15 49.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.107 0.48 . . . . 0.0 111.777 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.4 p -90.43 -45.61 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.467 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.6 mtt180 -147.7 149.33 32.23 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.418 ' NE1' HG21 ' A' ' 18' ' ' ILE . 69.5 m95 -114.79 140.62 48.77 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -121.74 12.23 10.59 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.004 0.365 . . . . 0.0 111.009 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 23' ' ' VAL . 5.3 m -126.09 131.07 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.81 141.65 36.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.187 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -54.91 135.77 47.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.879 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.27 6.48 84.17 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.516 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 28' ' ' MET . 64.2 t0 -110.82 146.95 35.53 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.245 0.522 . . . . 0.0 110.872 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.539 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 77.2 mtm -87.65 149.38 24.31 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.738 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.23 137.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.799 0.333 . . . . 0.0 110.444 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -90.21 158.83 17.03 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.51 138.16 58.26 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.42 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 58.6 37.02 25.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.057 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -144.33 87.21 1.87 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.489 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -172.82 167.09 5.25 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.733 0.302 . . . . 0.0 110.452 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -136.05 88.56 2.4 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.229 0.538 . . . . 0.0 110.138 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.16 128.61 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.522 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -117.08 118.01 31.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.561 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -109.52 129.3 64.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.0 ttp -117.14 154.97 30.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.647 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.59 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -140.16 -86.21 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.868 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.59 ' H ' HG23 ' A' ' 40' ' ' THR . 67.2 t0 -94.43 52.63 1.58 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.329 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 60.04 44.33 13.36 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 121.035 0.445 . . . . 0.0 110.835 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.9 t -130.1 138.32 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.748 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 m -94.89 118.13 31.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.215 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.83 117.54 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.148 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -93.1 128.84 39.16 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.87 0.367 . . . . 0.0 110.467 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.7 mt -137.99 90.21 14.16 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.451 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.74 144.62 92.84 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.528 2.152 . . . . 0.0 112.413 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.8 m -51.06 108.63 1.09 Allowed Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.803 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.9 -15.35 23.72 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 121.638 1.559 . . . . 0.0 115.035 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.89 124.6 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.42 0.555 . . . . 0.0 111.779 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -89.16 149.01 23.35 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 120.689 0.28 . . . . 0.0 111.112 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.24 -138.42 4.89 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -122.31 144.14 49.19 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.958 0.409 . . . . 0.0 111.084 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 73' ' ' LEU . 7.8 mm -99.75 120.58 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.7 t -83.52 -50.96 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -158.86 154.69 26.46 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.592 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 58' ' ' ILE . 3.2 tt -91.47 108.23 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.42 0.629 . . . . 0.0 109.513 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.4 tp -82.01 -27.65 32.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.803 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' CE2' HD22 ' A' ' 72' ' ' LEU . 4.2 m-85 -117.15 145.33 43.89 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.366 0.603 . . . . 0.0 111.649 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.568 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 90.2 mtm-85 -120.48 168.41 11.36 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.952 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -62.73 146.85 51.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 111.968 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.32 5.08 85.63 Favored Glycine 0 N--CA 1.467 0.764 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.182 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.568 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 86.0 mt-30 -89.22 132.1 35.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.444 0.64 . . . . 0.0 111.942 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.07 121.13 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.848 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.96 139.33 14.0 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.342 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.38 143.85 25.78 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.183 1.255 . . . . 0.0 112.246 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 p -61.68 129.2 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.162 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.35 52.54 0.07 OUTLIER Glycine 0 CA--C 1.528 0.899 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.452 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.4 t -167.05 153.65 8.42 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.991 0.396 . . . . 0.0 110.998 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.7 t -79.57 130.9 35.8 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.411 HD22 ' CE2' ' A' ' 60' ' ' TYR . 26.2 mt -105.52 0.07 26.31 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 74' ' ' GLN . 3.2 tp -173.13 143.35 1.12 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.661 ' N ' HD12 ' A' ' 73' ' ' LEU . 12.7 mm-40 -102.98 129.68 49.81 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.013 0.435 . . . . 0.0 110.47 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 83.1 mt -129.82 126.18 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.327 0.584 . . . . 0.0 111.611 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -89.78 138.75 31.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.653 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.329 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.402 ' H2 ' ' CB ' ' A' ' 77' ' ' THR . 22.5 ttm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -139.47 150.36 45.08 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.198 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -130.55 129.76 43.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.54 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CE2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -91.67 120.35 32.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -129.49 149.35 51.3 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.605 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.515 HD23 ' C ' ' A' ' 6' ' ' LEU . 3.2 tt -95.16 106.46 25.89 Favored Pre-proline 0 N--CA 1.473 0.675 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.677 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.46 159.2 25.75 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.874 1.716 . . . . 0.0 111.892 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -76.92 88.54 3.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.843 0.354 . . . . 0.0 110.74 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.39 -43.15 98.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.034 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.04 168.41 46.93 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.63 -37.02 83.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.775 0.322 . . . . 0.0 110.473 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.71 121.7 1.12 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.1 t -153.28 -52.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 110.218 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.8 p 42.93 72.26 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.202 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -174.3 144.66 0.95 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.637 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.57 110.52 0.5 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' OE1' ' CE ' ' A' ' 39' ' ' MET . 83.7 tt0 -122.87 135.88 54.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.842 0.353 . . . . 0.0 110.268 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 mm -102.56 121.24 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.931 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 20' ' ' ARG . 11.5 p -92.63 -42.44 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.36 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.515 ' N ' HG13 ' A' ' 19' ' ' VAL . 79.4 ttt-85 -142.31 137.51 30.64 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -109.27 141.05 42.12 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 10.8 p-10 -114.87 3.04 14.49 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.42 155.83 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.701 0.286 . . . . 0.0 110.684 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 99.0 mttt -135.11 150.54 50.23 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.221 0.534 . . . . 0.0 111.239 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -50.03 131.21 22.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.114 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.79 5.3 68.72 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.65 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 31.7 p-10 -106.67 150.06 26.63 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 117.52 0.66 . . . . 0.0 110.734 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.7 mmm -85.55 153.28 22.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.913 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 30' ' ' GLU . 26.6 t -125.18 160.57 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.957 0.408 . . . . 0.0 110.807 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.1 mp0 -118.45 152.26 36.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.355 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HB2' HH11 ' A' ' 52' ' ' ARG . 65.1 tttm -80.64 140.4 35.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.31 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.11 141.96 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.051 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 65.9 114.11 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.496 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 45.0 t0 -163.49 -173.03 3.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.489 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 84.8 mt -138.15 69.94 1.39 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.082 0.467 . . . . 0.0 111.341 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.88 131.06 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 37' ' ' GLU . 57.3 mp0 -128.54 123.27 33.04 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 110.937 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.78 131.85 64.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.425 ' CE ' ' OE1' ' A' ' 17' ' ' GLU . 63.2 ttp -99.5 121.59 41.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.659 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -96.49 -86.26 0.32 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.248 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' N ' ' OG1' ' A' ' 40' ' ' THR . 99.7 m-20 -101.26 49.98 0.87 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.206 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.1 tttm 73.08 28.25 1.92 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.932 0.396 . . . . 0.0 110.304 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.6 t -127.27 137.46 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.534 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.0 m -94.48 117.16 29.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.914 0.388 . . . . 0.0 110.13 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.5 m -124.16 131.22 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.557 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -90.07 139.23 30.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.593 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.8 mt -133.5 137.41 28.91 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.322 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 49' ' ' SER . 53.1 Cg_exo -51.99 140.59 49.02 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 121.79 1.66 . . . . 0.0 112.862 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.43 ' OG ' ' OD2' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -40.67 165.71 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.21 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.29 42.57 1.36 Allowed 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.079 2.52 . . . . 0.0 113.172 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.7 t 62.22 118.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.661 0.267 . . . . 0.0 110.974 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.401 HH11 ' HB2' ' A' ' 31' ' ' LYS . 35.5 ptt-85 -44.04 150.33 0.28 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.902 0.382 . . . . 0.0 111.756 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.04 -146.38 11.66 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -118.23 131.65 56.36 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.907 0.384 . . . . 0.0 110.383 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.415 ' CG2' HD11 ' A' ' 73' ' ' LEU . 8.1 mm -96.63 118.87 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.9 t -91.0 -52.5 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -150.49 156.9 42.33 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.109 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.511 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.7 tt -117.6 123.33 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.751 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.46 -16.85 16.69 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.172 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.516 ' CD2' ' OE1' ' A' ' 64' ' ' GLN . 15.6 m-85 -106.74 141.99 37.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.115 0.483 . . . . 0.0 111.161 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 80.4 mtp85 -122.2 168.92 11.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.204 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.22 134.65 57.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.833 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.91 4.9 90.4 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.704 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.516 ' OE1' ' CD2' ' A' ' 60' ' ' TYR . 49.7 tt0 -82.97 135.65 34.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.504 0.652 . . . . 0.0 110.919 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -126.93 131.92 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -147.08 140.65 15.13 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 119.328 -0.367 . . . . 0.0 111.083 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.3 148.88 48.6 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 121.42 1.413 . . . . 0.0 112.225 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 68' ' ' VAL . 7.5 p -57.8 132.55 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.204 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.78 51.84 0.11 Allowed Glycine 0 N--CA 1.467 0.722 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.4 p -159.06 163.27 36.44 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.445 0.623 . . . . 0.0 111.617 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.7 m -93.34 109.32 20.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.154 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.435 HD12 ' CE2' ' A' ' 4' ' ' PHE . 97.1 mt -63.75 -46.04 87.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.406 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.879 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.9 tt -152.55 146.47 25.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.492 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.879 ' N ' HD23 ' A' ' 73' ' ' LEU . 55.2 tt0 -102.95 130.06 49.89 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.6 mt -125.23 127.69 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.159 0.504 . . . . 0.0 111.342 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -91.92 137.27 32.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.151 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.402 ' CB ' ' H2 ' ' A' ' 1' ' ' MET . 19.1 m . . . . . 0 C--O 1.222 -0.392 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.252 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -139.78 149.9 44.09 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -126.92 133.78 50.57 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.265 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -88.23 112.82 23.21 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 109.933 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -117.64 117.57 29.73 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.697 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 6' ' ' LEU . 4.0 tt -47.26 107.66 0.75 Allowed Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.77 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.39 148.72 23.9 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.543 1.496 . . . . 0.0 111.55 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 21.8 p-10 -79.77 105.21 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.47 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.4 pt -127.84 157.06 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.896 0.379 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.99 -132.73 43.23 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -66.42 -35.78 81.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.504 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.06 170.55 13.31 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -133.12 110.81 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.445 ' OG1' ' OE1' ' A' ' 15' ' ' GLU . 12.2 p -72.38 -39.08 68.3 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.89 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.445 ' OE1' ' OG1' ' A' ' 14' ' ' THR . 57.0 mp0 -144.6 149.77 36.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.815 0.34 . . . . 0.0 110.266 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.99 117.81 5.94 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -123.27 131.98 53.86 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.435 HG21 ' NE1' ' A' ' 21' ' ' TRP . 9.0 mm -102.58 120.67 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.031 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.517 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.7 p -92.18 -43.12 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.72 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' NH2' ' OE1' ' A' ' 37' ' ' GLU . 86.2 mtm180 -144.92 151.4 38.61 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.435 ' NE1' HG21 ' A' ' 18' ' ' ILE . 68.2 m95 -118.68 140.98 49.04 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -116.64 9.06 14.0 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.1 0.409 . . . . 0.0 111.847 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.61 156.74 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.676 0.274 . . . . 0.0 110.342 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 62.6 mttp -115.34 142.34 46.81 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.275 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -57.33 134.64 56.17 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.36 6.43 66.32 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 40.1 p-10 -102.36 151.72 21.93 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.026 0.441 . . . . 0.0 110.86 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.9 mtm -81.64 144.61 31.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.199 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 56.0 t -122.54 133.61 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.389 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -104.03 159.94 15.25 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.114 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' HH11 ' A' ' 52' ' ' ARG . 87.9 tttt -62.87 133.46 54.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.279 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 58.1 37.96 26.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.522 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -139.43 81.46 1.83 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.727 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 49' ' ' SER . 68.0 t0 -177.67 132.17 0.16 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 41.5 tp -111.02 96.77 6.35 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.148 0.499 . . . . 0.0 109.99 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.77 124.03 72.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.542 ' OE1' ' NH2' ' A' ' 20' ' ' ARG . 76.0 tt0 -106.06 120.24 41.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.045 0.45 . . . . 0.0 110.6 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.32 131.55 67.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.678 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 43' ' ' VAL . 6.0 tpp -114.72 145.43 42.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.363 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 2.6 t -115.4 -131.35 0.32 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.027 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.532 ' N ' ' OG1' ' A' ' 40' ' ' THR . 67.3 t0 -65.13 -43.77 90.82 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.458 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -173.13 53.85 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.786 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.506 ' O ' ' SD ' ' A' ' 39' ' ' MET . 5.1 t -145.01 133.69 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.253 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -101.2 119.47 38.8 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.62 157.76 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.547 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -125.57 135.65 52.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.239 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.3 mt -133.58 88.26 34.52 Favored Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.503 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.18 142.53 97.26 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 122.409 2.072 . . . . 0.0 112.302 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.445 ' H ' ' HB3' ' A' ' 34' ' ' ASP . 74.2 m -41.55 102.45 0.27 Allowed Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.203 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.32 -23.12 38.86 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 121.081 1.188 . . . . 0.0 114.466 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.83 126.4 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 118.246 0.476 . . . . 0.0 111.32 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.402 HH11 ' HB2' ' A' ' 31' ' ' LYS . 33.5 ptt-85 -84.75 146.01 27.61 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 120.514 0.197 . . . . 0.0 110.897 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.23 -145.94 7.2 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.698 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -115.94 135.51 53.91 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.641 0.258 . . . . 0.0 110.392 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.5 mm -95.59 119.8 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.19 -53.27 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.531 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -164.1 157.73 18.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.727 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.7 tt -89.35 114.84 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.179 0.514 . . . . 0.0 110.691 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.3 tp -86.94 -25.17 24.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.352 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.37 145.98 39.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.096 0.474 . . . . 0.0 111.192 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -123.23 165.65 16.55 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.017 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.4 142.39 48.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.417 0.627 . . . . 0.0 112.159 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.37 4.95 90.33 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.075 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -86.69 130.18 34.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.236 0.541 . . . . 0.0 111.499 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.75 129.65 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.544 -0.753 . . . . 0.0 108.972 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.79 140.41 14.68 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 119.374 -0.346 . . . . 0.0 110.575 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.92 146.22 47.78 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.326 1.351 . . . . 0.0 112.584 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -56.12 130.47 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.09 49.78 0.15 Allowed Glycine 0 N--CA 1.47 0.903 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 p -160.52 164.52 32.02 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 117.135 0.467 . . . . 0.0 111.03 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.4 p -87.65 127.72 35.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.221 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 74.9 mt -93.58 -4.56 50.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.321 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.733 HD12 ' H ' ' A' ' 74' ' ' GLN . 2.0 tp 174.76 149.55 0.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.733 ' H ' HD12 ' A' ' 73' ' ' LEU . 58.2 tt0 -104.76 128.12 52.77 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.922 0.392 . . . . 0.0 111.394 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.3 mt -126.56 128.01 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.094 0.473 . . . . 0.0 110.976 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -96.9 110.97 23.37 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.068 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.506 -179.763 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -126.77 148.87 49.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.739 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -124.62 135.42 53.08 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.281 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -100.76 119.74 39.07 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.33 147.24 48.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.917 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 tt -76.24 116.68 58.19 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.686 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.82 155.3 39.16 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.949 1.766 . . . . 0.0 112.812 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -84.15 91.08 7.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.347 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.0 pt -97.45 -0.16 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.041 0.448 . . . . 0.0 110.324 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.24 127.29 4.12 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -65.94 -36.77 84.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.546 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.91 79.34 1.25 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.5 t -129.48 130.99 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 m -127.16 -20.27 4.16 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.177 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -171.08 146.04 2.36 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.362 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.09 168.31 13.74 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -156.68 142.78 18.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.482 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 mm -102.87 121.33 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.462 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 20' ' ' ARG . 27.0 m -92.35 -45.4 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.434 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' N ' HG23 ' A' ' 19' ' ' VAL . 95.7 mtt-85 -139.77 146.83 39.98 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.26 0.552 . . . . 0.0 112.077 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -114.57 142.99 45.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.263 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -118.17 8.34 12.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.451 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.21 156.06 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.792 0.33 . . . . 0.0 110.73 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.86 146.55 39.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.275 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -61.31 138.75 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.907 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.21 7.91 69.34 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.601 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 28' ' ' MET . 60.7 t0 -120.8 148.09 44.47 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.93 0.395 . . . . 0.0 111.038 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.537 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 96.9 mtp -83.94 150.13 25.87 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.561 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.4 t -119.73 133.59 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.807 0.337 . . . . 0.0 110.321 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 57.3 mp0 -101.96 155.41 18.18 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.443 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -71.34 140.8 50.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.024 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.5 t0 80.61 64.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.766 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -140.36 87.58 2.15 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -98.01 89.28 4.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.724 0.297 . . . . 0.0 111.354 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 93.9 mt -140.92 27.16 2.01 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 m -116.61 135.81 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -122.7 126.24 47.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.598 0.237 . . . . 0.0 110.602 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.33 155.74 34.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 110.464 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 43' ' ' VAL . 28.0 tpp -106.71 125.42 50.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.624 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.69 -49.77 3.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.974 0.416 . . . . 0.0 110.079 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' OD1' HG23 ' A' ' 43' ' ' VAL . 47.8 p-10 -139.23 49.72 1.83 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.438 ' C ' ' SD ' ' A' ' 39' ' ' MET . 48.5 tttm 72.76 23.8 2.84 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.589 ' N ' ' SD ' ' A' ' 39' ' ' MET . 47.6 t -123.69 134.57 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.754 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.3 m -95.68 118.74 32.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.661 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.12 155.11 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.251 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -109.67 135.1 51.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.711 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.32 157.88 75.73 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 49' ' ' SER . 37.2 Cg_exo -55.2 147.24 55.87 Favored 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 121.914 1.743 . . . . 0.0 112.452 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -48.4 179.9 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.352 179.174 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 49' ' ' SER . 88.0 Cg_endo -89.31 44.91 0.77 Allowed 'Trans proline' 0 N--CA 1.489 1.259 0 C-N-CA 123.094 2.529 . . . . 0.0 113.056 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.1 t 62.79 117.54 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 120.682 0.277 . . . . 0.0 111.745 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -39.26 147.12 0.07 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.695 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 162.53 -147.14 12.85 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.27 139.1 51.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.963 0.382 . . . . 0.0 110.309 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.9 mm -103.31 119.02 51.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -93.6 -51.62 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -147.17 157.5 43.62 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.52 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.4 tt -116.94 124.24 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.376 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.22 -16.42 15.21 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.533 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 8.1 m-85 -109.89 145.51 36.71 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.269 0.557 . . . . 0.0 111.751 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -124.87 161.8 25.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.254 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -56.11 138.52 49.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.558 0.694 . . . . 0.0 112.33 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.85 5.67 89.91 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.202 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -81.2 133.83 35.52 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 122.332 -0.51 . . . . 0.0 110.832 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.9 t -118.02 128.62 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.157 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 t -149.84 139.38 13.17 Favored Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.513 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -56.04 143.28 83.92 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.205 1.27 . . . . 0.0 111.746 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.21 130.95 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.876 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.73 50.13 0.05 OUTLIER Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.975 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.2 t -166.65 164.07 16.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.388 0.594 . . . . 0.0 111.451 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 71' ' ' THR . 7.8 t -94.71 114.43 26.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.188 0.518 . . . . 0.0 109.628 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.533 ' CD1' ' CD2' ' A' ' 60' ' ' TYR . 2.9 mm? -64.72 -40.32 95.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.334 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.9 tt -142.62 147.7 36.24 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.873 ' N ' HD23 ' A' ' 73' ' ' LEU . 55.5 tt0 -102.74 130.7 49.78 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.0 mt -128.3 127.78 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.982 0.42 . . . . 0.0 111.296 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -96.0 116.37 28.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.47 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.108 -179.82 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -80.32 141.05 35.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -115.66 138.51 51.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.737 0.303 . . . . 0.0 110.756 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -101.36 106.02 17.13 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -114.84 120.81 41.27 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.066 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.58 HD23 ' C ' ' A' ' 6' ' ' LEU . 4.4 tt -47.11 107.64 0.75 Allowed Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.447 ' N ' HD23 ' A' ' 6' ' ' LEU . 44.6 Cg_exo -54.27 144.65 59.09 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.533 1.488 . . . . 0.0 112.332 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -79.23 19.08 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.373 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.4 pt -121.59 147.02 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.036 0.446 . . . . 0.0 110.568 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.94 -162.35 29.69 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.33 -40.2 95.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.227 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.89 111.66 0.25 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.7 t -128.29 127.17 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.3 p -125.09 -14.44 6.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.916 0.388 . . . . 0.0 110.675 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.451 ' OE2' HG22 ' A' ' 65' ' ' VAL . 74.8 tt0 -159.4 153.27 23.15 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -98.69 144.59 17.31 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -157.06 126.7 6.16 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.417 HG21 ' NE1' ' A' ' 21' ' ' TRP . 5.4 mm -102.54 120.09 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.802 0.334 . . . . 0.0 111.65 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.1 p -87.27 -47.45 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.851 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.565 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.8 mtt180 -142.77 147.77 36.09 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.417 ' NE1' HG21 ' A' ' 18' ' ' ILE . 42.1 m95 -113.24 136.17 53.03 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 22.3 p-10 -99.69 -7.12 26.05 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.768 0.318 . . . . 0.0 110.93 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.8 m -145.37 161.12 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.48 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 99.0 mttt -139.36 155.44 47.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.151 0.501 . . . . 0.0 111.215 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -46.78 142.31 3.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.389 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.9 8.53 67.08 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.69 -0.505 . . . . 0.0 113.137 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 47.2 p-10 -129.65 149.47 51.39 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.015 0.908 . . . . 0.0 111.659 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.5 mtt -84.94 151.39 24.27 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.54 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -139.18 147.1 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.093 0.473 . . . . 0.0 110.309 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 31' ' ' LYS . 97.6 mt-10 -140.56 152.77 45.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.068 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 30' ' ' GLU . 33.7 tptt 94.59 124.11 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.955 0.784 . . . . 0.0 110.707 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 49' ' ' SER . 9.0 p-10 -72.75 -3.32 24.57 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.469 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -132.49 87.27 2.4 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.6 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 53.1 p-10 -97.82 -112.32 0.15 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.6 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 54.5 tp -166.84 80.51 0.23 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.275 0.559 . . . . 0.0 110.714 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.64 132.35 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -109.27 123.77 49.82 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 110.582 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.76 128.23 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.621 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 37.7 ttm -109.2 155.94 20.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.03 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.5 t -132.21 -118.33 0.21 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.629 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.536 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.2 p-10 -66.73 -46.33 75.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.941 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.488 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 30.8 ttmt -174.64 56.2 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.485 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -162.21 151.76 3.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.826 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.6 m -117.09 122.49 44.29 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.065 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.59 157.31 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.055 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.26 134.44 51.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 53.0 mt -118.53 137.63 24.99 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.92 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 49' ' ' SER . 50.2 Cg_exo -51.11 142.07 36.26 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 121.442 1.428 . . . . 0.0 112.467 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -36.58 157.44 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.37 44.93 1.72 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.496 2.131 . . . . 0.0 112.578 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.8 t 63.62 117.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.888 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -50.25 146.7 4.85 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.933 0.396 . . . . 0.0 111.704 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.73 -136.59 4.33 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -127.04 143.84 51.18 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.033 0.416 . . . . 0.0 110.239 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.474 HG23 HD21 ' A' ' 73' ' ' LEU . 7.3 mm -104.0 117.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.3 t -91.18 -50.72 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -149.97 157.17 42.89 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.427 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 58' ' ' ILE . 15.5 tt -132.02 126.84 57.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.766 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.13 -16.11 20.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.914 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.587 ' CE1' HD23 ' A' ' 72' ' ' LEU . 25.2 m-85 -102.01 134.65 44.9 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.36 0.6 . . . . 0.0 111.782 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.81 178.99 4.28 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.987 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.69 128.16 35.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.781 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.46 5.88 81.56 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.527 177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -83.72 139.49 32.71 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.198 0.999 . . . . 0.0 111.743 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 16' ' ' GLY . 12.9 p -125.73 132.63 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.378 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 t -147.99 137.59 12.24 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.032 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.51 150.6 41.99 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 121.472 1.448 . . . . 0.0 112.439 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.37 130.6 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.307 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.7 48.15 0.11 Allowed Glycine 0 N--CA 1.471 1.018 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.247 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.3 p -163.12 162.89 25.88 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 117.376 0.588 . . . . 0.0 111.171 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -90.28 130.79 36.35 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.587 HD23 ' CE1' ' A' ' 60' ' ' TYR . 78.3 mt -89.27 -12.36 40.9 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.3 tt -169.59 146.78 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.976 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.502 ' N ' HD23 ' A' ' 73' ' ' LEU . 2.7 tm0? -102.81 122.31 44.26 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 90.0 mt -124.97 128.73 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.398 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -98.54 111.26 23.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.229 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.56 -179.951 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -80.68 137.22 36.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -114.02 126.64 55.35 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -96.97 113.65 25.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.211 0.529 . . . . 0.0 110.161 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -117.71 139.42 51.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.023 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -71.51 113.15 17.25 Favored Pre-proline 0 N--CA 1.47 0.549 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.546 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -81.64 154.43 18.02 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.057 1.838 . . . . 0.0 111.929 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -69.67 138.67 53.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.3 pt -109.88 1.55 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.759 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.28 166.2 39.09 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -89.45 146.33 24.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.861 0.362 . . . . 0.0 110.414 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.44 25.24 66.11 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.9 t -123.49 130.88 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 p -152.73 70.08 0.88 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.475 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -162.14 143.63 10.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.43 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.22 110.22 0.79 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -123.23 137.04 54.97 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -102.03 121.42 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 112.056 -178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.8 p -87.19 -46.56 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.609 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' N ' HG13 ' A' ' 19' ' ' VAL . 72.2 ttt180 -149.16 137.28 20.71 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -100.84 145.6 28.36 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 11.5 p-10 -121.3 8.89 10.3 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.31 155.68 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.075 0.464 . . . . 0.0 111.018 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -134.74 147.57 50.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.715 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' A' ' 56' ' ' VAL . 24.0 tp10 -60.11 135.25 57.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.167 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.77 8.06 70.39 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.224 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -118.4 156.33 29.16 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.125 0.463 . . . . 0.0 111.322 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.2 mmt -96.4 150.96 20.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.278 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 30' ' ' GLU . 3.4 p -138.32 154.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.809 0.337 . . . . 0.0 110.405 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 30' ' ' GLU . 1.3 pm0 -109.98 155.19 22.11 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.974 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -83.8 92.75 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.765 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -178.61 75.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.99 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 38.74 91.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.957 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.45 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 27.4 t70 -84.67 11.97 8.02 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.339 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.9 mt 66.0 66.33 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.918 0.761 . . . . 0.0 110.859 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.06 128.93 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -120.56 125.54 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.14 0.495 . . . . 0.0 111.091 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.5 m -121.04 133.57 67.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.265 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.9 ttp -103.88 109.54 21.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.413 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 40' ' ' THR . 0.2 OUTLIER -63.67 -51.96 62.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.201 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -138.49 -65.48 0.5 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.545 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -149.47 43.83 0.93 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.701 0.286 . . . . 0.0 110.37 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.0 p -150.87 149.71 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.951 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.4 m -102.19 118.86 37.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.516 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.64 133.54 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.482 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -94.24 137.45 33.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.745 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.2 mt -132.03 139.15 34.11 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.059 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 49' ' ' SER . 50.4 Cg_exo -52.97 142.74 52.24 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.356 1.371 . . . . 0.0 112.379 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.93 164.85 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.551 -179.218 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.28 44.55 1.63 Allowed 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.149 2.566 . . . . 0.0 112.663 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t 64.38 116.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.732 0.301 . . . . 0.0 110.901 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -49.78 146.93 4.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.05 0.452 . . . . 0.0 111.665 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 167.3 -134.57 3.31 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.596 -1.001 . . . . 0.0 110.596 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.0 139.55 53.34 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.87 0.335 . . . . 0.0 110.192 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.5 mm -99.01 120.25 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.464 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 21.4 t -87.05 -54.76 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -154.13 158.76 40.89 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.302 0.572 . . . . 0.0 112.038 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.4 tt -116.87 119.54 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.198 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 74.3 mt -100.17 -18.22 17.02 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.3 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -115.17 142.75 46.23 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -123.7 165.92 16.42 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.142 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.42 150.25 11.99 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.014 0.435 . . . . 0.0 111.983 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.55 6.47 77.17 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.303 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -101.72 129.97 48.01 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 112.071 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 p -121.95 128.94 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 t -147.08 140.43 14.94 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.783 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.48 140.82 63.7 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.239 1.293 . . . . 0.0 112.05 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 68' ' ' VAL . 10.2 p -59.43 131.75 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.555 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.28 50.48 0.12 Allowed Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.014 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.1 p -156.36 164.55 38.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.269 0.535 . . . . 0.0 111.304 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.4 m -88.26 121.06 30.22 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.88 -27.69 13.48 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 74' ' ' GLN . 1.7 tt -156.12 141.71 17.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.796 ' N ' HD23 ' A' ' 73' ' ' LEU . 52.2 tt0 -104.25 132.81 50.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.86 0.362 . . . . 0.0 110.205 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.7 mt -130.99 127.47 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.191 0.519 . . . . 0.0 111.34 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -87.46 142.95 27.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.717 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 83.9 m . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.299 179.535 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -116.26 141.49 48.08 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -114.6 126.41 54.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.88 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -99.62 118.69 36.71 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.21 0.528 . . . . 0.0 110.503 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -124.65 140.91 52.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.882 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 tt -61.81 114.75 12.21 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.98 153.98 37.63 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.622 1.548 . . . . 0.0 112.662 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -90.16 106.39 18.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.587 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.5 pt -127.03 143.71 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.47 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.43 -5.52 43.86 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 52.96 171.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.78 28.67 64.56 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.518 HG22 ' OG1' ' A' ' 40' ' ' THR . 59.8 t -123.67 128.95 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.0 p -135.52 -7.26 2.22 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.291 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -142.06 148.71 38.87 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.768 0.318 . . . . 0.0 110.619 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.82 135.71 8.83 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -123.38 137.88 54.72 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.411 HG21 ' NE1' ' A' ' 21' ' ' TRP . 8.9 mm -102.66 121.18 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.688 0.28 . . . . 0.0 111.616 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 t -101.53 -34.65 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.751 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -153.49 133.21 13.06 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.88 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.411 ' NE1' HG21 ' A' ' 18' ' ' ILE . 67.6 m95 -105.37 130.48 53.47 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 16.8 p-10 -98.98 3.66 47.05 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.719 0.295 . . . . 0.0 111.086 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.46 157.64 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.792 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -132.33 145.7 51.45 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.32 0.581 . . . . 0.0 111.402 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -58.39 140.48 53.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.919 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.71 6.89 65.26 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -121.48 126.6 49.65 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.082 0.441 . . . . 0.0 111.225 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -71.34 141.17 50.44 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 30' ' ' GLU . 11.2 t -142.1 161.5 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 1.6 pm0 -127.66 152.1 48.11 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.055 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 30' ' ' GLU . 52.4 pttt -26.8 145.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.583 0.552 . . . . 0.0 111.752 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.5 ' O ' ' O ' ' A' ' 33' ' ' GLN . 94.6 m-20 61.69 58.31 2.03 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.227 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.699 ' NE2' ' H ' ' A' ' 49' ' ' SER . 1.4 pm0 -43.78 -106.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.488 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' H ' ' CG ' ' A' ' 33' ' ' GLN . 66.4 t0 -153.4 61.17 0.76 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.036 0.446 . . . . 0.0 110.672 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 34' ' ' ASP . 19.3 mt 55.73 124.62 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.999 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.73 131.78 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -92.87 120.53 33.31 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.331 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -129.22 134.93 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.967 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.0 ttp -116.43 153.15 32.6 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.723 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.518 ' OG1' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -135.31 -82.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.839 179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 40' ' ' THR . 99.0 m-20 -91.6 44.43 1.18 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.0 tttt 68.46 38.06 2.5 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.79 0.328 . . . . 0.0 110.443 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.3 t -132.31 136.95 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -94.22 113.78 25.77 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.03 0.443 . . . . 0.0 110.012 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.39 133.75 59.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.822 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -93.53 125.26 38.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.31 0.576 . . . . 0.0 110.58 179.368 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.4 mt -135.46 85.68 31.27 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.471 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.09 145.02 99.07 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 122.483 2.122 . . . . 0.0 111.722 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.699 ' H ' ' NE2' ' A' ' 33' ' ' GLN . 1.2 m -74.69 131.9 78.87 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.754 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.89 -15.45 40.33 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.816 1.677 . . . . 0.0 113.749 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -136.97 155.51 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 120.769 0.319 . . . . 0.0 111.424 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.18 160.02 9.4 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -172.42 -82.63 0.05 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -124.63 124.13 41.55 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -97.76 115.66 38.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.68 -54.07 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -165.36 152.64 10.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.514 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.8 tt -105.62 121.12 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.542 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -95.24 -17.48 21.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.077 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.529 ' CD1' HD13 ' A' ' 72' ' ' LEU . 12.3 m-85 -109.8 142.78 40.57 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.216 0.531 . . . . 0.0 111.261 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.493 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 60.7 ttm-85 -126.69 162.54 25.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.757 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -55.0 147.2 16.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.212 0.53 . . . . 0.0 111.875 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.44 6.48 87.56 Favored Glycine 0 N--CA 1.47 0.919 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.945 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.493 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 86.8 mt-30 -98.76 133.32 43.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.368 0.604 . . . . 0.0 111.715 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.81 129.14 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.29 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.9 t -147.64 141.04 15.29 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.722 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.04 142.47 34.39 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.466 1.444 . . . . 0.0 112.332 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 p -60.8 133.82 26.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.822 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.53 51.81 0.16 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 m -153.02 159.43 42.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 117.457 0.629 . . . . 0.0 111.561 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.2 m -88.04 98.08 11.33 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.867 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 3.1 mm? -65.21 -41.63 94.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.641 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.846 HD23 ' N ' ' A' ' 74' ' ' GLN . 1.8 tt -146.39 148.6 32.5 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.846 ' N ' HD23 ' A' ' 73' ' ' LEU . 54.3 mt-30 -103.26 127.18 50.66 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 mt -126.08 127.86 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.1 0.476 . . . . 0.0 111.575 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -101.83 114.16 28.0 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.961 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.4 -179.935 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 ttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -85.54 147.15 26.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.897 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -121.33 135.72 55.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.325 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.436 ' CE2' HD12 ' A' ' 72' ' ' LEU . 1.3 t80 -99.55 118.51 36.28 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -121.54 146.44 46.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.293 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.19 115.99 17.14 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -49.3 138.05 30.13 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.391 1.394 . . . . 0.0 113.291 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -81.53 12.72 3.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.339 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 pt -124.56 148.93 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 120.796 0.331 . . . . 0.0 110.489 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.82 -166.8 32.52 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -65.72 -37.1 85.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.37 . . . . 0.0 110.462 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASP . . . 170.81 134.78 1.81 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.98 129.44 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.815 0.34 . . . . 0.0 110.276 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 p -123.18 -26.81 4.26 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.354 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -173.77 156.41 2.85 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.373 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.11 122.61 6.97 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -131.63 135.19 46.75 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.436 HG21 ' NE1' ' A' ' 21' ' ' TRP . 8.4 mm -102.7 120.0 51.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.185 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 m -92.37 -43.58 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.719 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -142.93 145.52 33.11 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.436 ' NE1' HG21 ' A' ' 18' ' ' ILE . 46.3 m95 -118.22 140.28 50.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.1 m-20 -119.8 13.47 12.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 120.781 0.324 . . . . 0.0 110.82 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.35 158.92 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 26.4 pttm -138.94 144.36 39.0 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 110.574 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 26' ' ' GLY . 13.1 tm-20 -47.78 138.88 8.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.725 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' N ' ' CD ' ' A' ' 25' ' ' GLU . . . 87.56 6.82 76.61 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.451 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 42.4 p-10 -106.93 150.01 26.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.206 0.503 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.6 mtp -90.31 142.69 27.48 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.091 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.9 t -120.01 133.38 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.672 0.272 . . . . 0.0 110.705 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -101.47 156.49 17.43 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.238 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.39 135.9 55.83 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.704 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 57.9 34.4 24.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.303 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -144.43 88.27 1.92 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.76 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -172.67 170.87 4.63 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.938 0.399 . . . . 0.0 110.602 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.452 HD23 ' NZ ' ' A' ' 46' ' ' LYS . 81.0 mt -140.14 88.42 2.22 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.61 133.38 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.444 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -123.1 124.91 44.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.189 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.04 154.64 26.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.215 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 45.6 ttp -106.84 152.4 23.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.216 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.65 -42.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.479 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 12' ' ' GLY . 91.9 m-20 -136.0 49.0 2.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.92 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 56.81 43.46 25.0 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.066 0.46 . . . . 0.0 109.961 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.43 152.1 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.25 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.6 m -95.9 118.29 32.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.612 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.74 131.38 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.193 0.52 . . . . 0.0 110.769 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.452 ' NZ ' HD23 ' A' ' 35' ' ' LEU . 54.0 tttp -92.03 139.24 30.84 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.086 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 77.3 mt -134.73 135.2 22.95 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.078 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 49' ' ' SER . 43.0 Cg_exo -51.6 146.17 27.42 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 121.689 1.593 . . . . 0.0 112.308 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.26 166.31 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.466 -179.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.71 49.85 3.32 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 123.044 2.496 . . . . 0.0 113.082 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t 68.29 119.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.838 0.351 . . . . 0.0 111.492 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -47.41 135.9 10.25 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.753 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.15 -141.52 6.51 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -123.59 144.98 49.26 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.021 0.411 . . . . 0.0 110.559 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.409 HG23 HD21 ' A' ' 73' ' ' LEU . 8.2 mm -100.96 120.76 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.2 t -92.43 -51.13 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -154.6 159.15 40.67 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.761 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.1 tt -106.95 132.76 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.221 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.44 -24.6 10.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.459 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -108.4 141.41 40.29 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.035 0.445 . . . . 0.0 111.418 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.554 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 90.4 mtm180 -120.2 162.62 19.05 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.39 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 56.2 mp0 -56.17 134.83 53.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.174 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.75 4.98 84.62 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.929 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.554 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 79.8 mt-30 -83.27 135.53 34.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.688 0.744 . . . . 0.0 111.875 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.3 t -120.11 126.84 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 t -148.67 132.5 8.53 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -56.47 149.65 55.86 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 121.459 1.439 . . . . 0.0 112.106 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 68' ' ' VAL . 1.4 p -58.89 128.56 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.783 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.52 49.72 0.05 OUTLIER Glycine 0 CA--C 1.531 1.078 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.131 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m -163.92 166.97 21.18 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.388 0.594 . . . . 0.0 111.165 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 71' ' ' THR . 6.3 t -95.4 115.92 28.09 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.436 HD12 ' CE2' ' A' ' 4' ' ' PHE . 92.1 mt -65.99 -42.98 89.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.291 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.532 HD23 ' N ' ' A' ' 74' ' ' GLN . 4.0 tt -144.01 151.28 39.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.532 ' N ' HD23 ' A' ' 73' ' ' LEU . 36.8 mt-30 -102.62 121.12 41.77 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.9 127.19 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.965 0.412 . . . . 0.0 111.827 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.56 136.95 32.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.482 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.397 -179.872 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mtm . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -111.77 143.65 42.34 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.328 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -139.49 114.31 9.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.017 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -88.87 122.44 32.26 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.135 0.493 . . . . 0.0 110.633 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -121.76 157.85 30.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.178 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 8' ' ' ASP . 10.4 tp -44.43 126.24 4.76 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.92 13.19 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.186 1.257 . . . . 0.0 112.539 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 6' ' ' LEU . 99.1 m-20 46.17 82.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.773 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.38 -43.16 97.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.89 -168.88 41.79 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 57.96 77.16 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.019 0.438 . . . . 0.0 110.559 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.88 54.82 34.76 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.9 t -128.71 131.05 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 120.866 0.365 . . . . 0.0 110.274 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -163.47 46.59 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.234 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -169.17 154.09 5.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.896 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -124.79 137.09 10.29 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -151.97 133.47 14.63 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.921 0.391 . . . . 0.0 109.986 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.404 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.6 mm -102.77 124.34 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.561 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.5 p -91.58 -44.24 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.527 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.514 ' N ' HG13 ' A' ' 19' ' ' VAL . 71.3 ttt180 -151.61 137.87 18.42 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.404 ' NE1' HG21 ' A' ' 18' ' ' ILE . 60.9 m95 -107.75 136.9 46.72 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.1 m-20 -108.16 0.46 21.56 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.665 0.269 . . . . 0.0 110.766 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.5 m -133.54 158.49 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -137.5 154.33 49.89 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -54.73 143.21 25.94 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.059 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.51 7.13 76.29 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.762 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 28' ' ' MET . 62.0 t0 -123.19 150.57 43.2 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.602 0.701 . . . . 0.0 111.089 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.553 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 76.5 mtm -78.07 149.09 33.99 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.4 t -121.8 133.93 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.69 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.86 157.41 17.22 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.348 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -81.05 94.48 6.59 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' ASP . 8.0 p30 173.12 113.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.936 0.398 . . . . 0.0 111.381 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 53.67 -82.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.829 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' ASP . 9.7 t0 74.88 13.14 3.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.864 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.436 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.3 mt 21.08 84.48 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.001 -1.0 . . . . 0.0 112.761 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.93 130.33 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.6 mp0 -116.37 124.38 49.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.475 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.56 135.14 58.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.637 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.7 ttp -124.83 151.46 45.21 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.675 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -104.27 -51.83 3.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.742 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' OG1' ' A' ' 40' ' ' THR . 94.7 m-20 -138.01 -62.5 0.59 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.327 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -146.31 39.19 1.08 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.855 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 49.6 t -129.87 133.33 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.798 0.332 . . . . 0.0 110.134 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.5 m -114.96 115.79 27.45 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.09 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.0 m -129.46 131.13 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.852 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -95.2 133.35 39.15 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.095 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mt -128.85 134.48 26.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.993 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.35 144.23 50.27 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.678 1.586 . . . . 0.0 111.219 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.1 m -99.0 104.01 23.14 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.22 48.43 2.49 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.186 1.924 . . . . 0.0 110.663 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.61 158.91 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -160.36 144.98 14.45 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.128 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.01 -137.05 4.98 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -127.07 141.72 51.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.902 0.351 . . . . 0.0 110.087 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.3 mm -97.09 119.97 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.33 -49.61 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -158.26 158.43 34.43 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.734 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 58' ' ' ILE . 4.4 tt -123.96 122.8 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.255 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.3 mt -99.15 -18.02 17.88 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.668 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CE1' HD23 ' A' ' 72' ' ' LEU . 21.3 m-85 -105.43 136.5 44.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.156 0.503 . . . . 0.0 110.827 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -121.06 -176.45 3.27 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.031 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -64.57 126.78 28.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.59 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.47 5.57 86.79 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.22 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -70.48 133.97 47.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.802 0.801 . . . . 0.0 110.835 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.9 t -123.71 126.9 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.3 t -149.17 139.49 13.44 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.189 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.91 150.34 64.25 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.034 1.156 . . . . 0.0 111.707 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.0 p -64.05 127.66 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.347 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.74 52.38 0.07 OUTLIER Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.027 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.7 p -162.84 163.45 26.51 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 117.289 0.545 . . . . 0.0 111.38 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 p -89.76 113.09 24.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.156 0.503 . . . . 0.0 110.182 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.46 HD23 ' CE1' ' A' ' 60' ' ' TYR . 96.2 mt -67.19 -39.14 86.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.559 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 74' ' ' GLN . 0.8 OUTLIER -151.57 144.91 24.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.606 -177.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.469 ' N ' HD23 ' A' ' 73' ' ' LEU . 52.4 tt0 -103.38 125.91 50.25 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.4 mt -132.63 128.77 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.222 0.535 . . . . 0.0 111.333 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -100.65 136.08 41.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.838 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.431 -179.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.595 ' SD ' ' NE2' ' A' ' 74' ' ' GLN . 14.3 ptp . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -101.71 134.69 44.48 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 40.5 mp0 -111.51 116.87 31.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.747 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -76.93 100.56 5.62 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -105.83 155.75 19.0 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.108 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.9 mt -93.33 108.25 31.98 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.87 157.67 24.2 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.847 1.698 . . . . 0.0 112.169 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.455 ' OD1' HG21 ' A' ' 68' ' ' VAL . 90.1 m-20 -91.04 110.32 21.58 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.142 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 9' ' ' ILE . 14.5 tt -174.25 -21.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 110.408 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.71 -35.52 0.28 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.95 -37.33 81.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.894 0.378 . . . . 0.0 110.501 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -143.96 133.06 5.16 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 15' ' ' GLU . 1.2 p -155.0 151.82 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 13' ' ' VAL . 11.6 p 53.64 -72.86 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.245 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER -139.07 144.72 38.9 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.075 -0.391 . . . . 0.0 111.126 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.63 123.63 7.74 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -126.14 140.05 52.88 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 117.334 0.567 . . . . 0.0 110.158 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.54 121.8 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.29 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 20' ' ' ARG . 12.1 p -92.96 -42.74 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.762 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.482 ' N ' HG13 ' A' ' 19' ' ' VAL . 72.3 ttt180 -155.89 133.84 11.28 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -102.01 134.41 45.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 24.0 p-10 -106.21 -0.52 24.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.662 0.268 . . . . 0.0 111.149 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.63 160.37 37.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -139.6 155.78 47.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.873 0.368 . . . . 0.0 110.882 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -50.87 135.72 23.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.079 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.17 4.61 66.49 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.858 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 36.7 p-10 -114.46 154.06 28.84 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.628 0.714 . . . . 0.0 110.908 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.9 mtm -114.12 148.73 36.71 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.01 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -139.43 150.4 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.92 0.391 . . . . 0.0 110.706 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -90.06 159.35 16.88 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.354 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.54 136.62 58.08 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.986 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 60.0 36.43 21.5 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.821 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -145.4 86.32 1.75 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 17.3 t0 -176.27 161.06 2.24 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.531 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 76.6 mt -134.55 88.63 2.46 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.107 0.479 . . . . 0.0 109.882 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.38 130.09 70.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -111.92 124.63 52.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.582 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.5 m -121.91 131.21 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.1 ttm -101.93 123.31 45.62 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.692 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -88.1 -90.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.418 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 42' ' ' LYS . 23.0 p-10 -96.03 -68.98 0.77 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.726 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.502 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 25.0 pttm -149.2 43.17 0.95 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.73 0.3 . . . . 0.0 110.977 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -153.19 151.21 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.909 0.385 . . . . 0.0 110.598 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.5 m -99.63 117.78 34.74 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.069 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.9 m -118.0 134.02 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.239 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.43 134.18 41.03 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.928 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.0 mt -137.23 85.41 21.98 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.732 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -55.74 141.43 84.51 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.705 2.27 . . . . 0.0 112.333 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.9 t -36.23 100.27 0.19 Allowed Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.589 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.92 -21.92 36.82 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.073 1.182 . . . . 0.0 113.843 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.19 120.96 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 122.104 -0.372 . . . . 0.0 111.212 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -77.48 152.94 33.95 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 121.167 -0.213 . . . . 0.0 110.547 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.2 -134.29 3.04 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.31 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -136.93 134.03 36.32 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.741 0.305 . . . . 0.0 110.234 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.0 mm -90.77 118.44 36.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.95 -51.47 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -146.17 156.74 43.63 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.885 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 58' ' ' ILE . 5.6 tt -121.79 122.77 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.362 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.15 -18.88 16.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.639 0.257 . . . . 0.0 110.933 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -105.98 141.08 37.97 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.17 0.509 . . . . 0.0 111.406 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.05 162.89 25.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.313 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.03 140.78 42.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.545 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.55 6.09 81.03 Favored Glycine 0 N--CA 1.469 0.863 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.388 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -99.43 134.81 41.77 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.347 0.594 . . . . 0.0 111.854 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -126.38 129.2 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.566 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 t -147.79 138.03 12.65 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.38 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.15 140.95 70.73 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.43 1.42 . . . . 0.0 112.426 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.455 HG21 ' OD1' ' A' ' 8' ' ' ASP . 17.5 m -53.23 144.65 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.703 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.48 50.28 0.42 Allowed Glycine 0 N--CA 1.471 1.014 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.5 p -156.64 162.59 39.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 117.012 0.406 . . . . 0.0 111.024 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 m -82.33 100.61 10.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.005 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.19 -42.43 93.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.8 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.896 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.3 tt -158.27 148.32 19.98 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.896 ' N ' HD23 ' A' ' 73' ' ' LEU . 56.8 tt0 -103.05 128.24 49.99 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 86.8 mt -126.05 127.21 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.072 0.463 . . . . 0.0 111.262 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -98.56 111.98 24.17 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.212 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.182 179.771 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.39 141.01 40.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 33.8 mp0 -111.14 120.39 42.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.435 -178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -88.65 105.1 17.45 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -111.85 173.08 6.53 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.137 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.461 HD23 ' C ' ' A' ' 6' ' ' LEU . 2.5 tt -106.42 82.97 1.06 Allowed Pre-proline 0 N--CA 1.471 0.594 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.77 155.04 49.15 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.473 1.449 . . . . 0.0 111.854 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -80.29 107.43 13.09 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.103 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 9' ' ' ILE . 11.4 pt -103.0 -0.13 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.127 0.489 . . . . 0.0 110.163 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.28 177.56 46.27 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 11' ' ' GLU . 57.8 mp0 -83.77 172.56 12.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 110.217 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.44 8.51 61.05 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -127.33 130.26 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.978 0.418 . . . . 0.0 110.019 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 p -144.73 -16.49 0.53 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.593 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -145.04 151.17 38.12 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.362 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.59 110.74 3.38 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -125.14 134.01 52.6 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 mm -102.6 119.05 50.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.659 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 20' ' ' ARG . 8.8 p -90.1 -43.58 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.405 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.501 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.7 mtt180 -140.9 144.58 35.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.878 0.37 . . . . 0.0 111.405 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -109.36 136.89 48.05 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 18.7 p-10 -93.76 -11.66 30.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.731 0.301 . . . . 0.0 110.522 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.78 159.89 7.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.263 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 73.8 mmtt -129.52 144.73 51.39 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -46.51 138.3 5.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.914 0.388 . . . . 0.0 111.339 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.18 7.55 58.31 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.445 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 24' ' ' LYS . 50.0 p-10 -129.07 151.26 49.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.603 0.702 . . . . 0.0 111.212 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.3 mtt -103.08 150.32 23.72 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.496 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.462 ' CG2' ' OE1' ' A' ' 33' ' ' GLN . 3.5 p -138.34 154.26 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.343 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -102.82 160.84 14.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.801 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.486 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 86.4 tttt -65.65 137.17 57.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.055 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 8.9 m-20 92.63 81.39 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.676 0.61 . . . . 0.0 111.575 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.462 ' OE1' ' CG2' ' A' ' 29' ' ' VAL . 57.2 tt0 -153.56 98.73 2.26 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.887 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -96.49 77.12 2.93 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 35' ' ' LEU . 87.0 mt -141.25 25.84 2.04 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.926 0.393 . . . . 0.0 110.295 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.23 131.61 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -123.9 131.04 53.51 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.232 0.539 . . . . 0.0 111.557 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.2 124.28 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.176 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.3 ttp -110.78 157.39 19.84 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.911 0.386 . . . . 0.0 110.83 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.3 t -136.31 -118.08 0.16 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.034 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.521 ' N ' ' OG1' ' A' ' 40' ' ' THR . 87.5 m-20 -64.02 -49.41 72.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.793 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -175.46 56.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.503 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.52 150.22 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.977 0.417 . . . . 0.0 110.894 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 m -109.77 120.09 41.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.853 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.37 118.47 58.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.951 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -88.28 133.94 33.93 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.8 mt -145.69 117.63 5.1 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.318 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.34 142.94 19.25 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.947 1.765 . . . . 0.0 111.586 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 m -46.57 106.64 0.6 Allowed Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.86 -25.72 45.16 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.338 1.359 . . . . 0.0 114.539 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.5 123.35 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 118.066 0.394 . . . . 0.0 111.607 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 31' ' ' LYS . 52.8 ptt85 -85.53 149.89 25.06 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 176.65 -134.56 2.59 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.179 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -126.29 131.22 51.92 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.003 0.402 . . . . 0.0 110.828 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 mm -93.9 119.08 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.8 t -93.08 -49.39 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.463 ' O ' ' CD2' ' A' ' 73' ' ' LEU . 60.6 pttt -148.86 150.28 32.73 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 58' ' ' ILE . 10.5 tt -127.64 128.86 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.187 0.518 . . . . 0.0 110.968 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.5 mt -98.31 -17.36 18.94 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.141 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.54 ' CE1' HD23 ' A' ' 72' ' ' LEU . 30.1 m-85 -94.5 142.72 27.11 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.311 0.577 . . . . 0.0 111.404 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -125.82 159.83 31.42 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.491 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -56.86 128.99 39.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.526 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.06 3.54 88.98 Favored Glycine 0 N--CA 1.47 0.947 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.638 179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -77.28 132.33 38.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.179 0.514 . . . . 0.0 111.079 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.94 128.54 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.764 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.34 135.84 10.79 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 119.499 -0.286 . . . . 0.0 110.579 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.63 146.7 42.56 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.388 1.392 . . . . 0.0 112.305 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 p -58.68 126.97 17.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.682 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 133.32 51.65 0.08 OUTLIER Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.3 m -153.83 159.73 41.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.131 0.465 . . . . 0.0 110.749 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.8 m -84.63 112.4 20.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.033 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.54 HD23 ' CE1' ' A' ' 60' ' ' TYR . 85.4 mt -66.95 -43.84 82.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.991 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.7 OUTLIER -159.69 149.81 18.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.175 -177.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.475 ' H ' HD23 ' A' ' 73' ' ' LEU . 12.7 mm-40 -103.5 118.45 36.78 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.3 mt -118.18 128.68 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.486 0.66 . . . . 0.0 111.572 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -95.19 115.48 27.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.335 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.777 -179.715 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -84.13 131.56 34.77 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 51.9 mp0 -102.73 113.28 26.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.184 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -79.85 101.14 8.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.726 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.433 ' NZ ' ' OG1' ' A' ' 71' ' ' THR . 68.5 mttm -112.4 145.8 39.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.2 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -63.04 111.9 5.81 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -58.44 146.68 89.36 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.061 1.174 . . . . 0.0 112.013 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -79.1 16.26 0.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.189 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.1 pt -127.56 154.36 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.53 -154.85 26.05 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -63.88 -37.77 88.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.906 0.384 . . . . 0.0 110.071 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.06 117.04 0.53 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.78 130.34 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.819 0.343 . . . . 0.0 110.2 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.3 p -135.39 -15.03 1.93 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.323 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -163.56 152.09 13.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.169 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.79 139.46 14.5 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -152.48 116.05 4.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.1 118.27 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.897 0.379 . . . . 0.0 111.668 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 20' ' ' ARG . 12.0 p -92.65 -40.02 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.398 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.464 ' N ' HG13 ' A' ' 19' ' ' VAL . 62.8 ttm-85 -144.73 137.37 26.47 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -110.63 146.55 35.96 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 56.7 t0 -130.69 26.84 5.0 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.948 0.34 . . . . 0.0 111.304 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.89 155.01 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.822 0.344 . . . . 0.0 110.848 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -141.98 147.47 37.01 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.02 0.438 . . . . 0.0 111.158 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.18 140.48 38.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.938 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.85 5.3 88.08 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.233 178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -108.38 125.75 52.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.116 0.458 . . . . 0.0 111.356 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.9 mtm -85.61 129.42 34.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.108 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.77 135.46 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.313 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -90.99 156.3 18.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.961 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 88.5 tttt -61.24 130.32 45.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 16.2 t0 94.87 69.49 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.057 0.848 . . . . 0.0 110.802 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.486 ' O ' ' O ' ' A' ' 34' ' ' ASP . 52.2 tt0 -176.93 -118.58 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 33' ' ' GLN . 67.1 t0 29.49 104.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.8 tp -84.51 94.72 8.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.19 134.01 62.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.883 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.42 113.18 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.315 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.7 132.56 59.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 42.2 ttp -118.87 124.39 47.02 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.54 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -90.25 -86.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.54 -179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 18.4 p-10 -86.07 -59.18 2.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.625 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 7.5 tmtt? -172.83 57.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 p -153.39 151.3 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.353 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.4 m -94.3 116.11 28.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.155 0.503 . . . . 0.0 109.987 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.66 117.33 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.876 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.569 ' H ' ' CD ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -98.35 132.96 43.39 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.046 0.45 . . . . 0.0 111.316 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mt -138.63 85.29 17.43 Favored Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.588 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -87.35 53.82 2.66 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.516 2.144 . . . . 0.0 113.511 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.482 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 59.6 p -170.51 47.52 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.038 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 49' ' ' SER . 71.5 Cg_endo -73.26 25.12 0.31 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.36 2.04 . . . . 0.0 111.457 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.456 ' H ' ' C ' ' A' ' 49' ' ' SER . 4.5 t 66.79 67.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.229 0.537 . . . . 0.0 109.799 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -76.79 150.2 36.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.44 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.94 -92.99 0.09 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -122.36 133.78 54.64 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mm -104.69 120.31 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.3 t -87.55 -51.19 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -155.65 159.98 40.03 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.278 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.7 tt -98.04 116.04 39.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.873 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.4 mt -99.16 -16.81 18.45 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.679 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -119.79 143.83 47.64 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.175 0.512 . . . . 0.0 111.088 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 83.4 mtp180 -120.88 166.98 13.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.656 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.36 143.99 57.49 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.005 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.35 5.98 89.49 Favored Glycine 0 N--CA 1.466 0.693 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.168 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.584 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 24.5 mt-30 -82.34 126.88 32.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.268 0.556 . . . . 0.0 111.275 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -122.0 124.16 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.11 155.14 37.35 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.299 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.04 151.85 62.15 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.721 2.281 . . . . 0.0 111.685 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p -59.83 129.52 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.259 0.552 . . . . 0.0 110.999 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.82 55.01 0.12 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.825 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.6 m -154.68 166.2 34.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.978 0.418 . . . . 0.0 111.272 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.433 ' OG1' ' NZ ' ' A' ' 5' ' ' LYS . 19.3 m -94.59 114.17 26.1 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.285 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.07 -46.9 61.04 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.513 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.65 HD12 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -160.99 158.01 27.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -178.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.65 ' H ' HD12 ' A' ' 73' ' ' LEU . 58.7 tt0 -103.35 128.03 50.55 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 122.07 -0.394 . . . . 0.0 111.079 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.2 mt -127.12 128.71 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.215 0.531 . . . . 0.0 112.302 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -100.24 115.74 30.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.38 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.275 179.549 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' H2 ' ' CB ' ' A' ' 77' ' ' THR . 63.4 ttp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' ILE . 2.1 t80 -122.73 149.85 43.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.737 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -132.23 134.59 45.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.322 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -96.36 113.32 24.89 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -115.65 153.91 30.45 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.914 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 6' ' ' LEU . 1.5 tt -102.81 92.67 3.68 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.85 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.2 152.76 40.23 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.531 1.487 . . . . 0.0 111.98 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -67.53 137.77 56.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.512 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.9 pt -135.1 153.61 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.176 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.67 -130.67 51.36 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -161.39 154.31 20.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.694 0.283 . . . . 0.0 110.328 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.04 59.84 1.92 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.7 t -126.7 131.2 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 p -106.67 -54.26 2.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.404 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -143.81 157.47 44.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.505 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.46 145.82 18.22 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -145.32 138.11 26.14 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.509 0.654 . . . . 0.0 110.995 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -100.63 122.11 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.509 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.1 p -90.22 -44.76 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.234 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' N ' HG13 ' A' ' 19' ' ' VAL . 89.4 mtm180 -143.89 148.44 35.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -118.84 143.57 46.88 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 34' ' ' ASP . 1.1 m-20 -128.42 18.38 6.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.222 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.49 159.31 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.44 142.24 51.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.827 0.346 . . . . 0.0 110.414 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.2 137.27 58.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.083 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.67 7.23 71.9 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 28' ' ' MET . 58.0 t0 -114.55 142.34 46.56 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.045 0.45 . . . . 0.0 111.084 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.543 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 94.9 mtp -79.94 152.33 29.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.432 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 30' ' ' GLU . 21.4 t -126.89 160.82 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.363 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 29' ' ' VAL . 80.1 mm-40 -123.53 152.0 42.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.896 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -57.9 90.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.2 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 63.7 t0 -178.95 134.01 0.13 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.078 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 4.2 pp0? -45.06 124.91 4.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.663 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' ASP . 89.7 m-20 -95.07 9.44 39.51 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 32.8 tp 63.1 73.85 0.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.235 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.7 m -117.32 134.57 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -119.12 137.81 53.34 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.603 0.716 . . . . 0.0 110.999 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 p -131.89 128.94 60.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.309 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 64.1 ttp -101.41 109.34 21.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.812 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 40' ' ' THR . 0.5 OUTLIER -62.0 -48.9 78.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.209 -179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 23.8 p-10 -152.4 -45.92 0.1 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.33 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -165.22 52.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.956 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 44' ' ' THR . 13.6 p -160.89 155.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.796 0.331 . . . . 0.0 110.367 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 43' ' ' VAL . 5.9 m -95.22 117.85 30.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.161 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.22 118.26 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.135 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -98.54 133.59 42.69 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.797 0.332 . . . . 0.0 110.365 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.1 mt -135.95 137.37 25.01 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 49' ' ' SER . 38.3 Cg_exo -54.59 147.48 48.52 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.325 1.35 . . . . 0.0 111.408 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -40.48 166.61 0.05 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 120.746 0.308 . . . . 0.0 111.133 -179.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.99 47.92 2.69 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.752 2.301 . . . . 0.0 113.42 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t 64.39 119.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.943 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -49.76 150.51 2.09 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.912 0.387 . . . . 0.0 111.76 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.65 -143.55 8.95 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -113.16 132.7 55.37 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 122.569 -0.371 . . . . 0.0 110.64 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.8 mm -95.33 115.6 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.4 t -70.57 -50.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -173.84 155.03 2.52 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.667 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.7 tt -89.31 110.83 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.407 0.622 . . . . 0.0 110.633 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 71' ' ' THR . 36.2 tp -81.6 -27.51 34.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.237 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.49 ' CG ' HD13 ' A' ' 72' ' ' LEU . 5.0 m-85 -110.37 145.86 36.81 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.27 0.557 . . . . 0.0 112.002 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 91.4 mtm180 -115.24 169.21 9.3 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.353 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.63 133.29 53.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.591 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.11 6.26 88.99 Favored Glycine 0 N--CA 1.466 0.672 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.994 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -80.62 133.26 35.72 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.849 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 p -124.76 127.96 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.927 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 t -148.54 137.33 11.86 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.316 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.2 137.27 46.17 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.155 1.237 . . . . 0.0 111.66 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.5 m -52.37 144.1 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.774 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.29 50.74 0.28 Allowed Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.0 p -161.4 164.05 30.18 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.482 ' O ' HD23 ' A' ' 59' ' ' LEU . 5.7 p -91.29 108.28 19.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.122 0.487 . . . . 0.0 110.544 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.7 mm? -63.85 -38.81 92.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.522 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 74' ' ' GLN . 4.0 tp -155.04 143.96 20.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.645 ' N ' HD12 ' A' ' 73' ' ' LEU . 53.3 tt0 -104.5 131.92 51.34 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.87 0.366 . . . . 0.0 111.173 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' ' 2' ' ' TYR . 92.8 mt -128.12 127.78 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -93.65 134.8 35.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.032 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.452 ' CB ' ' H2 ' ' A' ' 1' ' ' MET . 20.2 m . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.363 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.566 ' N ' ' H ' ' A' ' 77' ' ' THR . 5.0 ptt? . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -79.6 147.12 32.2 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.95 125.47 50.49 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -95.05 112.33 24.04 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -119.11 148.88 42.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.927 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.33 159.08 86.0 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.49 140.19 74.72 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 121.573 1.516 . . . . 0.0 113.467 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -105.11 70.1 0.88 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.24 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 12' ' ' GLY . 79.4 mt -119.28 132.23 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.71 -40.93 89.98 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -66.36 -50.54 63.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 0.0 111.522 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' ILE . . . -101.35 168.42 19.83 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.2 t 56.61 105.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.6 p -120.02 -7.15 9.95 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.042 0.449 . . . . 0.0 109.911 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.459 ' OE2' ' CG2' ' A' ' 65' ' ' VAL . 43.6 tt0 -168.4 156.21 8.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.861 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.17 114.08 3.1 Favored Glycine 0 N--CA 1.468 0.795 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -130.28 127.46 39.57 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -102.02 121.32 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.738 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 20' ' ' ARG . 7.2 p -94.07 -42.3 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.293 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.464 ' N ' HG13 ' A' ' 19' ' ' VAL . 82.6 mtp180 -142.31 140.72 32.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.747 0.308 . . . . 0.0 110.613 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.566 ' O ' ' N ' ' A' ' 23' ' ' VAL . 14.5 m95 -101.81 -18.28 15.83 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.289 0.566 . . . . 0.0 109.71 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 35' ' ' LEU . 19.5 m-20 43.51 3.32 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.671 -1.15 . . . . 0.0 113.89 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 21' ' ' TRP . 3.7 m -140.18 156.54 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -126.26 136.6 52.98 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -45.99 142.09 2.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.039 0.447 . . . . 0.0 111.091 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.17 69.47 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.048 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 51.4 p-10 -107.74 149.67 27.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.0 0.4 . . . . 0.0 110.732 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.6 mtt -83.85 144.15 29.44 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.553 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 68.1 t -121.07 132.8 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -109.92 154.29 23.3 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.036 0.446 . . . . 0.0 111.202 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -69.13 138.97 54.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.633 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t0 70.01 23.53 5.38 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.303 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -149.62 86.35 1.46 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.411 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -173.64 141.87 0.89 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.131 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' ' OD2' ' A' ' 22' ' ' ASP . 76.5 mt -137.16 92.2 2.69 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.17 131.8 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 37' ' ' GLU . 58.6 mp0 -106.78 124.89 50.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.179 0.514 . . . . 0.0 111.224 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.15 132.06 70.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.768 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.6 ttp -116.46 117.53 30.16 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.207 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 40' ' ' THR . 1.7 p -64.83 -49.72 69.5 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.048 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -151.72 -64.7 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.686 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -138.23 36.87 2.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.122 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.34 133.76 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.635 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.6 m -102.36 118.22 36.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.375 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.77 162.21 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.784 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -134.77 134.95 41.47 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.926 0.393 . . . . 0.0 110.792 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.8 mt -123.78 85.62 53.49 Favored Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.448 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 49' ' ' SER . 92.0 Cg_endo -80.35 147.19 17.95 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.674 2.25 . . . . 0.0 112.482 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 48' ' ' PRO . 1.2 t 89.72 61.19 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.373 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.02 28.83 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.732 2.288 . . . . 0.0 111.343 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t 72.25 111.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.151 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -59.73 146.52 41.15 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.785 0.326 . . . . 0.0 111.775 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.04 -141.3 6.24 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -125.17 136.8 53.95 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.1 mm -91.85 118.58 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 t -79.0 -50.74 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -171.07 158.76 5.72 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.92 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.6 tt -108.96 123.61 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.869 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.0 mt -97.78 -17.92 19.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.919 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.494 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 6.3 m-85 -108.9 144.24 37.06 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.886 0.374 . . . . 0.0 110.696 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 -117.0 160.84 20.33 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.281 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 -57.24 140.58 49.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.698 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.32 4.97 90.35 Favored Glycine 0 N--CA 1.468 0.78 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.965 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -84.71 134.91 34.33 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.516 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' CG2' ' OE2' ' A' ' 15' ' ' GLU . 4.4 p -125.92 129.01 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.774 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.1 t -148.94 139.83 13.79 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.02 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.64 145.55 81.05 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.12 1.213 . . . . 0.0 111.378 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -55.33 125.94 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 121.088 0.471 . . . . 0.0 111.379 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.42 49.06 0.04 OUTLIER Glycine 0 CA--C 1.53 1.015 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.231 178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.9 p -160.68 162.38 32.6 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.972 0.386 . . . . 0.0 111.091 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -94.55 107.8 19.77 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.199 0.523 . . . . 0.0 109.993 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 72' ' ' LEU . 2.8 mm? -67.18 -39.28 86.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.813 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.815 HD23 ' N ' ' A' ' 74' ' ' GLN . 1.7 tt -153.19 145.72 24.15 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.332 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.815 ' N ' HD23 ' A' ' 73' ' ' LEU . 66.3 mt-30 -104.15 130.31 51.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 83.3 mt -127.73 126.62 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.279 0.561 . . . . 0.0 111.738 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -86.65 143.11 27.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.727 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.566 ' H ' ' N ' ' A' ' 1' ' ' MET . 8.9 t . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.127 -0.939 . . . . 0.0 110.017 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -88.53 129.56 35.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 52.9 mp0 -112.28 125.43 54.15 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -92.12 123.46 35.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.237 0.541 . . . . 0.0 110.745 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -122.14 145.79 47.85 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.286 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 8' ' ' ASP . 9.9 tp -63.78 115.63 20.28 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.807 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.21 -7.4 18.94 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.881 1.721 . . . . 0.0 112.3 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 10' ' ' GLY . 1.5 m-20 52.25 34.6 14.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.368 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 9' ' ' ILE . 90.7 mt 44.29 19.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.362 0.601 . . . . 0.0 109.966 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . 88.14 -178.8 46.6 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 56.98 -88.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.666 0.269 . . . . 0.0 110.292 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 10' ' ' GLY . . . 142.79 160.35 8.33 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 13' ' ' VAL . 55.9 t -145.93 -7.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 13' ' ' VAL . 68.7 p 53.92 55.84 7.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.362 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -174.99 141.69 0.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.567 179.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.79 109.87 0.44 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -123.4 142.64 50.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.017 0.436 . . . . 0.0 110.164 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 mt -102.0 121.85 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.545 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.8 p -101.29 -48.16 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.571 ' N ' HG13 ' A' ' 19' ' ' VAL . 61.3 ttt85 -146.9 136.64 23.1 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -109.76 137.62 47.29 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.61 177.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 8.0 p-10 -101.86 -5.04 25.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.018 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.25 160.18 32.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.371 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 27' ' ' ASP . 43.8 mmtm -129.22 153.29 47.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.842 0.353 . . . . 0.0 110.683 -179.271 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' OE1' HG22 ' A' ' 58' ' ' ILE . 16.5 pt-20 -53.09 142.44 20.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.37 6.69 66.05 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.859 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 53.0 p30 -123.41 151.98 42.05 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.901 0.85 . . . . 0.0 111.466 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -86.09 154.56 21.3 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.862 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.1 p -138.11 147.08 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.806 0.336 . . . . 0.0 110.203 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -107.33 155.47 19.95 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.492 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -62.3 138.07 58.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.273 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 t0 66.79 20.13 10.65 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.19 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -137.0 81.54 1.88 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 35.3 t70 -173.6 104.46 0.12 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.437 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.552 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 51.0 tp -84.06 99.38 10.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.688 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.63 130.01 73.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.42 ' OE2' HG23 ' A' ' 44' ' ' THR . 77.0 tt0 -115.74 123.76 49.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.842 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.82 137.03 59.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 120.955 0.407 . . . . 0.0 110.397 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.4 ptm -115.22 142.01 47.25 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.141 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -103.19 -64.35 1.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.817 0.341 . . . . 0.0 110.468 -179.595 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.529 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.4 t70 -128.39 56.08 1.65 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 43.4 tttp 73.71 47.46 0.17 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 44' ' ' THR . 16.9 t -133.69 159.57 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.946 -179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.435 ' N ' HG12 ' A' ' 43' ' ' VAL . 28.1 m -121.75 113.83 20.24 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.915 0.388 . . . . 0.0 110.404 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -132.84 130.63 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.972 179.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.477 ' HZ2' HD12 ' A' ' 35' ' ' LEU . 52.5 tttp -92.2 136.29 33.3 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.98 179.271 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -136.25 96.36 12.63 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.098 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.77 146.6 76.89 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.343 2.029 . . . . 0.0 111.505 178.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.5 m -85.36 112.87 47.2 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.442 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.48 24.94 0.72 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.191 1.928 . . . . 0.0 111.052 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.55 155.96 37.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.68 -177.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -145.91 146.95 31.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.297 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.59 -132.38 2.56 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -129.37 148.41 51.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.694 0.283 . . . . 0.0 110.309 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mm -99.56 120.37 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.7 t -78.55 -50.93 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -172.84 154.25 2.87 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.312 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.582 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.7 tt -101.72 114.92 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.194 0.521 . . . . 0.0 110.331 179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.27 -41.61 89.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.771 -179.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.461 ' CG ' ' NE2' ' A' ' 64' ' ' GLN . 5.5 m-85 -139.72 150.21 44.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.279 -178.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -109.93 -166.53 1.1 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.896 0.379 . . . . 0.0 110.678 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -53.62 150.96 6.44 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.734 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.47 6.3 57.54 Favored Glycine 0 N--CA 1.474 1.231 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.461 ' NE2' ' CG ' ' A' ' 60' ' ' TYR . 49.7 tt0 -98.81 135.23 40.57 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 p -142.91 116.83 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 t -148.53 142.62 16.46 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.03 146.21 70.65 Favored 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.456 1.438 . . . . 0.0 112.162 177.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 68' ' ' VAL . 12.9 p -48.79 131.27 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.587 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.29 51.2 0.06 OUTLIER Glycine 0 CA--C 1.527 0.785 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.809 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.8 t -165.18 157.56 15.68 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.779 179.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.7 p -89.92 131.01 36.05 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.117 179.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.45 -15.63 24.09 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.543 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.815 HD23 ' H ' ' A' ' 74' ' ' GLN . 0.8 OUTLIER -171.32 145.73 2.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.014 -0.674 . . . . 0.0 110.746 -179.218 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.815 ' H ' HD23 ' A' ' 73' ' ' LEU . 56.7 mt-30 -104.7 127.59 52.52 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.1 mt -129.25 126.95 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.311 0.577 . . . . 0.0 111.784 -177.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -88.0 135.98 33.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.825 178.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.6 m . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.541 -179.986 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttp . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -76.83 143.29 39.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.62 136.65 54.3 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.795 0.331 . . . . 0.0 110.181 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.568 ' CE2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -104.14 118.46 36.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.721 179.753 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -118.52 134.85 54.76 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.42 -179.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.95 126.1 91.92 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.8 148.77 59.07 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.198 1.265 . . . . 0.0 112.192 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -78.74 112.08 15.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.19 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.8 pt -126.42 157.34 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.776 0.322 . . . . 0.0 110.577 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.61 -167.68 50.55 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -75.42 -101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.778 0.323 . . . . 0.0 110.579 -179.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.8 122.96 7.38 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.6 t -130.79 131.11 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.3 p -148.71 5.97 0.71 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.93 0.395 . . . . 0.0 110.852 -179.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -138.28 144.43 40.48 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.584 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.46 151.08 17.49 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.476 ' OE1' HG22 ' A' ' 65' ' ' VAL . 40.5 tp10 -153.39 128.29 9.56 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.265 0.533 . . . . 0.0 110.984 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.0 mm -102.22 119.75 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.36 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.5 m -93.55 -40.06 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.729 178.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -139.8 149.06 43.06 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.013 0.435 . . . . 0.0 111.836 -178.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -116.1 145.36 43.09 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.769 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 51.7 t0 -109.33 -6.6 15.44 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.461 179.076 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.25 159.54 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.87 0.367 . . . . 0.0 111.574 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -136.38 155.74 49.61 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.582 179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -66.07 141.91 57.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.514 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.3 7.72 86.26 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.556 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -118.18 143.46 46.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.31 0.555 . . . . 0.0 111.621 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 76.7 mtm -87.87 147.13 25.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.563 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.09 151.4 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.032 0.444 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 32' ' ' ASP . 93.9 mt-10 -112.05 154.9 24.68 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.442 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.05 80.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.562 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' GLU . 68.0 t0 -179.44 94.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.17 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.408 ' HB2' ' H ' ' A' ' 49' ' ' SER . 37.4 mt-30 -142.27 151.89 42.49 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.155 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 63.8 t0 -165.74 24.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.976 0.417 . . . . 0.0 110.206 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.7 mt -121.99 27.84 7.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.689 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.42 129.24 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.07 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.453 ' OE2' ' N ' ' A' ' 45' ' ' VAL . 3.8 tm-20 -127.13 128.33 46.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.611 -179.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.36 141.52 43.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.046 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 62.9 ttp -126.16 136.59 53.04 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 -72.55 0.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.833 0.349 . . . . 0.0 110.421 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -97.56 41.12 1.13 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.525 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 tttp 71.22 37.76 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.909 0.385 . . . . 0.0 110.402 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.5 t -127.17 134.68 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.5 m -96.64 116.66 29.48 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.142 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.453 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 34.3 m -133.27 132.64 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.052 0.453 . . . . 0.0 111.642 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -94.04 139.22 31.23 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.948 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mt -138.89 121.6 10.6 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 119.605 -0.235 . . . . 0.0 110.645 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.28 143.17 19.59 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.33 2.02 . . . . 0.0 112.081 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.408 ' H ' ' HB2' ' A' ' 33' ' ' GLN . 82.1 p -69.7 114.13 22.38 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.394 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.71 8.43 4.63 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.947 1.765 . . . . 0.0 113.553 179.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -140.3 157.32 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.157 0.503 . . . . 0.0 111.841 -177.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -143.32 149.79 38.28 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.734 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.87 -134.94 2.91 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.069 -0.813 . . . . 0.0 111.069 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -118.37 131.34 56.31 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 117.224 0.512 . . . . 0.0 109.986 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mm -94.57 118.71 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.2 t -97.03 -48.91 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -143.36 157.17 44.69 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -177.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.0 tt -125.32 122.01 61.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.573 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.8 mt -98.86 -17.42 18.43 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.62 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.524 ' CE1' HD23 ' A' ' 72' ' ' LEU . 9.5 m-85 -104.13 138.65 40.33 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.165 0.507 . . . . 0.0 111.288 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -122.05 166.29 14.73 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.077 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.87 130.48 44.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.979 0.418 . . . . 0.0 111.214 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.22 5.58 89.62 Favored Glycine 0 N--CA 1.467 0.755 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.882 179.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -79.22 140.49 37.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.979 0.419 . . . . 0.0 110.898 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.476 HG22 ' OE1' ' A' ' 17' ' ' GLU . 77.4 t -117.92 130.62 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.752 -179.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.5 t -148.96 138.15 12.39 Favored Pre-proline 0 N--CA 1.474 0.769 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.332 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -54.13 139.6 71.51 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.394 1.396 . . . . 0.0 112.069 177.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.9 t -65.14 131.84 30.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.45 51.05 0.13 Allowed Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.7 p -159.82 162.79 34.81 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 122.508 -0.407 . . . . 0.0 111.31 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 71' ' ' THR . 4.9 t -84.53 114.25 21.82 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.482 0.658 . . . . 0.0 109.953 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.568 HD12 ' CE2' ' A' ' 4' ' ' PHE . 94.9 mt -65.83 -42.16 90.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.487 -178.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.5 tt -143.77 146.85 33.42 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -177.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.471 ' N ' HD23 ' A' ' 73' ' ' LEU . 57.5 tt0 -101.74 123.51 45.84 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 93.5 mt -127.26 129.53 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.495 -177.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -100.33 111.16 23.41 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.62 179.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.222 -0.358 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.021 -179.721 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OE2' ' A' ' 3' ' ' GLU . 68.4 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -77.43 133.9 38.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.917 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.545 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 54.4 mp0 -109.83 128.64 55.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.206 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -92.64 117.32 29.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.432 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -119.7 147.16 44.91 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.014 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mt -67.9 113.7 16.19 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.493 ' O ' ' CB ' ' A' ' 8' ' ' ASP . 32.1 Cg_exo -56.63 145.67 80.26 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 120.985 1.124 . . . . 0.0 112.14 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 7' ' ' PRO . 22.1 t0 93.04 113.91 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.188 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.1 pt -123.7 154.98 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 110.519 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.02 -121.75 19.73 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -60.59 145.49 48.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.987 0.422 . . . . 0.0 110.589 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.25 -52.61 1.85 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 179.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.3 t -127.93 129.42 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.3 p -131.86 -11.36 3.41 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.461 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -164.77 144.13 7.07 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.505 -179.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -135.77 153.19 21.27 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -138.28 142.87 39.81 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.421 HG21 ' NE1' ' A' ' 21' ' ' TRP . 5.9 mm -102.82 121.39 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.876 0.369 . . . . 0.0 111.992 -178.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 20' ' ' ARG . 31.4 m -94.27 -40.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.492 179.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.423 ' N ' HG23 ' A' ' 19' ' ' VAL . 95.9 mtt-85 -139.6 146.79 40.24 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.421 ' NE1' HG21 ' A' ' 18' ' ' ILE . 19.0 m95 -119.45 140.79 49.87 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.618 179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 9.1 p-10 -114.87 5.52 15.16 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.324 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -135.24 156.72 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.513 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -142.52 149.09 38.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.406 0.622 . . . . 0.0 111.516 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -56.62 140.11 47.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.489 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.93 9.14 78.07 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 116.328 -0.396 . . . . 0.0 112.695 178.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 28' ' ' MET . 67.3 t0 -121.86 135.85 54.91 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.184 0.492 . . . . 0.0 111.705 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.531 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 62.9 ttp -94.2 127.54 40.11 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.456 179.027 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.8 p -129.82 136.88 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.203 0.525 . . . . 0.0 111.956 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 30' ' ' GLU . 56.5 mp0 -83.86 157.19 22.09 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.584 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 37.0 ttpt -81.45 130.54 35.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.72 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 52.7 t0 130.5 122.02 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 O-C-N 124.433 1.083 . . . . 0.0 110.19 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.447 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 60.8 tp60 58.29 103.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.458 178.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 33' ' ' GLN . 97.3 m-20 -143.08 141.18 31.2 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.1 tp -101.73 79.44 1.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.198 0.523 . . . . 0.0 111.441 -178.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.61 126.06 74.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -118.34 118.58 32.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.741 -179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 m -125.57 132.79 70.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.927 0.394 . . . . 0.0 110.26 -179.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 50.9 ttp -96.35 123.69 40.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.258 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 1.1 p -89.53 -64.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.729 -179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 40' ' ' THR . 68.3 t0 -137.57 60.14 1.65 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.246 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 35.5 tttp 74.69 21.89 2.09 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.51 139.59 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 m -94.69 115.74 27.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.794 0.33 . . . . 0.0 110.269 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 m -125.69 131.04 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.898 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -99.67 135.02 41.71 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -131.76 85.27 52.03 Favored Pre-proline 0 N--CA 1.471 0.6 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.844 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.459 ' O ' ' OG ' ' A' ' 49' ' ' SER . 91.2 Cg_endo -80.44 151.22 19.89 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.571 2.181 . . . . 0.0 113.201 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 48' ' ' PRO . 6.0 p 80.74 67.6 0.14 Allowed Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.08 37.85 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.857 2.372 . . . . 0.0 112.755 178.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 t 63.25 114.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.725 0.298 . . . . 0.0 111.24 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB3' ' N ' ' A' ' 31' ' ' LYS . 32.2 ptt180 -77.37 152.77 34.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.475 179.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.72 -140.36 6.04 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -112.17 129.76 56.14 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.37 0.585 . . . . 0.0 110.465 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.422 HG23 HD21 ' A' ' 73' ' ' LEU . 5.8 mm -93.9 119.89 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.1 t -93.31 -52.74 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -151.87 158.65 43.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.902 -177.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.7 tt -112.25 121.76 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.027 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.6 mt -99.3 -17.15 18.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.19 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.421 ' CZ ' HD23 ' A' ' 72' ' ' LEU . 11.1 m-85 -109.25 143.35 38.83 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.062 0.458 . . . . 0.0 111.004 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 -120.58 164.42 16.5 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.084 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.38 127.09 30.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.171 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.2 5.4 89.02 Favored Glycine 0 N--CA 1.468 0.785 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 178.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -76.7 136.53 39.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.648 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.74 132.92 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.698 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.78 140.68 14.56 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.777 -178.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.03 147.17 76.56 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.265 1.31 . . . . 0.0 110.596 176.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.9 p -66.02 126.67 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.246 0.546 . . . . 0.0 110.997 -179.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 146.0 48.56 0.03 OUTLIER Glycine 0 CA--C 1.531 1.061 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.388 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.0 p -164.97 166.41 19.41 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.268 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 71' ' ' THR . 6.6 t -88.98 117.43 27.98 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.776 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.495 HD12 ' CE2' ' A' ' 4' ' ' PHE . 95.9 mt -63.46 -43.36 97.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.277 0.561 . . . . 0.0 110.428 -179.29 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 74' ' ' GLN . 3.8 tt -145.99 146.32 30.96 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.462 ' N ' HD23 ' A' ' 73' ' ' LEU . 37.4 tp60 -101.91 124.89 48.31 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.2 mt -127.2 127.3 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.223 -178.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -87.52 142.54 27.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.46 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.216 -179.886 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 75' ' ' ILE . 24.1 t80 -74.72 131.88 41.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 43.1 mp0 -95.95 125.9 40.82 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.697 -179.149 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -94.71 109.24 21.2 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -106.19 150.22 26.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.078 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.45 116.37 39.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.89 147.37 43.86 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.774 1.649 . . . . 0.0 112.985 -178.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -86.37 18.41 3.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.921 -179.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.53 -23.34 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.949 0.404 . . . . 0.0 110.085 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.98 168.28 19.69 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -179.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.66 -39.64 85.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.37 . . . . 0.0 110.404 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -173.87 154.82 20.58 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.8 t -153.06 89.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.03 0.443 . . . . 0.0 110.448 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 m -65.19 -31.7 73.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.992 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -164.4 153.88 13.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.85 111.43 4.23 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -118.38 125.01 49.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.069 0.461 . . . . 0.0 110.088 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.452 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.1 mm -102.41 120.35 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.232 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -107.92 -25.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -141.72 129.96 22.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.03 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.452 ' NE1' HG21 ' A' ' 18' ' ' ILE . 46.5 m95 -112.44 139.59 47.88 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 17.8 p-10 -111.49 2.09 17.27 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.54 HG11 ' NE2' ' A' ' 33' ' ' GLN . 33.3 m -135.5 161.23 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.81 0.338 . . . . 0.0 110.696 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.46 153.02 50.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.046 -178.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -52.74 140.76 22.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.376 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.71 8.33 76.89 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.374 177.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 41.7 p-10 -113.98 150.01 34.48 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.822 0.811 . . . . 0.0 110.691 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.6 mtm -97.63 149.63 22.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.284 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -145.16 140.12 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.906 0.384 . . . . 0.0 111.118 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 32' ' ' ASP . 95.7 mt-10 -87.03 163.93 16.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.869 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' N ' ' HB3' ' A' ' 52' ' ' ARG . 88.9 tttt -58.36 74.65 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.235 0.541 . . . . 0.0 110.435 -179.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 30' ' ' GLU . 11.5 p-10 170.07 78.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB2' ' H ' ' A' ' 49' ' ' SER . 18.1 tp60 -46.98 167.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.35 -179.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.432 ' O ' ' CB ' ' A' ' 35' ' ' LEU . 99.0 m-20 -87.77 -34.48 18.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.529 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 0.9 OUTLIER 159.62 106.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.784 0.678 . . . . 0.0 110.734 179.511 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.62 131.73 69.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -117.98 123.3 45.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.989 0.424 . . . . 0.0 111.459 -178.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.74 128.49 71.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.503 ' SD ' ' N ' ' A' ' 41' ' ' ASP . 10.6 tmm? -133.48 127.82 34.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.564 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 40' ' ' THR . 0.3 OUTLIER -70.5 -46.23 64.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.773 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.503 ' N ' ' SD ' ' A' ' 39' ' ' MET . 24.5 p-10 -152.47 -54.73 0.12 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.551 -179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.423 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 59.8 pttt -145.74 42.07 1.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.148 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.473 ' H ' ' HG2' ' A' ' 39' ' ' MET . 46.5 t -137.83 137.91 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.168 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -103.33 119.24 38.51 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.89 119.02 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.756 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -98.53 112.9 24.79 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 mt -129.99 109.78 16.89 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.63 147.66 17.61 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.37 2.047 . . . . 0.0 111.744 179.11 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.555 ' H ' ' HB2' ' A' ' 33' ' ' GLN . 6.9 t -58.39 120.39 43.94 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 119.73 -0.176 . . . . 0.0 111.17 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.96 -3.05 13.35 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 122.088 1.859 . . . . 0.0 114.218 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.23 125.45 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.027 0.376 . . . . 0.0 110.927 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HB3' ' N ' ' A' ' 31' ' ' LYS . 40.2 ptt180 -97.04 153.54 17.86 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.634 0.254 . . . . 0.0 111.037 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.89 -129.71 1.75 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.612 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -126.76 133.59 50.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.708 0.289 . . . . 0.0 110.408 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 mm -86.74 123.59 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 t -82.94 -52.17 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.679 -178.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -164.25 158.88 19.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.801 -178.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 58' ' ' ILE . 3.2 tt -91.14 114.54 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.281 0.562 . . . . 0.0 110.481 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -90.94 -24.36 20.18 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -113.2 140.21 48.13 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.284 0.564 . . . . 0.0 111.154 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.565 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 86.8 mtm-85 -114.42 166.52 11.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.636 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -62.16 129.34 40.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.861 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.57 5.26 69.38 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.808 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.565 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 78.5 mt-30 -80.99 134.68 35.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.616 0.708 . . . . 0.0 111.174 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.95 124.07 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.465 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 t -147.29 138.61 13.27 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 -179.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -55.07 148.81 46.61 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.138 1.225 . . . . 0.0 111.809 179.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.8 p -59.27 129.68 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.169 0.509 . . . . 0.0 111.112 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.09 49.16 0.09 OUTLIER Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.068 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.9 p -159.84 163.78 34.15 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 117.299 0.549 . . . . 0.0 110.846 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 71' ' ' THR . 8.5 t -86.75 114.21 23.24 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.261 0.553 . . . . 0.0 110.391 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -65.55 -41.4 93.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.442 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -152.37 153.99 34.72 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.616 ' H ' HD12 ' A' ' 73' ' ' LEU . 50.7 tt0 -103.11 129.4 49.95 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.171 0.51 . . . . 0.0 110.992 -178.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 2' ' ' TYR . 89.7 mt -128.7 129.15 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.665 -178.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -96.24 114.44 26.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.699 178.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.665 179.904 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -95.71 142.74 27.64 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -118.55 135.6 54.32 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.951 0.405 . . . . 0.0 110.638 -179.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -88.7 116.31 26.87 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.096 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -116.87 132.01 56.81 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.888 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.94 115.69 42.86 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.729 179.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.36 153.0 27.25 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.314 1.343 . . . . 0.0 111.977 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -87.16 85.78 7.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.614 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.2 mt -68.37 -42.97 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.101 179.226 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.19 137.13 13.18 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.475 ' OE1' ' N ' ' A' ' 11' ' ' GLU . 56.8 mp0 -82.19 147.52 28.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.633 0.254 . . . . 0.0 110.617 179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.02 21.28 65.85 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 50.2 t -126.66 133.09 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.1 p -148.55 80.13 1.44 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.937 0.398 . . . . 0.0 110.612 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -169.36 144.21 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.015 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.77 123.18 3.42 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -134.89 139.85 45.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.975 0.417 . . . . 0.0 110.174 179.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.43 119.02 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.554 -179.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.3 p -92.27 -41.98 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' N ' HG13 ' A' ' 19' ' ' VAL . 77.7 ttt180 -144.83 138.47 27.07 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -110.86 140.19 45.52 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 34' ' ' ASP . 4.4 p30 -108.02 -4.05 18.18 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.1 m -140.01 162.69 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.959 0.409 . . . . 0.0 111.383 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.2 151.91 35.9 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.842 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -61.06 138.37 58.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.883 0.373 . . . . 0.0 111.219 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.78 64.21 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.682 179.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 41.9 p-10 -117.73 152.22 35.69 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.399 0.6 . . . . 0.0 111.021 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -81.35 151.22 28.09 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.041 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -140.28 140.32 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.195 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -95.76 152.41 18.49 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.723 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HB2' ' H ' ' A' ' 52' ' ' ARG . 64.2 tttm -82.04 89.39 6.43 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.343 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 33' ' ' GLN . 62.6 t0 -176.3 78.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.188 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 32' ' ' ASP . 4.7 tp-100 37.08 93.02 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.047 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 31.8 t0 -90.17 15.33 10.49 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.0 mt 62.19 66.84 0.77 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.398 -179.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.57 130.25 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -110.15 123.38 49.62 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.332 0.587 . . . . 0.0 110.647 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 m -124.23 137.62 56.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.886 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 39' ' ' MET . 3.4 ppp? -121.92 147.44 46.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.148 0.499 . . . . 0.0 110.837 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -109.41 -59.41 1.91 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.415 -179.542 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.517 ' N ' ' OG1' ' A' ' 40' ' ' THR . 55.7 t0 -135.95 68.55 1.44 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.96 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 62.67 38.83 11.78 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -178.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.9 t -126.71 138.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.074 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.0 m -114.86 116.11 28.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.213 0.53 . . . . 0.0 110.758 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.71 157.81 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.431 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -100.72 136.16 41.03 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.925 179.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 47' ' ' ILE . 12.5 tt -127.26 135.11 26.93 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.446 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 49' ' ' SER . 33.9 Cg_exo -54.69 144.32 65.47 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 121.516 1.477 . . . . 0.0 112.226 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -41.32 164.46 0.09 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.649 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -81.45 47.12 2.44 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.772 2.315 . . . . 0.0 113.45 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 t 67.04 117.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.922 0.391 . . . . 0.0 111.417 179.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.473 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 73.7 ttt-85 -48.25 135.68 13.13 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.425 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.16 -145.45 8.11 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -118.51 133.91 55.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.033 0.417 . . . . 0.0 110.182 -179.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -95.05 121.38 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 t -81.63 -51.18 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -164.55 155.61 15.15 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.437 -178.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.7 tt -90.51 118.27 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.584 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -93.86 -18.24 22.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.716 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -119.08 140.58 49.84 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.089 0.471 . . . . 0.0 110.909 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -115.97 167.32 11.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.234 0.54 . . . . 0.0 111.523 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -62.57 132.65 53.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.902 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.01 3.38 90.59 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.6 tp60 -80.63 134.49 35.9 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.308 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.76 131.47 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.761 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.9 t -146.62 139.09 13.97 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.526 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.68 149.04 25.97 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.387 1.391 . . . . 0.0 111.626 178.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.7 p -59.35 133.61 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.723 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.46 48.03 0.12 Allowed Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.1 p -162.63 165.08 26.26 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 117.43 0.615 . . . . 0.0 111.367 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 71' ' ' THR . 14.7 t -96.95 118.16 32.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.985 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.052 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -66.26 -36.13 82.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.919 -179.188 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.69 HD12 ' H ' ' A' ' 74' ' ' GLN . 2.1 tp -151.18 149.97 30.07 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.69 ' H ' HD12 ' A' ' 73' ' ' LEU . 3.7 tm0? -103.78 131.97 50.47 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 -179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.5 mt -130.17 129.24 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.138 0.494 . . . . 0.0 111.958 -178.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -97.11 117.2 30.77 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.985 178.287 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.679 -179.527 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mmm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -74.39 130.38 39.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.131 -179.131 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 42.9 mp0 -102.51 125.19 49.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.174 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -86.4 116.26 24.44 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.28 147.27 49.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.791 -179.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 6' ' ' LEU . 4.8 tt -75.68 111.51 14.83 Favored Pre-proline 0 N--CA 1.471 0.604 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.001 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.438 ' N ' HD23 ' A' ' 6' ' ' LEU . 33.2 Cg_exo -58.36 143.46 97.49 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 CA-C-N 120.492 1.212 . . . . 0.0 112.388 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -77.55 22.14 0.26 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.598 179.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 7' ' ' PRO . 79.9 mt -112.1 131.18 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.946 0.403 . . . . 0.0 110.14 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 12' ' ' GLY . . . 163.55 -164.82 36.47 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 11' ' ' GLU . 58.0 mp0 -75.67 37.9 0.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.595 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 89.23 97.34 1.05 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.65 120.42 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.629 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.6 p -131.2 -2.89 3.94 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -141.32 143.73 34.21 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.806 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.55 133.38 8.88 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -140.03 133.07 29.48 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.973 0.416 . . . . 0.0 109.892 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.427 HG21 ' NE1' ' A' ' 21' ' ' TRP . 5.7 mm -102.81 119.62 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.879 -178.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 p -98.8 -37.37 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.03 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -141.01 133.43 28.36 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.427 ' NE1' HG21 ' A' ' 18' ' ' ILE . 33.5 m95 -110.55 144.85 38.79 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.08 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -128.65 19.91 6.13 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.094 0.407 . . . . 0.0 111.275 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.53 155.41 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -128.16 145.13 51.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.038 0.447 . . . . 0.0 110.512 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.79 137.86 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.054 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.56 7.75 71.53 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.133 179.452 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -116.73 147.82 41.67 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.121 0.461 . . . . 0.0 111.103 -179.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.4 mmm -84.37 147.71 27.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -133.4 133.98 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.252 179.019 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -91.61 158.31 16.49 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.193 -179.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.78 137.67 57.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.51 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.408 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 94.3 m-20 60.57 37.07 19.68 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.543 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 32' ' ' ASP . 99.4 mm-40 -143.44 86.78 1.91 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -174.36 162.73 3.63 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -134.06 89.74 2.61 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.233 0.539 . . . . 0.0 109.825 178.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.54 130.94 70.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.175 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.9 119.89 37.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.891 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.1 m -117.33 133.17 64.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.068 0.461 . . . . 0.0 109.975 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.0 ttp -113.55 132.57 55.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.321 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -116.77 -88.71 0.59 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.658 -179.663 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.601 ' H ' HG23 ' A' ' 40' ' ' THR . 23.2 p-10 -90.06 50.72 1.91 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.214 179.67 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 62.22 43.79 8.22 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 110.871 -179.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 44' ' ' THR . 35.3 t -131.7 158.25 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.735 178.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.48 ' N ' HG12 ' A' ' 43' ' ' VAL . 5.6 m -111.28 116.17 30.56 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.095 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.34 135.33 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.958 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -101.23 134.7 43.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.949 0.404 . . . . 0.0 110.808 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.8 mt -136.54 87.72 20.97 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.696 179.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.55 145.66 94.05 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 122.85 2.366 . . . . 0.0 112.543 179.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 52.9 m -51.65 108.41 1.06 Allowed Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.329 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.23 -14.72 28.6 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.461 1.441 . . . . 0.0 114.638 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.5 126.0 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 118.511 0.596 . . . . 0.0 111.228 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -92.01 150.44 20.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.574 0.226 . . . . 0.0 110.714 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.26 -134.33 2.89 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -119.29 147.26 44.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.944 0.372 . . . . 0.0 110.38 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mm -103.91 119.29 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.9 t -77.76 -52.92 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.874 -179.018 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -169.24 154.85 6.1 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.158 -178.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.1 tt -81.77 115.75 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.292 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.4 mt -93.99 -19.23 21.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.653 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -117.58 143.07 46.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.239 0.543 . . . . 0.0 111.192 -179.681 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -112.13 163.37 14.4 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.752 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.65 139.78 58.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.504 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.08 5.33 89.66 Favored Glycine 0 N--CA 1.468 0.79 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.86 179.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -79.01 133.63 36.82 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.227 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.45 127.75 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.18 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 t -149.35 136.19 10.75 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.45 148.97 69.01 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 121.615 1.543 . . . . 0.0 112.17 177.046 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -48.48 147.73 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.734 179.64 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 113.11 47.98 0.63 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.503 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.5 p -162.02 163.16 28.99 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.634 179.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.619 ' O ' HG23 ' A' ' 71' ' ' THR . 15.0 t -103.1 118.96 37.98 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.097 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.035 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -66.86 -35.75 80.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.891 -179.678 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.648 HD12 ' H ' ' A' ' 74' ' ' GLN . 1.8 tp -149.98 149.47 30.43 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.648 ' H ' HD12 ' A' ' 73' ' ' LEU . 57.9 tt0 -104.03 131.81 50.91 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.709 0.29 . . . . 0.0 110.793 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 87.5 mt -127.37 128.74 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.388 0.613 . . . . 0.0 112.036 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -94.54 140.93 29.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.915 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.472 179.389 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.8 mtm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -116.38 147.16 41.91 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.13 134.12 47.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -93.94 118.04 30.93 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.542 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -125.98 145.52 50.25 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tp -82.29 113.75 46.21 Favored Pre-proline 0 N--CA 1.474 0.729 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.74 149.75 30.18 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.841 1.694 . . . . 0.0 112.963 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 12' ' ' GLY . 53.2 m-20 -63.51 -33.18 75.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.984 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.7 pt -93.0 116.91 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 121.789 -0.57 . . . . 0.0 110.815 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 12' ' ' GLY . . . 60.03 152.17 0.01 OUTLIER Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 54.37 5.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.517 0.199 . . . . 0.0 111.206 179.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 177.01 162.21 27.06 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 14' ' ' THR . 61.3 t -150.06 -97.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.477 0.179 . . . . 0.0 110.562 179.43 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.429 ' N ' HG12 ' A' ' 13' ' ' VAL . 19.9 p -121.48 7.85 10.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.083 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -152.18 150.18 29.56 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.045 0.45 . . . . 0.0 111.321 -179.408 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.67 110.51 0.93 Allowed Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' OE1' ' CE ' ' A' ' 39' ' ' MET . 79.1 tt0 -115.81 129.59 56.5 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 ' HE1' ' A' ' 21' ' ' TRP . 18.0 mm -102.17 119.62 50.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.329 -178.152 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.8 m -109.37 -38.83 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -138.22 148.94 45.31 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.544 ' HE1' HG21 ' A' ' 18' ' ' ILE . 79.5 m95 -132.98 141.42 48.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.641 -1.163 . . . . 0.0 107.919 177.436 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -128.46 16.45 6.53 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.41 160.8 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.98 143.47 51.28 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.826 0.346 . . . . 0.0 110.812 -179.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -61.26 140.55 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.162 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.21 7.19 77.29 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.889 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -118.41 149.54 41.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.975 0.417 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 78.0 mtm -81.95 151.15 27.33 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.908 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -135.47 145.64 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.965 179.334 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -110.49 132.13 54.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.587 -179.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 32' ' ' ASP . 64.4 tttm -52.83 137.48 31.8 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.561 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 3.7 m-20 83.61 -11.7 0.88 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.408 0.442 . . . . 0.0 111.795 179.457 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -115.43 76.78 1.03 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.572 0.225 . . . . 0.0 110.42 179.229 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 57.2 t0 -176.66 137.73 0.27 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.245 179.559 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.477 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 81.2 mt -119.45 108.25 14.31 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.558 0.694 . . . . 0.0 110.598 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.21 133.1 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.631 179.576 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.462 ' OE2' ' CG2' ' A' ' 44' ' ' THR . 44.2 tt0 -116.57 120.0 37.33 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 110.397 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.21 140.85 46.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.539 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.444 ' CE ' ' OE1' ' A' ' 17' ' ' GLU . 66.0 ttp -124.71 144.46 50.21 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.832 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -129.18 -85.96 0.55 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.952 179.355 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.485 ' H ' HG23 ' A' ' 40' ' ' THR . 67.3 t0 -82.86 47.01 1.15 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.801 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 61.8 38.88 14.52 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.335 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.26 135.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.462 ' CG2' ' OE2' ' A' ' 37' ' ' GLU . 6.9 m -95.61 119.38 34.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.121 -179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.52 153.88 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 110.734 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -119.26 133.49 55.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.773 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.4 mt -125.63 137.97 30.99 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.088 -179.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 49' ' ' SER . 31.2 Cg_exo -52.49 153.97 12.72 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 121.54 1.493 . . . . 0.0 111.557 178.159 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -38.33 164.39 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.952 0.406 . . . . 0.0 111.304 -179.514 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.1 49.07 3.1 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.946 2.431 . . . . 0.0 113.669 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 t 69.93 117.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 120.889 0.376 . . . . 0.0 111.693 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -46.81 135.84 8.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.2 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.5 -143.41 7.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.26 144.76 48.44 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.084 0.442 . . . . 0.0 110.545 179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 mm -102.02 121.57 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.1 t -80.25 -52.14 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.54 -179.024 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -167.54 156.99 10.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.932 -179.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.463 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 2.6 tt -85.87 116.37 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.085 0.469 . . . . 0.0 110.398 -179.688 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.71 -29.68 22.24 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.8 -179.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.459 ' OH ' ' CB ' ' A' ' 70' ' ' SER . 15.4 m-85 -119.15 145.8 45.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.072 0.463 . . . . 0.0 111.387 -179.649 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -126.62 172.54 10.18 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.962 179.308 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.5 145.92 55.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.407 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.99 6.13 82.54 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.761 178.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -100.41 124.4 45.87 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.46 0.648 . . . . 0.0 112.059 -179.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 p -125.01 126.74 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.515 178.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 t -148.67 140.54 14.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.555 -177.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.09 148.45 48.61 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 121.164 1.242 . . . . 0.0 111.325 177.045 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.29 130.33 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 0.0 111.127 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.72 52.86 0.07 OUTLIER Glycine 0 CA--C 1.528 0.863 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.921 179.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.459 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 8.5 m -156.54 164.57 38.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.195 0.498 . . . . 0.0 111.077 179.608 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 p -96.07 111.85 23.75 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.56 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 72' ' ' LEU . 5.8 mp -64.01 -41.03 97.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.357 179.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 74' ' ' GLN . 2.3 tp -162.45 146.26 11.73 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.138 -178.614 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.633 ' N ' HD12 ' A' ' 73' ' ' LEU . 3.2 tm0? -103.09 130.54 50.26 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.921 0.391 . . . . 0.0 110.741 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.2 mt -128.2 128.92 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.301 0.572 . . . . 0.0 111.923 -178.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -95.82 139.98 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.686 178.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.42 ' H ' HG22 ' A' ' 77' ' ' THR . 1.3 t . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.439 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -80.16 148.08 31.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.824 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.79 118.92 29.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 -179.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE2' HD12 ' A' ' 72' ' ' LEU . 3.4 t80 -83.37 104.28 13.4 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -102.34 148.22 25.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.477 -179.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.38 117.32 59.48 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.288 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.23 157.6 33.55 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.939 1.76 . . . . 0.0 111.597 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -72.65 78.54 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.257 0.551 . . . . 0.0 110.159 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.73 -43.24 97.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.116 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.21 155.29 20.63 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -67.45 -37.98 83.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.151 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.11 114.74 1.71 Allowed Glycine 0 N--CA 1.464 0.507 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.8 t -131.09 133.29 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.3 p -89.17 -64.17 1.18 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.286 179.71 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.403 ' N ' ' OE1' ' A' ' 15' ' ' GLU . 43.9 mp0 -142.22 156.79 45.33 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.237 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.01 162.62 26.3 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -155.11 135.97 13.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.199 0.5 . . . . 0.0 110.55 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.413 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.3 mm -102.64 121.44 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.484 -179.781 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 20' ' ' ARG . 12.6 p -91.72 -44.53 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.407 -179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.49 ' N ' HG13 ' A' ' 19' ' ' VAL . 61.2 ttp180 -140.86 138.53 34.02 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.054 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.413 ' NE1' HG21 ' A' ' 18' ' ' ILE . 30.0 m95 -112.45 141.57 46.03 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD2' ' OD1' ' A' ' 34' ' ' ASP . 15.4 p-10 -125.59 18.43 8.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.13 0.423 . . . . 0.0 111.555 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.79 156.24 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.86 139.9 51.94 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.771 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.49 140.93 53.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.045 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.78 5.71 68.31 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.821 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 28' ' ' MET . 43.9 t0 -110.11 -174.39 2.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 117.02 0.41 . . . . 0.0 110.676 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.511 ' H ' ' CG ' ' A' ' 27' ' ' ASP . 94.9 mtp -120.22 151.95 38.42 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 30' ' ' GLU . 13.0 t -128.63 161.26 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.436 ' N ' HG12 ' A' ' 29' ' ' VAL . 80.8 mm-40 -130.85 156.01 45.75 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.684 -179.402 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -65.73 140.37 58.44 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.382 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 59.62 32.44 21.55 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.437 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -147.43 87.67 1.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.312 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' OD2' ' A' ' 22' ' ' ASP . 65.8 t0 -171.83 130.33 0.66 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.258 -178.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.5 mt -108.93 84.01 1.85 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.423 0.63 . . . . 0.0 110.34 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.48 132.83 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.494 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -111.1 116.54 31.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.635 179.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 m -113.25 131.99 63.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 110.568 -179.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.8 ttp -111.18 112.68 24.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.268 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.461 ' H ' HG23 ' A' ' 40' ' ' THR . 1.1 p -63.0 -47.87 81.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.175 0.512 . . . . 0.0 110.001 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -149.56 -68.1 0.21 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.67 -179.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -138.64 35.23 2.22 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.264 179.503 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.36 137.58 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 m -103.47 118.0 35.73 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.12 156.85 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.24 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -99.71 138.34 36.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.177 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 47' ' ' ILE . 19.8 tt -133.48 113.95 13.27 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.484 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.29 142.98 17.16 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.003 1.802 . . . . 0.0 112.289 -179.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.0 p -58.38 109.46 1.85 Allowed Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.15 -23.13 39.86 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.057 1.172 . . . . 0.0 114.705 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.99 127.46 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.253 0.479 . . . . 0.0 111.34 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -92.86 148.82 21.7 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.672 0.272 . . . . 0.0 110.849 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.11 -131.48 1.7 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.9 146.87 49.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.015 0.408 . . . . 0.0 110.448 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.9 mm -103.58 119.89 52.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.139 -179.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 t -79.28 -52.42 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.908 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -163.68 158.39 20.36 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.167 -179.203 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 58' ' ' ILE . 3.5 tt -88.73 118.28 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.054 0.454 . . . . 0.0 111.253 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.4 mt -96.92 -17.87 19.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.167 179.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.412 ' CE2' HD23 ' A' ' 72' ' ' LEU . 3.8 m-85 -113.24 146.61 39.05 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.018 0.437 . . . . 0.0 110.586 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -124.08 160.88 26.76 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.816 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.79 138.03 58.15 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.03 5.35 90.2 Favored Glycine 0 N--CA 1.467 0.735 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.543 178.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -75.69 129.18 36.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.209 0.528 . . . . 0.0 111.174 -179.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.9 t -119.7 127.64 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.31 154.92 36.67 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.499 -178.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.25 145.7 55.03 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.84 2.36 . . . . 0.0 112.238 179.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -55.4 130.42 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.193 0.521 . . . . 0.0 110.421 179.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.13 55.49 0.25 Allowed Glycine 0 N--CA 1.467 0.736 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -149.71 173.18 13.98 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.18 0.514 . . . . 0.0 111.07 -179.656 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -102.05 114.29 28.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.935 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.451 HD12 ' CE2' ' A' ' 4' ' ' PHE . 95.1 mt -67.68 -47.46 69.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.914 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.701 HD12 ' H ' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -159.01 159.4 34.73 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.806 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.701 ' H ' HD12 ' A' ' 73' ' ' LEU . 51.3 tt0 -104.5 127.91 52.31 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.834 0.349 . . . . 0.0 111.412 -178.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.6 mt -128.86 128.73 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.189 0.519 . . . . 0.0 111.757 -179.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -100.05 119.05 37.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.359 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.819 -179.832 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' OE2' ' A' ' 3' ' ' GLU . 99.3 mtp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -80.99 131.45 35.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 56.0 mp0 -113.52 123.78 50.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -95.85 122.16 38.34 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -128.72 129.46 45.79 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.973 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 tp -45.62 105.9 0.51 Allowed Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.0 145.41 85.8 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.351 1.367 . . . . 0.0 111.989 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 10' ' ' GLY . 38.5 p-10 -69.59 -2.61 11.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.707 -179.398 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 9' ' ' ILE . 95.7 mt 52.85 3.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.581 0.229 . . . . 0.0 111.184 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 8' ' ' ASP . . . 76.54 23.45 70.28 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.293 178.582 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -146.71 157.07 43.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.915 0.357 . . . . 0.0 110.34 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.95 135.79 32.59 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.49 130.24 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.806 0.336 . . . . 0.0 110.61 -179.468 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 p -76.13 -46.86 26.68 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.442 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -170.26 156.27 5.69 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.846 179.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.85 154.18 17.07 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -141.05 140.72 34.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.968 0.413 . . . . 0.0 110.096 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.468 HG21 ' NE1' ' A' ' 21' ' ' TRP . 7.4 mm -102.64 124.25 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.992 -178.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.45 -44.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.91 142.71 40.62 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -178.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.468 ' NE1' HG21 ' A' ' 18' ' ' ILE . 63.1 m95 -121.2 135.83 55.08 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.179 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER -106.99 -3.8 19.71 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.686 0.279 . . . . 0.0 111.186 179.053 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.08 159.17 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -144.99 161.12 40.18 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.065 0.46 . . . . 0.0 111.53 -178.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -56.78 139.78 49.84 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.371 -179.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.76 8.05 62.41 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.28 -0.486 . . . . 0.0 112.943 178.286 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -128.02 155.01 44.99 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 117.543 0.672 . . . . 0.0 111.837 -179.307 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.0 mtp -88.75 154.62 20.13 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.016 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -134.64 150.84 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.007 0.432 . . . . 0.0 110.624 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -111.63 159.66 17.97 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.147 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -71.43 87.79 0.88 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.034 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 34' ' ' ASP . 38.0 t0 -174.46 159.71 3.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.663 178.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -44.78 95.5 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.553 179.695 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' ASP . 79.4 m-20 -72.33 -3.65 25.16 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.588 0.709 . . . . 0.0 109.131 179.488 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.412 ' O ' ' CG ' ' A' ' 22' ' ' ASP . 35.6 tp 60.79 80.48 0.21 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.337 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.11 131.81 70.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.268 178.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -111.26 121.75 46.08 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.179 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.52 138.23 54.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.741 -178.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.405 ' HG3' ' H ' ' A' ' 43' ' ' VAL . 52.0 ttp -103.82 108.98 20.53 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.27 -46.14 74.55 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.246 -0.581 . . . . 0.0 110.903 -179.221 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 42' ' ' LYS . 18.9 p-10 -139.69 -63.83 0.5 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.156 -179.588 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.504 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 64.9 mttp -150.96 45.2 0.83 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.921 0.391 . . . . 0.0 110.624 179.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' H ' ' HG3' ' A' ' 39' ' ' MET . 7.4 p -158.71 146.01 7.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.311 178.747 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 m -98.84 120.94 40.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.274 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.47 156.53 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.64 135.47 52.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.902 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.9 mt -127.11 112.63 21.69 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.891 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.46 150.95 39.87 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.33 1.353 . . . . 0.0 110.954 178.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.7 m -104.29 97.72 12.48 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -88.12 41.97 0.69 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.675 2.25 . . . . 0.0 111.576 178.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.3 m -129.76 156.55 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.812 0.339 . . . . 0.0 111.508 -177.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.485 ' CD ' ' N ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -151.12 148.06 27.82 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.469 179.874 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 156.55 -137.52 5.5 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -131.14 147.53 52.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.969 0.414 . . . . 0.0 110.7 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 mm -97.88 118.07 43.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.15 -47.5 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -152.55 157.01 40.45 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -177.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 58' ' ' ILE . 19.9 tt -131.68 126.06 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.256 178.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.3 mt -104.46 -15.48 15.36 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.98 -178.359 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.536 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 8.5 m-85 -108.71 144.03 37.04 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.281 0.563 . . . . 0.0 111.581 -178.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.487 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 84.9 mtt85 -131.39 166.25 21.69 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.149 179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.58 138.66 51.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.581 -179.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.35 5.33 67.43 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.117 178.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 61' ' ' ARG . 34.9 mt-30 -96.11 131.26 42.73 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.234 0.54 . . . . 0.0 111.505 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.72 127.91 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 t -147.02 140.44 14.97 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -55.23 146.31 61.13 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.154 1.236 . . . . 0.0 111.275 177.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 68' ' ' VAL . 1.6 p -62.66 129.49 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.204 0.526 . . . . 0.0 110.811 -179.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.69 51.18 0.06 OUTLIER Glycine 0 CA--C 1.53 1.03 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.595 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 p -160.55 162.23 32.87 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 122.424 -0.456 . . . . 0.0 111.25 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.6 p -92.75 116.8 29.35 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.314 179.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.4 mm? -83.72 -18.23 38.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.589 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.55 144.16 4.27 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.05 -178.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -106.81 119.49 39.47 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 176.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.3 mt -126.79 127.54 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.267 0.556 . . . . 0.0 112.156 -177.031 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -85.15 145.68 27.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.738 179.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.537 179.785 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -110.98 142.48 43.05 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.32 130.83 55.58 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -96.0 118.67 33.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.06 0.457 . . . . 0.0 110.116 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -122.34 138.79 54.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.891 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 tp -64.1 115.25 17.86 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.05 158.89 41.77 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.967 1.778 . . . . 0.0 112.41 -178.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -87.17 108.35 18.87 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.137 -179.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.7 mt -65.15 -41.88 92.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.075 0.464 . . . . 0.0 109.755 179.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 8.13 31.73 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -64.75 -37.71 88.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.706 0.289 . . . . 0.0 110.364 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' VAL . . . 164.73 -43.32 0.3 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER 57.42 145.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.251 0.548 . . . . 0.0 110.987 179.648 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.6 p -151.44 -36.0 0.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.598 179.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -173.48 159.23 3.62 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.946 179.054 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.19 119.2 6.21 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -134.25 138.2 44.88 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.34 0.57 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.45 HG21 ' NE1' ' A' ' 21' ' ' TRP . 7.4 mm -103.45 121.8 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.749 -179.382 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -102.59 -40.75 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -138.69 147.93 43.37 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -177.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.45 ' NE1' HG21 ' A' ' 18' ' ' ILE . 54.4 m95 -128.2 141.58 51.42 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 54.9 t0 -125.46 22.65 7.66 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.79 0.329 . . . . 0.0 111.076 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.0 156.08 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.2 135.33 55.16 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -58.69 138.2 57.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.994 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.46 6.8 76.99 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -114.79 156.48 24.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.716 0.293 . . . . 0.0 110.402 179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.6 mtt -80.34 148.15 30.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.719 -179.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.4 t -121.36 135.42 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.458 -178.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -109.56 137.6 47.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 110.763 179.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.569 ' H ' ' HE ' ' A' ' 52' ' ' ARG . 37.1 ttmt -68.08 137.64 55.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 -179.276 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 31' ' ' LYS . 6.6 t0 84.73 -11.78 0.78 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.585 179.732 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -118.87 82.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.654 0.264 . . . . 0.0 110.478 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 35' ' ' LEU . 67.5 t0 -169.81 139.22 1.91 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.831 0.348 . . . . 0.0 110.423 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.526 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 69.4 mt -113.31 89.2 3.02 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.285 0.564 . . . . 0.0 109.919 179.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.64 130.92 71.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.43 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -121.29 126.36 49.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.821 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.93 149.88 32.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.489 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 60.9 ttp -118.41 134.86 54.72 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.384 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -110.99 -58.91 2.04 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.49 -179.58 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.482 ' N ' ' OG1' ' A' ' 40' ' ' THR . 51.9 p-10 -131.49 61.63 1.64 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.081 -179.41 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt 61.02 33.96 19.46 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 121.208 0.527 . . . . 0.0 110.119 -178.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.8 t -127.51 136.36 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.32 179.228 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.9 m -106.67 120.33 41.69 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.831 0.348 . . . . 0.0 110.139 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.89 156.59 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 121.244 0.545 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.55 135.74 53.74 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.31 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.41 155.59 77.02 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.218 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 49' ' ' SER . 31.5 Cg_exo -57.75 146.68 84.44 Favored 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 121.866 1.711 . . . . 0.0 112.168 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -40.6 166.15 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.921 179.665 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -77.35 54.59 4.75 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 123.029 2.486 . . . . 0.0 113.02 -179.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t 64.62 114.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.896 0.379 . . . . 0.0 111.24 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.569 ' HE ' ' H ' ' A' ' 31' ' ' LYS . 16.0 ptp180 -53.56 145.73 14.42 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.127 0.489 . . . . 0.0 111.705 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.99 -134.12 3.16 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -121.15 130.17 53.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.915 0.357 . . . . 0.0 110.19 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 73' ' ' LEU . 7.4 mm -96.46 119.56 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.1 t -77.13 -52.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.148 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -166.18 161.74 17.15 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.464 -178.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.5 tt -91.11 107.19 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.579 0.704 . . . . 0.0 109.78 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.505 HD22 HE22 ' A' ' 74' ' ' GLN . 54.8 tp -75.09 -32.2 61.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.857 -178.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.9 146.93 43.58 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.382 0.61 . . . . 0.0 112.123 -179.02 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.746 ' H ' ' NE2' ' A' ' 64' ' ' GLN . 95.8 mtt180 -122.06 161.32 23.24 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.927 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -56.5 142.29 39.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.678 -179.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.85 4.21 57.92 Favored Glycine 0 N--CA 1.473 1.127 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.237 178.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.746 ' NE2' ' H ' ' A' ' 61' ' ' ARG . 74.1 mt-30 -98.04 131.69 44.24 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.428 0.632 . . . . 0.0 111.668 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -122.49 122.75 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.758 179.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 t -148.95 138.87 12.97 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.834 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.21 142.92 44.35 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 121.473 1.449 . . . . 0.0 112.414 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.97 128.54 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.013 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 141.39 51.41 0.04 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.045 179.07 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -166.85 169.47 13.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 117.227 0.514 . . . . 0.0 111.323 179.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.585 ' O ' HG23 ' A' ' 71' ' ' THR . 15.2 t -103.7 120.42 40.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.868 179.727 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -88.89 -7.88 55.28 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.182 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.671 HD12 ' H ' ' A' ' 74' ' ' GLN . 5.8 tp -157.16 144.43 18.69 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.671 ' H ' HD12 ' A' ' 73' ' ' LEU . 28.4 mp0 -104.19 132.99 49.86 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.554 0.216 . . . . 0.0 111.039 -179.205 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 89.8 mt -131.72 130.03 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.43 . . . . 0.0 111.957 -179.426 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -100.88 113.82 27.11 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.078 178.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.411 ' H ' HG22 ' A' ' 77' ' ' THR . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.822 -1.085 . . . . 0.0 110.328 179.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 ttp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -89.36 132.88 34.75 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.543 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 52.9 mp0 -95.22 121.99 37.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.076 -179.043 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -91.46 113.01 25.16 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.169 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -115.47 146.27 41.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.599 -179.62 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 6' ' ' LEU . 4.9 tt -58.67 110.56 2.71 Favored Pre-proline 0 N--CA 1.469 0.516 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.448 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.486 ' N ' HD23 ' A' ' 6' ' ' LEU . 46.8 Cg_exo -54.87 141.27 77.86 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 120.21 1.111 . . . . 0.0 112.455 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -81.76 22.43 0.75 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.092 -179.877 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.1 mt -106.46 130.21 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.904 0.383 . . . . 0.0 110.415 -179.346 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.76 -175.76 34.24 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -67.27 -40.44 86.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.058 0.456 . . . . 0.0 110.065 179.651 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.05 158.28 19.96 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.669 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.8 t -151.93 85.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.328 179.867 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 m -65.1 -24.99 67.59 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.314 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -173.24 153.69 2.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.37 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.14 119.27 6.1 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -178.94 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -125.67 133.46 52.16 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.022 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.402 HG21 ' NE1' ' A' ' 21' ' ' TRP . 9.1 mm -103.15 122.23 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.634 -178.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.9 p -90.89 -44.8 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.536 179.595 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' N ' HG13 ' A' ' 19' ' ' VAL . 84.1 mtt85 -146.13 147.44 31.54 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.062 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.402 ' NE1' HG21 ' A' ' 18' ' ' ILE . 62.4 m95 -115.22 136.86 52.65 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 176.346 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 35' ' ' LEU . 7.8 p-10 -106.0 1.1 26.24 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.201 -0.312 . . . . 0.0 111.73 -179.443 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG11 ' OD2' ' A' ' 34' ' ' ASP . 32.0 m -136.62 159.63 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.681 0.277 . . . . 0.0 110.943 -179.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -136.91 153.02 50.85 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.076 0.465 . . . . 0.0 110.123 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -57.54 141.99 45.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.766 179.876 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.39 8.34 59.94 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.48 179.057 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 28' ' ' MET . 65.9 t0 -130.58 135.36 47.82 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.611 0.706 . . . . 0.0 110.847 -179.691 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.486 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 65.9 mtt -81.45 150.2 28.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.193 -179.43 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 p -143.46 147.64 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.001 0.429 . . . . 0.0 110.593 179.605 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -102.65 162.1 13.2 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.841 -178.453 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.07 137.85 50.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.497 -179.067 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 59.81 45.22 12.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.436 179.902 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.437 ' O ' ' CG ' ' A' ' 34' ' ' ASP . 59.3 tt0 -147.03 88.45 1.74 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.524 179.086 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.54 ' OD2' ' NH2' ' A' ' 52' ' ' ARG . 11.8 m-20 170.43 148.65 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.776 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.51 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 74.6 mt -121.03 102.14 8.14 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.646 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.74 131.32 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.216 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -117.46 127.41 53.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.031 -179.831 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 69.1 t -119.57 129.08 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.795 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.8 ttp -108.55 131.19 55.09 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.566 -179.864 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -114.5 -84.89 0.61 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.328 -179.838 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' H ' HG23 ' A' ' 40' ' ' THR . 42.8 p-10 -98.16 51.06 1.02 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.482 179.827 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 65.56 34.66 7.67 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.132 -178.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.4 t -127.54 135.84 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.9 m -98.13 117.97 33.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.581 -179.574 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.72 131.45 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.298 179.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -93.57 136.17 34.11 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.212 -179.57 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.1 mt -140.95 95.51 7.61 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.6 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.54 144.75 91.54 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 121.985 1.79 . . . . 0.0 111.35 179.321 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.579 ' CB ' ' NE ' ' A' ' 52' ' ' ARG . 8.0 t -64.81 113.06 9.48 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.546 -179.596 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.18 -24.64 44.08 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 120.932 1.088 . . . . 0.0 113.943 -178.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.0 125.07 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.579 ' NE ' ' CB ' ' A' ' 49' ' ' SER . 24.6 mmt180 -134.15 155.28 50.38 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.917 0.389 . . . . 0.0 110.873 -179.631 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.92 -84.71 0.06 OUTLIER Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.455 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -130.19 136.79 49.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.8 0.333 . . . . 0.0 110.565 179.379 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.401 ' CG2' HD11 ' A' ' 73' ' ' LEU . 9.4 mm -104.43 118.84 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.266 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.2 t -87.31 -52.36 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.318 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -160.83 154.36 22.07 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.752 -178.249 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 58' ' ' ILE . 2.4 tt -108.17 122.18 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.503 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.3 mt -97.54 -17.61 19.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.189 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -107.28 141.8 38.04 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.93 0.395 . . . . 0.0 110.747 -179.243 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.551 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 89.4 mtm-85 -122.65 162.19 22.4 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.512 179.926 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 56.2 mp0 -53.62 134.96 41.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.112 -179.067 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.62 6.27 83.4 Favored Glycine 0 N--CA 1.471 0.992 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.679 177.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.551 ' CD ' ' H ' ' A' ' 61' ' ' ARG . 80.4 mt-30 -85.86 134.15 33.92 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.109 0.954 . . . . 0.0 111.467 -179.472 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 65' ' ' VAL . 12.5 p -122.13 124.43 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.234 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 t -148.83 136.93 11.46 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.696 -179.53 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.97 152.47 58.13 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 C-N-CA 121.924 1.75 . . . . 0.0 112.243 178.289 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.8 t -53.87 133.21 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.691 179.648 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.86 51.81 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.804 179.229 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.7 m -153.99 169.08 24.35 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.354 -179.723 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -104.07 111.76 24.47 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.44 -45.3 55.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.541 -179.795 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.875 HD23 ' N ' ' A' ' 74' ' ' GLN . 2.8 tt -152.96 147.66 26.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.939 -177.772 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.875 ' N ' HD23 ' A' ' 73' ' ' LEU . 52.4 tt0 -103.21 133.42 48.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.115 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 56.8 mt -126.73 129.2 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.205 0.526 . . . . 0.0 111.891 -177.395 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -96.02 111.63 23.59 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.951 178.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.353 -179.664 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -85.73 126.24 33.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.665 -179.553 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 52.6 mp0 -92.86 134.4 35.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.736 -179.472 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -109.49 108.53 19.05 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.784 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -114.17 141.2 47.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.043 -179.64 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.544 HD23 ' C ' ' A' ' 6' ' ' LEU . 5.1 tt -69.26 112.12 10.8 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.413 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' N ' HD23 ' A' ' 6' ' ' LEU . 73.2 Cg_endo -71.45 156.27 58.57 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.8 1.667 . . . . 0.0 112.875 -178.251 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.407 ' OD1' HG11 ' A' ' 68' ' ' VAL . 81.2 m-20 -74.52 99.15 3.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.586 -179.566 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.08 -42.4 95.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.509 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.38 161.69 29.87 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.869 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' VAL . 58.0 mp0 -66.19 -31.13 71.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.723 0.296 . . . . 0.0 110.836 -179.39 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.5 26.91 0.36 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -179.836 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' GLU . 53.4 t -127.67 124.99 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.457 ' OG1' ' OE1' ' A' ' 15' ' ' GLU . 27.3 p -138.31 -1.18 1.94 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.119 -179.873 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 54.8 mp0 -140.54 144.01 35.7 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.826 0.346 . . . . 0.0 110.765 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.36 124.8 5.25 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' C ' ' OE1' ' A' ' 17' ' ' GLU . 10.1 tm-20 -128.02 137.8 52.34 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.128 0.464 . . . . 0.0 110.58 -179.309 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.2 mm -102.13 114.44 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.51 HG13 ' N ' ' A' ' 20' ' ' ARG . 9.4 p -85.17 -42.56 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.445 179.342 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.51 ' N ' HG13 ' A' ' 19' ' ' VAL . 82.2 mtp180 -140.88 147.05 38.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.82 0.343 . . . . 0.0 111.258 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -109.04 137.73 46.5 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.252 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.3 p-10 -72.77 -40.89 65.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.296 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.12 165.58 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.551 -178.193 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 99.4 mttt -119.27 149.69 41.36 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.933 -179.592 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 56' ' ' VAL . 85.7 tt0 -45.31 139.61 3.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.32 7.25 62.23 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.567 -0.574 . . . . 0.0 113.341 178.59 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 24' ' ' LYS . 40.4 p-10 -135.44 153.06 51.9 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.371 1.086 . . . . 0.0 111.226 179.759 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 96.0 mtp -78.52 155.19 29.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.777 -178.79 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.23 152.77 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.926 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -113.38 147.4 37.79 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.937 0.399 . . . . 0.0 110.83 -179.623 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.454 ' HB2' ' H ' ' A' ' 52' ' ' ARG . 50.3 tttp -85.06 84.45 7.7 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.108 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 34' ' ' ASP . 43.8 p30 -165.97 81.37 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.552 179.204 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 62.97 -66.47 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.048 179.493 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 32' ' ' ASP . 29.0 t0 62.78 -167.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.311 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.4 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 83.4 mt -126.54 75.75 1.57 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.183 0.516 . . . . 0.0 111.55 -179.768 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.06 128.14 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.51 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -124.73 128.68 49.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.114 -178.616 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.52 133.6 64.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.226 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.44 ' HG3' ' H ' ' A' ' 43' ' ' VAL . 65.3 ttp -119.1 113.41 20.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.381 -179.024 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.46 ' H ' HG23 ' A' ' 40' ' ' THR . 1.7 p -62.75 -52.05 64.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.108 0.48 . . . . 0.0 109.908 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' OG1' ' A' ' 40' ' ' THR . 36.8 t70 -146.87 -48.22 0.19 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.32 179.123 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -161.51 51.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.271 179.05 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 44' ' ' THR . 46.3 t -135.88 160.06 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.431 -179.792 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.502 ' N ' HG12 ' A' ' 43' ' ' VAL . 18.5 m -110.25 114.79 28.54 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.296 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.32 117.1 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.087 -179.354 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -97.76 136.42 38.12 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.646 178.959 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.5 mt -139.33 139.95 24.38 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 119.303 -0.38 . . . . 0.0 110.529 -178.744 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 49' ' ' SER . 52.8 Cg_exo -53.17 145.66 42.4 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.386 1.39 . . . . 0.0 111.725 178.195 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -47.34 179.19 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.858 -179.322 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 49' ' ' SER . 78.8 Cg_endo -87.86 49.67 1.74 Allowed 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.776 2.317 . . . . 0.0 113.855 -178.363 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.0 t 66.19 121.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 120.823 0.344 . . . . 0.0 111.599 178.759 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 42.2 ttm180 -50.23 136.38 19.79 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.524 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.62 -141.63 5.75 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.371 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -126.05 126.67 44.62 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.811 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.566 HG23 HD21 ' A' ' 73' ' ' LEU . 5.8 mm -91.74 119.23 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.676 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.4 ' O ' ' OE2' ' A' ' 25' ' ' GLU . 37.7 t -101.41 -41.52 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.222 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -145.16 154.89 42.91 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.557 -177.677 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 58' ' ' ILE . 12.5 tt -127.78 127.27 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.205 -179.824 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.8 tp -100.26 -21.18 15.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.211 -179.492 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.506 ' CD2' HD23 ' A' ' 72' ' ' LEU . 6.4 m-85 -106.08 141.93 36.64 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.225 0.536 . . . . 0.0 111.383 -178.951 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -122.18 165.74 15.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.143 179.371 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.0 mp0 -53.39 128.24 27.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.455 -179.463 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.72 5.95 85.98 Favored Glycine 0 N--CA 1.468 0.818 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.374 178.539 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -79.4 135.52 36.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.42 0.61 . . . . 0.0 110.71 -179.386 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.76 131.52 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.611 179.624 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -149.47 137.54 11.77 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.785 -178.78 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.92 137.48 52.38 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.077 1.185 . . . . 0.0 112.344 177.942 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.407 HG11 ' OD1' ' A' ' 8' ' ' ASP . 48.9 t -56.22 129.16 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.123 0.487 . . . . 0.0 110.721 179.774 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.68 49.3 0.08 OUTLIER Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.113 178.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.3 p -164.62 165.99 20.54 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 117.345 0.572 . . . . 0.0 110.858 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 71' ' ' THR . 14.9 t -98.98 122.15 41.87 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.057 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.8 ' N ' HD12 ' A' ' 72' ' ' LEU . 3.0 mp -90.57 -5.38 56.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -177.686 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.566 HD21 HG23 ' A' ' 55' ' ' ILE . 2.1 tt -162.34 142.43 9.83 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.101 -178.866 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.539 ' OE1' ' N ' ' A' ' 74' ' ' GLN . 2.3 mp0 -104.03 124.37 48.9 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.247 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 92.7 mt -122.89 127.48 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.47 0.652 . . . . 0.0 111.57 -177.7 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -98.12 111.36 23.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.219 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.77 -179.47 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -125.88 149.26 48.82 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.924 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.66 128.34 53.75 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.819 0.342 . . . . 0.0 110.384 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.831 ' CD2' HD23 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -87.08 126.13 34.57 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.058 -179.931 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -119.6 133.73 55.53 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.191 -179.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.0 123.3 79.58 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.821 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.08 148.39 44.63 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.598 1.532 . . . . 0.0 111.781 -179.41 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -67.79 123.5 20.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.399 -179.56 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 75.5 mt -119.77 133.51 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.9 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.99 -174.42 20.73 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.805 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -88.92 147.38 24.37 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -179.704 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.31 -112.15 4.34 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 t 59.73 106.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.501 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.2 p -124.42 11.88 8.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.539 -179.049 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.58 ' OE2' HG13 ' A' ' 65' ' ' VAL . 13.4 tm-20 -145.84 142.87 29.24 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.063 0.459 . . . . 0.0 111.377 179.951 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.47 ' N ' ' CD ' ' A' ' 15' ' ' GLU . . . -121.2 119.29 4.06 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.356 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -118.98 136.26 54.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 117.165 0.482 . . . . 0.0 110.658 -179.763 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.401 HG21 ' NE1' ' A' ' 21' ' ' TRP . 6.9 mm -101.35 119.97 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.125 -179.678 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 20' ' ' ARG . 10.0 p -89.9 -45.89 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.841 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.53 ' N ' HG13 ' A' ' 19' ' ' VAL . 99.7 mtt180 -143.41 148.46 36.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.192 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.401 ' NE1' HG21 ' A' ' 18' ' ' ILE . 36.3 m95 -118.25 144.54 45.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.432 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 35' ' ' LEU . 1.3 m-20 -124.48 12.94 8.75 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.136 0.426 . . . . 0.0 111.655 179.395 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.77 154.93 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.962 0.41 . . . . 0.0 110.764 179.605 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -121.9 153.68 38.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.096 -179.822 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -64.15 129.54 40.38 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.303 -179.955 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.04 5.66 63.88 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 27' ' ' ASP . 36.5 p-10 -101.86 151.93 21.5 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.066 0.433 . . . . 0.0 110.665 179.536 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.2 mmm -90.85 148.85 22.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.537 -179.791 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.66 141.07 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.174 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -109.57 159.97 16.64 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.818 0.342 . . . . 0.0 111.272 -178.714 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -59.73 136.4 57.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.184 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 58.92 29.64 19.15 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.209 -179.559 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.69 79.56 1.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.573 0.225 . . . . 0.0 110.42 179.332 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 35' ' ' LEU . 46.0 t0 -173.73 -178.56 1.61 Allowed 'General case' 0 C--O 1.232 0.159 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.534 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.487 ' H ' ' CG ' ' A' ' 34' ' ' ASP . 37.3 tp -153.95 97.84 2.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.922 0.391 . . . . 0.0 110.562 179.458 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.0 130.56 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.9 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 37' ' ' GLU . 56.4 mp0 -114.66 120.71 41.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.926 178.759 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.6 m -119.98 134.37 63.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.008 -179.805 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.9 ptm -130.13 129.41 43.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.344 -179.58 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -73.25 -43.07 61.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.325 179.922 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -154.78 -67.21 0.13 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.323 -179.648 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -132.67 37.15 3.49 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.228 179.523 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.1 t -133.82 136.01 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.901 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 m -116.26 120.61 39.48 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.516 -179.666 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.94 155.61 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.362 179.546 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -115.23 135.63 53.97 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.276 -179.782 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.1 mt -134.27 130.84 20.35 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.11 179.945 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.46 146.17 27.36 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.419 2.079 . . . . 0.0 112.626 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -60.59 110.91 3.32 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.806 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.29 -19.76 37.94 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.612 1.541 . . . . 0.0 114.951 -177.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.89 124.03 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 118.459 0.572 . . . . 0.0 111.606 -179.084 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -91.14 152.13 20.7 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.107 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.39 -133.34 2.39 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.214 179.49 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -125.05 143.33 50.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.688 0.28 . . . . 0.0 110.327 -179.371 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.4 mm -103.73 118.72 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.682 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.8 t -89.25 -55.36 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.097 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -143.52 153.5 42.65 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.289 0.566 . . . . 0.0 111.814 -178.364 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 58' ' ' ILE . 3.7 tt -101.57 114.38 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.148 178.884 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.75 -17.68 20.12 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.827 -179.648 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -109.3 142.21 40.5 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.083 0.468 . . . . 0.0 110.756 -179.225 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.416 ' H ' ' HG3' ' A' ' 64' ' ' GLN . 11.2 ptp85 -126.0 166.25 17.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.429 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.43 144.5 50.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.006 -179.391 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.03 5.8 87.27 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 179.259 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 61' ' ' ARG . 22.4 mm-40 -70.76 133.44 46.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.593 0.711 . . . . 0.0 111.355 -179.01 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.58 HG13 ' OE2' ' A' ' 15' ' ' GLU . 40.0 t -131.46 118.67 40.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 114.33 -1.304 . . . . 0.0 107.5 178.604 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.56 154.79 35.82 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.006 -178.472 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.12 140.33 41.06 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.739 2.293 . . . . 0.0 111.676 179.087 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.12 124.61 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.774 179.412 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.1 53.31 0.06 OUTLIER Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 179.448 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.0 t -162.51 168.27 22.16 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.961 0.38 . . . . 0.0 110.807 -179.889 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 71' ' ' THR . 14.8 t -105.45 128.41 53.52 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.039 HD22 ' H ' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -64.16 -41.81 97.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.182 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -161.27 177.28 10.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.757 -179.495 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -107.03 127.19 53.24 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.717 0.294 . . . . 0.0 110.889 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.47 125.29 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.25 0.548 . . . . 0.0 111.346 -179.323 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -90.27 140.49 29.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.8 178.913 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.449 179.792 . . . . . . . . 0 0 . 1 stop_ save_